Citrus Sinensis ID: 046311
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FIJ6 | 751 | Serine/threonine-protein | yes | no | 0.904 | 0.925 | 0.514 | 0.0 | |
| Q9LY50 | 814 | Putative serine/threonine | no | no | 0.936 | 0.883 | 0.371 | 1e-119 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.915 | 0.785 | 0.321 | 6e-93 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.904 | 0.771 | 0.318 | 2e-88 | |
| Q9S7D9 | 775 | Serine/threonine-protein | no | no | 0.791 | 0.784 | 0.301 | 8e-72 | |
| O80963 | 776 | Serine/threonine-protein | no | no | 0.752 | 0.744 | 0.300 | 8e-69 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.371 | 0.306 | 0.473 | 2e-67 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.503 | 0.451 | 0.360 | 1e-63 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.373 | 0.335 | 0.417 | 3e-63 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.373 | 0.310 | 0.427 | 4e-62 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/762 (51%), Positives = 506/762 (66%), Gaps = 67/762 (8%)
Query: 28 SLSTFSVSETGNQSLVCALIPSS--RPGDFSLNCSIPQLIPVN-PNASFASIVSGDGFLC 84
SLST S+S NQ+LVCAL S + F LN SIP + N N F+ +VSG+GF+C
Sbjct: 31 SLSTVSISHISNQTLVCALNNHSYLQCSSFPLN-SIPFSLTGNLRNRRFSGVVSGNGFVC 89
Query: 85 TLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQ 144
LI+ S++S + CWRFS DG +KRIY GP L++LEAGN ICG+ + L WQ
Sbjct: 90 GLISRLDSNTSTLLCWRFSVDGTNMLHKRIYHGPELEELEAGNFRICGVERVSRRLRCWQ 149
Query: 145 -----WPDFNSTSIHNFSNIAVGEDFVCGLLEN-GTITCFGSRNSPTSVTQKVPSGIFRV 198
PD N+ +IA+G++F CGL + G I+C G KVPSG +
Sbjct: 150 PYYLPRPD-------NYRSIALGDNFFCGLSQPPGMISCEG--------IAKVPSGDHYI 194
Query: 199 -VAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALR-NNQKVVCWGQNG 256
+AAG R CAI D ++ CWG + +P+ KF ALA+GE+R C +R +N VVCWG N
Sbjct: 195 AIAAGSRQACAITVDNDVECWGQT-QSLPREKFLALAVGEDRGCGVRWSNGTVVCWGNNN 253
Query: 257 -FTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSS------NHMVFERVLPG 309
F+LP +L+ F SI AK +FCGV T NY+L CWGNE+F S ++ + V+PG
Sbjct: 254 NFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICWGNENFKSGVFTPFQGLISQVVMPG 313
Query: 310 PCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVA 369
PC CP L GS ++CG +IC + + P ++ WS R +A
Sbjct: 314 PCRRECPYRPLSGSQSLCGNELMICD-------LKRNDGEFPDTRAQNSKNKTWSRRNIA 366
Query: 370 LLVVGCLGSLVVVLVSAFFGYK-HCKCKGCRVHDSGRLDEAEAQAQSAQPPMPPPPPSPP 428
LVVGC+G+ ++LV +F +K HC+C RVHDSGRLD+ P
Sbjct: 367 FLVVGCVGTFSLLLVISFLIFKSHCRC---RVHDSGRLDDTRT-------------IDIP 410
Query: 429 VLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAV 488
LEK+L LAS+GN G+L EFS++ L AT+ FS +G GSFG+VY+ L DG VA+
Sbjct: 411 KLEKRLCTLASLGNPGQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAI 470
Query: 489 KRAEISS-TSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEY 547
KRAE+++ T S R+ DKD+AF+NELES+SRL+HKNLVRLLGF ED ER+L+YEY
Sbjct: 471 KRAELTNPTLSGTTMRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEY 530
Query: 548 LENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607
++NG+L DHLHNPQ PL SW R+ +ALDAARGI+YLHE+ VP +IHRDIKSSN+LLD
Sbjct: 531 MKNGSLADHLHNPQFD-PL-SWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLD 588
Query: 608 ATWTAKVSDFGLSLIGP--EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVL 665
ATWTAKVSDFGLS +GP EDD SHLSL AAGT+GY+DPEYY+ QQLT KSDVYSFGVVL
Sbjct: 589 ATWTAKVSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVL 648
Query: 666 LEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLA 725
LE+LSG++AIH + PRN+V++VVPYI+ DE HR+LD+ +PPPTP+EIEAVA+VGYLA
Sbjct: 649 LELLSGHKAIHNNEDENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLA 708
Query: 726 ADCVTLEGRNRPSMTEIVNSLERALAACLVSP---SISRSAT 764
A+C+ R RPSM E+V+ LE ALAACL +P ++SRS T
Sbjct: 709 AECLMPCSRKRPSMVEVVSKLESALAACLTAPKTETVSRSNT 750
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LY50|ACCR3_ARATH Putative serine/threonine-protein kinase-like protein CCR3 OS=Arabidopsis thaliana GN=CCR3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 301/810 (37%), Positives = 428/810 (52%), Gaps = 91/810 (11%)
Query: 10 LLTTLLLLFFVSLVPFNSSLSTFSVSETGNQSLVCALI---PSSRPGDFSLNCSIPQLIP 66
+ T+ ++ F L P S S + + VCALI P+ R + +I +
Sbjct: 13 VTVTIAVIIFFLLSPVTSLGSGSTYAVVYGSDTVCALISGQPTQRILCYDTRLNIN--VT 70
Query: 67 VNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIIN---DYKRIYRGP--ALQ 121
+NP SF+SI +GD FLC + S + CW D I + + KRIY+ L+
Sbjct: 71 LNPGVSFSSIAAGDNFLCGI----RSGGYSLLCW----DNIGSYSPNRKRIYQNDNVLLE 122
Query: 122 QLEAGNSHICGLVNGTNDLHWWQWP--DFNSTSIHNFSNIAVGEDFVCGL-LENGTITCF 178
L G+ IC VNGTN L W+ D + F +I+ G F CG+ + N I C+
Sbjct: 123 TLSVGDKQICATVNGTNSLKCWRGSVSDQSKPPNERFRSISSGVGFSCGVSIRNNRILCW 182
Query: 179 GSRNSPTSVTQKVPSGI----FRVVAAGFRHVCAIDDDQELRCWGDS--------VGEVP 226
G+ P Q + +G ++AG H C ++ L C G++ + P
Sbjct: 183 GT--DPVKSNQ-IQTGFGNTPMVTISAGKSHACGLNTTGNLICIGNNDSGQLNVIAPDQP 239
Query: 227 QGKFKALALGENRSCALR-NNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSN 285
+L+LG N +CA+R +N VVCWG + F SI + + CG+++SN
Sbjct: 240 NLYSSSLSLGSNFTCAMRISNNSVVCWGGGAERFNNVTDSISFESISSGPGLICGLISSN 299
Query: 286 YSLYCWGNESFSSNHMVFERVLPGPCTNTCPCP-----MLPGSGNVCGEGQIICQPC--- 337
S+ CW +FS + F VLPGPC + + P S +C IC+ C
Sbjct: 300 LSIMCWNPTNFSRIFLPFPEVLPGPCVESSSSSLCSCGVYPQSDKLCSGTGSICKSCPIQ 359
Query: 338 -----------FEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSA 386
P P ++ +RG ++A +VG +G+ +
Sbjct: 360 FPASPPSQFPLPPPPPPPPPSPSTSSPPSKALTRG-----LLAFAIVGSVGAFAGICSVV 414
Query: 387 FFGYKHCKCKGCRVHDS-------GRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLAS 439
+ + +VH+S G + + S + + ++ S +S
Sbjct: 415 YCLWTGVCLGKKKVHNSVQPTITRGGSNSRSNSSNSRSLSIRRQGSRMLSMRRQRSGTSS 474
Query: 440 MGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSY 499
M +A + EEFS L AT NFS ++KIGSGSFG VY+ L+DG +VA+KR E+++
Sbjct: 475 MKHADKAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAK--- 531
Query: 500 AIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN 559
K+ ++K+ AF +E+ LSRLHHK+LVRL+G+CE+R E++L+Y+Y++NG L+DHLH+
Sbjct: 532 ---MKKFQEKETAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHD 588
Query: 560 P----QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615
+ SS + SW RIK+ALDAARGIEYLH YAVP IIHRDIKSSN+LLD+ W A+VS
Sbjct: 589 KNNVEKHSSLINSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVS 648
Query: 616 DFGLSLIGPEDDESH----LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
DFGLSL+GP + H +AAGTVGY+DPEYY L LT+KSDVY GVVLLE+L+G
Sbjct: 649 DFGLSLMGPVLGKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVLLELLTG 708
Query: 672 YRAIHRTHNG--------TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY 723
RAI R +NG P ++VD+ VP I DE+ +LD V P E +AV V Y
Sbjct: 709 KRAIFR-NNGDVEEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAVELVAY 767
Query: 724 LAADCVTLEGRNRPSMTEIVNSLERALAAC 753
A CV EGRNRP+MT+IV +LERAL C
Sbjct: 768 TAMHCVNAEGRNRPTMTDIVGNLERALDLC 797
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 265/825 (32%), Positives = 393/825 (47%), Gaps = 122/825 (14%)
Query: 17 LFFVSLVPFNS---------SLSTFSVSETGNQSLVCALIPSSRPGDFSLNCSIPQLIPV 67
+ V LV F S S+S+ ++S S+ C L + L
Sbjct: 12 ILLVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSDGSHLVVCYGSNSAILYGT 71
Query: 68 NPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGN 127
+ F + GDGF+C L+ S +CW SA + + + +G ++ AG+
Sbjct: 72 PGHLQFIGLTGGDGFMCGLLMLSHQP----YCWGNSAFIQMGVPQPMTKGAEYLEVSAGD 127
Query: 128 SHICGL------------VNGTNDLHWWQWPDFNSTSIHNFS----NIAVGEDFVCGLL- 170
H+CGL + ++ + W +N T F +++ G +F C L
Sbjct: 128 YHLCGLRKPIVGRRKNSNIISSSLVDCW---GYNMTRNFVFDKQLHSLSAGSEFNCALSS 184
Query: 171 ENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELR--CWGDSVG---EV 225
++ ++ C+G NS ++ F+ +AAG HVC I D E R CWG S+ EV
Sbjct: 185 KDKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWGKSLEFEEEV 244
Query: 226 -------------PQGKFKALALGENRSCAL-RNNQKVVCWGQNGFTLPDSLQGKPFVSI 271
P+ A+ G+ +C + R + VCWG + G F +
Sbjct: 245 TGTSTEEKILDLPPKEPLLAVVGGKFYACGIKRYDHSAVCWGFFVNRSTPAPTGIGFYDL 304
Query: 272 EAKRSVFCGVLT-SNYSLYCWGNESFSSNHMVFERVLPGPCTNTCPCPMLPGSGNVCGE- 329
A CGVLT ++ S CWG +S + V PG C +T PCP PG+ + +
Sbjct: 305 AAGNYFTCGVLTGTSMSPVCWGLGFPASIPLA---VSPGLCIDT-PCP--PGTHELSNQE 358
Query: 330 -------GQIICQPC-------FEKTSVTPSPTPQ------------------PQQPPES 357
G IC PC + SV + Q
Sbjct: 359 NSPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSSSATSG 418
Query: 358 GSRGG--WSGRM-VALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGRLDEAEAQAQ 414
G G WS ++ +A +G LV V+ Y + + CR ++ ++
Sbjct: 419 GKEKGKFWSLQLPIATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRSSKDSAFT 478
Query: 415 SAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGA 474
+ P L + R F+ E L +A + F E+ +G GSF
Sbjct: 479 KDNGKIRP-------------DLDELQKRRRARVFTYEELEKAADGFKEESIVGKGSFSC 525
Query: 475 VYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534
VYK L DG+ VAVKRA +SS ++ N F EL+ LSRL+H +L+ LLG+
Sbjct: 526 VYKGVLRDGTTVAVKRAIMSSD---------KQKNSNEFRTELDLLSRLNHAHLLSLLGY 576
Query: 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALDAARGIEYLHEYAVPS 593
CE+ ER+L+YE++ +G+LH+HLH + + W R+ +A+ AARGIEYLH YA P
Sbjct: 577 CEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPP 636
Query: 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT 653
+IHRDIKSSN+L+D A+V+DFGLSL+GP D S L+ AGT+GY+DPEYYRL LT
Sbjct: 637 VIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYRLHYLT 696
Query: 654 EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPF 713
KSDVYSFGV+LLEILSG +AI + N+V++ VP I +I+ +LD + P+
Sbjct: 697 TKSDVYSFGVLLLEILSGRKAIDMHYE--EGNIVEWAVPLIKAGDINALLDPVLKHPS-- 752
Query: 714 EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758
EIEA+ + +A CV + G++RPSM ++ +LERALA + +PS
Sbjct: 753 EIEALKRIVSVACKCVRMRGKDRPSMDKVTTALERALAQLMGNPS 797
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 264/828 (31%), Positives = 397/828 (47%), Gaps = 133/828 (16%)
Query: 19 FVSLVPFNS----SLSTFSVSETGNQSLVCALIPSSRPGDFSLNCSIPQLIPVNPNASFA 74
F++L+P + S+S+ +VS + + C L L PN F
Sbjct: 14 FLALLPGWACGLGSMSSIAVSYGEDGPVFCGLNSDGSHLVACFGADASVLYGAPPNIPFL 73
Query: 75 SIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGL- 133
+ +GDGF+C L+ + +CW ++ + + G +L AG++H+C L
Sbjct: 74 GLTAGDGFVCGLLL----DTRQPYCWGSNSYVKSGVPQPMVEGARYSELSAGDNHLCALR 129
Query: 134 ---------VNGTNDLHWWQWPDFNSTSIHNF----SNIAVGEDFVCGLL-ENGTITCFG 179
T+ + W +N T+ H S ++ G F CGL N T+ C+G
Sbjct: 130 AAQDGGRGSSAATSLIDCW---GYNMTATHAVDEAVSTVSAGSVFNCGLFARNRTVFCWG 186
Query: 180 SRNSPTSVTQKVPSGI-FRVVAAGFRHVCAIDDDQELRCWGDS----------------V 222
+ + V P + F+ + AG HVC + ++ ++ CWG S V
Sbjct: 187 D-ETVSGVVGLAPRDLHFQSIGAGGYHVCGVLENAQVFCWGRSLEMQQVVPSSAIGDGDV 245
Query: 223 GEVPQGKFKALALGENRSCALRN-NQKVVCWGQNGFTLPDSL---QGKPFVSIEAKRSVF 278
VP + G +C +R+ + +V CWG FTL +S +G ++ A
Sbjct: 246 NIVPMDAMSTVVGGRFHACGIRSLDHQVACWG---FTLHNSTSPPKGLKMYALVAGDYFT 302
Query: 279 CGVLTSNYSL-YCWGNES---------------FSSNHMVFERVLPG------------- 309
CGV + CWGN + +H +E V G
Sbjct: 303 CGVPAETSLMPRCWGNSGPLALPMAVPPGICVPTACSHGYYEYVNHGEVGSIKVCKPANS 362
Query: 310 ----PCTNTCP------CPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGS 359
PC+ CP P + VC Q C C ++ + Q+ +S
Sbjct: 363 RLCLPCSTGCPEGLYESSPCNATADRVC---QFDCLKCVTDECLSFCLS---QKRTKSRK 416
Query: 360 RGGWSGRM-VALLVVGCLGSLVVVLVSAFF---GYKHCKCKGCRVHDSGRLDEAEAQAQS 415
+ R+ VA +V + L V + + + +HC+C + L A++ A S
Sbjct: 417 LMAFQMRIFVAEIVFAVVLVLSVSVTTCLYVRHKLRHCQCS------NRELRLAKSTAYS 470
Query: 416 AQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAV 475
+ P L+ + R +EFS E L +AT FSED ++G GSF V
Sbjct: 471 FRKDNMKIQPDMEDLKIR-----------RAQEFSYEELEQATGGFSEDSQVGKGSFSCV 519
Query: 476 YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535
+K L DG+ VAVKRA I + F NEL+ LSRL+H +L+ LLG+C
Sbjct: 520 FKGILRDGTVVAVKRA---------IKASDVKKSSKEFHNELDLLSRLNHAHLLNLLGYC 570
Query: 536 EDRNERVLIYEYLENGTLHDHLH--NPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPS 593
ED +ER+L+YE++ +G+L+ HLH +P L +W R+ +A+ AARGIEYLH YA P
Sbjct: 571 EDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRL-NWARRVTIAVQAARGIEYLHGYACPP 629
Query: 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT 653
+IHRDIKSSN+L+D A+V+DFGLS++GP D + LS AGT+GY+DPEYYRL LT
Sbjct: 630 VIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLSELPAGTLGYLDPEYYRLHYLT 689
Query: 654 EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPF 713
KSDVYSFGVVLLEILSG +AI N+V++ VP I +I +LD + PP+
Sbjct: 690 TKSDVYSFGVVLLEILSGRKAIDMQFE--EGNIVEWAVPLIKAGDIFAILDPVLSPPS-- 745
Query: 714 EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISR 761
++EA+ + +A CV + G++RPSM ++ +LE ALA + SP I +
Sbjct: 746 DLEALKKIASVACKCVRMRGKDRPSMDKVTTALEHALALLMGSPCIEQ 793
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 231/766 (30%), Positives = 346/766 (45%), Gaps = 158/766 (20%)
Query: 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRI---YRGPALQQLEAGNS 128
S A + GDGFLC ++ S++S C FS+ G + + YR A Q+ AGNS
Sbjct: 85 SMAVLSGGDGFLCGIL----SNTSQAFC--FSSLGSSSGMDLVPLAYRTTAYSQIAAGNS 138
Query: 129 HICGL--------------------VNGTNDLHWWQWPDFNSTSIHN--FSNIAVGEDFV 166
H+C + N L + P+F + N F+NI G+ F
Sbjct: 139 HVCAVRGAYYSDHDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDGFS 198
Query: 167 CGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDD-DQELRCWGDSVGEV 225
CG + +G + CFG +S ++ S F+V+AAG VCAI + +E++CWG+ V
Sbjct: 199 CGGIRDGGMLCFGPNSS--NLGFNTTSDNFQVLAAGKNSVCAILNLSREVKCWGEDESFV 256
Query: 226 P----QGKFKALALGENRSCALR-NNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCG 280
+F +L G C +R +N +V CWG + F+L +G F +I + + CG
Sbjct: 257 NSPMNDSRFVSLTAGPRHFCGIREDNHEVECWGNSNFSLIP--KGSGFKAIASSDFIVCG 314
Query: 281 VLTSNYSLYCW---------------------------GNESFSSNHMVF---------- 303
+ + L CW + F+ N +
Sbjct: 315 IREEDLVLDCWMVNGSSTLAYDPPLELCSPGMCRAGPCNEKEFAFNASILNEPDLTSLCV 374
Query: 304 --ERVLPGPCTNTCPCPMLPGSGNVCGEGQIICQPC--FEKTSVTPSPTPQPQQPPESGS 359
E ++ PC + C S +I C PC + +S + P+
Sbjct: 375 RKELMVCSPCGSDCSHGFFLSSSCTANSDRI-CTPCSLCQNSSCSDICKLHNSNFPDKH- 432
Query: 360 RGGWSGRMVALLVVG-CLGSLVVVLVSAFFGYKHCKCKGCRVHDS-GRLDEAEAQAQS-- 415
W +L++G C +L+++++ C R+ S + D A Q +S
Sbjct: 433 ---WHQLQRLVLIIGSCASALLIIIIGC--------CVVPRIVTSPNKEDGAANQFKSCI 481
Query: 416 ------AQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGS 469
P+ P+P V +Q+ F L L +ATN F E +++G
Sbjct: 482 GKPDLDTDQPLENVSPAPSV--TPFAQV-----------FRLSELKDATNGFKEFNELGR 528
Query: 470 GSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529
GS+G VYKA L DG QVAVKRA ++ I T +E F ELE L + H N+V
Sbjct: 529 GSYGFVYKAVLADGRQVAVKRANAATI----IHTNTRE-----FETELEILCNIRHCNIV 579
Query: 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY 589
LLG+ + ER+L+YEY+ +GTLHDHLH+ SPL SW RIK+A+ A+G+EYLH
Sbjct: 580 NLLGYSTEMGERLLVYEYMPHGTLHDHLHS--GFSPL-SWSLRIKIAMQTAKGLEYLHNE 636
Query: 590 AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL 649
A P IIH D+KSSNVLLD+ W A+V+DFGL E
Sbjct: 637 AEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNE------------------------ 672
Query: 650 QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPP 709
+ L K DVY FGVVLLEIL+G + R + P +V++ VP I + ++D +
Sbjct: 673 KNLDIKRDVYDFGVVLLEILTGRKRYDR--DCDPPEIVEWTVPVIREGKAAAIVDTYIAL 730
Query: 710 PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755
P +E + + +A CV + +P+M+E+ N LE L+
Sbjct: 731 PR--NVEPLLKLADVAELCVREDPNQQPTMSELANWLEHVARDALI 774
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80963|ACCR2_ARATH Serine/threonine-protein kinase-like protein CCR2 OS=Arabidopsis thaliana GN=CCR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 218/725 (30%), Positives = 331/725 (45%), Gaps = 147/725 (20%)
Query: 73 FASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHIC- 131
S+ G+GFLC + S++S CW D N R ++ + Q+ +GN+H+C
Sbjct: 76 MTSLSGGEGFLCAI----TSNTSRAFCWNLE-DPSENLVPRAFQYNSYLQIASGNNHVCA 130
Query: 132 --GLVNGTND---LHWWQWPD---FNS-----TSIHN-------FSNIAVGEDFVCGLLE 171
GL D +H W++ D F S +S HN F I G+ F CG+ +
Sbjct: 131 ISGLYYSGPDYGPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGVTK 190
Query: 172 NGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQ-ELRCWGDSV--GEVP-Q 227
+G + C+G +++ + + F V+A+G VC + D +L C+GD G +P +
Sbjct: 191 DGDLVCWGPKSNLLNFSNNEE---FEVLASGRNSVCGVSKDSGQLHCFGDETEFGSLPNR 247
Query: 228 GKFKALALGENRSCALR-NNQKVVCWGQN--GFTLPDSLQGKPFVSIEAKRSVFCGVLTS 284
+F AL+ G N C +R ++ V CWG+N + + FV+I + S CGV
Sbjct: 248 PRFIALSAGANHYCGIREDDHGVECWGRNLNSSSSSSAPNTSGFVAISSSDSTTCGVREL 307
Query: 285 NYSLYCW--GNESFSSNHMVFERVLPGPCTNTCPC---------PMLPGS---------- 323
+ L CW + S + E PG C+ C +L S
Sbjct: 308 DLVLDCWRVHDSSKADYSPPLELCSPGMCSPRGNCGDGWFAFNASILKESELTSLCSFHN 367
Query: 324 -------GNVCGEGQI-----------ICQPC--------FEKTSVTPSPTPQPQQPPES 357
G C EG +C PC + + + + + +Q +
Sbjct: 368 LNICLRCGISCLEGYFPSSTCNPNADRVCTPCSLCQNSSCYGICKIRATKSKEHEQKEQR 427
Query: 358 GSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGR--------LDEA 409
R R+V ++ LG LV+++ +F KG + D R D+
Sbjct: 428 EVR-----RLVIIIGCSVLGFLVMLIGLSFIPKMT---KGSKRDDEERSKMTCCFCFDKN 479
Query: 410 EAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGS 469
+A P P P VL L + + G + F L L +AT+ F E +++G
Sbjct: 480 SVEAD------PDPVPHQSVL------LPTAVSLGETKIFRLSELKDATHGFKEFNELGR 527
Query: 470 GSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529
GSFG VYKA L DG VAVKRA ++ + F +ELE L ++ H N+V
Sbjct: 528 GSFGFVYKAVLSDGIHVAVKRANAATI---------IHSNNRGFESELEILCKIRHNNIV 578
Query: 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY 589
LLG+C + ER+L+YEY+ +GTLHDHLH S W R+K+ L AARG++YLH
Sbjct: 579 NLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQ---LDWSMRLKIMLQAARGLDYLHNE 635
Query: 590 AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL 649
P IIHRD+K+SN+LLD A+++DFG L+ + +S S R
Sbjct: 636 VDPPIIHRDVKTSNILLDGEMCARIADFG--LVSSNERDSSNSDR--------------- 678
Query: 650 QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPP 709
+ DVY FG+VLLEILSG +AI R + P + ++ VP I + + ++DRN+
Sbjct: 679 -----EGDVYDFGIVLLEILSGRKAIDRESD--PAGIAEWAVPLIRKGKAAAIIDRNICL 731
Query: 710 PTPFE 714
P E
Sbjct: 732 PRNVE 736
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 143/302 (47%), Positives = 197/302 (65%), Gaps = 17/302 (5%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
SL +L EAT+NFS+ K+G GSFG+VY + DG +VAVK I++ S + RQ
Sbjct: 596 ISLPVLEEATDNFSK--KVGRGSFGSVYYGRMKDGKEVAVK---ITADPSSHLN--RQ-- 646
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
F+ E+ LSR+HH+NLV L+G+CE+ + R+L+YEY+ NG+L DHLH PL
Sbjct: 647 ----FVTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPL-D 701
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
W R+++A DAA+G+EYLH PSIIHRD+KSSN+LLD AKVSDFGLS E+D
Sbjct: 702 WLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSR-QTEEDL 760
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
+H+S A GTVGY+DPEYY QQLTEKSDVYSFGVVL E+LSG + + G N+V
Sbjct: 761 THVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVH 820
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ I + ++ ++D + + +IE+V V +A CV G NRP M E++ +++
Sbjct: 821 WARSLIRKGDVCGIIDPCI--ASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQD 878
Query: 749 AL 750
A+
Sbjct: 879 AI 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 150/416 (36%), Positives = 223/416 (53%), Gaps = 29/416 (6%)
Query: 340 KTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSA--FFGY-KHCKCK 396
K P+P P P Q E + + + V+G G + VL A F Y + K
Sbjct: 404 KNLAGPNPKPSPMQANEDVKKDFQGDKRITAFVIGSAGGVAAVLFCALCFTMYQRKRKFS 463
Query: 397 GCRVHDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGN--AGRLEEFSLEIL 454
G H S L SA + + K + + + N AG FSL +
Sbjct: 464 GSDSHTSSWLPIYGNSHTSA---------TKSTISGKSNNGSHLSNLAAGLCRRFSLSEI 514
Query: 455 LEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
T+NF E + IG G FG VYK +D G++VA+K++ +S E N F
Sbjct: 515 KHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNS-----------EQGLNEFE 563
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E+E LSRL HK+LV L+G+C++ E LIY+Y+ GTL +HL+N + P +W R++
Sbjct: 564 TEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYN--TKRPQLTWKRRLE 621
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
+A+ AARG+ YLH A +IIHRD+K++N+LLD W AKVSDFGLS GP + H++
Sbjct: 622 IAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTV 681
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
G+ GY+DPEY+R QQLTEKSDVYSFGVVL E+L A++ + + ++ D+ +
Sbjct: 682 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCK 741
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
+ + ++D N+ E + A C++ G +RP+M +++ +LE AL
Sbjct: 742 RKGTLEDIIDPNL--KGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFAL 795
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 126/302 (41%), Positives = 187/302 (61%), Gaps = 15/302 (4%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
F + +++ATN F E +G G FG VYK TL+DG++VAVKR G R E
Sbjct: 498 FMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKR-----------GNPRSEQ 546
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
F E+E LS+L H++LV L+G+C++R+E +L+YEY+ NG L HL+ + P S
Sbjct: 547 GMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG--ADLPPLS 604
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
W R+++ + AARG+ YLH A SIIHRD+K++N+LLD AKV+DFGLS GP D+
Sbjct: 605 WKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQ 664
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
+H+S G+ GY+DPEY+R QQLTEKSDVYSFGVVL+E+L A++ N+ +
Sbjct: 665 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAE 724
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ + + + + +++D N+ ++ G A C+ G +RPSM +++ +LE
Sbjct: 725 WAMAWQKKGLLDQIMDSNLTGKV--NPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEY 782
Query: 749 AL 750
AL
Sbjct: 783 AL 784
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 129/302 (42%), Positives = 187/302 (61%), Gaps = 15/302 (4%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
F+LE + +AT + IG G FG+VY+ TLDDG +VAVK +ST GT+
Sbjct: 586 FTLEYIEQATEQYKT--LIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQ----GTRE--- 636
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
F NEL LS + H+NLV LLG+C + ++++L+Y ++ NG+L D L+ S +
Sbjct: 637 ----FDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILD 692
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
WP R+ +AL AARG+ YLH + S+IHRD+KSSN+LLD + AKV+DFG S P++ +
Sbjct: 693 WPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGD 752
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
S++SL GT GY+DPEYY+ QQL+EKSDV+SFGVVLLEI+SG ++ ++V+
Sbjct: 753 SYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVE 812
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ PYI ++ ++D + + EA+ V +A C+ RP M +IV LE
Sbjct: 813 WAKPYIRASKVDEIVDPGI--KGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELED 870
Query: 749 AL 750
AL
Sbjct: 871 AL 872
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | ||||||
| 224146317 | 765 | predicted protein [Populus trichocarpa] | 0.966 | 0.969 | 0.638 | 0.0 | |
| 10998537 | 794 | cytokinin-regulated kinase 1 [Nicotiana | 0.993 | 0.960 | 0.619 | 0.0 | |
| 359493414 | 773 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.932 | 0.631 | 0.0 | |
| 449441548 | 752 | PREDICTED: serine/threonine-protein kina | 0.950 | 0.970 | 0.605 | 0.0 | |
| 449529048 | 767 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.966 | 0.967 | 0.601 | 0.0 | |
| 351727198 | 769 | cytokinin-regulated kinase precursor [Gl | 0.958 | 0.957 | 0.585 | 0.0 | |
| 147832989 | 764 | hypothetical protein VITISV_029649 [Viti | 0.895 | 0.900 | 0.622 | 0.0 | |
| 357470699 | 746 | Serine/threonine protein kinase-like pro | 0.910 | 0.936 | 0.551 | 0.0 | |
| 297795371 | 753 | hypothetical protein ARALYDRAFT_331197 [ | 0.915 | 0.933 | 0.522 | 0.0 | |
| 15238823 | 751 | serine/threonine-protein kinase-like pro | 0.904 | 0.925 | 0.514 | 0.0 |
| >gi|224146317|ref|XP_002325962.1| predicted protein [Populus trichocarpa] gi|222862837|gb|EEF00344.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2496), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/778 (63%), Positives = 584/778 (75%), Gaps = 36/778 (4%)
Query: 6 NNPFLLTTLLLLFFVSLVPFNSSLSTFSVSETGNQSLVCALIPSSRPGDFSLNC-SIPQ- 63
N P L + F S +PF LST S+SET NQ+LVCAL+ LNC S P
Sbjct: 7 NQPLLHLFFYFILFSSFIPFVFPLSTVSISETSNQTLVCALVHVPGATQSVLNCLSFPSG 66
Query: 64 -LIPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQ 122
IP N N SF++IVSGDGFLC LI+ S ++S+++ CWRFS +G YKRIY+ AL Q
Sbjct: 67 IQIPFNSNTSFSAIVSGDGFLCGLISLSPATSTLV-CWRFSVNGTNMYYKRIYQDLALSQ 125
Query: 123 LEAGNSHICGLVNGTNDLHWWQWPDFNSTSI-HNFSNIAVGEDFVCGLLENGTITCFGSR 181
LEAGNS CGLVN TN L W F ++S+ NFS++AVGEDFVCGLLE+G ITC GS
Sbjct: 126 LEAGNSVTCGLVNDTNRLECWPRRKFKTSSVGQNFSSMAVGEDFVCGLLESGNITCLGSN 185
Query: 182 NSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVP-QGKFKALALGENRS 240
N+ V ++ P G + +AAG H CAI + EL CWG GE P QG F ++ALGENR
Sbjct: 186 NA---VVRQQPKGNYSTIAAGSTHACAIKFNGELDCWGSMAGEKPPQGGFISMALGENRG 242
Query: 241 CALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNH 300
CALR N+ VVCWGQ F+LP+ L+ F +IEAKR VFCGVL SN+SLYCWGNE+F+ N
Sbjct: 243 CALRTNETVVCWGQGNFSLPERLRETYFSTIEAKRKVFCGVLKSNFSLYCWGNENFNPNS 302
Query: 301 MVFERVLPGPCTNTCPCP-MLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQ--------- 350
+VF+ VLPGPC ++C ++ GSG +C EGQ IC K+++ S P
Sbjct: 303 IVFKDVLPGPCRSSCGLDRIIEGSGRLCPEGQQICS--HSKSNIHNSVPPAVAPPPPPTL 360
Query: 351 PQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGRLDEAE 410
SR WSG+M+A LVVGC+GSL+++LV FF +K+CKC+GCRVHDSGRLD
Sbjct: 361 ENNQERCCSRCKWSGKMIAFLVVGCVGSLILLLVVGFFLFKYCKCRGCRVHDSGRLDGT- 419
Query: 411 AQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSG 470
P +P EK+LSQLASMGNAG LEEFSL+++LEATNNFS D IG+G
Sbjct: 420 ------------GPGAPVEQEKRLSQLASMGNAGHLEEFSLQVILEATNNFSHDKTIGTG 467
Query: 471 SFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR 530
SFG+VY+ATL+DG +VA+KRAEIS+TSSYA+GT+RQEDKD+AFINELESLSRLHHKNLVR
Sbjct: 468 SFGSVYQATLEDGREVAIKRAEISNTSSYAVGTRRQEDKDSAFINELESLSRLHHKNLVR 527
Query: 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA 590
LLGFCED NERVL+YEY+ NGTLHDHLH +SPL SW ARIKVALDAARG+EYLH YA
Sbjct: 528 LLGFCEDSNERVLVYEYVHNGTLHDHLHK-LDNSPLMSWAARIKVALDAARGVEYLHRYA 586
Query: 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ 650
VP IIHRDIKSSN+LLD+TWTAKVSDFGLSL+GPEDD SHLSL AAGTVGY+DPEYYRLQ
Sbjct: 587 VPPIIHRDIKSSNILLDSTWTAKVSDFGLSLMGPEDDMSHLSLSAAGTVGYIDPEYYRLQ 646
Query: 651 QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP 710
QLT KSDVYSFGVVLLEILSG +AIH+ NG PRNVVDFVVPYIV+DEIHRVLD VPPP
Sbjct: 647 QLTTKSDVYSFGVVLLEILSGLKAIHKNENGVPRNVVDFVVPYIVQDEIHRVLDARVPPP 706
Query: 711 TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP-SISRSATSSS 767
TPFEIEAV Y+GYLAADCVTLEGR+RPSM +VNSLE+ALAACLV P S+SRS T S
Sbjct: 707 TPFEIEAVIYIGYLAADCVTLEGRDRPSMAGVVNSLEKALAACLVHPTSLSRSTTGGS 764
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10998537|gb|AAG25966.1|AF302082_1 cytokinin-regulated kinase 1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/798 (61%), Positives = 602/798 (75%), Gaps = 35/798 (4%)
Query: 1 MANKPNNPFLLTTLLLLFFVSLVPFNSSLSTFSVSETGNQSLVCALIPSSRPGDFS-LNC 59
MA L +L+LL F+ + SSLST ++S+T NQ+L+CALI SS S LNC
Sbjct: 1 MAILDKKTHLFFSLVLLCFLISLSPISSLSTVAISKTSNQTLICALISSSSFPQQSSLNC 60
Query: 60 -SIPQ--LIPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYR 116
S P+ IP+NP+ F+ IV G+GFLC L + +SS+S+M CWRF +G YK IY
Sbjct: 61 TSFPEGIQIPLNPSVYFSGIVGGNGFLCGLTSSYSSSTSIMVCWRFLNNGTNLSYKSIYL 120
Query: 117 GPALQQLEAGNSHICGLVNGTND-LHWWQWPDFNSTSIHNF-SNIAVGEDFVCGLLENGT 174
GP + L++GNSHICG+VNGTN+ L WQW +FNS++ SN+AVGEDFVCGLL G
Sbjct: 121 GPLITNLDSGNSHICGIVNGTNNRLECWQWHEFNSSNRSLMTSNLAVGEDFVCGLLTFGQ 180
Query: 175 ITCFGS-RNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKAL 233
I C GS RN VT +PSG + +A+G +HVCAI + L CWG+ VGE P G+FK+L
Sbjct: 181 IQCLGSFRN----VTDAIPSGNYSEIASGSQHVCAISKNNSLVCWGNMVGEKPIGQFKSL 236
Query: 234 ALGENRSCALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGN 293
ALG+NRSCALR N KVVCWG+ GF+LP SL G+ F ++EAK+ +FCG++TSNYSL+CWGN
Sbjct: 237 ALGDNRSCALRINGKVVCWGETGFSLPSSLSGEFFETLEAKQDIFCGIVTSNYSLFCWGN 296
Query: 294 ESFSSNHMVFERV--LPGPCTNTCPCPMLPGSGNVCGEGQIICQPCF-EKTSVTP----- 345
+ F+SN VF V +PGPCT +CPC LP + CG G +ICQ C + +SV P
Sbjct: 297 DIFNSNPAVFNGVGVVPGPCTTSCPCVPLPNYESFCGRGLMICQHCVGQDSSVNPPIVNG 356
Query: 346 ----------SPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHCKC 395
P P P SG WS R VA LVVGC+GSL+++ V +K+CK
Sbjct: 357 SGPSLPPLPPQPMPSPTPSQTSGRSDPWSRRNVAFLVVGCVGSLMMLSVLVILFFKYCKI 416
Query: 396 KGCRVHDSGRLDEA----EAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSL 451
+GCRVHDSGRLDEA + +Q+++ P PPVLEK+LSQL S+GN G L+EFSL
Sbjct: 417 RGCRVHDSGRLDEAGSPPQQGSQTSRVQDQQGTPQPPVLEKRLSQLISIGNGGHLDEFSL 476
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK-RQEDKD 510
++LL+ TNNFS++HKIGSGSFGAVY ATL+DG +VA+KRAE S++SSYA GTK RQEDKD
Sbjct: 477 QVLLQVTNNFSDEHKIGSGSFGAVYHATLEDGREVAIKRAEASASSSYAGGTKYRQEDKD 536
Query: 511 NAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP 570
NAF+NELE LSRL+HKNLV+LLG+CED NERVLI+EY+ NGTLHDHLH +SS PL SW
Sbjct: 537 NAFLNELEFLSRLNHKNLVKLLGYCEDNNERVLIFEYMNNGTLHDHLHGLESS-PLMSWV 595
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
RIKVALDAARGIEYLHEYAVP++IHRDIKSSN+LLD TW AKVSDFGLSL+GP+DDE+H
Sbjct: 596 GRIKVALDAARGIEYLHEYAVPTVIHRDIKSSNILLDVTWNAKVSDFGLSLMGPQDDETH 655
Query: 631 LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690
LS+RAAGTVGYMDPEYYRLQQLT KSDVYSFGV+LLE+LSGY+AIH+ N PRNVVDFV
Sbjct: 656 LSMRAAGTVGYMDPEYYRLQQLTTKSDVYSFGVMLLELLSGYKAIHKNENKVPRNVVDFV 715
Query: 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
VPYIV+DEIHRVLDR VPPPTPFEIE+VAYVGYLAADC TLEGR+RP+MT++VN+LERAL
Sbjct: 716 VPYIVQDEIHRVLDRRVPPPTPFEIESVAYVGYLAADCTTLEGRDRPTMTQVVNTLERAL 775
Query: 751 AACLVSPSISRSATSSSA 768
ACL +P SRS T S+
Sbjct: 776 KACLATPIFSRSNTDDSS 793
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493414|ref|XP_002280064.2| PREDICTED: serine/threonine-protein kinase-like protein CCR4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 916 bits (2367), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/746 (63%), Positives = 583/746 (78%), Gaps = 25/746 (3%)
Query: 24 PFNSSLSTFSVSETGNQSLVCALIPSSRPGDFSLNC-SIPQLIPV-NPNASFASIVSGDG 81
PF SSLS+ S+SET NQ+L+CAL+ SSR LNC S P I + + N SF+ IV+GDG
Sbjct: 20 PFISSLSSVSISETSNQTLICALLESSR-----LNCTSFPTGIQIPSVNRSFSGIVAGDG 74
Query: 82 FLCTLITFSASSSSVMHCWRFSADGIINDYKRIY-RGPALQQLEAGNSHICGLVNGTNDL 140
F C L S S+++M C+RFSA+G KR+Y AL ++ AGN+H+CGLVNGTN L
Sbjct: 75 FQCVL---SFPSATIMLCYRFSANGTNMHSKRLYYNDSALTEVAAGNTHVCGLVNGTNIL 131
Query: 141 HWWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTS-VTQKVPSGIFRVV 199
H WQW FN++ +FS IAVGE FVCGL +G ITC G+ +S +S + +VPSG F+ V
Sbjct: 132 HCWQWRGFNTSVQSDFSGIAVGEGFVCGLSSSGRITCIGTNSSSSSTIRDRVPSGSFQKV 191
Query: 200 AAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGFTL 259
AAGFRH CAI +Q L CWG++VGE PQG+F +LALGENRSCA+R N VVCWG+NGF+L
Sbjct: 192 AAGFRHACAIYRNQSLVCWGETVGEEPQGEFVSLALGENRSCAMRGNGTVVCWGENGFSL 251
Query: 260 PDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMVFERVLPGPCTNT-CPCP 318
P+SL+ F++IEAKRSVFCGV N+SL CWGNE F SN MVF +VLPG CT++ CP
Sbjct: 252 PESLRETVFMTIEAKRSVFCGVDQYNFSLLCWGNEIFDSNSMVFPKVLPGSCTSSECPNG 311
Query: 319 MLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGS 378
++PGSG++CG G I C ++ ++ P+ P PPE +R GW+ +MVA LVVGC+GS
Sbjct: 312 VVPGSGSMCGRGHI-CNA-YQNRTLVEGPSQPPSPPPEVRNRSGWNDKMVAFLVVGCVGS 369
Query: 379 LVVVLVSAFFGYKHCKCKGC-RVHDSGRLDEAEAQAQS--AQPPMPPPPPSPPVLEKKLS 435
+ V FF +++CK +GC +VHDSGRLDEA + +Q + PVLEK+LS
Sbjct: 370 ASFLAVICFFLFRYCKGRGCSKVHDSGRLDEAGMPPEHGLSQRQTVQAQRAAPVLEKRLS 429
Query: 436 QLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISS 495
QL S+GN GRLEEFSL+ L +ATN+FS++H+IG+GSFG VY+ATL+DG +VA+KRAE+S+
Sbjct: 430 QLVSLGNGGRLEEFSLQELRQATNDFSQEHRIGTGSFGCVYRATLEDGKEVAIKRAEVST 489
Query: 496 TSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE------RVLIYEYLE 549
TSS A+GT+RQEDKD AF++EL+SLSRL+H+NLVRLLG+CED NE R+L+YEY+
Sbjct: 490 TSSNAVGTRRQEDKDTAFVSELDSLSRLNHRNLVRLLGYCEDYNEKIPAYERILVYEYMN 549
Query: 550 NGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609
NGTLHDHLH SS PL SW R++VALDAARGIEYLH YAVP IIHRDIKSSN+LLDA+
Sbjct: 550 NGTLHDHLHKLHSS-PLMSWTNRLRVALDAARGIEYLHMYAVPQIIHRDIKSSNILLDAS 608
Query: 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
TAKVSDFGLSL+GPED++SHLSL AAGTVGYMDPEYYRLQQLT KSDVYSFGV+LLE+L
Sbjct: 609 LTAKVSDFGLSLMGPEDEDSHLSLHAAGTVGYMDPEYYRLQQLTPKSDVYSFGVLLLELL 668
Query: 670 SGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCV 729
SG++AIH+ NG PRNVVD VVPYIV+DEIHRVLD NVPPPTP+EIEAV Y+GY+AADCV
Sbjct: 669 SGHKAIHKNENGVPRNVVDLVVPYIVQDEIHRVLDPNVPPPTPYEIEAVTYIGYIAADCV 728
Query: 730 TLEGRNRPSMTEIVNSLERALAACLV 755
TLEGR+RPSMT+IV+SLERALAAC
Sbjct: 729 TLEGRDRPSMTDIVHSLERALAACFT 754
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441548|ref|XP_004138544.1| PREDICTED: serine/threonine-protein kinase-like protein CCR4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/763 (60%), Positives = 549/763 (71%), Gaps = 33/763 (4%)
Query: 18 FFVSLVPF----NSSLSTFSVSETGNQSLVCALIPSSRPGDFSLNCS-IPQ--LIPVNPN 70
F + PF SSL T S+SET NQ+L+C+L FSLNCS P IP NPN
Sbjct: 9 FIFQIFPFLFLSVSSLQTLSISETANQTLICSL-----NARFSLNCSSFPSGIQIPFNPN 63
Query: 71 ASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHI 130
S++ IV+GDGF C L F +S+S++ CWRFS +G + KR+Y GP L++L AGNSHI
Sbjct: 64 DSYSGIVAGDGFFCGLRNFPTTSNSIVVCWRFSVNGTNMETKRVYDGPNLKELRAGNSHI 123
Query: 131 CGLVNGTNDLHWWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQK 190
CG+VN TN L WQW F+ +FS+IAVG DF+CGL G I C G+ NS +V
Sbjct: 124 CGVVNATNQLECWQWRRFDRNFTFDFSSIAVGSDFICGLSNPGVIRCEGTGNSTVAVDG- 182
Query: 191 VPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVV 250
G + V AGFRHVCAI+ EL CWG VGE P G+FK LALG++RSC LR N V
Sbjct: 183 --GGRYTAVTAGFRHVCAINLRNELECWGMGVGERPAGEFKMLALGDDRSCGLRLNGTAV 240
Query: 251 CWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHM-VFERVLPG 309
CWG+ FTLP+ L+G+ F IEAK++VFCG L N+SL CWGNE N + +F+ V PG
Sbjct: 241 CWGEKNFTLPERLKGEFFTVIEAKKNVFCGSLRGNFSLLCWGNEILDRNLLPIFDFVSPG 300
Query: 310 PCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGG--WSGRM 367
PC + CPC P + C +IC+PC + P P P P S G WSG M
Sbjct: 301 PCRSQCPCGPFPYTQQFCTPPTMICKPCENRAQFPPPPPPSSPPPEISHHSSGQRWSGGM 360
Query: 368 VALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGRLDEAEAQAQSAQPPMPPPPPSP 427
VALLVVGC+GSL +VL+ +FF YK+CK + CRVHDSG +++ P
Sbjct: 361 VALLVVGCVGSLSLVLICSFFVYKYCKNRVCRVHDSGPMED------------PVGTTDG 408
Query: 428 PVLEKKLSQLASMGNAG---RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGS 484
VLEK+LS L S+GN G +LE+F L +L+EATNNFSE+HKIGSGSFG+VYKA L+DG
Sbjct: 409 RVLEKRLSHLISLGNGGQFGKLEDFPLSVLVEATNNFSEEHKIGSGSFGSVYKAVLNDGR 468
Query: 485 QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544
+VA+KRAE SS SS A GTKRQEDKDNAF+NELESLSR++HKNLVRLLGF +D +ER+L+
Sbjct: 469 EVAIKRAEFSSISSSAWGTKRQEDKDNAFLNELESLSRINHKNLVRLLGFFDDTHERMLV 528
Query: 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNV 604
YE++ NGTLHDHLHN SSS SW RI VALDAARGI+YLH+Y P IIHRDIKSSN+
Sbjct: 529 YEFMSNGTLHDHLHNLPSSSLATSWARRIAVALDAARGIQYLHDYLSPPIIHRDIKSSNI 588
Query: 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664
LLD WTAKVSDFGLSL+GP+D ESHLSLRAAGTVGYMDPEYYRLQQLT KSDVYSFGVV
Sbjct: 589 LLDNRWTAKVSDFGLSLMGPDDGESHLSLRAAGTVGYMDPEYYRLQQLTTKSDVYSFGVV 648
Query: 665 LLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYL 724
LLE+LSG +AIH+ G PRNVVD +VPYIVRDEIHRVLD VPPPTPFEIEAV YVGYL
Sbjct: 649 LLELLSGCKAIHKNEIGVPRNVVDVMVPYIVRDEIHRVLDVKVPPPTPFEIEAVKYVGYL 708
Query: 725 AADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISRSATSSS 767
AADCV EGR+RPSMT+IVN LERALAACL ++SRS+T SS
Sbjct: 709 AADCVITEGRHRPSMTDIVNCLERALAACLAPTTLSRSSTESS 751
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449529048|ref|XP_004171513.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase-like protein CCR4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/766 (60%), Positives = 549/766 (71%), Gaps = 24/766 (3%)
Query: 18 FFVSLVPF----NSSLSTFSVSETGNQSLVCALIPSSRPGDFSLNCS-IPQ--LIPVNPN 70
F + PF SSL T S+SET NQ+L+C+L FSLNCS P IP NPN
Sbjct: 9 FIFHIFPFLFLSVSSLQTLSISETANQTLICSL-----NARFSLNCSSFPSGIQIPFNPN 63
Query: 71 ASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHI 130
S++ IV+GDGF C L F +S+S++ CWRFS +G + KR+Y GP L++L AGNSHI
Sbjct: 64 DSYSGIVAGDGFFCGLRNFPTTSNSIVVCWRFSVNGTNMETKRVYDGPNLKELRAGNSHI 123
Query: 131 CGLVNGTNDLHWWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQK 190
CG+VN TN L WQW F+ +FS+IAVG DF+CGL G I C GS NS +V
Sbjct: 124 CGVVNATNQLECWQWRRFDRNFTFDFSSIAVGSDFICGLSNAGVIRCEGSGNSTVAVDG- 182
Query: 191 VPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVV 250
G + V AGFRHVCAI+ EL CWG VGE P G+FK LALG++RSC LR N V
Sbjct: 183 --GGRYTAVTAGFRHVCAINLRNELECWGMGVGERPAGEFKMLALGDDRSCGLRLNGTAV 240
Query: 251 CWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHM-VFERVLPG 309
CWG+ FTLP+ L+G+ F IEAK++ FCG L N+SL CWGNE N + +F+ V PG
Sbjct: 241 CWGEKNFTLPERLKGEFFTVIEAKKNXFCGSLRGNFSLLCWGNEILDRNLLPIFDFVSPG 300
Query: 310 PCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGG--WSGRM 367
PC + CPC P + C +IC+PC + P P P P S G WSG M
Sbjct: 301 PCRSQCPCGPFPYTQQFCTPPTMICKPCENRAQFPPPPPPSSPPPEISHHSSGQRWSGGM 360
Query: 368 VALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGRLDEAEAQAQSA---QPPMPPPP 424
VALLVVGC+GSL +VL+ +FF YK+CK + CRVHDSG +++ + + P
Sbjct: 361 VALLVVGCVGSLSLVLICSFFVYKYCKNRVCRVHDSGPMEDPVGTTDGVDHRETVVGRPG 420
Query: 425 PSPPVLEKKLSQLASMGNAG---RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLD 481
VLEK+LS L S+GN G +LE+F L +L+EATNNFSE+HKIGSGSFG+VYKA L+
Sbjct: 421 NGKRVLEKRLSHLISLGNGGQFGKLEDFPLSVLVEATNNFSEEHKIGSGSFGSVYKAVLN 480
Query: 482 DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541
DG +VA+KRAE SS SS A GTKRQEDKDNAF+NELESLSR++HKNLVRLLGF +D +ER
Sbjct: 481 DGREVAIKRAEFSSISSSAWGTKRQEDKDNAFLNELESLSRINHKNLVRLLGFFDDTHER 540
Query: 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601
+L+YE++ NGTLHDHLHN SS SW RI VALDAARGI+YLH+Y P IIHRDIKS
Sbjct: 541 MLVYEFMSNGTLHDHLHNLPSSPLATSWARRIAVALDAARGIQYLHDYLSPPIIHRDIKS 600
Query: 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSF 661
SN+LLD WTAKVSDFGLSL+GP+D ESHLSLRAAGTVGYMDPEYYRLQQLT KSDVYSF
Sbjct: 601 SNILLDNRWTAKVSDFGLSLMGPDDGESHLSLRAAGTVGYMDPEYYRLQQLTTKSDVYSF 660
Query: 662 GVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYV 721
GVVLLE+LSG +AIH+ G PRNVVD +VPYIVRDEIHRVLD VPPPTPFEIEAV YV
Sbjct: 661 GVVLLELLSGCKAIHKNEIGVPRNVVDVMVPYIVRDEIHRVLDVKVPPPTPFEIEAVKYV 720
Query: 722 GYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISRSATSSS 767
GYLAADCV EGR+RPSMT+IVN LERALAACL ++SRS+T SS
Sbjct: 721 GYLAADCVITEGRHRPSMTDIVNCLERALAACLAPTTLSRSSTESS 766
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727198|ref|NP_001235105.1| cytokinin-regulated kinase precursor [Glycine max] gi|223452420|gb|ACM89537.1| cytokinin-regulated kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/786 (58%), Positives = 559/786 (71%), Gaps = 50/786 (6%)
Query: 8 PFLLTTLLLLFFVSLVPFNSSLSTFSVSETGN--QSLVCALIPSSRPGDFSLNC-SIPQ- 63
PFL+ L + F L N+ +T S+SET N Q+L+C L ++ G +LNC S PQ
Sbjct: 3 PFLINHLFVFLFC-LRAINTLSTTVSISETSNSNQTLICVLQHPNQQGQSNLNCTSFPQA 61
Query: 64 ---LIPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIIN-DYKRIYRGPA 119
+ VNPN S++ IV G+GF+C L S SS SVM CWRFSA+ N YKRIYRGP
Sbjct: 62 QAITLDVNPNVSYSQIVGGNGFVCALGPLS-SSISVMGCWRFSANATYNVPYKRIYRGPI 120
Query: 120 LQQLEAGNSHICGLV-----NGTNDLHWWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGT 174
++ +++GNSH+CGLV N + +L WQW FNS+ S++AVGE+FVCGL E G
Sbjct: 121 VEDIDSGNSHVCGLVRKGNKNNSLELECWQWHGFNSSMSMPMSSVAVGENFVCGLSERGD 180
Query: 175 ITCF------GSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGD-SVGEVP- 226
+ C GSR V P G + +AAGFRH C I D L CWGD G+ P
Sbjct: 181 VNCRERGRGNGSR-VRVVVDAPAPGGNYSYIAAGFRHACVISGDGSLHCWGDMEEGQKPP 239
Query: 227 -QGKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSN 285
G F +LALGE RSCAL ++++VVCWG N F++P LQ F SI AKR+VFCGVL+S+
Sbjct: 240 QAGSFISLALGEKRSCALGDDRRVVCWGSNNFSMPRRLQDTYFESIVAKRTVFCGVLSSD 299
Query: 286 YSLYCWGNESFSSNHMVFERVLPGPCTNTCPCPMLPGSGNVCGE-GQIICQPCFEKTSVT 344
YSL CWG++ F SN+ VF+ VLPGPC N CPC S +C G +ICQPC + +
Sbjct: 300 YSLLCWGSKIFESNNKVFDDVLPGPCRNECPCGPQSNSAKLCNSPGGVICQPCSPRVVQS 359
Query: 345 PSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHC--KCKGCRVHD 402
PSP S GGWS +MVA LVVGC+G ++LV+AFF ++C K +G RVHD
Sbjct: 360 PSPP--------SNQSGGWSSQMVAFLVVGCVGCSSLLLVTAFFLNRYCNSKRRGSRVHD 411
Query: 403 SGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFS 462
SGRLD+ + QAQ VL+K+LS SMGN LEEFSLE LL+ TNNF
Sbjct: 412 SGRLDD-DPQAQDGSR----------VLQKRLSHAISMGNGSPLEEFSLETLLQVTNNFC 460
Query: 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
ED +IG GSFGAVY +TL+DG +VA+KRAE SS++ +G + Q DKDNAF+NELESLSR
Sbjct: 461 EDKRIGLGSFGAVYHSTLEDGKEVAIKRAEASSSTYTVLGGQGQVDKDNAFVNELESLSR 520
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
LHHKNLVRLLGF ED ER+L+Y+Y++NG+L DHLH QSS+ L SW RIKVALDAARG
Sbjct: 521 LHHKNLVRLLGFYEDSKERILVYDYMDNGSLSDHLHKLQSSA-LMSWAVRIKVALDAARG 579
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP--EDDESHLSLRAAGTVG 640
IEYLH+YA P IIHRDIKS+N+LLDA WTAKVSDFGLSL+GP ED+++HLSL AAGTVG
Sbjct: 580 IEYLHQYATPPIIHRDIKSANILLDAKWTAKVSDFGLSLMGPDPEDEDAHLSLLAAGTVG 639
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
YMDPEYYRLQ LT KSDVYSFGVVLLE+LSGY+AIH+ NG PRNVVDFVVP+I +DEIH
Sbjct: 640 YMDPEYYRLQHLTPKSDVYSFGVVLLELLSGYKAIHKNENGVPRNVVDFVVPFIFQDEIH 699
Query: 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSIS 760
RVLDR V PPTPFEIEAVAYVGYLAADCV LEGR+RP+M+++VN+LERALAACL P +S
Sbjct: 700 RVLDRRVAPPTPFEIEAVAYVGYLAADCVRLEGRDRPTMSQVVNNLERALAACLAKPILS 759
Query: 761 RSATSS 766
RS T S
Sbjct: 760 RSTTDS 765
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147832989|emb|CAN70665.1| hypothetical protein VITISV_029649 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2218), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/713 (62%), Positives = 552/713 (77%), Gaps = 25/713 (3%)
Query: 24 PFNSSLSTFSVSETGNQSLVCALIPSSRPGDFSLNC-SIPQLIPV-NPNASFASIVSGDG 81
PF SSLS+ S+SET NQ+L+CAL+ SSR LNC S P I + + N SF+ IV+GDG
Sbjct: 20 PFISSLSSVSISETSNQTLICALLESSR-----LNCTSFPTGIQIPSVNRSFSGIVAGDG 74
Query: 82 FLCTLITFSASSSSVMHCWRFSADGIINDYKRIY-RGPALQQLEAGNSHICGLVNGTNDL 140
F C L S S+++M C+RFSA+G KR+Y AL ++ AGN+H+CGLVNGTN L
Sbjct: 75 FQCVL---SFPSATIMLCYRFSANGTNMHSKRLYYNDSALTEVAAGNTHVCGLVNGTNIL 131
Query: 141 HWWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTS-VTQKVPSGIFRVV 199
H WQW FN++ +FS IAVGE FVCGL +G ITC G+ +S +S + +VPSG F+ V
Sbjct: 132 HCWQWRGFNTSVQSDFSGIAVGEGFVCGLSSSGRITCIGTNSSSSSTIRDRVPSGSFQKV 191
Query: 200 AAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGFTL 259
AAGFRH CAI +Q L CWG++VGE PQG+F +LALGENRSCA+R N VVCWG+NGF+L
Sbjct: 192 AAGFRHACAIYRNQSLVCWGETVGEEPQGEFVSLALGENRSCAMRGNGTVVCWGENGFSL 251
Query: 260 PDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMVFERVLPGPCTNT-CPCP 318
P+SL+ F++IEAKRSVFCGV N+SL CWGNE F SN MVF +VLPG CT++ CP
Sbjct: 252 PESLRETVFMTIEAKRSVFCGVDQYNFSLLCWGNEIFDSNSMVFPKVLPGSCTSSECPNG 311
Query: 319 MLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGS 378
++PGSG++CG G I C ++ ++ P+ P PPE +R GW+ +MVA LVVGC+GS
Sbjct: 312 VVPGSGSMCGRGHI-CNA-YQNRTLVEGPSQPPSPPPEVRNRSGWNDKMVAFLVVGCVGS 369
Query: 379 LVVVLVSAFFGYKHCKCKGC-RVHDSGRLDEAEAQAQS--AQPPMPPPPPSPPVLEKKLS 435
+ V FF +++CK +GC +VHDSGRLDEA + +Q + PVLEK+LS
Sbjct: 370 ASFLAVICFFLFRYCKGRGCSKVHDSGRLDEAGMPPEHGLSQRQTVQAQRAAPVLEKRLS 429
Query: 436 QLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISS 495
QL S+GN GRLEEFSL+ L +ATN+FS++H+IG+GSFG VY+ATL+DG +VA+KRAE+S+
Sbjct: 430 QLVSLGNGGRLEEFSLQELRQATNDFSQEHRIGTGSFGCVYRATLEDGKEVAIKRAEVST 489
Query: 496 TSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE------RVLIYEYLE 549
TSS A+GT+RQEDKD AF++EL+SLSRL+H+NLVRLLG+CED NE R+L+YEY+
Sbjct: 490 TSSNAVGTRRQEDKDTAFVSELDSLSRLNHRNLVRLLGYCEDYNEKIPAYERILVYEYMN 549
Query: 550 NGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609
NGTLHDHLH SS PL SW R++VALDAARGIEYLH YAVP IIHRDIKSSN+LLDA+
Sbjct: 550 NGTLHDHLHKLHSS-PLMSWTNRLRVALDAARGIEYLHMYAVPQIIHRDIKSSNILLDAS 608
Query: 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
TAKVSDFGLSL+GPED++SHLSL AAGTVGYMDPEYYRLQQLT KSDVYSFGV+LLE+L
Sbjct: 609 LTAKVSDFGLSLMGPEDEDSHLSLHAAGTVGYMDPEYYRLQQLTPKSDVYSFGVLLLELL 668
Query: 670 SGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVG 722
SG++AIH+ NG PRNVVD VVPYIV+DEIHRVLD NVPPPTP+EIEAV Y+G
Sbjct: 669 SGHKAIHKNENGVPRNVVDLVVPYIVQDEIHRVLDPNVPPPTPYEIEAVTYIG 721
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357470699|ref|XP_003605634.1| Serine/threonine protein kinase-like protein CCR4 [Medicago truncatula] gi|355506689|gb|AES87831.1| Serine/threonine protein kinase-like protein CCR4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/784 (55%), Positives = 530/784 (67%), Gaps = 85/784 (10%)
Query: 16 LLFFVS--LVPFNSSLSTFSVSETGN--QSLVCALIPSSRPGDFSLNC-------SIPQL 64
L FF+S L+P ++LST S+S T N Q+L+C L ++ +LNC S
Sbjct: 12 LYFFLSFILLPIINTLSTVSISHTSNSNQTLICVLQSQNQQKHSNLNCTSFSPSISFGTK 71
Query: 65 IPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLE 124
+ +N N S++ IV G+ ++
Sbjct: 72 LELNSNVSYSQIVGGN-----------------------------------------DID 90
Query: 125 AGNSHICGLVNGTND--LHWWQWPDFNSTS--IHNFSNIAVGEDFVCGLLENG---TITC 177
+GNSH+CGLV G N L WQW FNS+S N SNIAVGE+FVCGLLENG +TC
Sbjct: 91 SGNSHVCGLVKGNNGFRLECWQWRGFNSSSGMNMNMSNIAVGENFVCGLLENGKGNVVTC 150
Query: 178 FGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGE 237
GS N K G + V+ AG HVCAI +D L CWGD VGE P+G+F +LALGE
Sbjct: 151 KGSNNRVVGNEPK-NGGNYSVIEAGSNHVCAISNDGGLDCWGDMVGEKPKGRFISLALGE 209
Query: 238 NRSCALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCW-GNESF 296
NRSCAL + V CWG N FTLP +L+ F SI AK+SVF V+ + C+ G F
Sbjct: 210 NRSCALGYDGIVTCWGLNNFTLPLTLKNTFFESIVAKKSVF--VVFCLLIILCFVGAMKF 267
Query: 297 SSNHMVFERVLPGPCTNTCPCPMLPGSGNVCGEGQIICQPC---FEKTSVTPS--PTPQP 351
S VF+ VLPGPC N CPC L S +C IIC+PC FE ++ PS P+ P
Sbjct: 268 LSQKKVFDNVLPGPCKNQCPCGPLSDSAKLCVSPAIICKPCSPSFEIPTLPPSNPPSQMP 327
Query: 352 QQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHCK---CKGCRVHDSGRLDE 408
+ P +SG+ WS + VA LVVGC+G ++LV +FF YK+CK CK RVHDSGRLD+
Sbjct: 328 ENPSKSGT---WSNKNVAFLVVGCVGCTSLLLVLSFFLYKYCKGTACKSSRVHDSGRLDD 384
Query: 409 AEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRL-EEFSLEILLEATNNFSEDHKI 467
+ + +S P + VLEK+LS + SMGN G L EE SL+ LLEATNNFSE++KI
Sbjct: 385 LDRENESQ------PRANHAVLEKRLSHVISMGNGGTLLEEISLQTLLEATNNFSEENKI 438
Query: 468 GSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIG---TKRQEDKDNAFINELESLSRLH 524
G GSFG+VY+A L+DG +VA+KRAEISSTS+ TKRQED D+AF+NELESLSRLH
Sbjct: 439 GVGSFGSVYRAKLEDGKEVAIKRAEISSTSTSHANFGVTKRQEDTDSAFVNELESLSRLH 498
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
HKNLV+LLGF ED+NER+L+YEY+ NG+L+DHLH Q+S+ + SW RIKVALDAARGIE
Sbjct: 499 HKNLVKLLGFYEDKNERILVYEYMNNGSLNDHLHKFQTST-IMSWSGRIKVALDAARGIE 557
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH+YA P IIHRDIK+SN+LLD+ W AKVSDFGLSL+GPED+ESHLSL AAGTVGYMDP
Sbjct: 558 YLHKYAQPPIIHRDIKTSNILLDSKWVAKVSDFGLSLMGPEDEESHLSLLAAGTVGYMDP 617
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD 704
EYYRLQ LT KSDVYSFGVVLLE+LSGY+AIH+ NG PRNVVDFVVPYIV+DEIHR+LD
Sbjct: 618 EYYRLQYLTSKSDVYSFGVVLLELLSGYKAIHKNENGVPRNVVDFVVPYIVQDEIHRILD 677
Query: 705 RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISRSAT 764
+PPPTPFEIEAV +VGYLA DCV LEGR+RP+M+ +VNSLE+AL ACL P S
Sbjct: 678 TKLPPPTPFEIEAVTFVGYLACDCVRLEGRDRPNMSHVVNSLEKALEACLAQPIFCESTR 737
Query: 765 SSSA 768
++S
Sbjct: 738 TTST 741
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297795371|ref|XP_002865570.1| hypothetical protein ARALYDRAFT_331197 [Arabidopsis lyrata subsp. lyrata] gi|297311405|gb|EFH41829.1| hypothetical protein ARALYDRAFT_331197 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/756 (52%), Positives = 503/756 (66%), Gaps = 53/756 (7%)
Query: 28 SLSTFSVSETGNQSLVCALIPSS--RPGDFSLNCSIPQLIPVNPNASFASIVSGDGFLCT 85
SLST S+S NQ+LVCAL S + F LN L N F+ +VSG+GF+C
Sbjct: 31 SLSTVSISHISNQTLVCALTNHSYLQCSSFPLNSIRFSLTDNLRNRRFSGVVSGNGFVCG 90
Query: 86 LITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQW 145
L T S+ S + CWRFS +G +KRIY GP L++LEAGNS ICG+ + L WQ
Sbjct: 91 LRTVLDSNISTLLCWRFSVNGTSLLHKRIYHGPELEELEAGNSRICGVERVSRSLRCWQ- 149
Query: 146 PDFNSTSIHNFSNIAVGEDFVCGLLEN-GTITCFGSRNSPTSVTQKVPSG-IFRVVAAGF 203
F N+S+IA+G++F CGL + G I+C G S KVPSG + +AAG
Sbjct: 150 -PFYLPRSDNYSSIALGDNFFCGLSQPPGRISCEGEGIS------KVPSGDRYIAIAAGS 202
Query: 204 RHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALR-NNQKVVCWGQN-GFTLPD 261
R CAI D ++ CWG + +P KF ALA+GENRSC +R +N VVCWG N F+LP
Sbjct: 203 RQACAITVDNDVECWGQT-ESLPHEKFLALAVGENRSCGIRWSNGTVVCWGNNKNFSLPQ 261
Query: 262 SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSS------NHMVFERVLPGPCTNTC 315
SL+ F SI AK +FCGV T NY+LYCWGNE+F S ++ + V+PGPC C
Sbjct: 262 SLKDIHFTSIYAKGQIFCGVATKNYTLYCWGNENFKSGVFAPFQGLISQVVMPGPCRREC 321
Query: 316 PCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGC 375
P L GS ++CG +IC E P ++ WS R +A LVVGC
Sbjct: 322 PYRPLSGSQSLCGNELMICDLKKEDGEF-------PDTKAQNSMNKTWSRRNIAFLVVGC 374
Query: 376 LGSLVVVLVSAFFGYK-HCKCKGCRVHDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKL 434
G+ ++LV +F +K H +C RVHDSGRLD+ P LEK+L
Sbjct: 375 GGTFSLLLVISFLIFKSHSRC---RVHDSGRLDDTRTIDM-------------PKLEKRL 418
Query: 435 SQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEIS 494
S L S+GN G+L EFS++ L AT+ FS ++G GSFG+VY+ L DG VA+KRAE++
Sbjct: 419 SSLVSLGNTGQLMEFSIDELALATDGFSVRFQLGIGSFGSVYQGVLSDGRHVAIKRAELT 478
Query: 495 S-TSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTL 553
+ T S R+ DKD+AF+NELES+SRL+HKNLVRLLGF ED ERVL+YEY++NG+L
Sbjct: 479 NPTLSGTTMRNRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDEEERVLVYEYMKNGSL 538
Query: 554 HDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613
DHLHNPQ PL +W R+ +ALDAARGI+YLHE+ VP +IHRDIKSSN+LLDATWTAK
Sbjct: 539 ADHLHNPQFD-PL-TWQTRLMIALDAARGIQYLHEFVVPPVIHRDIKSSNILLDATWTAK 596
Query: 614 VSDFGLSLIGP--EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
VSDFGLS +GP EDD SHLSL AAGT+GY+DPEYY+ QQLT KSDVYSFGVVLLE+LSG
Sbjct: 597 VSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSG 656
Query: 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTL 731
++AIH+ + PRNVV++VVPYI+ D++HRVLD+ +PPPTP+EIEAVA+VGYLAA+C+
Sbjct: 657 HKAIHKNEDENPRNVVEYVVPYILLDDVHRVLDQRIPPPTPYEIEAVAHVGYLAAECLMP 716
Query: 732 EGRNRPSMTEIVNSLERALAACLVSP---SISRSAT 764
R RPSM E+V+ LE ALAACL +P ++SRS T
Sbjct: 717 CSRKRPSMAEVVSKLESALAACLTAPKTETVSRSNT 752
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238823|ref|NP_199596.1| serine/threonine-protein kinase-like protein CCR4 [Arabidopsis thaliana] gi|75333916|sp|Q9FIJ6.1|ACCR4_ARATH RecName: Full=Serine/threonine-protein kinase-like protein CCR4; AltName: Full=CRINKLY 4-related kinase 1; Short=AtCRK1; AltName: Full=Protein CRINKLY 4 RELATED 4; Short=AtCCR4; Flags: Precursor gi|10177921|dbj|BAB11332.1| receptor kinase-like protein [Arabidopsis thaliana] gi|332008197|gb|AED95580.1| serine/threonine-protein kinase-like protein CCR4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/762 (51%), Positives = 506/762 (66%), Gaps = 67/762 (8%)
Query: 28 SLSTFSVSETGNQSLVCALIPSS--RPGDFSLNCSIPQLIPVN-PNASFASIVSGDGFLC 84
SLST S+S NQ+LVCAL S + F LN SIP + N N F+ +VSG+GF+C
Sbjct: 31 SLSTVSISHISNQTLVCALNNHSYLQCSSFPLN-SIPFSLTGNLRNRRFSGVVSGNGFVC 89
Query: 85 TLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQ 144
LI+ S++S + CWRFS DG +KRIY GP L++LEAGN ICG+ + L WQ
Sbjct: 90 GLISRLDSNTSTLLCWRFSVDGTNMLHKRIYHGPELEELEAGNFRICGVERVSRRLRCWQ 149
Query: 145 -----WPDFNSTSIHNFSNIAVGEDFVCGLLEN-GTITCFGSRNSPTSVTQKVPSGIFRV 198
PD N+ +IA+G++F CGL + G I+C G KVPSG +
Sbjct: 150 PYYLPRPD-------NYRSIALGDNFFCGLSQPPGMISCEG--------IAKVPSGDHYI 194
Query: 199 -VAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALR-NNQKVVCWGQNG 256
+AAG R CAI D ++ CWG + +P+ KF ALA+GE+R C +R +N VVCWG N
Sbjct: 195 AIAAGSRQACAITVDNDVECWGQT-QSLPREKFLALAVGEDRGCGVRWSNGTVVCWGNNN 253
Query: 257 -FTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSS------NHMVFERVLPG 309
F+LP +L+ F SI AK +FCGV T NY+L CWGNE+F S ++ + V+PG
Sbjct: 254 NFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICWGNENFKSGVFTPFQGLISQVVMPG 313
Query: 310 PCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVA 369
PC CP L GS ++CG +IC + + P ++ WS R +A
Sbjct: 314 PCRRECPYRPLSGSQSLCGNELMICD-------LKRNDGEFPDTRAQNSKNKTWSRRNIA 366
Query: 370 LLVVGCLGSLVVVLVSAFFGYK-HCKCKGCRVHDSGRLDEAEAQAQSAQPPMPPPPPSPP 428
LVVGC+G+ ++LV +F +K HC+C RVHDSGRLD+ P
Sbjct: 367 FLVVGCVGTFSLLLVISFLIFKSHCRC---RVHDSGRLDDTRT-------------IDIP 410
Query: 429 VLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAV 488
LEK+L LAS+GN G+L EFS++ L AT+ FS +G GSFG+VY+ L DG VA+
Sbjct: 411 KLEKRLCTLASLGNPGQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAI 470
Query: 489 KRAEISS-TSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEY 547
KRAE+++ T S R+ DKD+AF+NELES+SRL+HKNLVRLLGF ED ER+L+YEY
Sbjct: 471 KRAELTNPTLSGTTMRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEY 530
Query: 548 LENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607
++NG+L DHLHNPQ PL SW R+ +ALDAARGI+YLHE+ VP +IHRDIKSSN+LLD
Sbjct: 531 MKNGSLADHLHNPQFD-PL-SWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLD 588
Query: 608 ATWTAKVSDFGLSLIGP--EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVL 665
ATWTAKVSDFGLS +GP EDD SHLSL AAGT+GY+DPEYY+ QQLT KSDVYSFGVVL
Sbjct: 589 ATWTAKVSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVL 648
Query: 666 LEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLA 725
LE+LSG++AIH + PRN+V++VVPYI+ DE HR+LD+ +PPPTP+EIEAVA+VGYLA
Sbjct: 649 LELLSGHKAIHNNEDENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLA 708
Query: 726 ADCVTLEGRNRPSMTEIVNSLERALAACLVSP---SISRSAT 764
A+C+ R RPSM E+V+ LE ALAACL +P ++SRS T
Sbjct: 709 AECLMPCSRKRPSMVEVVSKLESALAACLTAPKTETVSRSNT 750
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 768 | ||||||
| TAIR|locus:2160952 | 751 | CCR4 "CRINKLY4 related 4" [Ara | 0.455 | 0.466 | 0.615 | 9.2e-178 | |
| TAIR|locus:2082033 | 814 | CCR3 "CRINKLY4 related 3" [Ara | 0.412 | 0.389 | 0.535 | 1.3e-124 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.381 | 0.325 | 0.495 | 1.8e-94 | |
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.382 | 0.328 | 0.483 | 3.8e-92 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.369 | 0.305 | 0.475 | 4.2e-67 | |
| TAIR|locus:2075074 | 775 | CCR1 "CRINKLY4 related 1" [Ara | 0.207 | 0.205 | 0.526 | 1.1e-65 | |
| TAIR|locus:2118344 | 863 | AT4G29450 [Arabidopsis thalian | 0.386 | 0.344 | 0.421 | 4e-60 | |
| TAIR|locus:2056033 | 776 | CCR2 "CRINKLY4 related 2" [Ara | 0.226 | 0.224 | 0.454 | 4.3e-60 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.376 | 0.259 | 0.429 | 5.2e-59 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.384 | 0.345 | 0.419 | 5.8e-59 |
| TAIR|locus:2160952 CCR4 "CRINKLY4 related 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 9.2e-178, Sum P(2) = 9.2e-178
Identities = 229/372 (61%), Positives = 282/372 (75%)
Query: 387 FFGYK-HCKCKGCRVHDSGRLDEAEXXXXXXXXXXXXXXXXXXVLEKKLSQLASMGNAGR 445
F +K HC+C RVHDSGRLD+ LEK+L LAS+GN G+
Sbjct: 384 FLIFKSHCRC---RVHDSGRLDDTRTIDIPK-------------LEKRLCTLASLGNPGQ 427
Query: 446 LEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISS-TSSYAIGTK 504
L EFS++ L AT+ FS +G GSFG+VY+ L DG VA+KRAE+++ T S
Sbjct: 428 LMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTMRH 487
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS 564
R+ DKD+AF+NELES+SRL+HKNLVRLLGF ED ER+L+YEY++NG+L DHLHNPQ
Sbjct: 488 RRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQFD- 546
Query: 565 PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624
PL SW R+ +ALDAARGI+YLHE+ VP +IHRDIKSSN+LLDATWTAKVSDFGLS +GP
Sbjct: 547 PL-SWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQMGP 605
Query: 625 --EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
EDD SHLSL AAGT+GY+DPEYY+ QQLT KSDVYSFGVVLLE+LSG++AIH +
Sbjct: 606 TEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNEDEN 665
Query: 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742
PRN+V++VVPYI+ DE HR+LD+ +PPPTP+EIEAVA+VGYLAA+C+ R RPSM E+
Sbjct: 666 PRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRKRPSMVEV 725
Query: 743 VNSLERALAACL 754
V+ LE ALAACL
Sbjct: 726 VSKLESALAACL 737
|
|
| TAIR|locus:2082033 CCR3 "CRINKLY4 related 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 1.3e-124, Sum P(2) = 1.3e-124
Identities = 182/340 (53%), Positives = 238/340 (70%)
Query: 430 LEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVK 489
+ ++ S +SM +A + EEFS L AT NFS ++KIGSGSFG VY+ L+DG +VA+K
Sbjct: 465 MRRQRSGTSSMKHADKAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIK 524
Query: 490 RAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLE 549
R E+++ K+ ++K+ AF +E+ LSRLHHK+LVRL+G+CE+R E++L+Y+Y++
Sbjct: 525 RGEVNAKM------KKFQEKETAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMK 578
Query: 550 NGTLHDHLHNPQS----SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605
NG L+DHLH+ + SS + SW RIK+ALDAARGIEYLH YAVP IIHRDIKSSN+L
Sbjct: 579 NGALYDHLHDKNNVEKHSSLINSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNIL 638
Query: 606 LDATWTAKVSDFGLSLIGPEDDESH----LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSF 661
LD+ W A+VSDFGLSL+GP + H +AAGTVGY+DPEYY L LT+KSDVY
Sbjct: 639 LDSNWVARVSDFGLSLMGPVLGKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGL 698
Query: 662 GVVLLEILSGYRAIHRTHNG--------TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPF 713
GVVLLE+L+G RAI R +NG P ++VD+ VP I DE+ +LD V P
Sbjct: 699 GVVLLELLTGKRAIFR-NNGDVEEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELG 757
Query: 714 EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753
E +AV V Y A CV EGRNRP+MT+IV +LERAL C
Sbjct: 758 EGDAVELVAYTAMHCVNAEGRNRPTMTDIVGNLERALDLC 797
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 1.8e-94, Sum P(3) = 1.8e-94
Identities = 153/309 (49%), Positives = 211/309 (68%)
Query: 445 RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK 504
R +EFS E L +AT FSED ++G GSF V+K L DG+ VAVKRA I ++
Sbjct: 489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRA-IKASDV------ 541
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH--NPQS 562
++ K+ F NEL+ LSRL+H +L+ LLG+CED +ER+L+YE++ +G+L+ HLH +P
Sbjct: 542 KKSSKE--FHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNL 599
Query: 563 SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
L +W R+ +A+ AARGIEYLH YA P +IHRDIKSSN+L+D A+V+DFGLS++
Sbjct: 600 KKRL-NWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSIL 658
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
GP D + LS AGT+GY+DPEYYRL LT KSDVYSFGVVLLEILSG +AI
Sbjct: 659 GPADSGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFE-- 716
Query: 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742
N+V++ VP I +I +LD + PP+ ++EA+ + +A CV + G++RPSM ++
Sbjct: 717 EGNIVEWAVPLIKAGDIFAILDPVLSPPS--DLEALKKIASVACKCVRMRGKDRPSMDKV 774
Query: 743 VNSLERALA 751
+LE ALA
Sbjct: 775 TTALEHALA 783
|
|
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 704 (252.9 bits), Expect = 3.8e-92, Sum P(3) = 3.8e-92
Identities = 149/308 (48%), Positives = 205/308 (66%)
Query: 445 RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK 504
R F+ E L +A + F E+ +G GSF VYK L DG+ VAVKRA +SS
Sbjct: 496 RARVFTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSD-------- 547
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS 564
++ N F EL+ LSRL+H +L+ LLG+CE+ ER+L+YE++ +G+LH+HLH +
Sbjct: 548 -KQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKAL 606
Query: 565 PLK-SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
+ W R+ +A+ AARGIEYLH YA P +IHRDIKSSN+L+D A+V+DFGLSL+G
Sbjct: 607 KEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 666
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
P D S L+ AGT+GY+DPEYYRL LT KSDVYSFGV+LLEILSG +AI +
Sbjct: 667 PVDSGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYE--E 724
Query: 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
N+V++ VP I +I+ +LD + P+ EIEA+ + +A CV + G++RPSM ++
Sbjct: 725 GNIVEWAVPLIKAGDINALLDPVLKHPS--EIEALKRIVSVACKCVRMRGKDRPSMDKVT 782
Query: 744 NSLERALA 751
+LERALA
Sbjct: 783 TALERALA 790
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 4.2e-67, Sum P(2) = 4.2e-67
Identities = 143/301 (47%), Positives = 196/301 (65%)
Query: 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDK 509
SL +L EAT+NFS+ K+G GSFG+VY + DG +VAVK + SS+ RQ
Sbjct: 597 SLPVLEEATDNFSK--KVGRGSFGSVYYGRMKDGKEVAVKIT--ADPSSHL---NRQ--- 646
Query: 510 DNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSW 569
F+ E+ LSR+HH+NLV L+G+CE+ + R+L+YEY+ NG+L DHLH PL W
Sbjct: 647 ---FVTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPL-DW 702
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
R+++A DAA+G+EYLH PSIIHRD+KSSN+LLD AKVSDFGLS E+D +
Sbjct: 703 LTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSR-QTEEDLT 761
Query: 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689
H+S A GTVGY+DPEYY QQLTEKSDVYSFGVVL E+LSG + + G N+V +
Sbjct: 762 HVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHW 821
Query: 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
I + ++ ++D + + +IE+V V +A CV G NRP M E++ +++ A
Sbjct: 822 ARSLIRKGDVCGIIDPCIA--SNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDA 879
Query: 750 L 750
+
Sbjct: 880 I 880
|
|
| TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 1.1e-65, Sum P(3) = 1.1e-65
Identities = 90/171 (52%), Positives = 115/171 (67%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
F L L +ATN F E +++G GS+G VYKA L DG QVAVKRA ++ I T +E
Sbjct: 508 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATI----IHTNTRE- 562
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
F ELE L + H N+V LLG+ + ER+L+YEY+ +GTLHDHLH+ SPL S
Sbjct: 563 ----FETELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHS--GFSPL-S 615
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
W RIK+A+ A+G+EYLH A P IIH D+KSSNVLLD+ W A+V+DFGL
Sbjct: 616 WSLRIKIAMQTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGL 666
|
|
| TAIR|locus:2118344 AT4G29450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 4.0e-60, Sum P(2) = 4.0e-60
Identities = 129/306 (42%), Positives = 189/306 (61%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE- 507
F+ + TNNF++ IG G FG VY +L+DG+++AVK SS + GT
Sbjct: 556 FTYNEVSSITNNFNK--VIGKGGFGIVYLGSLEDGTKIAVKMINDSSLAKPK-GTSSSSL 612
Query: 508 -DKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPL 566
N F E E L +HH+NL +G+C+D LIYEY+ NG L +L + +++ L
Sbjct: 613 SRASNQFQVEAELLLTVHHRNLASFVGYCDDDRSMALIYEYMANGNLQAYLSS-ENAEDL 671
Query: 567 KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
SW R+ +A+D+A+G+EYLH+ P+I+HRD+K++N+L++ AK++DFGLS + PED
Sbjct: 672 -SWEKRLHIAIDSAQGLEYLHDGCRPAIVHRDVKTANILINDNLEAKIADFGLSKVFPED 730
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686
D SH+ GT GY+DPEYYR L EKSDVYSFGVVLLE+++G RAI +T G +V
Sbjct: 731 DLSHVVTTVMGTPGYVDPEYYRTFVLNEKSDVYSFGVVLLELITGQRAIIKTEEGDNISV 790
Query: 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
+ +V P+ E+ V+D + + A +V +A CV +G NRP+M +IV L
Sbjct: 791 IHYVWPFFEARELDGVVDPLLRGDFSQD-SAWKFVD-VAMSCVRDKGSNRPTMNQIVAEL 848
Query: 747 ERALAA 752
++ LAA
Sbjct: 849 KQCLAA 854
|
|
| TAIR|locus:2056033 CCR2 "CRINKLY4 related 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 403 (146.9 bits), Expect = 4.3e-60, Sum P(3) = 4.3e-60
Identities = 85/187 (45%), Positives = 118/187 (63%)
Query: 444 GRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT 503
G + F L L +AT+ F E +++G GSFG VYKA L DG VAVKRA ++T ++
Sbjct: 502 GETKIFRLSELKDATHGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRAN-AATIIHS--- 557
Query: 504 KRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
+ F +ELE L ++ H N+V LLG+C + ER+L+YEY+ +GTLHDHLH S
Sbjct: 558 -----NNRGFESELEILCKIRHNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQ 612
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
W R+K+ L AARG++YLH P IIHRD+K+SN+LLD A+++DFGL +
Sbjct: 613 L---DWSMRLKIMLQAARGLDYLHNEVDPPIIHRDVKTSNILLDGEMCARIADFGL-VSS 668
Query: 624 PEDDESH 630
E D S+
Sbjct: 669 NERDSSN 675
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 5.2e-59, Sum P(2) = 5.2e-59
Identities = 133/310 (42%), Positives = 194/310 (62%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
F+ +++ATNNF E +G G FG VY+ DDG++VAVK KR +
Sbjct: 711 FTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVL------------KRDDQ 758
Query: 509 KDNA-FINELESLSRLHHKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHN-PQSSSP 565
+ + F+ E+E LSRLHH+NLV L+G C EDRN R L+YE + NG++ HLH ++SSP
Sbjct: 759 QGSREFLAEVEMLSRLHHRNLVNLIGICIEDRN-RSLVYELIPNGSVESHLHGIDKASSP 817
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625
L W AR+K+AL AARG+ YLHE + P +IHRD KSSN+LL+ +T KVSDFGL+ +
Sbjct: 818 L-DWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALD 876
Query: 626 DDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684
D+++ H+S R GT GY+ PEY L KSDVYS+GVVLLE+L+G + + +
Sbjct: 877 DEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQE 936
Query: 685 NVVDFVVPYIVRDE-IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
N+V + P++ E + ++D+++ P F+ ++A V +A+ CV E +RP M E+V
Sbjct: 937 NLVSWTRPFLTSAEGLAAIIDQSLGPEISFD--SIAKVAAIASMCVQPEVSHRPFMGEVV 994
Query: 744 NSLERALAAC 753
+L+ C
Sbjct: 995 QALKLVSNEC 1004
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 5.8e-59, P = 5.8e-59
Identities = 132/315 (41%), Positives = 194/315 (61%)
Query: 437 LASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISST 496
LAS + GR F + +++ATN F E +G G FG VYK TL+DG++VAVKR
Sbjct: 489 LAST-HLGRC--FMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKR------ 539
Query: 497 SSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDH 556
G R E F E+E LS+L H++LV L+G+C++R+E +L+YEY+ NG L H
Sbjct: 540 -----GNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSH 594
Query: 557 LHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616
L+ + P SW R+++ + AARG+ YLH A SIIHRD+K++N+LLD AKV+D
Sbjct: 595 LYG--ADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVAD 652
Query: 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH 676
FGLS GP D++H+S G+ GY+DPEY+R QQLTEKSDVYSFGVVL+E+L A++
Sbjct: 653 FGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALN 712
Query: 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRN 735
N+ ++ + + + + +++D N+ P ++ G A C+ G +
Sbjct: 713 PVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKF---GETAEKCLAEYGVD 769
Query: 736 RPSMTEIVNSLERAL 750
RPSM +++ +LE AL
Sbjct: 770 RPSMGDVLWNLEYAL 784
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FIJ6 | ACCR4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5144 | 0.9049 | 0.9254 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 768 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| pfam13540 | 30 | pfam13540, RCC1_2, Regulator of chromosome condens | 3e-04 | |
| pfam13540 | 30 | pfam13540, RCC1_2, Regulator of chromosome condens | 3e-04 | |
| COG5184 | 476 | COG5184, ATS1, Alpha-tubulin suppressor and relate | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 5e-52
Identities = 74/222 (33%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G FG VY A G +VA+K I + + E+E L +L+H
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI----------IKKEDSSSLLEELLREIEILKKLNH 50
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
N+V+L G ED N L+ EY E G+L D L + L S +++ L G+EY
Sbjct: 51 PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKL-SEDEILRILLQILEGLEY 107
Query: 586 LHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
LH IIHRD+K N+LLD+ K++DFGLS + D ++ GT YM P
Sbjct: 108 LHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAP 162
Query: 645 EYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685
E +EKSD++S GV+L E+ I + P
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEK 204
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 93/287 (32%), Positives = 125/287 (43%), Gaps = 32/287 (11%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ K+GSGSFG VYKA G VAVK + S S KD E+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS---------KKDQTARREIRI 51
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
L RL H N+VRL+ ED++ L+ EY E G L D+L S S K+AL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQI 107
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
RG+EYLH IIHRD+K N+LLD K++DFGL+ + S + GT
Sbjct: 108 LRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTP 162
Query: 640 GYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
YM PE K DV+S GV+L E+L+G + N + +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQLQL----------- 210
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745
I R+L + P L C+ + RP+ EI+
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 9e-51
Identities = 90/294 (30%), Positives = 135/294 (45%), Gaps = 45/294 (15%)
Query: 466 KIGSGSFGAVYKATLDDGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
K+G G+FG VYK L +VAVK + ++ +R++ F+ E +
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKD-----FLKEARVMK 51
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN-----PQSSSPLKSWPARIKVA 576
+L H N+VRLLG C + L+ EY+E G L D+L P S + A
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ A+G+EYL +HRD+ + N L+ K+SDFGLS +DD
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-RNVVDF-VVPYI 694
+ +M PE + T KSDV+SFGV+L EI T TP + + V+ Y+
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF--------TLGATPYPGLSNEEVLEYL 220
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLE 747
+ +R L + P P E+ Y L C L+ +RP+ +E+V LE
Sbjct: 221 RKG--YR-LPK--PEYCPDEL-------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 44/291 (15%)
Query: 464 DHKIGSGSFGAVYKATLDDGS-----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
K+G G+FG VYK TL +VAVK + ++ Q+ ++ F+ E
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--------QQIEE--FLREAR 53
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H N+V+LLG C + +++ EY+ G L D+L + S + AL
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--SLSDLLSFALQ 111
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
ARG+EYL + IHRD+ + N L+ K+SDFGLS +DD +
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLP 167
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI---V 695
+ +M PE + + T KSDV+SFGV+L EI + G PY
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT---------LGEE--------PYPGMSN 210
Query: 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
+ + + P P + L C + +RP+ +E+V L
Sbjct: 211 AEVLEYLKKGYRLPKPP---NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 86/292 (29%), Positives = 137/292 (46%), Gaps = 47/292 (16%)
Query: 464 DHKIGSGSFGAVYKATLDDGS-----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
K+G G+FG VYK L +VAVK + ++ Q+ ++ F+ E
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--------EQQIEE--FLREAR 53
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H N+V+LLG C + ++ EY+E G L +L + + P S + AL
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQ 110
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
ARG+EYL + IHRD+ + N L+ K+SDFGLS DD+ +
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLP 166
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYI 694
+ +M PE + + T KSDV+SFGV+L EI + Y + + V++++
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM------SNEEVLEYL---- 216
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
+R L + PP P E+ Y L C + +RP+ +E+V L
Sbjct: 217 --KNGYR-LPQ--PPNCPPEL----Y--DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 86/292 (29%), Positives = 133/292 (45%), Gaps = 46/292 (15%)
Query: 464 DHKIGSGSFGAVYKATLDDGS-----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
K+G G+FG VYK TL +VAVK + ++ +R+E F+ E
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE-----EREE-----FLEEAS 53
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H N+VRLLG C ++ EY+ G L D L L +++AL
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTL---KDLLQMALQ 110
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A+G+EYL + +HRD+ + N L+ K+SDFGLS EDD
Sbjct: 111 IAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYI 694
+ +M PE + + T KSDV+SFGV+L EI + Y + + V++ +
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM------SNEEVLELL---- 217
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
++ +R L R P P E+ L C + +RP+ +E+V L
Sbjct: 218 --EDGYR-LPR--PENCPDELYE------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 68/208 (32%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G GSFG VY A G VA+K I K+ + + E++ L +L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKV----------IKKKKIKKDRERILREIKILKKLK 55
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N+VRL ED ++ L+ EY E G L D L L AR +E
Sbjct: 56 HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK---RGRLSEDEAR-FYLRQILSALE 111
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH I+HRD+K N+LLD K++DFGL+ ++ GT YM P
Sbjct: 112 YLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT---TFVGTPEYMAP 165
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGY 672
E + + D++S GV+L E+L+G
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G GSFG+VY A D G +AVK E+S S E++ A E+ LS L
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---------EEELEALEREIRILSSL 56
Query: 524 HHKNLVRLLGFCEDRNERVL-IY-EYLENGTLHDHLHNPQSSSPLKSWPARIKV-ALDAA 580
H N+VR G D + L I+ EY+ G+L L L I+
Sbjct: 57 QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLP--EPVIRKYTRQIL 111
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
G+ YLH I+HRDIK +N+L+D+ K++DFG + + + + GT
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
+M PE R ++ +D++S G ++E+ +G
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G+FG VYK L+ G VA+K+ + A+ + + E++ L L
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---------KSIMQEIDLLKNLK 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVALDAARG 582
H N+V+ +G E + +I EY ENG+L + P S + + ++ +G
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQG 111
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ YLHE +IHRDIK++N+L K++DFG++ +D S GT +M
Sbjct: 112 LAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWM 166
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
PE + + SD++S G ++E+L+G
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 49/302 (16%)
Query: 466 KIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
++G G FG V D G QVAVK S +E + F E+E L
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG----------EEQHRSDFEREIEIL 60
Query: 521 SRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVA 576
L H+N+V+ G CE R LI EYL +G+L D+L H Q + + +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR-----LLLFS 115
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+G++YL IHRD+ + N+L+++ K+SDFGL+ + PED + + +
Sbjct: 116 SQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV-KEP 171
Query: 637 GT--VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
G + + PE R + + SDV+SFGV L E+ + + + +P ++
Sbjct: 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-----YGDPSQSPPAEFLRMIGIA 226
Query: 695 VRDEIH----RVLDRNV----PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
I +L PP P E V L C E ++RPS +++ +
Sbjct: 227 QGQMIVTRLLELLKEGERLPRPPSCPDE------VYDLMKLCWEAEPQDRPSFADLILIV 280
Query: 747 ER 748
+R
Sbjct: 281 DR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
IG G FG V G +VAVK K AF+ E ++ L H
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKC------------LKDDSTAAQAFLAEASVMTTLRHP 60
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586
NLV+LLG N ++ EY+ G+L D+L + + + ++ ALD G+EYL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYL 118
Query: 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG-TVGYMDPE 645
E + +HRD+ + NVL+ AKVSDFGL+ E+ + V + PE
Sbjct: 119 EE---KNFVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPE 169
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705
R ++ + KSDV+SFG++L EI S R + PR + VVP++ + +R+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPHVEKG--YRMEAP 221
Query: 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
PP ++ + DC L+ RP+ ++ L
Sbjct: 222 EGCPPEVYK---------VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IG GSFG VY DG +K ++S+ S ++++++A +NE++ L +L+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--------EKEREDA-LNEVKILKKLN 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N+++ E++ + ++ EY + G L + + + + ++
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH I+HRDIK N+ L + K+ DFG+S + + ++ GT Y+ P
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSP 172
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674
E + + KSD++S G VL E+ +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
KIG G FG VYKA G +VA+K ++ S ++K INE++ L +
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----------KEKKEKIINEIQILKKC 54
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALDAARG 582
H N+V+ G ++E ++ E+ G+L D L + ++ L S A V + +G
Sbjct: 55 KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--TNQTLTESQIA--YVCKELLKG 110
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG-PEDDESHLSLRAAGTVGY 641
+EYLH IIHRDIK++N+LL + K+ DFGLS + + GT +
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYW 163
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
M PE + K+D++S G+ +E+ G
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-H 524
K+G GSFG VY A D VA+K S + + F+ E++ L+ L H
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLES--------KSKEVERFLREIQILASLNH 56
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
N+V+L F +D L+ EY++ G+L D L PL + + +E
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE-SEALFILAQILSALE 115
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLS-LIGPEDDESHLSLRAA---GTV 639
YLH IIHRDIK N+LLD K+ DFGL+ L+ S + + GT
Sbjct: 116 YLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 640 GYMDPEYYRLQQL---TEKSDVYSFGVVLLEILSGYR 673
GYM PE L + SD++S G+ L E+L+G
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 67/253 (26%), Positives = 114/253 (45%), Gaps = 36/253 (14%)
Query: 447 EEFSLEILLEA---TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIG 502
+ +L+ ++ + KIG G+ G VYKAT G +VA+K+ +
Sbjct: 4 LKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL--------- 54
Query: 503 TKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS 562
++ INE+ + H N+V +E ++ EY++ G+L D + Q+
Sbjct: 55 ---RKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--QN 109
Query: 563 SSPLKSWPARIK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621
+ +I V + +G+EYLH V IHRDIKS N+LL + K++DFG +
Sbjct: 110 FVRMNE--PQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAA 164
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY--------- 672
++ S+ GT +M PE + + K D++S G++ +E+ G
Sbjct: 165 QLTKEKSKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222
Query: 673 RAIHR-THNGTPR 684
RA+ T G P
Sbjct: 223 RALFLITTKGIPP 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 79/235 (33%), Positives = 112/235 (47%), Gaps = 30/235 (12%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE---D 508
EI L A F E+ +G G+FG VYK L E S +S AI T ++
Sbjct: 1 EIPLSAVR-FLEE--LGEGAFGKVYKGEL-------TGPNERLSATSVAIKTLKENAEPK 50
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQS---- 562
F E E +S L H N+V LLG C +++EYL +G LH+ L ++P S
Sbjct: 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 563 -------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615
S L + +A+ A G+EYL + +HRD+ + N L+ T K+S
Sbjct: 111 ESGDETVKSSL-DCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKIS 166
Query: 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
DFGLS D + ++ V +M PE + T +SD++SFGVVL EI S
Sbjct: 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 80/292 (27%), Positives = 129/292 (44%), Gaps = 53/292 (18%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
KIG G+FG VYK L ++VAVK + + K F+ E E L + H
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---------PDLKRK-FLQEAEILKQYDH 51
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
N+V+L+G C + ++ E + G+L L ++ +K ++++LDAA G+EY
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEY 108
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT----VGY 641
L + IHRD+ + N L+ K+SDFG+S ++E + + G + +
Sbjct: 109 LES---KNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKW 161
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--IVRDEI 699
PE + T +SDV+S+G++L E S PY + +
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLG-----------------DTPYPGMSNQQT 204
Query: 700 HRVLDRN--VPPP--TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
++ +P P P EI L C + NRPS +EI N L+
Sbjct: 205 RERIESGYRMPAPQLCPEEIYR------LMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 45/231 (19%)
Query: 467 IGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQ---EDKDNAFINELESLSR 522
IG GSF V A + + A+K + KRQ E K E E L+R
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILD-----------KRQLIKEKKVKYVKIEKEVLTR 57
Query: 523 L-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA--LDA 579
L H +++L +D + EY NG L ++ S K R A L A
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKC--TRFYAAEILLA 114
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL------ 633
+EYLH IIHRD+K N+LLD K++DFG + + + +
Sbjct: 115 ---LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 634 ---------RAA---GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
R A GT Y+ PE + + SD+++ G ++ ++L+G
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G+G FG V+ T + ++VAVK + + S AF+ E + + +L H
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP------------EAFLQEAQIMKKLRH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV+L C + ++ EY+ G+L D L + + L+ P + +A A G+ Y
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LR-LPQLVDMAAQIAEGMAY 118
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGTVGYMDP 644
L IHRD+ + N+L+ K++DFGL+ LI EDDE A + + P
Sbjct: 119 LESRNY---IHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAP 173
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEI 668
E + T KSDV+SFG++L EI
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 460 NFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+F +KIG GSFG V+K D A+K+ ++S + + +E I+E
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----RRERE----EAIDEAR 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS---WPARIKV 575
L++L ++R D+ + ++ EY ENG LH L Q PL W I++
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQI 110
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
L G+ +LH I+HRDIKS N+ LDA K+ D G++ + D ++ +
Sbjct: 111 LL----GLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTI 161
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
GT Y+ PE + EKSDV++ GVVL E +G P+
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH------------------PFDA 203
Query: 696 RDEIHRVLD--RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
++ +L R V PP + L C+T + R RP +++
Sbjct: 204 NNQGALILKIIRGVFPPVSQMYSQQ--LAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 81/296 (27%), Positives = 144/296 (48%), Gaps = 54/296 (18%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G++G VY A + G +AVK+ E+ +T + RQ+D A +E+E+L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIA-GRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 526 KNLVRLLGFCEDRNERVLIY-EYLENGTLHDHLHNPQSSSP--LKSWPARIKVALDAARG 582
N+V+ LGF E E + I+ EY+ G++ L ++ + ++ G
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEG 120
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE--DDESHLSLRAAGTVG 640
+ YLH I+HRD+K+ N+L+DA K+SDFG+S + D++ ++S++ G+V
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVF 175
Query: 641 YMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
+M PE + K D++S G V+LE+ +G R P+ +E
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR------------------PW-SDEE 216
Query: 699 ----IHRVLDRNVPPPTPFEI------EAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+ ++ ++ PP P ++ A+ ++ C T+ NRP+ E++
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLN----ACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 57/290 (19%)
Query: 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G GS G VYK G A+K+ I E+ + EL++L
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKK----------IHVDGDEEFRKQLLRELKTLRSC 56
Query: 524 HHKNLVRLLG-FCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVALDA 579
+V+ G F + + ++ EY++ G+L D L + P + +A
Sbjct: 57 ESPYVVKCYGAFY--KEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQI 108
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA--- 636
+G++YLH IIHRDIK SN+L+++ K++DFG+S L
Sbjct: 109 LKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGIS--------KVLENTLDQCN 158
Query: 637 ---GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV--V 691
GTV YM PE + + + +D++S G+ LLE G P F +
Sbjct: 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG------KFPFLPPGQPSFFELM 212
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741
I P F E ++ + C+ + + RPS E
Sbjct: 213 QAICDGPPPS------LPAEEFSPEFRDFI----SACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/228 (32%), Positives = 108/228 (47%), Gaps = 34/228 (14%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI----NELES 519
+KIG G+FG VY A LD G +AVK EI R +D D I +E++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVK--EI-----------RIQDNDPKTIKEIADEMKV 52
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIY-EYLENGTLHDHLHNPQSSSPLKSWPARIKV-AL 577
L L H NLV+ G E E+V I+ EY GTL + L + + I+V L
Sbjct: 53 LELLKHPNLVKYYGV-EVHREKVYIFMEYCSGGTLEELLEHGRILDE-----HVIRVYTL 106
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL-IGPEDDESHLSLRA- 635
G+ YLH + I+HRDIK +N+ LD K+ DFG ++ + +++
Sbjct: 107 QLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 636 AGTVGYMDPEYYRLQQLTEK---SDVYSFGVVLLEILSGYRAIHRTHN 680
AGT YM PE + +D++S G V+LE+ +G R N
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 87/284 (30%), Positives = 130/284 (45%), Gaps = 44/284 (15%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G FGAV + G +VAVK + T+ AF+ E +++LHH
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA-------------QAFLEETAVMTKLHH 58
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
KNLVRLLG N ++ E + G L + L L S ++ +LD A G+EY
Sbjct: 59 KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEY 115
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED-DESHLSLRAAGTVGYMDP 644
L ++HRD+ + N+L+ AKVSDFGL+ +G D S L V + P
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTAP 166
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD 704
E + ++ + KSDV+S+GV+L E+ S RA + P + E+ ++
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY---------------PKMSLKEVKECVE 211
Query: 705 RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ P A YV L C E + RPS ++ LE+
Sbjct: 212 KGYRMEPPEGCPADVYV--LMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 59/298 (19%)
Query: 447 EEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQ 506
EEF+LE K+GSG FG V++ + +VA+K +
Sbjct: 6 EEFTLE------------RKLGSGYFGEVWEGLWKNRVRVAIK-------------ILKS 40
Query: 507 EDKDNA--FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNP---- 560
+D F E+++L RL HK+L+ L C +I E +E G+L L +P
Sbjct: 41 DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV 100
Query: 561 QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ L I +A A G+ YL E + IHRD+ + N+L+ KV+DFGL+
Sbjct: 101 LPVASL------IDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLA 151
Query: 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN 680
+ ED +LS + PE + KSDV+SFG++L E+ T+
Sbjct: 152 RLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF--------TYG 201
Query: 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS 738
P P + E++ + P P + Y L C E +RPS
Sbjct: 202 QVP-------YPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE--CWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+IGSG FG V+ + +VA+K + S +ED FI E + + +L H
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--------EED----FIEEAQVMMKLSH 58
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV+L G C +R+ L++E++E+G L D+L ++ S + + LD G+ Y
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
L ++IHRD+ + N L+ KVSDFG++ DD+ S V + PE
Sbjct: 116 LES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPE 171
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILS 670
+ + + KSDV+SFGV++ E+ S
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 467 IGSGSFGAVYKAT---LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+GSG+FG VYK + ++ V + +S + ++E ++ +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK--------ANKEILDEAYVMASV 66
Query: 524 HHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDA 579
H ++VRLLG C + +V LI + + G L D++ N + S L +W +I
Sbjct: 67 DHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------ 118
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
A+G+ YL E ++HRD+ + NVL+ K++DFGL+ L+ ++ E H G
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE---GGK 172
Query: 639 V--GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
V +M E + T KSDV+S+GV + E++ T P + V
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELM--------TFGAKPYEGIPAV------ 218
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
EI +L++ P P Y+ + C ++ +RP+ E++N +
Sbjct: 219 -EIPDLLEKGERLPQPPICTIDVYM--VLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 465 HKIGSGSFGAVYKATLDD--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG G FG V L D G++VAVK + +T+ AF+ E +++
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATA-------------QAFLAEASVMTQ 55
Query: 523 LHHKNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
L H NLV+LLG E++ ++ EY+ G+L D+L + S + +K +LD
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCE 113
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
+EYL + +HRD+ + NVL+ AKVSDFGL+ + S V +
Sbjct: 114 AMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 165
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701
PE R ++ + KSDV+SFG++L EI S R + PR + VVP + ++ ++
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPRV--EKGYK 217
Query: 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ + PP +++ C L+ RPS ++ LE
Sbjct: 218 MDAPDGCPPVVYDV---------MKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 467 IGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G G+FG V+ +D VAVK + KD F E E L
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVK--------TLKETASNDARKD--FEREAELL 62
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR------ 572
+ H+N+V+ G C + + ++++EY+E+G L+ L H P ++
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 573 --IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
+++A+ A G+ YL A +HRD+ + N L+ K+ DFG+S D +
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDVYTT 175
Query: 631 LSLRAAGT----VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
R G + +M PE ++ T +SDV+SFGVVL EI +
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G+G+ G V K G +AVK + + + EL+ L + +
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA----------IQKQILRELDILHKCN 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVALDAARG 582
+V G + + + EY++ G+L L + + P RI K+A+ +G
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRI---PERILGKIAVAVLKG 112
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVG 640
+ YLHE IIHRD+K SN+L+++ K+ DFG+S L+ + L+ GT
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NS---LAKTFVGTSS 164
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
YM PE + + KSD++S G+ L+E+ +G R + N P + + ++ YIV
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATG-RFPYPPENDPPDGIFE-LLQYIV----- 217
Query: 701 RVLDRNVPPPT----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742
N PPP F + +V C+ + R RPS E+
Sbjct: 218 -----NEPPPRLPSGKFSPDFQDFV----NLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/214 (32%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IGSGSFG+VY G +AVK+ E+ S S A R+ +A E+ L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVS--ASSKDRKRSMLDALAREIALLKELQH 65
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS--SSPLKSWPARIKVALDAARGI 583
+N+V+ LG D + + EY+ G++ L+N + + ++++ +I +G+
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS------LIGPEDDESHLSLRAAG 637
YLH IIHRDIK +N+L+D K+SDFG+S + + + + SL+ G
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--G 174
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+V +M PE + T K+D++S G +++E+L+G
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 460 NFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF 513
N E +G G FG V+ A + V VK A+ + E+ + F
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK----------ALQKTKDENLQSEF 55
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL------HNPQSSSPLK 567
EL+ +L HKN+VRLLG C + +I EY + G L L PL
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ ++ + A G+++L + +HRD+ + N L+ + KVS LS +
Sbjct: 116 T-KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNS 170
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
E + A + ++ PE + + KSDV+SFGV++ E+ +
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 76/301 (25%), Positives = 134/301 (44%), Gaps = 46/301 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
++ ++ IG+G FG V++ L VA+K + T E + F+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----------EKQRQDFL 54
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-SPLKSWPARI 573
+E + + H N++RL G ++I EY+ENG L +L + S + +
Sbjct: 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ----LV 110
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+ A G++YL + + +HRD+ + N+L+++ KVSDFGLS + +D E +
Sbjct: 111 GMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 634 RAAGT-VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691
+ + PE ++ T SDV+SFG+V+ E++S G R
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER------------------ 209
Query: 692 PY--IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
PY + E+ + ++ P P + + Y L C + RP +IVN L++
Sbjct: 210 PYWDMSNHEVMKAINDGFRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLDKL 267
Query: 750 L 750
L
Sbjct: 268 L 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 62/303 (20%)
Query: 467 IGSGSFGAVYKATL----DDGS--QVAVK-RAEISSTSSYAIGTKRQEDKDNAFINELES 519
+G G+FG VY+ D QVAVK E S Q++ D F+ E
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---------EQDESD--FLMEALI 62
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH----NPQSSSPLKSWPARIKV 575
+S+ +H+N+VRL+G +R R ++ E + G L L P+ S L + +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL-TMKDLLFC 121
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFGLSLIGPEDDESHLS 632
A D A+G +YL E IHRDI + N LL AK++DFG++
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691
RA + +M PE + T K+DV+SFGV+L EI S GY N + V++FV
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVT 235
Query: 692 -------PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
P ++R++ DC +RP+ I+
Sbjct: 236 GGGRLDPPKGCPGPVYRIM----------------------TDCWQHTPEDRPNFATILE 273
Query: 745 SLE 747
++
Sbjct: 274 RIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G+G FG V++ ++ + VAVK + GT +D F+ E + + +L H
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVK--------TLKPGTMDPKD----FLAEAQIMKKLRH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
L++L C ++ E ++ G+L ++L + LK P I +A A G+ Y
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LK-LPQLIDMAAQVASGMAY 118
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD-ESHLSLRAAGTVGYMDP 644
L + IHRD+ + NVL+ KV+DFGL+ + ED E+ + + + P
Sbjct: 119 LEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAP 173
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILS 670
E + + KSDV+SFG++L EI++
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 467 IGSGSFGAVYKATL--DDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G FG+V + L DDGSQ VAVK ++ + I E+ F++E +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-----EE----FLSEAACMKD 57
Query: 523 LHHKNLVRLLGFC---EDRNE---RVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR--IK 574
H N+++L+G C + ++I ++++G LH L + + P + +K
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
+D A G+EYL + + IHRD+ + N +L T V+DFGLS D
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
A V ++ E + T KSDV++FGV + EI T TP P +
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA--------TRGQTP-------YPGV 219
Query: 695 VRDEIHRVLDR----NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
EI+ L P E+ + Y C + ++RP+ T++ LE L
Sbjct: 220 ENHEIYDYLRHGNRLKQPEDCLDELYDLMY------SCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
++G+G FG V VA+K + S S ED+ FI E + + +L H
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDE---FIEEAKVMMKLSH 58
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGT----LHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+ LV+L G C + ++ EY+ NG L +H Q S L ++ D
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-------EMCKDVCE 111
Query: 582 GIEYL--HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
G+ YL ++ IHRD+ + N L+D KVSDFGLS DDE S+ + V
Sbjct: 112 GMAYLESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPV 165
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ PE + + KSDV++FGV++ E+ S
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 78/282 (27%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G+G FG V+ + ++VA+K + S S AF+ E + +L H
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP------------EAFLAEANLMKQLQH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LVRL + +I EY+ENG+L D L P+ + I +A A G+ +
Sbjct: 61 PRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAF 117
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
+ + IHRD++++N+L+ T K++DFGL+ + ED+E A + + PE
Sbjct: 118 IER---KNYIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 173
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705
T KSDV+SFG++L EI+ T+ P P + E+ + L+R
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIV--------TYGRIP-------YPGMTNPEVIQNLER 218
Query: 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
P P Y L C + RP+ + + LE
Sbjct: 219 GYRMPRPDNCPEELY--ELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+ K+G+G FG V+ AT + ++VAVK + S S AF+ E + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------------EAFLAEANVMKTL 58
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS-PLKSWPARIKVALDAARG 582
H LV+L + +I E++ G+L D L + + S PL P I + A G
Sbjct: 59 QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEG 114
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ ++ + + IHRD++++N+L+ A+ K++DFGL+ + ED+E A + +
Sbjct: 115 MAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWT 170
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILS 670
PE T KSDV+SFG++L+EI++
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT--KRQEDKDNAF---INELESLS 521
+G GSFG V D ++ YA+ K++ K + E LS
Sbjct: 1 LGKGSFGKVLLVRKKDTGKL------------YAMKVLKKKKIIKRKEVEHTLTERNILS 48
Query: 522 RLHHKNLVRLL-GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
R++H +V+L F + + L+ EY G L HL AR A +
Sbjct: 49 RINHPFIVKLHYAF-QTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAA-EIV 103
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+EYLH II+RD+K N+LLDA K++DFGL+ + + GT
Sbjct: 104 LALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPE 158
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE + + D +S GV+L E+L+G
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
NF + KIG G F VYKA L DG VA+K+ +I K ++D + E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD----AKARQD----CLKE 52
Query: 517 LESLSRLHHKNLVRLL-GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
++ L +L H N+++ L F E+ NE ++ E + G L + + + L K
Sbjct: 53 IDLLKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
+ +E++H I+HRDIK +NV + AT K+ D GL + SL
Sbjct: 112 FVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
GT YM PE KSD++S G +L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 467 IGSGSFG--AVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+G G+FG +Y+ T +D S V K ++ S +++ +A +NE+ LS L
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSE--------KERRDA-LNEIVILSLLQ 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL--DAARG 582
H N++ D N ++ EY GTL+D + + + + + +
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSA 113
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ Y+H+ I+HRDIK+ N+ L K+ DFG+S I E ++ GT YM
Sbjct: 114 VSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYM 168
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
PE + + KSD+++ G VL E+L+ + RT + T N ++ VV IV+
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLT----LKRTFDAT--NPLNLVVK-IVQGN---- 217
Query: 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
P + + E ++ V + + RP+ E++
Sbjct: 218 ---YTPVVSVYSSELISLV----HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 78/298 (26%), Positives = 123/298 (41%), Gaps = 58/298 (19%)
Query: 465 HKIGSGSFGAVYKAT--LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA---FINELES 519
++G G+FG+V K + G +V V A+ T +QE F+ E
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEV-----------AVKTLKQEHIAAGKKEFLREASV 49
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVAL 577
+++L H +VRL+G C+ +L+ E G L +L + S LK A
Sbjct: 50 MAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AH 102
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA 636
A G+ YL +HRD+ + NVLL AK+SDFG+S +G + A
Sbjct: 103 QVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTA 157
Query: 637 GT--VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS----GYRAIHRTHNGTPRNVVDFV 690
G + + PE + + KSDV+S+GV L E S Y + V+ +
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM------KGAEVIAML 211
Query: 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ R L R P P EI + + C +RP+ +E+ ++ R
Sbjct: 212 ------ESGER-LPR--PEECPQEIYS------IMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 92/306 (30%), Positives = 136/306 (44%), Gaps = 34/306 (11%)
Query: 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSS----YAIGTKRQEDKDNA--- 512
NF E K+G G FG V+ D + K + + A+ R + DNA
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLH-----NPQSSSP 565
F+ E++ LSRL N+ RLLG C + L I EY+ENG L+ L +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 566 LKSWPAR--IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
KS + +A A G+ YL + +HRD+ + N L+ +T K++DFG+S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
D + RA + +M E L + T KSDV++FGV L EIL+ R H
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
Query: 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEI 742
+ V++ + D L R PP P +I Y L +C + +RP+ EI
Sbjct: 241 Q-VIENAGHFFRDDGRQIYLPR--PPNCPKDI-------YELMLECWRRDEEDRPTFREI 290
Query: 743 VNSLER 748
L+R
Sbjct: 291 HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G+G FG V+ ++ ++VAVK + + S AF+ E + L H
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV------------QAFLEEANLMKTLQH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LVRL +I EY+ G+L D L + + L P I + A G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
+ + IHRD++++NVL+ + K++DFGL+ + ED+E A + + PE
Sbjct: 119 IER---KNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 174
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILS 670
T KSDV+SFG++L EI++
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 81/294 (27%), Positives = 134/294 (45%), Gaps = 53/294 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG G FG V + L + VA+K + S+ K++ D F+ E + +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS------DKQRLD----FLTEASIMGQ 61
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVALDAAR 581
H N++RL G ++I EY+ENG+L L N + + + + A
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQ----LVGMLRGIAS 117
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG---T 638
G++YL E + +HRD+ + N+L+++ KVSDFGLS ++S + G
Sbjct: 118 GMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIP 171
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY---I 694
+ + PE ++ T SDV+SFG+V+ E++S G R PY
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER------------------PYWDMS 213
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+D I V D PP P + + Y L DC + RP+ ++IV++L++
Sbjct: 214 NQDVIKAVEDGYRLPP-PMDCPSALY--QLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG GSFG V K DG + K EI Y T E + ++E+ L L
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWK--EID----YGNMT---EKEKQQLVSEVNILRELK 57
Query: 525 HKNLVRLLGFCEDR-NERVLIY-EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
H N+VR DR N+ + I EY E G L + + ++
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 583 IEYLH--EYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+ H +++HRD+K +N+ LDA K+ DFGL+ I D S A VG
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTYVG 172
Query: 641 ---YMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
YM PE EKSD++S G ++ E+ +
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 68/225 (30%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNA---FINELESLSR 522
IG G+FG V D ++ A+K ++ K++ + + +NE L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMK--YMN---------KQKCVEKGSVRNVLNERRILQE 56
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVALDAA 580
L+H LV L +D L+ + L G L HL S +K W I +AL+
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE-- 114
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
YLH IIHRDIK N+LLD ++DF ++ D L+ +GT G
Sbjct: 115 ----YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPG 164
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685
YM PE Q + D +S GV E L G R H+ T R+
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR-GHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 86/300 (28%), Positives = 136/300 (45%), Gaps = 36/300 (12%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSY----AIGTKRQEDKDNA---FINELE 518
K+G G FG V+ + + + + + A+ R + NA F+ E++
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN---------------PQSS 563
LSRL N++RLLG C D + +I EY+ENG L+ L + P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
P S+ + + VAL A G++YL + + +HRD+ + N L+ T K++DFG+S
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
D + RA + +M E + + T SDV++FGV L EIL + T
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE-QPYGELTD 247
Query: 684 RNVVDFVVPYIVRDEIHRV-LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742
V++ RD+ +V L R PPP P + L C + + R RPS ++I
Sbjct: 248 EQVIE-NAGEFFRDQGRQVYLFR--PPPCPQGLYE------LMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI--GTKRQEDKDNAFINELESLSRLH 524
+GSG FG V+ VA+K I G ++D FI E + + +L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK----------MIREGAMSEDD----FIEEAKVMMKLS 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H NLV+L G C + ++ EY+ NG L ++L + + + D +E
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAME 114
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS---LIGPEDDESHLSLRAAGTVGY 641
YL IHRD+ + N L+ KVSDFGL+ L DD+ S V +
Sbjct: 115 YLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----DDQYTSSQGTKFPVKW 167
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE + + + KSDV+SFGV++ E+ S
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKD--NAFINELESLSRLH 524
IG G FG VY TL D + A + S + R D + F+ E +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCA-VKSLN-------RITDLEEVEQFLKEGIIMKDFS 54
Query: 525 HKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H N++ LLG C +++ Y+++G L + + + + +K I L A+G+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGM 111
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGY 641
EYL A +HRD+ + N +LD ++T KV+DFGL+ + E H A V +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
M E + Q+ T KSDV+SFGV+L E+++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI--GTKRQEDKDNAFINELESLSRL 523
++GSG FG V+ +VA+K AI G +ED FI E + + +L
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK----------AINEGAMSEED----FIEEAKVMMKL 56
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H LV+L G C + ++ E++ENG L ++L Q S + + D G+
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKL---SKDMLLSMCQDVCEGM 113
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYL S IHRD+ + N L+ +T KVSDFG++ DDE S A V +
Sbjct: 114 EYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSP 169
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILS 670
PE + + + KSDV+SFGV++ E+ +
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 51/308 (16%)
Query: 464 DHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA-FINE 516
+G G+FG V KA ++ S VAVK + +T +KD + ++E
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-----------EKDLSDLVSE 65
Query: 517 LESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQ----------SS 563
+E + + HKN++ LLG C ++ EY +G L D L P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
+ + A ARG+E+L A IHRD+ + NVL+ K++DFGL+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
D + V +M PE + T +SDV+SFGV+L EI T G+P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF--------TLGGSP 234
Query: 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
+ + + E +R +++ P E+ L DC RP+ ++V
Sbjct: 235 YPGIPVEELFKLLKEGYR-MEK--PQNCTQELYH------LMRDCWHEVPSQRPTFKQLV 285
Query: 744 NSLERALA 751
L+R L
Sbjct: 286 EDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSS----YAIGTKRQEDKDNA---FINELE 518
K+G G FG V+ + + K + + + A+ R++ NA F+ E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQ-----SSSPLKSWPA 571
+SRL N++RLL C + +I EY+ENG L+ L H PQ + S+
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
I +A A G++YL + +HRD+ + N L+ +T K++DFG+S D +
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
RA + +M E L + T SDV++FGV L EIL+
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 87/316 (27%), Positives = 136/316 (43%), Gaps = 60/316 (18%)
Query: 461 FSEDH-----KIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
F E H ++G G+FG+V D G VAVK+ + S+ D
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-------LRD-- 51
Query: 511 NAFINELESLSRLHHKNLVRLLGFC--EDRNERVLIYEYLENGTLHDHLHNPQS---SSP 565
F E+E L L H N+V+ G C R L+ EYL G+L D+L +
Sbjct: 52 --FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK 109
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625
L + ++I +G+EYL +HRD+ + N+L+++ K+ DFGL+ + P+
Sbjct: 110 LLLYASQI------CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160
Query: 626 DDESHLSLRAAGT--VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
D E + +R G + + PE + + SDV+SFGVVL E+ + + + +P
Sbjct: 161 DKE-YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YSDKSCSP 214
Query: 684 RNVV------DFVVPYIVRDEIHRVLDRN----VPPPTPFEIEAVAYVGYLAADCVTLEG 733
D IV I +L N PP P EI A + +C +
Sbjct: 215 PAEFMRMMGNDKQGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYA------IMKECWNNDP 267
Query: 734 RNRPSMTEIVNSLERA 749
RPS +E+ +E
Sbjct: 268 SQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-22
Identities = 76/223 (34%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-H 524
IG G+FG V +A + DG ++ A I +A E+ F ELE L +L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMN---AAIKMLKEFA-----SENDHRDFAGELEVLCKLGH 61
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA------------- 571
H N++ LLG CE+R + EY G L D L + S L++ PA
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 572 --RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
++ A D A G++YL E IHRD+ + NVL+ +K++DFGLS +E
Sbjct: 119 QQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEV 171
Query: 630 HLSLRAAG--TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
++ + G V +M E T KSDV+SFGV+L EI+S
Sbjct: 172 YVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 95/308 (30%), Positives = 138/308 (44%), Gaps = 65/308 (21%)
Query: 467 IGSGSFGAVYKATL-DDGSQV--AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
IG G+FG V KA + DG ++ A+KR + YA +D F ELE L +L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYA-----SKDDHRDFAGELEVLCKL 64
Query: 524 -HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA----------- 571
HH N++ LLG CE R L EY +G L D L + S L++ PA
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTL 121
Query: 572 ----RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ A D ARG++YL + IHRD+ + N+L+ + AK++DFGLS G E
Sbjct: 122 SSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQE-- 175
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQL-----TEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
+ T+G + + ++ L T SDV+S+GV+L EI+S GT
Sbjct: 176 -----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGT 222
Query: 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742
P + E++ L + P + Y L C + RPS +I
Sbjct: 223 PYCGMTCA-------ELYEKLPQGYRLEKPLNCDDEVY--DLMRQCWREKPYERPSFAQI 273
Query: 743 VNSLERAL 750
+ SL R L
Sbjct: 274 LVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 40/230 (17%)
Query: 466 KIGSGSFGAVYKATLDDGSQ---------------VAVK--RAEISSTSSYAIGTKRQED 508
K+G G FG V+ + ++ VAVK RA+++ T+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR---------- 61
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS---- 564
N F+ E++ +SRL + N++RLLG C + +I EY+ENG L+ L + S
Sbjct: 62 --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 565 ----PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
P S + +A+ A G++YL A + +HRD+ + N L+ +T K++DFG+S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
D + RA + +M E L + T SDV++FGV L E+ +
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 459 NNFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N+ +G G+FG VY +D G ++AVK+ S + + NA E+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET------KKEVNALECEI 55
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIY-EYLENGTLHDHL--HNPQSSSPLKSWPARIK 574
+ L L H+ +V+ G C +E + I+ EY+ G++ D L + + + + + +I
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI- 113
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
G+EYLH I+HRDIK +N+L D+ K+ DFG S S ++
Sbjct: 114 -----LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 635 A-AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ GT +M PE + K+DV+S G ++E+L+
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 77/223 (34%), Positives = 108/223 (48%), Gaps = 38/223 (17%)
Query: 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-H 524
IG G+FG V KA + DG ++ A I YA +D F ELE L +L H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRM---DAAIKRMKEYA-----SKDDHRDFAGELEVLCKLGH 54
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA------------- 571
H N++ LLG CE R L EY +G L D L + S L++ PA
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSS 111
Query: 572 --RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
+ A D ARG++YL + IHRD+ + N+L+ + AK++DFGLS E
Sbjct: 112 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEV 164
Query: 630 HLSLRAAG--TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
++ + G V +M E T SDV+S+GV+L EI+S
Sbjct: 165 YVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 74/289 (25%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
IG+G FG V + L ++ KR + + G ++ +D F++E + + H
Sbjct: 12 IGAGEFGEVCRGRL----KLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQFDHP 65
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLH-NPQSSSPLKSWPARIKVALDAARGIEY 585
N++ L G ++I E++ENG L L N + ++ + + A G++Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ----LVGMLRGIAAGMKY 121
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED--DESHLS-LRAAGTVGYM 642
L E + +HRD+ + N+L+++ KVSDFGLS +D D ++ S L + +
Sbjct: 122 LSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701
PE ++ T SDV+S+G+V+ E++S G R N N ++
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE------------- 225
Query: 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
D +PPP ++ + L DC + RP +IV++L++ +
Sbjct: 226 -QDYRLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 72/284 (25%), Positives = 132/284 (46%), Gaps = 32/284 (11%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
IG+G FG V L ++ KR + + G ++ +D F++E + + H
Sbjct: 12 IGAGEFGEVCSGRL----KLPGKREIPVAIKTLKAGYTEKQRRD--FLSEASIMGQFDHP 65
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586
N++ L G +++ EY+ENG+L L + ++ A G++YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL 122
Query: 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT-VGYMDPE 645
+ +HRD+ + N+L+++ KVSDFGLS + +D E+ + R + + PE
Sbjct: 123 SDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD 704
++ T SDV+S+G+V+ E++S G R N ++V+ + +E +R+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAI------EEGYRL-- 228
Query: 705 RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
P P + A + L DC + RP +IV+ L++
Sbjct: 229 -----PAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 17/213 (7%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+F K+G GS+G+VYK L D A+K ++ S S Q+++++A +NE+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--------QKEREDA-VNEIR 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L+ ++H N++ D N+ ++ EY G L + + L ++ +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
RG++ LHE I+HRD+KS+N+LL A K+ D G+S + + +++ GT
Sbjct: 112 LLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGT 164
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
YM PE ++ + + KSD++S G +L E+ +
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 466 KIGSGSFGAVYKATLDDGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
K+G GSFG V + VAVK + + + D + F+ E +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK----------CLKSDKLSDIMDDFLKEAAIMH 51
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI-KVALDAA 580
L H+NL+RL G + +++ E G+L D L L S + A+ A
Sbjct: 52 SLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLIS---TLCDYAVQIA 107
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD-----ESHLSLRA 635
G+ YL IHRD+ + N+LL + K+ DFGL P+++ E HL +
Sbjct: 108 NGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
A + PE R + + SDV+ FGV L E+ +
Sbjct: 165 A----WCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 54/300 (18%)
Query: 467 IGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G GSFG VY+ ++VA+K +++ + F+NE +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM----------RERIEFLNEASVM 63
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQS-SSPLKSWPARIKV-- 575
+ ++VRLLG +++ E + G L +L P++ ++P P K
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 576 -ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
A + A G+ YL +HRD+ + N ++ T K+ DFG++ E D +
Sbjct: 124 MAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS----GYRAIHRTHNGTPRNVVDFV 690
V +M PE + T KSDV+SFGVVL E+ + Y+ + + V+ F
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL------SNEEVLKF- 233
Query: 691 VPYIVRDEIHRVLDRNV--PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
V+D P + + L C + RP+ EIV+SL+
Sbjct: 234 -----------VIDGGHLDLPENCPD-----KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-21
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+G+F + Y+A + G+ +AVK+ +S QE+ A E+ ++RL+H
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-----SEQEEVVEALRKEIRLMARLNH 62
Query: 526 KNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHN--PQSSSPLKSWPARIKVALDAARG 582
+++R+LG CED + + + E++ G++ L + + I RG
Sbjct: 63 PHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVI------INYTEQLLRG 115
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKVSDFG----LSLIGPEDDESHLSLRAAG 637
+ YLHE IIHRD+K +N+L+D+T +++DFG L+ G E + G
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLG 170
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
T+ +M PE R +Q DV+S G V++E+ +
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 72/246 (29%), Positives = 112/246 (45%), Gaps = 26/246 (10%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
+G G+FG V+K TL D + VAVK + I F++E L + H
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI----------KFLSEARILKQYDHP 52
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586
N+V+L+G C R ++ E + G L + K +K ALDAA G+ YL
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL---VKFALDAAAGMAYL 109
Query: 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS--LRAAGTVGYMDP 644
+ IHRD+ + N L+ K+SDFG+S EDD + S L+ + + P
Sbjct: 110 ES---KNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQI-PIKWTAP 163
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVD----FVVPYIVRDEI 699
E + + +SDV+S+G++L E S G N R V+ P D++
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDV 223
Query: 700 HRVLDR 705
++V+ R
Sbjct: 224 YKVMQR 229
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IG G+ G V+KA + G VA+K+ + + + N + E+++L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVAL---------RRLEGGIPNQALREIKALQACQ 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK-VALDAARGI 583
H +V+LL + VL+ EY+ L + L + PL A++K +G+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRD--EERPLP--EAQVKSYMRMLLKGV 112
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
Y+H I+HRD+K +N+L+ A K++DFGL+ + E++ S + A T Y
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRA 168
Query: 644 PE-YYRLQQLTEKSDVYSFGVVLLEILSG 671
PE Y ++ D+++ G + E+L+G
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 88/298 (29%), Positives = 133/298 (44%), Gaps = 46/298 (15%)
Query: 467 IGSGSFGAVYKATLDDGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G G FG+V + L+ +VAVK +I AI T R E +D F++E +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKI------AICT-RSEMED--FLSEAVCMKEF 57
Query: 524 HHKNLVRLLGFCEDRNER------VLIYEYLENGTLHDHLHNPQSSSPLKSWPAR--IKV 575
H N++RL+G C E V+I ++++G LH L + + P + +K
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
D A G+EYL + S IHRD+ + N +L+ V+DFGLS D A
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
V ++ E + T KSDV+SFGV + EI T TP P +
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI--------ATRGQTP-------YPGVE 219
Query: 696 RDEIHRVL---DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
EI+ L +R PP + + + L + C L ++RPS + LE+AL
Sbjct: 220 NSEIYDYLRQGNRLKQPP-----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 80/300 (26%), Positives = 129/300 (43%), Gaps = 37/300 (12%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA-FINELESLSRL-H 524
+G G FG V +A + + R + + T + + DKD A I+E+E + +
Sbjct: 20 LGEGCFGQVVRA---EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN------------PQSSSPLKSWPAR 572
HKN++ LLG C +I EY G L + L + S+
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
+ A ARG+EYL IHRD+ + NVL+ K++DFGL+ + D +
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692
V +M PE + T +SDV+SFG+++ EI T G+P +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF--------TLGGSPYPGIPVEEL 245
Query: 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752
+ + E HR +D+ P E+ L +C RP+ ++V +L++ LAA
Sbjct: 246 FKLLREGHR-MDK--PSNCTHELYM------LMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 62/294 (21%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F K+G GS+G+VYKA + G VA+K + I E+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-------------EIIKEISI 51
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-D 578
L + +V+ G + ++ EY G++ D + + I L
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT----EEEIAAILYQ 107
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAA 636
+G+EYLH IHRDIK+ N+LL+ AK++DFG+S L + +
Sbjct: 108 TLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV----I 160
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVDFVVPY 693
GT +M PE + K+D++S G+ +E+ G Y IH P + F++P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH------PMRAI-FMIP- 212
Query: 694 IVRDEIHRVLDRNVPPPTPFEI------EAVAYVGYLAADCVTLEGRNRPSMTE 741
N PPPT E +V C+ + RPS +
Sbjct: 213 ------------NKPPPT-LSDPEKWSPEFNDFV----KKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 1e-20
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 33/169 (19%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAE-------ISSTSSYAIGTKRQEDKDNA 512
+ + K+G G++G VYKA G VA+K+ I ST+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--------------- 45
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
+ E+ L L H N+V+LL + L++EY + L +L P
Sbjct: 46 -LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNL 99
Query: 573 IK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
IK + RG+ Y H + I+HRD+K N+L++ K++DFGL+
Sbjct: 100 IKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 64/236 (27%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELES 519
+IG G++G VYKA G VA+K+ R E++ F I E++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-------------RMENEKEGFPITAIREIKL 51
Query: 520 LSRLHHKNLVRLLGFC--EDRNERVLIYEYLENGTLHDH---LHNPQSSSPLKSWPARIK 574
L +L H N+VRL + + +++EY++ HD L +P+ K ++IK
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEV----KFTESQIK 103
Query: 575 -VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
G++YLH I+HRDIK SN+L++ K++DFGL+ +
Sbjct: 104 CYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA--------RPYTK 152
Query: 634 RAAG-------TVGYMDPE-------YYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675
R + T+ Y PE Y + D++S G +L E+ G + I
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 40/284 (14%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G G FG V+ T + ++VA+K + + S AF+ E + + +L H
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------------EAFLQEAQVMKKLRH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
+ LV+L + ++ EY+ G+L D L + L+ P + +A A G+ Y
Sbjct: 61 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG-EMGKYLR-LPQLVDMAAQIASGMAY 117
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
+ + +HRD++++N+L+ KV+DFGL+ + ED+E A + + PE
Sbjct: 118 VERM---NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 173
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--IVRDEIHRVL 703
+ T KSDV+SFG++L E+ + R VPY +V E+ +
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQV 216
Query: 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+R P P E + L C E RP+ + LE
Sbjct: 217 ERGYRMPCPPECPESLH--DLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G+ VY A L + +VA+KR ++ K Q D E++++S+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLE---------KCQTSVDEL-RKEVQAMSQCN 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL--DAARG 582
H N+V+ +E L+ YL G+L D + +SS P I + + +G
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKG 114
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVG 640
+EYLH IHRDIK+ N+LL + K++DFG+S L D + GT
Sbjct: 115 LEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 641 YMDPEYYRLQQL---TEKSDVYSFGVVLLEILSG 671
+M PE ++Q+ K+D++SFG+ +E+ +G
Sbjct: 172 WMAPEV--MEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 465 HKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKD-NAFINELESLSR 522
HK+G G +G VY+ VAVK T +++ + F+ E +
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVK-------------TLKEDTMEVEEFLKEAAVMKE 58
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH--NPQSSSPLKSWPARIKVALDAA 580
+ H NLV+LLG C +I E++ G L D+L N Q + + + +A +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLYMATQIS 114
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD-ESHLSLRAAGTV 639
+EYL + + IHRD+ + N L+ KV+DFGLS + D +H A +
Sbjct: 115 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPI 169
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
+ PE + + KSDV++FGV+L EI T+ +P +D Y + ++
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEI--------ATYGMSPYPGIDLSQVYELLEKG 221
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+R ++R P P + V L C +RPS EI + E
Sbjct: 222 YR-MER--PEGCPPK------VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 467 IGSGSFGAVYKATLDD-------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+GSG+FG VY+ T D +VAVK + G QE K+ F+ E
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVK--------TLRKGATDQEKKE--FLKEAHL 52
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS---PLKSWPARIKVA 576
+S +H N+V+LLG C + +I E +E G L +L + + PL + + +
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLL-----DATWTAKVSDFGLSLIGPEDDESHL 631
LD A+G YL + IHRD+ + N L+ DA K+ DFGL+ D
Sbjct: 113 LDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RDIYKSD 165
Query: 632 SLRAAG----TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
R G V +M PE + T +SDV+SFGV++ EIL+
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 86/317 (27%), Positives = 129/317 (40%), Gaps = 60/317 (18%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVK--RAEISSTSSYAIGTKRQEDKD 510
NN IG G+FG V++A + + VAVK + E S+ D
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA------------DMQ 52
Query: 511 NAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN----------- 559
F E ++ H N+V+LLG C L++EY+ G L++ L +
Sbjct: 53 ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 560 --------PQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611
+ PL S ++ +A A G+ YL E +HRD+ + N L+
Sbjct: 113 STSSARKCGLNPLPL-SCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 168
Query: 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
K++DFGLS D S A + +M PE + T +SDV+++GVVL EI S
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS- 227
Query: 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTL 731
+ + V+ Y VRD VL + P P E+ L C +
Sbjct: 228 -YGMQPYYGMAHEEVI-----YYVRD--GNVL--SCPDNCPLELYN------LMRLCWSK 271
Query: 732 EGRNRPSMTEIVNSLER 748
+RPS I L+R
Sbjct: 272 LPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 39/249 (15%)
Query: 467 IGSGSFGAVY----KATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
I G++G V+ K+T G A+K I ++++ + + E + LS+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKV--IKKAD------MIRKNQVDQVLTERDILSQ 49
Query: 523 LHHKNLVRLL-GFCEDRNERVLIYEYLENGTLHDHLHN----PQSSSPLKSWPARIKVAL 577
+V+L F +N L+ EYL G L L N + + + + A I +AL
Sbjct: 50 AQSPYVVKLYYSFQGKKN-LYLVMEYLPGGDLASLLENVGSLDEDVA--RIYIAEIVLAL 106
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG------PEDDESHL 631
EYLH IIHRD+K N+L+D+ K++DFGLS +G +D+
Sbjct: 107 ------EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR-THNGTPRNVVDFV 690
R GT Y+ PE Q ++ D +S G +L E L G H T +N+++
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
Query: 691 VPYIVRDEI 699
+ + E+
Sbjct: 218 IEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 74/296 (25%), Positives = 115/296 (38%), Gaps = 53/296 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
E ++G G+ G+V K L + + + I++ + + ++Q + ELE
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-ITTDPNPDL--QKQ------ILRELE 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHNPQSSSPLKSWPARI--- 573
+V+ G D + + EY E G+L +K RI
Sbjct: 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK------VKKRGGRIGEK 105
Query: 574 ---KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
K+A +G+ YLH IIHRDIK SN+LL K+ DFG+S E
Sbjct: 106 VLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS------GELV 156
Query: 631 LSLRAA--GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR---THNGTPRN 685
SL GT YM PE + + + SDV+S G+ LLE+ A +R G P
Sbjct: 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV-----AQNRFPFPPEGEPPL 211
Query: 686 VVDFVVPYIVRDEIHRVLD---RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS 738
++ YIV + D + F+ C+ + RP+
Sbjct: 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFK--------DFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG G++G VYKA G VA+K+ + + + A + E++ L L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKK--------IKLRFESEGIPKTA-LREIKLLKELN 56
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLH--DHLHNPQSSSPLKSWPARIKVALDAARG 582
H N+++LL + + L++E+++ S +KS+ ++ +G
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL------LQG 110
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL--SLIGPEDDESHLSLRAAGTVG 640
+ + H + I+HRD+K N+L++ K++DFGL S P +H T
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YVVTRW 163
Query: 641 YMDPE-YYRLQQLTEKSDVYSFGVVLLEILSG 671
Y PE + + D++S G + E+LS
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSGSFG+VY+ LDDG AVK ++ +Q ++ E+ LS+L H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ------EIALLSKLQH 61
Query: 526 KNLVRLLGFCEDRNERVLIY-EYLENGTLHDHLHNPQS-SSPLKSWPARIKVALDAARGI 583
N+V+ LG E + + I+ E + G+L L S P+ R + G+
Sbjct: 62 PNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GL 115
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYLH+ + +HRDIK +N+L+D K++DFG++ E + S + G+ +M
Sbjct: 116 EYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFK--GSPYWMA 169
Query: 644 PEYYRLQQL-TEKSDVYSFGVVLLEILSG 671
PE Q +D++S G +LE+ +G
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 466 KIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++G G+FG V+ A D VAVK + +S S+ RQ+ F E E
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------RQD-----FQREAEL 60
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNP----------QSSSPLK 567
L+ L H+++VR G C + ++++EY+ +G L+ L H P + L
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL- 119
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ + +A A G+ YL A +HRD+ + N L+ K+ DFG+S D
Sbjct: 120 TLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ R + +M PE ++ T +SD++SFGVVL EI +
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
K+G+G FG V+ T + ++VAVK + GT E +F+ E + + +L H
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVK--------TLKPGTMSPE----SFLEEAQIMKKLRH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV+L + ++ EY+ G+L D L + + + LK P + +A A G+ Y
Sbjct: 61 DKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRA-LK-LPNLVDMAAQVAAGMAY 117
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGTVGYMDP 644
+ + IHRD++S+N+L+ K++DFGL+ LI ED+E A + + P
Sbjct: 118 IERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
E + T KSDV+SFG++L E+++ R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 43/290 (14%)
Query: 464 DHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
IG G FG VY+ ++ VAVK + ++ ++ F+ E
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---------PSVREK-FLQEAYI 60
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + H ++V+L+G + N ++ E G L +L + S L S I +
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASL---ILYSYQL 116
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
+ + YL +HRDI + NVL+ + K+ DFGLS + ED+ + + +
Sbjct: 117 STALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLP 171
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697
+ +M PE ++ T SDV+ FGV + EIL G + N D
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---------------ND 216
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
I R ++ P P Y L C + RP TE+ L
Sbjct: 217 VIGR-IENGERLPMPPNCPPTLY--SLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 467 IGSGSFGAV----YKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
+G G FG V Y D G VAVK + + + + + E+ L
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVK----------TLKRECGQQNTSGWKKEINILK 61
Query: 522 RLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV-ALD 578
L+H+N+V+ G C ++ + LI EY+ G+L D+L P+ L A++ + A
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL----AQLLLFAQQ 115
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
G+ YLH IHRD+ + NVLLD K+ DFGL+ PE E + +R G
Sbjct: 116 ICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGD 171
Query: 639 --VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
V + E + + + SDV+SFGV L E+L+
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GS G V AT G QVAVK+ ++ ++Q+ ++ F NE+ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDL----------RKQQRRELLF-NEVVIMRDYQ 74
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTL-----HDHLHNPQSSSPLKSWPARIKVALDA 579
H N+V + +E ++ E+LE G L H ++ Q ++ V L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCLAV 124
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
+ + +LH V IHRDIKS ++LL + K+SDFG ++ SL GT
Sbjct: 125 LKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTP 179
Query: 640 GYMDPEYY-RLQQLTEKSDVYSFGVVLLEILSG 671
+M PE RL TE D++S G++++E++ G
Sbjct: 180 YWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 68/237 (28%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 460 NFSEDHKIGSGSFGAVYKAT------LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF 513
N +G G FG V KAT + VAVK + +++SS +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS----------ELRDL 50
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP--LKSWPA 571
++E L +++H ++++L G C +LI EY + G+L L + P L S
Sbjct: 51 LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110
Query: 572 RIKVALDA------------------ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613
R LD +RG++YL E ++HRD+ + NVL+ K
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMK 167
Query: 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+SDFGLS E+D + V +M E T +SDV+SFGV+L EI++
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
+G G++G VY + G +AVK+ E+ +++ A +++ +K E++ L L H
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK---LQEEVDLLKSLKHV 62
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-----DAAR 581
N+V+ LG C D N + E++ G++ SS L + +
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSI---------SSILNRFGPLPEPVFCKYTKQILD 113
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG----LSLIGPEDDESHLSLRAAG 637
G+ YLH V +HRDIK +NV+L K+ DFG L+ +G S++ G
Sbjct: 114 GVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
T +M PE KSD++S G + E+ +G + R F +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYI------ 220
Query: 698 EIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
HR L +P P F A+ +V C+T + RPS +++
Sbjct: 221 GAHRGL---MPRLPDSFSAAAIDFV----TSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 466 KIGSGSFGAVYKAT------LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++G G+FG V+ A D VAVK + + ++ KD F E E
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---------RKD--FQREAEL 60
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQS-----SSPLKS---- 568
L+ L H+++V+ G C D + ++++EY+++G L+ L H P + P ++
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 569 -WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ +A A G+ YL A +HRD+ + N L+ A K+ DFG+S D
Sbjct: 121 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ + +M PE ++ T +SDV+SFGV+L EI +
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSG FG V+K + +G + + + I + + + ++ L H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKI------PVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-SP--LKSWPARIKVALDAARG 582
+VRLLG C + + L+ + G+L DH+ + S P L +W +I A+G
Sbjct: 69 AYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKG 121
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ YL E+ ++HR++ + N+LL + +++DFG++ + DD+ + + +M
Sbjct: 122 MYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILS 670
E + T +SDV+S+GV + E++S
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 467 IGSGSFGAVYKAT---LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD-NAFINELESLSR 522
+G G FG V A LD V + + S A +KD + I+E+E +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA------TEKDLSDLISEMEMMKM 79
Query: 523 L-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-----------HNP-QSSSPLKSW 569
+ HKN++ LLG C +I EY G L ++L +NP Q S+
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
+ A ARG+EYL A IHRD+ + NVL+ K++DFGL+ D
Sbjct: 140 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-----RDIH 191
Query: 630 HLSLRAAGTVG-----YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684
H+ T G +M PE + T +SDV+SFGV+L EI T G+P
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF--------TLGGSP- 242
Query: 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
P + +E+ ++L P Y+ + DC RP+ ++V
Sbjct: 243 ------YPGVPVEELFKLLKEGHRMDKPSNCTNELYM--MMRDCWHAVPSQRPTFKQLVE 294
Query: 745 SLERALA 751
L+R LA
Sbjct: 295 DLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
NN S +G+G+FG V +AT D +VAVK + ++ SS +R+ A
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----ERE-----A 84
Query: 513 FINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
++EL+ +S L +H+N+V LLG C ++I EY G L + L + S L
Sbjct: 85 LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDL 143
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+ + A+G+ +L A + IHRD+ + NVLL K+ DFGL+ D +
Sbjct: 144 -LSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
A V +M PE T +SDV+S+G++L EI S
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 30/215 (13%)
Query: 467 IGSGSFGAV----YKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
+G G FG V Y D+ G QVAVK + S ++ K+ E+E L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK----------EIEILR 61
Query: 522 RLHHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
L+H+N+V+ G C + LI E+L +G+L ++L ++ LK ++K A+
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ---QLKYAVQI 118
Query: 580 ARGIEYL--HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR--A 635
+G++YL +Y +HRD+ + NVL+++ K+ DFGL+ E D+ + +++
Sbjct: 119 CKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDL 172
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
V + PE + SDV+SFGV L E+L+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 36/255 (14%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG G+ G VY A + G +VA+K+ + Q+ K INE+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----------QQPKKELIINEILVMRENK 74
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK-VALDAARGI 583
H N+V L +E ++ EYL G+L D + +I V + + +
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAVCRECLQAL 128
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL-SLIGPEDDESHLSLRAAGTVGYM 642
E+LH V IHRDIKS N+LL + K++DFG + I PE + + GT +M
Sbjct: 129 EFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWM 182
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHR-THNGTPRNVVDFVVP 692
PE + K D++S G++ +E++ G RA++ NGTP +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 693 YIVRDEIHRVLDRNV 707
I RD ++R L+ +V
Sbjct: 243 AIFRDFLNRCLEMDV 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 466 KIGSGSFG-AVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GSFG A+ + +DG Q +K IS S +R+E + E+ LS +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP----KEREESR-----KEVAVLSNMK 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-----SWPARIKVALDA 579
H N+V+ E+ ++ +Y E G L+ + N Q W +I +AL
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLAL-- 114
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
+++H+ I+HRDIKS N+ L T K+ DFG++ + E L+ GT
Sbjct: 115 ----KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTP 165
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
Y+ PE + KSD+++ G VL E+ +
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 77/293 (26%), Positives = 134/293 (45%), Gaps = 40/293 (13%)
Query: 466 KIGSGSFGAVY----KATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
++G GSFG VY K + D + R I + + A +R E F+NE +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPET---RVAIKTVNEAASMRERIE-----FLNEASVMK 64
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPA---RIKV 575
+ ++VRLLG ++I E + G L +L + + ++P+++ P+ I++
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A + A G+ YL+ +HRD+ + N ++ +T K+ DFG++ E D +
Sbjct: 125 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG-TPRNVVDFVVPYI 694
V +M PE + T SDV+SFGVVL EI + + + G + V+ FV+
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGMSNEQVLRFVMEGG 238
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ D+ P FE+ + C + RPS EI++S++
Sbjct: 239 LLDKPDNC------PDMLFELMRM---------CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 30/250 (12%)
Query: 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IG G+FG V+ L D + VAVK T + K F+ E L +
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR---------ETLPPDLKAK-FLQEARILKQYS 51
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N+VRL+G C + ++ E ++ G D L ++ P I++ +AA G+E
Sbjct: 52 HPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGME 108
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT----VG 640
YL IHRD+ + N L+ K+SDFG+S ++E + G V
Sbjct: 109 YLES---KHCIHRDLAARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVK 161
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVD----FVVPYIV 695
+ PE + + +SDV+SFG++L E S G N R ++ P +
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC 221
Query: 696 RDEIHRVLDR 705
D ++R+++R
Sbjct: 222 PDAVYRLMER 231
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 54/232 (23%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN--- 515
F + ++IG G++G VY+A G VA+K+ + ++D I+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKK------------VRMDNERDGIPISSLR 55
Query: 516 ELESLSRLHHKNLVRLLGFCEDR--NERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPA 571
E+ L L H N+V L + + L+ EY E +L D++ P S S +K
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC--- 112
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+ L RG++YLHE IIHRD+K SN+LL K++DFGL+
Sbjct: 113 ---LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA----------- 155
Query: 632 SLRAAGT-VGYMDPE----YYRLQQL-------TEKSDVYSFGVVLLEILSG 671
R G M P+ +YR +L T D+++ G +L E+L+
Sbjct: 156 --RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 459 NNFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N + +G G++G V K G VA+K+ + S ED + E+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD---------EDVKKTALREV 51
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+ L +L H+N+V L + L++EY+E TL + L P P ++ +
Sbjct: 52 KVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLP----PDAVRSYI 106
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ I Y H + +IIHRDIK N+L+ + K+ DFG + S L+
Sbjct: 107 WQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT---- 159
Query: 637 GTVGYMDPEYYRLQQLTEKS-------DVYSFGVVLLEILSG 671
Y+ +YR +L DV++ G ++ E+L G
Sbjct: 160 ---DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 28/169 (16%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN--- 515
+ + K+G G++ VYKA + G VA+K+ ++ +R+E KD IN
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG---------ERKEAKDG--INFTA 49
Query: 516 --ELESLSRLHHKNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
E++ L L H N++ LL F N L++E++E L + + S L PA
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSN-INLVFEFME-TDLEKVIKDK--SIVLT--PAD 103
Query: 573 IK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
IK L RG+EYLH I+HRD+K +N+L+ + K++DFGL+
Sbjct: 104 IKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 68/251 (27%), Positives = 115/251 (45%), Gaps = 38/251 (15%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
D K+G G FG V+ T + ++VA+K + GT E AF+ E + + +L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIK--------TLKPGTMMPE----AFLQEAQIMKKL 58
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H LV L + ++ E++ G+L D L + P + +A A G+
Sbjct: 59 RHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQIADGM 115
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
Y+ + IHRD++++N+L+ K++DFGL+ + ED+E A + +
Sbjct: 116 AYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTA 171
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--IVRDEIHR 701
PE + T KSDV+SFG++L E+++ R VPY +V E+
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGR-----------------VPYPGMVNREVLE 214
Query: 702 VLDRNVPPPTP 712
++R P P
Sbjct: 215 QVERGYRMPCP 225
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 70/286 (24%), Positives = 133/286 (46%), Gaps = 40/286 (13%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA---FINELESLSR 522
++GSG+FG V K +++ +I AI + E++ + + E E + +
Sbjct: 2 ELGSGNFGCVKKGVY------KMRKKQID----VAIKVLKNENEKSVRDEMMREAEIMHQ 51
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
L + +VR++G CE +L+ E G L+ L + + + +++ + G
Sbjct: 52 LDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNV---VELMHQVSMG 107
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT--VG 640
++YL + +HRD+ + NVLL AK+SDFGLS DD S+ R+AG +
Sbjct: 108 MKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLK 163
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
+ PE ++ + +SDV+S+G+ + E S + ++ G V+ +I + +
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGK-- 215
Query: 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
R+ + P P E+ A L DC + +RP+ ++ +
Sbjct: 216 RL---DCPAECPPEMYA------LMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
NF + KIG G F VY+AT L DG VA+K+ +I + K + D I E++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL----MDAKARAD----CIKEID 54
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L +L+H N+++ + NE ++ E + G L + + + L K +
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+E++H ++HRDIK +NV + AT K+ D GL + SL GT
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
YM PE KSD++S G +L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 36/260 (13%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++ KIG G+ G V+ A + G +VA+K+ + +++ K INE+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-----------QKQPKKELIINEILV 69
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK-VALD 578
+ L + N+V L +E ++ EYL G+L D + A+I V +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE------AQIAAVCRE 123
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL-SLIGPEDDESHLSLRAAG 637
+ +E+LH +IHRDIKS NVLL + K++DFG + I PE + + G
Sbjct: 124 CLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---G 177
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHR-THNGTPRNVV 687
T +M PE + K D++S G++ +E++ G RA++ NGTP
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
Query: 688 DFVVPYIVRDEIHRVLDRNV 707
+ I RD ++R L+ +V
Sbjct: 238 PEKLSPIFRDFLNRCLEMDV 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 8e-17
Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 39/287 (13%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA-FINELESLSRLH 524
+GSG+FG VYK + +G V + A I + K N F++E ++ +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVA-------IKILNETTGPKANVEFMDEALIMASMD 67
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAAR 581
H +LVRLLG C + L+ + + +G L D++H + S L +W +I A+
Sbjct: 68 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
G+ YL E ++HRD+ + NVL+ + K++DFGL+ + D++ + + + +
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701
M E ++ T +SDV+S+GV + E++ T G P + I EI
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELM--------TFGGKPYD-------GIPTREIPD 222
Query: 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+L++ P P Y+ + C ++ +RP E+ R
Sbjct: 223 LLEKGERLPQPPICTIDVYM--VMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+GSFG V + A+K S I +Q + +NE L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKI-----LSKAKIVKLKQVEH---VLNEKRILQSIRH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH------NPQSSSPLKSWPARIKVALDA 579
LV L G +D + L+ EY+ G L HL P + + + A++ +AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA----RFYAAQVVLAL-- 114
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA---A 636
EYLH I++RD+K N+LLD+ K++DFG + + R
Sbjct: 115 ----EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTLC 159
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
GT Y+ PE + + D ++ G+++ E+L+GY
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
NF + KIG G F VY+AT L D VA+K+ +I + K ++D + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM----MDAKARQD----CVKEID 54
Query: 519 SLSRLHHKNLVRLL-GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L +L+H N+++ L F ED NE ++ E + G L + + L K +
Sbjct: 55 LLKQLNHPNVIKYLDSFIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+E++H ++HRDIK +NV + AT K+ D GL + SL G
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VG 168
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
T YM PE KSD++S G +L E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEIS-STSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G++G VYKA L+ G VA+K+ + S + T R+ I L+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-------IALLKQLESFE 59
Query: 525 HKNLVRLLGFCED-RNER----VLIYEYLENGTLHDHLHN-PQSSSPLKSWPARIK-VAL 577
H N+VRLL C R +R L++E+++ L +L P+ P P IK +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLP----PETIKDLMR 114
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
RG+++LH + I+HRD+K N+L+ + K++DFGL+ I E L+
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVV- 168
Query: 638 TVGYMDPEYYRLQQLTEKS--DVYSFGVVLLEI 668
T+ Y PE L Q + + D++S G + E+
Sbjct: 169 TLWYRAPEV--LLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKD--NAFINELESLSRLH 524
I G+FG+VY +A KR S+ +AI ++ D N N + +
Sbjct: 4 ISKGAFGSVY---------LAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMM 51
Query: 525 HK----NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
+ + +L + ++ L+ EYL G + ++ L A+ + +
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK-QYIAEVV 107
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
G+E LH+ IIHRDIK N+L+D T K++DFGLS G + + GT
Sbjct: 108 LGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPD 158
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
Y+ PE + SD +S G V+ E L GY H TP V D ++
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA---ETPDAVFDNIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
+N ++G G+FG V+ A D VAVK + +S DNA
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------------DNA 50
Query: 513 ---FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLK 567
F E E L+ L H+++V+ G C + + ++++EY+++G L+ L H P + +
Sbjct: 51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110
Query: 568 SWPAR-------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ +A A G+ YL A +HRD+ + N L+ K+ DFG+S
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
Query: 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
D + + +M PE ++ T +SDV+S GVVL EI +
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G+FG VY +D G ++A K+ + S + +A E++ L L H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP------ETSKEVSALECEIQLLKNLQH 63
Query: 526 KNLVRLLGFCEDRNERVL--IYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVALDAAR 581
+ +V+ G DR E+ L EY+ G++ D L + + S + + +I
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LE 117
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTVG 640
G+ YLH I+HRDIK +N+L D+ K+ DFG S S +R+ GT
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
+M PE + K+DV+S G ++E+L+ P Y I
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLT---------EKPPW------AEYEAMAAIF 219
Query: 701 RVLDRNVPPPTPFEI--EAVAYVGYLAADCVTLEGRNRPSMTEIV 743
++ + P P I A ++G C+ +E R+RPS E++
Sbjct: 220 KIATQPTNPQLPSHISEHARDFLG-----CIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 39/179 (21%)
Query: 457 ATNNFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
++ K+G G+FG VYKA + G VA+K+ + + +KD I
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN------------EKDGFPIT 53
Query: 516 ---ELESLSRLHHKNLVRLL--------GFCEDRNERVLIYEYLENGTLHD---HLHNPQ 561
E++ L +L H N+V L+ R ++ Y++ HD L NP
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD----HDLSGLLENPS 109
Query: 562 SSSPLKSWPARIK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+K ++IK L GI YLHE I+HRDIK++N+L+D K++DFGL
Sbjct: 110 ----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQE 507
++ +L + E++ I G GA YK ++ +G Q VK
Sbjct: 683 ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN--------------- 724
Query: 508 DKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
D ++ +E+ + +L H N+V+L+G C LI+EY+E L + L N
Sbjct: 725 DVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------L 777
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
SW R K+A+ A+ + +LH P+++ ++ +++D + LSL G
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCT 834
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
++ + +A Y+ PE + +TEKSD+Y FG++L+E+L+G
Sbjct: 835 DTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTG 874
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 466 KIGSGSFGAVYKATLDDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFIN-ELESLSR 522
IG GSFG VYKA D + VA+K ++ ED + I E++ LS+
Sbjct: 8 CIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEA----------ED-EIEDIQQEIQFLSQ 55
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
+ + G ++ +I EY G+ D L L + + G
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAF-ILREVLLG 110
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA------A 636
+EYLHE IHRDIK++N+LL K++DFG+S L+
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFV 159
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT +M PE + EK+D++S G+ +E+ G
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G+FG VYKA + G A K +I S E++ F+ E++ LS H
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-----------EEELEDFMVEIDILSECKH 61
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
N+V L N+ ++ E+ + G L + + L R V + +
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIML--ELERGLTEPQIRY-VCRQMLEALNF 118
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
LH + +IHRD+K+ N+LL K++DFG+S + + GT +M PE
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPE 173
Query: 646 Y-----YRLQQLTEKSDVYSFGVVLLEI 668
++ K+D++S G+ L+E+
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 466 KIGSGSFGAVYKATL-----DDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAFINELES 519
++G +FG +YK L D VA+K +I++ + F E
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG-----------EFQQEASL 60
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKS-WPARIKVA 576
++ LHH N+V LLG +++EYL G LH+ L +P S S +K +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 577 LD----------AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
LD A G+EYL + +H+D+ + N+L+ K+SD GLS
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
D + ++ + +M PE + + SD++SFGVVL EI S
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 34/259 (13%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++ KIG G+ G VY A + G +VA+++ + +Q+ K INE+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----------QQQPKKELIINEILV 70
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + N+V L +E ++ EYL G+L D + + V +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCREC 125
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL-SLIGPEDDESHLSLRAAGT 638
+ +E+LH V IHRDIKS N+LL + K++DFG + I PE + GT
Sbjct: 126 LQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGT 179
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHR-THNGTPRNVVD 688
+M PE + K D++S G++ +E++ G RA++ NGTP
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 689 FVVPYIVRDEIHRVLDRNV 707
+ I RD ++R LD +V
Sbjct: 240 EKLSAIFRDFLNRCLDMDV 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 39/299 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA-FINELESLSRL-H 524
+G G FG V A + + + + + T + + +KD + ++E+E + +
Sbjct: 23 LGEGCFGQVVMA---EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH-------------NPQSSSPLKSWPA 571
HKN++ LLG C +I EY G L ++L + ++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM-TFKD 138
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+ ARG+EYL A IHRD+ + NVL+ K++DFGL+ D
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
+ V +M PE + T +SDV+SFGV++ EI T G+P
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--------TLGGSP-------Y 240
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
P I +E+ ++L P Y+ + DC +RP+ ++V L+R L
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYM--MMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL----ESLS 521
++GSG+FG V K +K++E + A+ + ++ D A +EL +
Sbjct: 2 ELGSGNFGTVKKGMYK------MKKSE----KTVAVKILKNDNNDPALKDELLREANVMQ 51
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+L + +VR++G CE + +L+ E E G L+ L + + ++ +
Sbjct: 52 QLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNI----TELVHQVSM 106
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT--V 639
G++YL E + +HRD+ + NVLL AK+SDFGLS DE++ + G V
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPV 162
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ PE + + KSDV+SFGV++ E S
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G+FG V+ D V +K+ + + +D+ A NE + L L H
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT---------KDERLAAQNECQVLKLLSH 58
Query: 526 KNLVRLL-GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
N++ F ED +++ EY GTL +++ + +S L L I
Sbjct: 59 PNIIEYYENFLED-KALMIVMEYAPGGTLAEYI-QKRCNSLLDE-----DTILHFFVQIL 111
Query: 585 Y-LHEYAVPSIIHRDIKSSNVLLDATWTA-KVSDFGLSLIGPEDDESHLSLRAA-----G 637
LH I+HRD+K+ N+LLD K+ DFG+S I LS ++ G
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSSKSKAYTVVG 163
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674
T Y+ PE + +KSD+++ G VL E+ S RA
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELESLSR 522
+IGSG++G VYKA + G VA+K K + D I E+ L
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKV------------IKLEPGDDFEIIQQEISMLKE 56
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
H N+V G R++ ++ EY G+L D + PL V + +G
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPLSE-LQIAYVCRETLKG 113
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA--GTV 639
+ YLHE IHRDIK +N+LL K++DFG+S + + ++ R + GT
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSFIGTP 165
Query: 640 GYMDPEYY---RLQQLTEKSDVYSFGVVLLE 667
+M PE R K D+++ G+ +E
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 4e-16
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 43/224 (19%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
IGSG++G V A G +VA+K+ IS+ I KR + E++ L L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDLIDAKR-------ILREIKLLRHL 56
Query: 524 HHKNLVRLLGF-----CEDRNERVLIYEYLENGT-LHDHLHNPQSSSPLKSWPARIKVAL 577
H+N++ LL ED N+ ++ E +E T LH + +PQ + I+ L
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQPLTD-----DHIQYFL 109
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDE-SHLSLR 634
RG++YLH ++IHRD+K SN+L+++ K+ DFGL+ + P++DE L+
Sbjct: 110 YQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-- 164
Query: 635 AAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
Y+ +YR + T+ D++S G + E+L+
Sbjct: 165 -----EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 80/304 (26%), Positives = 142/304 (46%), Gaps = 53/304 (17%)
Query: 451 LEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDK 509
L IL E F + +GSG+FG VYK + +G +V + A I +E
Sbjct: 1 LRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA-IKELREATSPKANKEIL 57
Query: 510 DNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPL 566
D A++ ++ + + ++ RLLG C + LI + + G L D++ + S L
Sbjct: 58 DEAYV-----MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 111
Query: 567 KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPE 625
+W +I A+G+ YL E ++HRD+ + NVL+ K++DFGL+ L+G +
Sbjct: 112 LNWCVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
Query: 626 DDESHLSLRAAG---TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681
+ E H A G + +M E + T +SDV+S+GV + E+++ G + ++G
Sbjct: 163 EKEYH----AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDG 214
Query: 682 TPRNVVDFVVPYIVRDEIHRVLDRN--VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739
P + EI +L++ +P P I+ V + C ++ +RP
Sbjct: 215 IPAS------------EISSILEKGERLPQPPICTID----VYMIMVKCWMIDADSRPKF 258
Query: 740 TEIV 743
E++
Sbjct: 259 RELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 82/308 (26%), Positives = 134/308 (43%), Gaps = 59/308 (19%)
Query: 461 FSEDHKIGSGSFGAVYKATL--DDGS--QVAVK--RAEISSTSSYAIGTKRQEDKDNAFI 514
F+ +G G FG+V +A L +DGS +VAVK +A+I S+S F+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI-----------EEFL 49
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNER------VLIYEYLENGTLHDHL------HNPQS 562
E + H N+++L+G + ++I ++++G LH L P
Sbjct: 50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP-F 108
Query: 563 SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+ PL++ ++ +D A G+EYL + + IHRD+ + N +L+ T V+DFGLS
Sbjct: 109 TLPLQTL---VRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
D + V ++ E T SDV++FGV + EI+ T T
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM--------TRGQT 214
Query: 683 PRNVVDFVVPYIVRDEIHRVL---DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739
P + EI+ L +R PP + + V L C + E + RPS
Sbjct: 215 P-------YAGVENSEIYNYLIKGNRLKQPP-----DCLEDVYELMCQCWSPEPKCRPSF 262
Query: 740 TEIVNSLE 747
+ + LE
Sbjct: 263 QHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GSFG +Y A D +K EI T K + A E+ L+++
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIK--EIDLT-------KMPVKEKEASKKEVILLAKMK 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ----SSSPLKSWPARIKVALDAA 580
H N+V ++ ++ EY + G L ++ + S + SW +I +
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------S 111
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
G++++H+ I+HRDIKS N+ L AK+ DFG++ +D L+ GT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTP 166
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
Y+ PE + + K+D++S G VL E+
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G+FG VY D G ++AVK+ + S + NA E++ L L H
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESP------ETSKEVNALECEIQLLKNLLH 63
Query: 526 KNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
+ +V+ G D ER L E++ G++ D L +S L R K G+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTR-KYTRQILEGV 119
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTVGYM 642
YLH I+HRDIK +N+L D+ K+ DFG S S +++ GT +M
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILS 670
PE + K+D++S G ++E+L+
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKD-NAFINELESL-S 521
+H +GSG+FG VYK + Q + EI+ + KR+ DK ++E+ +
Sbjct: 6 EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 522 RLHHKNLVRLL-GFCEDRNERV-LIYEYLENGTLHDHLHN----PQSSSPLKSWPARIKV 575
+L H N+VR F E N+R+ ++ + +E L +H ++ Q + + W +++
Sbjct: 65 QLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
L + YLH+ I+HRD+ +N++L ++DFGL+ + ES L+
Sbjct: 123 VL----ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLA--KQKQPESKLT-SV 173
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
GT+ Y PE + + EK+DV++FG +L ++
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GS G V AT G QVAVK+ ++ R++ + NE+ + H
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-----------RKQQRRELLFNEVVIMRDYH 77
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVALDAARGI 583
H+N+V + +E ++ E+LE G L D + H + + + V L R +
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRAL 131
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
YLH V IHRDIKS ++LL + K+SDFG ++ SL GT +M
Sbjct: 132 SYLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMA 186
Query: 644 PEYY-RLQQLTEKSDVYSFGVVLLEILSG 671
PE RL TE D++S G++++E++ G
Sbjct: 187 PEVISRLPYGTE-VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 466 KIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++G GSFG VY+ D ++VAVK S++ I F+NE
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI----------EFLNEASV 62
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-------HNPQSSSPLKSWPAR 572
+ ++VRLLG +++ E + +G L +L N P +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEM 121
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
I++A + A G+ YL+ +HRD+ + N ++ +T K+ DFG++ E D
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ V +M PE + T SD++SFGVVL EI S
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 55/231 (23%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
NF + KIG G++G VYKA G VA+K+ + + + E + I E+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---------EGVPSTAIREIS 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP-ARIKVAL 577
L L+H N+V+LL N+ L++E+L H L +SPL P IK L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-----HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+G+ + H + V +HRD+K N+L++ K++DFGL+ RA
Sbjct: 107 FQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLA-------------RAF 150
Query: 637 G-----------TVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILS 670
G T+ Y PE YY + D++S G + E+++
Sbjct: 151 GVPVRTYTHEVVTLWYRAPEILLGCKYY-----STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 47/304 (15%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE--DKD-NAFINELESLSRL 523
+G G FG V A + + + + + + A+ + + DKD + ++E+E + +
Sbjct: 20 LGEGCFGQVVMA-----EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI 74
Query: 524 -HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN---------------PQSSSPLK 567
HKN++ LLG C ++ EY G L ++L P+ K
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ A ARG+EYL A IHRD+ + NVL+ K++DFGL+ D
Sbjct: 135 DL---VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687
+ V +M PE + T +SDV+SFGV+L EI T G+P
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF--------TLGGSP---- 236
Query: 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
P I +E+ ++L P Y+ + +C RP+ ++V L+
Sbjct: 237 ---YPGIPVEELFKLLKEGHRMDKPANCTHELYM--IMRECWHAVPSQRPTFKQLVEDLD 291
Query: 748 RALA 751
R L
Sbjct: 292 RVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 466 KIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFIN-----ELES 519
+G GS+G V K + Q VA+K K E +D+ + E+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--------------KFLESEDDKMVKKIAMREIRM 53
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
L +L H+NLV L+ + L++E++++ L D P L R K
Sbjct: 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVR-KYLFQI 109
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAG 637
RGIE+ H + +IIHRDIK N+L+ + K+ DFG + L P + +
Sbjct: 110 LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD------- 159
Query: 638 TVGYMDPEYYRLQQLTEKS-------DVYSFGVVLLEILSG 671
Y+ +YR +L D+++ G ++ E+L+G
Sbjct: 160 ---YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G GSFG VY + AV + +G + A E + LS+L
Sbjct: 6 QRLGKGSFGTVYLVK----DKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLD 60
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H +V+ +R+ +I EY E L L + + S + + G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGYM 642
Y+H+ I+HRD+K+ N+ L K+ DFG+S L+G D L+ GT YM
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATTFTGTPYYM 172
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEI 668
PE + Q KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G G +G V+ A D G VA+KR + S + ++ + E + L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKS--------LLFKLNEVRHVLTERDILTTTK 59
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
+ LV+LL +D L EY+ G L+N L AR +A + ++
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMA-EMFEAVD 115
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
LHE IHRD+K N L+DA+ K++DFGLS S G+ YM P
Sbjct: 116 ALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAP 167
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGY 672
E R + D +S G +L E L G+
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGF 195
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 34/259 (13%)
Query: 461 FSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++ KIG G+ G VY A + G +VA+K+ + +Q+ K INE+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-----------QQQPKKELIINEILV 69
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + N+V L +E ++ EYL G+L D + + V +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCREC 124
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL-SLIGPEDDESHLSLRAAGT 638
+ +++LH V IHRDIKS N+LL + K++DFG + I PE + + GT
Sbjct: 125 LQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GT 178
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHR-THNGTPRNVVD 688
+M PE + K D++S G++ +E++ G RA++ NGTP
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 689 FVVPYIVRDEIHRVLDRNV 707
+ + RD ++R L+ +V
Sbjct: 239 ERLSAVFRDFLNRCLEMDV 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 467 IGSGSFGAVY---KATLDDGSQV----AVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+G GSFG V+ K T D Q+ +K+A + R K E +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD-------RVRTK-----MERDI 51
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVAL 577
L+ ++H +V+L + + LI ++L G L L + +K + A + +AL
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
D +LH II+RD+K N+LLD K++DFGLS + ++ S G
Sbjct: 112 D------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CG 160
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
TV YM PE + T+ +D +SFGV++ E+L+G
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 52/244 (21%), Positives = 104/244 (42%), Gaps = 40/244 (16%)
Query: 513 FINELESLSRLHHKNLVRLLGF----CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
NE+++L R+ N++++ GF +D LI EY G L + L + S
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLS---- 120
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
+ ++ +A+D +G+ L++Y + ++++ S + L+ + K+ GL E
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGL-----EKIL 173
Query: 629 SHLSLRAAGTVGYMDPEYYR--LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686
S + + Y + + T K D+YS GVVL EI +G
Sbjct: 174 SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK-------------- 219
Query: 687 VDFVVPYIVRD--EIHR-VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
+P+ EI+ ++++N P ++ + + C + + RP++ EI+
Sbjct: 220 ----IPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
Query: 744 NSLE 747
+L
Sbjct: 274 YNLS 277
|
Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 81/294 (27%), Positives = 127/294 (43%), Gaps = 59/294 (20%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
F++ +IG GSFG VYK +D+ ++ VA+K I + ED+ E+
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIK----------IIDLEEAEDEIEDIQQEIT 54
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL- 577
LS+ + R G + +I EYL G+ D L PL+ I L
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEE--TYIATILR 108
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ +G++YLH IHRDIK++NVLL K++DFG++ G D G
Sbjct: 109 EILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVG 163
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
T +M PE + K+D++S G+ +E+ G H P V+ F++P
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH---PMRVL-FLIP----- 214
Query: 698 EIHRVLDRNVPP------PTPFE--IEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
+N PP PF+ +EA C+ + R RP+ E++
Sbjct: 215 -------KNSPPTLEGQYSKPFKEFVEA----------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAF 513
E TN + + +G G+FG V A G VA+K+ + ST A T R
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-------- 58
Query: 514 INELESLSRLHHKNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
EL+ L L H+N++ L F + + E L GT LH +S PL+ +
Sbjct: 59 --ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQ 111
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
RG++Y+H V +HRD+K SN+L++ K+ DFGL+ I + ++
Sbjct: 112 Y-FLYQILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARI----QDPQMT 163
Query: 633 LRAAGTVGYMDPEYYRL-------QQLTEKSDVYSFGVVLLEILSG 671
GY+ YYR Q+ + D++S G + E+L G
Sbjct: 164 -------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 513 FINELESLSRLHHKNLVRLL--GFCEDRNERVL-IYEYLENGTLHDHLHNPQSSSPLKSW 569
F E +RL+H N+V LL G + ++EY+ TL + L + ++
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPP--GLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 570 PARIKVALDA-----ARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSL 621
++V LDA +GI +HRD+K N+++ AKV DFG+
Sbjct: 83 RLMLQV-LDALACAHNQGI-----------VHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 622 IGP---EDDESHLSL--RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675
+ P + D + L+ GT Y PE R + +T SD+Y++G++ LE L+G R +
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 72/269 (26%), Positives = 113/269 (42%), Gaps = 59/269 (21%)
Query: 419 PMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSE---DHKIGSGSFGAV 475
P+P PPPS S +S ++ S A + SE ++IGSG+ G V
Sbjct: 44 PLPLPPPSS-------SSSSSSSSSASGSAPS------AAKSLSELERVNRIGSGAGGTV 90
Query: 476 YKATLDDGSQVAVKRAEISSTSSYA---IGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532
YK + R + YA I ++ E+E L ++H N+V+
Sbjct: 91 YKV---------IHR---PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 533 GFCEDRNERVLIYEYLENGTLHDH--LHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA 590
+ E ++ E+++ G+L + VA GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD----------VARQILSGIAYLHRR- 187
Query: 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED-DESHLSLRAAGTVGYMDPEYYRL 649
I+HRDIK SN+L+++ K++DFG+S I + D + S+ GT+ YM PE R+
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPE--RI 240
Query: 650 QQLTEK-------SDVYSFGVVLLEILSG 671
D++S GV +LE G
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F++ +IG GSFGAVY A ++ VA+K+ S K+ +K I E+
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------KQSNEKWQDIIKEVRF 68
Query: 520 LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARI-KVAL 577
L +L H N + G C R L+ EY G+ D L PL+ I +
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILE--VHKKPLQE--VEIAAICH 122
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG-LSLIGPEDDESHLSLRAA 636
A +G+ YLH + IHRDIK+ N+LL T K++DFG SL+ P +
Sbjct: 123 GALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------FV 172
Query: 637 GTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEI 668
GT +M PE Q K DV+S G+ +E+
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 467 IGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDK--DNAFINELESLSRL 523
+G G FG V + G A K+ + KR + + + +NE + L ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLD----------KKRLKKRKGEQMALNEKKILEKV 50
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
+ +V L E +++ L+ + G L H++N P I A G+
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGL 108
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
E+LH+ I++RD+K NVLLD ++SD GL++ + AGT GYM
Sbjct: 109 EHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMA 162
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE + + D ++ G L E+++G
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 26/160 (16%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELESL 520
KIG G++G VYKA G VA+K+ R E +D I E+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------------RLETEDEGVPSTAIREISLL 52
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DA 579
L+H N+VRLL N+ L++E+L+ D SS P IK L
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+GI Y H + ++HRD+K N+L+D K++DFGL
Sbjct: 109 LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 64/289 (22%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IGSG+ G VYK V AVK+ + ++E+K + +L+ + + H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--------KEENK--RILMDLDVVLKSHD 72
Query: 526 -KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVALDAARG 582
+V+ G + V I L T D L + P+ P I K+ + +
Sbjct: 73 CPYIVKCYG-YFITDSDVFICMELM-STCLDKLLK-RIQGPI---PEDILGKMTVAIVKA 126
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVG 640
+ YL E +IHRD+K SN+LLDA+ K+ DFG+S L+ D ++ R+AG
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAK--TRSAGCAA 179
Query: 641 YMDPEYYRLQQLTEK------SDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVDFVV 691
YM PE R+ +DV+S G+ L+E+ +G Y+ +F V
Sbjct: 180 YMAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN----------CKTEFEV 227
Query: 692 PYIVRDEIHRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRP 737
+ ++L P P F + ++V C+T + R RP
Sbjct: 228 -------LTKILQEEPPSLPPNEGFSPDFCSFV----DLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 68/238 (28%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 454 LLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
L + T F IG G++G VYKA G VA+K +I I ++E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEI---KEE----- 52
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERV------LIYEYLENGTLHDHLHNPQSSSPL 566
N L S +H N+ G +N L+ E G++ D + L
Sbjct: 53 -YNILRKYS--NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG------L 103
Query: 567 KSWPARIKVAL------DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ R+K + RG+ YLHE V IHRDIK N+LL K+ DFG+S
Sbjct: 104 RKKGKRLKEEWIAYILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVS 160
Query: 621 LIGPEDDESHLSLRAA--GTVGYMDPE-----YYRLQQLTEKSDVYSFGVVLLEILSG 671
+S L R GT +M PE +SDV+S G+ +E+ G
Sbjct: 161 ----AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+G+ G+V K + G+ +A K I + SS ++Q + EL+ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS----VRKQ------ILRELQIMHECRS 62
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI----KVALDAAR 581
+V G + N + E+++ G+L D ++ K P + K+A+
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK-------KGGPIPVEILGKIAVAVVE 114
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTV 639
G+ YL Y V I+HRDIK SN+L+++ K+ DFG+S LI D GT
Sbjct: 115 GLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT------FVGTS 166
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
YM PE + + T KSDV+S G+ ++E+ G
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 78/286 (27%), Positives = 122/286 (42%), Gaps = 43/286 (15%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
F++ KIG GSFG V+K +D+ +Q VA+K I + ED+ E+
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIK----------IIDLEEAEDEIEDIQQEIT 54
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL- 577
LS+ + + G + +I EYL G+ D L PL +I L
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDE--TQIATILR 108
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ +G++YLH IHRDIK++NVLL K++DFG++ G D G
Sbjct: 109 EILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVG 163
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
T +M PE + K+D++S G+ +E+ G H P V+ F++P
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH---PMKVL-FLIP----- 214
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
+N PP E + C+ E RP+ E++
Sbjct: 215 -------KNNPP--TLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 466 KIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GS G V AT+ G VAVK+ ++ R++ + NE+ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL-----------RKQQRRELLFNEVVIMRDYQ 75
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVALDAARGI 583
H+N+V + +E ++ E+LE G L D + H + + + V L + +
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKAL 129
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
LH V IHRDIKS ++LL K+SDFG ++ SL GT +M
Sbjct: 130 SVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMA 184
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE + D++S G++++E++ G
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSG+FG VYK + DG V + A I +E D A++ ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVA-IKVLRENTSPKANKEILDEAYV-----MAGVGS 68
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAARG 582
+ RLLG C + L+ + + G L D++ + S L +W +I A+G
Sbjct: 69 PYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ YL E ++HRD+ + NVL+ + K++DFGL+ + D+ + + + +M
Sbjct: 122 MSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
E ++ T +SDV+S+GV + E+++ + A + ++G P EI +
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT-FGA--KPYDGIPAR------------EIPDL 223
Query: 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
L++ P P Y+ + C ++ RP E+V+ R
Sbjct: 224 LEKGERLPQPPICTIDVYM--IMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
N+ +G G+FG VY D G ++AVK+ ++ + NA E++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDP------DSQETSKEVNALECEIQ 56
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
L L H +V+ G D E+ L EY+ G++ D L ++ L R +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYT 112
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA- 635
+G+ YLH I+HRDIK +N+L D+ K+ DFG S S +++
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
GT +M PE + K+DV+S ++E+L+
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F H+IG GSFGAVY AT ++ VAVK+ S K+ +K I E++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--------KQTNEKWQDIIKEVKF 74
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-- 577
L +L H N + G + L+ EY G+ D L PL+ +++A
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQ----EVEIAAIT 127
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG-LSLIGPEDDESHLSLRA 635
A +G+ YLH + +IHRDIK+ N+LL K++DFG S P +
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------F 177
Query: 636 AGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEI 668
GT +M PE Q K DV+S G+ +E+
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
F++ +IG GSFG V+K +D+ +Q VA+K I + ED+ E+
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIK----------IIDLEEAEDEIEDIQQEIT 54
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL- 577
LS+ + + G + +I EYL G+ D L + P + +I L
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEF--QIATMLK 108
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ +G++YLH IHRDIK++NVLL K++DFG++ G D G
Sbjct: 109 EILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVG 163
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
T +M PE + K+D++S G+ +E+ G
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 53/228 (23%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELESLS 521
IG G++G VYKA D G VA+K+ R +++ F I E++ L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-------------RLDNEKEGFPITAIREIKILR 61
Query: 522 RLHHKNLVRL----------LGFCEDRNERVLIYEY--------LENGTLHDHLHNPQSS 563
+L+H+N+V L L F +D+ L++EY LE+G +H + +S
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
+K L+ G+ Y H+ + +HRDIK SN+LL+ K++DFGL+ +
Sbjct: 122 ---------MKQLLE---GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILS 670
+ES T+ Y PE ++ DV+S G +L E+ +
Sbjct: 167 -NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 28/168 (16%)
Query: 466 KIGSGSFGAVYKATLDDGSQ---VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG G++G VYKA +G A+K+ + I + E+ L
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--------SACREIALLRE 58
Query: 523 LHHKNLVRLLG-FCEDRNERV-LIYEYLENGTLHDHLH--NPQSSSPLKSWPAR-IKVAL 577
L H+N+V L+ F E ++ V L+++Y E HD + S P +K L
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLS 620
G+ YLH ++HRD+K +N+L+ K+ D GL+
Sbjct: 115 WQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 461 FSEDHKIGSGSFGAV----YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
F + +G G FG V +AT G A KR E ++ ++ +NE
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKRLEKKRI--------KKRKGESMALNE 50
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+ L +++ + +V L E ++ L+ + G L H++N +P + A
Sbjct: 51 KQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYA 108
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA- 635
+ G+E LH + ++RD+K N+LLD ++SD GL++ PE + S+R
Sbjct: 109 AEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGR 161
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GTVGYM PE Q+ T D + G ++ E++ G
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 75/277 (27%), Positives = 112/277 (40%), Gaps = 86/277 (31%)
Query: 467 IGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G+G+FG V +AT D+ +VAVK + S+ + D+ A ++EL+ L
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT----------DEREALMSELKIL 95
Query: 521 SRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN-------------------- 559
S L HKN+V LLG C ++I EY G L + L
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSS 155
Query: 560 ------------------------------PQSSSPLKS------------WPARI---- 573
P SSS +S WP +
Sbjct: 156 DYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLL 215
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+ + A+G+++L A + IHRD+ + NVLL AK+ DFGL+ D +
Sbjct: 216 RFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
A V +M PE T +SDV+S+G++L EI S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 27/229 (11%)
Query: 457 ATNNFSEDHKIGSGSFGAVYKATL---DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF 513
+T F E+ +G FG VYK L G Q + I + A G R+E K A
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQT--QAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPA 571
+ SRL H N+V LLG +I+ Y + LH+ L +P S
Sbjct: 61 MR-----SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 572 RIKVALDA----------ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621
+K L+ A G+E+L + V +H+D+ + NVL+ K+SD GL
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
D L + + +M PE + + SD++S+GVVL E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 466 KIGSGSFGAVYKATLDDG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+IG+G FG V G ++V VK S+T D+ F+ E++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP----------DEQLLFLQEVQPYRE 51
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP-ARIKVALDAAR 581
L+H N+++ LG C + +L+ E+ G L ++L + + + ++A + A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG-PED----DESH-LSLRA 635
G+ +LH+ IH D+ N L A + K+ D+GL+L PED + H + LR
Sbjct: 112 GLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR- 167
Query: 636 AGTVGYMDPEYYRLQQ-------LTEKSDVYSFGVVLLEI 668
++ PE ++ T+KS+++S GV + E+
Sbjct: 168 -----WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G++G V AT G +VA+K+ ++ T R E++ L R
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----------EIKILRRFK 61
Query: 525 HKNLVRLL-----GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-D 578
H+N++ +L E N+ ++ E +E L+ + L + I+ L
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-----DLYKLIKTQHLSN--DHIQYFLYQ 114
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
RG++Y+H V +HRD+K SN+LL+ K+ DFGL+ + PE D +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 638 TVGYMDPEYYRLQQLTEKS-DVYSFGVVLLEILSG 671
T Y PE + K+ D++S G +L E+LS
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
F++ +IG GSFGAVY A V+ E+ + + K+ +K I E++ L
Sbjct: 27 FTDLREIGHGSFGAVYFAR-------DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL--- 577
R+ H N + G + L+ EY G+ D L PL+ +++A
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQ----EVEIAAITH 132
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG-LSLIGPEDDESHLSLRAA 636
A +G+ YLH + ++IHRDIK+ N+LL K++DFG S+ P +
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-------FV 182
Query: 637 GTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEI 668
GT +M PE Q K DV+S G+ +E+
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL-SRLH 524
+G G++G VY A L ++A+K ++ + ++E +L S L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE------------RDSRYVQPLHEEIALHSYLK 63
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV-ALDAARGI 583
H+N+V+ LG + + E + G+L L + PLK I G+
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGL 121
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFGLS--LIGPEDDESHLSLRAAGTV 639
+YLH+ I+HRDIK NVL++ T++ K+SDFG S L G + GT+
Sbjct: 122 KYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT----GTL 173
Query: 640 GYMDPEY--YRLQQLTEKSDVYSFGVVLLEILSG 671
YM PE + +D++S G ++E+ +G
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+G++G VYK + G A+K +++ G + +E K IN L+ S HH
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------GDEEEEIKQE--INMLKKYS--HH 62
Query: 526 KNLVRLLGFCEDRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+N+ G +N + L+ E+ G++ D + N + ++ + W A I +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREI 120
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
RG+ +LH++ V IHRDIK NVLL K+ DFG+S D GT
Sbjct: 121 LRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTP 175
Query: 640 GYMDPEYYRLQQLTE-----KSDVYSFGVVLLEILSG 671
+M PE + + KSD++S G+ +E+ G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 467 IGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G+FG V K G+ +AVKR I ST +++ + +L+ + R
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKR--IRSTV---DEKEQKR-----LLMDLDVVMRSSD 61
Query: 526 -KNLVRLLG---------FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI-- 573
+V+ G C + L+ L+ + +++ S P I
Sbjct: 62 CPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSV----IPEEILG 110
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHL 631
K+A+ + + YL E IIHRD+K SN+LLD K+ DFG+S L+ +S
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIA 163
Query: 632 SLRAAGTVGYMDPEYYRLQQLTE-----KSDVYSFGVVLLEILSG 671
R AG YM PE R+ +SDV+S G+ L E+ +G
Sbjct: 164 KTRDAGCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 76/310 (24%), Positives = 136/310 (43%), Gaps = 47/310 (15%)
Query: 446 LEEFSLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTK 504
L++ L L + F +G+G++G VYK + G A+K ++ T+
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV---------TE 53
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLG-FCEDR-----NERVLIYEYLENGTLHDHLH 558
+E++ IN L+ S HH+N+ G F + ++ L+ E+ G++ D +
Sbjct: 54 DEEEEIKLEINMLKKYS--HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK 111
Query: 559 NPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618
N + ++ + W A I + RG+ +LH + V IHRDIK NVLL K+ DFG
Sbjct: 112 NTKGNALKEDWIAYI--CREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLVDFG 166
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTE-----KSDVYSFGVVLLEILSGYR 673
+S D GT +M PE + + +SD++S G+ +E+ G
Sbjct: 167 VS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 674 AIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEG 733
+ H P + F++P RN PP + + ++ ++ C+
Sbjct: 225 PLCDMH---PMRAL-FLIP------------RNPPPKLKSKKWSKKFIDFIEG-CLVKNY 267
Query: 734 RNRPSMTEIV 743
+RPS +++
Sbjct: 268 LSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG GS G V A G QVAVK ++ R++ + NE+ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDL-----------RKQQRRELLFNEVVIMRDYQ 76
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA-RGI 583
H+N+V + E ++ E+L+ G L D + S + +I ++ + +
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQAL 130
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
YLH V IHRDIKS ++LL K+SDFG +D SL GT +M
Sbjct: 131 CYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMA 185
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHRTHNGTPRNVVDF--VVP 692
PE + D++S G++++E++ G +A+ R + P + + + P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245
Query: 693 YIVRDEIHRVLDRN 706
++RD + R+L R
Sbjct: 246 -VLRDFLERMLTRE 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 79/284 (27%), Positives = 122/284 (42%), Gaps = 61/284 (21%)
Query: 461 FSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
FS+ +IG GSFGAVY A + + VA+K+ S K+ +K I E+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRF 68
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-- 577
L +L H N ++ G + L+ EY G+ D L PL+ +++A
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQ----EVEIAAVT 121
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG-LSLIGPEDDESHLSLRA 635
A +G+ YLH + ++IHRD+K+ N+LL K+ DFG S++ P +
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------F 171
Query: 636 AGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEI---------LSGYRAI-HRTHNGT 682
GT +M PE Q K DV+S G+ +E+ ++ A+ H N +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
Query: 683 P-----------RNVVDFVVPYIVRDEI-------HRVLDRNVP 708
P RN VD + I +D HR + R P
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 46/284 (16%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G GS+G V DG Q +K+ + + S R+E K A E + LS+L H
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-------RRERK--AAEQEAQLLSQLKH 58
Query: 526 KNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQS----SSPLKSWPARIKVALDAA 580
N+V E + + ++ + E G L+ L + + + W +I +AL
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL--- 115
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+YLHE I+HRD+K+ NV L T KV D G++ + +++ ++ GT
Sbjct: 116 ---QYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
YM PE + + KSDV++ G + E+ + + N N + ++
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMAT----LKHAFNAKDMNSL-----------VY 212
Query: 701 RVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
R+++ +PP P + E +G L A ++ RPS+ I+
Sbjct: 213 RIIEGKLPPMPKDYSPE----LGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 34/165 (20%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKR--AEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
++G G+FG+VY A + G VA+K+ + S + E++SL +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC---MN---------LREVKSLRK 53
Query: 523 L-HHKNLVRLLGFCEDRNERVLIYEYLENGTLH----DHLHNPQSSSPLKSWPARIKVAL 577
L H N+V+L + +E ++EY+E G L+ D P S S ++S +I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQI---- 108
Query: 578 DAARGIEYLHE--YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+G+ ++H+ + HRD+K N+L+ K++DFGL+
Sbjct: 109 --LQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 467 IGSGSFGAVY----KATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G FG V +AT G A K+ K+++ + A + E L++
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRL-------KKRKGYEGAMV-EKRILAK 49
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
+H + +V L + + + L+ + G L H++N +P P G
Sbjct: 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTVGY 641
+E+LH+ II+RD+K NVLLD ++SD GL++ E + + AGT G+
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGF 163
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
M PE + ++ D ++ GV L E+++
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIA 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 59/242 (24%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED--KDN---AFINELESLS 521
IG G+FG V+ D QV YA+ R+ D K N E + L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQV------------YAMKVLRKSDMIKRNQIAHVRAERDILA 56
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN----PQSSSPLKSWPARIKVAL 577
+V+L +D L+ EY+ G L + L P+ ++ + + A + +AL
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA--RFYIAELVLAL 114
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES-------- 629
D+ + + IHRDIK N+L+DA K++DFGL + +
Sbjct: 115 DSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 630 -------------------HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ GT Y+ PE R + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 671 GY 672
G+
Sbjct: 226 GF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 48/222 (21%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN-----ELES 519
KIG GS+G V+K + G VA+K K E +D+ I E+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIK--------------KFVESEDDPVIKKIALREIRM 53
Query: 520 LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L +L H NLV L+ R ++ L++EY ++ L++ NP+ K+
Sbjct: 54 LKQLKHPNLVNLIEVFR-RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI----KKIIWQ 108
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAA 636
+ + + H++ IHRD+K N+L+ K+ DFG + L GP DD +
Sbjct: 109 TLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD------ 159
Query: 637 GTVGYMDPEYYRLQQL----TEKS---DVYSFGVVLLEILSG 671
Y+ +YR +L T+ DV++ G V E+L+G
Sbjct: 160 ----YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
I +G++GAVY + Q R + + + + Q + F+ E + L+ +
Sbjct: 9 ISNGAYGAVYLVRHKETRQ----RFAMKKINKQNLILRNQIQQ--VFV-ERDILTFAENP 61
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586
+V + E + ++ EY+E G L N L AR+ A + +EYL
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN---IGALPVDMARMYFA-ETVLALEYL 117
Query: 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG-------------PEDDESHLSL 633
H Y I+HRD+K N+L+ + K++DFGLS IG +D L
Sbjct: 118 HNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+ GT Y+ PE Q + D ++ G++L E L G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 43/195 (22%)
Query: 543 LIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
LI +Y+ G L HL+ + + S ++ + A I +ALD +LH+ II+RDIK
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLG---IIYRDIK 132
Query: 601 SSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKS-- 656
N+LLD+ ++DFGLS + E++ ++ GT+ YM PE R
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAV 189
Query: 657 DVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE-------IHRVLDRNVPP 709
D +S GV+ E+L+G P+ V E R+L P
Sbjct: 190 DWWSLGVLTFELLTG------------------ASPFTVDGEQNSQSEISRRILKSKPPF 231
Query: 710 PTPFEIEAVAYVGYL 724
P EA ++ L
Sbjct: 232 PKTMSAEARDFIQKL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 27/237 (11%)
Query: 461 FSEDHKIGSGSFGAV----YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
F + +G G FG V +AT G A K+ E K+++ + A +NE
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRI-------KKRKGESMA-LNE 50
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKV 575
+ L +++ + +V L E ++ L+ + G L H+ H ++ +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFY 107
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A + G+E LH+ I++RD+K N+LLD ++SD GL++ PE +++
Sbjct: 108 AAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKG 160
Query: 636 -AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
GTVGYM PE + ++ T D ++ G +L E+++G + R V+ +V
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
++G G+FG VYKA + +A + I TK +E+ ++ ++ E++ L+ H
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKV---------IDTKSEEELED-YMVEIDILASCDH 61
Query: 526 KNLVRLL-GFCEDRNERVLIYEYLENGTLHD---HLHNPQSSSPLKSWPARIKVALDAAR 581
N+V+LL F + N +LI E+ G + L P + ++ K L+A
Sbjct: 62 PNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIR---VVCKQTLEA-- 115
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
+ YLHE IIHRD+K+ N+L K++DFG+S + S GT +
Sbjct: 116 -LNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYW 169
Query: 642 MDPEYYRLQQLTE-----KSDVYSFGVVLLEI 668
M PE + + K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+G+FG V+ A+K I +QE + NE L + H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-----KQEQHVH---NEKRVLKEVSH 60
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGI 583
++RL D+ ++ EY+ G L +L N S+S + + I A +
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA------L 114
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA---AGTVG 640
EYLH I++RD+K N+LLD K++DFG + L R GT
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPE 163
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE + + + D ++ G+++ E+L GY
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 66/221 (29%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 467 IGSGSFGAV----YKATLDDGSQVAVK---------RAEISSTSSYAIGTKRQEDKDNAF 513
+G G FG V YK T G A+K R E+ S KR
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMC----EKRI------- 52
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
E+ + H LV L C + V + EY G L H+H S P + A
Sbjct: 53 ---FETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA- 107
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL--IGPEDDESH 630
V L G++YLHE I++RD+K N+LLD K++DFGL +G D S
Sbjct: 108 ACVVL----GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160
Query: 631 LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT ++ PE T D + GV++ E+L G
Sbjct: 161 F----CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 82/309 (26%), Positives = 127/309 (41%), Gaps = 51/309 (16%)
Query: 451 LEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDK 509
LE L + T+ + IG G++G VYK T DGS AVK + S I
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-------- 65
Query: 510 DNAFINELESLSRLHHKNLVRLLGFCEDRNERV-----LIYEYLENGTLHDHLHNPQSSS 564
A N L+SL +H N+V+ G ++ V L+ E G++ + +
Sbjct: 66 -EAEYNILQSLP--NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 565 PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624
+ A G+++LH IIHRD+K +N+LL K+ DFG+S
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA--- 176
Query: 625 EDDESHLSLRAAGTVG---YMDPEYYRLQQLTEKS-----DVYSFGVVLLEILSGYRAIH 676
+ LR +VG +M PE +Q + S DV+S G+ +E+ G +
Sbjct: 177 --QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEA-VAYVGYLAADCVTLEGRN 735
H P + F +P RN PPPT E + + C+ +
Sbjct: 235 DMH---PVKTL-FKIP------------RN-PPPTLLHPEKWCRSFNHFISQCLIKDFEA 277
Query: 736 RPSMTEIVN 744
RPS+T ++
Sbjct: 278 RPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG GSFG V A DGS AVK + + I K++++ A N L L L H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKT-----ILKKKEQNHIMAERNVL--LKNLKH 55
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV L + + + +Y+ G L HL + + AR A + A I Y
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR---ARFYAA-EVASAIGY 111
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
LH +II+RD+K N+LLD+ ++DFGL G E +E+ + GT Y+ PE
Sbjct: 112 LHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF--CGTPEYLAPE 166
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSG 671
R + D + G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEI-SSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+IG G++G VYKA G VA+K + ++ + T R+ + L+ L
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-------VALLKRLEAF 59
Query: 524 HHKNLVRLLGFCE----DRNERV-LIYEYLENGTLHDHLHN-PQSSSPLKSWPARIKVAL 577
H N+VRL+ C DR +V L++E+++ L +L P P ++ ++ L
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR-AA 636
RG+++LH I+HRD+K N+L+ + K++DFGL+ I ++L
Sbjct: 119 ---RGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVV 168
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
T+ Y PE D++S G + E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 69/294 (23%), Positives = 117/294 (39%), Gaps = 50/294 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G+G FG + + L S+ VA+ + G F+ E +L +
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG----------FLAEALTLGQ 62
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQ-SSSPLKSWPARIKVALDA 579
H N+VRL G N +++ EY+ NG L L H Q + L +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL------ 116
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED--DESHLSLRAAG 637
A G++YL E +H+ + + VL+++ K+S F ED + + ++
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKS 170
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696
V + PE + + SDV+SFG+V+ E++S G R ++V+ V
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIK-----AVE 222
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
D RN P + L DC E RP ++I + L + +
Sbjct: 223 DGFRLPAPRNCPNL----------LHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+IG G++G V+KA L +G + VA+KR + + G ++ A + LE+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETF--- 61
Query: 524 HHKNLVRLLGFCE----DRNERV-LIYEYLENGTLHDHLHN-PQSSSPLKSWPARIK-VA 576
H N+VRL C DR ++ L++E+++ L +L P+ P IK +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP----TETIKDMM 116
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
RG+++LH + V +HRD+K N+L+ ++ K++DFGL+ I S + A
Sbjct: 117 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARI--------YSFQMA 165
Query: 637 GTV-----GYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
T Y PE D++S G + E+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 70/266 (26%), Positives = 108/266 (40%), Gaps = 56/266 (21%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR-----QEDKDNAFINE--LES 519
+G GSFG V A L ++ YA+ + Q+D + E + +
Sbjct: 3 LGKGSFGKVLLAELKGTDEL------------YAVKVLKKDVILQDDDVECTMTEKRVLA 50
Query: 520 LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L+ H L +L C +R+ + EY+ G L H+ Q S AR A +
Sbjct: 51 LAG-KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARF-YAAE 104
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL--IGPEDDESHLSLRAA 636
G+++LHE II+RD+K NVLLD+ K++DFG+ I S
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----C 157
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
GT Y+ PE Q D ++ GV+L E+L+G ++ P+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QS-----------------PFEGD 199
Query: 697 DE---IHRVLDRNVPPPTPFEIEAVA 719
DE +L+ V P EA +
Sbjct: 200 DEDELFQSILEDEVRYPRWLSKEAKS 225
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
KIG G++G V+KA + VA+KR + E ++ + E+ L L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---------EGVPSSALREICLLKELK 57
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENG--TLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
HKN+VRL + L++EY + D + +KS+ +G
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF------MFQLLKG 111
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ + H + +++HRD+K N+L++ K++DFGL+
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 466 KIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKD--NAFINELESLSR 522
KIG G++G VYKA ++ +A+K+ + QED+ + I E+ L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLE-----------QEDEGVPSTAIREISLLKE 57
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DAAR 581
+ H N+VRL L++EYL+ L H+ SS P IK L R
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM---DSSPDFAKNPRLIKTYLYQILR 113
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLS 620
GI Y H + V +HRD+K N+L+D T K++DFGL+
Sbjct: 114 GIAYCHSHRV---LHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++++ KIG G++G VYK G VA+K+ + S +E + I E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---------EEEGVPSTAIREIS 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS-----SSPLKSWPARI 573
L L H N+V L + LI+E+L L +L + + +KS+ +I
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+GI + H V +HRD+K N+L+D K++DFGL+
Sbjct: 111 ------LQGILFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 45/170 (26%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELESL 520
+I G++G VY+A G VA+K+ ++ E + F + E+ L
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKM-------------EKEKEGFPITSLREINIL 58
Query: 521 SRLHHKNLVRLLGFCEDRNERVL------IY---EYLENG--TLHDHLHNPQSSSPLKSW 569
+L H N+V + E V+ IY EY+E+ +L + + P S +K
Sbjct: 59 LKLQHPNIVTV-------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC- 110
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+ L G+ +LH+ I+HRD+K+SN+LL+ K+ DFGL
Sbjct: 111 -----LMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 49/236 (20%)
Query: 466 KIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNA-----FINEL 517
IG G G VY A D +VA+K+ R++ +N F+ E
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKI-------------REDLSENPLLKKRFLREA 53
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-------SWP 570
+ + L H +V + C D + Y+E TL L + L S
Sbjct: 54 KIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI--GPEDDE 628
A + + IEY+H ++HRD+K N+LL + D+G ++ E+D
Sbjct: 114 AFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 629 SHLSL--------------RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+ + + GT YM PE +E +D+Y+ GV+L ++L+
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 57/231 (24%)
Query: 464 DHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN------ 515
D IG G+FG V+ T D DG +VA+K+ N F N
Sbjct: 5 DRPIGYGAFGVVWSVT-DPRDGKRVALKKMP------------------NVFQNLVSCKR 45
Query: 516 ---ELESLSRLHHKNLVRLLGFCE----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
EL+ L H N++ L + D E + + L LH + +PQ S
Sbjct: 46 VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS--- 102
Query: 569 WPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+KV L RG++YLH I+HRDIK N+L+++ K+ DFGL+ + D+
Sbjct: 103 --DHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
H++ +YYR ++ T D++S G + E+L
Sbjct: 158 SKHMTQEVV-------TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 17/106 (16%)
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHL 631
K+A+ + +EYLH S+IHRD+K SNVL++ K+ DFG+S L+ +S
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-----DSVA 159
Query: 632 SLRAAGTVGYMDPEYYRL------QQLTEKSDVYSFGVVLLEILSG 671
AG YM PE R+ + KSDV+S G+ ++E+ +G
Sbjct: 160 KTIDAGCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+F +IGSG++G VYKA ++ G A+K ++ +A+ + E+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ-----------EII 58
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHD--HLHNPQSSSPLKSWPARIKVA 576
+ H N+V G R++ + E+ G+L D H+ P S S + V+
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY------VS 112
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ +G+ YLH +HRDIK +N+LL K++DFG+S + ++ R +
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS----AQITATIAKRKS 165
Query: 637 --GTVGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEI 668
GT +M PE +++ + D+++ G+ +E+
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 14/102 (13%)
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHL 631
K+++ RG+ YL E I+HRD+K SN+L+++ K+ DFG+S LI +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------DSM 154
Query: 632 SLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSG 671
+ GT YM PE RLQ T +SD++S G+ L+E+ G
Sbjct: 155 ANSFVGTRSYMSPE--RLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 35/214 (16%)
Query: 467 IGSGSFGAVYKATLDDGSQVAV----KRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G+GSFG V A + K+ EI +Q E L
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM--------KQVQHVAQ---EKSILME 74
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN----PQSSSPLKSWPARIKVALD 578
L H +V ++ +D N + E++ G L HL P + K + A + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA--KFYHAELVLAF- 131
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
EYLH II+RD+K N+LLD KV+DFG + P+ + GT
Sbjct: 132 -----EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGT 178
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE + + + D ++ GV+L E ++GY
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212
|
Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
++G G+FG VYKA + +A + I TK +E+ ++ ++ E+E L+ +H
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKV---------IETKSEEELED-YMVEIEILATCNH 68
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGT-------LHDHLHNPQSSSPLKSWPARIKVALD 578
+V+LLG + ++ E+ G L L PQ + L+
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ-------MLE 121
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A ++YLH IIHRD+K+ NVLL K++DFG+S + + S GT
Sbjct: 122 A---LQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF--IGT 173
Query: 639 VGYMDPEYYRLQQLTE-----KSDVYSFGVVLLEI 668
+M PE + + + K+D++S G+ L+E+
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 39/171 (22%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELESL 520
KIG G+FG V+KA VA+K+ E++ F + E++ L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKV-------------LMENEKEGFPITALREIKIL 65
Query: 521 SRLHHKNLVRLLGFC--------EDRNERVLIYEYLENGTLHD---HLHNPQSSSPLKSW 569
L H+N+V L+ C + L++E+ E HD L N L
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEI 121
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+K+ L+ G+ Y+H I+HRD+K++N+L+ K++DFGL+
Sbjct: 122 KKVMKMLLN---GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE------DKDNAFINELESL 520
+G GSFG V A L ++ +AI +++ D + +
Sbjct: 3 LGKGSFGKVMLAELKGTNEF------------FAIKALKKDVVLEDDDVECTMVERRVLA 50
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIY--EYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
H L L FC + + L + EYL G L H+ QSS AR A +
Sbjct: 51 LAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI---QSSGRFDEARARFYAA-E 104
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
G+++LH+ II+RD+K NVLLD K++DFG+ + + GT
Sbjct: 105 IICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--CGT 159
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH 676
Y+ PE + Q+ E D +SFGV+L E+L G H
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 460 NFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
NF + K+G G++ VYK G VA+K + + +E + I E+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----------EEGTPSTAIREIS 50
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK-VAL 577
+ L H+N+VRL N+ +L++EY++ L ++ L P +K
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALD--PNTVKSFTY 107
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+GI + HE V +HRD+K N+L++ K++DFGL+ RA G
Sbjct: 108 QLLKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLA-------------RAFG 151
Query: 638 -----------TVGYMDPEYYRLQQLTEKS-DVYSFGVVLLEILSGY 672
T+ Y P+ + S D++S G ++ E+++G
Sbjct: 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF--IN 515
+++ + K+G GS+ VYK +G VA+K + QE++ F I
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL------------QEEEGTPFTAIR 52
Query: 516 ELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
E L L H N+V L + L++EY+ H L P P +K+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-----HTDLCQYMDKHPGGLHPENVKL 107
Query: 576 AL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
L RG+ Y+H+ I+HRD+K N+L+ T K++DFGL+ + SH
Sbjct: 108 FLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSN 162
Query: 635 AAGTVGYMDPEYYRLQQLTEKS---DVYSFGVVLLEILSGYRA 674
T+ Y P+ L TE S D++ G + +E++ G A
Sbjct: 163 EVVTLWYRPPDV--LLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 470 GSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529
G+FG ++ L D + + + +A E + + E L L H+N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-----SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 530 RLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR----IKVALDAARGIE 584
+L C ED ++Y Y+ G L L + + +A+ A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH+ V IH+DI + N ++D K++D LS D L V +M
Sbjct: 132 YLHKRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILS 670
E ++ + SDV+SFGV+L E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 65/259 (25%), Positives = 104/259 (40%), Gaps = 73/259 (28%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
KIG G+F V KA + G A+K + S ++ N E+++L RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---------EQVNNL-REIQALRRL 54
Query: 524 -HHKNLVRLLGFCEDR-NERV-LIYEYLENGTLHDHLHN---PQSSSPLKSWPARIKVAL 577
H N++RL+ DR R+ L++E ++ L++ + P +KS+ ++
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQL---- 109
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA- 636
+ ++++H I HRDIK N+L+ K++DFG S R
Sbjct: 110 --LKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFG-------------SCRGIY 150
Query: 637 ---------GTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSGY--------- 672
T Y PE YY K D+++ G V EILS +
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYY-----GPKMDIWAVGCVFFEILSLFPLFPGTNEL 205
Query: 673 RAIHRTHN--GTPRNVVDF 689
I + H+ GTP V
Sbjct: 206 DQIAKIHDVLGTPDAEVLK 224
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 460 NFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ IGSG++G V A +D G +VA+K+ I KR + EL
Sbjct: 6 RYKPIENIGSGAYGVVCSA-IDTRSGKKVAIKK--IPHAFDVPTLAKRT-------LREL 55
Query: 518 ESLSRLHHKNLVRLLG-FCEDRNERVLIYEYLE--NGTLHDHLHNPQSSSPLKSWPARIK 574
+ L H N++ + + +Y ++ LH +H S PL I+
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH---SDQPLTE--EHIR 110
Query: 575 VAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS---LIGPEDDESH 630
L RG++Y+H ++IHRD+K SN+L++ ++ DFG++ P + +
Sbjct: 111 YFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 631 LSLRAAGTVGYMDPE-YYRLQQLTEKSDVYSFGVVLLEIL 669
++ A T Y PE L + T D++S G + E+L
Sbjct: 168 MTEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 466 KIGSGSFGAVYKAT---LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
++G G++G V A + VA+K+ I++ S I KR + EL+ L
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKK--ITNVFSKKILAKRA-------LRELKLLRH 57
Query: 523 LH-HKNLVRLLG----FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
HKN+ L F + NE + +YE L LH + S PL A + +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNE-LYLYEELMEADLHQIIR---SGQPLTD--AHFQSFI 111
Query: 578 -DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL---IGPEDDESHLSL 633
G++Y+H V +HRD+K N+L++A K+ DFGL+ P ++ ++
Sbjct: 112 YQILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 634 RAAGTVGYMDPE-YYRLQQLTEKSDVYSFGVVLLEILSG 671
A T Y PE Q T+ DV+S G +L E+L
Sbjct: 169 YVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELESLSRLH 524
IG G++GAVY+ + G VA+K + + D D + I E+ LS+L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDT-----------PDDDVSDIQREVALLSQLR 57
Query: 525 H---KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR-IKVALDAA 580
N+ + G +I EY E G++ + + S R + VAL
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVAL--- 114
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+Y+H+ +IHRDIK++N+L+ T K+ DFG++ + ++ + GT
Sbjct: 115 ---KYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPY 166
Query: 641 YMDPEYYR-LQQLTEKSDVYSFGVVLLEILSG 671
+M PE + K+D++S G+ + E+ +G
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 66/208 (31%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG GSFG V A DG AVK AI K+++ A N L L + H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK-----VLQKKAILKKKEQKHIMAERNVL--LKNVKH 55
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV L + ++ + +Y+ G L HL +S + AR A + A + Y
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR---ARFYAA-EIASALGY 111
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL--IGPEDDESHLSLRAAGTVGYMD 643
LH +II+RD+K N+LLD+ ++DFGL I S GT Y+
Sbjct: 112 LHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF----CGTPEYLA 164
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE R Q D + G VL E+L G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 467 IGSGSFGAV----YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G FG V +AT G A K+ E K+++ + A +NE L +
Sbjct: 8 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRI-------KKRKGEAMA-LNEKRILEK 56
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
++ + +V L E ++ L+ + G L H++N +P I A + G
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCG 114
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTVGY 641
+E L I++RD+K N+LLD ++SD GL++ PE + ++R GTVGY
Sbjct: 115 LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGY 167
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
M PE ++ T D + G ++ E++ G + R VD
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 37/221 (16%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G+ G VYKA L +AVK + T + ++Q ++ELE L +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT----VELQKQ------IMSELEILYKCDS 58
Query: 526 KNLVRLLG--FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
++ G F E+R + E+++ G+L + P+ RI VA+ +G+
Sbjct: 59 PYIIGFYGAFFVENRIS--ICTEFMDGGSLDVYRKIPEHVL------GRIAVAV--VKGL 108
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGY 641
YL I+HRD+K SN+L++ K+ DFG+S L+ + ++ GT Y
Sbjct: 109 TYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------NSIAKTYVGTNAY 159
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIHRTH 679
M PE +Q SDV+S G+ +E+ G Y I +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 26/237 (10%)
Query: 466 KIGSGSFGAVYKATLDDG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+IG+G FG V ++ G +QV VK +S++ QE F+ E +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--------QEQMK--FLEEAQPYRS 51
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI-KVALDAAR 581
L H NL++ LG C + +L+ E+ G L +L + + + + P + ++A + A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
G+ +LH+ + IH D+ N LL A T K+ D+GLS ++D + + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 642 MDPEYYR-------LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
+ PE + T++S+V+S GV + E+ +R + V+ + V
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL--SDEQVLTYTV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
++G G++G+VYK L + V + EI + E K N I EL+ L +
Sbjct: 8 ELGKGNYGSVYKV-LHRPTGVTMAMKEIR--------LELDESKFNQIIMELDILHKAVS 58
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
+V G + EY++ G+L D L+ ++ ++ +G+++
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
L E +IIHRD+K +NVL++ K+ DFG+S + + L+ G YM PE
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPE 171
Query: 646 YYRLQQLTE------KSDVYSFGVVLLEILSG 671
+ + +SDV+S G+ +LE+ G
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 50/240 (20%), Positives = 98/240 (40%), Gaps = 61/240 (25%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN-----ELESL 520
+G G++G V KA G VA+K+ +I S+ TK ++ I+ EL+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDV--TKDRQLVGMCGIHFTTLRELKIM 74
Query: 521 SRLHHKNLVRLLG-FCEDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA- 576
+ + H+N++ L+ + E N L+ + + S K +I++
Sbjct: 75 NEIKHENIMGLVDVYVEGDFIN---LVMDIMA-------------SDLKKVVDRKIRLTE 118
Query: 577 -------LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-------LI 622
L G+ LH++ +HRD+ +N+ +++ K++DFGL+
Sbjct: 119 SQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 623 GPEDDESHLSLRAAGTVGYMDPE----YYRLQQL-------TEKSDVYSFGVVLLEILSG 671
+ + R M + +YR +L D++S G + E+L+G
Sbjct: 176 DTLSKDETMQRREE-----MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 27/238 (11%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IG+G FG V + + + VA R + + A +K Q + F+ + + L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVA--RVVVKELKANA-SSKEQNE----FLQQGDPYRILQ 53
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N+++ LG C + +L++EY E G L +L Q ++A + A G+
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE---------DDESHLSLR- 634
++H++ + +H D+ N L + T KV D+G IGP +D+ + LR
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRW 167
Query: 635 -AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
A VG +Q T+ S+V++ GV L E+ A + + R V++ V+
Sbjct: 168 LAPELVGEFHGGLITAEQ-TKPSNVWALGVTLWELFEN--AAQPYSHLSDREVLNHVI 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 511 NAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP 570
N I EL+ L + +V G E + E+++ G+L L K P
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA------KRIP 101
Query: 571 ARI--KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
I KV++ RG+ YL E I+HRD+K SN+L+++ K+ DFG+S G D
Sbjct: 102 EEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS 157
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
S GT YM PE + + +SD++S G+ L+E+ G
Sbjct: 158 MANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 51/264 (19%)
Query: 467 IGSGSFGAVYKATLDD----------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
IG G+FG VY+ D + V + E++ T R ++ FI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
L+ F D ++ L+ +Y+ G L HL Q A+ +A
Sbjct: 61 LK-------------FSFQTD-SDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIA 103
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ +E+LH+Y I++RD+K N+LLDAT + DFGLS D+++ +
Sbjct: 104 -ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--C 157
Query: 637 GTVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSG------------YRAIHRTHNGTP 683
GT Y+ PE ++ T+ D +S GV++ E+ G YR I P
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP 217
Query: 684 RNVV-----DFVVPYIVRDEIHRV 702
+NV+ FV + R+ HR+
Sbjct: 218 KNVLSDEGRQFVKGLLNRNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 15/133 (11%)
Query: 543 LIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
LI +Y+ G + HL+ S ++ + I +AL E+LH+ I++RDIK
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL------EHLHKLG---IVYRDIK 132
Query: 601 SSNVLLDATWTAKVSDFGLSL-IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKS-DV 658
N+LLD+ ++DFGLS E+ E S GT+ YM PE R + K+ D
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--CGTIEYMAPEIIRGKGGHGKAVDW 190
Query: 659 YSFGVVLLEILSG 671
+S G+++ E+L+G
Sbjct: 191 WSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 37/244 (15%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE----DKDNAFINELESLSR 522
IG GS+ V L Q+ YA+ ++E D+D ++ + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQI------------YAMKVVKKELVHDDEDIDWVQTEKHVFE 50
Query: 523 LHHKN--LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP---LKSWPARIKVAL 577
N LV L + + L+ EY+ G L H+ Q P + + A I +AL
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIAL 109
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL--IGPEDDESHLSLRA 635
+ +LHE II+RD+K NVLLDA K++D+G+ +GP D S
Sbjct: 110 N------FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF---- 156
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
GT Y+ PE R ++ D ++ GV++ E+++G + N D++ I+
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL 216
Query: 696 RDEI 699
I
Sbjct: 217 EKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-10
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 56/230 (24%)
Query: 465 HKIGSGSFGAVYKATLDDGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFIN------- 515
K+G G++G V+KA +D ++ VA+K+ +AF N
Sbjct: 13 QKLGKGAYGIVWKA-IDRRTKEVVALKKIF------------------DAFRNATDAQRT 53
Query: 516 --ELESLSRL-HHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSPLKSWP 570
E+ L L H N+V+LL + N++ L++EY+E D LH ++ L+
Sbjct: 54 FREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVH 108
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL--SLIGPEDDE 628
R + + ++Y+H V IHRD+K SN+LL++ K++DFGL SL E++
Sbjct: 109 KRY-IMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGV-------VLLEILSG 671
+ L Y+ +YR ++ S Y+ GV +L E+L G
Sbjct: 165 ENPVL-----TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 79/270 (29%)
Query: 467 IGSGSFGAVYKAT---LDDGSQ---VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G G+FG V +A+ +D S VAVK + +T+S + A ++EL+ L
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS----------EHKALMSELKIL 64
Query: 521 SRL-HHKNLVRLLGFCEDRNERVL-IYEYLENGTLHDHL--------------------- 557
+ +H N+V LLG C N ++ I E+ + G L + L
Sbjct: 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRF 124
Query: 558 ---------------------------HNPQSSSPLKS----WPARIKV------ALDAA 580
S++P + W + + + + A
Sbjct: 125 RAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVA 184
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
RG+E+L A IHRD+ + N+LL K+ DFGL+ +D + A +
Sbjct: 185 RGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+M PE + T +SDV+SFGV+L EI S
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 467 IGSGSFGAV----YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G FG V +AT G A K+ E K+++ + A +NE + L +
Sbjct: 8 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRI-------KKRKGEAMA-LNEKQILEK 56
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
++ + +V L E ++ L+ + G L H++N +P + A + G
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCG 114
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTVGY 641
+E LH I++RD+K N+LLD ++SD GL++ PE + ++R GTVGY
Sbjct: 115 LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGY 167
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
M PE + ++ T D + G ++ E++ G
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++F + ++G+G+ G V+K S + + R I AI N I EL+
Sbjct: 5 DDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAI--------RNQIIRELQ 55
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVA 576
L + +V G E + E+++ G+L Q P +I KV+
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD------QVLKKAGRIPEQILGKVS 109
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ +G+ YL E I+HRD+K SN+L+++ K+ DFG+S G D S
Sbjct: 110 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF--V 163
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT YM PE + + +SD++S G+ L+E+ G
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 55/270 (20%)
Query: 428 PVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHK------IGSGSFGAVYKAT-L 480
+ +KKL + N E+ E +++ N S + IG+GSFG VY+A +
Sbjct: 29 EMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICI 88
Query: 481 DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN-ELESLSRLHHKNLVRLLGF----C 535
D +VA+K+ +D + N EL + L+H N++ L + C
Sbjct: 89 DTSEKVAIKKVL----------------QDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 536 EDRNERVL----IYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVALDAARGIEYLHEYA 590
+NE+ + + E++ T+H ++ H +++ L + ++ + R + Y+H
Sbjct: 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIHS-- 188
Query: 591 VPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL 649
I HRD+K N+L+D T T K+ DFG + L +V Y+ +YR
Sbjct: 189 -KFICHRDLKPQNLLIDPNTHTLKLCDFG---------SAKNLLAGQRSVSYICSRFYRA 238
Query: 650 QQL-------TEKSDVYSFGVVLLEILSGY 672
+L T D++S G ++ E++ GY
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGY 268
|
Length = 440 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR-----QEDKDNAFINELESLS 521
+G GSFG V A L + ++ YA+ + Q+D + E LS
Sbjct: 3 LGKGSFGKVMLARLKESGRL------------YAVKVLKKDVILQDDDVECTMTEKRILS 50
Query: 522 RLHHKNLVRLLGFCEDRNERVL-IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
+ + L C +R+ + E++ G L H+ Q S AR A +
Sbjct: 51 LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAA-EIT 106
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+ +LH+ II+RD+K NVLLD K++DFG+ G + ++ + GT
Sbjct: 107 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF--CGTPD 161
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE + D ++ GV+L E+L G+
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQV----AVKRAEISSTSSYAIGTKRQEDKDNAFI-NELESLS 521
+G G FG V + ++ VK+ I T Q+ I +E E L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET--------GQQ----EHIFSEKEILE 48
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+H +V+L +D+ ++ EY G L L + + AR +A
Sbjct: 49 ECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIAC-VVL 104
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA----- 636
EYLH II+RD+K N+LLD+ K+ DFG + L
Sbjct: 105 AFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFA--------KKLKSGQKTWTFC 153
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
GT Y+ PE + D +S G++L E+L+G
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 21/183 (11%)
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP---LKSWPARIKVALDAA 580
+H LV L + + + EY+ G L H+ Q P + + A I +AL+
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALN-- 110
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG--PEDDESHLSLRAAGT 638
YLHE II+RD+K NVLLD+ K++D+G+ G P D S GT
Sbjct: 111 ----YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGT 159
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA--IHRTHNGTPRNVVDFVVPYIVR 696
Y+ PE R + D ++ GV++ E+++G I + + +N D++ I+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219
Query: 697 DEI 699
+I
Sbjct: 220 KQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 467 IGSGSFGAVYKATLDDGSQV----AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG GSFG V + D ++ +++A I S S + E L++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEV-----------THTLAERTVLAQ 49
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
++ +V L + + L+ ++ G L HL Q AR A +
Sbjct: 50 VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTA-ELLCA 105
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+E LH++ V I+RD+K N+LLD + DFGL + +DD+ + GT Y+
Sbjct: 106 LENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYL 160
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE T+ D ++ GV+L E+L+G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE-----DKDNAFINELESLS 521
+G GSFG V+ A L +Q +AI +++ D + E LS
Sbjct: 3 LGKGSFGKVFLAELKGTNQF------------FAIKALKKDVVLMDDDVECTMVEKRVLS 50
Query: 522 -RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
H L L + + + EYL G L H+ QS P A +
Sbjct: 51 LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI---QSCHKF-DLPRATFYAAEII 106
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL---SLIGPEDDESHLSLRAAG 637
G+++LH I++RD+K N+LLD K++DFG+ +++G + G
Sbjct: 107 CGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-----CG 158
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH 676
T Y+ PE Q+ D +SFGV+L E+L G H
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
++GSG++G VYKA L G AVK ++ +++ E+ +
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----------IQQEIFMVKEC 63
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL---DAA 580
H N+V G R + + EY G+L D H + PL + +++A +
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH---VTGPL----SELQIAYVCRETL 116
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA--GT 638
+G+ YLH +HRDIK +N+LL K++DFG++ + ++ R + GT
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGT 169
Query: 639 VGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEI 668
+M PE +++ + D+++ G+ +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 30/180 (16%)
Query: 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602
+ EY+ G L + Q K P + A + A G+ +LH II+RD+K
Sbjct: 78 FVMEYVNGGDLMYQI---QQVGRFKE-PHAVFYAAEIAIGLFFLHS---KGIIYRDLKLD 130
Query: 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFG 662
NV+LD+ K++DFG+ D + + GT Y+ PE Q + D ++FG
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKTF--CGTPDYIAPEIIAYQPYGKSVDWWAFG 188
Query: 663 VVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE---IHRVLDRNVPPPTPFEIEAVA 719
V+L E+L+G P+ DE +++ NV P EAVA
Sbjct: 189 VLLYEMLAGQ------------------APFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 230
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 45/289 (15%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G++G V+K +GS+ AVK + +++ A N L++LS H
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD---------PIHDIDEEIEAEYNILKALS--DH 74
Query: 526 KNLVRLLGFCEDRNERV-----LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
N+V+ G ++ + L+ E G++ D + P + +A
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
G+++LH IHRD+K +N+LL K+ DFG+S + GT
Sbjct: 135 MGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189
Query: 641 YMDPEYYRLQQ-----LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
+M PE +Q + DV+S G+ +E+ G + H P + F +P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH---PMRAL-FKIP--- 242
Query: 696 RDEIHRVLDRNVPPPTPFEIEA-VAYVGYLAADCVTLEGRNRPSMTEIV 743
RN PPPT + E C+T + RP++++++
Sbjct: 243 ---------RN-PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 42/278 (15%)
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNP-QSSSPLKSWPA-- 571
+EL L+ H +V+ + ++ +LI EY G L+ + + P + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 572 ---RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
+I +ALD E ++HRD+KS+N+ L T K+ DFG S +
Sbjct: 174 LFYQIVLALD---------EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG-TPRNVV 687
++ GT Y+ PE + ++ ++K+D++S GV+L E+L+ +HR G + R ++
Sbjct: 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT----LHRPFKGPSQREIM 280
Query: 688 DFVV-------PYIVRDEIHRVLD---RNVPPPTP-----FEIEAVAYVGYLAADCV--- 729
V+ P V + +LD P P E + YV L D V
Sbjct: 281 QQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHS 340
Query: 730 -TLEGRNRPSMTEIVNSLERALAACLVSPSISRSATSS 766
T+ +R EI+ L+ + SI +S
Sbjct: 341 ETISPHDR---EEILRQLQESGERAPPPSSIRYGVVTS 375
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 460 NFSEDHKIGSGSFGAVY---KATLDDGSQV----AVKRAEISSTSSYAIGTKRQEDKDNA 512
NF +G+G++G V+ K + D ++ +K+A I + T R E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWP 570
I + L LH+ F D LI +Y+ G L HL + ++ +
Sbjct: 60 HIRQSPFLVTLHY-------AFQTDTKLH-LILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
I +AL E+LH+ II+RDIK N+LLD+ ++DFGLS E DE
Sbjct: 112 GEIVLAL------EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVE 161
Query: 631 LSLRAAGTVGYMDPEYYRLQQLTEKS--DVYSFGVVLLEILSG 671
+ GT+ YM P+ R D +S GV++ E+L+G
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 53/288 (18%)
Query: 480 LDDGSQVAVKRAEISSTSSYAIGTKRQEDK------------DNAFINELESLSRLHHKN 527
L G+ + + + S I QE AF +S+L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 528 LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH 587
LV+L G C R+E +++ EY++ G L LH + ++ W ++ VA A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHR-EKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 588 EYAVPSIIHRDIKSSNVLL----DATWT---AKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+ ++H ++ N+L+ K+SD G+ + R
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP---- 169
Query: 641 YMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
++ PE R Q LT +D +SFG LLEI S T ++
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST--------------LSSSEK 215
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
D++ P + A + L C T + RPS I+ L
Sbjct: 216 ERFYQDQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG GSFG V A DG AVK + + ++++ A N L L + H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQ-----KKIVLNRKEQKHIMAERNVL--LKNVKH 55
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
LV L + + + +++ G L HL +S + AR A + A + Y
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR---ARFYAA-EIASALGY 111
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
LH +I++RD+K N+LLD+ ++DFGL G ++ + GT Y+ PE
Sbjct: 112 LHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF--CGTPEYLAPE 166
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSG 671
R Q D + G VL E+L G
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE-----DKDNAFINELESLS 521
+G G+FG V + V+ E +S YA+ ++E D+ + E L
Sbjct: 3 LGKGTFGKV----------ILVR--EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK 50
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDA 579
H L L + ++ + EY+ G L HL + S + + A I ALD
Sbjct: 51 NTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD- 109
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
YLH I++RD+K N++LD K++DFGL G D + + GT
Sbjct: 110 -----YLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTP 159
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE D + GVV+ E++ G
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 543 LIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
I + + G LH HL H S ++ + I + G+E++H V ++RD+K
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHNRFV---VYRDLK 124
Query: 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT---EKSD 657
+N+LLD ++SD GL+ D + GT GYM PE LQ+ T +D
Sbjct: 125 PANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV--LQKGTAYDSSAD 178
Query: 658 VYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
+S G +L ++L G+ R H ++ +D
Sbjct: 179 WFSLGCMLFKLLRGHSPF-RQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR-----QEDKDNAFINELESLS 521
+G GSFG V A + YAI + Q+D + E L+
Sbjct: 8 LGKGSFGKVMLAERK------------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLA 55
Query: 522 RLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
+ L C +R+ + EY+ G L H+ Q K P + A + +
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKE-PQAVFYAAEIS 111
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-AGTV 639
G+ +LH II+RD+K NV+LD+ K++DFG+ E ++ R GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC---KEHMVDGVTTRTFCGTP 165
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE Q + D +++GV+L E+L+G
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 21/151 (13%)
Query: 543 LIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
I + + G LH HL H S + ++ + A I + G+E++H V ++RD+K
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLEHMHNRFV---VYRDLK 124
Query: 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT---EKSD 657
+N+LLD ++SD GL+ + H S+ GT GYM PE LQ+ +D
Sbjct: 125 PANILLDEHGHVRISDLGLA-CDFSKKKPHASV---GTHGYMAPEV--LQKGVAYDSSAD 178
Query: 658 VYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
+S G +L ++L G+ R H ++ +D
Sbjct: 179 WFSLGCMLFKLLRGHSPF-RQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 460 NFSEDHKIGSGSFGAVYKATLDDGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+F+ +G+GSFG V AT + VA+KR E S +Q+ D+ F +E
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-------KQKQVDHVF-SER 82
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV-- 575
+ L+ ++H V L G +D + L+ E++ G L K +P +
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN------KRFPNDVGCFY 136
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A EYL +I++RD+K N+LLD K++DFG + + D +L
Sbjct: 137 AAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTL-- 188
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE + +D ++ G+ + EIL G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 30/85 (35%), Positives = 49/85 (57%)
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
+H +IHRDIKS+N+LL + K+ DFG S + + GT Y+ PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILS 670
+R + ++K+D++S GV+L E+L+
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 69/234 (29%)
Query: 465 HKIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521
IGSG+ G V A D G VA+K+ +S KR A+ EL +
Sbjct: 22 KPIGSGAQGIVCAA--YDTVTGQNVAIKK--LSRPFQNVTHAKR------AY-RELVLMK 70
Query: 522 RLHHKNLVRLLG-FCEDRN--ERVLIYEYLENGTLHDH-LHNPQSSSPLKSWPARIKVAL 577
++HKN++ LL F ++ E +Y +E L D L I++ L
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVME---LMDANLCQV------------IQMDL 115
Query: 578 DAAR----------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
D R GI++LH IIHRD+K SN+++ + T K+ DFGL+
Sbjct: 116 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------- 165
Query: 628 ESHLSLRAAGTVGYMDPE----YYRLQQL------TEKSDVYSFGVVLLEILSG 671
R AGT M P YYR ++ E D++S G ++ E++ G
Sbjct: 166 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G+FG V QV A+K S + + KR D+AF E + + H
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKL-----LSKFEM-IKRS---DSAFFWEERDI--MAH 99
Query: 526 KN---LVRLLGFCEDRNERVL--IYEYLENGTLHDHLHN---PQSSSPLKSWPARIKVAL 577
N +V+L ++++ L + EY+ G L + + N P+ + + + A + +AL
Sbjct: 100 ANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA--RFYTAEVVLAL 155
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
DA +H IHRD+K N+LLD + K++DFG + + A G
Sbjct: 156 DA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD-TAVG 205
Query: 638 TVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSG 671
T Y+ PE + Q + D +S GV L E+L G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
I + ARG+E+L A IHRD+ + N+LL K+ DFGL+ +D +
Sbjct: 176 ISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
A + +M PE + T +SDV+SFGV+L EI S
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 49/264 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQV-------AVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+G G +G V++ G+ +K+A I TK + N LE+
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER-------NILEA 56
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVAL 577
+ H +V L+ + + LI EYL G L HL + + I +AL
Sbjct: 57 VK---HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
E+LH+ II+RD+K N+LLDA K++DFGL + ++ G
Sbjct: 114 ------EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCG 162
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVDFVV--- 691
T+ YM PE + D +S G ++ ++L+G + A +R + +D ++
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK 216
Query: 692 ----PYI---VRDEIHRVLDRNVP 708
PY+ RD + ++L RN
Sbjct: 217 LNLPPYLTPEARDLLKKLLKRNPS 240
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 9/128 (7%)
Query: 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603
+ EY+ G L H+ Q K P + A + A G+ +LH II+RD+K N
Sbjct: 79 VMEYVNGGDLMYHI---QQVGKFKE-PHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131
Query: 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGV 663
V+LDA K++DFG+ ++ + GT Y+ PE Q + D ++FGV
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKTTRTF--CGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 664 VLLEILSG 671
+L E+L+G
Sbjct: 190 LLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE-----DKDNAFINELESLS 521
+G G+FG V + V+ E ++ YA+ R+E D+ + E L
Sbjct: 3 LGKGTFGKV----------ILVR--EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 50
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDA 579
H L L + + + EY G L HL + + + + A I AL
Sbjct: 51 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL-- 108
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
EYLH +++RDIK N++LD K++DFGL G D + + GT
Sbjct: 109 ----EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTP 159
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE D + GVV+ E++ G
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N F +G G++G V K + + VA+K+ + S + E+ + EL
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS---------EENEEVKETTLREL 51
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP--LKSWPARIKV 575
+ L L +N+V L R + L++EY+E L P P ++S+ ++
Sbjct: 52 KMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL-- 109
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
+ I + H+ I+HRDIK N+L+ K+ DFG + E ++ +
Sbjct: 110 ----IKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
A T Y PE + D++S G +L E+ G
Sbjct: 163 A-TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
+G GSFG + Q + SS A+ R+E A + L+++ H
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE----AVL-----LAKMKHP 58
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ----SSSPLKSWPARIKVALDAARG 582
N+V E ++ EY + G L + + + W ++ + G
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------G 112
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVG 640
++++HE V +HRDIKS N+ L K+ DFG + L P + GT
Sbjct: 113 VQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----GAYACTYVGTPY 165
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
Y+ PE + KSD++S G +L E+
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 467 IGSGSFGAVYKAT---LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G G+F ++K + D ++ + + K + +F +S+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLK------VLDKSHRNYSESFFEAASMMSQL 56
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
HK+LV G C +E +++ EY++ G+L +L ++ + SW +++VA A +
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI-SW--KLEVAKQLAWAL 113
Query: 584 EYLHEYAVPSIIHRDIKSSNVLL-----DATWTA---KVSDFGLSL-IGPEDDESHLSLR 634
+L + + H ++ + NVLL T K+SD G+S+ + P++ L R
Sbjct: 114 HFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLER 167
Query: 635 AAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSG 671
+ ++ PE Q L+ +D +SFG L EI SG
Sbjct: 168 ----IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE----DKDNAFINE----LE 518
IG GS+ V L ++ YA+ ++E D+D ++ E
Sbjct: 3 IGRGSYAKVLLVELKKTRRI------------YAMKVIKKELVNDDEDIDWVQTEKHVFE 50
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP---LKSWPARIKV 575
+ S +H LV L + + + E++ G L H+ Q P + + A I +
Sbjct: 51 TAS--NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISL 107
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL--IGPEDDESHLSL 633
AL+ +LHE II+RD+K NVLLDA K++D+G+ I P D S
Sbjct: 108 ALN------FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-- 156
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE R + D ++ GV++ E+++G
Sbjct: 157 --CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 41/188 (21%)
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
+ A+G+E+L A IHRD+ + N+LL K+ DFGL+ +D + A
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS----GYRAIH-------RTHNGTPR 684
+ +M PE + T +SDV+SFGV+L EI S Y + R GT
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
D+ P E+++ + DC E RP+ +E+V
Sbjct: 302 RAPDYTTP-----EMYQTM----------------------LDCWHGEPSQRPTFSELVE 334
Query: 745 SLERALAA 752
L L A
Sbjct: 335 HLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 67/293 (22%), Positives = 110/293 (37%), Gaps = 41/293 (13%)
Query: 411 AQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGS- 469
+++ PP+PP S ++ L S G+ LE + + + S+D
Sbjct: 1 SESMDTTPPLPPRSYSGGAADEDLYSDISDGD--------LEYSDDDSASESDDDDDDGL 52
Query: 470 -----------GSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
S G TL GS+ VA K + IG K +
Sbjct: 53 IPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQ-PDPVVLKIGQK------GTTL 105
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E L ++H +++R+ ++ + + L+ +L P+ K
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
L G+ YLH IIHRD+K+ N+ ++ + D G + P + L L
Sbjct: 165 QIL---EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGL- 216
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687
AGTV PE + K+D++S G+VL E+L+ I TP V
Sbjct: 217 -AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G++G V A + +VA+K+ I++ I KR + E++ L L H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRT-------LREIKLLRHLDH 63
Query: 526 KNLVRLLGF----CEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
+N++ + + V ++YE L + LH + + Q L + +
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQ---TLSDDHCQYFL-YQLL 118
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
RG++Y+H +++HRD+K SN+LL+A K+ DFGL+ E +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE-------- 167
Query: 641 YMDPEYYRLQQL-------TEKSDVYSFGVVLLEIL 669
Y+ +YR +L T DV+S G + E+L
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE-----DKDNAFINELESLS 521
+G G+FG V + VK E ++ YA+ ++E D+ + E L
Sbjct: 3 LGKGTFGKV----------ILVK--EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 50
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDA 579
H L L + + + EY G L HL + S + + A I ALD
Sbjct: 51 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD- 109
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
YLH + ++++RD+K N++LD K++DFGL G +D + + GT
Sbjct: 110 -----YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTP 160
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE D + GVV+ E++ G
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 467 IGSGSFGAVYKATLDDGSQV----------AVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
IG G+FG V L + +V +KRAE T+ + +E++D +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE---TACF------REERDVLVNGD 59
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP---LKSWPARI 573
+ ++ LH+ +D N L+ +Y G L L + P + + A +
Sbjct: 60 NQWITTLHYA--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+A+D+ + Y +HRDIK N+L+D +++DFG L ED S+
Sbjct: 112 VIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162
Query: 634 RAAGTVGYMDPEYYRLQQLTE-------KSDVYSFGVVLLEILSG 671
A GT Y+ PE LQ + + + D +S GV + E+L G
Sbjct: 163 -AVGTPDYISPEI--LQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 14/149 (9%)
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
+ N ++L VLI +Y+++G L D L S + K+ +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV----KKIIRQLVEAL 122
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
LH++ IIH DIK NVL D A + D+GL I S GT+ Y
Sbjct: 123 NDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD----GTLDYF 173
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
PE + D ++ GV+ E+L+G
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQ----EDKDNAFINELESLSR 522
IG G+FG +V + R + SS YA+ + + D+AF E +
Sbjct: 51 IGRGAFG-----------EVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 523 LHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHN---PQSSSPLKSWPARIKVAL 577
+ V L FC ++++ L + EY+ G L + + N P+ + K + A + +AL
Sbjct: 99 FANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLAL 155
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
DA + +IHRD+K N+LLD K++DFG + E A G
Sbjct: 156 DAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD-TAVG 205
Query: 638 TVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSG 671
T Y+ PE + Q + D +S GV L E+L G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 466 KIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G GS+ VYK + +G VA+K I K +E I E L L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALK----------VISMKTEEGVPFTAIREASLLKGLK 61
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DAARGI 583
H N+V L + ++EY+ H L P P +++ + RG+
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYM-----HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
Y+H I+HRD+K N+L+ K++DFGL+ +++ S T+ Y
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS--EVVTLWYRP 171
Query: 644 PEYYRLQQLTEKS---DVYSFGVVLLEILSG 671
P+ L T+ S D++ G + +E+L G
Sbjct: 172 PDV--LLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSG++G+V A G +VAVK+ +S I KR EL L + H
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRT-------YRELRLLKHMKH 75
Query: 526 KNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
+N++ LL F R+ YL + L+N L + + RG++
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLK 134
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
Y+H IIHRD+K SN+ ++ K+ DFGL+ DDE GY+
Sbjct: 135 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE---------MTGYVAT 180
Query: 645 EYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
+YR ++ + D++S G ++ E+L+G
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 467 IGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDK--DNAFINELESLSRL 523
+G G FG V + + G A K+ + KR + K + + E E L ++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK----------LDKKRLKKKSGEKMALLEKEILEKV 50
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS----SPLKSWPARIKVALDA 579
+ +V L E + L+ + G L H++N + + A+I
Sbjct: 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------ 104
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
GI +LH I++RD+K NVLLD ++SD GL++ E + + AGT
Sbjct: 105 TCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTN 158
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GYM PE + + + D ++ G + E+++G
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 15/137 (10%)
Query: 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602
+ E+L G L H+ Q + A A + G+++LH II+RD+K
Sbjct: 73 FVMEFLNGGDLMFHI---QDKGRFDLYRATFYAA-EIVCGLQFLHS---KGIIYRDLKLD 125
Query: 603 NVLLDATWTAKVSDFGL---SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVY 659
NV+LD K++DFG+ ++ G ++ S GT Y+ PE + + T D +
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFG-DNRASTF----CGTPDYIAPEILQGLKYTFSVDWW 180
Query: 660 SFGVVLLEILSGYRAIH 676
SFGV+L E+L G H
Sbjct: 181 SFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK 526
IG GSFG V A + K + AI K++E + N L L + H
Sbjct: 3 IGKGSFGKVLLAR----HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVL--LKNVKHP 56
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586
LV L + ++ + +Y+ G L HL Q AR A + A + YL
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAA-EIASALGYL 112
Query: 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEY 646
H +I++RD+K N+LLD+ ++DFGL E + + + GT Y+ PE
Sbjct: 113 HSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF--CGTPEYLAPEV 167
Query: 647 YRLQQLTEKSDVYSFGVVLLEILSG 671
Q D + G VL E+L G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 23/158 (14%)
Query: 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDH----LHNPQSSSPLKSWPARIKVALDAARG 582
N+V L + + L+ ++ E G L H L+ P+ +K W A + VALDA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC--VKRWAAEMVVALDA--- 100
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG-LSLIGPEDDESHLSLRAAGTVGY 641
LH I+ RD+ +N+LLD +++ F S + D A Y
Sbjct: 101 ---LHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD------GEAVENMY 148
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679
PE + + TE D +S G +L E+L+G + + H
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECH 185
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 459 NNFSEDHKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + + KIG G++G VYKA + G VA+K+ + T +E I+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE------ISLL 54
Query: 518 ESLSRLHHKNLVRLLGF--CEDRNERVLIY---EYLENGTLHDHL-------HNPQSSSP 565
+ LS + +VRLL E++N + +Y EYL++ L + P +
Sbjct: 55 QMLSESIY--IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKT 111
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLS 620
+KS+ ++ +G+ + H++ V +HRD+K N+L+D K++D GL
Sbjct: 112 IKSFMYQL------LKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G G++ V+K + VA+K I + +E I E+ L L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKE----------IRLEHEEGAPCTAIREVSLLKNLK 61
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLH--DHLHNPQSSSPLKSWPARIKVALDAARG 582
H N+V L L++EYL++ D+ N S +K + ++ RG
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------LRG 115
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ Y H+ I+HRD+K N+L++ K++DFGL+
Sbjct: 116 LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 467 IGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSG++G+V A Q VAVK+ +S I +R EL L + H
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK--LSRPFQSLIHARRT-------YRELRLLKHMKH 73
Query: 526 KNLVRLLGF------CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+N++ LL E+ NE YL + L+N L + +
Sbjct: 74 ENVIGLLDVFTPATSIENFNE-----VYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQL 127
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
RG++Y+H IIHRD+K SNV ++ ++ DFGL+ DDE
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE---------MT 173
Query: 640 GYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
GY+ +YR ++ + D++S G ++ E+L G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 73/275 (26%)
Query: 467 IGSGSFGAVYKATLDDGSQV----------AVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
IG G+FG V + + QV +KRAE T+ + +E++D +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE---TACF------REERDVLVNGD 59
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTL-------HDHLHNPQSSSPLKSW 569
++ LH+ F +D N L+ +Y G L D L P+ + + +
Sbjct: 60 RRWITNLHY-------AF-QDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMA--RFY 107
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
A + +A+D+ + Y +HRDIK NVLLD +++DFG S + D +
Sbjct: 108 LAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGT 157
Query: 630 HLSLRAAGTVGYMDPEYYRLQQLTE-------KSDVYSFGVVLLEILSG----------- 671
S A GT Y+ PE LQ + + + D +S GV + E+L G
Sbjct: 158 VQSNVAVGTPDYISPEI--LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 672 -YRAI--HRTHNGTPRNVVDFVVPYIVRDEIHRVL 703
Y I H+ H P +V D V +D I R++
Sbjct: 216 TYGKIMNHKEHFQFPPDVTD--VSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR-----QEDKDNAFINE--LES 519
+G GSFG V A L +V YAI + Q+D + + E + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEV------------YAIKVLKKDVILQDDDVDCTMTEKRILA 50
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
L+ H L L + ++ + EY+ G D + Q S +R A +
Sbjct: 51 LAA-KHPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAA-EV 105
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
+ +LH + V I+RD+K N+LLDA K++DFG+ G + + GT
Sbjct: 106 TLALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTP 160
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE + + D ++ GV++ E+++G
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 467 IGSGSFGAVYKATLDDGSQV----------AVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
IG G+FG V + ++ +KRAE T+ + +E+++ +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE---TACF------REERNVLVNGD 59
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP---LKSWPARI 573
+ ++ LH+ +D N L+ +Y G L L + P + + A +
Sbjct: 60 CQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+A+ + + Y +HRDIK NVLLD +++DFG S + D + S
Sbjct: 112 VLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSS 161
Query: 634 RAAGTVGYMDPEYYRLQQLTE-------KSDVYSFGVVLLEILSG 671
A GT Y+ PE LQ + + + D +S GV + E+L G
Sbjct: 162 VAVGTPDYISPEI--LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 48/228 (21%)
Query: 467 IGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G GS G V+ A D +VAVK+ ++ S + E++ + RL H
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-----------KHALREIKIIRRLDH 61
Query: 526 KNLVRLLGFCEDRNERV--------------LIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
N+V++ + ++ EY+E L N PL A
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-----DLANVLEQGPLSEEHA 116
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESH 630
R+ RG++Y+H V +HRD+K +NV ++ K+ DFGL+ I + SH
Sbjct: 117 RL-FMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARI-VDPHYSH 171
Query: 631 LSLRAAGTVGYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
+ G V ++YR +L T+ D+++ G + E+L+G
Sbjct: 172 KGYLSEGLV----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 19/171 (11%)
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
A+G+ +L A + IHRD+ + N+LL K+ DFGL+ D + A V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
+M PE T +SDV+S+G++L EI S + + P VD Y + E
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY------PGMPVDSKF-YKMIKEG 333
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
+R+L P ++I C + RP+ +IV +E+ L
Sbjct: 334 YRMLSPECAPSEMYDI---------MKSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 38/225 (16%)
Query: 462 SEDHK----IGSGSFGAV----YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF 513
+ED++ IG G+FG V +K+T + + + E+ S A F
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-----------F 90
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN---PQSSSPLKSWP 570
E + ++ + +V+L +D ++ EY+ G L + + N P+ + + +
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYT 148
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
A + +ALDA + + IHRD+K N+LLD + K++DFG + ++
Sbjct: 149 AEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 631 LSLRAAGTVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSG 671
A GT Y+ PE + Q + D +S GV L E+L G
Sbjct: 200 CD-TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 469 SGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDK--------DNAFINELESL 520
+G+FG ++ L ++ A R ++ST+ +R K NE+ +L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 521 SRLHHKNLVRLLGFCEDRNERVLI---YEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
RL+H+N++++ +I Y++ ++D + + LK A +K L
Sbjct: 218 GRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLL 277
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
A +EY+H+ +IHRDIK N+ L+ + DFG + + E + G
Sbjct: 278 CA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDYGWVG 330
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
TV PE E +D++S G++LL++LS
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 26/100 (26%)
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
GI++LH IIHRD+K SN+++ + T K+ DFGL+ R AGT
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RTAGTSFM 181
Query: 642 MDPE----YYRLQQL------TEKSDVYSFGVVLLEILSG 671
M P YYR ++ E D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 38/166 (22%)
Query: 466 KIGSGSFGAVYK--ATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
K+G G++ VYK + L D + VA+K I + +E I E+ L L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKE----------IRLEHEEGAPCTAIREVSLLKDL 61
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGT---LHD-----HLHNPQSSSPLKSWPARIKV 575
H N+V L L++EYL+ L D ++HN +K+
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-------------VKL 108
Query: 576 AL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
L RG+ Y H V +HRD+K N+L++ K++DFGL+
Sbjct: 109 FLFQLLRGLNYCHRRKV---LHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
R I+YLHE IIHRDIK+ N+ ++ + DFG + P D ++ AGT+
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIA 248
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675
PE D++S G+VL E+ + + ++
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 39/233 (16%)
Query: 463 EDHKIGSGSFGAVYKATLDDG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
E K+G G++G VYKA DG + A+K+ E + S A E+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-------------CREIAL 51
Query: 520 LSRLHHKNLVRLLG-FCEDRNERV-LIYEYLENGTLHD---HLHNPQSSSPLKSWPARIK 574
L L H N++ L F + +V L+++Y E+ H H + + P++ + +K
Sbjct: 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 575 VAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGL-----SLIGP 624
L GI YLH V +HRD+K +N+L+ K++D G S + P
Sbjct: 112 SLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 625 EDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIH 676
D + + T Y PE + T+ D+++ G + E+L+ H
Sbjct: 169 LADLDPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 42/250 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR--QEDKDNAFINE 516
N + KIG+G FG V+ VK + + R +E + + + E
Sbjct: 13 NEYEVIKKIGNGRFGEVF----------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 517 LESLSRLHHKNLVRLLG-FCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
+ + L HKN+VR + F N+++ I E+ + G L ++ A +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 575 VALDAARGIEYLHEYAV----PSIIHRDIKSSNVLL-----------------DATWTAK 613
+ + Y H ++HRD+K N+ L + AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 614 VSDFGLSL-IGPEDDESHLSLRAAGTVGYMDPEY--YRLQQLTEKSDVYSFGVVLLEILS 670
+ DFGLS IG E ++ GT Y PE + + +KSD+++ G ++ E+ S
Sbjct: 183 IGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 671 GYRAIHRTHN 680
G H+ +N
Sbjct: 239 GKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 30/212 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE-----DKDNAFINELESLS 521
+G G+FG V + V+ E ++ YA+ ++E D+ + E L
Sbjct: 3 LGKGTFGKV----------ILVR--EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ 50
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDA 579
H L L + + + EY G L HL + S + + A I AL
Sbjct: 51 NTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG- 109
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
YLH +++RD+K N++LD K++DFGL G D + + GT
Sbjct: 110 -----YLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTP 159
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
Y+ PE D + GVV+ E++ G
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 57/226 (25%)
Query: 467 IGSGSFGAVYKATLDD--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IGSG+ G V A D G VAVK+ +S KR EL L ++
Sbjct: 29 IGSGAQGIVCAA-FDTVLGINVAVKK--LSRPFQNQTHAKRA-------YRELVLLKCVN 78
Query: 525 HKNLVRLLGF------CEDRNERVLIYEYLENG---TLHDHLHNPQSSSPLKSWPARIKV 575
HKN++ LL E+ + L+ E ++ +H L + + S L
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC---- 134
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
GI++LH IIHRD+K SN+++ + T K+ DFGL+ R
Sbjct: 135 ------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RT 172
Query: 636 AGTVGYMDP----EYYRLQQL------TEKSDVYSFGVVLLEILSG 671
A T M P YYR ++ E D++S G ++ E++ G
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 36/124 (29%), Positives = 49/124 (39%), Gaps = 41/124 (33%)
Query: 590 AVPSI-----IHRDIKSSNVLLDATWTAKVSDFGL--------------------SLIGP 624
A+ SI IHRDIK N+LLDA K+SDFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 625 EDDESHLS-------------LRAAGTVG---YMDPEYYRLQQLTEKSDVYSFGVVLLEI 668
+ +S A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 669 LSGY 672
L GY
Sbjct: 233 LVGY 236
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 64/254 (25%), Positives = 96/254 (37%), Gaps = 61/254 (24%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED----KDNAFI 514
++F IG G+FG V D + YA+ R+ D + A I
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHI------------YAMKILRKADMLEKEQVAHI 48
Query: 515 N-ELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPA 571
E + L +V++ +D+ LI E+L G + L + S + + A
Sbjct: 49 RAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA 108
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS----------- 620
+A+DA +H+ IHRDIK N+LLDA K+SDFGL
Sbjct: 109 ETVLAIDA------IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159
Query: 621 ----LIGPEDDES------------------HLSLRAAGTVGYMDPEYYRLQQLTEKSDV 658
P D S L+ GT Y+ PE + + D
Sbjct: 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW 219
Query: 659 YSFGVVLLEILSGY 672
+S GV++ E+L GY
Sbjct: 220 WSLGVIMYEMLIGY 233
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 73/232 (31%)
Query: 467 IGSGSFG---AVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
IGSG+ G A Y A LD VA+K+ +S KR EL + +
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKK--LSRPFQNQTHAKRA-------YRELVLMKCV 73
Query: 524 HHKNLVRLLGF------CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+HKN++ LL E+ + L+ E ++ I++ L
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-----------------VIQMEL 116
Query: 578 DAAR----------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
D R GI++LH IIHRD+K SN+++ + T K+ DFGL+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA------- 166
Query: 628 ESHLSLRAAGTVGYMDP----EYYRLQQL------TEKSDVYSFGVVLLEIL 669
R AGT M P YYR ++ E D++S G ++ E++
Sbjct: 167 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 49/233 (21%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKR------AEISSTSSYAIGTKRQE 507
E + + + ++GSG++G V A LD G++VA+K+ +E+ + +Y
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAY-------- 62
Query: 508 DKDNAFINELESLSRLHHKNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPL 566
EL L + H+N++ LL F D + YL + L L
Sbjct: 63 -------RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 567 KSWPARIK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625
RI+ + +G++Y+H IIHRD+K N+ ++ K+ DFGL+
Sbjct: 116 SE--DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----R 166
Query: 626 DDESHLSLRAAGTVGYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
+S ++ GY+ +YR ++ T+ D++S G ++ E+L+G
Sbjct: 167 QTDSEMT-------GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH IIHRD+K+ N+ LD A + DFG + ++ +GT+ P
Sbjct: 200 YLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEIL 669
E L K+D++S G+VL E+
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 39/233 (16%)
Query: 463 EDHKIGSGSFGAVYKATLDDG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
E K+G G++G VYKA DG A+K+ E + S A E+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-------------CREIAL 51
Query: 520 LSRLHHKNLVRLLG-FCEDRNERV-LIYEYLENGTLHD---HLHNPQSSSPLKSWPARIK 574
L L H N++ L F + +V L+++Y E+ H H + + P++ +K
Sbjct: 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111
Query: 575 VAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGL-----SLIGP 624
L GI YLH V +HRD+K +N+L+ K++D G S + P
Sbjct: 112 SLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 625 EDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIH 676
D + + T Y PE + T+ D+++ G + E+L+ H
Sbjct: 169 LADLDPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQ-VAVKR-AEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+GSG++G V A + VA+K+ + ++ +A T R EL L +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----------ELRLLKHMD 72
Query: 525 HKNLVRLLG-FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DAARG 582
H+N++ LL F + YL + L+N L I+ + RG
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD--DHIQFLVYQILRG 130
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG-- 640
++Y+H IIHRD+K SN+ ++ K+ DFGL+ H G V
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA--------RHTDDEMTGYVATR 179
Query: 641 -YMDPE-YYRLQQLTEKSDVYSFGVVLLEILSG 671
Y PE + D++S G ++ E+L+G
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 59/252 (23%)
Query: 460 NFSEDHKIGSGSFGAVYKATLDDGSQV----AVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+F IG G+FG V D V +++A++ +G R E +D +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ--VGHIRAE-RD--ILV 56
Query: 516 ELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
E +SL +V++ +D+ LI E+L G + L + L + +
Sbjct: 57 EADSLW------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYI 107
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL---------------- 619
A + I+ +H+ IHRDIK N+LLD+ K+SDFGL
Sbjct: 108 A-ETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 620 --SLIGPED-----------------DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYS 660
SL P D + L+ GT Y+ PE + + D +S
Sbjct: 164 NHSL--PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 661 FGVVLLEILSGY 672
GV++ E+L GY
Sbjct: 222 LGVIMYEMLIGY 233
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
E ++ ++GSG++G+V A G +VA+K+ +S I KR A+
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK--LSRPFQSEIFAKR------AY- 62
Query: 515 NELESLSRLHHKNLVRLLGF------CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
EL L + H+N++ LL ++ + L+ Y++ L + +P S ++
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY 121
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
+ G++Y+H IIHRD+K N+ ++ K+ DFGL+
Sbjct: 122 ------LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA-------- 164
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG 671
H A GY+ +YR ++ + D++S G ++ E+L+G
Sbjct: 165 RHAD---AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
ARG+E+L A + +HRD+ + NVLL K+ DFGL+ D V
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+M PE T SDV+S+G++L EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 64/283 (22%), Positives = 103/283 (36%), Gaps = 60/283 (21%)
Query: 466 KIGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+G G G V+ L ++ A+K + + +K + E E L+ L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--------KRNKVKRVLTEQEILATLD 59
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA-LDAARGI 583
H L L + L+ +Y G L L Q L AR A + A +
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLA--L 116
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA------- 636
EYLH + I++RD+K N+LL + +SDF LS D E +A
Sbjct: 117 EYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSK--QSDVEPPPVSKALRKGSRRS 171
Query: 637 ----------------------GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG--- 671
GT Y+ PE D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 672 YRAIHRTHNGTPRNVV--------DFVVPYIVRDEIHRVLDRN 706
++ +R + T N++ V RD I ++L ++
Sbjct: 232 FKGSNR--DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKD 272
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 459 NNFSEDHKIGSGSFGAVY----KATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
+F +G G FG V KAT G A+K + S + ++ + F
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLA--------QETVSFFE 49
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH---NPQSSSPLKSWPA 571
E + LS + + +L +D++ L+ EY G L L+ + + + A
Sbjct: 50 EERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA 109
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+ +A+ + +H+ +HRDIK NVL+D T K++DFG S ++
Sbjct: 110 ELVLAIHS------VHQMG---YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVN 159
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKS------DVYSFGVVLLEILSG 671
S GT Y+ PE K D +S GV+ E++ G
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 466 KIGSGSFGAVYK--ATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
K+G G++ V+K + L + + VA+K I + +E I E+ L L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKE----------IRLEHEEGAPCTAIREVSLLKDL 61
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLH--DHLHNPQSSSPLKSWPARIKVALDAAR 581
H N+V L L++EYL+ D N S +K + +I R
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQI------LR 115
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
G+ Y H V +HRD+K N+L++ K++DFGL+
Sbjct: 116 GLAYCHRRKV---LHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 19/126 (15%)
Query: 562 SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621
+ SP S+ + + A G+E+L A + +HRD+ + NVL+ K+ DFGL+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLA- 286
Query: 622 IGPED---DESHLSLRAAG-TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
D D +++S + + +M PE T SDV+SFG++L EI
Sbjct: 287 ---RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF-------- 335
Query: 678 THNGTP 683
T GTP
Sbjct: 336 TLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 53/261 (20%), Positives = 95/261 (36%), Gaps = 67/261 (25%)
Query: 464 DHKIGSGSFGA----VYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELE 518
IG + K + VAVK+ + S S +D + E+
Sbjct: 3 LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCS----------KEDLKLLQQEII 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN------PQSSSPLKSWPAR 572
+ +L H N++ + +E ++ + G+ D L P+ +
Sbjct: 52 TSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------- 102
Query: 573 IKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF--GLSLIG------ 623
I L D ++Y+H IHR +K+S++LL +S +S+I
Sbjct: 103 IAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159
Query: 624 -----PEDDESHLSLRAAGTVGYMDPE--YYRLQQLTEKSDVYSFGVVLLEILSG---YR 673
P+ +L ++ PE LQ EKSD+YS G+ E+ +G ++
Sbjct: 160 VVHDFPKSSVKNLP--------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
Query: 674 AIHRTH------NGTPRNVVD 688
+ T GT ++D
Sbjct: 212 DMPATQMLLEKVRGTVPCLLD 232
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 30/162 (18%), Positives = 52/162 (32%), Gaps = 27/162 (16%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+ G VY D +K +K E+ L L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKI-------------NPSREKGADREREVAILQLLAR 50
Query: 526 KNLV--RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
K L ++L E L+ E++E TL + S + ++ L
Sbjct: 51 KGLPVPKVLASGESDGWSYLLMEWIEGETL-----DEVSEEEKEDIAEQLAELLAK---- 101
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625
LH+ + + H D+ N+L+D + D+ + GP
Sbjct: 102 --LHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 24/160 (15%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF--INELESLS 521
K+G GS+ VYK + G VA+K EI + ++ F I E L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALK--EIR----------LEHEEGAPFTAIREASLLK 58
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DAA 580
L H N+V L + L++EYL L +++ L
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
RG+ Y H+ ++HRD+K N+L+ K++DFGL+
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 459 NNFSEDHKIGSGSFGAV-YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+F IG G+FG V D G A+K + + + ++D+ E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMF------KKDQLAHVKAER 52
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKV 575
+ L+ +V L +D LI E+L G L L S + + A +
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL 112
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
A++A + + IHRDIK N+L+D K+SDFGLS
Sbjct: 113 AIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 512 AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
AF +S++ H +L + G C +E +++ E++E+G L L + P+ +W
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AW-- 118
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA-------KVSDFGLSLIGP 624
+I VA A + YL + +++H ++ + N+LL A K+SD G+S
Sbjct: 119 KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 625 EDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEI 668
+E + ++ PE L+ +D +SFG LLEI
Sbjct: 176 SREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 22/102 (21%)
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV- 639
R ++Y+H ++ HRD+K N+L +A K+ DFGL+ + D +
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND--------TPTAIF 162
Query: 640 --GYMDPEYYRLQQL--------TEKSDVYSFGVVLLEILSG 671
Y+ +YR +L T D++S G + E+L+G
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 467 IGSGSFGAVYKATLDDGS------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+GSG+FG V +AT S +VAVK + ++ SS + A ++EL+ +
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS----------EKQALMSELKIM 94
Query: 521 SRLH-HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLH 558
S L H N+V LLG C +I EY G L D+LH
Sbjct: 95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/186 (25%), Positives = 72/186 (38%), Gaps = 30/186 (16%)
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
I+Y+H IIHRDIK+ NVL++ + DFG + + AGTV
Sbjct: 273 IDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR------ 696
PE T D++S G+V+ E ++ G R D + I+R
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389
Query: 697 DEI-------------HRVLDRNVPPPTP------FEIEAVAYVGYLAADCVTLEGRNRP 737
DE HR P T ++++ V YL +T +G RP
Sbjct: 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLD--LDVEYLVCRALTFDGARRP 447
Query: 738 SMTEIV 743
S E++
Sbjct: 448 SAAELL 453
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 17/112 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
N S +G+G+FG V +AT D VAVK + S+ T+R+ A
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-----TERE-----A 84
Query: 513 FINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
++EL+ LS L +H N+V LLG C ++I EY G L + L + S
Sbjct: 85 LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 512 AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
AF + ++ HK++V L G C E +++ E++E G L +H + S L + P
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTT-PW 106
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL-------DATWTAKVSDFGLSLIGP 624
+ KVA A + YL + ++H ++ + N+LL + K+SD G+ +
Sbjct: 107 KFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL 163
Query: 625 EDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEI 668
E + ++ PE + L+ +D +SFG L EI
Sbjct: 164 SRQE------CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|205718 pfam13540, RCC1_2, Regulator of chromosome condensation (RCC1) repeat | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 10/22 (45%), Positives = 13/22 (59%)
Query: 199 VAAGFRHVCAIDDDQELRCWGD 220
+AAG H A+ D + CWGD
Sbjct: 4 IAAGDYHTLALTSDGTVYCWGD 25
|
Length = 30 |
| >gnl|CDD|205718 pfam13540, RCC1_2, Regulator of chromosome condensation (RCC1) repeat | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 9/28 (32%), Positives = 16/28 (57%)
Query: 230 FKALALGENRSCALRNNQKVVCWGQNGF 257
++A G+ + AL ++ V CWG N +
Sbjct: 1 VVSIAAGDYHTLALTSDGTVYCWGDNSY 28
|
Length = 30 |
| >gnl|CDD|227511 COG5184, ATS1, Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 41/208 (19%), Positives = 69/208 (33%), Gaps = 54/208 (25%)
Query: 143 WQWPDFNST-SIHNFSNIAVGEDFVCGLLENGTITCFGSRNS------PTSVTQK----- 190
++ P +S S +A G + L +G + +G+ +QK
Sbjct: 164 FKVPGGSSAKSHLRVVKLACGWEISVILTADGRVYSWGTFRCGELGQGSYKNSQKTSIQF 223
Query: 191 ----VPSGIFRVVAAGFRHVCAIDDDQELRCWGDS---------------VGEVPQ---- 227
VP +AAG H+ A+ ++ ++ WG + V V
Sbjct: 224 TPLKVPKKAIVQLAAGADHLIALTNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAI 283
Query: 228 GKFKALALGENRSCALRNNQKVVCWGQNGF------------------TLPDSLQGKPFV 269
K +A G++ S AL + ++ WG N F L G
Sbjct: 284 RNIKYVACGKDHSLALDEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTIC 343
Query: 270 SIEAKRSVFCGVLTSNYSLYCWGNESFS 297
SI A S +L + +LY +G
Sbjct: 344 SISAGESHSL-ILRKDGTLYAFGRGDRG 370
|
Length = 476 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 30/164 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA-----FINELESLS 521
I G+FG VY + S++ YA+ ++ D N E ++L+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKL------------YAVKVVKKADMINKNMVHQVQAERDALA 59
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSW---PARIKVALD 578
+V L + N L+ EYL G + LH + + +K +
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH-------IYGYFDEEMAVKYISE 112
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
A ++YLH + IIHRD+K N+L+ K++DFGLS +
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 75/264 (28%)
Query: 461 FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDN----AFIN- 515
F + +G G+FG V A ++ + + YA+ T R++D N A +
Sbjct: 3 FVKIKTLGIGAFGEVCLA------------CKVDTHALYAMKTLRKKDVLNRNQVAHVKA 50
Query: 516 ELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP---AR 572
E + L+ ++ +V+L +D++ + +Y+ G + L ++ +P AR
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR------MEVFPEVLAR 104
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL----------- 621
+A + IE +H+ IHRDIK N+L+D K++DFGL
Sbjct: 105 FYIA-ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 622 ----------IGPE---DDESH---------LSLRA------------AGTVGYMDPEYY 647
+ P DD S+ L RA GT Y+ PE
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 648 RLQQLTEKSDVYSFGVVLLEILSG 671
+ T+ D +S GV+L E+L G
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 42/221 (19%)
Query: 467 IGSGSFGAVYKAT---LDDGSQ---VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G G+FG V +A +D + VAVK + +T S + A ++EL+ L
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----------EHRALMSELKIL 64
Query: 521 SRL-HHKNLVRLLGFCEDRNERVL-IYEYLENGTLHDHLHNPQSS-SPLKSWPARIKVAL 577
+ HH N+V LLG C ++ I E+ + G L ++L + + P K+ AR
Sbjct: 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDAR----- 119
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+G + + R + S + + V + LS + E+ E
Sbjct: 120 -FRQGKSGYG--DISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE------- 169
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVL-LEILSGYRAIHR 677
+ Y+ E YSF V +E L+ + IHR
Sbjct: 170 -------DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHR 203
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 37/142 (26%), Positives = 53/142 (37%), Gaps = 45/142 (31%)
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL----------- 619
AR +A + IE +H+ IHRDIK N+L+D K++DFGL
Sbjct: 103 ARFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 620 -----------SLIGPE--DDESHLSLRA-----------------AGTVGYMDPEYYRL 649
S+ E + L+ GT Y+ PE
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 650 QQLTEKSDVYSFGVVLLEILSG 671
T+ D +S GV+L E+L G
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVG 240
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 463 EDHKIGSGSFGAVYKATLDDGSQVAVK 489
++ I + S V++A L DG +VAVK
Sbjct: 15 DEEPIAAASIAQVHRAVLKDGEEVAVK 41
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.85 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.47 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.15 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 97.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.93 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.81 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.62 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.0 | |
| PLN02236 | 344 | choline kinase | 95.92 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.37 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=453.20 Aligned_cols=294 Identities=45% Similarity=0.779 Sum_probs=252.9
Q ss_pred ccccccHHHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC
Q 046311 445 RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524 (768)
Q Consensus 445 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 524 (768)
....|+++++..++++|...+.||+|+||.||+|.++++..||||++..... .. ..+|.+|++++.+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~----------~~-~~eF~~Ei~~ls~l~ 129 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG----------QG-EREFLNEVEILSRLR 129 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC----------cc-hhHHHHHHHHHhcCC
Confidence 4677999999999999999999999999999999999999999998754311 11 456999999999999
Q ss_pred CCCceeEEEEEEcCC-eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 525 HKNLVRLLGFCEDRN-ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 525 HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
|||+|+|+|||.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...|+||||||||+|
T Consensus 130 H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 130 HPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred CcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 999999999999998 599999999999999999986544 56999999999999999999999988899999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
||||+++++||+|||+|+..+.. .........||.+|+|||++..+..++|+|||||||+|+||+||+.+.+.......
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred eeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 99999999999999999765542 11111111799999999999989999999999999999999999999887654555
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
..+++|..+.+....+.+++|+.+........+....+.+++.+|++.+|++||+|.||++.|+.+...
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 568999988888888999999988642212125667788999999999999999999999999776644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=400.33 Aligned_cols=262 Identities=37% Similarity=0.545 Sum_probs=212.0
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC-e
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN-E 540 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~ 540 (768)
...+.||+|+||+||++.++....||||++..... .....++|.+|+.+|.+++|||||+|+|++.+.. .
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~---------~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDF---------DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhc---------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 33456999999999999999544499999875422 1222779999999999999999999999999887 7
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEEEeeccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSDFGL 619 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~kl~DFGl 619 (768)
..+||||+++|+|.++|+.. ....+++..+++++.||++||+|||+++ | ||||||||+||||+.++ ++||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCcc
Confidence 89999999999999999874 2345799999999999999999999997 3 99999999999999997 999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccc--cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYR--LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++...... .......||+.|||||++. ...|+.|+||||||++||||+||+.||...... .
T Consensus 191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---------------~ 253 (362)
T KOG0192|consen 191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---------------Q 253 (362)
T ss_pred ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---------------H
Confidence 97644322 1112357999999999999 569999999999999999999999999754331 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
-...+.....++..+. +....+..|+.+||+.||++||++.|++..|+.+......
T Consensus 254 ~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 VASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1122222222222222 2556778899999999999999999999999998875543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=378.29 Aligned_cols=267 Identities=29% Similarity=0.415 Sum_probs=204.0
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh--cCCCCCceeEEEEEEcCC
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS--RLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~HpnIv~l~~~~~~~~ 539 (768)
+..++||+|+||.||||.++ ++.||||++.. +..+.|++|-++++ .|+|+||+++++.-....
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--------------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--------------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH--------------HHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 34578999999999999998 49999998753 34556777766655 468999999999876554
Q ss_pred ----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeEecCCCCCCeEECCC
Q 046311 540 ----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY------AVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 540 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~------~~~~ivHrDiKp~NILl~~~ 609 (768)
+++||+||.+.|+|.+||.. ...+|....+|+..+++||+|||+. .+|+|+|||||++||||.+|
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 89999999999999999965 4579999999999999999999974 35789999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccccC-C-----CCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-Q-----LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-----~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
+++.|+|||||...............+||.+|||||++.+. . .-.+.||||+|.|||||++....++...
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~---- 428 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP---- 428 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC----
Confidence 99999999999877665554444557899999999999753 1 2247899999999999999765543211
Q ss_pred ccccccccchh-------hhhhHH-hhhccCCCCCCcc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 684 RNVVDFVVPYI-------VRDEIH-RVLDRNVPPPTPF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 684 ~~~~~~~~~~~-------~~~~~~-~~~~~~~~~~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
..+|..|+. ..+++. .++.++.++..+. .-.....|.+.+..||..||+-|.|+.=+.+++.++...
T Consensus 429 --vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 429 --VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred --CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111111111 012222 2333333332211 113457788999999999999999999999999988865
Q ss_pred cc
Q 046311 753 CL 754 (768)
Q Consensus 753 ~~ 754 (768)
..
T Consensus 507 ~~ 508 (534)
T KOG3653|consen 507 WE 508 (534)
T ss_pred CC
Confidence 54
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=373.05 Aligned_cols=252 Identities=29% Similarity=0.399 Sum_probs=206.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
++..+.||+|..|+|||+.++ +++.+|+|.+... .++...+++.+|++++++.+||+||++++.|..+.
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----------IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 344578999999999999987 7899999998432 23456788999999999999999999999999998
Q ss_pred -eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 540 -ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 540 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..++||||++|||++++... ...++...-+|+.++++||.|||+ ++ ||||||||+|||++..|++||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 599999999999999999753 235788889999999999999996 55 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|.+...-.. ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... .. + ..+
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~---~------~~~ 289 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL---D------IFE 289 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC---C------HHH
Confidence 999754332 334568999999999999999999999999999999999999999754111 00 1 112
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
-+..+++...+.. +.. ..++++..++..||++||.+||+++|+++.
T Consensus 290 Ll~~Iv~~ppP~l-P~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 LLCAIVDEPPPRL-PEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHhcCCCCCC-Ccc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2444555333221 111 467788899999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=404.09 Aligned_cols=269 Identities=30% Similarity=0.443 Sum_probs=224.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.+.+..+.||+|.||+||+|+.. +...||||.++.. ...+..++|++|++++..|+|||||+|+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----------a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----------AENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----------ccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34556688999999999999753 3567999988753 3345788999999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSS----------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
|+|.+++..+||+|||..|||.+||+..... ...++..+.+.||.|||.||+||-++. +|||||..+
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATR 632 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATR 632 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhh
Confidence 9999999999999999999999999654211 233678899999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~ 681 (768)
|+||.++..|||+||||++.....++++......-..+|||||.|..++++.+||||||||+|||++| |+.|+.....
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn- 711 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN- 711 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-
Confidence 99999999999999999998877777766555566899999999999999999999999999999998 7888765433
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
.+-+..+-++++. +.....+..+.+||..||+.+|++||+++||-..|+...+++.+..+
T Consensus 712 --------------~EVIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 712 --------------QEVIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred --------------HHHHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 1223344444442 22334567788999999999999999999999999999887765443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=388.74 Aligned_cols=256 Identities=29% Similarity=0.488 Sum_probs=216.3
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
...++||+|-||.||.|.++....||||.++.. .....+|.+|+++|++|+|+|||+++++|..++.+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------------SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc------------ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 345789999999999999998889999998753 23456899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+||||||+.|+|.+||+.. ....+.....+.++.||++||+||++++ +|||||..+||||+++..+||+|||||+
T Consensus 277 yIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 9999999999999999863 2345678899999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHH
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
... ++.........-+..|.|||.+....++.|||||||||+||||+| |+.|+.... ..++.
T Consensus 352 ~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~ 414 (468)
T KOG0197|consen 352 LIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----------------NEEVL 414 (468)
T ss_pred ccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----------------HHHHH
Confidence 443 333333344456889999999999999999999999999999999 666665322 23455
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+.+++..+.+.+.. ++..+.+||..||+.+|++|||++.+...|+++....
T Consensus 415 ~~le~GyRlp~P~~--CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 ELLERGYRLPRPEG--CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHhccCcCCCCCC--CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 66666666555433 5677889999999999999999999999999987644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=388.15 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=212.0
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|...+.||+|+|..||+++. .+|+.||+|++..... ......+...+|+++.++|+|||||+++++|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--------~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--------KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--------cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 3688899999999999999997 7899999999976432 123455678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|||+|+|++++|..+++. ...+++++...+..||+.||.|||+++ |+|||||..|+||+++.++||+||
T Consensus 90 s~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred CCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccc
Confidence 9999999999999999999973 345688999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|||.....+.+.+. ..+|||.|+|||++....++..+||||+||+||.||.|++||+...- .+
T Consensus 163 GLAt~le~~~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---------------ke 225 (592)
T KOG0575|consen 163 GLATQLEYDGERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---------------KE 225 (592)
T ss_pred ceeeeecCcccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---------------HH
Confidence 99987665544333 45899999999999999999999999999999999999999975321 22
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
-+.++.......+. ..+....+||.++|+.+|.+|||+++|++.
T Consensus 226 ty~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 226 TYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 23334333333333 333445689999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.01 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=206.9
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++....... ............+|+++|++|+|||||+++++|+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~----~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTG----CSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccc----ccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 35678889999999999999975 489999999997653321 1111223345679999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC---CcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~---~~~k 613 (768)
..+..||||||++||+|.+++-.+.. +.+..-..+++|++.|+.|||+++ |+||||||+|||+..+ ..+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEE
Confidence 99999999999999999999965432 344455789999999999999999 9999999999999765 7899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCC---CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
|+|||+|+...... .....+||+.|.|||++.... +..+.|+|||||+||-+|+|..||.......
T Consensus 320 ItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred ecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 99999998765333 233568999999999997653 3348899999999999999999997543321
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.-.+.+...++........+..++..+||.+||..||++|||+.|+++.
T Consensus 389 ------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 ------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0122333444444444556677778899999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=367.52 Aligned_cols=202 Identities=31% Similarity=0.471 Sum_probs=177.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
..+|...++||+|+|++||+|+++ ++..||||.+.... ......+.+..|+++|+.++|||||.|+++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---------l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---------LNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---------cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 357888889999999999999875 68999999986542 23445677889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC------C
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT------W 610 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~------~ 610 (768)
..+..|||||||.+|+|.+||+..+ .+++.....++.|++.||++||+++ ||||||||.||||+.. -
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~ 152 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSP 152 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCc
Confidence 9999999999999999999998643 3577888899999999999999999 9999999999999764 5
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
.+||+|||+|+....... ....+|++-|||||++...+|+.|+|+||+|++||+|++|+.||+..
T Consensus 153 ~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 153 VLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred eEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 689999999997664332 23568999999999999999999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=352.50 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=212.1
Q ss_pred CCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE-EEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG-FCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~ 537 (768)
+|+++++||+|.||+|||+. +.+|..||.|.+... .-+....++...|+.+|++|+|||||++++ -+.+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---------~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---------MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---------hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 46777899999999999997 458999999987643 223456678899999999999999999998 4444
Q ss_pred CCe-eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCCeEECCCCcEEE
Q 046311 538 RNE-RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPS--IIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 538 ~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+ .+|||||+..|+|...++..+.....+++...++++.|++++|.++|+.- |+ |+||||||.||+|+.+|.+||
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceee
Confidence 444 89999999999999999776666677899999999999999999999943 44 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+||||++........ ....+|||.||+||.+....|+.||||||+||++|||..-+.||.... +
T Consensus 170 GDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~-------- 233 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L-------- 233 (375)
T ss_pred ccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H--------
Confidence 999999976544432 335689999999999999999999999999999999999999997541 1
Q ss_pred hhhhHH-hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 695 VRDEIH-RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 695 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.++. ++-+...++ -.....+..|..|+..|+..||+.||+...++..++.-+
T Consensus 234 --~~L~~KI~qgd~~~--~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 234 --LSLCKKIEQGDYPP--LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred --HHHHHHHHcCCCCC--CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 1111 222333332 123567788999999999999999999766666665543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.54 Aligned_cols=269 Identities=28% Similarity=0.464 Sum_probs=212.3
Q ss_pred HHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 452 EILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 452 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
++.....+.+.+.+.||+|.||+||+|.+- ..||||.++... ..++..+.|++|+..+++-+|.||+-+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~---------pt~~qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDD---------PTPEQLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCC---------CCHHHHHHHHHHHHHHhhcchhhheee
Confidence 333334455677889999999999999986 479999998653 234578899999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.|++..... .+|.-+|+|-+|+.+||..+ ..++....+.|+.||++||.|||.++ |||||||+.||||.++++
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence 999988877 99999999999999999754 33577888999999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
|||+||||+...............-|...|||||+++. .+|++.+||||||+++|||+||..||.. ... ..+.-
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~--dqIif 603 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNR--DQIIF 603 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CCh--hheEE
Confidence 99999999965333222222223457889999999975 3689999999999999999999999972 211 11111
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
++-.-+... .......+..+++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 604 mVGrG~l~p-----------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVGRGYLMP-----------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EecccccCc-----------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111001 11112234556788999999999999999999999999998863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.93 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||.++.+ +++.+|+|+++..... ...+.+....|..+|.+++||+||+++-.|++
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--------~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--------EKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--------hhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 46888999999999999999754 6899999998765321 12356678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|||+||+.||.|+.+|++.. .+++....-.+..|+.||.|||+++ ||||||||+|||||.+|+++|+||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecc
Confidence 999999999999999999997543 2455555667789999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
||++..-.... .+...+||+.|||||++....|+..+|.||||+++||||+|.+||...+. ..
T Consensus 170 gL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---------------~~ 232 (357)
T KOG0598|consen 170 GLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---------------KK 232 (357)
T ss_pred ccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---------------HH
Confidence 99985433322 22346999999999999999999999999999999999999999975432 12
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 737 (768)
...+++....+.... -......+++.+.+..||++|.
T Consensus 233 ~~~~I~~~k~~~~p~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPG---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhcCcCCCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence 233333333222221 1233455899999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=373.57 Aligned_cols=259 Identities=27% Similarity=0.490 Sum_probs=215.0
Q ss_pred CCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
...++++||.|.||.||+|+++ ....||||.++.. ..+....+|+.|+.+|.+++||||++|.|+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----------ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----------YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC----------ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 4567789999999999999976 2467999998754 3456778999999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
...+..++|.|||++|+|+.||+.+.. .+.+.+..-++..|+.||.||.+.+ +|||||..+|||++.+..+|++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEec
Confidence 999999999999999999999987653 3577888999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCcccc-cccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 616 DFGLSLIGPEDDESHLS-LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
||||++...++.....+ ....-..+|.|||.+..++++.+|||||||++|||.++ |.+||....++
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------------ 841 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------ 841 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------------
Confidence 99999865444322221 11223689999999999999999999999999999886 88998754332
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
+..+-++..++.+. ..+++..|.+||+.||++|-.+||.+.+|+..|.+++..
T Consensus 842 ----dVIkaIe~gyRLPp--PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 842 ----DVIKAIEQGYRLPP--PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----HHHHHHHhccCCCC--CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22233333333333 334567788999999999999999999999999998864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.26 Aligned_cols=265 Identities=27% Similarity=0.405 Sum_probs=216.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.....+.++||+|-||.|.++..+.+..||||.++... ......+|.+|+++|.+|+||||+.|+++|..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a----------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA----------TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc----------chhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 34567789999999999999999988999999987642 23456899999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++.+++|+|||++|+|.+||..+.... ..-...++|+.||+.||+||.+.+ +|||||.++|+|++.++++||+||
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 999999999999999999998754322 334455789999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc--CCcccccCCCCCcccccccccchhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS--GYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|+++.....++.+...+.+-..+|||||.+..++++.+||||+||++|||+++ .+.||....++. .
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~------------v 749 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ------------V 749 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH------------H
Confidence 99998777888777777788999999999999999999999999999999875 566765432211 1
Q ss_pred hhhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.++..++++...+.. .....-.+..|.++|.+||..|.++||+++++...|++.
T Consensus 750 ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222333333322110 011122345566999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.06 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=202.6
Q ss_pred cCCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 530 (768)
.++|++.++||+|+||.||++.+ .+++.||||+++.. ........+.+|+.++.++ +||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----------ATASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----------cchHHHHHHHHHHHHHHHhccCcceee
Confidence 35788899999999999999974 23568999987532 1123456789999999999 8999999
Q ss_pred EEEEEEcCC-eeEEEEEeccCCChhhhccCCCCC----------------------------------------------
Q 046311 531 LLGFCEDRN-ERVLIYEYLENGTLHDHLHNPQSS---------------------------------------------- 563 (768)
Q Consensus 531 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------- 563 (768)
+++++...+ ..++||||+++|+|.++++.....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 999887644 578999999999999998653210
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCccc
Q 046311 564 ------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631 (768)
Q Consensus 564 ------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 631 (768)
...+++...++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 232 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhc
Confidence 123567788899999999999999998 99999999999999999999999999975433222111
Q ss_pred ccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCC
Q 046311 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP 710 (768)
Q Consensus 632 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (768)
.....+++.|+|||++....++.++||||||++||||++ |..||....... .....+.+.....
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~- 297 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--------------EFCQRLKDGTRMR- 297 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--------------HHHHHHhcCCCCC-
Confidence 222345788999999988899999999999999999997 999986432110 0001111111111
Q ss_pred CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 711 TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 711 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
. .......+.+|+.+||+.||++|||+.|+++.|++++.
T Consensus 298 ~--~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 A--PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred C--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 11224567799999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.24 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=198.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+...++|+|+||+|||++.+ +|+.||||++..+ ..++...+--+||+++|++|+|||+|.|+++|...
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 5777789999999999999976 6999999998643 23334455678999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...+||+||++.--|++ |.... .-.+.....++++|+++|+.|+|+++ +|||||||+||||+.++.+||+|||
T Consensus 74 rklhLVFE~~dhTvL~e-Le~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 74 RKLHLVFEYCDHTVLHE-LERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred ceeEEEeeecchHHHHH-HHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccch
Confidence 99999999998844444 43322 22466777899999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+|+...... ...+..+.|..|+|||++.+ .+|....||||+||++.||++|.+.|....+-+.........-.+. .
T Consensus 147 FAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~-p 223 (396)
T KOG0593|consen 147 FARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI-P 223 (396)
T ss_pred hhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC-H
Confidence 998755322 12234578999999999887 6899999999999999999999887754433221111111000000 0
Q ss_pred hHHhhhccC-------CCCC---Ccch---HHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRN-------VPPP---TPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~-------~~~~---~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.-.+++..+ ++.+ .+.+ ......+.+++..||+.||++|++-+|++.
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111122111 1111 1111 123456779999999999999999999885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.46 Aligned_cols=277 Identities=25% Similarity=0.362 Sum_probs=208.3
Q ss_pred ccccccHHHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHH--hc
Q 046311 445 RLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL--SR 522 (768)
Q Consensus 445 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~ 522 (768)
+-...++-..+....+..+.+.||+|.||.||+|+++ |+.||||++... ++..+.+|.+++ ..
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--------------dE~SWfrEtEIYqTvm 261 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--------------DERSWFRETEIYQTVM 261 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--------------chhhhhhHHHHHHHHH
Confidence 3345566666777788999999999999999999999 899999998643 233455555555 45
Q ss_pred CCCCCceeEEEEEEcCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCC
Q 046311 523 LHHKNLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-----YAVPS 593 (768)
Q Consensus 523 l~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-----~~~~~ 593 (768)
|+|+||+.+++.-..++ ..+||.+|.+.|||+|||.. ..++....+++++.+|.||+|||. +++|.
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 69999999998754433 67999999999999999965 346788899999999999999995 56799
Q ss_pred eEecCCCCCCeEECCCCcEEEeeccccccCCCCC-C-cccccccccccCccCccccccC------CCCChhhHHHHHHHH
Q 046311 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD-E-SHLSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVL 665 (768)
Q Consensus 594 ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~-~-~~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll 665 (768)
|.|||||+.|||+.+++.+.|+|+|||....... . .......+||.+|||||++... +.-..+||||||+|+
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999999999999999999997544332 1 1222346899999999998642 123478999999999
Q ss_pred HHHHcC----------CcccccCCCCCcccccccccchhhhhhHHhhh-ccCCCCCC---cchHHHHHHHHHHHHHcccc
Q 046311 666 LEILSG----------YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL-DRNVPPPT---PFEIEAVAYVGYLAADCVTL 731 (768)
Q Consensus 666 ~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~Li~~Cl~~ 731 (768)
||+.-. +.||...-+.++ ..+++.+++ .+++++.. -...+....+.+||+.||..
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DP-----------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~ 485 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDP-----------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA 485 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCC-----------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC
Confidence 999742 234332222111 122333322 22333221 23446678888999999999
Q ss_pred cCCCCCCHHHHHHHHHHHHhh
Q 046311 732 EGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 732 dP~~RPs~~evl~~L~~~l~~ 752 (768)
+|.-|-|+-.|-+.|.++.+.
T Consensus 486 Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 486 NPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CchhhhHHHHHHHHHHHHhcC
Confidence 999999999999999988753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=374.21 Aligned_cols=265 Identities=32% Similarity=0.470 Sum_probs=215.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc--CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.+.+..+.||+|.||.||+|... ++. .||||.++. ...+++..+|++|..+|++++|||||+++
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----------~~~~~~~~~Fl~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----------LSSEQEVSDFLKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----------cCCHHHHHHHHHHHHHHhcCCCcceeeEE
Confidence 34566788999999999999865 233 488887753 23467788999999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
|++.+....++++|||++|+|..||++.+. ....+.....+.++.|||+|+.||++++ +|||||..+|+||+..
T Consensus 762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~ 838 (1025)
T KOG1095|consen 762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDER 838 (1025)
T ss_pred EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeeccc
Confidence 999999999999999999999999987522 2455688899999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~ 688 (768)
..+||+|||||+.....++........-..+|||||.+....++.|+|||||||+|||++| |..||....+.
T Consensus 839 r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------- 911 (1025)
T KOG1095|consen 839 RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------- 911 (1025)
T ss_pred CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------
Confidence 9999999999996555555544444455789999999999999999999999999999998 78888643321
Q ss_pred cccchhhhhhHHhhhc-cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 689 FVVPYIVRDEIHRVLD-RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
+-+..++. .+++++ ..++..+.+||..||+.+|++||++..|+++++.+.+.-..
T Consensus 912 --------~v~~~~~~ggRL~~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 912 --------EVLLDVLEGGRLDPP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --------HHHHHHHhCCccCCC----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 11111222 223222 23345566999999999999999999999999998876544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.75 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=205.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|..++.||+|+|++||+|+.. +++++|||++...- .+ .+.+.+-..+|-..|.+| .||.|++|+..|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~----Ii----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY----II----KEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH----HH----hhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 357888999999999999999854 78999999986542 11 233445667788889999 899999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.++..+|+|+||.++|+|.++|++.+ .+++......+.+|+.+|+|||+++ ||||||||+|||||+|+++||+
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 99999999999999999999998753 2466666789999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCc---------ccc--cccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 616 DFGLSLIGPEDDES---------HLS--LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 616 DFGla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|||.|+........ ... ..++||..|.+||++.....++.+|+|+|||+||.|+.|++||...+.
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---- 292 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---- 292 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----
Confidence 99999865432211 111 347899999999999999999999999999999999999999975432
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+. -.+++++-.+..+..+. +...+|+.+.|..||.+|++..||.+.
T Consensus 293 --------yl---iFqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 --------YL---IFQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------HH---HHHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 12334433333332333 456689999999999999999888764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.46 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=206.2
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|++.+.||.|..++||+|+. ..++.||||++...+. ....+.+.+|+..|+.++||||++++..|..
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----------~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----------NNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----------hhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 4688899999999999999985 4679999999976422 2336789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+...|+||.||.+||+.+++...-. ..+++..+..|..++++||.|||+++ .||||||+.||||+.+|.+||+||
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCc
Confidence 9999999999999999999975332 22678888899999999999999999 899999999999999999999999
Q ss_pred ccccc-CCCCCCcccc-cccccccCccCccccc--cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 618 GLSLI-GPEDDESHLS-LRAAGTVGYMDPEYYR--LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 618 Gla~~-~~~~~~~~~~-~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|.+.. .....+.... ....||+.|||||++. ...|+.|+||||||++..||.+|..||....+.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------------ 238 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------------ 238 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------------
Confidence 98743 2222222222 4568999999999964 357999999999999999999999999865431
Q ss_pred hhhhhHHhhhccCCC------CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVP------PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+.+..-++...+ ...+........+.+++..||+.||++|||++++++.
T Consensus 239 ---kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 239 ---KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111112222221 1122333445678899999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.46 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=209.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .+.+.+.+.+.+|++++++|+||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---------gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---------GRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---------CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 46778899999999999999866 6889999988653 4556677889999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
..+.++|.||+.| +|+.+|... ..+++.....|+.+++.||.|||++. |+|||+||.||||+..+.+|++||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdF 144 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDF 144 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechh
Confidence 9999999999987 999999753 33578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+...... .......|||-|||||++.+..|+..+|+||+|||||||++|++||....- ..
T Consensus 145 g~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---------------~~ 207 (808)
T KOG0597|consen 145 GLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---------------TQ 207 (808)
T ss_pred hhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---------------HH
Confidence 9998654432 334466899999999999999999999999999999999999999963210 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
-++.++.... .+..++...+..++...|.+||.+|.+-.+++..
T Consensus 208 Lv~~I~~d~v----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 208 LVKSILKDPV----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHhcCCC----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122222222 2233667778899999999999999999998763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.28 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=209.1
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|...++||+|..|.||.++. .+++.||||++.... ....+-+.+|+.+|+..+|+|||++++.|..
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-----------Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-----------QPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-----------CCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 4577788999999999999974 478999999997642 2334567899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.++.|+|||||++|+|.|.+... .+++.++..|+.++++||+|||.++ |+|||||.+|||++.++.+||+||
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred cceeEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeee
Confidence 99999999999999999999652 3678889999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ .....+||+.|||||++....|++|.||||||++++||+-|++||-....- .
T Consensus 414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------------r 476 (550)
T KOG0578|consen 414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------R 476 (550)
T ss_pred eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---------------H
Confidence 99976554433 223568999999999999999999999999999999999999998642210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.. +..+..+........+..+.+++.+||+.|+++||++.|+|+.
T Consensus 477 AlyL-Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 477 ALYL-IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHH-HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1222 2222333334455677889999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.28 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=200.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++...+.||+|+||+||++... +|+..|||.+...+ ....+.+.+|+.+|.+|+|||||+++|.....
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----------~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----------SPTSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----------chhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 5667789999999999999875 48999999886531 11156789999999999999999999985544
Q ss_pred C--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEe
Q 046311 539 N--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVS 615 (768)
Q Consensus 539 ~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~ 615 (768)
+ .++++|||+++|+|.+++.+... .+++....+...||++||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 87 ~~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 87 ENDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred cCeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEec
Confidence 4 68999999999999999986543 3688899999999999999999998 999999999999999 7999999
Q ss_pred eccccccCCC-CCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 616 DFGLSLIGPE-DDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 616 DFGla~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|||++..... ...........||+.|||||++... ....++|||||||++.||+||+.||..... .
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~------- 228 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----E------- 228 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----h-------
Confidence 9999975543 1122223346799999999999853 344599999999999999999999865300 0
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
...+.++......+ ......+....+++.+|+..+|++|||++|+++..-..
T Consensus 229 --~~~~~~ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 229 --AEALLLIGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred --HHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11111222111111 22223455677899999999999999999999875443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.22 Aligned_cols=269 Identities=25% Similarity=0.371 Sum_probs=200.5
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|+.+++||+|+||.||||+. .+|+.||+|+++.... .+.......+||.+|++|+||||++|.+...+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~---------~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE---------KEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC---------CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 4577789999999999999974 5899999999986532 23344567899999999999999999998877
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. ..+|||+|||+. +|.-++.... ..++..++.-++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+
T Consensus 188 ~~~~siYlVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred cCCceEEEEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEec
Confidence 6 689999999987 8988887532 34678899999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||||+++........ +..+-|..|+|||++.+ ..|+.+.|+||.||||.||++|++.|+....-+..+.+....-.-
T Consensus 261 DFGLAr~y~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccceeeccCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 9999997665554333 34467999999999876 589999999999999999999998886543211111000000000
Q ss_pred hhhhHHhhhc----cCCCCCCcch-------HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLD----RNVPPPTPFE-------IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~----~~~~~~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++.+...+ ..+.+..++. ........+|+..+|..||.+|.|+.++++.
T Consensus 340 -~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 -TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred -ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000000000 0001111100 1122344589999999999999999988764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.91 Aligned_cols=267 Identities=19% Similarity=0.315 Sum_probs=205.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
++|...++||.|+||.||+|+.. +++.||||+++.+- ..-++.-=+||++.|++|+ ||||++|.+++.
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf----------~s~ee~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF----------YSWEECMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh----------ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 57888899999999999999854 78999999876431 1122233468999999998 999999999998
Q ss_pred cCC-eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRN-ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+.+ .+++|||||+. +|+++++.+ ...+++..+..|+.||++||+|+|+++ +.|||+||+|||+..+..+||+
T Consensus 80 d~~~~L~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 80 DNDRILYFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred ccCceEeeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEec
Confidence 888 99999999976 999999764 456789999999999999999999999 9999999999999988999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc-ccc-cc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV-DFV-VP 692 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~~~-~~ 692 (768)
|||||+........ +..+.|..|+|||++. ..-|+.+.||||+|||++|+.+-++.|.....-+....+ +.. .|
T Consensus 153 DFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 153 DFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred ccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 99999876544332 2456799999999875 568999999999999999999988777543321110000 000 00
Q ss_pred ---hhh-hhhHHhhhccCCCCCCcch-----HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 ---YIV-RDEIHRVLDRNVPPPTPFE-----IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 ---~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+. ...+.+.+.-+++.-.+.. .....+..+|+.+|+.+||++|||+.|.++.
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 1233444444444322211 1245667799999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=348.36 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=202.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 535 (768)
.++|...+.||+|.||.|+++... +++.||||.++..... ... ....+.+.+|+.++++++ ||||+++++++
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~-----~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVS-----SKS-QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccc-----ccc-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 468999999999999999999754 7899999976543111 011 123455668999999998 99999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-CcEEE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKV 614 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~~~kl 614 (768)
......++||||+.+|+|++++.... .+.+....+++.|++.|++|||+++ |+||||||+|||++.+ +++||
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence 99999999999999999999997622 2355778899999999999999999 9999999999999999 99999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCC-CC-ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ-LT-EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....
T Consensus 163 ~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------- 229 (370)
T KOG0583|consen 163 SDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----------- 229 (370)
T ss_pred eccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-----------
Confidence 9999998763 1222334568999999999999876 75 7999999999999999999999862210
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
.-...+....+.-+.... ...+..|+.+|+..+|.+|+++.||+
T Consensus 230 ----~l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 230 ----NLYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----HHHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111222332232222221 55677899999999999999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.81 Aligned_cols=264 Identities=29% Similarity=0.442 Sum_probs=210.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcC--C---CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD--G---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~--g---~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++....++||+|.||.||+|+++. + ..||||..+... ...++...+|++|+++|++++|||||+++|
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--------~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--------ELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--------cccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345556899999999999998652 2 238999876421 234567889999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++..+..+++|||+++||+|.++|++... .++..++++++.++++||+|||+++ ++||||..+|+|++.+..+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 99999999999999999999999987543 4688999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+||||++........ .....-..+|+|||.+....++.++|||||||++||+++ |..||......
T Consensus 303 ISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------- 369 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------- 369 (474)
T ss_pred eCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----------
Confidence 9999999765411111 111235789999999999999999999999999999998 77787643221
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
+-..+++....+.+.+. ..+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 370 ----~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 ----EVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11112212222222211 4456677899999999999999999999999998876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.05 Aligned_cols=267 Identities=20% Similarity=0.341 Sum_probs=202.3
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|...++||+|.||.||+|+. ++|+.||||+++.... .+.......||++.|+.++|+||+.|+++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~---------kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA---------KDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc---------ccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 3677889999999999999985 5899999999986522 22334567899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+...||+|||+- +|+..++.. ...+.-.....++.++++||+|||++. |+||||||.|+|++.++.+||+||
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADF 145 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADF 145 (318)
T ss_pred CCceEEEEEeccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecc
Confidence 9999999999986 999999753 344566778899999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc----------cc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR----------NV 686 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~----------~~ 686 (768)
|+++.+........ ..+-|..|+|||++.+ ++|+...||||.|||+.||+-+.+-|....+-++. ..
T Consensus 146 GLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 146 GLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP 223 (318)
T ss_pred cchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence 99998765554332 2367999999999875 68999999999999999999987666443221110 00
Q ss_pred cccccchhhh-hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VDFVVPYIVR-DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+| |.+.. .+..++..-..++....-........+|+.+++..||.+|+++.|.++.
T Consensus 224 ~~W--P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 224 DQW--PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccC--ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 11110 0111111000011111112233445699999999999999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.34 Aligned_cols=264 Identities=29% Similarity=0.418 Sum_probs=198.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcC-----------------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD-----------------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 521 (768)
++|++.++||+|+||.||++.+++ +..||+|.+... .......+|.+|++++.
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----------ANKNARNDFLKEVKILS 74 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----------CCHHHHHHHHHHHHHHh
Confidence 478888999999999999997542 236999987542 12234567999999999
Q ss_pred cCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 046311 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS---------------SSPLKSWPARIKVALDAARGIEYL 586 (768)
Q Consensus 522 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~ia~~ia~gL~yL 586 (768)
+++||||+++++++.+.+..++||||+++++|.+++..... ....+++...++++.|+++||+||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999854321 112457788899999999999999
Q ss_pred hhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHH
Q 046311 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLL 666 (768)
Q Consensus 587 H~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ 666 (768)
|+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|
T Consensus 155 H~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 155 SSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred HHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 9998 9999999999999999999999999997543333222222345678999999998888999999999999999
Q ss_pred HHHcC--CcccccCCCCCcccccccccchhhhhhHHhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 667 EILSG--YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 667 elltG--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
||+++ ..|+...... .... .....+...... ........+..+.+|+.+||+.+|++|||+.||.
T Consensus 232 el~~~~~~~p~~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 232 EILMLCKEQPYGELTDE---QVIE---------NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHccCCCCCCcCCHH---HHHH---------HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 99974 4555432211 0100 011111000000 0000112235677999999999999999999999
Q ss_pred HHHH
Q 046311 744 NSLE 747 (768)
Q Consensus 744 ~~L~ 747 (768)
+.|+
T Consensus 300 ~~l~ 303 (304)
T cd05096 300 AFLT 303 (304)
T ss_pred HHHh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=354.81 Aligned_cols=261 Identities=28% Similarity=0.392 Sum_probs=202.0
Q ss_pred CCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.++||+|+||.||+++. +++..||||+++... .....+.+.+|++++..+ +||||+++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----------HLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----------CcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 3688889999999999999963 245689999886321 122346788999999999 89999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC-------------------------------------------------
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------------------------------------------- 562 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 562 (768)
++++.+.+..++||||+++|+|.++++....
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 9999999999999999999999999864321
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 563 ----------------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 563 ----------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
....+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccc
Confidence 0123578888999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhH
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
................++..|+|||++....++.++||||||+++|||++ |..||...... ...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---------------~~~ 326 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---------------SKF 326 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---------------HHH
Confidence 75443322222222345678999999998899999999999999999998 88887543211 111
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.+.+........+ ......+.+|+.+||+.||++||++.||++.|++.
T Consensus 327 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1122221111111 11234577999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=352.10 Aligned_cols=262 Identities=31% Similarity=0.420 Sum_probs=202.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.+.||+|+||.||+++.. ++..||||+++... .......+.+|+++++.+ +|+||+++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----------HTDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----------CHHHHHHHHHHHHHHHhhccCCceeeE
Confidence 46888999999999999998742 34579999886431 123456788999999999 89999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC-------------------------------------------------
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------------------------------------------- 562 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 562 (768)
++++......++||||+++|+|.++++....
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 9999999999999999999999999854211
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 563 -----------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 563 -----------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
....+++...++++.||++||+|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 0123577888999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhhc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD 704 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (768)
...........++..|||||++....++.++||||||+++|||++ |+.||...... ......+.
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---------------~~~~~~~~ 329 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---------------SKFYKMVK 329 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---------------HHHHHHHH
Confidence 222112222335678999999988899999999999999999997 99998643211 01111111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 705 RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.......+ ...+..+.+++.+||+.||++||++.||++.|++++
T Consensus 330 ~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 330 RGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cccCccCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11111111 112356779999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=317.20 Aligned_cols=238 Identities=26% Similarity=0.389 Sum_probs=200.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||.|+||.|.+++.+ +|..+|+|+++.... ..-...+...+|..+|+.+.||+++++++.+.+.
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--------VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--------VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--------HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence 5777899999999999999876 689999999875422 1123445677899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..||||||++||.|+.+|++.++ ++.+.....+.||+.+|+|||+.+ |++|||||+|||||.+|.+||+|||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999999986432 466777889999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+|+..... ....+|||.|+|||++..+.+..++|.|||||++|||+.|++||..... ..-
T Consensus 190 FAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------~~i 249 (355)
T KOG0616|consen 190 FAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------IQI 249 (355)
T ss_pred ceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------HHH
Confidence 99865432 2356899999999999999999999999999999999999999975433 122
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCC
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 736 (768)
.++++...+..+.-+. ..+.+|+.+.|+.|-.+|
T Consensus 250 Y~KI~~~~v~fP~~fs----~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKVKFPSYFS----SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcccCCcccC----HHHHHHHHHHHhhhhHhh
Confidence 4456666555544333 446688899999999988
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.62 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=197.4
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc----CCe
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED----RNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 540 (768)
..|++|+++.||+|.++ ++.||||+++... .......+.|.+|+.+|++++||||+++++++.+ ...
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFH--------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccc--------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 57999999999999985 8999999986431 1112234678899999999999999999999876 346
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
.++||||+++|+|.+++... ..+++...++++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence 78999999999999999753 2357888999999999999999985 5 78999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++...... ....++..|+|||++.. ..++.++||||||+++|||++|+.||...... +
T Consensus 170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---------------~ 229 (283)
T PHA02988 170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---------------E 229 (283)
T ss_pred Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---------------H
Confidence 87543221 12357899999999975 68999999999999999999999999643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
-...++........ ....+..+.+|+.+||+.||++|||++|+++.|+++..
T Consensus 230 ~~~~i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 230 IYDLIINKNNSLKL--PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHhcCCCCCC--CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11112111111111 11235568899999999999999999999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=386.78 Aligned_cols=265 Identities=25% Similarity=0.454 Sum_probs=207.7
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|...+.||+|+||.||+|+. .++..||||+++.... ...+|++.+++++||||+++++++.+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------------IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------------ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 3577788999999999999987 4789999998753210 11246888999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++++. ++|..+.+++.|+++||+|||....++|+||||||+|||++.++..++. |
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 9999999999999999999953 5899999999999999999997655569999999999999999888875 6
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+........ ....+|+.|||||++....++.++|||||||++|||+||+.|++.... ....+.+|........
T Consensus 827 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 827 SLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC 899 (968)
T ss_pred ccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc
Confidence 655432111 122578999999999988999999999999999999999999864322 2223444433222222
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.....+++..........+....+.+++.+||+.+|++||+|+|+++.|+++.+..
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 23444555544333344455667889999999999999999999999999987644
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.86 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=199.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..+.||+|+||.||++... +++.||+|.+..... ........+.+|++++++++|+||+++++++.+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh--------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 3677899999999999999864 789999998864321 1122345678999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... ...+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999998885432 223578888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... ....||..|+|||++....++.++||||||+++|||++|+.||........ .+.
T Consensus 148 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~------------~~~ 212 (285)
T cd05631 148 LAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK------------REE 212 (285)
T ss_pred CcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh------------HHH
Confidence 99764322211 234689999999999989999999999999999999999999975432110 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
+...+.. .......+....+.+|+.+||+.||++||+ ++|+++.
T Consensus 213 ~~~~~~~---~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 213 VDRRVKE---DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHhhc---ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111110 001112223456778999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.23 Aligned_cols=248 Identities=31% Similarity=0.446 Sum_probs=198.7
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
..++-||.|+.|.||+|++. ++.||||+++.- -..+|+-|++|+||||+.|.|+|.....+
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el------------------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL------------------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh------------------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 34578999999999999998 699999976421 13478899999999999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++|||||..|-|.+.|+..+ .+.-.....+..+||.||.|||.+. |||||||+-||||..+..+||+|||-++
T Consensus 188 CIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred EEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 99999999999999997643 2344566789999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHh
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (768)
..... .....++||..|||||++++...++|+|||||||||||||||..||...... ..-|-+ ..+
T Consensus 261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGV----GsN--- 326 (904)
T KOG4721|consen 261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGV----GSN--- 326 (904)
T ss_pred hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEec----cCC---
Confidence 54332 2233578999999999999999999999999999999999999998653221 111111 010
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.+. .+....++.-+.-|+++||+..|..||++++|+..|+-+-...+.
T Consensus 327 sL~------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 327 SLH------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred ccc------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 011 112223455666799999999999999999999999754443333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.58 Aligned_cols=266 Identities=26% Similarity=0.321 Sum_probs=203.5
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCccc---ccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSY---AIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
...++|++.+.||+|.||.|-+|+.. +++.||||++........ ...........+...+|+.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999865 789999999975432111 11111111234678999999999999999999
Q ss_pred EEEEEcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 532 LGFCEDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 532 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
+++..+. +..|||+|||..|.+...-. ..+.+...+..+++.+++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998764 57899999999888765432 2233678888999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccCCCCC---CcccccccccccCccCccccccC----CCCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 610 WTAKVSDFGLSLIGPEDD---ESHLSLRAAGTVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
+++||+|||.+....... ........+|||.|||||....+ ..+.+.||||+||+||.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999997553221 11112346899999999998753 235688999999999999999999964321
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+-.++++...+..+ ...+....+.+||+++|++||++|.+..+|...
T Consensus 325 -------------~~l~~KIvn~pL~fP--~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 -------------LELFDKIVNDPLEFP--ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -------------HHHHHHHhcCcccCC--CcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 122334444433322 223456778899999999999999999998754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.66 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=191.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|+||.||+++.. +++.||||++... ..+.....|.+|++++++++|+||+++++++.+.
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 4556688999999999999865 6899999987532 1223456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+... ........++.||++||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 145 ~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG 213 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTHI--------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFG 213 (353)
T ss_pred CeEEEEEecCCCCccccccc--------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccc
Confidence 99999999999999876432 245667789999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
++........ ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |.
T Consensus 214 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~--- 282 (353)
T PLN00034 214 VSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WA--- 282 (353)
T ss_pred cceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HH---
Confidence 9975432211 1123468999999998743 234568999999999999999999997322211 10
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.......... .. .........+.+|+.+||+.||++||++.|+++.
T Consensus 283 ---~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 283 ---SLMCAICMSQ-PP--EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---HHHHHHhccC-CC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111100 00 1112234567899999999999999999999975
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=312.57 Aligned_cols=266 Identities=22% Similarity=0.377 Sum_probs=211.9
Q ss_pred cCCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+|+.||+++ ..+++.+|+|++.... .+..+..++|++..++++|||+++++++..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----------QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----------hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 4689999999999999999998 5578999999987542 245677899999999999999999998764
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.+ .+.||+++|+..|+|.+.++....+....++.+.++++.++++||++||+.. |+++||||||.|||+.+++.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence 33 4589999999999999999887767777899999999999999999999987 78999999999999999999
Q ss_pred EEEeeccccccCCCCCCcc-------cccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 612 AKVSDFGLSLIGPEDDESH-------LSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
++|.|||.+...+-.-... ......-|..|+|||++.- ...++++|||||||+||+|+.|..||+.....
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 9999999987543221111 0112346899999999863 46789999999999999999999999864331
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
. .-+.++. ....+.-+. ....++.+.+|+++|++.||.+||+..|++..+++++
T Consensus 248 G--gSlaLAv-----------~n~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 G--GSLALAV-----------QNAQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred C--CeEEEee-----------eccccccCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 1112211 111111111 1125677889999999999999999999999998875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=346.83 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=206.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
-|+.++.||+|+-|.|.+|++. +|+.+|||++.... ...+.....+.+|+-+|+.|+|||++++++++++.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeecccc--------ccccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 4677889999999999999864 89999999987542 22334456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
.++|||.||+++|.|+++|-..+ .++..+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccc
Confidence 99999999999999999997543 3467788899999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCC-ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+|.....+.- ....+|.+.|.+||++.+.+|. .++||||-|||||.||||+.||+.++- +.
T Consensus 158 MAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---------------r~ 219 (786)
T KOG0588|consen 158 MASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---------------RV 219 (786)
T ss_pred eeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---------------HH
Confidence 9976544332 2345899999999999998884 799999999999999999999984321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
-+.++....+..+. +.+.+..+|+.+|+..||++|.|++||++.
T Consensus 220 LLlKV~~G~f~MPs----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 220 LLLKVQRGVFEMPS----NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHcCcccCCC----cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 23334444443332 334556689999999999999999999886
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.86 Aligned_cols=256 Identities=22% Similarity=0.405 Sum_probs=201.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|.++ .+..||+|.++.. ........|.+|+..+++++||||++++++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----------CSDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----------CCHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 46888899999999999999753 3568999987642 112344679999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+|+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l 148 (266)
T cd05064 75 ITRGNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKI 148 (266)
T ss_pred EecCCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEE
Confidence 999999999999999999999997532 24578899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||++......... ......++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 149 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------------ 215 (266)
T cd05064 149 SGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------------ 215 (266)
T ss_pred CCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------------
Confidence 999987643221111 1112235678999999998999999999999999999875 99998643211
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+..+.+......+. ....+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 216 ----~~~~~~~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 ----DVIKAVEDGFRLPA--PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HHHHHHHCCCCCCC--CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111111111111 122345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.00 Aligned_cols=258 Identities=30% Similarity=0.466 Sum_probs=204.0
Q ss_pred CCCcCceeccCCceEEEEEEEcC------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
+|++.+.||+|+||.||++.... ...|++|.++.. .......+|.+|++++.+++||||+++++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----------AEPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----------CCHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 57788999999999999998642 257899987532 12234567899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSS------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
++.+.+..+++|||+++++|.+++...... ...+++...+.++.|++.+|+|||+.+ |+|+||||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp 152 (283)
T cd05048 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAA 152 (283)
T ss_pred EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccc
Confidence 999999999999999999999999653211 134678888999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
+|||+++++.+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 153 ~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred ceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999975443332222233456889999999988889999999999999999998 9888864321
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.++.+.+....... .....+..+.+|+.+||+.+|++||+++||++.|+.
T Consensus 233 ----------------~~~~~~i~~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 ----------------QEVIEMIRSRQLLP--CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------------HHHHHHHHcCCcCC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111121111111 122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.17 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++..+ +++.||+|++..... ........+.+|++++++++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD 72 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc
Confidence 36888999999999999999876 689999999864311 112234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 73 QRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred CCeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEec
Confidence 999999999999999999996532 3577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++....... ....||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 146 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------------~~ 205 (291)
T cd05612 146 GFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---------------FG 205 (291)
T ss_pred CcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 9987543221 134689999999999988899999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
....+.......+. .....+.+|+.+||+.||.+||+ ++|+++.
T Consensus 206 ~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 206 IYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHhCCcCCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11222222222111 12345678999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.72 Aligned_cols=264 Identities=27% Similarity=0.340 Sum_probs=204.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~ 530 (768)
.++|++.++||+|+||.||+|+.. .+..||||+++... .....+.|.+|++++++++ ||||++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----------RSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----------ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 457888999999999999999853 23479999885431 1233467999999999996 999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------------------------------------------
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------------------------------------------ 562 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 562 (768)
+++++.+....+|||||+++|+|.++|+....
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 99999999999999999999999998864311
Q ss_pred --------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 046311 563 --------------------------------------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRD 598 (768)
Q Consensus 563 --------------------------------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 598 (768)
....+++..+++++.|+++||+|||+.+ |+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 262 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRD 262 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 0123577788899999999999999998 99999
Q ss_pred CCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCccccc
Q 046311 599 IKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHR 677 (768)
Q Consensus 599 iKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~ 677 (768)
|||+|||++.++.+||+|||++................++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999999975433222222223346788999999988889999999999999999997 8888754
Q ss_pred CCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.... +.....+....... ........+.+++.+||+.+|++||++.+|.+.|++++.
T Consensus 343 ~~~~---------------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 343 MIVD---------------STFYNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred cchh---------------HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2111 01111111111111 112334667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.48 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=206.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|+..+.||+|.||.||||... .++.||+|++... ..++...++++|+.+|..++++||.++++.+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----------~~~deIediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----------EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh----------hcchhhHHHHHHHHHHHhcCcchHHhhhhheee
Confidence 35777789999999999999864 7899999998764 234567789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
...++++|||+.+|++.++|+... .+++....-+..+++.||.|||.++ .+|||||+.|||+..++.+||+||
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEec
Confidence 999999999999999999997532 2355556678889999999999998 899999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|.+.......... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.. + -+
T Consensus 156 gVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---v-lf-------- 221 (467)
T KOG0201|consen 156 GVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---V-LF-------- 221 (467)
T ss_pred ceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---E-EE--------
Confidence 9997654444332 46789999999999998899999999999999999999999987654411 1 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+-+..++.. +....+.+.+++..||+++|+.||++.++++.
T Consensus 222 ----lIpk~~PP~L--~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 ----LIPKSAPPRL--DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----eccCCCCCcc--ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1112222221 22556778899999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.71 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=202.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|+..+.||+|+||.||+|++. +++ .||+|.++.. .......+|.+|+.+++.++||||+++++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46888999999999999999864 333 3899987532 12234567899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++... ..++++||+++|+|.++++... ..+++...++++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~k 149 (316)
T cd05108 77 ICLTS-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVK 149 (316)
T ss_pred EEcCC-CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEE
Confidence 98765 5679999999999999997543 23578888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++................+..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------------ 217 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------ 217 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999999986543322211122234678999999998899999999999999999998 9888853211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.++...+......+.+ ......+.+++.+||+.+|++||++.+++..|.++.+..
T Consensus 218 ----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 218 ----SEISSILEKGERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----HHHHHHHhCCCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1112222222111111 112345678999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=356.00 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=204.7
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
...++|.+.+.||+|+||+||+++.. +++.||||++.... ..+.....+.+|+..+..++|+||+++...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---------~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---------MSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---------CCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 34568999999999999999999854 78999999986531 123445678899999999999999999887
Q ss_pred EEcCC--------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE
Q 046311 535 CEDRN--------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 535 ~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl 606 (768)
+...+ ..++||||+++|+|.++|+........+++.....++.|++.+|+|||+.+ |+||||||+|||+
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl 176 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILL 176 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence 65432 367999999999999999764444445688888999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 607 DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.++.+||+|||+++...............||+.|+|||++....++.++||||||++||||++|+.||.....
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------ 250 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------ 250 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------
Confidence 99999999999999754432222222345789999999999988999999999999999999999999864321
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+...+.....+ ........+.+|+.+||+.+|++||++.++++.
T Consensus 251 ---------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 ---------EEVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---------HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01112222221111 111234567799999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.17 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=203.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|.+.+.||+|+||.||+++.. +++.||||.++.. ...+....|.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 74 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----------ASNDARKDFEREAELLTNFQHENIVKFY 74 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----------CCHHHHHHHHHHHHHHHhcCCCCchhee
Confidence 35777889999999999999864 2478999987532 1123457899999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS----------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+++......++||||+++++|.++++.... ....+++.....++.|++.+|.|||+++ |+||||||+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~ 151 (280)
T cd05049 75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATR 151 (280)
T ss_pred eEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccc
Confidence 999999999999999999999999975421 2234578888999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~ 681 (768)
|||++.++.+||+|||++................+++.|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 152 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~ 231 (280)
T cd05049 152 NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231 (280)
T ss_pred eEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999875433222222223346788999999998999999999999999999998 99988643221
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+....+........ .......+.+++.+||+.||++||++.||++.|++
T Consensus 232 ---------------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 ---------------EVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---------------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111111111 11234567799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=340.84 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=194.6
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
+.||+|+||.||+++.+ +++.||||+++.... ........+.+|++++++++||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEE
Confidence 46999999999999865 789999999864311 122344578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||||+++++|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 73 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 73 VMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999999999998653 23578888899999999999999998 999999999999999999999999998743
Q ss_pred CCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||...... .....+.
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------------~~~~~~~ 208 (323)
T cd05571 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------KLFELIL 208 (323)
T ss_pred ccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---------------HHHHHHH
Confidence 22211 112346899999999999889999999999999999999999998642210 0111111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
......+ ......+.+|+.+||+.||++|| ++.|+++
T Consensus 209 ~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 209 MEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1111111 12345577899999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.16 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=207.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.. +++.||||.+.... .........|.+|++++++++||||+++++++.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--------MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--------cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence 47888999999999999999865 78999999875421 1223445678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+++|||+++++|.+++..........+....+.++.|+++||+|||+++ |+|+||||+|||++.++.++|+||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999988643333344677888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+++.|+|||.+....++.++|+||||+++|||++|+.|+....... .
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~ 214 (267)
T cd08228 151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------F 214 (267)
T ss_pred ccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--------------H
Confidence 998754332211 112357889999999988889999999999999999999999985432110 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.+...+.....++ .........+.+++.+||+.+|++||+++||++.|+++
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 215 SLCQKIEQCDYPP-LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHhcCCCCC-CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111111111111 11123446678999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.05 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|+..+.||+|+||.||+|.+.. ...||||.++.. .......+|.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----------SSDKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----------CChHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 468889999999999999998742 457999987532 123345678999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+...+..+++|||+++++|.+++.... ..+++..+++++.|++.+|+|||+++ |+|+||||+|||+++++.++|
T Consensus 74 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l 147 (266)
T cd05033 74 VTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKV 147 (266)
T ss_pred EecCCceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999999999997533 24688899999999999999999988 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||++................++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------------- 214 (266)
T cd05033 148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------------- 214 (266)
T ss_pred CccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------------
Confidence 99999986542222111112335678999999998899999999999999999998 9888753211
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.+..+.+......+. ....+..+.+++.+||+.+|++||+++||++.|++++
T Consensus 215 ---~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 215 ---QDVIKAVEDGYRLPP--PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ---HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111111111111 1123456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=332.10 Aligned_cols=268 Identities=21% Similarity=0.261 Sum_probs=198.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.+ +++.||+|+++... ..+...+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---------ENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---------ccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 46888999999999999999976 67899999986431 112334678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||++++.|..+... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Df 144 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeec
Confidence 9999999999998777655432 123577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~ 696 (768)
|++......... ......+++.|+|||++.+..++.++||||||+++|||++|+.||......... .......+ ...
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~ 222 (287)
T cd07848 145 GFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-LPA 222 (287)
T ss_pred cCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC-CCH
Confidence 999764332211 112346899999999998888999999999999999999999998643221100 00000000 000
Q ss_pred hhHHhhhc------cCCCCC---Cc----chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLD------RNVPPP---TP----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~------~~~~~~---~~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....... ...+.. .. .....+..+.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000000 00 01123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=339.44 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=199.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.+ +++.||||.+..... ........+.+|+.++++++||||+++++++.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 46888899999999999999876 689999999864311 112334678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997532 3467777889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++....... ....||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 163 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------------~~ 222 (329)
T PTZ00263 163 GFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---------------FR 222 (329)
T ss_pred cCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---------------HH
Confidence 9997543322 134689999999999988899999999999999999999999864221 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
....+....+..+.. ....+.+|+.+||+.||++||+ ++++++.
T Consensus 223 ~~~~i~~~~~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 223 IYEKILAGRLKFPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHhcCCcCCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112222222222111 2345678999999999999996 6887744
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.35 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=201.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. ++..+|+|.+... ..+.....|.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57899999999999999999876 6888999987642 112345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ .|+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Df 148 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDF 148 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccC
Confidence 999999999999999999996532 3577888899999999999999864 2999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc---------
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD--------- 688 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~--------- 688 (768)
|++....... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9987543221 123468999999999998899999999999999999999999986422110000000
Q ss_pred ---cc------------------cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 ---FV------------------VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ---~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. .+.....+..+.+.....+.. ........+.+|+.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000001111111111110 011234568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.66 Aligned_cols=263 Identities=29% Similarity=0.402 Sum_probs=202.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.+.||+|+||.||++... +++.||+|+++... .....+.+.+|+.++.++ +|+||+++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----------TASEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----------CHHHHHHHHHHHHHHHhhccCcchhhe
Confidence 46888999999999999999632 35789999875321 123345688899999999 89999999
Q ss_pred EEEEEcC-CeeEEEEEeccCCChhhhccCCCCC-----------------------------------------------
Q 046311 532 LGFCEDR-NERVLIYEYLENGTLHDHLHNPQSS----------------------------------------------- 563 (768)
Q Consensus 532 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------- 563 (768)
++++... ...+++|||+++++|.+++......
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 9988654 5678999999999999998542210
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCccccc
Q 046311 564 ----------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633 (768)
Q Consensus 564 ----------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 633 (768)
...+++..+++++.||+++|+|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~ 233 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence 124688899999999999999999998 9999999999999999999999999997543322211122
Q ss_pred ccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCc
Q 046311 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTP 712 (768)
Q Consensus 634 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (768)
...++..|+|||++....++.++|||||||+||||++ |+.||...... +.+.+.+........
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~- 297 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---------------EEFCRRLKEGTRMRA- 297 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---------------HHHHHHHhccCCCCC-
Confidence 2345778999999998999999999999999999998 99888642211 011111111111111
Q ss_pred chHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 713 FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 713 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.......+.+++.+||+.+|++||++.|+++.|++++.
T Consensus 298 -~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11223557799999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=353.31 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=200.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-C-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-D-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.|.+.+.||+|+||.||++... + ++.||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----------DERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 4788899999999999999754 3 678888865422 12334567889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+|||||+++|+|.++|+........+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence 99999999999999999988653333344678888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...............||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---------------~~ 278 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---------------RE 278 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 999765433222223345699999999999988999999999999999999999999863211 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+..++.....+ ........+.+++.+||+.+|++||++++++.
T Consensus 279 ~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 279 IMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 122222222211 11123356779999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.24 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=195.3
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||+||++... +++.+|+|.+..... ......+.+..|++++++++||||+++.+++..+...++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 72 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVM 72 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEE
Confidence 699999999999865 689999998864311 11223456788999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++|+|.+++.........+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 999999999888543333445688899999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhcc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (768)
.... .....||+.|+|||++....++.++||||||+++|||++|+.||........ ........+..
T Consensus 150 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----------~~~~~~~~~~~ 216 (280)
T cd05608 150 GQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----------NKELKQRILND 216 (280)
T ss_pred CCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----------HHHHHHhhccc
Confidence 2221 1234689999999999989999999999999999999999999864322110 00001111111
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
. .......+..+.+++.+||+.||++|| +++|+++.
T Consensus 217 ~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 217 S----VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred C----CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1 111223445677999999999999999 67777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.02 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=206.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|.+.+.||+|+||.||++... ++..+|+|.+... .......|.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46888899999999999999742 3456888977532 123456789999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQ---------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+++...+..++||||+++++|.+++.... .....+++..++.++.|++.+|+|||+++ |+||||||+|
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~N 150 (288)
T cd05093 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 150 (288)
T ss_pred EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcce
Confidence 99999999999999999999999986432 12234688999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCC
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGT 682 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~ 682 (768)
||+++++.+||+|||++................++..|+|||++....++.++||||||+++|||++ |..||......
T Consensus 151 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~- 229 (288)
T cd05093 151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 229 (288)
T ss_pred EEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999975433222222223345778999999998889999999999999999998 88887543211
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+....+......... ...+..+.+|+.+||+.+|.+|||+.|+++.|+++.+..
T Consensus 230 --------------~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 230 --------------EVIECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --------------HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 111122221111111 112345789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.65 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=201.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||+++.... ........+.+|++++..++||||+++++++.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~ 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--------FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence 36888999999999999999876 589999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999643 23577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++..... ......||+.|+|||++....++.++||||||+++|||++|+.||....... ... .+ .
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~----~i--~ 211 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWE----NL--K 211 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHH----HH--H
Confidence 99975433 1123468999999999998899999999999999999999999986432211 000 00 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+.. +............+.+++.+||..+|++||+++|+++.
T Consensus 212 ~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 212 YWKETLQR--PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hccccccC--CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001110 00000012334567789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.17 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=198.5
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+|+..+.||+|+||.||++.++++..+|+|.+... +....+|.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------------AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC------------CccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 57778899999999999999888889999986532 122457889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.++++... ..+++..++.++.|++.+|+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCC
Confidence 9999999999999999997532 23578889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...... +.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---------------~~ 210 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---------------EV 210 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---------------HH
Confidence 8754322211 1112235678999999988889999999999999999999 88888643210 11
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
...+....... .+ ......+.+++.+||+.+|++||++.|+++.|
T Consensus 211 ~~~i~~~~~~~-~~--~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 211 VEMISRGFRLY-RP--KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHCCCCCC-CC--CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11111111111 00 11234577999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.85 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=200.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|+..+.||+|+||.||++..+ .+..||||.+... .......+|.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 457889999999999999999753 2467999986432 111234578999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSS------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
++++.+....++||||+++++|.+++...... ....++..++.++.|++++|+|||+.+ ++|+||||+|||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil 151 (277)
T cd05062 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 151 (277)
T ss_pred EEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEE
Confidence 99999999999999999999999998653211 123467888999999999999999988 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPR 684 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 684 (768)
+++++.+||+|||++................+++.|+|||++....++.++||||||+++|||++ |..||......
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--- 228 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--- 228 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999875433322222222345788999999998889999999999999999999 67777532210
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+....+........ .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 229 ------------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ------------QVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ------------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111111111 11223567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.26 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=214.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCC-CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEE-E
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDG-SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLG-F 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g-~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~-~ 534 (768)
..++++.+.|.+|||+.||.+....+ .++|+|++-.. ++...+...+|+++|++|+ |||||.+++ .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----------de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----------DEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----------CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 35678889999999999999997765 99999987532 4567788999999999996 999999999 3
Q ss_pred EEc------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 535 CED------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 535 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
... .-+.+|+||||.+|+|-|++..+.... +++.++++|+.|+++|+++||... |+|||||||-+||||..
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSA 181 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcC
Confidence 322 136789999999999999998654333 688999999999999999999997 78999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcc--c-----ccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 609 TWTAKVSDFGLSLIGPEDDESH--L-----SLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~--~-----~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
+++.||||||.+.......... . .....-|+-|++||++. +..+++|+|||+|||+||-|+....||+..
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999999999986322211100 0 01224699999999874 678999999999999999999999999754
Q ss_pred CCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
.. ..+++.++..+ ....+...|.+||..||+.+|++||++-+|+..+.+++......+.
T Consensus 262 g~-------------------laIlng~Y~~P--~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 262 GK-------------------LAILNGNYSFP--PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred cc-------------------eeEEeccccCC--CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence 22 12233333221 1245677888999999999999999999999999999876655544
Q ss_pred Cc
Q 046311 759 IS 760 (768)
Q Consensus 759 ~~ 760 (768)
..
T Consensus 321 ~~ 322 (738)
T KOG1989|consen 321 IY 322 (738)
T ss_pred cc
Confidence 43
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=332.87 Aligned_cols=256 Identities=25% Similarity=0.314 Sum_probs=196.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+.+.+||+|+||.||+++.+ +|..+|+|+++.+.. ....+.+..+.|-.+|...++|+||+|+-.|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M--------~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM--------LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH--------HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 467999999999999999999754 799999999986532 22345567788999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+.+||||||++||++..+|... ..+++......+.+++.||+.||+++ ||||||||+|+|||..|++||+|
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence 999999999999999999999753 23456666677788999999999999 99999999999999999999999
Q ss_pred ccccccCCC----------------------CCCcc----cc-------------------cccccccCccCccccccCC
Q 046311 617 FGLSLIGPE----------------------DDESH----LS-------------------LRAAGTVGYMDPEYYRLQQ 651 (768)
Q Consensus 617 FGla~~~~~----------------------~~~~~----~~-------------------~~~~gt~~y~aPE~l~~~~ 651 (768)
|||+.-... .+... .. ...+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999842110 00000 00 0236999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccc
Q 046311 652 LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTL 731 (768)
Q Consensus 652 ~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~ 731 (768)
|+...|.||||||+||||.|++||........ ..+++.-+.....+.+.+...+..+||.+|+.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T---------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQET---------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-
Confidence 99999999999999999999999986543211 11111111001111122223555689999998
Q ss_pred cCCCCCC---HHHHHH
Q 046311 732 EGRNRPS---MTEIVN 744 (768)
Q Consensus 732 dP~~RPs---~~evl~ 744 (768)
||++|.- ++||.+
T Consensus 429 d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKK 444 (550)
T ss_pred CHHHhcCcccHHHHhc
Confidence 9999964 555543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.19 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=202.3
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||++..+++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 468888999999999999999888889999986532 12346789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.++++... ....++..++.++.|++++|+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCc
Confidence 99999999999999999997532 233578888999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---------------- 211 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---------------- 211 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----------------
Confidence 99764332211 1112235678999999988889999999999999999998 88888543211
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.....+......+. ....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 DVMSALQRGYRMPR--MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHcCCCCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111111111111 11233557789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.79 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=199.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|...++||+|.||+|+++..+ +++.+|||.+++... ...++.+..+.|.+++... +||.+++|+..|+
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--------l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--------LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--------eccccHHHHHHHHHHHHHhccCCeEeecccccc
Confidence 57899999999999999999876 688999999987532 2234566777888887776 6999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+++.|+||||+.||++..+.+. ..+++....-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecc
Confidence 99999999999999996655543 23577777889999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|||++...... ..+..++|||.|||||++....|+..+|.|||||+|||||.|+.||..++.
T Consensus 512 FGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---------------- 573 (694)
T KOG0694|consen 512 FGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---------------- 573 (694)
T ss_pred cccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----------------
Confidence 99998643222 234467999999999999999999999999999999999999999975432
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
+ +++|..+.....+...++.+...|+.++|.++|++|.-+
T Consensus 574 e---e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 E---EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred H---HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 222222222223334455666789999999999999866
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.23 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=195.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||.||++..+ +++.||+|+++... .......+.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------EEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----------cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 46888999999999999999875 68999999886431 11223467889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..++||||+++ +|.+++.... ...++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 147 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADF 147 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcC
Confidence 9999999999975 9999886432 23577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc-c-------
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV-D------- 688 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~------- 688 (768)
|+++........ .....+++.|+|||++.+ ..++.++||||||+++|||+||+.||............ .
T Consensus 148 G~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 148 GLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred cceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 998753322211 123457899999998865 56899999999999999999999998643211100000 0
Q ss_pred cccchhh-hhhHHhhhccCCCCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIV-RDEIHRVLDRNVPPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
-.++.+. .++......+...... .........+.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0011111111100000 000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=336.89 Aligned_cols=242 Identities=23% Similarity=0.303 Sum_probs=192.1
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||.||+++.. +++.||+|+++... .........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--------IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--------hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEE
Confidence 799999999999875 68899999986431 112234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++|+|.+++.... .+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 73 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 73 AFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 9999999999996532 3578888899999999999999998 99999999999999999999999999875322
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhcc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (768)
... ......||+.|+|||++....++.++||||||+++|||++|+.||..... .+.....+..
T Consensus 146 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------------~~~~~~~~~~ 208 (312)
T cd05585 146 DDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------------NEMYRKILQE 208 (312)
T ss_pred CCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---------------HHHHHHHHcC
Confidence 221 12234689999999999988999999999999999999999999864321 0111222222
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccccCCCCCC---HHHHHH
Q 046311 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS---MTEIVN 744 (768)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~evl~ 744 (768)
....+ ......+.+++.+||+.||++||+ +.|+++
T Consensus 209 ~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 209 PLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 22211 123455778999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.23 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=205.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.+|...+.||+|+||.||+++.. +...+++|.+... .....+.|.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----------TLAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----------cHHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 35777889999999999999742 3456888876532 123346789999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK 600 (768)
+++...+..++||||+++++|.+++..... ....+++..+++++.|++.+|+|||+++ |+|||||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 150 (291)
T cd05094 74 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLA 150 (291)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccC
Confidence 999999999999999999999999965321 1234688899999999999999999998 9999999
Q ss_pred CCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCC
Q 046311 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTH 679 (768)
Q Consensus 601 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~ 679 (768)
|+|||++.++.++|+|||++................++..|+|||++....++.++||||||+++|||+| |+.||....
T Consensus 151 p~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred cceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999975433322222223456788999999998899999999999999999999 999876432
Q ss_pred CCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
... ............. ....+..+.+++.+||+.+|++||++++|++.|+++.+.
T Consensus 231 ~~~---------------~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 231 NTE---------------VIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHH---------------HHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 210 0111111111111 111235577999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=303.23 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++++.||+|.||.||.|+.+ ++-.||+|++..+.. .......++.+|+++-..|+||||++++++|.+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi--------~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI--------LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH--------HHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 46888999999999999999865 688999999865421 112345688999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+...||++||.+.|+|+..|..... ..++......+..|+|.||.|+|..+ ++||||||+|+|++.++.+||+||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 9999999999999999999985432 22455566788999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|-+...+.... ...+||..|.+||...+..++...|+|++|++.||+|.|.+||+.... .+
T Consensus 169 GwsV~~p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------------~e 229 (281)
T KOG0580|consen 169 GWSVHAPSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------------SE 229 (281)
T ss_pred CceeecCCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------HH
Confidence 99976553322 245899999999999999999999999999999999999999975432 12
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
-..++..-.+..+ ........++|.+|+..+|.+|.+..|+++.
T Consensus 230 tYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 230 TYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233333233222 2234455689999999999999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=328.49 Aligned_cols=251 Identities=35% Similarity=0.538 Sum_probs=191.2
Q ss_pred cCceeccCCceEEEEEEEc-----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 463 EDHKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.|.+|++.+++++||||+++++++..
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~ 72 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE 72 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----------cccccceeeeecccccccccccccccccccccc
Confidence 3478999999999999876 3578999988432 223446889999999999999999999999998
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++|+... ...+++..+++|+.|+++||+|||+++ |+|+||+++|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEEST
T ss_pred cccccccccccccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 888999999999999999998651 234689999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++....................|+|||.+....++.++||||||+++|||++ |+.|+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---------------- 211 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---------------- 211 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------
Confidence 99976533222222233456789999999998889999999999999999999 6777643311
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
.++...+....... .....+..+.+++.+||+.+|++||+++|+++.|
T Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 EEIIEKLKQGQRLP--IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHTTEETT--SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccce--eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111111111111 1112345577899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=325.99 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=203.0
Q ss_pred CCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
+|++.+.||+|+||.||+|+.. ....+++|.+... .......++.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 70 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----------ASSSELRDLLSEFNLLKQVNHPHVIKLYG 70 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----------CCHHHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 4677899999999999999753 2356888876432 11234467899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQS--------------------SSPLKSWPARIKVALDAARGIEYLHEYAVPS 593 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ 593 (768)
.+...+..+++|||+++++|.+++..... ....+++...+.++.|++.+|+|||+++
T Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--- 147 (290)
T cd05045 71 ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--- 147 (290)
T ss_pred EEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999864221 1124678889999999999999999998
Q ss_pred eEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CC
Q 046311 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GY 672 (768)
Q Consensus 594 ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~ 672 (768)
|+||||||+|||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||+| |.
T Consensus 148 ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999875433222111122345778999999988889999999999999999998 88
Q ss_pred cccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 673 RAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 673 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.||..... .++...+........ .......+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 228 ~p~~~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 228 NPYPGIAP----------------ERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCCCH----------------HHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 88753211 111122222111111 112345677999999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.30 Aligned_cols=262 Identities=28% Similarity=0.391 Sum_probs=202.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l 531 (768)
++|.+.++||+|+||.||++++. .++.||||+++... .......+.+|+++|.++. ||||+++
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----------RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----------ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 35777899999999999999853 34689999986421 1223457889999999997 9999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC-------------------------------------------------
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------------------------------------------- 562 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 562 (768)
++++...+..++||||+++|+|.++++....
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 9999999999999999999999999965321
Q ss_pred ---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 563 ---------------------------------------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 563 ---------------------------------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
....+++...++++.|++.||+|||+.+ |+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcc
Confidence 1123567778899999999999999987 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999975432221111122356789999999988889999999999999999998 888875
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.... .+...+.+........ .......+.+|+.+||+.+|++||+++||++.|++++
T Consensus 344 ~~~~---------------~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 344 ELPM---------------NEQFYNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCc---------------hHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 3221 0111122222211111 1123456789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.24 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||++..++++.||+|.++... ...++|.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT------------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc------------ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 4688889999999999999998778899999875321 1245688999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++.... ...+++..+++++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcc
Confidence 99999999999999999997543 234588999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... .......+..|+|||++....++.++||||||+++|||+| |+.||..... .
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~ 211 (261)
T cd05068 149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----------------A 211 (261)
T ss_pred eEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----------------H
Confidence 99765422211 1111123457999999998899999999999999999999 8888853221 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.....+....... ........+.+++.+|++.+|++||++.++++.|++
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 212 EVLQQVDQGYRMP--CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHcCCCCC--CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111211111 111234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.78 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=194.7
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
+.||+|+||.||++..+ +++.||+|++.... .........+.+|+++++.++||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV--------IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEE
Confidence 36999999999999865 68999999986431 1122345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||||+++++|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 73 v~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 73 VMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99999999999988643 23578888999999999999999998 999999999999999999999999998743
Q ss_pred CCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +....+.
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---------------~~~~~~~ 208 (328)
T cd05593 146 ITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------KLFELIL 208 (328)
T ss_pred CCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---------------HHHHHhc
Confidence 22111 112346899999999999889999999999999999999999998643210 0011111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
......+. .....+.+|+.+||+.||++|| ++.|+++.
T Consensus 209 ~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 MEDIKFPR----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCccCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111111 2234567899999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.41 Aligned_cols=269 Identities=21% Similarity=0.343 Sum_probs=194.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.++||+|+||.||++..+ +++.||||++.... ........+.+|++++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---------ccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 4788899999999999999865 68999999886321 1122345788999999999999999999987543
Q ss_pred -----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 539 -----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 539 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
...++||||+. ++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 143 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLK 143 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEE
Confidence 24799999995 6899988643 23578889999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCC-cccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-ccc
Q 046311 614 VSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-VDF 689 (768)
Q Consensus 614 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~~~ 689 (768)
|+|||+++....... ........+|+.|+|||++.. ..++.++||||||+++|||+||+.||........... .+.
T Consensus 144 L~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~ 223 (338)
T cd07859 144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223 (338)
T ss_pred EccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 999999975322211 111123468999999999865 6789999999999999999999999864321100000 000
Q ss_pred -------ccchhhhhhHHhhh---ccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 -------VVPYIVRDEIHRVL---DRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 -------~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+......+.+ ....+.. ..........+.+++.+||+.||++||+++|+++.
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000001111111 1111100 00001123456799999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=321.09 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=196.3
Q ss_pred CCcCceeccCCceEEEEEEEcCC-C--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 461 FSEDHKIGSGSFGAVYKATLDDG-S--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~g-~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
|.+.++||+|+||.||+|.+.+. . .+|+|.++... ........|.+|+++++.++||||+++++++..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ 71 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence 34568899999999999987643 2 58999875431 123445788999999999999999999998743
Q ss_pred C------CeeEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 538 R------NERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 538 ~------~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
. ...+++|||+++|+|.+++.... .....+++...+.++.|++.||+|||+++ |+||||||+|||++++
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN 148 (272)
T ss_pred CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC
Confidence 2 24689999999999999874322 12234688889999999999999999988 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~ 688 (768)
+.+||+|||++.................++.|++||.+....++.++||||||+++|||++ |+.||...... ..
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~-- 223 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EI-- 223 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH--
Confidence 9999999999976543222111122345778999999998899999999999999999999 78887532110 00
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
...+........ .......+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 224 ----------~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 224 ----------YDYLRQGNRLKQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred ----------HHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111111110 1123345779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.05 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=205.6
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
..+|++.+.||+|.||.|-++.. ..|+.||||.++.++. .++...-.+.+|+++|..|+||||+.++++|+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--------kdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--------KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--------ccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 35788889999999999999974 6899999999876532 33456678899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+.+.|||||..+|.|+||+.+.+ .+++.+..+++.||..++.|+|.+. ++|||||.+|||||.++++||+|
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeec
Confidence 9999999999999999999997643 3577888899999999999999998 89999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+..+.... ....++|++-|.+||++.+..| .+..|-|||||+||.|+.|..||+....
T Consensus 197 FGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------------- 258 (668)
T KOG0611|consen 197 FGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------------- 258 (668)
T ss_pred cchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------------
Confidence 99997765433 3346799999999999998887 5789999999999999999999975421
Q ss_pred hhhHHhhh-ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 696 RDEIHRVL-DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 696 ~~~~~~~~-~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
..+-+.+ ...+..+.. +....-||++||..+|++|.|+++|....
T Consensus 259 -k~lvrQIs~GaYrEP~~-----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 259 -KRLVRQISRGAYREPET-----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -HHHHHHhhcccccCCCC-----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111222 222222111 11223589999999999999999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.69 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=194.5
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
+.||+|+||.||++..+ ++..||+|+++... .........+.+|++++++++||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEE
Confidence 46999999999999865 68999999986431 1122345677889999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||||+++++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 73 v~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 73 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99999999999988643 23578888999999999999999998 999999999999999999999999998643
Q ss_pred CCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||...... .....+.
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------------~~~~~~~ 208 (323)
T cd05595 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------RLFELIL 208 (323)
T ss_pred cCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHh
Confidence 22211 112346899999999999889999999999999999999999998643211 1111112
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
......+. .....+.+++.+||+.||++|| ++.++++.
T Consensus 209 ~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 MEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCCCCCCC----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11111111 2245567899999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=323.98 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=200.8
Q ss_pred CCCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.++||+|+||.||+|.+ ..+..+++|.++.. .......+|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----------NNPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----------CCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 3577789999999999999974 24578999987532 11234467899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQS-------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK 600 (768)
++...+..++||||+++++|.+++..... ....+++...+.++.|++.+|+|||+++ |+|||||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 151 (283)
T cd05090 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151 (283)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccc
Confidence 99999999999999999999999853211 1223578888999999999999999998 9999999
Q ss_pred CCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCC
Q 046311 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTH 679 (768)
Q Consensus 601 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~ 679 (768)
|+|||+++++.+||+|||++................++..|+|||++....++.++||||||+++|||++ |..||....
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999975433322222223345778999999988889999999999999999998 888875321
Q ss_pred CCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
. .++.+.+......+. .......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 232 ~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 N----------------QEVIEMVRKRQLLPC--SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----------------HHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111112211111111 11233567789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.34 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=200.0
Q ss_pred CCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
|.+.+.||+|+||.||+|++.. +..||||+++... ........+.+|++.++.++||||+++++++.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 71 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCF 71 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeec
Confidence 5677899999999999998642 3679999886431 12234567899999999999999999999886
Q ss_pred cCCe------eEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 537 DRNE------RVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 537 ~~~~------~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
..+. .+++|||+++++|.+++.... .....+++...+.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 72 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~ 148 (273)
T cd05035 72 EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLRE 148 (273)
T ss_pred cCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECC
Confidence 6554 789999999999999985432 12234688889999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~ 687 (768)
++.+||+|||+++................+..|+|||.+....++.++||||||+++|||++ |..||......
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------ 222 (273)
T cd05035 149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------ 222 (273)
T ss_pred CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999975543332222222335678999999988889999999999999999999 88887543210
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
+....+.+..... ........+.+++.+||+.||++||++.|+++.|++++
T Consensus 223 ---------~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 223 ---------EIYDYLRHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred ---------HHHHHHHcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 0111111111111 11123456779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=318.06 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=194.9
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
+.||+|+||.||+++.. +++.+|+|.+... ...+....|.+|++++++++||||+++++++......++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 70 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEE
Confidence 46999999999999875 7899999976422 123345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||||+++++|.+++.... ..+++...+.++.|++.+|+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 71 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 71 VMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred EEeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccc
Confidence 999999999999996432 33578889999999999999999998 999999999999999999999999998653
Q ss_pred CCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
..............+..|+|||.+....++.++||||||+++|||++ |..|+..... .+....
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----------------~~~~~~ 208 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----------------QQTREA 208 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----------------HHHHHH
Confidence 32211111111123467999999988889999999999999999998 8777753211 111122
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
+....+... ....+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 209 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 IEQGVRLPC--PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHcCCCCCC--cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222211111 1123456779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=305.89 Aligned_cols=261 Identities=21% Similarity=0.349 Sum_probs=214.3
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
..++|...+.||+|..++|.+...+ ++.++|+|++......... ....+..++-.+|+.+|+++ -||+|+++.++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~---e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESG---ETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCC---ccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3456788889999999999998755 7899999999876543322 11233445667899999998 69999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
|+.+...++|+|.|+.|.|+|+|.. ...+++....+|+.|+.+|++|||.++ ||||||||+|||++++.++||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEE
Confidence 9999999999999999999999965 344677788899999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCcccccc------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
+|||+++...+..... ..+|||+|+|||.+.. ..|+...|+|+.||+||.||.|.+||....+
T Consensus 165 sDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------- 233 (411)
T KOG0599|consen 165 SDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------- 233 (411)
T ss_pred eccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------
Confidence 9999998776655433 4589999999999863 3678899999999999999999999964211
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. -.+.-+++..+....+...+......+||.+||+.||.+|.|++|.+..
T Consensus 234 ----m---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ----M---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----H---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0 1133345555555556666777888899999999999999999999874
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.53 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=198.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCe----EEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|++.+.||+|+||.||++.+. +++. +++|.+... .......++..|+..+++++||||+++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 36778899999999999999864 4553 666655321 11233457888999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.. ...++++||+++|+|.++++... ..+++...+.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 77 ~~~~-~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 77 ICPG-ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred EECC-CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEE
Confidence 8754 45789999999999999997532 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............++..|++||.+....++.++||||||+++|||++ |+.||......
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----------- 218 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----------- 218 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 999999976543332222223456788999999988889999999999999999998 98888543211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
...+.+........+. .....+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 219 -----~~~~~~~~~~~~~~~~--~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 219 -----EVPDLLEKGERLAQPQ--ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----HHHHHHHCCCcCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1111222111111110 1123456799999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=325.38 Aligned_cols=267 Identities=22% Similarity=0.356 Sum_probs=191.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~ 533 (768)
++|++.+.||+|+||.||+++.. +++.||+|+++.... .+.....+.+|+.+++.+ +||||+++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~ 71 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------EEGMPLSTIREVAVLRHLETFEHPNVVRLFD 71 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC---------CCCchHHHHHHHHHHHhhcccCCCCcceEEE
Confidence 36888999999999999999863 468899998865321 112233456677666655 7999999999
Q ss_pred EEE-----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 534 FCE-----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 534 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
++. .....++||||++ ++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~ 145 (290)
T cd07862 72 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS 145 (290)
T ss_pred EEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcC
Confidence 885 2456899999996 599999865332 23578889999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVV 687 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~ 687 (768)
++.+||+|||++....... ......+|+.|+|||++....++.++||||||+++|||++|+.||......+.. .+.
T Consensus 146 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 146 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred CCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 9999999999997543321 122346899999999998888999999999999999999999998753221100 000
Q ss_pred ccccchhhhhhHH-------hhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 688 DFVVPYIVRDEIH-------RVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 688 ~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+..... ...+.. ..+....... .....+....+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLP-GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCC-ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 000000 0000000000 0001123456679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.12 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=194.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..+.||+|+||+||+++.. +++.||||++..... ........+.+|++++++++||||+++++++.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 73 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK 73 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC
Confidence 5788899999999999999865 688999999864311 1123456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCc
Confidence 99999999999999999996532 3567777888999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCC---------------------------------------------cccccccccccCccCccccccCCCC
Q 046311 619 LSLIGPEDDE---------------------------------------------SHLSLRAAGTVGYMDPEYYRLQQLT 653 (768)
Q Consensus 619 la~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s 653 (768)
++........ ........||+.|+|||++....++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9753211000 0001124699999999999988899
Q ss_pred ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHH--cccc
Q 046311 654 EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAAD--CVTL 731 (768)
Q Consensus 654 ~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~--Cl~~ 731 (768)
.++|||||||++|||+||+.||...... +...++++.......+........+.+|+.+ |+..
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPT---------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHH---------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence 9999999999999999999999653221 1111111110000001111123445577776 5566
Q ss_pred cCCCCCCHHHHHHH
Q 046311 732 EGRNRPSMTEIVNS 745 (768)
Q Consensus 732 dP~~RPs~~evl~~ 745 (768)
++..||+++|+++.
T Consensus 292 ~~~~R~~~~~~l~h 305 (381)
T cd05626 292 ERLGRNGADDIKAH 305 (381)
T ss_pred cccCCCCHHHHhcC
Confidence 66679999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.75 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=208.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.++||.+.... ........+|.+|+++++.++||||+++++++.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--------hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence 46778899999999999999864 78999999876432 1122345688999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+++|||+++++|.+++.........+++...+.++.|++++|+|||+++ |+|+||||+||+++.++.++|+||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999998653333445688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....++..|+|||.+....++.++||||||+++|||++|..||....... . .
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~---------~ 215 (267)
T cd08229 151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----Y---------S 215 (267)
T ss_pred hhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----H---------H
Confidence 998754332211 112357899999999988889999999999999999999999985432110 0 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
....+.....++. ........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 216 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 LCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HhhhhhcCCCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0111111111111 11234556789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.88 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=209.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.|++|.++.... ......+.+.+|++++++++|+||+++++++.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~ 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--------MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--------cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 57888999999999999999876 789999998864311 122345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.........+++..++.++.+++++|.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecc
Confidence 99999999999999999998654333445688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....++..|+|||.+....++.++||||||+++|||++|+.||...... ..+
T Consensus 151 ~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~--------- 215 (267)
T cd08224 151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS--------- 215 (267)
T ss_pred ceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH---------
Confidence 998754322211 12235788999999998888999999999999999999999998543211 000
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
..+.+.....++.+ .......+.+++.+||..+|++||++.+|++.|+++.
T Consensus 216 -~~~~~~~~~~~~~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 -LCKKIEKCDYPPLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -HHhhhhcCCCCCCC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111111111111 1133456779999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.27 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=205.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
++|.+.+.||+|+||.||++... +...+|+|.++.. ..+....++.+|+++++++ +||||+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----------CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 46888999999999999999752 2346999987532 1123446788999999999 799999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++...+..++||||+++++|.+++..... ....+++..+++++.|++.+|+|||+++ ++||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~ 164 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHR 164 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 999999999999999999999999999975432 1124688899999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||++................+++.|+|||++....++.++||||||+++|||++ |..||.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999875433221111112234578999999988889999999999999999998 777774
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... +++.+.+....... ........+.+|+.+||+.+|++||++.|+++.|+++++..
T Consensus 245 ~~~~----------------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 245 GVPV----------------EELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred cCCH----------------HHHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 3211 11111222211111 11123456778999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=326.34 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=203.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|+..+.||+|+||.||++... ....+|+|.+... .......++.+|+++++++ +|+||+++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----------CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 46788899999999999999864 2367899987532 1123446788999999999 89999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQ------------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI 599 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 599 (768)
++++...+..+++|||+++++|.++++... .....+++..+++++.|++.+|+|||+.+ |+||||
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dl 158 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL 158 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 999999999999999999999999996432 12345688899999999999999999998 999999
Q ss_pred CCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccC
Q 046311 600 KSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRT 678 (768)
Q Consensus 600 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~ 678 (768)
||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..|+...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999976543322222222235678999999988889999999999999999998 88877532
Q ss_pred CCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.. .+..+.+........ .......+.+|+.+||+.+|++|||+.|+++.|++++
T Consensus 239 ~~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PV----------------EELFKLLKEGYRMEK--PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CH----------------HHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111111111111111 1122345778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=319.99 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=201.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|+||.||++..+ .++.|++|.+... .....++.+|++++++++||||+++++++...
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------------chHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 4777789999999999999865 5889999987532 12346789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...+++|||+++++|.+++.... ...+++..++.++.|++++|+|||+++ ++||||||+|||+++++.+||+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCc
Confidence 99999999999999999996532 234688889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... .......+..|+|||.+....++.++||||||+++|||++ |..|+..... +
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----------------~ 212 (263)
T cd05052 150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------S 212 (263)
T ss_pred cccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----------------H
Confidence 98754332211 1111234678999999988899999999999999999998 8888753211 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+..+.+....... .....+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 213 QVYELLEKGYRME--RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHCCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111111111111 1112345677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.81 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=202.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.. +++.||||+++.... ........+.+|++++..++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--------IKRNQIAHVRAERDILADADSPWIVKLYYSFQD 72 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--------hhccHHHHHHHHHHHHHhcCCCCccchhhheec
Confidence 36888999999999999999876 789999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 73 EEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred CCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecC
Confidence 99999999999999999999753 23577888899999999999999988 999999999999999999999999
Q ss_pred cccccCCCCC---------------------------CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 618 GLSLIGPEDD---------------------------ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 618 Gla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
|++....... .........||+.|+|||++....++.++|||||||+||||++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9987543322 0011223468999999999998999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccchhhhhhHHhhhc--cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-HHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD--RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-MTEIVNS 745 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~~ 745 (768)
|+.||...... ....++.. .....+. .......+.+|+.+|+. +|++||+ ++|+++.
T Consensus 226 g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 226 GFPPFYSDTLQ---------------ETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCCHH---------------HHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99998643211 11112222 1111111 11134567789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=313.82 Aligned_cols=269 Identities=20% Similarity=0.244 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE- 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 536 (768)
++|+.++.|++|+||.||+|+.+ +++.||+|+++..... +.-....++|+.+|.+++|||||.+.++..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek---------~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK---------EGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc---------CCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 35777889999999999999865 7899999999875321 122345689999999999999999999874
Q ss_pred -cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 -DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+-+.+||||||++. +|..+++... ..+...+..-+..|+++||+|||.+. |+|||||++|+|++..|.+||+
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEec
Confidence 34579999999987 9999998654 23456677789999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc--------
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-------- 686 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-------- 686 (768)
|||||+.+..... ..+..+-|..|+|||++.+ ..|+...|+||+|||+.||+++++.|.....-+..+.
T Consensus 220 DFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 220 DFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 9999997655432 2234567999999999875 5799999999999999999999887764332111100
Q ss_pred cccccchhhhhhHHhhhccCCCCCC----cchHH-HHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPT----PFEIE-AVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+-.+|-+..-.....+...-.+.. .+... ....-.+|+...|..||++|.|++|.++.
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111111111110000000000000 01111 22445589999999999999999998864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.64 Aligned_cols=199 Identities=27% Similarity=0.398 Sum_probs=170.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||++..+ ++..+|+|.+... ........+.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 57899999999999999999876 6788999987642 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++.....++.|++.+|.|||+.+ .|+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeC
Confidence 99999999999999999999653 23577788899999999999999753 2999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
|++....... .....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 149 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred Ccchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9986442221 1123589999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=333.85 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=198.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcC--CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||++..+. +..||+|++..... ........+.+|+++++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--------IKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 468888999999999999998653 36899998864311 11234567889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++|+|.+++.... .+++.....++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEec
Confidence 9999999999999999999997532 3577888899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++....... ....||+.|+|||++....++.++|||||||++|||++|+.||......
T Consensus 175 FG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------------- 234 (340)
T PTZ00426 175 FGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------------- 234 (340)
T ss_pred CCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---------------
Confidence 99997543221 2346899999999999888999999999999999999999999643210
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
....++.......+.. ....+.+++.+||+.||++|+ +++|+++.
T Consensus 235 ~~~~~i~~~~~~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 LIYQKILEGIIYFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHhcCCCCCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112222222221111 234466899999999999995 88888764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.57 Aligned_cols=264 Identities=29% Similarity=0.403 Sum_probs=200.7
Q ss_pred CCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------THSEHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----------ChHHHHHHHHHHHHHHhccCCccHhhh
Confidence 4788999999999999999973 346889999986421 123456788999999999 78999999
Q ss_pred EEEEEcC-CeeEEEEEeccCCChhhhccCCCCC-----------------------------------------------
Q 046311 532 LGFCEDR-NERVLIYEYLENGTLHDHLHNPQSS----------------------------------------------- 563 (768)
Q Consensus 532 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------- 563 (768)
++++... ...+++|||+++|+|.++++.....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 9987654 4678999999999999998643210
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCC
Q 046311 564 ----------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627 (768)
Q Consensus 564 ----------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~ 627 (768)
...+++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 113577788899999999999999998 9999999999999999999999999987543222
Q ss_pred CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhhccC
Q 046311 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRN 706 (768)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (768)
.........++..|+|||.+....++.++||||||+++|||++ |..|+...... ......+...
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------------~~~~~~~~~~ 298 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------------EEFCRRLKEG 298 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---------------HHHHHHHhcc
Confidence 2111122345678999999988889999999999999999997 88887532110 0111111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 707 VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 707 ~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.....+. .....+.+++.+||+.+|++||++.||++.|+++++.
T Consensus 299 ~~~~~~~--~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 299 TRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCC--CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111110 1234567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.93 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=204.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
.+|.+.+.||+|+||.||+++.. ++..||+|.+... .......++.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----------cchHHHHHHHHHHHHHHhhccCCCch
Confidence 46778899999999999999741 2457999987532 1123456789999999999 899999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++......++||||+++++|.+++..... ....+++..++.++.|+++||+|||+++ |+||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~ 161 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHR 161 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 999999999999999999999999999975421 1234578889999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |..|+.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976543332222222345678999999988889999999999999999998 677764
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... .++.+.+........ .......+.+++.+||+.+|++||++.|+++.|++++...
T Consensus 242 ~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 242 GIPV----------------EELFKLLKEGHRMDK--PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred cCCH----------------HHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 3211 111111111111111 1123456778999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.58 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||+|... ...+.+|++++++|+||||+++++++..
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 57999999999999999999865 68999999632 1246789999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++|||++. ++|.+++... ..+++...+.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeC
Confidence 999999999985 6898888643 23578889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc-----ccccccc--
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-----RNVVDFV-- 690 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~-----~~~~~~~-- 690 (768)
|++........ .......||+.|+|||++....++.++||||||++||||++|+.|+........ ..+....
T Consensus 227 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 227 GAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred Ccccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 99964322111 111234689999999999988999999999999999999999987653221100 0000000
Q ss_pred -------cchhhhhhHHh----hhccCCC-----CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 -------VPYIVRDEIHR----VLDRNVP-----PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 -------~~~~~~~~~~~----~~~~~~~-----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+......... ....... +......+....+.+|+.+||+.||++|||++|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000111 0010000 000111234567889999999999999999999986
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.73 Aligned_cols=255 Identities=21% Similarity=0.245 Sum_probs=199.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||+++.. +++.||+|+++... .........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~ 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--------LLAQETVSFFEEERDILSISNSPWIPQLQYAFQD 72 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--------hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 36888999999999999999865 68999999987431 1122345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... ..+++.....++.|++++|+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccC
Confidence 999999999999999999997542 23578888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc------cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR------LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|++......... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------- 215 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------- 215 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----------
Confidence 999754332221 122346899999999986 456789999999999999999999998643211
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.....++........+........+.+|+..|++ +|++||+++++++
T Consensus 216 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 -----KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111222111100011111234556789999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=339.11 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||||++..... ........+.+|++++..++||||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQD 72 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence 46888999999999999999875 689999999864311 112344568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 73 ENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred CCeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeec
Confidence 999999999999999999996532 3578888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcc------------------------------------cccccccccCccCccccccCCCCChhhHHHH
Q 046311 618 GLSLIGPEDDESH------------------------------------LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSF 661 (768)
Q Consensus 618 Gla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSl 661 (768)
|++.......... ......||+.|+|||++....++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9986432111000 0012358999999999998899999999999
Q ss_pred HHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC---
Q 046311 662 GVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS--- 738 (768)
Q Consensus 662 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs--- 738 (768)
||++|||++|+.||...... +....++........+........+.+|+.+|+. +|.+|++
T Consensus 226 G~il~el~~G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQ---------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHH---------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 99999999999999643211 1111111111110011111223456688899986 9999997
Q ss_pred HHHHHHH
Q 046311 739 MTEIVNS 745 (768)
Q Consensus 739 ~~evl~~ 745 (768)
++|+++.
T Consensus 290 ~~~ll~h 296 (364)
T cd05599 290 VNEIKSH 296 (364)
T ss_pred HHHHhcC
Confidence 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.56 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=172.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||+||++... +++.||||+++.... ........+.+|+.++.+++||||+++++.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~ 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--------LEKEQVGHIRAERDILVEADSLWVVKMFYSFQD 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--------HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 36888999999999999999865 689999999864311 112344578889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....+|||||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeec
Confidence 99999999999999999999753 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCC---------------------------------cccccccccccCccCccccccCCCCChhhHHHHHHH
Q 046311 618 GLSLIGPEDDE---------------------------------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664 (768)
Q Consensus 618 Gla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl 664 (768)
|+++....... ........||+.|+|||++....++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 99864321110 000123469999999999998899999999999999
Q ss_pred HHHHHcCCccccc
Q 046311 665 LLEILSGYRAIHR 677 (768)
Q Consensus 665 l~elltG~~p~~~ 677 (768)
+|||++|+.||..
T Consensus 226 l~ell~G~~Pf~~ 238 (363)
T cd05628 226 MYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.40 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=211.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...+++|+|+||.++..+.+ ++..+++|.+..... .+......++|+.++++++|||||.+.+.+.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~---------t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL---------TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc---------CchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 46888899999999999999866 678999999876532 22334477899999999999999999999988
Q ss_pred CCe-eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNE-RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
++. .++||+|++||+|.+.|.+.+ ...++...+++++.|++.++.|||++. |+|||||+.|||++.+..+||.|
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecc
Confidence 887 899999999999999998754 456788889999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+|+........ .....||+.||.||++.+.+|..|+|||||||++|||++-+++|...+..
T Consensus 150 fGlaK~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--------------- 212 (426)
T KOG0589|consen 150 FGLAKILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--------------- 212 (426)
T ss_pred hhhhhhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---------------
Confidence 9999976655422 23468999999999999999999999999999999999999999755331
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.-+.+++.....+ ........+..|+..|+..+|..||++.+++..
T Consensus 213 ~Li~ki~~~~~~P---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 213 ELILKINRGLYSP---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHhhccCCC---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122333333222 233445677889999999999999999999987
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.42 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=198.8
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+|++.+.||+|+||.||+++.+++..+|||.++.. .....+|.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC------------cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 57778899999999999999887778999987532 112356899999999999999999999999988
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++..... .+++..+++++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcc
Confidence 99999999999999999975322 3588899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......++..|++||.+....++.++||||||+++|||++ |+.||...... +.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---------------~~ 210 (256)
T cd05113 147 SRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---------------ET 210 (256)
T ss_pred ceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---------------HH
Confidence 8754332211 1112235678999999988889999999999999999999 88887543210 01
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
...+.+....... ......+.+++.+||+.+|++||++.+|++.|+
T Consensus 211 ~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 211 VEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111111111100 112356779999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.73 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=205.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC-----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD-----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.++|++.+.||+|+||.||+|...+ +..|++|++... ........+.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~ 74 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----------ASEIQVTLLLQESCLLYGLSHQNILPIL 74 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----------CCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4578888999999999999998765 688999987532 1234457789999999999999999999
Q ss_pred EEEEc-CCeeEEEEEeccCCChhhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 533 GFCED-RNERVLIYEYLENGTLHDHLHNPQSS----SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 533 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~----~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+++.. ....++++||+++++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~ 151 (280)
T cd05043 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVID 151 (280)
T ss_pred EEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEc
Confidence 98765 56789999999999999998654322 134688899999999999999999998 99999999999999
Q ss_pred CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccc
Q 046311 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNV 686 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~ 686 (768)
+++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |+.||..... .
T Consensus 152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~-- 226 (280)
T cd05043 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---F-- 226 (280)
T ss_pred CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---H--
Confidence 999999999999975433322111122345778999999988889999999999999999999 9998864321 1
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
++...+........ ....+..+.+++.+||..+|++|||+.|+++.|+++.+
T Consensus 227 -----------~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 227 -----------EMAAYLKDGYRLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----------HHHHHHHcCCCCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111111111111 11234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.05 Aligned_cols=266 Identities=22% Similarity=0.327 Sum_probs=193.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||.||+++.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----------EEGTPFTAIREASLLKGLKHANIVLLHDIIH 73 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc----------ccccchhHHHHHHHHhhCCCCCcCeEEEEEe
Confidence 467999999999999999999876 68999999886431 1122346778999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||++ ++|.+++.... ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~D 146 (303)
T cd07869 74 TKETLTLVFEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLAD 146 (303)
T ss_pred cCCeEEEEEECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECC
Confidence 9999999999996 58888886532 23567788899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh-
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI- 694 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~- 694 (768)
||++........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ....+......
T Consensus 147 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 222 (303)
T cd07869 147 FGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLG 222 (303)
T ss_pred CCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhC
Confidence 999864322211 1123457899999999864 46889999999999999999999999643210 00000000000
Q ss_pred --hhhhH---H---hhhccCCC--CCCcchH-----HHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 --VRDEI---H---RVLDRNVP--PPTPFEI-----EAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 --~~~~~---~---~~~~~~~~--~~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+.. . ........ .+..... .....+.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0 00000000 0000000 01245678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.49 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=204.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..+|+..++||+|+||.||++...++..+++|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----------LLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----------hhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 34678889999999999999998889999999875431 1234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++++... ...+++..+++++.|++++|+|||+.+ |+|+||||+|||+++++.+||+||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccc
Confidence 999999999999999999997643 233588899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++.......... ....++..|++||.+....++.++||||||+++|||++ |+.||......
T Consensus 149 g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------------- 211 (261)
T cd05148 149 GLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------------- 211 (261)
T ss_pred cchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---------------
Confidence 9997543322111 12345778999999988889999999999999999998 88888543210
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+....+. .....+ .....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 212 ~~~~~~~-~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 212 EVYDQIT-AGYRMP--CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHH-hCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111111 111111 112334567799999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.16 Aligned_cols=258 Identities=27% Similarity=0.383 Sum_probs=199.6
Q ss_pred CCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
+|++.++||+|+||.||+++.. .+..||+|+++... .......|.+|+.++..++||||+++++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----------EGPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----------CHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 3566788999999999999863 24789999876321 1223467889999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQ------------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
++...+..++++||+++++|.+++.... .....+++..+++++.|+++||+|||+++ |+||||||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp 152 (283)
T cd05091 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152 (283)
T ss_pred EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 9999999999999999999999985321 11223577888999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
+|||+++++.+||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |..|+.....
T Consensus 153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred hheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999875433322222223345789999999988889999999999999999998 7777753211
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.+-...+.+....+ .....+..+.+|+.+||+.+|++||+++||++.|+.
T Consensus 233 ---------------~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ---------------QDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------------HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11112222222111 112334567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=332.87 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=193.2
Q ss_pred ceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
++||+|+||.||+++. .+++.||||.++.... .........+.+|+++++.++||||+++++++..++.
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-------VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-------HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 6799999999999975 3578999999864311 1112234567889999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.++||||+++++|.+++... ..+.+.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999999653 23466777889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHH
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
+....... ......||+.|+|||++....++.++||||||+++|||++|+.||..... .....
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---------------~~~~~ 210 (323)
T cd05584 148 KESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---------------KKTID 210 (323)
T ss_pred eecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---------------HHHHH
Confidence 64322221 11234689999999999988899999999999999999999999864321 11122
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
.+.......+. .....+.+++.+||+.+|++|| +++++++
T Consensus 211 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 211 KILKGKLNLPP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHcCCCCCCC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22222222111 2234567899999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.04 Aligned_cols=259 Identities=28% Similarity=0.390 Sum_probs=202.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|...+.||+|+||.||+++.. .+..||||+++.. ......+.+.+|+++++++ +||||+++
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----------AHSSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----------CChHHHHHHHHHHHHHHhccCCCCcceE
Confidence 46888899999999999999742 3457999987532 1123456789999999999 79999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++++...+..+++|||+++++|.++++.... ..+++..++.++.|++.+|+|||+++ |+|+||||+|||++.++.
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~ 179 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKI 179 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCe
Confidence 9999999999999999999999999975322 23688999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 690 (768)
++|+|||++................++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------- 250 (302)
T cd05055 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------- 250 (302)
T ss_pred EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---------
Confidence 99999999875433222111122345788999999988889999999999999999998 98887543211
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+...+.+........ .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 251 ------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 ------SKFYKLIKEGYRMAQ--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------HHHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111122222111111 112235677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.06 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=196.7
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
+|++.+.||+|+||.||+++. .+++.||+|++..... .......+.+.+|+.+++++ +||||++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-------VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA 73 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-------hhhhhHHHHHHHHHHHHHhccCCCCcccEEEE
Confidence 478889999999999999975 3578999999864311 11223345688899999999 59999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+...+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 74 FQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred EecCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEE
Confidence 99999999999999999999998643 23577888899999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||+||+.||.........
T Consensus 147 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------- 216 (332)
T cd05614 147 TDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------- 216 (332)
T ss_pred eeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---------
Confidence 999999754322211 11234689999999998764 4788999999999999999999999643221100
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
..-...+....... .......+.+++.+||+.||++|| +++++++.
T Consensus 217 --~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 217 --SEVSRRILKCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --HHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00011122211111 112345567899999999999999 77788753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=339.56 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=194.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||++... +++.||||++.... .........+.+|++++++++||||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~ 72 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--------MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD 72 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--------HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 36888999999999999999865 78999999886421 1112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 73 AQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred CCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999653 23567777889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCc------------c---------------------------------cccccccccCccCccccccCCC
Q 046311 618 GLSLIGPEDDES------------H---------------------------------LSLRAAGTVGYMDPEYYRLQQL 652 (768)
Q Consensus 618 Gla~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~ 652 (768)
|+++........ . ......||+.|+|||++....+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632110000 0 0012368999999999998899
Q ss_pred CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHccccc
Q 046311 653 TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLE 732 (768)
Q Consensus 653 s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~d 732 (768)
+.++|||||||+||||++|+.||...... +....+.........+........+.+|+.+|+. +
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSH---------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHH---------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-C
Confidence 99999999999999999999999643211 0011111100000001111223456789999997 6
Q ss_pred CCCC---CCHHHHHHH
Q 046311 733 GRNR---PSMTEIVNS 745 (768)
Q Consensus 733 P~~R---Ps~~evl~~ 745 (768)
|.+| +++.|+++.
T Consensus 290 ~~~r~~r~~~~~~l~h 305 (377)
T cd05629 290 AENRLGRGGAHEIKSH 305 (377)
T ss_pred HhhcCCCCCHHHHhcC
Confidence 6665 699998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.50 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=197.4
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+|++.+.||+|+||.||++.++++..+|+|.+... .....+|.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG------------AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC------------CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 46778899999999999999887788999987532 112356889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++..... ..++...+.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccc
Confidence 99999999999999999975332 4688899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......++..|+|||.+....++.++||||||+++|||++ |+.||...... +
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~ 209 (256)
T cd05059 147 ARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----------------E 209 (256)
T ss_pred ceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----------------H
Confidence 8754322111 1111223467999999998899999999999999999999 78887643211 0
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
..+.+........+ ...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 210 ~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 210 VVESVSAGYRLYRP--KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHcCCcCCCC--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111111111111 12345677999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=324.13 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=199.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.||+|++..... ........+.+|+.++++++||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--------hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC
Confidence 4778899999999999999865 689999999864311 1122345678899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999886432 233688889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... ....|++.|+|||++....++.++||||||+++|||++|+.||....... ..++
T Consensus 148 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~------------~~~~ 212 (285)
T cd05605 148 LAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV------------KREE 212 (285)
T ss_pred CceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh------------HHHH
Confidence 98754322211 12368999999999988889999999999999999999999996432110 0011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
+...+.... ..........+.+|+.+||+.||++|| +++++++.
T Consensus 213 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRVKEDQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHhhhcc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111111111 111223455677999999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.38 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=198.2
Q ss_pred CCCCcCceeccCCceEEEEEEEcC---------------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD---------------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~---------------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 523 (768)
++|++.++||+|+||.||++.... ...||+|.+... ........|.+|+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----------VTKTARNDFLKEIKIMSRL 74 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----------CCHHHHHHHHHHHHHHHhC
Confidence 478889999999999999987532 234889987532 1223456799999999999
Q ss_pred CCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 046311 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS--------SSPLKSWPARIKVALDAARGIEYLHEYAVPSII 595 (768)
Q Consensus 524 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~iv 595 (768)
+|+||+++++++...+..++||||+++++|.+++..... .....++..+++++.|+++||+|||+++ ++
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~ 151 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FV 151 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 999999999999999999999999999999999864321 1123578889999999999999999998 99
Q ss_pred ecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc--CCc
Q 046311 596 HRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS--GYR 673 (768)
Q Consensus 596 HrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt--G~~ 673 (768)
||||||+|||+++++.+||+|||++................++..|+|||++....++.++||||||+++|||++ +..
T Consensus 152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999875433322222223345778999999988889999999999999999998 445
Q ss_pred ccccCCCCCcccccccccchhhhhhHHhhhccCCC-CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 674 AIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVP-PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 674 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
||....... ... ...+..+.... .........+..+.+|+.+||+.+|++||++.+|++.|++
T Consensus 232 p~~~~~~~~---~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 232 PYSLLSDEQ---VIE---------NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCcccChHH---HHH---------HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 554322110 000 00111110000 0000011123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.50 Aligned_cols=261 Identities=31% Similarity=0.434 Sum_probs=201.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||++..+ ++. .+++|.++.. ......+.|.+|++++.++ +||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 71 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----------ASENDHRDFAGELEVLCKLGHHPNIINLLGA 71 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----------CCHHHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence 46888899999999999999875 333 4688876521 1123346789999999999 79999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+......+++|||+++++|.++++.... ....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~ 148 (297)
T cd05089 72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAAR 148 (297)
T ss_pred EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcc
Confidence 9999999999999999999999965321 1124678889999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~ 681 (768)
|||+++++.+||+|||++........ ......+..|+|||++....++.++||||||+++|||++ |..||......
T Consensus 149 Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 149 NVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred eEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999864221111 111123567999999988889999999999999999998 98888543211
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+..+.+........ .......+.+|+.+||+.+|.+||+++++++.|++++...
T Consensus 226 ----------------~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ----------------ELYEKLPQGYRMEK--PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----------------HHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111111111 1123456779999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.42 Aligned_cols=265 Identities=29% Similarity=0.423 Sum_probs=201.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcC-----------------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD-----------------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 521 (768)
.+|++.++||+|+||.||+++... +..||+|++... ........|.+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~e~~~l~ 74 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----------ASDNAREDFLKEVKILS 74 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----------cCHHHHHHHHHHHHHHH
Confidence 478889999999999999997642 245888987532 11234567899999999
Q ss_pred cCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 046311 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS-------SSPLKSWPARIKVALDAARGIEYLHEYAVPSI 594 (768)
Q Consensus 522 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~i 594 (768)
+++||||+++++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+++ |
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---F 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---c
Confidence 99999999999999999999999999999999999975431 1124688899999999999999999998 9
Q ss_pred EecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc--CC
Q 046311 595 IHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS--GY 672 (768)
Q Consensus 595 vHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt--G~ 672 (768)
+||||||+|||++.++.++|+|||++................++..|+|||++....++.++||||||+++|||++ +.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999875443332222333456789999999988889999999999999999998 55
Q ss_pred cccccCCCCCcccccccccchhhhhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 673 RAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 673 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.|+...... ... ......+.. ......+.....+..+.+++.+||+.||++|||+.||++.|++
T Consensus 232 ~p~~~~~~~---~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 232 QPYEHLTDQ---QVI---------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCcChH---HHH---------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 666432110 000 001111000 0000001111223567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.05 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=203.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|++.++||+|+||.||+|..+ .+..||+|.+... .......++.+|+.++++++||||+++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----------ASLRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----------CCHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 457889999999999999999753 2457999976432 111234568899999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
++++.+.+..++||||+++|+|.++++.... .....++..+++++.|++.+|.|||+++ |+||||||+|||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nil 151 (288)
T cd05061 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151 (288)
T ss_pred EEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEE
Confidence 9999999999999999999999999965321 1234467778899999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPR 684 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 684 (768)
++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---- 227 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---- 227 (288)
T ss_pred EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999875433222222222345678999999988889999999999999999998 6777753211
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.+....+.+...... .......+.+++.+||+.+|++|||+.|+++.|++.+-.
T Consensus 228 -----------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 228 -----------EQVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -----------HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 011112222211111 112235678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.08 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=216.3
Q ss_pred CCCcCceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+.....+||.|-||.||.|.|+. ...||||.++.+ ....++|+.|+.+|+.++|||+|+|+|+|..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED------------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc------------chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 45566899999999999999873 578999988643 24578899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
..+|||.|||.+|+|.|||++.... .++-...+.++.||..+|+||..++ +|||||..+|+|+.++..+||+|||
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 9999999999999999999876543 3455677899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...+.+. ..........|.|||-+....++.|+|||+|||+||||.| |..||.. +...
T Consensus 411 LsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG----------------idlS 473 (1157)
T KOG4278|consen 411 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 473 (1157)
T ss_pred hhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC----------------ccHH
Confidence 99976554432 2222345788999999999999999999999999999998 6666532 2234
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
++..++++.+++..+.. +++.+.+||+.||+++|.+||+++|+-+.||.++.....
T Consensus 474 qVY~LLEkgyRM~~PeG--CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEG--CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHHHHHhccccccCCCC--CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 55666777666654433 456677999999999999999999999999998865544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=314.03 Aligned_cols=269 Identities=22% Similarity=0.293 Sum_probs=197.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC-ceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN-LVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~ 537 (768)
.|...++||+|+||+||+|+.+ +|+.||+|+++.... .+.....-.+|+.+|++|+|+| |+.|++++..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~---------~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE---------EEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc---------ccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 4556688999999999999865 789999999986522 1223445678999999999999 9999999988
Q ss_pred CC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 538 RN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 538 ~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.+ ..+|||||++. +|.+++..........+...+..++.||++||+|||+++ |+||||||.||||+++|.
T Consensus 83 ~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV 158 (323)
T ss_pred cccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence 77 78899999976 999999765432223455678899999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc------
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR------ 684 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~------ 684 (768)
+||+|||+|+...-.... ......|..|+|||++.+. .|+...||||+|||++||++++.-|.....-+..
T Consensus 159 lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 999999999865433222 2345789999999998765 7999999999999999999988877644321000
Q ss_pred ----cccccccchhhhhhHHhhhccCCCCCCcchH---HHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 685 ----NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEI---EAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 685 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+|. ....-.-.+..-.....+..... .......+++.+|++.+|.+|.|++..++.
T Consensus 237 lGtP~e~~Wp--~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWP--GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCC--CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 001111 10000000000000010111111 111356689999999999999999999886
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.41 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=201.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||++++++...||+|+++... ...++|.+|++++++++||||+++++++. .
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc------------cCHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4688899999999999999998777789999876321 12356899999999999999999999875 4
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++.... ....++..++.++.|++++|+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCC
Confidence 56799999999999999997532 234578899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||++....++.++||||||+++|||+| |+.||..... .
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----------------~ 210 (262)
T cd05071 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------R 210 (262)
T ss_pred ceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----------------H
Confidence 99754332221 1112345678999999988889999999999999999999 7777753321 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
+..+.+...... +...+.+..+.+|+.+|++.+|++||++.++++.|++.+
T Consensus 211 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 211 EVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 111111111111 112234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.12 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=199.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|.+.+.||+|+||.||++.+.+ +..|++|.+... ........|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----------CSEQDESDFLMEALIMSKFNHQNIVRL 74 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3568888999999999999998753 567888876432 122345679999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
++++.+.+..++||||+++++|.++++.... ....+++..+++++.||+++|+|||+.+ ++||||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~ 151 (277)
T cd05036 75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151 (277)
T ss_pred EEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEec
Confidence 9999999999999999999999999975432 1234688999999999999999999998 999999999999986
Q ss_pred CC---cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcc
Q 046311 609 TW---TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPR 684 (768)
Q Consensus 609 ~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 684 (768)
++ .+||+|||+++................+..|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--- 228 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--- 228 (277)
T ss_pred cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 54 699999999975432222111112233568999999988889999999999999999997 88888643211
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
++...+....... .....+..+.+++.+||+.+|++||++.||++.|+
T Consensus 229 -------------~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -------------EVMEFVTGGGRLD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------------HHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111111111 11122456778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.06 Aligned_cols=271 Identities=24% Similarity=0.329 Sum_probs=203.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
...|...+.||+|+||.|+.+..+ +|+.||||++... .......++-.+|+++|++++|+||+.+++++.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 456666789999999999999865 7899999987521 233445677889999999999999999999885
Q ss_pred c-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 D-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
. -+..|+|+|+|+ -+|...++.. ..++......+++|+++||.|+|+.+ |+||||||+|+|++.+..
T Consensus 92 p~~~~~f~DvYiV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCD 163 (359)
T ss_pred cccccccceeEEehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCC
Confidence 4 357899999995 4999999753 22567788889999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||||+...........+..+.|..|.|||++. ...|+...||||.||||.|||+|+..|...+.-.+..+....
T Consensus 164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 9999999998765432333334567899999999975 568999999999999999999999888654322211111111
Q ss_pred --------cchhhhhhHHhhhccCCC-CCCcch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 --------VPYIVRDEIHRVLDRNVP-PPTPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 --------~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+..+...+.+..... ++.++. ........+|+.+||..||.+|+|++|.++.
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111222222222111 112211 1234555699999999999999999998875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=337.13 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=198.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||+++.+ +++.||+|++..... ........+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--------IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 357889999999999999999875 688999999864211 11223455788999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++|+|.+++... .++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999998642 2466777888999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccC----CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
||++......... ......||+.|+|||++... .++.++|||||||+||||++|+.||.....
T Consensus 186 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------ 252 (370)
T cd05596 186 FGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------ 252 (370)
T ss_pred ccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------------
Confidence 9998754322211 11234689999999998643 478899999999999999999999964321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
......+++.......+.....+..+.+|+.+||+.+|++ ||+++|+++.
T Consensus 253 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 ---VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0112222222111111112223456778999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.26 Aligned_cols=266 Identities=28% Similarity=0.408 Sum_probs=198.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-----------------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-----------------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS 521 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 521 (768)
++|++.++||+|+||.||++... +...+|+|++... .......+|.+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~~~E~~~l~ 74 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----------ANKNARNDFLKEIKIMS 74 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----------CCHHHHHHHHHHHHHHH
Confidence 46889999999999999998533 2346888876532 12234568999999999
Q ss_pred cCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 046311 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-------SPLKSWPARIKVALDAARGIEYLHEYAVPSI 594 (768)
Q Consensus 522 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~i 594 (768)
.++|+||+++++++...+..++||||+++++|.+++...... ...+++...++++.|++.+|+|||+.+ |
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i 151 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---F 151 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999999999999999999999999999999999999754321 123577889999999999999999998 9
Q ss_pred EecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc--CC
Q 046311 595 IHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS--GY 672 (768)
Q Consensus 595 vHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt--G~ 672 (768)
+|+||||+|||++.++.++|+|||++.................+..|++||......++.++||||||+++|||++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999875433222122222344678999999888889999999999999999998 66
Q ss_pred cccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 673 RAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 673 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.|+....... .... . .............+ .....+..+.+|+.+||+.||++||++.||++.|++
T Consensus 232 ~p~~~~~~~~---~~~~----~-~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 232 QPYSQLSDEQ---VIEN----T-GEFFRDQGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCccccChHH---HHHH----H-HHHHhhccccccCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6765332111 0000 0 00000000000000 011123567799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=330.71 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=192.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH---HhcCCCCCceeEEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES---LSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~HpnIv~l~~~~~ 536 (768)
|++.+.||+|+||.||++..+ +++.||||+++.... ......+.+.+|+++ +++++||||+++++++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~ 72 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--------IARDEVESLMCEKRIFETANSERHPFLVNLFACFQ 72 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE
Confidence 567789999999999999865 689999999874311 111233456666555 45678999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|..+++. ..+++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 73 TEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCc
Confidence 99999999999999999998854 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 145 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------------- 207 (324)
T cd05589 145 FGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------------- 207 (324)
T ss_pred ccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---------------
Confidence 999864322211 112346899999999999889999999999999999999999998643210
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
+....+.......+. .....+.+++.+||+.||++|| ++.++++.
T Consensus 208 ~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 EVFDSIVNDEVRYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111122222222111 2245567899999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.99 Aligned_cols=269 Identities=26% Similarity=0.397 Sum_probs=201.3
Q ss_pred CCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
|+..+.||+|+||+||++.. .++..||+|.++... .......|.+|++++++++||||+++++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----------GQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 37889999999999988653 357889999875421 123456788999999999999999999987
Q ss_pred EcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 536 EDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 536 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
... ...+++|||+++++|.+++... .+++..++.++.|++++|+|||+++ |+||||||+|||+++++.+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~ 147 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVK 147 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEE
Confidence 654 4578999999999999999642 3688999999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++......... .......++..|+|||.+....++.++||||||+++|||+||+.|+....... .........
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~ 226 (283)
T cd05080 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG 226 (283)
T ss_pred EeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc
Confidence 9999998754432211 11112235677999999988889999999999999999999999976432211 011111111
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
..........++.....+ .....+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 QMTVVRLIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccchhhhhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111222222222111 11223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.10 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=198.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||+++.. +++.+|+|.+.... .........+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE--------MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--------hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 467999999999999999999876 67899999986421 111223456889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+++..++||||+++|+|.+++... .++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999642 2467788899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccC----CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
||++......... ......||+.|+|||++... .++.++||||||++||||++|+.||.....
T Consensus 186 FG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------ 252 (370)
T cd05621 186 FGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------ 252 (370)
T ss_pred cccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------
Confidence 9999754322211 11234699999999998754 378899999999999999999999964321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
.....++++.......+........+.+++..|+..++.+ |+++.|+++.
T Consensus 253 ---~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 ---VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1112223322211111222234556678899999755543 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.44 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=201.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcC------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|++.+.||+|+||.||++.... +..||+|.+... ........|.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----------ASMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----------cCHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 468888999999999999998642 368999986432 1123345788999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSS------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl 606 (768)
+++......++||||+++++|.+++...... ...+++..++.++.|++.+|.|||+.+ |+||||||+|||+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill 152 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMV 152 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEE
Confidence 9999999999999999999999999653221 223578889999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccc
Q 046311 607 DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRN 685 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 685 (768)
+.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||+| |+.||...... .
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~ 229 (277)
T cd05032 153 AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---E 229 (277)
T ss_pred cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---H
Confidence 9999999999999875433322222223346789999999988889999999999999999998 88887532211 0
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
......+..... .+ ...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 230 ------------~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 ------------VLKFVIDGGHLD-LP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------------HHHHHhcCCCCC-CC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 011111111111 11 112456779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.15 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=199.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|++.+.||+|+||.||++..+ +++.||+|++... .....+.|.+|++++++++||||+++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 72 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----------TAEHLRDFEREIEILKSLQHDNIVKYKG 72 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 46788899999999999999742 5789999987532 1234567899999999999999999999
Q ss_pred EEEc--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 534 FCED--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 534 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++.. ....++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~ 146 (284)
T cd05081 73 VCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENR 146 (284)
T ss_pred EEccCCCCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCe
Confidence 8754 346789999999999999996532 23588899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcc-cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESH-LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++.......... ......++..|+|||++....++.++||||||+++|||++|..++...............
T Consensus 147 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 9999999997654322211 111122345699999998888999999999999999999987665322110000000000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
........+.+.+......+. .......+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccchHHHHHHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000001112222222221111 112345677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.21 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=203.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
.+|++.+.||+|+||.||++... ....||+|.++.. .......++.+|+++++++ +||||+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----------ATDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----------cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 36888899999999999999742 1236899976532 1223456889999999999 899999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++...+..+++|||+++++|.+++..... ....+++..++.++.|+++||+|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~ 158 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHR 158 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 999999999999999999999999999865321 1234678889999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999875433222111122234568999999998889999999999999999998 777775
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... ++..+.+........ .......+.+++.+||+.+|++||++.|+++.|++++...
T Consensus 239 ~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 239 GIPV----------------EELFKLLKEGHRMDK--PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCH----------------HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 3211 111111111111111 1122346779999999999999999999999999998655
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.06 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=193.2
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
+.||+|+||.||+++.. +++.||+|.++.... ........+.+|+++++.++||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEE
Confidence 46999999999999864 789999999864311 112344677889999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
||||+++++|.+++... ..+++.....++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++..
T Consensus 73 v~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 73 VMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 99999999999988643 235788889999999999999997 56 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||++||||+||+.||...... .....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---------------~~~~~i 208 (325)
T cd05594 146 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------KLFELI 208 (325)
T ss_pred cCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---------------HHHHHH
Confidence 322211 112346899999999999889999999999999999999999998643210 011111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
.......+. .....+.+|+.+||+.||++|+ ++.|+++.
T Consensus 209 ~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LMEEIRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111111111 1234567899999999999996 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.19 Aligned_cols=262 Identities=33% Similarity=0.478 Sum_probs=201.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|.++ ++. .+++|+++.. ........|.+|++++.++ +||||++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 46788899999999999999865 454 3566665421 1233456788999999999 89999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+.+.+..++||||+++++|.++++.... ....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~ 153 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 153 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchh
Confidence 9999999999999999999999975421 1234678899999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~ 681 (768)
|||++.++.+||+|||++........ ......+..|+|||++....++.++||||||+++|||+| |..||......
T Consensus 154 Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 154 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred eEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999999999863221111 111234678999999988889999999999999999998 99888533211
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
+..+.+........+ ......+.+|+.+||+.+|++||++.++++.|++++....
T Consensus 231 ----------------~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 231 ----------------ELYEKLPQGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----------------HHHHHHhcCCcCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 011111111111111 1123456789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.23 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=200.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|+..++||+|+||+||+|++. +++ .||+|.++.. .......++.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----------TSPKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----------CCHHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 46888899999999999999854 444 4789987532 12234567889999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++... ..+++|||+++|+|.++++... ..+++...+.++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 77 ~~~~~-~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 77 ICLTS-TVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred EEcCC-CcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEE
Confidence 98754 5789999999999999997532 23578889999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------ 217 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------------ 217 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999999976543222111112234678999999988889999999999999999998 8888753221
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..+...+......+. .......+.+++.+||+.||++||++.|+++.|+++....
T Consensus 218 ----~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 218 ----REIPDLLEKGERLPQ--PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----HHHHHHHHCCCcCCC--CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111211111111 1123456778999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.58 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=199.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||++..+++..+|+|.+.... .....|.+|+.++++++|+|++++++++. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT------------MSPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC------------CCHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 3678889999999999999998888899999876431 12356899999999999999999999875 4
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...+++|||+++++|.++++... ...+++..+++++.|++.+|+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCce
Confidence 56889999999999999997532 233588899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||++....++.++||||||+++|||++ |+.||..... .
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----------------~ 210 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----------------R 210 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----------------H
Confidence 99754332211 1112235668999999988889999999999999999999 8888853221 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+..+.+......+ .....+..+.+|+.+||+.+|++|||++++.+.|++
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 EVLEQVERGYRMP--CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111122211111 112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.06 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=202.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++-+.||+|.|+.||+.... +|+.+|+|.+...... ....+++.+|+++.+.|+||||++|.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---------~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---------ARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---------cccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 356777789999999999999654 7999999988755322 235677899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~k 613 (768)
+....|||+|+|.|++|..-|-.. ...++...-..+.||+++|.|+|.++ |||||+||+|+||- ..--+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCcee
Confidence 999999999999999998766432 22344555677899999999999999 99999999999994 334689
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++...... ......+|||.|||||+++..+|+..+|||+-||+||-||.|+.||......
T Consensus 154 L~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------------ 218 (355)
T KOG0033|consen 154 LADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------ 218 (355)
T ss_pred ecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------------
Confidence 9999999866522 2233568999999999999999999999999999999999999999753321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+-.+.++...+..+.+.-....+...+|+++||..||.+|.|+.|.++
T Consensus 219 ---rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 219 ---RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 112334444444333333445566678999999999999999988764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=351.90 Aligned_cols=268 Identities=23% Similarity=0.337 Sum_probs=206.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+|... +++.||||++.... ...+...++|.+|++++++++||||+++++++.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee
Confidence 57889999999999999999875 68999999986421 1122345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQS-------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.+..+++|||+++++|.+++..... .....++...++++.||++||+|||+++ |+||||||+|||++.++
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg 150 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFG 150 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCC
Confidence 9999999999999999999864211 1123456778899999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCC----------------cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcc
Q 046311 611 TAKVSDFGLSLIGPEDDE----------------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p 674 (768)
.+||+|||++........ ........||+.|||||++.+..++.++||||||+++|||+||+.|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999975421110 0011124689999999999988999999999999999999999999
Q ss_pred cccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCC-CCHHHHHHHHHHHHhhc
Q 046311 675 IHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR-PSMTEIVNSLERALAAC 753 (768)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Ps~~evl~~L~~~l~~~ 753 (768)
|....... ... . ....+.. ......+.+..+.+++.+|++.||++| ++++++++.|+..++..
T Consensus 231 F~~~~~~k---i~~-------~---~~i~~P~---~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 231 YRRKKGRK---ISY-------R---DVILSPI---EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred CCCcchhh---hhh-------h---hhccChh---hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 86532110 000 0 0000000 000011334567789999999999999 57888889999887654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.54 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=192.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|+||.||+++.. +++.||+|++..... ........+.+|++++++++||||+++++.+.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--------LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC
Confidence 5888999999999999999865 688999998864311 1123456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... .++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECC
Confidence 99999999999999999996532 3467777889999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCC---------------------------------------------CcccccccccccCccCccccccCCCC
Q 046311 619 LSLIGPEDD---------------------------------------------ESHLSLRAAGTVGYMDPEYYRLQQLT 653 (768)
Q Consensus 619 la~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s 653 (768)
++....... .........||+.|+|||++....++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 975221000 00001123689999999999988999
Q ss_pred ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccC
Q 046311 654 EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEG 733 (768)
Q Consensus 654 ~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP 733 (768)
.++|||||||+||||++|+.||...... +...+++........+........+.+++.+++ .+|
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPL---------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHH---------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 9999999999999999999999643211 111111111111001111122344556777765 599
Q ss_pred CCCCC---HHHHHH
Q 046311 734 RNRPS---MTEIVN 744 (768)
Q Consensus 734 ~~RPs---~~evl~ 744 (768)
++|++ +.|+++
T Consensus 291 ~~R~~~~~~~ei~~ 304 (382)
T cd05625 291 EDRLGKNGADEIKA 304 (382)
T ss_pred hHcCCCCCHHHHhc
Confidence 99987 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=312.45 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=202.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+++.+ +++.|++|.+.... .......++.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 4677789999999999999875 68999999886431 1133456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.++++... ...+++..+++++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~ 146 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLG 146 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccc
Confidence 99999999999999999997642 234678888999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....+++.|+|||++....++.++|+||||+++|||++|+.||...... ..
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~ 209 (256)
T cd08529 147 VAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---------------AL 209 (256)
T ss_pred cceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------------HH
Confidence 98754432221 12335788999999999888999999999999999999999998643210 11
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.........+. ........+.+++.+||+.+|++||++.|+++.
T Consensus 210 ~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 ILKIIRGVFPP---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHcCCCCC---CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11222222111 111334567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.61 Aligned_cols=259 Identities=30% Similarity=0.419 Sum_probs=201.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|+..+.||+|+||.||++..+ ++..+|+|.+... .......+|.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----------cCHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 56888899999999999999863 4678999987532 1123456799999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS------------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSI 594 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~i 594 (768)
+++.+.+..+++|||+++++|.+++..... ....+++..++.++.|++.+|+|||+.+ +
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i 151 (288)
T cd05050 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---F 151 (288)
T ss_pred EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999999964221 1123578888999999999999999998 9
Q ss_pred EecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCc
Q 046311 595 IHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYR 673 (768)
Q Consensus 595 vHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~ 673 (768)
+||||||+|||++.++.++|+|||++.................+..|+|||.+....++.++||||||+++|||++ |..
T Consensus 152 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875433222111222234678999999988899999999999999999998 777
Q ss_pred ccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 674 AIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 674 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
||..... .+....+.+....+. ....+..+.+|+.+||+.+|++|||+.|+++.|++
T Consensus 232 p~~~~~~---------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 232 PYYGMAH---------------EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCH---------------HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7743211 011111222221111 11234567789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=338.48 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=194.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||++..... ........+.+|++++++++||||+++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--------LMRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--------HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 36889999999999999999865 689999998864211 112234668899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..++......++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999653 23567777888999999999999998 999999999999999999999999
Q ss_pred cccccCCCCC-----------------------------------------CcccccccccccCccCccccccCCCCChh
Q 046311 618 GLSLIGPEDD-----------------------------------------ESHLSLRAAGTVGYMDPEYYRLQQLTEKS 656 (768)
Q Consensus 618 Gla~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~s 656 (768)
|++....... .........||+.|||||++....++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 9974221000 00001124689999999999988999999
Q ss_pred hHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCC
Q 046311 657 DVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736 (768)
Q Consensus 657 DVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 736 (768)
|||||||++|||++|+.||....... ....+.........+...+....+.+++.+|+ .+|.+|
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTPAE---------------TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCHHH---------------HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999999999996432210 01111110000000111122344557777766 599999
Q ss_pred C---CHHHHHHH
Q 046311 737 P---SMTEIVNS 745 (768)
Q Consensus 737 P---s~~evl~~ 745 (768)
+ ++.|+++.
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.16 Aligned_cols=258 Identities=29% Similarity=0.507 Sum_probs=201.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC---eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~---~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|+..+.||+|+||.||+++.. ++. .+++|.++.. .......+|.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----------YTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----------CCHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 46777899999999999999875 333 6899987532 112345678999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+ |+|+||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl 148 (268)
T cd05063 75 VTKFKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKV 148 (268)
T ss_pred EccCCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEE
Confidence 999999999999999999999996532 23578889999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccc-cccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLS-LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++............ .....+..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------------ 216 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------------ 216 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------------
Confidence 999998754332211111 11123567999999988889999999999999999997 9999854321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.+..+.+......+. ..+....+.+++.+||+.+|++||++.+|++.|++++
T Consensus 217 ----~~~~~~i~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 217 ----HEVMKAINDGFRLPA--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ----HHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111111111111 1223456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.42 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=193.3
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||.||++..+ +++.+|+|++..... ........+..|++++++++||||+++++++.+....++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--------KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVM 72 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh--------hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEE
Confidence 799999999999865 689999999864311 11123345667999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++++|.+++..... ...++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 73 e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 73 SLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred ecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 99999999998865322 23578888999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhcc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (768)
... .....++..|+|||++....++.++||||||+++|||++|+.||........ ........+..
T Consensus 148 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-----------~~~~~~~~~~~ 213 (277)
T cd05607 148 GKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-----------KEELKRRTLED 213 (277)
T ss_pred Cce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-----------HHHHHHHhhcc
Confidence 221 1234689999999999888899999999999999999999999864321100 00111122222
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
..... .......+.+|+.+||+.||++||+++|+++.+.
T Consensus 214 ~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 214 EVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 21111 1123455779999999999999999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.43 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=199.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||++..+++..+++|++.... ...+.|.+|++++++++|||++++++++. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT------------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC------------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3578889999999999999998877789999865321 12356889999999999999999999875 4
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.++++... ....++..++.++.|++.+|+|||+.+ |+|+||||+|||+++++.++|+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCc
Confidence 56789999999999999997532 233588899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||.+....++.++||||||+++|||+| |+.||......
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------------- 210 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---------------- 210 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------
Confidence 99754322211 1112235678999999988889999999999999999999 88888643210
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+..+.+....... .....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 EVLEQVERGYRMP--CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHcCCCCC--CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111111111 112345667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.73 Aligned_cols=239 Identities=26% Similarity=0.320 Sum_probs=189.0
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.+ +++.||||+++... ...+.....+.+|..++..+ +||||+++++++...+..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 72 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--------ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF 72 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--------HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEE
Confidence 46999999999999875 68899999986431 11223455677888888876 7999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 iv~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 999999999999998653 23577888899999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------------~~~~~i 208 (320)
T cd05590 146 GIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---------------DLFEAI 208 (320)
T ss_pred cCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------------HHHHHH
Confidence 322211 112346899999999999889999999999999999999999999643210 111122
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
.......+. .....+.+++.+||+.||++||++
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 209 LNDEVVYPT----WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHcccCHHHCCCC
Confidence 222222111 233556789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.46 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=199.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.+|+..++||+|+||.||++... ++..+++|.+... .......|.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------SESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----------CHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 35777899999999999999642 3567888876532 223456799999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS-----------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
+++.+....+++|||+++++|.+++..... ....+++..++.++.|++.+|+|||+.+ |+||||||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp 150 (280)
T cd05092 74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLAT 150 (280)
T ss_pred EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccH
Confidence 999999999999999999999999975421 1124678899999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
+|||+++++.+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 151 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred hhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 999999999999999999875433222122222345788999999988899999999999999999998 8888754321
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
. +......... .... ....+..+.+|+.+||+.||++||+++||++.|+
T Consensus 231 ~---------------~~~~~~~~~~-~~~~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 T---------------EAIECITQGR-ELER--PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H---------------HHHHHHHcCc-cCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 1111111111 1111 1122355779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.07 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=192.7
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
++||+|+||.||+++.. +++.||||+++.... ..+.....+..|.+++..+ +||||+++++++.+.+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~ 72 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF 72 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEE
Confidence 36999999999999876 578999999864311 1223445677888888866 8999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 9999999999999886432 3577888899999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------------~~~~~i 208 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------------DLFESI 208 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---------------HHHHHH
Confidence 322221 112346899999999999889999999999999999999999999643211 111222
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-------CHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-------SMTEIVNS 745 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-------s~~evl~~ 745 (768)
.......+. .....+.+++.+||+.||++|| +++++++.
T Consensus 209 ~~~~~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHDDVLYPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 222221111 1234567899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.17 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=194.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~ 537 (768)
+|++.+.||+|+||.||+++.+ +++.||||++..... ......+.+..|.+++..++| ++|+++++++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 72 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Confidence 4778899999999999999876 578999999864311 122345678889999999976 568889999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 73 MDRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeec
Confidence 99999999999999999998643 23577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......||+.|+|||++....++.++||||||+++|||+||+.||..... .+
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---------------~~ 208 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---------------DE 208 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 99864322111 11234689999999999988999999999999999999999999864321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 744 (768)
....+.......+. .....+.+++.+||+.||++|++. +++++
T Consensus 209 ~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 209 LFQSIMEHNVSYPK----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11222222222111 223456789999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.51 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=189.1
Q ss_pred ceeccCCceEEEEEEEcC---CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 465 HKIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~---g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
+.||+|+||.||+|...+ +..+++|.++... .......|.+|+.++++++||||+++++++.+....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc
Confidence 359999999999998653 4578999875431 123345789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQS-SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
++||||+++|+|.++++.... .....++...++++.|++++|+|||+.+ ++||||||+||+++.++++||+|||++
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccc
Confidence 999999999999999975332 1223466777889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccCccccccC-------CCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-------QLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
................++..|+|||++... .++.++||||||+++|||++ |+.||....... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~---- 220 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLT---- 220 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHH----
Confidence 754333222222234567889999998632 35789999999999999996 999986432211 000
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
...... ....+.+. ........+.+++..|+ .+|++|||++||++.|+
T Consensus 221 ~~~~~~-----~~~~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YTVREQ-----QLKLPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhhcc-----cCCCCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000 00111110 01112344667899998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.02 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=200.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...+.||+|+||.||++... +++.+++|.+...... .........+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS------PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence 46888999999999999999864 6899999988653211 1112234678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..++.....+++.|++.+|.|||+.+ |+|+||||+||++++++.++|+||
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999998643 23567788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCccc-ccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHL-SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........... .....++..|+|||++....++.++||||||+++|||++|+.||......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------- 213 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------------- 213 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---------------
Confidence 99865432211111 12335788999999999888999999999999999999999998642110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
............. .........+.+++.+||..+|++||++.|+++.
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 AAIFKIATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhccCCCC--CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111111111111 1112334567789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.25 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=187.7
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc-CCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR-LHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.+ +++.||||.++.... ..+.....+..|..++.. .+||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~ 72 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--------LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 36999999999999875 578999999874311 112233455666666665 48999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++|+|.+++.... .++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 9999999999999986532 3577788899999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +....+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---------------~~~~~i 208 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---------------ELFDSI 208 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Confidence 33222 1122346899999999999888999999999999999999999998643210 011111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH-HHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT-EIVN 744 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 744 (768)
.......+ ......+.+++.+||+.+|++||++. ++++
T Consensus 209 ~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 209 LNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11111111 11234567899999999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=311.27 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=193.1
Q ss_pred eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 466 KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
+||+|+||.||+|.++ ++..+|+|+++... ......++|.+|+.++++++||||+++++++. .+..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 71 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---------NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWM 71 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcE
Confidence 5899999999999653 57889999875331 12234567899999999999999999999875 45678
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ...++...++++.|++.+|+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~ 144 (257)
T cd05116 72 LVMELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 144 (257)
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccc
Confidence 999999999999999643 23578889999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHH
Q 046311 623 GPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
....... .......++..|+|||.+....++.++||||||+++|||++ |+.||...... ++.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~ 208 (257)
T cd05116 145 LGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----------------EVT 208 (257)
T ss_pred cCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence 4332211 11112234678999999988889999999999999999998 99888643211 111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
..++....... ....+..+.+++.+||+.||++||++.+|.+.|++
T Consensus 209 ~~i~~~~~~~~--~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 209 QMIESGERMEC--PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHCCCCCCC--CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12222111111 11234567799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=312.44 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=200.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||++..++++.||+|.+... .....+|.+|+.++++++|+||+++++++. .
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG------------SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCC------------CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 468888999999999999999888899999987532 123457899999999999999999999874 4
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++.... ...+++...+.++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCc
Confidence 57899999999999999986533 234578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------------- 210 (260)
T cd05067 148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---------------- 210 (260)
T ss_pred ceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----------------
Confidence 98754422211 1112235678999999988889999999999999999999 99988643210
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+..+.+......+. ....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 211 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 EVIQNLERGYRMPR--PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHcCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111111111111 11223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.48 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=192.2
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.+ +++.||+|+++.... ........+.+|+.++.++ +||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--------cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEE
Confidence 46999999999999875 678999999875311 1123445678888888776 8999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 999999999999988643 23578888999999999999999998 99999999999999999999999999874
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH-Hh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI-HR 701 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 701 (768)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ...+.+ ..
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~-------~~~~~~~~~ 216 (329)
T cd05618 146 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQV 216 (329)
T ss_pred ccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc-------ccHHHHHHH
Confidence 322111 11234689999999999988999999999999999999999999964221110000 000111 11
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC------HHHHHHH
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS------MTEIVNS 745 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~evl~~ 745 (768)
+.......+. .....+.+|+.+||+.||++||+ +.++++.
T Consensus 217 i~~~~~~~p~----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 217 ILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HhcCCCCCCC----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2222222111 22345678999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.80 Aligned_cols=240 Identities=26% Similarity=0.356 Sum_probs=186.6
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHH-HHhcCCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE-SLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||+||+++.. +++.||||++..... .......++.+|.. +++.++||||+++++.+.+.+..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~ 72 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--------LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE
Confidence 46999999999999875 689999999864311 11122344555554 567899999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 73 FVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 999999999999998653 23577788889999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||..... .+....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---------------~~~~~~i 208 (323)
T cd05575 146 GIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---------------AEMYDNI 208 (323)
T ss_pred cccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---------------HHHHHHH
Confidence 322211 12234689999999999988999999999999999999999999864321 0111222
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 740 (768)
+........ .....+.+++.+||+.||++||+++
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 209 LNKPLRLKP----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HcCCCCCCC----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 222221111 1245567899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=321.16 Aligned_cols=264 Identities=27% Similarity=0.423 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
++|.+.++||+|+||.||+++.. ....+|+|.++.. .......++.+|+++++++ +||||+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----------ATDKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----------CChHHHHHHHHHHHHHHhccCCCCee
Confidence 46788899999999999999742 2457899987532 1123456788999999999 699999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++.+....+++|||+++++|.+++..... ....+++..+++++.|++.+|.|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~ 158 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHR 158 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 999999999999999999999999999965321 1234688889999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999975443222111112234567999999988889999999999999999999 787775
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... .+..+.+........ .......+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 239 ~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 239 GIPV----------------EELFKLLREGHRMDK--PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCH----------------HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 3211 011111111111111 1122345678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=317.02 Aligned_cols=272 Identities=26% Similarity=0.373 Sum_probs=200.7
Q ss_pred CCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.|++.+.||+|+||.||+++. .++..||+|.++... .......+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------GGNHIADLKKEIEILRNLYHENIVKYKGI 74 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----------cHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 467889999999999999974 357889999875321 12344679999999999999999999999
Q ss_pred EEcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 535 CEDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 535 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
+.+. ...++||||+++++|.+++.... ...++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 75 CTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQV 148 (284)
T ss_pred EecCCCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCE
Confidence 8775 56889999999999999986432 23688999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 613 KVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
||+|||++......... .......++..|+|||.+....++.++||||||+++|||+|++.|.................
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence 99999998754332211 11123346778999999988889999999999999999999876543211100000000000
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
... .....+.+......+ .....+..+.+|+.+||+.+|++||++.++++.|++++
T Consensus 229 ~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 229 QMT-VTRLVRVLEEGKRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred ccc-HHHHHHHHHcCccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 000 001111111111111 11123456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.29 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=195.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 537 (768)
+|++.+.||+|+||.||++... +++.||||.++.... ........+..|..++..+ +|++|+++++++.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--------IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT 72 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence 4778899999999999999876 578999999864311 1123345567788888777 68999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccC
Confidence 99999999999999999998643 23577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......||+.|+|||++....++.++|||||||++|||+||+.||...... .
T Consensus 146 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------------~ 208 (323)
T cd05616 146 GMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------------E 208 (323)
T ss_pred CCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---------------H
Confidence 99874322211 112346899999999999999999999999999999999999999643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 744 (768)
....+.......+. .....+.+++.+||+.+|++|++. .++++
T Consensus 209 ~~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 209 LFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHHHHhCCCCCCC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 11222222222222 234556789999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.37 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=199.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CC---CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g---~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
.|++.+.||+|+||.||+|... ++ ..||||.++.. ..+....+|.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 4777899999999999999865 33 35999987532 1234457899999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+++ ++|+||||+|||++.++.+||+
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEEC
Confidence 99999999999999999999997532 23588899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCccccc-cc--ccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccccccc
Q 046311 616 DFGLSLIGPEDDESHLSL-RA--AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~-~~--~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 691 (768)
|||++............. .. ..+..|+|||.+....++.++||||||+++|||++ |..||......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---------- 218 (269)
T cd05065 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------- 218 (269)
T ss_pred CCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----------
Confidence 999986543322111111 11 12457999999998899999999999999999986 98888643211
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+..+.+......+. ..+.+..+.+++.+||+.+|++||++++|+..|+++
T Consensus 219 ------~~~~~i~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 ------DVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------HHHHHHHcCCcCCC--cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111111111111 112345577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=329.28 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=190.3
Q ss_pred ceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
+.||+|+||.||+++. .+++.+|+|+++.... .......+.+|++++++++||||+++++++.+.+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE
Confidence 5799999999999874 3578999999864311 11233467789999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.++||||+++++|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 145 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 145 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCC
Confidence 99999999999999999642 23578889999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHH
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
........ ......||+.|+|||++....++.++||||||+++|||++|+.||..... .+...
T Consensus 146 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---------------~~~~~ 208 (318)
T cd05582 146 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---------------KETMT 208 (318)
T ss_pred cccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---------------HHHHH
Confidence 75433211 11234689999999999888899999999999999999999999864321 01111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 741 (768)
.+.......+. .....+.+|+.+||+.||++||++.+
T Consensus 209 ~i~~~~~~~p~----~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 209 MILKAKLGMPQ----FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22222221111 22345678999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.24 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=202.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.++||+|+||.||++..+++..++||.+.... ...+++.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT------------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc------------cCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 35788899999999999999998888899999876421 234578999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++.... ...+++..++.++.+++.+|.|||+++ |+|+||||+||+++.++.+||+||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcc
Confidence 899999999999999999997643 234688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........ ........+..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------------- 211 (261)
T cd05034 148 GLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------------- 211 (261)
T ss_pred ccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---------------
Confidence 99875433211 11112234578999999998889999999999999999999 88888532110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
.....+.. ......+ ...+..+.+++.+|++.+|++||+++|+.+.|++
T Consensus 212 ~~~~~~~~-~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 212 EVLEQVER-GYRMPRP--PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHc-CCCCCCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11111111 1111111 1124567799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.14 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=195.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...++||+|+||.||+++.+ +++.||+|+++.... ......+.+|++++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----------EGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc----------CCcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46888999999999999999865 678899999864321 1223457789999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..++||||+++ +|.+++.... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Df 148 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADF 148 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 9999999999975 8888886532 23577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc-------
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF------- 689 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~------- 689 (768)
|++......... .....+++.|+|||++.. ..++.++||||||+++|||+||+.||......+.......
T Consensus 149 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (309)
T cd07872 149 GLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226 (309)
T ss_pred ccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 998753322211 123357899999998864 4688999999999999999999999865432111000000
Q ss_pred -ccchhhhhhHHhhhccCCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 -VVPYIVRDEIHRVLDRNVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.++.+... .+..+...+... .........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 227 ETWPGISSN--DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhhhcch--hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 000000011000 001123455679999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.14 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=189.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|...+++|.|+||.||+|.+. +++.||||+...+.. ---+|+++|++++|||||+|+-+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------------~knrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------------YKNRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------------cCcHHHHHHHhcCCcCeeeEEEEEEec
Confidence 4666789999999999999875 579999998754321 112599999999999999999988643
Q ss_pred C-----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-CcE
Q 046311 539 N-----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTA 612 (768)
Q Consensus 539 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~~~ 612 (768)
. ...||||||+. +|.++++........++.....-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+
T Consensus 90 ~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred CCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeE
Confidence 3 23479999987 999999743222233444555678899999999999988 9999999999999976 999
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc-
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV- 690 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~- 690 (768)
||+|||.|+.....+... ...-|..|+|||++.+ ..|+.+.||||.|||+.||+-|+.-|...+..+. ++...
T Consensus 166 KicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik 240 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIK 240 (364)
T ss_pred EeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHH
Confidence 999999998655444332 2245889999999875 5899999999999999999999988875433221 11111
Q ss_pred -cchhhhhhHHhhh-------ccCCCCCC---cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 -VPYIVRDEIHRVL-------DRNVPPPT---PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 -~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.-.-.++++..+- .+.+.... -.......++.+|+.++++.+|.+|.++.|++..
T Consensus 241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000011111111 00111000 0222345667799999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.82 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=194.8
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 544 (768)
+.||+|+||.||++..+++..+|+|.+... ........|.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED----------LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc----------CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 369999999999999888899999987532 1123345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCC
Q 046311 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624 (768)
Q Consensus 545 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~ 624 (768)
|||+++++|.+++.... ..+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 99999999999986532 23578899999999999999999998 9999999999999999999999999986433
Q ss_pred CCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 625 EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
..... ......++..|+|||++....++.++||||||+++|||++ |..||...... .....+
T Consensus 145 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----------------~~~~~~ 207 (250)
T cd05085 145 DGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----------------QAREQV 207 (250)
T ss_pred ccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHHH
Confidence 22111 1111234677999999988889999999999999999998 88888533210 011111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
........ ....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 208 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMSC--PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCCC--CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11111111 1123456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.43 Aligned_cols=252 Identities=34% Similarity=0.482 Sum_probs=193.8
Q ss_pred ceeccCCceEEEEEEEc-CCC--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATLD-DGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 540 (768)
+.||+|+||.||+++++ ++. .+++|.++.. ........|.+|++++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence 35899999999999875 343 4678876421 1223456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 541 RVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
.+++|||+++++|.++++.... ....+++..++.++.|++.+|+|||+.+ ++||||||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcC
Confidence 9999999999999999975321 1224678899999999999999999988 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~ 687 (768)
++.+||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||......
T Consensus 148 ~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------ 218 (270)
T cd05047 148 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ 218 (270)
T ss_pred CCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------
Confidence 9999999999985322111 1111234567999999988889999999999999999997 98888532210
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
+..+.+........ .......+.+|+.+||+.+|.+|||+.|+++.|++++
T Consensus 219 ----------~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ----------ELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------HHHHHHhCCCCCCC--CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111111111111 1122345779999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=313.68 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=200.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-C---CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-D---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~---g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|+.. + ...+|+|.++.. ......+.|.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----------YTEKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 46788899999999999999864 2 336899987532 112345688999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+...+..++||||+++++|.+++.... ..+++...++++.|++.+|+|||+++ |+||||||+|||++.++.++|
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l 147 (267)
T cd05066 74 VTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKV 147 (267)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEe
Confidence 999999999999999999999997532 23588889999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCccc-ccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHL-SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++........... .....++..|++||.+....++.++|+||||+++|||++ |+.||......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----------- 216 (267)
T cd05066 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----------- 216 (267)
T ss_pred CCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----------
Confidence 99999975433221111 111223568999999998889999999999999999887 99888643211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+....+.+. ...+. ....+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 217 ----~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 ----DVIKAIEEG-YRLPA--PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----HHHHHHhCC-CcCCC--CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011111111 11111 112345667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.88 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=193.1
Q ss_pred eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 466 KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
.||+|+||.||+|.+. .+..||+|++... ......+.|.+|+.++++++||||+++++++. .+..+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~ 70 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALM 70 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc----------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeE
Confidence 3899999999999764 3557999987532 11234467999999999999999999999875 45789
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++.... ..+++..+++++.|++++|+|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 71 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred EEEEeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccc
Confidence 9999999999999996432 34688899999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcc-cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHH
Q 046311 623 GPEDDESH-LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 623 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
........ ......++..|+|||.+....++.++||||||+++|||++ |+.||...... +..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~ 208 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----------------EVM 208 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHH
Confidence 43322211 1111233578999999988889999999999999999996 99988643211 111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
..+....+... .......+.+++.+||..+|++||++.+|.+.|+.+.
T Consensus 209 ~~~~~~~~~~~--~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 209 SFIEQGKRLDC--PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHCCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 12222111111 1122456778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.64 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=211.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 535 (768)
...|++.+.||+|.||.||+++.+ +|+.+|+|.++.... ........+.+|+.+|+++. ||||+.+.+.|
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~--------~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKL--------RGKEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhc--------cccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 356888899999999999999876 599999999875422 11224568899999999998 99999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC----CCc
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA----TWT 611 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~----~~~ 611 (768)
++....++|||++.||.|++.+... ..++.....++.|++.++.|||+.+ |+||||||+|+|+.. ++.
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCc
Confidence 9999999999999999999999764 2678888999999999999999998 999999999999954 357
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+|++|||++....... .....+||+.|+|||++....|+...||||+|+++|.|++|..||.......
T Consensus 178 ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------- 245 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------- 245 (382)
T ss_pred EEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---------
Confidence 9999999998766522 2235689999999999999999999999999999999999999997653311
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+....+....+........+.+++..++..||.+|+|+.++++.
T Consensus 246 ------~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 246 ------IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 122344444443444445567778899999999999999999999984
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.82 Aligned_cols=258 Identities=21% Similarity=0.246 Sum_probs=197.2
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
...++|++.+.||+|+||.||+++.+ +++.+|+|++.... .........+.+|+.+++.++||||+++++.
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~--------~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--------MIKRSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH--------hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34578999999999999999999876 68899999986421 1112234567889999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+....++||||+++|+|.+++... .++......++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999642 2466777889999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccC----CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ----QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+|||++........ .......||+.|+|||++... .++.++|||||||+||||++|+.||......
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------- 253 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------- 253 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------
Confidence 99999975432221 111234699999999998754 3789999999999999999999999643210
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
....+++........+........+.+++.+|+..++.+ ||+++|+++.
T Consensus 254 ------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 254 ------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111222221111111111233455678999999844433 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.61 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=193.5
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..++.++ +||||+++++++.+.+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~ 72 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE
Confidence 46999999999999875 688999999874311 1223445688899999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999999999999988643 23688889999999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc--ccccccccchhhhhhHH
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP--RNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 700 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||+....... ....++. ..
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~ 215 (329)
T cd05588 146 GIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL--------FQ 215 (329)
T ss_pred cccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH--------HH
Confidence 222111 11234689999999999988999999999999999999999999964321110 0000110 11
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC------HHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS------MTEIVN 744 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~evl~ 744 (768)
.+.......+.. ....+.+++.+||+.||.+||+ ++++++
T Consensus 216 ~~~~~~~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 216 VILEKQIRIPRS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHcCCCCCCCC----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122222222211 2345678999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=334.34 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=194.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++|+|+||+++++++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------------~~~~~E~~iL~~L~HpnIv~l~~~~~ 230 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------------ASSVHEARLLRRLSHPAVLALLDVRV 230 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------------cCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 457999999999999999999876 578899995321 23568999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..++|||++. ++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 231 ~~~~~~lv~e~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 231 VGGLTCLVLPKYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred ECCEEEEEEEccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence 9999999999995 68998886432 24689999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-----ccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-----NVVDFVV 691 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-----~~~~~~~ 691 (768)
||+++...............||+.|+|||++.+..++.++|||||||+||||++|..++......... .+.....
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 99997543322222222356899999999999889999999999999999999987665332211100 0000000
Q ss_pred ---------chhh----hhhHHhhhccCCCCC--C-cc--hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 ---------PYIV----RDEIHRVLDRNVPPP--T-PF--EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ---------~~~~----~~~~~~~~~~~~~~~--~-~~--~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+... .............+. . .+ .......+.+|+.+||+.||++|||+.|+++.
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000000000000 0 00 01223457789999999999999999999874
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.98 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=193.4
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.. +++.||||+++.... ........+.+|.+++..+ +||||+++++++.+.+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~ 72 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF 72 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 46999999999999876 578999999874311 1123445677888998888 7999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 999999999999988653 23688889999999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+
T Consensus 146 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---------------~~~~~i 208 (318)
T cd05570 146 GILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---------------ELFQSI 208 (318)
T ss_pred cCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---------------HHHHHH
Confidence 3222211 12346899999999999889999999999999999999999998643210 111122
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVNS 745 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 745 (768)
.......+ ......+.+|+.+||+.||++||++ .++++.
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 22222111 1234557799999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.08 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=188.8
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc-CCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR-LHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||++... +++.||||+++.... ..+.....+..|..++.. ++||||+++++++.+.+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF 72 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE
Confidence 46999999999999876 578999999875311 112234456677777776 49999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++|+|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999999999999999642 23578888999999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... .+ ...+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~------------~~~i 208 (316)
T cd05619 146 NMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL------------FQSI 208 (316)
T ss_pred CCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH------------HHHH
Confidence 322111 112346899999999999889999999999999999999999998643210 00 1111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH-HHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT-EIVN 744 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 744 (768)
.......+ ......+.+++.+||+.||++||++. ++++
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 209 RMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11111111 11234567899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.41 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=186.5
Q ss_pred eeccCCceEEEEEEEcC---CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 466 KIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~---g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
.||+|+||.||+|+..+ ...+++|.+... ........|.+|++.++.++||||+++++.+......+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~ 71 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc----------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceE
Confidence 59999999999997543 346777765432 12334567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSS-SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+||||+++|+|.+++...... ....++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccc
Confidence 999999999999999764322 223356777899999999999999998 9999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccCccCcccccc-------CCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRL-------QQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
...............++..|+|||++.. ..++.++||||||+++|||++ |..||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------ 216 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------------ 216 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------------
Confidence 5333222111223345778999998743 356889999999999999999 67777533210
Q ss_pred hhhhhHHhhhcc---CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 694 IVRDEIHRVLDR---NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 694 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+.+...+.. .++.+ .........+.+++..|+ .||++||+++||++.|
T Consensus 217 ---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 217 ---QVLKQVVREQDIKLPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ---HHHHHHhhccCccCCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 001111111 11111 112233455667888888 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.67 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=196.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|+||+||++... +++.+|+|.+..... ........+.+|++++++++|+||+++.+.+..++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--------KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--------hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC
Confidence 666789999999999999875 688999998864311 11223456788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..+++|||+++++|.+++.... ...+++...+.++.|++.+|.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCc
Confidence 9999999999999999886432 224688999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+......... ....|+..|+|||++....++.++|+||||+++|||++|+.||....... ....+
T Consensus 149 ~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~------------~~~~~ 213 (285)
T cd05632 149 AVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV------------KREEV 213 (285)
T ss_pred ceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------------HHHHH
Confidence 8654322211 13368999999999988889999999999999999999999986432110 00111
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
.+.+.... .....+....+.+|+.+||+.||++||+ +.|+++.
T Consensus 214 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 214 DRRVLETE---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHhhhccc---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11111100 0111223345678999999999999999 6676664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.28 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=194.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... +++.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---------QNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 90 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---------cchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 468999999999999999999865 68999999885421 12234567889999999999999999999886
Q ss_pred cCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
..+ ..++||||+++ +|.+.++. .+++.....++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~ 160 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 160 (359)
T ss_pred cCCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCC
Confidence 443 57999999975 67776642 2467778889999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~ 689 (768)
.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 161 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 161 TLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997532221 1123468999999999998899999999999999999999999997432110000 0000
Q ss_pred -ccch--h---hhhhHHhhhccCCCC----------------CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 -VVPY--I---VRDEIHRVLDRNVPP----------------PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 -~~~~--~---~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+. + ............... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0 000011111110000 000111123557799999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.54 Aligned_cols=255 Identities=27% Similarity=0.331 Sum_probs=204.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..+.||+|--|+||++.++ ++..+|+|++..... ....+..+.+.|-++|+.++||.++.|+..++.+
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--------~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--------ASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--------hhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4556688999999999999987 468999999976432 1234566778899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+|+||||+||+|+.+++++.. ..++.......+..++-||+|||-.+ ||.|||||+||||.++|++.|+||.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence 999999999999999999987654 33567777788999999999999999 9999999999999999999999999
Q ss_pred ccccCCC---------------------------------CCCc---------------------ccccccccccCccCc
Q 046311 619 LSLIGPE---------------------------------DDES---------------------HLSLRAAGTVGYMDP 644 (768)
Q Consensus 619 la~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aP 644 (768)
|+..... .... ..+..++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 9743110 0000 011235799999999
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHH
Q 046311 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYL 724 (768)
Q Consensus 645 E~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 724 (768)
|++.+...+.++|.|+|||+|||||.|..||...... +-+..++-+.+..+. ..+.+..+.+|
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~--~~~vs~~akDL 367 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPE--EPEVSSAAKDL 367 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCC--CCcchhHHHHH
Confidence 9999999999999999999999999999999865432 223344444333222 22455677899
Q ss_pred HHHcccccCCCCCC----HHHHHH
Q 046311 725 AADCVTLEGRNRPS----MTEIVN 744 (768)
Q Consensus 725 i~~Cl~~dP~~RPs----~~evl~ 744 (768)
|++.|.+||++|.. +.||-+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc
Confidence 99999999999987 666654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.79 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.+ +++.||+|.++.... ..+.....+..|..++..+ +||||+++++++.+.+..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 72 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--------LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE
Confidence 46999999999999876 688999999864311 1122344567777777754 8999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 999999999999998653 23577888899999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... .....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---------------~~~~~~ 208 (316)
T cd05620 146 NVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---------------ELFESI 208 (316)
T ss_pred cccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Confidence 321111 122346899999999999889999999999999999999999999643210 001111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH-HHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT-EIV 743 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl 743 (768)
.......+. .....+.+++.+||+.||++||++. +++
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 209 RVDTPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HhCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111111111 1234567899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.08 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=184.5
Q ss_pred eeccCCceEEEEEEEcCCC---eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 466 KIGSGSFGAVYKATLDDGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~g~---~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
.||+|+||.||++...++. .+++|.++.. ......+.|.+|+.+++.++||||+++++.+.+....+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 71 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----------CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccE
Confidence 5999999999999755443 3455554322 11234578999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++|+|.++++.........++...+.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 999999999999999764333334466677889999999999999998 99999999999999999999999999854
Q ss_pred CCCCCCcccccccccccCccCcccccc-------CCCCChhhHHHHHHHHHHHHcC-CcccccCCCCCcccccccccchh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRL-------QQLTEKSDVYSFGVVLLEILSG-YRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
..............++..|+|||++.. ..++.++||||||+++|||+++ ..||...... .. ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~ 221 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EV----LNHV 221 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHH
Confidence 322221111223457889999998753 2457899999999999999975 5566432110 00 0000
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
..+......+..... .....+.+++..|| .+|++||+++||++.|.
T Consensus 222 ~~~~~~~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 IKDQQVKLFKPQLEL------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HhhcccccCCCccCC------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111111111 12345667889999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=312.90 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=196.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 46888999999999999999864 68899999886431 1233467889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++++.. ..+++..+..++.|++++|+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcC
Confidence 99999999999999999998643 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++......... .....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ ...
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~------ 220 (267)
T cd06646 151 GVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL------ 220 (267)
T ss_pred ccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee------
Confidence 998754322111 12235788999999884 34578899999999999999999999854322110 000
Q ss_pred hhhhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
.......++ ..........+.+++.+||+.+|++||+++++++.|
T Consensus 221 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 221 -------MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -------eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000001100 001112345677999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.35 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=199.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||++... +++.+++|.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------QPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----------cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 47888899999999999999864 68999999876431 1234668899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++... .+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999998642 2578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+++.|+|||.+....++.++||||||+++|||++|+.||....... ..
T Consensus 161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~----------- 225 (296)
T cd06654 161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL----------- 225 (296)
T ss_pred ccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hH-----------
Confidence 998754322211 112357899999999988888999999999999999999999986432210 00
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....... .+...........+.+++.+||..+|++||++.|+++.
T Consensus 226 -~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 226 -YLIATNG--TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -HHHhcCC--CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000011 01111122344567789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.22 Aligned_cols=252 Identities=32% Similarity=0.508 Sum_probs=200.5
Q ss_pred ceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
+.||+|+||.||++.... +..+++|.+.... .......+.+|++.+..++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----------SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc----------chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCc
Confidence 469999999999998763 7899999886431 11245788999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSS-----SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.++||||+++++|.+++...... ...+++..+++++.|++++|+|||+++ |+|+||||+||+++.++.+||+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEc
Confidence 99999999999999999764221 245689999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||.+................++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------- 214 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------------- 214 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------------
Confidence 9999976554332222233457889999999988889999999999999999999 58888643110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
+....+.+. ... ......+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 215 --~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 215 --EVLEYLRKG-YRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHHHHHHcC-CCC--CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001111111 111 111223566789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.09 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=196.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-c
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE-D 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 537 (768)
.+|++.+.||+|+||.||++..+ +..+++|.++.. ...+.|.+|+.++++++|+|++++++++. +
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 36788899999999999999876 788999986432 23457899999999999999999999764 5
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+++|||+++++|.++++.... ...++..+++++.|++.+|+|||+++ |+||||||+|||+++++.+||+||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCC
Confidence 5678999999999999999975432 33678899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........ ....+..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 147 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---------------- 205 (256)
T cd05082 147 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------- 205 (256)
T ss_pred ccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----------------
Confidence 99874332211 2234668999999988889999999999999999998 8888753211
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.++...+....... .....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 206 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 KDVVPRVEKGYKMD--APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111111111111 1112345677999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.74 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=185.9
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHH-HHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL-ESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.. +++.||+|++..... ........+.+|. .+++.++||||+++++++.+.+..+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~ 72 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI--------LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 72 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--------HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEE
Confidence 46999999999999876 578899999864311 0112233444444 4567889999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++.... .+.......++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 73 FVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999996532 2456677789999999999999998 99999999999999999999999999874
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------~~~~~i 208 (325)
T cd05602 146 NIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---------------EMYDNI 208 (325)
T ss_pred cccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---------------HHHHHH
Confidence 322211 122346899999999999889999999999999999999999998643211 111122
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
....... ..+....+.+++.+||+.+|.+||++.+.+
T Consensus 209 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 209 LNKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HhCCcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2221111 112345567899999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.45 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=187.2
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHH-HHhcCCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE-SLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.. +++.+|+|++..... ........+.+|.. +++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~ 72 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--------LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLY 72 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEE
Confidence 36999999999999865 689999999864311 11223345556655 567799999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 73 FVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 999999999999988642 23578888899999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +....+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------------~~~~~~ 208 (325)
T cd05604 146 GIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------------EMYDNI 208 (325)
T ss_pred CCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---------------HHHHHH
Confidence 322211 122346899999999999889999999999999999999999998643210 111222
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 742 (768)
+........ .....+.+++.+|++.+|.+||++++.
T Consensus 209 ~~~~~~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 209 LHKPLVLRP----GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HcCCccCCC----CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 222221111 123446689999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.58 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... ++..+|+|.+... ..+....++.+|++++++++||||+++++++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 70 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----------IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS 70 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 36888999999999999999865 6788899987532 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
++..++||||+++++|.++++.. ..+++.....++.|++++|+|||+. + |+|+||||+|||++.++.+||+|
T Consensus 71 ~~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 71 DGEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred CCEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEcc
Confidence 99999999999999999999753 2357788899999999999999984 5 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc----
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP---- 692 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~---- 692 (768)
||++........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||.................
T Consensus 144 fg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
T cd06615 144 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219 (308)
T ss_pred CCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccc
Confidence 999864322211 234678999999999888899999999999999999999999853321110000000000
Q ss_pred -----------------hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 -----------------YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.....+... ++..+. ......+.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCcccccCCCCCccchhhHHHHHHHHhcCC-CccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011111111 111111 1134567899999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.34 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=202.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||.++.. +++.+++|.+.... ..+....++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---------LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---------cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5788899999999999999854 68999999886432 1233456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++.... ...+++..++.++.|++++|+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~ 146 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFG 146 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCc
Confidence 99999999999999999997542 234588889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------------~~~ 209 (256)
T cd08221 147 ISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---------------LNL 209 (256)
T ss_pred ceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---------------HHH
Confidence 9875433321 11234689999999999888889999999999999999999999864221 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..++......+. .......+.+++.+||+.+|++||+++|+++.
T Consensus 210 ~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 VVKIVQGNYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHcCCCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 122222222211 12334567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.04 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=200.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|+..+.||+|+||.||++.++ +++ .+|+|.+.... ......++.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----------SPKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----------CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46788899999999999999864 333 58888765331 1334567899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.. ...++||||+++|+|.++++.... .+++...++++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 77 ICLS-SQVQLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred EEec-CceEEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEE
Confidence 9987 788999999999999999975432 3688899999999999999999988 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++................++..|+|||.+....++.++|+||||+++|||++ |+.||.....
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------ 217 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------------ 217 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------------
Confidence 999999976543222111112224578999999988889999999999999999999 9998864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.++...+........+ ......+.+++.+||..+|++||++.++++.|+++++
T Consensus 218 ----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 ----VEIPDLLEKGERLPQP--PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----HHHHHHHhCCCCCCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111111111111 1122446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.02 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.++||+|+||.||++... +++.+++|.++... .....+.+.+|+.++++++||||+++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 70 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD 70 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence 4778899999999999999865 68999999876431 122446788899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++.... ...++....+.++.|++++|.|||+++ |+|+||||+|||+++++.++|+|||
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccC
Confidence 99999999999999999886432 233577888899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......+++.|+|||++....++.++|+||||+++|+|++|+.||..... ...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---------------~~~ 208 (255)
T cd08219 146 SARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---------------KNL 208 (255)
T ss_pred cceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---------------HHH
Confidence 9875433221 11234688999999999888899999999999999999999999864321 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+......+ ........+.+|+.+||+.||++||++.|++..
T Consensus 209 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 ILKVCQGSYKP---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhcCCCCC---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111111111 111233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.42 Aligned_cols=254 Identities=32% Similarity=0.480 Sum_probs=195.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|+||+||+++.. +++.+|+|++.... ..........+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---------ccccccchhhhhhhccccccccccccccccccccc
Confidence 566789999999999999976 56689999987542 11222234456999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++.. ...+++..++.++.|++++|+|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~ 144 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGS 144 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTT
T ss_pred cccccccccccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 99999999999999999972 234588899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+...... ........++..|+|||++. ...++.++||||||+++|+|++|..|+........ .......
T Consensus 145 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--------~~~~~~~ 214 (260)
T PF00069_consen 145 SVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--------LEIIEKI 214 (260)
T ss_dssp TEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--------HHHHHHH
T ss_pred ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhh--------hhhhhhc
Confidence 8753111 11222446899999999998 88899999999999999999999999874411000 0000111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.......... ........+.+++.+||+.||++||++.|+++
T Consensus 215 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 215 LKRPLPSSSQ----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTHHHHHTT----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccc----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1101110000 00011267889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.28 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=195.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+|.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 5778899999999999999864 78999999875421 123456799999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|..+. ..++.....++.|++.+|+|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg 140 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFG 140 (279)
T ss_pred CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999997653 1367778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ....++..|+|||++....++.++||||||+++|||++|+.||.......... .+ ...
T Consensus 141 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-----~~---~~~ 208 (279)
T cd06619 141 VSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-----MP---LQL 208 (279)
T ss_pred cceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-----ch---HHH
Confidence 9875432211 13468999999999998889999999999999999999999986532211100 00 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+...+.. ........+.+++.+||+.+|++||+++|+++.
T Consensus 209 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQCIVDEDPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhccCCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111110 011123456799999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=329.78 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=194.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++..+ +++.||+|+++... .........+.+|+.++..++||||+++++.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 72 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--------MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD 72 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 36888899999999999999875 68999999986421 1122345678889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 73 KRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred CCEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999653 23577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCC---------------------------------cccccccccccCccCccccccCCCCChhhHHHHHHH
Q 046311 618 GLSLIGPEDDE---------------------------------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664 (768)
Q Consensus 618 Gla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl 664 (768)
|++........ ........||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 99864321100 000113468999999999998999999999999999
Q ss_pred HHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC---HHH
Q 046311 665 LLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS---MTE 741 (768)
Q Consensus 665 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~e 741 (768)
+|||++|+.||...... .....++........+........+.+|+.+++ .+|++|++ ++|
T Consensus 226 lyel~tG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 289 (360)
T cd05627 226 MYEMLIGYPPFCSETPQ---------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEE 289 (360)
T ss_pred eeecccCCCCCCCCCHH---------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence 99999999999643221 111111111000000001112334557777766 49999985 666
Q ss_pred HHHH
Q 046311 742 IVNS 745 (768)
Q Consensus 742 vl~~ 745 (768)
+++.
T Consensus 290 i~~h 293 (360)
T cd05627 290 IKSH 293 (360)
T ss_pred HhcC
Confidence 6654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.60 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=200.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||.||++... ++.||+|.++.. ....+++.+|+.++++++|+||+++++++.+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDD------------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccc------------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 46788899999999999999876 789999988542 11456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++..... ..+++..++.++.|++.+|.|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccc
Confidence 999999999999999999975432 24688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ ....+..|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~ 206 (256)
T cd05039 148 LAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------------K 206 (256)
T ss_pred cccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----------------H
Confidence 9975532211 1234668999999988889999999999999999997 9888753321 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
++...+........ ....+..+.+++.+||..+|++||+++|++++|++
T Consensus 207 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 207 DVVPHVEKGYRMEA--PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHhcCCCCCC--ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11111111111111 11224567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.33 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=190.5
Q ss_pred ceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-cCC
Q 046311 465 HKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE-DRN 539 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 539 (768)
+.||+|+||.||+|.+. ....+|+|++... ........+.+|+.+++.++||||+++++++. .+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc----------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC
Confidence 36899999999999853 2357999986421 12234567889999999999999999999775 455
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..+++|||+.+++|.++++... ...++...+.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 71 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 71 SPLVVLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred CcEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccc
Confidence 6889999999999999997532 22466778899999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcc--cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCc-ccccCCCCCcccccccccchhhh
Q 046311 620 SLIGPEDDESH--LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR-AIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 620 a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
+.......... ......++..|+|||.+....++.++||||||+++|||++|.. |+..... .
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~------------ 209 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---F------------ 209 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---H------------
Confidence 87443221111 1112345778999999988889999999999999999999644 4432111 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
+....+....... . ....+..+.+++.+||+.+|++||++.||++.|++++.
T Consensus 210 ~~~~~~~~~~~~~-~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 210 DITVYLLQGRRLL-Q--PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHhcCCCCC-C--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011111111111 1 11123457799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=338.90 Aligned_cols=274 Identities=15% Similarity=0.214 Sum_probs=191.1
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC------CCCCc
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL------HHKNL 528 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnI 528 (768)
...++|++.++||+|+||+||++... .++.||||+++... ....++..|+++++.+ +|.++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------------~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------------KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------------hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 34678999999999999999999865 67899999985321 1122344455555554 45668
Q ss_pred eeEEEEEEcC-CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEE
Q 046311 529 VRLLGFCEDR-NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 529 v~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl 606 (768)
+++++++... ...++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||+
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl 265 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILM 265 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999988765 4688999987 67899988643 2357888899999999999999984 6 9999999999999
Q ss_pred CCCC----------------cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 607 DATW----------------TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 607 ~~~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
+.++ .+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred ecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence 8765 4999999987542211 123578999999999999999999999999999999999
Q ss_pred CCcccccCCCCCccccccccc---ch-h----hhhhHHhhhccCCC--C-------------CCcchHHHHHHHHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVV---PY-I----VRDEIHRVLDRNVP--P-------------PTPFEIEAVAYVGYLAAD 727 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~---~~-~----~~~~~~~~~~~~~~--~-------------~~~~~~~~~~~l~~Li~~ 727 (768)
|+.||................ +. + ..++...+++.... + ...........+.+|+.+
T Consensus 341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 999996533211100000000 00 0 00000111110000 0 000011123557799999
Q ss_pred cccccCCCCCCHHHHHH--HHHHHHhhcc
Q 046311 728 CVTLEGRNRPSMTEIVN--SLERALAACL 754 (768)
Q Consensus 728 Cl~~dP~~RPs~~evl~--~L~~~l~~~~ 754 (768)
||+.||++|||++|+++ .|.+....+.
T Consensus 421 mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~ 449 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTTHPYVLKYYPECR 449 (467)
T ss_pred hCCcChhhCCCHHHHhcCccccccCCccc
Confidence 99999999999999997 4655444343
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.67 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=194.0
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
+.+.|+..+.||+|+||.||++... +++.||+|++... ......+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 71 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------GDEEEEIKQEINMLKKYSHHRNIATYYGA 71 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------------CccHHHHHHHHHHHHHhcCCCCeeeEeeE
Confidence 4567888899999999999999865 6889999987642 12335678899999998 79999999999
Q ss_pred EEcC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 535 CEDR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 535 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
+... ...+++|||+++++|.+++.... ...+++..+..++.|++.+|+|||+++ |+|+||||+||++++
T Consensus 72 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~ 146 (272)
T cd06637 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE 146 (272)
T ss_pred EeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECC
Confidence 8653 46889999999999999997532 234578888999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
++.+||+|||++........ ......|+..|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~- 223 (272)
T cd06637 147 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR- 223 (272)
T ss_pred CCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-
Confidence 99999999999875432211 122346889999999986 3357889999999999999999999986432110
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
............ .........+.+|+.+||..+|.+|||+.|+++
T Consensus 224 --------------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 --------------ALFLIPRNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------------HHHHHhcCCCCC--CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000000000000 011123345779999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=323.28 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=190.1
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.. +++.||+|+++... ...+.....+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 72 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF 72 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE
Confidence 46999999999999875 67899999987431 11223456688899999888 6999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 999999999999988643 23688889999999999999999998 99999999999999999999999999874
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++.+..++.++||||||++||||++|+.||............++. ...+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~ 215 (327)
T cd05617 146 GLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL--------FQVI 215 (327)
T ss_pred ccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH--------HHHH
Confidence 322111 112346899999999999889999999999999999999999999643322111111111 1111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
.......+. .....+.+++.+||+.||++|+++
T Consensus 216 ~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 216 LEKPIRIPR----FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 222111111 123456689999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.17 Aligned_cols=269 Identities=21% Similarity=0.298 Sum_probs=191.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
..+|+..++||+|+||.||+|... +++.||||++... .....+|+.+++.++||||+++++++.
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---------------~~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---------------PQYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---------------cchHHHHHHHHHhcCCCCCcceeeeEe
Confidence 457999999999999999999875 6899999987432 112346999999999999999998864
Q ss_pred cC--------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 537 DR--------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 537 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
.. ...++||||+++ +|.+++.........+++.....++.||++||+|||+++ |+||||||+||||+.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~ 205 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDP 205 (440)
T ss_pred ecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcC
Confidence 32 246689999985 787777543223345688888999999999999999998 999999999999986
Q ss_pred CC-cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 609 TW-TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 609 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
++ .+||+|||+++........ ....+|+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~ 280 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QL 280 (440)
T ss_pred CCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 54 7999999999754332221 23467999999999865 468999999999999999999999986432211 00
Q ss_pred cccccchh---hhhhHHh----hhccCCCCCCc------chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHh
Q 046311 687 VDFVVPYI---VRDEIHR----VLDRNVPPPTP------FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALA 751 (768)
Q Consensus 687 ~~~~~~~~---~~~~~~~----~~~~~~~~~~~------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~ 751 (768)
... .... ..+.... ..+..++.... .....+..+.+|+.+||+.||.+|||+.|+++. ++.+..
T Consensus 281 ~~i-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 281 VRI-IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHH-HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 0000 0000000 00000110000 001123467799999999999999999999854 555543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=350.01 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=196.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|.+.++||+|+||+||++... ++..+|+|.+.... ..+.....|.+|+.++++|+||||++++++|.
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---------l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---------LKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---------cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 357999999999999999999875 57789999886431 12234567899999999999999999999885
Q ss_pred c--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEecCCCCCCeEECC--
Q 046311 537 D--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAV----PSIIHRDIKSSNVLLDA-- 608 (768)
Q Consensus 537 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~----~~ivHrDiKp~NILl~~-- 608 (768)
+ ...+||||||+++++|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 356899999999999999997543333456888999999999999999998542 24999999999999964
Q ss_pred ---------------CCcEEEeeccccccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcC
Q 046311 609 ---------------TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 609 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG 671 (768)
...+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||+||
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 33589999999975432221 123468999999999854 4588999999999999999999
Q ss_pred CcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+.||...... ..+...+......+. ......+.+||..||+.+|.+||++.|++.
T Consensus 240 k~PF~~~~~~---------------~qli~~lk~~p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 240 KTPFHKANNF---------------SQLISELKRGPDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCcCCcH---------------HHHHHHHhcCCCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999643210 011111111111110 112355778999999999999999999985
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.88 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=194.6
Q ss_pred eeccCCceEEEEEEEcC-------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 466 KIGSGSFGAVYKATLDD-------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~-------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.||+|+||.||+++..+ ++.++||.+... ........|.+|+.+++.++||||+++++++...
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----------ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN 71 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc----------cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC
Confidence 58999999999998642 257899976432 1123456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-----
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----- 610 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----- 610 (768)
+..++||||+++++|.+++..... ....+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.+.
T Consensus 72 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 72 EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCc
Confidence 999999999999999999965321 1234578899999999999999999988 99999999999999877
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 689 (768)
.++|+|||++................++..|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------- 220 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------- 220 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------
Confidence 899999999875433222222222345788999999998899999999999999999998 98888532210
Q ss_pred ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+....+...... ......+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 221 --------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 --------EVLQHVTAGGRL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------HHHHHHhcCCcc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011111111111 1112234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=329.91 Aligned_cols=268 Identities=23% Similarity=0.350 Sum_probs=195.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|+||.||++... +++.||||++... .......+++.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---------FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---------ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 4778899999999999999864 7899999987532 11223446788999999999999999999999877
Q ss_pred C-----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 539 N-----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 539 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
+ ..++||||+. ++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~k 143 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLK 143 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEE
Confidence 6 7899999997 5888887542 23578888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc-
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV- 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~- 690 (768)
|+|||++......... ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.......... +.+..
T Consensus 144 L~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g 222 (372)
T cd07853 144 ICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222 (372)
T ss_pred eccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999754332211 11234578999999998764 57899999999999999999999996543211000 00000
Q ss_pred cchh-----hhhhHHhhh-ccCCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 VPYI-----VRDEIHRVL-DRNVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 ~~~~-----~~~~~~~~~-~~~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.. ..+.....+ .....++. ....+....+.+|+.+||+.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000011111 11111100 0011124567799999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.91 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=200.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..++||+|+||.||++..+++..+++|.+... ......|.+|++++++++|+||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC------------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 578889999999999999999877888999986532 1234678999999999999999999999887
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...+++|||+++++|.+++.... ....++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCc
Confidence 77899999999999999997532 234578888999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++......... ......++..|+|||++....++.++|+||||+++|||+| |+.||......
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---------------- 210 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---------------- 210 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----------------
Confidence 98754322211 1112235678999999988889999999999999999999 88888643211
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
...+.+......+. .......+.+++.+||+.+|++||++.++++.|++
T Consensus 211 ~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 EVIRALERGYRMPR--PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHhCCCCCCC--cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111111111111 11234567799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.74 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=195.6
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 544 (768)
++||+|+||.||++..++++.|++|.+.... .......|.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL----------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC----------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 4699999999999998779999999875431 113456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCC
Q 046311 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624 (768)
Q Consensus 545 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~ 624 (768)
|||+++++|.+++.... ...++...+.++.+++.+|+|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 99999999999996532 23578888999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 625 EDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
.............+..|+|||.+....++.++||||||+++|||+| |..||...... .....+
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----------------~~~~~~ 208 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----------------QTRERI 208 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----------------HHHHHH
Confidence 2221111111234667999999988889999999999999999999 77777543211 111111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
....... .....+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 209 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRMP--APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1111111 11123456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.96 Aligned_cols=240 Identities=28% Similarity=0.375 Sum_probs=185.0
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHH-HHhcCCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE-SLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
++||+|+||.||+++.. +++.||+|++..... ........+.+|.. +++.++||||+++++++.+.+..+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~ 72 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLY 72 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEE
Confidence 46999999999999875 688999999864311 11123344555554 678899999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..++......++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 73 FVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999999999888642 23466777889999999999999998 99999999999999999999999999874
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
...... ......||+.|+|||++....++.++||||||+++|||++|+.||..... ......+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~i 208 (321)
T cd05603 146 GVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---------------SQMYDNI 208 (321)
T ss_pred CCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---------------HHHHHHH
Confidence 322211 12234689999999999988899999999999999999999999864321 0111222
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 740 (768)
.......+. .....+.+++.+||+.+|++||+..
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHKPLQLPG----GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222221111 1234567899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.41 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=197.1
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|+||.||++... +++.+|||.+..... ........+.+|+.++++++|+||+++++.+.+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--------cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC
Confidence 667789999999999999865 689999998864311 11223456788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999864322 23578888999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+......... ....|+..|+|||++....++.++||||||+++|||++|+.||........ .+..
T Consensus 149 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~------------~~~~ 213 (285)
T cd05630 149 AVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK------------REEV 213 (285)
T ss_pred eeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch------------HHHH
Confidence 8654322211 123689999999999988999999999999999999999999975322110 0111
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVN 744 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~ 744 (768)
......... .........+.+|+.+||+.||++||| ++|+++
T Consensus 214 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 ERLVKEVQE---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Hhhhhhhhh---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111110000 001122345678999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=322.30 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=191.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 537 (768)
+|+..+.||+|+||.||++... +++.||+|++..... ......+.+..|..++..+. |++|+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT 72 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEec
Confidence 3677799999999999999865 689999999864311 11234456788888888885 5788889999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 73 VDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecc
Confidence 99999999999999999998643 23678899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......||+.|+|||++....++.++||||||+++|||++|+.||..... ..
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---------------~~ 208 (323)
T cd05615 146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---------------DE 208 (323)
T ss_pred ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 99874322211 11234689999999999988899999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
....++......+. .....+.+++.+||+.+|.+|++.
T Consensus 209 ~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 209 LFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 12222222222111 223456789999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.39 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=189.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~ 535 (768)
+|+..+.||+|+||.||++... +++.||+|.++.... .......+.+|+++++++ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN---------EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC---------CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 4788899999999999999865 689999998864311 111223455676666655 799999999987
Q ss_pred Ec-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 536 ED-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 536 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.. ....+++|||+++ +|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~ 145 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG 145 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 64 2457899999975 89888865322 33688889999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~ 689 (768)
.+||+|||++........ .....+|..|+|||++....++.++||||||+++|||++|+.||......... .+...
T Consensus 146 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 146 QVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred CEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 999999999975432221 12335789999999998888999999999999999999999988643221000 00000
Q ss_pred ccchhhhhhHHh---hhccCCCCC-----CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VVPYIVRDEIHR---VLDRNVPPP-----TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~~~~~~~~~~~---~~~~~~~~~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... ........ ......... .....+....+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGL-PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCC-CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 000000000 0011123456779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.25 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=194.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.+ +++.+|+|.+.... .........|.+|+.++..++|+||+++++.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--------MLKRAETACFREERDVLVNGDNQWITTLHYAFQD 72 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--------HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence 36888999999999999999876 57889999885321 1112234568889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++++... ..+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997532 23577788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++........ .......||+.|+|||++. ...++.++||||||++||||++|+.||......
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----------- 214 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------- 214 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----------
Confidence 99864332221 1112346899999999986 346789999999999999999999998643210
Q ss_pred hhhhhhHHhhhccCCCCCC-cchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
+....+......... .........+.+|+.+|+..++++ |++++|+++.
T Consensus 215 ----~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ----ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111122211110000 011123455668888888655444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.54 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=200.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.+++|.+... ....+|.+|++++++++||||+++++++.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 69 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------------EDLQEIIKEISILKQCDSPYIVKYYGSYFK 69 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------------HHHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence 57888899999999999999976 4789999987532 115689999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++++||+++++|.+++.... ..+++...+.++.|++++|.|||+.+ |+|+||+|+||+++.++.+||+||
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccc
Confidence 999999999999999999986432 34688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------------- 207 (256)
T cd06612 144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------------- 207 (256)
T ss_pred ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------------
Confidence 99875433221 11223478899999999888899999999999999999999999864322110
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... ..................+.+++.+||+.+|++||++.|+++
T Consensus 208 -~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 208 -IFM-IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -hhh-hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 000111111112233456789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.03 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=197.0
Q ss_pred HHHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 452 EILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 452 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
+.+....++|++.+.||+|+||.||++... +++.+|+|.++.. .....++.+|+.+++++ +||||+
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------------~~~~~~~~~e~~~l~~l~~h~~i~ 78 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------------HDIDEEIEAEYNILKALSDHPNVV 78 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------------cchHHHHHHHHHHHHHHhcCCCee
Confidence 334445678999999999999999999865 6789999986432 12235678899999999 799999
Q ss_pred eEEEEEE-----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCe
Q 046311 530 RLLGFCE-----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNV 604 (768)
Q Consensus 530 ~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NI 604 (768)
++++++. ..+..++||||+++++|.++++........+++..+..++.|++++|.|||+++ |+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni 155 (286)
T cd06638 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNI 155 (286)
T ss_pred eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhE
Confidence 9999874 345689999999999999988643323344678888899999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 605 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
+++.++.+||+|||++........ ......+++.|+|||++.. ..++.++||||||+++|||++|+.|+....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999875432221 1123358999999999853 447889999999999999999999986432
Q ss_pred CCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... .+.... ....+...........+.+|+.+||+.+|++||++.|+++.
T Consensus 234 ~~~---------------~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PMR---------------ALFKIP-RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhH---------------HHhhcc-ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 110 000000 00000000011123457789999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=307.35 Aligned_cols=239 Identities=24% Similarity=0.411 Sum_probs=184.2
Q ss_pred ceeccCCceEEEEEEEcC-------------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 465 HKIGSGSFGAVYKATLDD-------------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~-------------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
+.||+|+||.||+|++.. ...|++|.+... .......|.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~~~~~l~~l~hp~iv~~ 69 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----------HRDISLAFFETASMMRQVSHKHIVLL 69 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----------hhhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 468999999999998542 225778875432 12345578899999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++++..+...++||||+++++|..+++... ..+++..+++++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 70 YGVCVRDVENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGI 143 (262)
T ss_pred EEEEecCCCCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCc
Confidence 999999999999999999999999886532 23578889999999999999999998 999999999999987654
Q ss_pred -------EEEeeccccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHH-cCCcccccCCCCC
Q 046311 612 -------AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEIL-SGYRAIHRTHNGT 682 (768)
Q Consensus 612 -------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~ell-tG~~p~~~~~~~~ 682 (768)
++++|||++....... ...++..|+|||.+. ...++.++||||||+++|||+ +|+.|+......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~- 216 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA- 216 (262)
T ss_pred cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-
Confidence 8999999986432211 234788999999886 467899999999999999998 577776432110
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+.............+ ....+.+|+.+||+.||++||++.||++.|
T Consensus 217 ---------------~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 ---------------EKERFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------------HHHHHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111111111111111 124567899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.14 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=199.7
Q ss_pred cHHHHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCC
Q 046311 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKN 527 (768)
Q Consensus 450 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpn 527 (768)
.++++....++|+..+.||+|+||.||++... +++.+|+|++... ......+.+|+.++.++ +|||
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~l~~h~n 80 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------SDVDEEIEAEYNILQSLPNHPN 80 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------------ccHHHHHHHHHHHHHHhcCCCC
Confidence 33444556788999999999999999999874 6889999987532 12345677899999998 8999
Q ss_pred ceeEEEEEEcC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 528 LVRLLGFCEDR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 528 Iv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
++++++++... ...++||||+++++|.++++........+++..++.++.|++.+|+|||+.+ |+||||||+
T Consensus 81 i~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~ 157 (291)
T cd06639 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGN 157 (291)
T ss_pred eEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 99999998654 3589999999999999998653333344688899999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-----CCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-----QLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
||+++.++.+||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 158 nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 158 NILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred HEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 999999999999999998754332211 1123578999999998643 368899999999999999999999864
Q ss_pred CCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.... ..+.+..... .+......+....+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~---------------~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 236 MHPV---------------KTLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CcHH---------------HHHHHHhcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 3211 0111111111 1101111223456789999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=313.02 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=208.3
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.-|..++.||+|.|..|-++++ -+|+.||||+++..+ .+......+.+|++.|+.++|||||+||++...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK---------lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK---------LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc---------cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 3466778899999999999974 489999999997653 334455678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE-CCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL-DATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl-~~~~~~kl~D 616 (768)
...+|||+|.-++|+|+|||.++.. .+.+....+.+.||+.++.|+|+.+ +|||||||+||.+ ..-|-+||.|
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999976543 3466677889999999999999999 8999999999977 4578999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCC-ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++..+.+..... ..+|...|-|||++.+..|+ ++.||||||||||.|+.|+.||+..++.
T Consensus 163 FGFSNkf~PG~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------- 225 (864)
T KOG4717|consen 163 FGFSNKFQPGKKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------- 225 (864)
T ss_pred ccccccCCCcchhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------------
Confidence 99998776655443 45899999999999998886 6889999999999999999999876542
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+-+-.++|-.+.- ......+..+||..||..||++|.+.+||...
T Consensus 226 -ETLTmImDCKYtv----PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 226 -ETLTMIMDCKYTV----PSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -hhhhhhhcccccC----chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2234455544433 23455667799999999999999999998764
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.07 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=193.3
Q ss_pred ceeccCCceEEEEEEEc-C---CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATLD-D---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~---g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
++||+|+||.||+|+.. . +..+|+|.+.... .....+++.+|++++++++||||+++++++. .+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 69 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----------IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEP 69 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc----------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCc
Confidence 46999999999999753 2 2689999876431 1134567899999999999999999999876 456
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.++||||+++++|.+++.... .+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~ 142 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMS 142 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccccc
Confidence 799999999999999997533 4588899999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcc-cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhh
Q 046311 621 LIGPEDDESH-LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 621 ~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
.......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...... .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~------------- 206 (257)
T cd05060 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---E------------- 206 (257)
T ss_pred ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---H-------------
Confidence 7543322211 1111223568999999988889999999999999999998 99988643211 1
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
..+.+....+.. .....+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 207 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 207 VIAMLESGERLP--RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHcCCcCC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111111111111 11123356779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.70 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=195.1
Q ss_pred ceeccCCceEEEEEEEcC--C--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATLDD--G--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~--g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
++||+|+||.||++.+.+ + ..||||.+..... ....++|.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 69 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP 69 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce
Confidence 468999999999998643 2 3689998764311 1456789999999999999999999999988 88
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.++||||+++++|.+++..... ..+++...+.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~ 144 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLM 144 (257)
T ss_pred EEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccc
Confidence 9999999999999999976432 34688999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCC-cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhh
Q 046311 621 LIGPEDDE-SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 621 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
........ ........++..|+|||.+....++.++||||||+++|||++ |+.|+...... +.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---------------~~ 209 (257)
T cd05040 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---------------QI 209 (257)
T ss_pred ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---------------HH
Confidence 76543221 111122356788999999988899999999999999999999 99988533211 00
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
........... ......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 210 LKKIDKEGERL--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHhcCCcC--CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01111000000 011123456778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=307.74 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+|+..+.||+|+||.||++...+++.+|||.++..... ..........+.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN-----VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc-----hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 47778999999999999999888999999988653211 0111233467899999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..+++|||+++++|.+++.... .+++.....++.|++.+|+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 9999999999999999996532 2467888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCC----CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 620 SLIGPEDD----ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 620 a~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
+....... .........++..|+|||++....++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------------- 214 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------------- 214 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--------------
Confidence 86432111 111112345889999999999888999999999999999999999998642210
Q ss_pred hhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......... ...+ .........+.+++.+||+.+|++||++.|+++
T Consensus 215 -~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 215 -AAMFYIGAHRGLMP--RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHHHHhhhccCCCC--CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0000 011123455678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.44 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=195.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.+ +++.||+|.++.... ......+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE----------EGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc----------cCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 46888999999999999999875 678999998864321 1223457789999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||++ ++|.+++.... ...++.....++.|++++|+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcC
Confidence 999999999997 59999886532 23577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc--------c
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV--------D 688 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~--------~ 688 (768)
|++......... .....+++.|+|||++.. ..++.++||||||+++|||+||+.||............ +
T Consensus 149 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 226 (301)
T cd07873 149 GLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226 (301)
T ss_pred cchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 998653322211 112356889999998764 45788999999999999999999998643221000000 0
Q ss_pred cccchhhhhhHHhhhccCCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..++.+...+ .......+... .........+.+|+.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 227 ETWPGILSNE--EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhchhhhccc--cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 00000000000 001123456779999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.83 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=195.2
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|+..+.||+|+||.||++... .++.||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---------cChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 3468999999999999999999864 68899999875321 1223456788999999999999999999988
Q ss_pred EcC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 536 EDR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 536 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
... ...++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~ 155 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 155 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCC
Confidence 543 357999999975 67777642 2577788899999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVD 688 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~ 688 (768)
+.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..+
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 156 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999975432211 123468999999999998899999999999999999999999986432110000 000
Q ss_pred -cc--cchh---hhhhHHhhhccC----------------CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 -FV--VPYI---VRDEIHRVLDRN----------------VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 -~~--~~~~---~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. .+.. ........++.. .+............+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000 000011111100 000001111223567799999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.73 Aligned_cols=269 Identities=22% Similarity=0.277 Sum_probs=195.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+++.+ +++.||||+++... ..+.....+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---------EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 4778899999999999999875 68999999886431 1122345688899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||++ ++|.+++..... ...+++..++.++.|+++||+|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 146 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFG 146 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECccc
Confidence 99999999997 589888865332 234678888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccc-------cc
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVV-------DF 689 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~-------~~ 689 (768)
++........ ......+++.|+|||++.. ..++.++||||||+++|||+||+.||......... ... ..
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 147 LARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred ceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9865432211 1122356889999998865 45789999999999999999999998643211000 000 00
Q ss_pred ccchhh-hhhHHhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VVPYIV-RDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.++... .......+...... ...........+.+++.+||+.||++|||++||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00000000000000 00001113456678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.38 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=197.2
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.+|+..+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA------------MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC------------CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 3577789999999999999988778899999875321 1235688999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++.... ..+++...+.++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCc
Confidence 99999999999999999996532 23578888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ .......++..|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------------- 208 (256)
T cd05112 146 MTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---------------- 208 (256)
T ss_pred ceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----------------
Confidence 9875432211 11112234678999999988889999999999999999998 88888643211
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+..+.+........+ ......+.+|+.+||+.+|++||++.|+++.|
T Consensus 209 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 209 EVVETINAGFRLYKP--RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHhCCCCCCCC--CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 011111111110000 01235577899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.22 Aligned_cols=260 Identities=25% Similarity=0.441 Sum_probs=198.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|+..+.||+|+||.||++.+. ++. .||+|.+... .......++.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----------TGPKANVEFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 46778889999999999999864 444 4678876432 11233456889999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++... ..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~k 149 (303)
T cd05110 77 VCLSP-TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVK 149 (303)
T ss_pred EEcCC-CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceE
Confidence 98754 4679999999999999987532 23578888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------------ 217 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------------ 217 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 999999975433222111122345778999999988899999999999999999997 8888753211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.+..+.+......+.+ ......+.+++.+||..+|++||+++|+++.|+++....
T Consensus 218 ----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 218 ----REIPDLLEKGERLPQP--PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----HHHHHHHHCCCCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111122111111111 112345678999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.99 Aligned_cols=264 Identities=20% Similarity=0.352 Sum_probs=202.8
Q ss_pred CCCcCceeccCCceEEEEEEEcC--CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc-CCCCCceeEEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDD--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR-LHHKNLVRLLGFCE 536 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~ 536 (768)
+|+..+.||+|+||.||++..+. ++.+|+|.+........ ......+....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc-cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 37778899999999999999764 68899998865422110 0112233455678889998875 79999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+.+..+++|||+++++|.+++.........+++..+++++.|++.+|.|||+ .+ |+|+||||+|||++.++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999999885432233446788899999999999999996 55 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||++....... ......++..|++||.+....++.++||||||+++|||++|+.||......
T Consensus 157 dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------------- 219 (269)
T cd08528 157 DFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------------- 219 (269)
T ss_pred cccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------------
Confidence 999997544332 112345889999999999888999999999999999999999998533110
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
.....+.+....+.. .......+.+++.+||+.||++||++.|+..+|+
T Consensus 220 -~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 -SLATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHHHHhhccCCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 011112222111111 1123456779999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=327.27 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=205.2
Q ss_pred CCcCceeccCCceEEEEEEEc-CC----CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DG----SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g----~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
++..++||+|+||+||||.+- .| .+||||++... .......+|++|+..|.+++|||+++|++++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----------t~~~~s~e~LdeAl~masldHpnl~RLLgvc 767 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----------TSPKASIELLDEALRMASLDHPNLLRLLGVC 767 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----------CCchhhHHHHHHHHHHhcCCCchHHHHhhhc
Confidence 344688999999999999753 33 57888887543 2234567899999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.... ..||++||+.|+|.||++.++. .+-....+.+..||++||.|||++. ++||||..+|||+..-..+||.
T Consensus 768 ~~s~-~qlvtq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 768 MLST-LQLVTQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred ccch-HHHHHHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEE
Confidence 8776 7899999999999999987543 2455677899999999999999988 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||+++....+..........-.+.|||-|.+....|+.++|||||||++||++| |..|++...
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--------------- 905 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--------------- 905 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------------
Confidence 9999987655443333223344678999999999999999999999999999998 888876432
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.+++...+...-+.+. .......+..++.+||..|++.||+++|+...+.+...
T Consensus 906 -~~eI~dlle~geRLsq--PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 906 -AEEIPDLLEKGERLSQ--PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -HHHhhHHHhccccCCC--CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 2445555554333222 22334556678999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.60 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=196.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
..+|.+.+.||+|+||.||++... .+..|++|.+... ..+.+|++++++++||||++++++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------------~~~~~E~~il~~l~h~~iv~~~~~ 154 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------------KTPGREIDILKTISHRAIINLIHA 154 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------------ccHHHHHHHHHhcCCCCccceeee
Confidence 357999999999999999999753 3578999976421 234679999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+......+++||++. ++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 155 ~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 155 YRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEE
Confidence 999999999999986 589888843 234688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc---
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV--- 690 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~--- 690 (768)
+|||++................||+.|+|||++....++.++|||||||+||||++|+.||.......... +....
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99999975443332222234568999999999998899999999999999999999999986543221000 00000
Q ss_pred ------cchhhhhhHHhh---hccCCCCCCc-----chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 ------VPYIVRDEIHRV---LDRNVPPPTP-----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 ------~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+......+.+. +.....++.. ........+.+++.+||..||++||++.|++..
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0000000000 001123567789999999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.52 Aligned_cols=198 Identities=23% Similarity=0.336 Sum_probs=158.0
Q ss_pred CceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc--C
Q 046311 464 DHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED--R 538 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 538 (768)
.++||+|+||.||+++.. +++.+|+|.++.. .....+.+|++++++++||||+++++++.. .
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-------------GISMSACREIALLRELKHPNVISLQKVFLSHAD 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-------------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC
Confidence 468999999999999864 4678999987532 112356789999999999999999998854 4
Q ss_pred CeeEEEEEeccCCChhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE----CCC
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQS-----SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DAT 609 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl----~~~ 609 (768)
...+++|||+.+ +|.+++..... ....+++.....++.|++.||+|||+++ |+||||||+|||+ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER 148 (317)
T ss_pred cEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCc
Confidence 567899999864 88888753221 1224677888999999999999999998 9999999999999 456
Q ss_pred CcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 610 WTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
+.+||+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7899999999975433221 111223468999999999876 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.02 Aligned_cols=271 Identities=28% Similarity=0.419 Sum_probs=203.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.|+..+.||+|+||.||+++++ ++..+|||.++.... ......|.+|+++++.++||||++++++
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~~ei~~l~~l~~~~i~~~~~~ 74 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----------EQHRSDFEREIEILRTLDHENIVKYKGV 74 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc----------hHHHHHHHHHHHHHHhCCCCChheEEee
Confidence 5677789999999999999854 368899998864311 1345689999999999999999999999
Q ss_pred EEc--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 535 CED--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 535 ~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
+.. ....+++|||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+ |+|+||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 75 CEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLV 148 (284)
T ss_pred eecCCCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCE
Confidence 877 557899999999999999997543 23688899999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 613 KVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+|+|||++......... .......++..|++||.+....++.++||||||+++|||+||+.|+............. ..
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~ 227 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQ 227 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-cc
Confidence 99999999765422211 11112234567999999988889999999999999999999998875432211000000 00
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.......+.+.+........ ....+..+.+|+.+||+.+|++||++.||+++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 GQMIVTRLLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccHHHHHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00011122222222221111 112335677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.14 Aligned_cols=239 Identities=25% Similarity=0.415 Sum_probs=183.2
Q ss_pred eeccCCceEEEEEEEcC-------------------------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHH
Q 046311 466 KIGSGSFGAVYKATLDD-------------------------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~-------------------------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 520 (768)
.||+|+||.||+|.+.. ...|++|.+... ......+|.+|+.++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~~~~~~ 70 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----------HRDIALAFFETASLM 70 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----------HHHHHHHHHHHHHHH
Confidence 59999999999997521 134777776432 122345788999999
Q ss_pred hcCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 046311 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600 (768)
Q Consensus 521 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK 600 (768)
+.++||||+++++++.+....++||||+++++|.+++.... ..+++..+++++.|+++||+|||+++ |+|||||
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlk 144 (274)
T cd05076 71 SQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVC 144 (274)
T ss_pred hcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCC
Confidence 99999999999999999999999999999999999986532 23578889999999999999999988 9999999
Q ss_pred CCCeEECCCC-------cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHH-cC
Q 046311 601 SSNVLLDATW-------TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEIL-SG 671 (768)
Q Consensus 601 p~NILl~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~ell-tG 671 (768)
|+|||++.++ .+|++|||++....... ...++..|+|||.+.. ..++.++||||||+++|||+ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997643 48999999885432211 1246788999998865 56899999999999999984 78
Q ss_pred CcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
+.||....... ..+.+......+.+ ....+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~~p~~~~~~~~----------------~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 219 EVPLKERTPSE----------------KERFYEKKHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CCCccccChHH----------------HHHHHHhccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 88886432211 11111111111111 1235678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.77 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=199.5
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||.|+||.||++.. .+++.|++|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----------QPKKELIINEILVMKELKNPNIVNFLDSFLV 87 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----------CchHHHHHHHHHHHHhcCCCceeeeeeeEec
Confidence 3688889999999999999985 478999999885421 1234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... .+++..++.++.|++.+|+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999998542 3588899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....++..|+|||.+....++.++||||||+++|||++|+.||...... +
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---------------~ 222 (296)
T cd06655 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------R 222 (296)
T ss_pred ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Confidence 998754332221 12335789999999998888999999999999999999999998643221 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.... .+...........+.+++.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 223 ALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHhcC-CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011111111 11111112234567789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.33 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=193.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||+|.+.... .......+.|.+|+.++..++|+||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--------MLKRAETACFREERDVLVNGDRRWITNLHYAFQD 72 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--------HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 46888999999999999999865 68999999986421 1112345668899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999999996422 23577788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++......... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 147 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----------- 214 (331)
T cd05597 147 GSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------- 214 (331)
T ss_pred CceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----------
Confidence 998654322211 1122358999999999863 45788999999999999999999998643210
Q ss_pred hhhhhhHHhhhccC--CCCCCcchHHHHHHHHHHHHHcccccCC--CCCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRN--VPPPTPFEIEAVAYVGYLAADCVTLEGR--NRPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~Cl~~dP~--~RPs~~evl~~ 745 (768)
+....++... ...+ ......+..+.+++.+|+..+++ .||+++++++.
T Consensus 215 ----~~~~~i~~~~~~~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 215 ----ETYGKIMNHKEHFQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----HHHHHHHcCCCcccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0111111110 1100 00111344566788887755443 37899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.78 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=193.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+++++.++||||+++++++...+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence 556688999999999999876 5778888887432 2234567899999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++.... ..+++..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccc
Confidence 9999999999999999886422 23688899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+........ ......++..|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------- 214 (282)
T cd06643 150 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------------- 214 (282)
T ss_pred ccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------------
Confidence 865432211 112345889999999984 345778999999999999999999998643210
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+..........+ ...........+.+++.+||+.+|.+||++.++++.
T Consensus 215 --~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 215 --RVLLKIAKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --HHHHHHhhcCCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111111110 001111234567799999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=310.21 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=196.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|++.++||+|+||.||+++.. +++.+++|.+... .......+.+|+.+++.++||||+++++.+..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 56888899999999999999876 5889999987532 23446778899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+...++||||+++++|..++.+.. ..+++..++.++.|++.+|+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccC
Confidence 999999999999999998875432 23578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++........ ......+++.|+|||++. ...++.++||||||+++|||++|+.|+......
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------- 221 (292)
T cd06644 155 GVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------- 221 (292)
T ss_pred ccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----------
Confidence 99864322111 112335788999999984 345688999999999999999999988543210
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+......+ ...........+.+++.+||+.+|++||+++|+++
T Consensus 222 ----~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 ----RVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----HHHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011111111111 11111223345678999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=306.82 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=199.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|.+.+.||+|+||.||+|... +++.+|+|.+....... ....+.....+.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSA--SSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCccc--chhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Confidence 4677889999999999999864 68899999886542211 00111223346788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++... ..+++.....++.|++.+|+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 9999999999999999999653 23577788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCC----cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 619 LSLIGPEDDE----SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 619 la~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+++....... ........++..|+|||.+....++.++||||||+++|||++|+.||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------- 218 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------------- 218 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------------
Confidence 9875432111 01111235788999999998888999999999999999999999998643210
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+.+......+ .........+.+++.+||+.+|++||++.|+++
T Consensus 219 --~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 --QAIFKIGENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --HHHHHHhccCCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111111111 111123456778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=307.67 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=196.2
Q ss_pred CCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
|.+.+.||+|+||.||++.+. +++.||||++... .......+++.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---------IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSL 71 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---------cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 556788999999999999753 3688999988543 122334567899999999999999999999886
Q ss_pred cCC------eeEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 537 DRN------ERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 537 ~~~------~~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
..+ ..++++||+++++|.+++.... .....+++...++++.|++.+|+|||+.+ |+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~ 148 (273)
T cd05074 72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNE 148 (273)
T ss_pred cCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcC
Confidence 532 2478899999999998875322 11223578888999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~ 687 (768)
++.+||+|||+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+...... ..
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~- 224 (273)
T cd05074 149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI- 224 (273)
T ss_pred CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH-
Confidence 99999999999875433322222222345678999999988889999999999999999999 78877533210 00
Q ss_pred ccccchhhhhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 688 DFVVPYIVRDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
....... ..... ......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 225 -----------~~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 -----------YNYLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----------HHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111111 11111 12235677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.56 Aligned_cols=268 Identities=18% Similarity=0.263 Sum_probs=192.3
Q ss_pred cCceeccC--CceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 463 EDHKIGSG--SFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 463 ~~~~LG~G--~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+.++||+| +|++||++..+ +++.||+|+++... ........+.+|+++++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh---------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 35789999 68899999865 78999999986431 11234456788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++..... ..+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+++.||+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~ 147 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS 147 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccch
Confidence 99999999999999999964322 23578889999999999999999998 99999999999999999999999986
Q ss_pred cccCCCCCC-c----ccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccccccc
Q 046311 620 SLIGPEDDE-S----HLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFVV 691 (768)
Q Consensus 620 a~~~~~~~~-~----~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~ 691 (768)
......... . .......++..|+|||++.. ..++.++||||||+++|||++|+.||......... .......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 227 (327)
T cd08227 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 227 (327)
T ss_pred hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCc
Confidence 532211110 0 01112346778999999875 46899999999999999999999999643211000 0000000
Q ss_pred chhh------hhhHH-----hhhcc----------CC-----CCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIV------RDEIH-----RVLDR----------NV-----PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~------~~~~~-----~~~~~----------~~-----~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+... .++.. ...+. .. ....+........+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00000 00000 00 0001122234567889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.34 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|.+.+.||+|+||.||+|...+ ...|+||..... ......+.|.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----------TSPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----------CCHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 457788999999999999998643 246889976532 112345679999999999999999999998
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+ +..++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||
T Consensus 76 ~~~-~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 76 ITE-NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred EcC-CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEE
Confidence 875 45789999999999999996532 23588899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||++.......... .....++..|+|||.+....++.++||||||+++|||++ |+.||.......
T Consensus 149 ~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------- 216 (270)
T cd05056 149 GDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----------- 216 (270)
T ss_pred ccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----------
Confidence 9999987543332111 112234568999999988889999999999999999996 999986432211
Q ss_pred hhhhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 694 IVRDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 694 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
....+... ..+.+ ...+..+.+++.+|+..+|++|||+.|+++.|+++...
T Consensus 217 ----~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 217 ----VIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----HHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01111111 11111 12235677899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=322.11 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=194.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... .++.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---------cCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 468999999999999999999865 68899999875321 12234467889999999999999999999875
Q ss_pred cC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.. ...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCC
Confidence 43 357999999975 77777742 2467788899999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~ 689 (768)
.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... +...
T Consensus 164 ~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 164 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999975432211 123468999999999998899999999999999999999999996432111000 0000
Q ss_pred -c--cchhh---hhhHHhhhccCCC----------------CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 -V--VPYIV---RDEIHRVLDRNVP----------------PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 -~--~~~~~---~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. .+.+. ...+...+..+.. ............+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00000 0000111110000 0000111123456799999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.37 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----------QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----------cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 5788999999999999999986 478999999886431 1234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.+. ..++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcC
Confidence 99999999999999999998542 3577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+++.|+|||.+....++.++||||||+++|+|++|+.||........ ..
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~---------- 225 (297)
T cd06656 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY---------- 225 (297)
T ss_pred ccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----------
Confidence 998754332211 1233578899999999888899999999999999999999999964322110 00
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...... .+...........+.+++.+||+.+|++||+++++++.
T Consensus 226 ---~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 226 ---LIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---eeccCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00011112234556789999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.34 Aligned_cols=192 Identities=23% Similarity=0.310 Sum_probs=162.3
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
...+|++.+.||+|+||.||+++.. +++.||+|..... ....|+.++++++||||+++++++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------------~~~~E~~~l~~l~h~~iv~~~~~~ 126 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------------TTLIEAMLLQNVNHPSVIRMKDTL 126 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------------ccHHHHHHHHhCCCCCCcChhheE
Confidence 3457999999999999999999876 5678999964211 134689999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
......++||||+. ++|.+++.... ..+++..+++++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 127 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 127 VSGAITCMVLPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EeCCeeEEEEEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999995 58998886432 34688999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
|||+++....... .....||+.|+|||++....++.++||||||+++|||+++..++
T Consensus 200 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999874322111 12346899999999999889999999999999999999876554
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.31 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=199.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||.|+||.||+++.. +++.|++|.+.... .......+.+|+++++.++|+||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK 70 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE
Confidence 36778899999999999999865 68999999876431 12344678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++|+||+++++|.++++.. .+++...+.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 142 (274)
T cd06609 71 GSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADF 142 (274)
T ss_pred CCeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccc
Confidence 99999999999999999999753 4588899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......++..|+|||.+....++.++||||||+++|||+||+.||.......
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------------- 205 (274)
T cd06609 143 GVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------------- 205 (274)
T ss_pred ccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---------------
Confidence 99976543221 1123457889999999998889999999999999999999999986432110
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.....+... .......+.+++.+||..+|++||+++++++.
T Consensus 206 -~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 206 -VLFLIPKNNPPSLE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -HHHHhhhcCCCCCc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00011111111111 01134557789999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.26 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=198.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|...+.||+|+||.||+|... +++.+|+|.++....... ..........+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAG-RHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhc-ccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 4677889999999999999864 689999998864321100 00011122345788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.++++.. ..+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 9999999999999999999754 23577888899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCC--CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
++................++..|+|||.+.... ++.++|+||||+++|||++|+.|+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------------- 218 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------------- 218 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---------------
Confidence 987543222111122345789999999987654 789999999999999999999998532110
Q ss_pred hhHHhhhccC--CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRN--VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+..... ...+.....+....+.+++.+||+.+|++||++++|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0011111110 01111112234567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.13 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=197.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc-
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED- 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 537 (768)
+|++.+.||+|+||.||+++.+ +++.+++|++.... ......+.+.+|++++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4788899999999999999865 57899999986431 112345578899999999999999999998764
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....+++|||+++++|.+++.... ...+++..++.++.+++.+|+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecc
Confidence 446789999999999999997532 234688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ......+++.|+|||++....++.++||||||+++|||++|+.||..... ..
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---------------~~ 209 (257)
T cd08223 147 GIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------------NS 209 (257)
T ss_pred cceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------------HH
Confidence 99875432221 12234578999999999988899999999999999999999998853211 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..........+. ........+.+++.+||+.+|++||++.|+++
T Consensus 210 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 210 LVYRIIEGKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHhcCCCC---CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111122221211 11234456779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.23 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=193.9
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
+++++.....||+|+||.||+++.. ++..|++|.+... .....+.+.+|++++++++|+||+++++++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----------DSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----------CHHHHHHHHHHHHHHHhcCCCCeeeeeeee
Confidence 3456666678999999999999865 6788999987532 122446789999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKV 614 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl 614 (768)
...+..++||||+++++|.+++...... ...++..+..++.|++++|+|||+.+ |+||||||+||+++. ++.++|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 75 SENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred ccCCEEEEEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEE
Confidence 9999999999999999999999753211 11267778889999999999999998 999999999999976 679999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccC--CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... .....+++.|+|||++... .++.++||||||+++|||++|+.|+........ ..
T Consensus 151 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~---- 221 (268)
T cd06624 151 SDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AM---- 221 (268)
T ss_pred ecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hH----
Confidence 999998654322211 1123578999999998654 478999999999999999999999854221100 00
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......... ..........+.+++.+||+.+|++|||+.|+++
T Consensus 222 ------~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 222 ------FKVGMFKIH---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------hhhhhhccC---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000000000 0111223455778999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=303.21 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=200.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.+|++... +++.|++|++.... .......++.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK---------MSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh---------CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 4788899999999999999865 68999999986431 1123446789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++..... ...++...++++.|++.+|.|||+++ ++|+||+|+|||++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~ 146 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFG 146 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999999865321 23578888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....+++.|+|||++....++.++|+||||+++|||++|+.|+..... .+.
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------------~~~ 209 (256)
T cd08218 147 IARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---------------KNL 209 (256)
T ss_pred ceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---------------HHH
Confidence 98754332211 1233578899999999888899999999999999999999999863211 111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+.+....+. ........+.+++.+||+.+|++||++.||++
T Consensus 210 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 210 VLKIIRGSYPP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHhcCCCCC---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22222222221 11233456779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.69 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=195.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||+|.+.... .........+.+|..++..++|+||+++++++.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~ 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--------MLKRAETACFREERNVLVNGDCQWITTLHYAFQD 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 46888999999999999999876 67889999886421 1112334568889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++++... ..+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEec
Confidence 999999999999999999997532 23577788889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++.......... .....||+.|+|||++.. ..++.++||||||++||||++|+.||......
T Consensus 147 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------- 214 (331)
T cd05624 147 GSCLKMNQDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------- 214 (331)
T ss_pred cceeeccCCCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----------
Confidence 9987543322211 123468999999999875 46788999999999999999999998643210
Q ss_pred hhhhhhHHhhhccC--CCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRN--VPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
+....++... .+.+. ...+....+.+++.+|+..++++ |++++++++.
T Consensus 215 ----~~~~~i~~~~~~~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ----ETYGKIMNHEERFQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----HHHHHHHcCCCcccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111222111 11111 11123455678899988866544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.45 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=198.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++..+ ++..+|+|.+... .....+.|.+|++++++++||||+++++++..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence 46888899999999999999875 6899999987642 22345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++.... ..+++...++++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~ 147 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADF 147 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccC
Confidence 999999999999999999986532 23678889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++......... .....+++.|++||++. ...++.++||||||+++|||++|+.||......
T Consensus 148 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----------- 214 (280)
T cd06611 148 GVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----------- 214 (280)
T ss_pred ccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----------
Confidence 998654322211 12345789999999975 344678999999999999999999998643210
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.......... .+...........+.+++.+||+.+|++||++.++++.
T Consensus 215 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 ----RVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----HHHHHHhcCC-CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111111111 11111112234567789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.64 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=194.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||+|.++... ......+.+|+.+++.++||||+++++.+..
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~ 77 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR 77 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 36777789999999999999865 68899999876431 1233567889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... .+++...+.++.|++.+|+|||+++ |+|+||||+||+++.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 999999999999999999986432 3578889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++........ ......|+..|+|||++. ...++.++||||||+++|||++|+.|+........
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----------- 217 (267)
T cd06645 151 GVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----------- 217 (267)
T ss_pred eeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----------
Confidence 99865432211 112346899999999874 45688999999999999999999999854321100
Q ss_pred hhhhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..........++ ..........+.+++.+||+.+|++||++++|++
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 218 ----LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ----HHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000111100 0001122345678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.43 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----------GDDFEIIQQEISMLKECRHPNIVAYFGSYLR 71 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----------hhhHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence 57888999999999999999875 57889999886431 1245678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+++|||+++++|.+++.... ..++......++.|++.+|+|||+++ |+|+||||+||+++.++.+||+||
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECcc
Confidence 999999999999999999986532 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC---CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++........ ......++..|+|||.+... .++.++||||||+++|||+||+.|+......
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------------- 210 (262)
T cd06613 146 GVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------------- 210 (262)
T ss_pred ccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------------
Confidence 99865432211 11233578899999998766 7899999999999999999999998643211
Q ss_pred hhhhHHhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+...........+ ...........+.+++.+||..+|.+||++.+|++
T Consensus 211 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 211 --RALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --HHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011111111111 11122344567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.97 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=199.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc-
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED- 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 537 (768)
+|+..+.||.|+||.||++... +++.+++|++.... ......+.+.+|++++++++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---------MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---------CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 4777899999999999999864 67899999886431 123345678899999999999999999998754
Q ss_pred -CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEecCCCCCCeEECCCCc
Q 046311 538 -RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH-----EYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 538 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH-----~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
....+++|||+++++|.+++.........+++...+.++.|++.+|+||| +.+ |+|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45678999999999999999754333445688899999999999999999 666 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||++......... .....+++.|+|||.+....++.++|+||||+++|+|++|+.|+.....
T Consensus 149 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------- 215 (265)
T cd08217 149 VKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----------- 215 (265)
T ss_pred EEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----------
Confidence 999999999765433321 1233588999999999888899999999999999999999999864321
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++.+.+.....+ .........+.+++.+|++.+|++||+++||++.
T Consensus 216 -----~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 -----LQLASKIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----HHHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111111111111 1122344667799999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.59 Aligned_cols=238 Identities=28% Similarity=0.434 Sum_probs=184.5
Q ss_pred ceeccCCceEEEEEEEcCCC-----------eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 465 HKIGSGSFGAVYKATLDDGS-----------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~-----------~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
+.||+|+||.||++.+.+.. .+++|.+... ......|.+|+.++++++||||+++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------------HRDSLAFFETASLMSQLSHKHLVKLYG 68 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------------hhhHHHHHHHHHHHHcCCCcchhheee
Confidence 46999999999999876432 4677765422 111578899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC---
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW--- 610 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~--- 610 (768)
++.. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 69 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 69 VCVR-DENIMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred EEec-CCcEEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCcccc
Confidence 9988 778999999999999999975432 4578889999999999999999998 99999999999999887
Q ss_pred ----cEEEeeccccccCCCCCCcccccccccccCccCccccccC--CCCChhhHHHHHHHHHHHHcC-CcccccCCCCCc
Q 046311 611 ----TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSG-YRAIHRTHNGTP 683 (768)
Q Consensus 611 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltG-~~p~~~~~~~~~ 683 (768)
.+||+|||++....... ...++..|+|||++... .++.++||||||+++|||++| ..|+.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~- 214 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE- 214 (259)
T ss_pred CCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-
Confidence 79999999987543311 22467789999998876 789999999999999999994 66654332110
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
. ..........+ .+. ...+.+++.+||..+|++||++.|+++.|+
T Consensus 215 --~------------~~~~~~~~~~~-~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 --K------------ERFYQDQHRLP-MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --H------------HHHHhcCCCCC-CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00001111111 111 156779999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.38 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=194.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||++... ++..|++|++...... .........+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES------PETSKEVSALECEIQLLKNLQHERIVQYYGCLRD 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC------chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence 46888999999999999999864 6899999988643211 1112344678899999999999999999998865
Q ss_pred --CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 --RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
....+++|||+++++|.+++.... .+++...+.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 356789999999999999996532 2577888899999999999999988 9999999999999999999999
Q ss_pred eccccccCCCCCC-cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||++........ ........++..|+|||.+....++.++||||||+++|||++|+.||.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------------- 214 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------------- 214 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------------
Confidence 9999865432111 1111123578899999999888899999999999999999999999864311
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+.........+ .........+.+++ +||..+|++||+++||++
T Consensus 215 -~~~~~~~~~~~~~~--~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 -MAAIFKIATQPTNP--QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HHHHHHHhcCCCCC--CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111111111111 11122334555666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.19 Aligned_cols=260 Identities=24% Similarity=0.303 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||.|++|.||++... +++.+|+|.+.... ......++.+|++++++++||||+++++++.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 70 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----------NPDLQKQILRELEINKSCKSPYIVKYYGAFLD 70 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc
Confidence 36778899999999999999975 68899999876431 12345678999999999999999999998865
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. ...++||||+++++|.+++.........++......++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~ 147 (287)
T cd06621 71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLC 147 (287)
T ss_pred cCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEe
Confidence 4 4689999999999999987643323344577888999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||++........ ....++..|+|||.+....++.++||||||+++|||++|+.||........ ...+
T Consensus 148 dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~------- 215 (287)
T cd06621 148 DFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIE------- 215 (287)
T ss_pred ecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHH-------
Confidence 9999864332211 123468899999999888999999999999999999999999875422100 0000
Q ss_pred hhhHHhhhccC---CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRN---VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~---~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
......+.. +.............+.+++.+||+.+|.+|||+.|+++.
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 216 --LLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --HHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 011111100 011111112245668899999999999999999999883
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.18 Aligned_cols=247 Identities=32% Similarity=0.513 Sum_probs=195.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.+|++.+.||+|+||.||++.. +++.||+|.++.. .....|.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-------------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-------------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 3578889999999999999975 4788999987532 1235788999999999999999999998654
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
..+++|||+++++|.+++.... ....++..++.++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCc
Confidence 5799999999999999997543 223578888999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ ....+..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 146 ~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------------- 204 (254)
T cd05083 146 LARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---------------- 204 (254)
T ss_pred cceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----------------
Confidence 9875332111 1234568999999988889999999999999999998 88887543211
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
+....+........ ....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 205 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 205 EVKECVEKGYRMEP--PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHhCCCCCCC--CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111111211111 11234567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.30 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=184.5
Q ss_pred ceeccCCceEEEEEEEcC--------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 465 HKIGSGSFGAVYKATLDD--------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~--------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
+.||+|+||.||++..+. ...+++|.+... .....+.|.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----------HRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-----------hHHHHHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 469999999999997642 234777766422 1234457889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc-----
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT----- 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~----- 611 (768)
..+..++||||+++|+|.++++.... .+++..+++++.|++.+|+|||+++ |+||||||+|||++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCC
Confidence 98999999999999999999975432 4578888999999999999999998 999999999999987765
Q ss_pred ---EEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCC-cccccCCCCCcccc
Q 046311 612 ---AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGY-RAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~ 686 (768)
++++|||++....... ...++..|+|||++.. ..++.++||||||+++|||++|. .|+.....
T Consensus 144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------ 211 (258)
T cd05078 144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------ 211 (258)
T ss_pred CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------
Confidence 6999999886433211 2357889999999876 45799999999999999999995 44432111
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
.............+.. ....+.+|+.+||+.+|++|||++++++.|+
T Consensus 212 ----------~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 ----------QKKLQFYEDRHQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------HHHHHHHHccccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011111111111111 1245679999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=308.45 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=198.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.+.||+|+||.||++..+ ++..+|+|.+... ..+.....+.+|++++++++||||+++++.+...
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 5778899999999999999876 7899999987532 1223456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..++||||+++++|.++++.... ...+++..+..++.|++.+|.|||+. + |+|+||||+|||++.++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999875321 23468889999999999999999974 5 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC------CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|++........ ....+++.|+|||.+... .++.++||||||+++|||++|+.||.......
T Consensus 148 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------- 214 (286)
T cd06622 148 GVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------- 214 (286)
T ss_pred CCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---------
Confidence 99865422211 123578899999998543 35889999999999999999999986432110
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+....+...+ ....+....+.+++.+||+.+|++||+++++++.
T Consensus 215 ---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 ---IFAQLSAIVDGDPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---HHHHHHHHhhcCCC---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 01112222222111 1122345667799999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.65 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||++... ++..+++|++.... .......+.+|++.++.++|+||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----------CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----------cchHHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence 36888999999999999999865 67899999875431 11245678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++++.... ...+++.....++.|++.+|+|||+.+ |+|+||||+||++++++.++|+||
T Consensus 71 ~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df 146 (267)
T cd06610 71 GDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADF 146 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccc
Confidence 9999999999999999999975322 123578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCc--ccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++......... .......++..|++||++... .++.++|+||||+++|||++|+.||.......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------------ 214 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------------ 214 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------------
Confidence 998654332221 122234688999999998766 78999999999999999999999986432210
Q ss_pred hhhhHHhhhccCCCCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+.+........ .........+.+++.+||+.+|++||+++|+++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 ---VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---hHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01111111111000 011233466779999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.49 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=198.3
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
..++|++.+.||+|+||.||++..+ +++.+++|.+... .....+|.+|+++++++ +|+||++++++
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 71 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------------EDEEEEIKEEYNILRKYSNHPNIATFYGA 71 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------------chhHHHHHHHHHHHHHhcCCCChheEEEE
Confidence 3578999999999999999999875 6789999987643 12346789999999999 79999999999
Q ss_pred EEcCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 535 CEDRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 535 ~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
+.+.. ..++||||+++++|.++++........+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~ 148 (275)
T cd06608 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTK 148 (275)
T ss_pred EEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEcc
Confidence 97644 489999999999999998754322344678889999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
++.+||+|||++........ ......++..|+|||++.. ..++.++||||||++||||++|+.||......
T Consensus 149 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-- 224 (275)
T cd06608 149 NAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-- 224 (275)
T ss_pred CCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--
Confidence 99999999999865432221 1123457899999998753 34678999999999999999999998632211
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.....+... ..+......+....+.+|+.+||..||++|||+.|+++
T Consensus 225 -------------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 -------------RALFKIPRN-PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -------------HHHHHhhcc-CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 11111122234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.08 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=210.5
Q ss_pred CCCcCceeccCCceEEEEEEEcC---C--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDD---G--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~---g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.....+.||.|-||.||+|...+ | -.||||..+.. ...+..+.|+.|..+|++++||||++|+|+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----------~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----------CTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----------CChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 34556789999999999997532 3 35888877653 334567889999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
|.+. ..++|||.++.|.|..||+.+.. .++.......++||..+|+|||+.. +|||||..+|||+...--+||
T Consensus 460 ~~e~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 460 CVEQ-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eecc-ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeee
Confidence 9765 67999999999999999987543 3467778899999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+||||++......+.+.+ ...-...|||||-+..++++.+||||-|||.+||+|. |..||....+.+...
T Consensus 533 aDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------- 603 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------- 603 (974)
T ss_pred cccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------
Confidence 999999987766665554 4456789999999999999999999999999999886 899998654432110
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.++..-+. +...++++.|..|+.+||..+|.+||.+.|+...|+++++....
T Consensus 604 --------~iEnGeRl--P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 604 --------HIENGERL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred --------EecCCCCC--CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 11111111 12234566777899999999999999999999999999984433
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.89 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.+|+..+.||+|+||.||+++.+ +.+.+++|.+... ..+.....|.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----------KDENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----------cchHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 46888899999999999999864 2467888876432 1223456799999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSS-----SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+++.+.+..++||||+++++|.++++..... ...+++..++.++.|++.+|+|||+.+ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~ 151 (275)
T cd05046 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVS 151 (275)
T ss_pred EEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEe
Confidence 9999999999999999999999999754321 124689999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccc
Q 046311 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNV 686 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~ 686 (768)
.++.++|+|||++......... ......++..|+|||.+....++.++||||||+++|||++ |..||......
T Consensus 152 ~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----- 225 (275)
T cd05046 152 SQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----- 225 (275)
T ss_pred CCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----
Confidence 9999999999998643222111 1112345778999999988888999999999999999998 77777532110
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
.............. .....+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 226 ----------~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 ----------EVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------HHHHHHHcCCcCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111111111110 01123356779999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.15 Aligned_cols=266 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
...++|+..+.||+|+||.||++... +++.||||++.... ........+.+|++++++++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---------QSLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---------hhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 44578999999999999999999864 68899999875321 112234567889999999999999999988
Q ss_pred EEcC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 535 CEDR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 535 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
+... ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~ 153 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNE 153 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECC
Confidence 7533 3568999987 7799888753 23578888999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NV 686 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~ 686 (768)
++.+||+|||++....... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ..
T Consensus 154 ~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 154 DCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999997543221 23468999999999876 57899999999999999999999998643211000 00
Q ss_pred ccc-------ccchhhhhhHHhhhccCCCCCCcch-----HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VDF-------VVPYIVRDEIHRVLDRNVPPPTPFE-----IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... ....+......+.+.. ++...... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000001111110 10000000 0112346789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.31 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=196.1
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
+..++||+|+|-+||||.+. +|.+||=-.++..+ ..+.+...++|..|+++|+.|+||||++++.++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d-------~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD-------VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH-------hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 33467999999999999765 57777754443321 12345567899999999999999999999999877654
Q ss_pred --eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEeec
Q 046311 541 --RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDF 617 (768)
Q Consensus 541 --~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~DF 617 (768)
..+|+|.+..|+|..|+++.+. .+......++.||++||.|||++. |||||||||-+||+|+. .|.|||+|+
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence 7899999999999999986543 467788999999999999999997 88999999999999975 589999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|||......... ...|||.|||||++. ..|++..||||||+.++||.|+..||...... .
T Consensus 191 GLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---------------A 250 (632)
T KOG0584|consen 191 GLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---------------A 250 (632)
T ss_pred hHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---------------H
Confidence 999764433222 357999999999988 89999999999999999999999999765331 1
Q ss_pred hH-HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EI-HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~-~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+ +++... .+|.. +..-..+.+.++|.+|+.. ..+|||+.|+|+.
T Consensus 251 QIYKKV~SG-iKP~s-l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 251 QIYKKVTSG-IKPAA-LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHcC-CCHHH-hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 22 223322 22211 1111135577999999999 9999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.59 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=197.9
Q ss_pred cHHHHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCC
Q 046311 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKN 527 (768)
Q Consensus 450 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpn 527 (768)
++.++....+.|+..+.||+|+||.||++... +++.+|+|.+... .....++..|+.+++++ +|+|
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~e~~~l~~~~~h~~ 74 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------EDEEEEIKLEINMLKKYSHHRN 74 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------------hHHHHHHHHHHHHHHHhcCCCc
Confidence 44445556678999999999999999999874 6889999987532 12345688899999998 7999
Q ss_pred ceeEEEEEEc------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 528 LVRLLGFCED------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 528 Iv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
|+++++++.. ....+++|||+++++|.+++..... ..+++..++.++.|++.+|+|||+.+ |+|+||||
T Consensus 75 i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~ 149 (282)
T cd06636 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149 (282)
T ss_pred EEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 9999999853 4578999999999999999965332 23567778889999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccc
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIH 676 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~ 676 (768)
+||++++++.++|+|||++........ ......+++.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 150 ~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 150 QNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 999999999999999999864432111 112345889999999985 3467889999999999999999999985
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..... ..+..... ... ........+..+.+++.+||+.||.+||++.||++
T Consensus 228 ~~~~~---------------~~~~~~~~-~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPM---------------RALFLIPR-NPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHH---------------hhhhhHhh-CCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 43211 00111111 111 11111234456789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.91 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=199.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.|++|.+.... .........+.+|+++++.++||||+++++.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--------LILRNQIQQVFVERDILTFAENPFVVSMFCSFET 72 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence 36888899999999999999876 57899999876431 1112334578899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..++||||+++++|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeC
Confidence 99999999999999999999653 23577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCC-------------cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 618 GLSLIGPEDDE-------------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 618 Gla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|+++....... ........++..|+|||.+....++.++|+||||+++|||++|+.||......
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--- 222 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--- 222 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 99863211100 00111235788999999998888999999999999999999999998532110
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
+............+.. ....+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 223 ------------~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 223 ------------ELFGQVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ------------HHHHHHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111111111111111 112345567999999999999999977666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.32 Aligned_cols=267 Identities=22% Similarity=0.350 Sum_probs=196.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.+ +++.||+|++..... .....+.+.+|++++++++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---------DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---------CccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 36888899999999999999876 689999998864311 11233567899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|..++... ..+++..++.++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~df 144 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDF 144 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcc
Confidence 99999999999998888876532 23588899999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++......... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+..............
T Consensus 145 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07847 145 GFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222 (286)
T ss_pred ccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999765433211 112357889999999865 46789999999999999999999998643321100000000000000
Q ss_pred hhHHhhhcc-------CCCCCC---c---chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDR-------NVPPPT---P---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~-------~~~~~~---~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+..+. ..+... + ........+.+|+.+||+.+|++||++.|+++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 223 -RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred -HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 000000 0 00122456779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.61 Aligned_cols=198 Identities=23% Similarity=0.341 Sum_probs=157.4
Q ss_pred CceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc--C
Q 046311 464 DHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED--R 538 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 538 (768)
..+||+|+||.||+++.+ ++..||+|.+... .....+.+|++++++++||||+++++++.. .
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-------------GISMSACREIALLRELKHPNVIALQKVFLSHSD 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-------------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC
Confidence 368999999999999865 3578999987532 122457789999999999999999998853 5
Q ss_pred CeeEEEEEeccCCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE----CCC
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQ-----SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DAT 609 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl----~~~ 609 (768)
...++||||+++ +|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER 148 (317)
T ss_pred CeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCC
Confidence 578899999875 8888774321 11224677888899999999999999998 9999999999999 566
Q ss_pred CcEEEeeccccccCCCCCCc-ccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 610 WTAKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
+.+||+|||+++........ .......+|+.|+|||++.. ..++.++||||||+++|||+||+.||...
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 79999999999754332211 11123467999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=311.53 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=194.7
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
.....||+|+||.||++... ++..||||.+... .....+.+.+|+.+++.++||||+++++.+...+.
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 33467999999999999865 6889999987532 12345668899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.++||||+++++|.+++... .+++...+.++.|++.+|+|||+++ |+||||||+||++++++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcch
Confidence 99999999999999988532 2578889999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHH
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
......... .....++..|+|||.+....++.++||||||+++|||++|+.||...... .. ...+.
T Consensus 166 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~---------~~~~~ 231 (292)
T cd06658 166 AQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QA---------MRRIR 231 (292)
T ss_pred hhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---------HHHHH
Confidence 643322211 12345789999999998888999999999999999999999998632210 00 00111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+..... ........+.+++.+||..||++|||++|+++.
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPRVK----DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCccc----cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 111234457789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.06 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=201.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||++... +++.+|+|++... ..+...+.|.+|+++++.++||||+++++++..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----------AKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----------CcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 45777889999999999999865 6889999987542 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
....++||||+++++|.+++... ..+++.....++.+++.+|.|||+. + |+||||||+||++++++.++|+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEcc
Confidence 99999999999999999998653 2357888899999999999999974 5 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ ....++..|+|||++....++.++||||||+++|||+||+.||.......... ..+....
T Consensus 148 ~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~----~~~~~~~ 219 (284)
T cd06620 148 FGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ----DDPMGIL 219 (284)
T ss_pred CCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh----hhhhHHH
Confidence 999864322111 13468999999999988889999999999999999999999997543211000 0000001
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+.....+....+. ....+....+.+|+.+||+.||++||++.|+++..
T Consensus 220 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 DLLQQIVQEPPPR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHhhccCCC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1122222211111 11112445678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.80 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=199.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..+.||+|+||.||++..+ ++..||+|.++... .......+.+|++++++++||||+++++++.+.
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 4667788999999999999875 58899999876421 123456889999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++... .+++.....++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg 146 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccc
Confidence 9999999999999999998642 2467788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......++..|+|||++....++.++|+||||+++|||+||+.|+.......
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------------- 208 (277)
T cd06640 147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---------------- 208 (277)
T ss_pred cceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----------------
Confidence 9965433221 1122357889999999988889999999999999999999999986432110
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+....++ .........+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 209 VLFLIPKNNPP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HhhhhhcCCCC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00111111111 1223455678899999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.93 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=198.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.+|||++.... ........+.+|++++++++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---------MTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---------cccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 4778899999999999999864 68899999986431 1223456799999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-CcEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~~~kl~DF 617 (768)
+..++||||+++++|.+++.... ...+++..+++++.+++++|+|||+++ |+|+||||+||+++++ ..+||+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~ 146 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDF 146 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccC
Confidence 99999999999999999997532 233578888999999999999999998 9999999999999855 46899999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... ....++..|+|||.+....++.++||||||+++|+|++|+.||...... .
T Consensus 147 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---------------~ 208 (256)
T cd08220 147 GISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---------------A 208 (256)
T ss_pred CCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---------------H
Confidence 999754432221 1235788999999998888899999999999999999999998543211 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+........ ........+.+++.+||+.+|++|||++|+++
T Consensus 209 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 209 LVLKIMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHhcCCCC---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111111111 11123455779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.86 Aligned_cols=243 Identities=24% Similarity=0.296 Sum_probs=184.3
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEEEEEEcCCeeE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~ 542 (768)
||+|+||+||+++.. +++.||||++..... ..+.....+.+|..++.++ +||||+++++++.+.+..+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~ 72 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLY 72 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEE
Confidence 799999999999865 689999999864311 1122334455666666655 7999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 73 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 73 LVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 999999999999998643 23577888899999999999999998 99999999999999999999999999865
Q ss_pred CCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (768)
...... ......||+.|+|||++... .++.++||||||+++|||++|+.||...... +....
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---------------~~~~~ 208 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---------------QMYRN 208 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---------------HHHHH
Confidence 322221 12234689999999998754 5899999999999999999999998643210 01111
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC----CHHHHHH
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP----SMTEIVN 744 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP----s~~evl~ 744 (768)
+.......+.. .....+.+++.+||+.||++|| ++.|+++
T Consensus 209 i~~~~~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 209 IAFGKVRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHcCCCCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11111111111 1234566899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.52 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=197.3
Q ss_pred CCcCceeccCCceEEEEEEEcC-----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLDD-----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
|++.+.||+|+||.||+++... +..||+|.+.... .....+.+.+|++++++++|+||+++++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----------DEQQIEEFLREARIMRKLDHPNIVKLLGVC 70 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----------ChHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 3456889999999999998763 3889999875431 112556889999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..+++|||+++++|.+++...... .+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~ 145 (258)
T smart00219 71 TEEEPLMIVMEYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKIS 145 (258)
T ss_pred cCCCeeEEEEeccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEc
Confidence 9999999999999999999999753321 1588899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||++............ ...+++.|+|||.+....++.++||||||+++|||++ |+.|+.....
T Consensus 146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------------- 210 (258)
T smart00219 146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------------- 210 (258)
T ss_pred ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------------
Confidence 99999765443222211 2236789999999988889999999999999999998 7777653211
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
..+.+.+........ ....+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 211 --~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 --EEVLEYLKKGYRLPK--PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --HHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111111111111 111355678899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.41 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 537 (768)
..|++.++||+||.+.||++...+.+.+|+|++... ..+......|.+|+.+|.+| .|.+|++|++|-..
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~---------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL---------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh---------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 468888999999999999999888888999876432 34556678899999999999 59999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++.+||||||=+ .+|..+|++.... ..+| .+..+..|++.++.++|+++ |||.||||.|+|+- .|.+||+||
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeee
Confidence 999999999864 5999999865432 2345 66778899999999999999 99999999999985 479999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC-----------CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-----------QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
|+|.....+.........+||+.||+||.+... +.+.+|||||||||||+|+.|+.||......
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----- 578 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----- 578 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----
Confidence 999988777776667778999999999998532 2567999999999999999999999743211
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+..+.++...-+.+.-.+ ...+.++|+.||+.||++||+..|+|+.
T Consensus 579 ---------~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 ---------IAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---------HHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 123455555533211111111 1126799999999999999999999863
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.14 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=193.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH-HhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES-LSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||++..+ +++.||+|+++... ......++..|+.. ++.++||||+++++++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~ 70 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----------NSQEQKRLLMDLDISMRSVDCPYTVTFYGALF 70 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----------CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe
Confidence 36888899999999999999876 68999999886431 11223455566665 66679999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.....+++|||++ ++|.+++.........+++...+.++.|++.||+|||++ + ++||||||+|||++.++.+||+
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 71 REGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred cCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999999997 689888865333334578899999999999999999987 6 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|||++........ .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||......
T Consensus 147 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------- 213 (283)
T cd06617 147 DFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------- 213 (283)
T ss_pred ecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----------
Confidence 9999875432211 112357889999998864 45688999999999999999999998532110
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+...+....+. . .....+..+.+++.+||..+|++||++.++++
T Consensus 214 ----~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 214 ----FQQLKQVVEEPSPQ-L-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----HHHHHHHHhcCCCC-C-CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122222211111 0 01123456779999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.35 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=201.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++..+ +++.+++|++.... .+....++.+|++++++++||||+++++.+...
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 5677789999999999999876 68999999886431 124557789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
...++++||+++++|.+++.... ..++.....+++.|++++|+|||+ .+ ++|+||||+||++++++.++|+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~ 145 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDF 145 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999997532 345778888999999999999999 77 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... ...++..|+|||.+....++.++||||||+++|+|++|+.|+....... ... .+
T Consensus 146 g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~---------~~ 211 (265)
T cd06605 146 GVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGI---------FE 211 (265)
T ss_pred ccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccH---------HH
Confidence 998643221111 1457889999999988899999999999999999999999986542211 000 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....++...+.. . .......+.+++.+||..+|++||++.|+++.
T Consensus 212 ~~~~~~~~~~~~~-~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 212 LLQYIVNEPPPRL-P-SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHhcCCCCCC-C-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1222222221111 1 11145667899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.62 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=198.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.|++|.++... ..+.....+.+|++++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---------NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---------cchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5778899999999999999865 68999999986532 1134567899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++|+||+++++|.+++... ...++..+..++.+++++|+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g 144 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFG 144 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999999753 23577888899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCccc--ccccccccCccCccccccCC---CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 619 LSLIGPEDDESHL--SLRAAGTVGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 619 la~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
++........... .....++..|+|||++.... ++.++||||||+++|||++|+.||....... ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~-- 215 (264)
T cd06626 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QI-- 215 (264)
T ss_pred cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HH--
Confidence 9875443322111 11245788999999998665 8899999999999999999999986432100 00
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...... ...+..+........+.+++.+||+.+|++||++.|++.
T Consensus 216 -----~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 216 -----MFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----HHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 111111112223455678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.95 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=196.0
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|+||.||+|.+. +++.||+|.++... .......+.+|++++++++||||+++++++....
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 555678999999999999865 57889999875321 1234567899999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++.. ..+++..+..++.|++++|.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccc
Confidence 99999999999999999854 23577888999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+........ ......++..|+|||++....++.++||||||+++|||++|+.|+....... . .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~------------~ 210 (277)
T cd06642 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---V------------L 210 (277)
T ss_pred cccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---H------------H
Confidence 865432221 1112357889999999998889999999999999999999999986432111 0 0
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+.....+ .........+.+++.+||+.+|++||++.|+++.
T Consensus 211 -~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 -FLIPKNSPP--TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhhcCCCC--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011111111 1111234567799999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.94 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=200.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+.+|++++++++||||+++++.+.+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--------IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--------chHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence 6888899999999999999876 589999999864321 1123456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+.+++|.+++.... ...+++...+.++.|++++|+|||+.+ ++|+||||+|||++.++.++|+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 99999999999999999987432 234678888899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCc---------------------------ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC
Q 046311 619 LSLIGPEDDES---------------------------HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 619 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG 671 (768)
++......... .......||..|+|||++....++.++||||||+++|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98643221110 001123578899999999888899999999999999999999
Q ss_pred CcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC----HHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS----MTEIVN 744 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs----~~evl~ 744 (768)
+.||...... ....++.+.....+. .......+.+++.+||+.+|++||+ ++|+++
T Consensus 229 ~~pf~~~~~~---------------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 229 TTPFKGSNRD---------------ETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCchH---------------HHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9998643211 112223332222211 1124567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.86 Aligned_cols=265 Identities=20% Similarity=0.280 Sum_probs=193.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+++.. +|+.+++|+++.... .+.....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---------DEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---------cccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4778899999999999999875 689999999864311 122335677899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++|+||++ ++|.+++.... ..+++...+.++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg 144 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFG 144 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccc
Confidence 99999999997 48888875432 23688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh---
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI--- 694 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 694 (768)
++......... .....++..|+|||++.+. .++.++||||||+++|||+||..|+....... ...+......
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~ 220 (284)
T cd07839 145 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTP 220 (284)
T ss_pred hhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCC
Confidence 98754322111 1223568899999998664 47899999999999999999998864322110 0000000000
Q ss_pred hh---hhHHhhhccCCCCCC-------cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VR---DEIHRVLDRNVPPPT-------PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~---~~~~~~~~~~~~~~~-------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. ..+....+....+.. .........+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000010000000 001123456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.38 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=198.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+|... +++.|++|.+...... ...++..+.+.+|++++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG------QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc------ccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence 4677889999999999999876 7899999988654211 11233456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...+++|||+++++|.+++... ..+++..++.++.|++++|+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999653 23578888899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCC-CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++....... ......++..|++||.+.... ++.++|+||||+++|||++|+.||...... +
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---------------~ 209 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---------------A 209 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---------------H
Confidence 987543322 112345789999999987666 899999999999999999999998643210 0
Q ss_pred hHHhhhc-cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLD-RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~-~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+... ...+ .........+.+++.+||+.+|++||++.|+++
T Consensus 210 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 210 AVFKIGRSKELP---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhcccCC---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111111 0011 111123455678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.99 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=193.6
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
...||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 457999999999999865 68999999885431 123456889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++.. ..+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 95 iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 99999999999998753 23578889999999999999999998 99999999999999999999999999864
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
....... .....++..|+|||++....++.++||||||+++|||++|+.||...... +... .
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---------------~~~~-~ 228 (297)
T cd06659 167 ISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMK-R 228 (297)
T ss_pred ccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHH-H
Confidence 4322211 12345889999999998888999999999999999999999998643210 0001 1
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+.................+.+++.+||+.+|++||+++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1111111111111233557789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=298.96 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=194.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|++.+.||+|+||.||++... +++.|+||.+..... ..........+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE------SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcC------CcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence 46888999999999999999865 689999998764311 11112345678899999999999999999998876
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. ...+++|||+++++|.+++... ..+++...++++.|++.+|+|||+.+ |+|+||||+|||++.++.++|+
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 4 4678999999999999998643 22467778899999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||++......... .......++..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------- 215 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------------- 215 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------------
Confidence 99998753321111 1112235788999999998888999999999999999999999998632110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+.......+ .........+.+++.+|+. +|++||+++||++
T Consensus 216 --~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 216 --AAIFKIATQPTNP--VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --HHHHHHhcCCCCC--CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111111111111 1122334566788899984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.16 Aligned_cols=268 Identities=21% Similarity=0.322 Sum_probs=197.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+|... +++.|+||+++..... .........+.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERK------EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccc------cccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence 4777889999999999999865 6899999998754221 01122345678899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+ +++|.+++.... ..+++..++.++.|++++|+|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999 889999997533 24688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh---
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI--- 694 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 694 (768)
++.......... ....+++.|+|||.+.. ..++.++||||||+++|||++|..+|....... .........
T Consensus 148 ~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~ 222 (298)
T cd07841 148 LARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTP 222 (298)
T ss_pred eeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCC
Confidence 997544322111 12346788999998854 467899999999999999999977765432110 000000000
Q ss_pred hhhh------HHhhhccCCCCC---CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDE------IHRVLDRNVPPP---TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~------~~~~~~~~~~~~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.... ............ ..........+.+++.+||+.+|++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 000000000000 00111234667799999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.96 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=197.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.+.||+|+||.||+++.. +++.|++|++..... .+.....+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---------EGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 4778899999999999999875 689999999865321 123356789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+ +++|.+++.... ..+++..++.++.|++++|+|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeee
Confidence 9999999999 999999986533 34688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccc-c------
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVD-F------ 689 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~-~------ 689 (768)
++........ .......++..|+|||.+... .++.++||||||+++|||++|+.+|.......... ... .
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07832 145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223 (286)
T ss_pred ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence 9875543321 111234588999999998654 46899999999999999999977775332110000 000 0
Q ss_pred ccchhhh-hhHHhhhccCCCC--CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 VVPYIVR-DEIHRVLDRNVPP--PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++.... .....+....... ......+....+.+++.+||+.+|++||+++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000000000000 000001224677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.29 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=198.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.+|+|.+..... ........+.+|++++++++||||+++++++.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence 36888899999999999999875 689999998864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++... ..++...++.++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999653 23577888899999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++...... .....+++.|+|||.+.....+.++||||||+++|||++|+.||..... ..
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------------~~ 205 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---------------IQ 205 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 998764333 1233588999999999888889999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
....+.......+. .....+.+++.+||+.+|++|+ +++|+++
T Consensus 206 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 206 IYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHhcCCccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11122222222111 1245677899999999999998 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.10 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=200.0
Q ss_pred CCcCceeccCCceEEEEEEEc--CC--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD--DG--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~--~g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
....++||+|.||.|++|.|+ +| -.||||.++.... .....+|++|+.+|.+|+|||+++|||+..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----------~~~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----------NAIMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----------chhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 345578999999999999876 34 4689999876432 125678999999999999999999999998
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+ ....||||.++.|||.+.|++ .....+.......++.|||.||.||..+. +|||||..+|+||-....+||+|
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence 8 678899999999999999987 23344567778899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCC-cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchh
Q 046311 617 FGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 617 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||.+.....+. +.......-...|+|||.++..+++.+||||+|||+||||+| |+.|+-....
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------- 321 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------- 321 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------
Confidence 999986554332 222222334678999999999999999999999999999999 5566543221
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
..+.+.+|.+-+.+ ....+++.|.++++.||..+|++|||+..|.+.+
T Consensus 322 --~qIL~~iD~~erLp--RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 --IQILKNIDAGERLP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --HHHHHhccccccCC--CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 12333334322221 2234567788999999999999999999998544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.47 Aligned_cols=266 Identities=21% Similarity=0.320 Sum_probs=193.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||+++.. +++.|+||+++.... .......+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---------ccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 4788899999999999999875 689999998764321 122335788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+. ++|.+++.... ...+++...+.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg 145 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 145 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999996 58999886533 234578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc--------
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF-------- 689 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~-------- 689 (768)
++......... .....++..|+|||++... .++.++||||||+++|||+||+.||....... .....
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~ 221 (284)
T cd07860 146 LARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPD 221 (284)
T ss_pred chhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 98654322211 1223468899999988654 46889999999999999999999986432110 00000
Q ss_pred --ccchhhh-hhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 --VVPYIVR-DEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 --~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+.... .+....+....... ..........+.+++.+||+.||++||+++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000 00000000000000 0000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.83 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=199.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|..++.||.|+||.||.++.. +.+.||||++..+ .+...++..++++|+..|.+++|||++.+.++|..+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS--------GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--------GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccc--------ccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 3666788999999999999854 7889999988643 234456778999999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...|||||||-| |-.|+|.-.. ..+...++..|..+.+.||+|||+++ .||||||..||||++.+.|||+|||
T Consensus 99 ~TaWLVMEYClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 99 HTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred chHHHHHHHHhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeecccc
Confidence 999999999964 8888875432 23456677889999999999999999 8999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
.|.+..+.. .++|||.|||||++. .+.|+-|+||||||++..||...++|+..-+.
T Consensus 172 SAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------------- 230 (948)
T KOG0577|consen 172 SASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------- 230 (948)
T ss_pred chhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---------------
Confidence 987644332 458999999999975 56899999999999999999999888642211
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..-+.-+.+...+ .-...+.+..+.+++..||++-|.+|||.+++++.
T Consensus 231 MSALYHIAQNesP--tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 231 MSALYHIAQNESP--TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhcCCC--CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111122221111 11244677889999999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.60 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=192.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
+.+|+..+.||+|+||.||++... +++.|++|++.... .+.....+.+|+++++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 73 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT----------EEGVPFTAIREASLLKGLKHANIVLLHDIIH 73 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC----------cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 467899999999999999999864 68999999986431 1122346778999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.++..++||||+. ++|.+++.... ..+.+.....++.|+++||+|||+.+ |+|+||||+|||++.++++||+|
T Consensus 74 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~D 146 (291)
T cd07870 74 TKETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLAD 146 (291)
T ss_pred cCCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEec
Confidence 9999999999996 67877765422 22466777889999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc-c---c
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF-V---V 691 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~-~---~ 691 (768)
||+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||+...... ..+.+. . .
T Consensus 147 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~ 223 (291)
T cd07870 147 FGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGV 223 (291)
T ss_pred cccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCC
Confidence 9998753322211 122356899999999875 357889999999999999999999986432210 000000 0 0
Q ss_pred chhh--------hhhHHhhhccCCCCCC---cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIV--------RDEIHRVLDRNVPPPT---PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+.-. .+..........+... .........+.+++.+|++.||++|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 0000000000000000 000011345678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.55 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=192.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.+ +++.||||.+..... ......+.+|++++++++|+||+++++++.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE----------EGAPFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc----------cCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 57888999999999999999876 689999999864311 1122346789999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++ +|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 147 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADF 147 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcc
Confidence 9999999999985 9999886533 24578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh--
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI-- 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 694 (768)
|+++........ .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ..........
T Consensus 148 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~ 223 (291)
T cd07844 148 GLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGT 223 (291)
T ss_pred ccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCC
Confidence 998643221111 112246889999998865 457899999999999999999999985432100 0000000000
Q ss_pred -hhhhHH------hhhccCCCC--CCc-----chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 -VRDEIH------RVLDRNVPP--PTP-----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 -~~~~~~------~~~~~~~~~--~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+... +........ ... ........+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 000000000 000 00011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=318.07 Aligned_cols=195 Identities=29% Similarity=0.350 Sum_probs=166.6
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-C-----CCceeEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-H-----KNLVRLL 532 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~ 532 (768)
+|.+.+.||+|+||.|.|+.. ++++.||||+++... .-..+-..|+.+|..|+ | -|+|+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k------------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK------------RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh------------HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 788899999999999999975 479999999987542 22344567899999986 4 3899999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--CC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--TW 610 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--~~ 610 (768)
++|..+++.+||+|.++. +|+++|+.+... .++......|+.||+.+|.+||+.+ |||+||||+||||.+ ..
T Consensus 255 d~F~fr~HlciVfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eccccccceeeeehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcC
Confidence 999999999999999965 999999876543 3688899999999999999999998 999999999999964 34
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
.+||+|||.|+.....-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 799999999987544333 23457889999999999999999999999999999999776654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=298.28 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=200.0
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++.. .+++.+|+|.+...... ....+...+.+.+|++++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-----SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC-----chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 477889999999999999986 47899999988643211 111223457899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~kl~DF 617 (768)
+..++||||+++++|.+++... ..+++...+.++.|++.||+|||+++ ++|+||||+||+++.++ .+||+||
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 9999999999999999999643 23577888999999999999999998 99999999999998775 5999999
Q ss_pred cccccCCCCCCc--ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 618 GLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 618 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|++......... .......++..|+|||.+....++.++||||||+++|||++|+.||.........
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----------- 217 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----------- 217 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----------
Confidence 998654332111 1112345788999999998888999999999999999999999998643211100
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+.+....... ..........+.+++.+||+.+|++||++.|+++
T Consensus 218 -~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 -ALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HHHHHHhccCCC--CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011111111111 1122334566788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.90 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=196.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||.||++..+ +++.||+|++.... ......+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---------DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---------CcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 36888899999999999999976 58999999875421 112234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++.... ..+++..++.++.|++++|+|||+.+ |+|+||||+||++++++.++|+||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~df 144 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDF 144 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEee
Confidence 99999999999999998877542 22588999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccccccchhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFVVPYIV 695 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~ 695 (768)
|++......... .....++..|+|||++.. ..++.++||||||+++|||++|+.||......... ..... .....
T Consensus 145 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~-~~~~~ 221 (286)
T cd07846 145 GFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC-LGNLI 221 (286)
T ss_pred eeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-hCCCc
Confidence 998754332211 122357889999999865 45788999999999999999999888543211000 00000 00000
Q ss_pred hhhHHhhhcc------CCCCCCc-------chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDR------NVPPPTP-------FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~------~~~~~~~-------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......++. ...+... ........+.+++.+||+.+|++||++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 222 -PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred -hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 0000000 00123466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.44 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=197.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++..+ ++..+|+|.+.... ......+.+.+|++++++++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---------MPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---------ccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4778899999999999999876 58899999876431 1122345788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~kl~DF 617 (768)
...++||||+++++|.+++.... ...+++..++.++.|++++|+|||+.+ |+|+||||+||++++++ .+||+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~ 146 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDF 146 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccc
Confidence 99999999999999999996532 224588899999999999999999998 99999999999998875 4699999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|.+........ ......+++.|+|||++....++.++|+||||+++|||++|+.|+..... .+
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------------~~ 209 (257)
T cd08225 147 GIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---------------HQ 209 (257)
T ss_pred ccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HH
Confidence 99875433221 11223588999999999888899999999999999999999999853221 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+......... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 210 LVLKICQGYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHhcccCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112222211111 11223457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.36 Aligned_cols=267 Identities=20% Similarity=0.272 Sum_probs=192.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|+..+.||+|+||.||++... +++.||||.++... ........+.+|+.+++++ +||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---------DEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---------cccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36888899999999999999875 68999999875431 1122345688899999999 4699999999987
Q ss_pred cCCe-----eEEEEEeccCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-C
Q 046311 537 DRNE-----RVLIYEYLENGTLHDHLHNPQSS-SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-T 609 (768)
Q Consensus 537 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~ 609 (768)
..+. .++||||+++ +|.+++...... ...+++...+.++.||+++|.|||+++ |+||||||+||+++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7665 8999999986 898888653322 234688999999999999999999998 999999999999998 8
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
+.+||+|||++......... .....+++.|+|||.+.. ..++.++||||||+++|||++|..||....... ....
T Consensus 148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~ 223 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH 223 (295)
T ss_pred CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH
Confidence 89999999998754322111 112346888999998764 457899999999999999999999886432100 0000
Q ss_pred cc----------cchhhhhhHHhhhc-cCCCCC--CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FV----------VPYIVRDEIHRVLD-RNVPPP--TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~----------~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. .+.... ...... ....+. ..........+.+++.+||+.+|++||+++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 224 IFKLLGTPTEQVWPGVSK--LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHhCCCChhhCcchhh--ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000 000000 000000 0001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.31 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=195.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~ 535 (768)
.|+..+.||+|+||.||++... +++.+++|.++... ......++.+|+.++++++ |||++++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~ 71 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee
Confidence 4677889999999999999864 78999999875421 1234457889999999986 99999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+....++||||+++++|.++++.. .+++...+.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~ 143 (277)
T cd06917 72 LKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLC 143 (277)
T ss_pred eeCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEc
Confidence 9999999999999999999998642 3578889999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||++......... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||........
T Consensus 144 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----------- 210 (277)
T cd06917 144 DFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----------- 210 (277)
T ss_pred cCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----------
Confidence 99998754433221 123468899999998864 4568999999999999999999999864321110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. .+....++... .......+.+++.+||+.||++||++.|+++.
T Consensus 211 ----~~-~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 ----MM-LIPKSKPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----hh-ccccCCCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00 00000011000 11134567789999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.67 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|++|.||+++.+ +++.|+||++.... .......+.+|++.+.+++|+||+++++++..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYK 70 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc
Confidence 36788899999999999999876 58999999876431 11345789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+..++||||+++++|.+++... ..++...+++++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~d 143 (264)
T cd06623 71 EGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIAD 143 (264)
T ss_pred CCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999653 345788899999999999999999 88 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++.......... ....++..|+|||.+....++.++|+||||+++|||+||+.|+........ .
T Consensus 144 f~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~------------~ 209 (264)
T cd06623 144 FGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF------------F 209 (264)
T ss_pred CccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH------------H
Confidence 99987544322221 133578899999999988899999999999999999999999865432110 0
Q ss_pred hhHHhhhccCCCCCCcchHH-HHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIE-AVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+....+.....+. .... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 210 ELMQAICDGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHhcCCCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111222211111 1112 44667899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.25 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=194.6
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|...+.||+|++|.||++... +++.+++|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~ 89 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD 89 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC
Confidence 444578999999999999864 6889999987532 1123456889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
+.++++||+++++|.+++.. ..+++..++.++.|++.+|+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEccccc
Confidence 99999999999999999865 22577888999999999999999998 99999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+......... .....+++.|+|||.+....++.++||||||+++|||++|+.||...... ...
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---------------~~~ 224 (285)
T cd06648 162 CAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---------------QAM 224 (285)
T ss_pred chhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---------------HHH
Confidence 8644322211 12245889999999998888999999999999999999999998542110 001
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...... ..+...........+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 225 KRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHhc-CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111111 11111111123456789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.44 Aligned_cols=268 Identities=22% Similarity=0.326 Sum_probs=197.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++..+ +++.|++|+++... ........+.+|++++++++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---------DDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---------ccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 36888899999999999999876 58899999876431 122344678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+++|||++++.|..++... ..+++.....++.|++.+|+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~ 144 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEee
Confidence 99999999999987776665432 22578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++......... ......++..|+|||++... .++.++||||||+++|||++|+.||......+.............
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~- 222 (288)
T cd07833 145 GFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP- 222 (288)
T ss_pred ecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence 998765443321 11234578899999999877 889999999999999999999988864321100000000000000
Q ss_pred hhHHhhh------cc-CCCCCC-c------chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVL------DR-NVPPPT-P------FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~------~~-~~~~~~-~------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+ .. ..+... . ........+.+++.+||..+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 00 000000 0 01112566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.70 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=198.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...+.||+|+||.||++... ++..|++|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----------QQPKKELIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----------cchHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence 57888899999999999999864 6789999987532 11234678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++|+||+++++|.+++.+. .+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccC
Confidence 99999999999999999999642 2477888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+++.|++||.+....++.++||||||+++|||++|+.||........ +..
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~--------- 226 (293)
T cd06647 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL--------- 226 (293)
T ss_pred cceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee---------
Confidence 988644332221 1223578899999999888899999999999999999999999964322110 000
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..... .+...........+.+++.+||+.+|++||++.+++..
T Consensus 227 ----~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 ----IATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----hhcCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01111112234567789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.72 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=197.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
-|+..+.||+|+||.||++... +++.+|+|.+.... .......|.+|+.++++++||||+++++++.++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 3667789999999999999864 68899999875321 123446789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++... .+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecc
Confidence 9999999999999999998642 3578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....++..|+|||.+....++.++|+||||+++|||++|..|+...... .
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~ 208 (277)
T cd06641 147 VAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----------------K 208 (277)
T ss_pred cceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----------------H
Confidence 98654332211 11235788999999998888899999999999999999999988532210 0
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.....+ .........+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 209 VLFLIPKNNPP--TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHhcCCCC--CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01111111111 1112234557789999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.93 Aligned_cols=249 Identities=28% Similarity=0.391 Sum_probs=194.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||+++.. +++.||+|.+.... ........++.+|+++++.++||||+++++++.+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--------cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 45788899999999999999875 68999999875431 1122345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||++ |+|.+++.... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.+||+||
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeec
Confidence 999999999997 57877775422 23688889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++....... ...+++.|+|||++. ...++.++||||||+++|||+||+.|+......
T Consensus 160 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------------- 220 (307)
T cd06607 160 GSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------- 220 (307)
T ss_pred CcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------------
Confidence 9986543221 235788999999874 356888999999999999999999988532110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...........+ ..........+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 221 --SALYHIAQNDSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --HHHHHHhcCCCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000111111111 11122345568899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.78 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=200.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.+.|+..+.||+|+||.||++..+ ++..+++|+++... .....+.+|++.+++++|+||+++++++.
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------------QNKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc------------hhHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 456788889999999999999876 68999999986431 14567889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..++++||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d 159 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLAD 159 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECc
Confidence 9999999999999999999997643 24688899999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ ......++..|++||++....++.++||||||+++|||++|+.|+......
T Consensus 160 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------------- 222 (286)
T cd06614 160 FGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------------- 222 (286)
T ss_pred cchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------------
Confidence 999864332221 111234788999999998888999999999999999999999998532210
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
............ ...........+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 223 RALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHhcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 001111111111 111112244667899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.07 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=202.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++... +++.+++|++.... ........+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---------MSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---------CChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4778899999999999999875 68999999986431 1234556788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++|+||+++++|.+++.........+++..++.++.+++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999999765433355788999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ......+++.|+|||.+....++.++|+||||+++|+|++|+.|+...... +-
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------------~~ 211 (258)
T cd08215 149 ISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---------------EL 211 (258)
T ss_pred ceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---------------HH
Confidence 9875443321 122346788999999998888999999999999999999999998543210 01
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
............. ......+.+++.+||..+|++||++.|+++
T Consensus 212 ~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 212 ALKILKGQYPPIP---SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111221111111 123355778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=295.66 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=201.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.++||+|+||.||+++.+ +++.+++|.+.... ..+....++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---------MSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---------ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 4778899999999999999765 68899999886431 1223456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++.........+++...+.++.|++++|+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999998653333345688889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ ....++..|++||.+....++.++|+||||+++|||++|+.||...... +.
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------------~~ 209 (256)
T cd08530 149 ISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---------------DL 209 (256)
T ss_pred chhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HH
Confidence 9976543311 1235788999999998888999999999999999999999998643210 00
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.........+. ........+.+++.+|++.+|++||++.|+++
T Consensus 210 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 210 RYKVQRGKYPP---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHhcCCCCC---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111122221 11244566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.30 Aligned_cols=250 Identities=25% Similarity=0.288 Sum_probs=199.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|+||.||++..+ +++.+|+|.+.... .......+.+.+|++++++++||||+++++.+.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--------CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE 72 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--------hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC
Confidence 4788899999999999999876 68999999986431 11223457899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++... ..++......++.|++++|.|||+++ |+|+||||+||++++++.++|+|||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecc
Confidence 9999999999999999999653 24577888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ .....++..|+|||.+....++.++|+||||+++|+|++|+.||....... .+.
T Consensus 146 ~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------------~~~ 209 (258)
T cd05578 146 IATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-------------RDQ 209 (258)
T ss_pred cccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-------------HHH
Confidence 9875443321 123457889999999988889999999999999999999999987543211 111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH--HHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM--TEIV 743 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~--~evl 743 (768)
+........ .......+..+.+++.+||+.+|++||++ +|++
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 210 IRAKQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111111100 11112234667799999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=303.36 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=194.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+|+.+ +++.+++|.++.... .+.....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---------KEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc---------cccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 46888899999999999999976 688999999875421 12233467789999999999999999999877
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. ...++||||+++ +|.+++.... ..+++...++++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 76 SNLDKIYMVMEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred cCCCcEEEEehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEe
Confidence 7 889999999975 9999886533 24688899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccc-----
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVD----- 688 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~----- 688 (768)
|||++......... .....+++.|+|||.+... .++.++|+||||+++|||++|+.||.......... +..
T Consensus 149 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (293)
T cd07843 149 DFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226 (293)
T ss_pred ecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99998754432211 1123568899999998654 46899999999999999999999986432111000 000
Q ss_pred ----cc----cchhhhhhHHhhhccCCCCCCcchHH-HHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 ----FV----VPYIVRDEIHRVLDRNVPPPTPFEIE-AVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ----~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
|. .+........+.....+. ...... ....+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhh--ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000000000000000000 000001 2456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=300.66 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=193.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||.|.+|.||++... ++..|++|++..... .+.....+.+|++++++++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---------DEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---------cccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 566789999999999999865 789999999864321 1223356888999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..+++|||++ ++|.+++..... ..+++..++.++.|++++|+|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~ 145 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGL 145 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccc
Confidence 9999999995 699999865332 24688999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCc-ccccccc-------
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-RNVVDFV------- 690 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~------- 690 (768)
+......... .....++..|+|||++... .++.++||||||+++|||++|+.||........ ....+..
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 146 ARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred ccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 8654322111 1123468899999987654 578999999999999999999999864321100 0000000
Q ss_pred cchh-hhhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYI-VRDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
++.. ...+....+.. ...............+.+++.+||+.+|++||+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 00000000000 000000111122356779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=313.70 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=193.8
Q ss_pred eeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEE
Q 046311 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 544 (768)
+||+|.||+||.|+.. +...+|||.+... .....+-+.+|+.+-++|+|+|||+++|.+.+++.+-+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIF 650 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIF 650 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc-----------cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEE
Confidence 6999999999999865 5678899987543 223445688999999999999999999999999999999
Q ss_pred EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCcEEEeeccccccC
Q 046311 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLSLIG 623 (768)
Q Consensus 545 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~~kl~DFGla~~~ 623 (768)
||.++||||.++|+..-.... ..+.+.-...+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++..
T Consensus 651 MEqVPGGSLSsLLrskWGPlK-DNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLK-DNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCc-cchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh
Confidence 999999999999986433221 145566678899999999999998 99999999999996 4789999999988653
Q ss_pred CCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHh
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (768)
..-. .....+.||..|||||++.. ..|..++|||||||++.||.||++||....... ...+.+-
T Consensus 727 Agin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVG--------- 792 (1226)
T KOG4279|consen 727 AGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVG--------- 792 (1226)
T ss_pred ccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhc---------
Confidence 2222 22335679999999999975 468999999999999999999999997543211 0000000
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.-..+...+.......+|.+|+.+||.+||++.++++.
T Consensus 793 ----myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 793 ----MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ----ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 0111123345667777899999999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.30 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=199.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..+.||+|++|.||++... +++.+++|++.... ......+.+|++++++++|+||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 69 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----------KEKKEKIINEIQILKKCKHPNIVKYYGSYLKK 69 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 3677789999999999999976 68899999986431 13456889999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++++||+++++|.+++.... ..+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 70 ~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 70 DELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred CeEEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecc
Confidence 99999999999999999987532 34688899999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++........ .....++..|++||.+....++.++||||||+++|+|++|+.|+...... ..
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~ 205 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---------------KA 205 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---------------HH
Confidence 9876544332 12345789999999998888999999999999999999999998643210 00
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...... ...+...........+.+++.+||+.||++|||+.|+++
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 206 LFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 101111 111111111112456779999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=290.75 Aligned_cols=253 Identities=27% Similarity=0.425 Sum_probs=202.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|++|.||++..+ +++.|++|++..... .....+.+.+|++.+++++||||+++++.+.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---------SEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc---------chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4677899999999999999876 789999999865421 134567889999999999999999999999988
Q ss_pred --CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 539 --NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 539 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
...+++|||+++++|.+++.... .+++..++.++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcc
Confidence 88999999999999999997532 4688899999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||.+................++..|++||.+.....+.++||||||+++|+|++|+.||...... .
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~ 210 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--------------M 210 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------------H
Confidence 99987654433211122345789999999998888999999999999999999999998654310 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+........ .........+.+++.+|++.+|++||++.|+++
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 211 AALYKIGSSGEPP--EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhccccCCCc--CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0111111100111 111223567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.13 Aligned_cols=266 Identities=22% Similarity=0.338 Sum_probs=195.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|++|.||+++.+ +++.||||+++.... ......+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 70 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----------EGTPSTAIREISLMKELKHENIVRLHDVIHTE 70 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----------ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC
Confidence 4788899999999999999976 689999998864321 12345677899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++ +|.+++..... ...+++..+++++.|++++|+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 71 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 71 NKLMLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred CcEEEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecc
Confidence 999999999985 89888865432 234688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccccc-cchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFV-VPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~-~~~~~ 695 (768)
++........ ......++..|++||.+.. ..++.++||||||+++|||++|+.||......... ...+.. .+.
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (284)
T cd07836 146 LARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT-- 221 (284)
T ss_pred hhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC--
Confidence 9864332211 1112356889999998765 45788999999999999999999998643221100 000000 000
Q ss_pred hhhHHhhh-----ccCCCCCCc-----chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVL-----DRNVPPPTP-----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~-----~~~~~~~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+. ....+.... ........+.+++.+|++.||++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 000010000 01122456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.83 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||.||+++.. +++.+++|.+..... ......+.+.+|++++++++||||+++++++.+....+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 72 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--------VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM 72 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--------hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEE
Confidence 689999999999976 589999999864321 11234567999999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++++|.+++.+.. .+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 73 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 73 EYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred ecCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9999999999997532 3577888899999999999999988 99999999999999999999999999875543
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhcc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (768)
... .....++..|++||.+....++.++|+||||+++|||++|+.||....... .+...++...
T Consensus 146 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~ 209 (262)
T cd05572 146 GQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-------------MEIYNDILKG 209 (262)
T ss_pred ccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-------------HHHHHHHhcc
Confidence 321 122357889999999988889999999999999999999999986543210 1112222211
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHH
Q 046311 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVN 744 (768)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~ 744 (768)
..... ........+.+++.+||+.+|++||+ ++|+++
T Consensus 210 ~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 NGKLE--FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCC--CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11111 11112456789999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=302.34 Aligned_cols=268 Identities=18% Similarity=0.235 Sum_probs=184.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCccccccc-ccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGT-KRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.++||+|+||.||++...+ +..+++|........ ...+. ............++..+..++|+||+++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~-~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET-IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc-hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 579999999999999999998754 345666654322110 00000 000001122334555677789999999998
Q ss_pred EEEcCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 534 FCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 534 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
.+.... ..++++|++.. ++.+.+.... ..++.....++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 765443 34677887643 6666664321 1356777899999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 610 WTAKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
+.++|+|||+++........ .......||+.|+|||++.+..++.++||||||++||||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999754321110 11122468999999999999999999999999999999999999997542211
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
.... ....+.+.++....... ......+.+++..|++.+|++||++.++++.|
T Consensus 241 ~~~~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIH----AAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHH----HhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 00011112222221111 12245677999999999999999999999876
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=323.63 Aligned_cols=282 Identities=20% Similarity=0.294 Sum_probs=188.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcc------cccccccchhhHHHHHHHHHHHhcCCCCCce
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSS------YAIGTKRQEDKDNAFINELESLSRLHHKNLV 529 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~------~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 529 (768)
.++|++.++||+|+||+||++..+ .+...++|.+....... ..............|.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754 23333333221110000 0000111223455788999999999999999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
++++++.+.+..|+|+|++. ++|.+++...... ..........+++.|++.||+|||+++ |+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999985 5787777543211 111234566789999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc-cccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-RNVV 687 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~ 687 (768)
++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||+||||++|..++.......+ ..+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999976543222 112234689999999999988999999999999999999998754332211111 1111
Q ss_pred ccc---------cchhhhhhHHhhhccC-CCCC-Cc-----chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 688 DFV---------VPYIVRDEIHRVLDRN-VPPP-TP-----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 688 ~~~---------~~~~~~~~~~~~~~~~-~~~~-~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+.. .+.. ...+...++.. +... .. ........+.+++.+||+.||++|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDP-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCc-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000 00011111100 0000 00 000122345678999999999999999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=289.65 Aligned_cols=269 Identities=23% Similarity=0.287 Sum_probs=213.2
Q ss_pred HHHHHHHcCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC
Q 046311 451 LEILLEATNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524 (768)
Q Consensus 451 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 524 (768)
..++.....+++....+-+|.||.||+|.+. +.+.|-||.++. ...+.....|+.|--++..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----------~AS~iQv~~~L~es~lly~~s 345 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----------HASQIQVNLLLQESMLLYGAS 345 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----------cccHHHHHHHHHHHHHHhcCc
Confidence 3344445567888889999999999999553 345677776543 234456678899999999999
Q ss_pred CCCceeEEEEEEc-CCeeEEEEEeccCCChhhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 046311 525 HKNLVRLLGFCED-RNERVLIYEYLENGTLHDHLHNPQS----SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI 599 (768)
Q Consensus 525 HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~----~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 599 (768)
|||++++.+++.+ .+..+++|.++.-|+|..||...+. ........+...++.|++.|++|||+++ |||.||
T Consensus 346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDi 422 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDI 422 (563)
T ss_pred CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchh
Confidence 9999999998754 4577889999999999999983221 1223455677889999999999999999 999999
Q ss_pred CCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccC
Q 046311 600 KSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRT 678 (768)
Q Consensus 600 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~ 678 (768)
..+|.+||+..++||+|-.|++...+.++.........+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999999999987666666655556667899999999999999999999999999999998 77777532
Q ss_pred CCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
+ ..++...+.+..+...+ .+++.+|..+|.-||...|++||++++++.-|.+--
T Consensus 503 D----------------PfEm~~ylkdGyRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 503 D----------------PFEMEHYLKDGYRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred C----------------HHHHHHHHhccceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2 12333333333333222 345677889999999999999999999999998754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.40 Aligned_cols=207 Identities=22% Similarity=0.338 Sum_probs=166.9
Q ss_pred CCCcCceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
+|++.++||+|+||.||++..+ +++.||+|.+..... ..+.....+.+|+.++++++||||+++++++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------QYTGISQSACREIALLRELKHENVVSLVEVFL 72 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------cccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence 4777899999999999999875 478999999875321 11223456788999999999999999999998
Q ss_pred cC--CeeEEEEEeccCCChhhhccCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC----C
Q 046311 537 DR--NERVLIYEYLENGTLHDHLHNPQSSS-PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA----T 609 (768)
Q Consensus 537 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~----~ 609 (768)
+. ...++||||+++ +|.+++....... ..++......++.|++.+|+|||+.+ |+||||||+|||++. +
T Consensus 73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPER 148 (316)
T ss_pred CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCcc
Confidence 88 789999999975 7777775433222 24677888899999999999999998 999999999999999 9
Q ss_pred CcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 610 WTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
+.+||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999875433222 111123457889999998765 45789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.79 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=190.5
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||+||++..+ +++.+++|.+..... ........+.+|++++++++||||+++++.+...+..++||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--------KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVM 72 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--------hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEE
Confidence 689999999999765 689999998864311 11223456788999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++++|.+++..... ..+++..++.++.|++.+|.|||+.+ ++|+||||+|||+++++.+||+|||++.....
T Consensus 73 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 73 TLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred ecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 99999999999975432 24578888999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHh-hhc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR-VLD 704 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 704 (768)
... .....++..|+|||.+....++.++||||||+++|||++|+.||........ ..++.+ ...
T Consensus 148 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~ 212 (277)
T cd05577 148 GKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE------------KEELKRRTLE 212 (277)
T ss_pred CCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc------------HHHHHhcccc
Confidence 111 1123578899999999888899999999999999999999999864322110 011111 111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 705 RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
... .........+.+++.+||+.+|++|| ++.++++
T Consensus 213 ~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAV----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccc----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 111 11112345677999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.13 Aligned_cols=269 Identities=24% Similarity=0.298 Sum_probs=193.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++..+ +++.||+|.++.... .......+.+|+.++++++|+||+++++++..
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---------RDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC---------CCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 57889999999999999999875 689999998865321 11223356789999999999999999999876
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. +..++||||+++ +|.+++.... ..+++..++.++.|++++|+|||+.+ ++||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 78 KHLDSIFLVMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred CCCCeEEEEEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEC
Confidence 5 468999999975 8888886532 34688899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc----
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF---- 689 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~---- 689 (768)
|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +.+.
T Consensus 151 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 151 DFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred ccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999755432211 112245788999999865 567899999999999999999999986432211000 0000
Q ss_pred ---ccchhhhhhHHhhhccCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 ---VVPYIVRDEIHRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++....-.....+.....+... ........+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000000000000 001124566789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.98 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=195.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|+..+.||+|+||.||++... +++.+|+|++.... ........+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~ 76 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---------RNATDAQRTFREIMFLQELGDHPNIVKLLNVI 76 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---------CcchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence 457888899999999999999875 68899999875321 1122345677899999999 999999999988
Q ss_pred EcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 536 EDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 536 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
... ...++||||++ ++|.+++... .+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 77 KAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred ccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence 654 36899999997 5999988642 4578888899999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCc---ccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-cc
Q 046311 614 VSDFGLSLIGPEDDES---HLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-VD 688 (768)
Q Consensus 614 l~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~~ 688 (768)
|+|||++......... .......++..|+|||++.. ..++.++||||||+++|||+||+.||........... .+
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999754332211 12223468899999998754 4678899999999999999999999864322110000 00
Q ss_pred cc-------cchhhhhhHHhhhc----cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FV-------VPYIVRDEIHRVLD----RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~-------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. ...+........++ ...........+....+.+++.+||+.+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00000000111111 11111111111235667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=294.44 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|.++++||+|+||.|||+.++ +|+.+|||.+... ...+++.+|+.+|.+++.|++|+++|.|....
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 445688999999999999765 7999999988653 35678899999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
.+++|||||..|+..|.++.+ +..+.+.++-.++.+.++||+|||... =+|||||..||||+.+|.+||+|||.
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccc
Confidence 999999999999999999753 345678888899999999999999987 59999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+-..... ........||+.|||||++..-.|+.++||||||++..||..|++||..-.+.. .. +
T Consensus 176 AGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AI-F---------- 239 (502)
T KOG0574|consen 176 AGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AI-F---------- 239 (502)
T ss_pred cchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---ee-E----------
Confidence 8643221 122234579999999999999899999999999999999999999997543311 00 0
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
++-.+.++......+.+..+.+++++||-++|++|.|+.++++
T Consensus 240 --MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 240 --MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred --eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0111222222334566788889999999999999999988875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.99 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=195.1
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|+..+.||+|+||.||+++.. +++.||||++... .........+.+|+.++++++||||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc---------ccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 3468999999999999999999865 7899999987532 11223445678899999999999999999988
Q ss_pred EcC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 536 EDR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 536 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
... ...++||||+.+ +|.+.+... ++......++.|+++||+|||+++ |+||||||+|||++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~ 154 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 154 (353)
T ss_pred ccCCCccccCcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC
Confidence 643 356999999964 888887532 577788899999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVD 688 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~ 688 (768)
+.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||......... .+..
T Consensus 155 ~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 155 CTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999975433221 12235788999999999889999999999999999999999998643211000 0000
Q ss_pred -cccch--h---hhhhHHhhhccCC---------------CCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 -FVVPY--I---VRDEIHRVLDRNV---------------PPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 -~~~~~--~---~~~~~~~~~~~~~---------------~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+..+. + ........++... .+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 0000001111100 0000 0011234567799999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.58 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=191.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 537 (768)
+|...+.||+|+||.||++... +++.+|+|.+.... .......+.+|+.++.++. |+||+++++++..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----------DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----------ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 4555678999999999999865 68999999876431 1134567889999999996 9999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNP-QSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+...+++|||+.. +|.++.... ......+++....+++.|++.+|+|||+. + |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEe
Confidence 9999999999864 665543211 11123467888899999999999999975 5 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccC---CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|||++......... ....++..|+|||++... .++.++||||||+++|||++|+.||..... .
T Consensus 151 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~------ 216 (288)
T cd06616 151 DFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----V------ 216 (288)
T ss_pred ecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----H------
Confidence 99998643322111 123578899999998765 689999999999999999999999864321 0
Q ss_pred hhhhhhHHhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+.+......+. ......+....+.+|+.+||+.+|++|||++||++.
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 217 ---FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112221111110 111112345667899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=299.15 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=195.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|...+.||+|+||.||+++.. ++..+|+|++.... ....+....+.+|++++++++|||++++++++.+.
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3667788999999999999865 68899999876431 11223456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++ +|.+++.... ..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCC
Confidence 999999999974 8888775422 23688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
++....... ...++..|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------- 230 (317)
T cd06635 171 SASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------- 230 (317)
T ss_pred CccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------------
Confidence 986433221 235788999999974 456889999999999999999999987542110
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
...........+.. ........+.+++.+||+.+|.+||++.++++.+-.
T Consensus 231 -~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 231 -SALYHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -HHHHHHHhccCCCC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11111111111111 112234567899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.52 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=202.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
...|.+...||+|.|+.|.+++.. ++..||||.++... ........+.+|+++|+.|+|||||+++.+.+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~---------ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ---------LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc---------cChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 457889999999999999999865 79999999887542 22334455889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+...|+||||..+|.++++|.++.... + .....++.|+.++++|||+++ |+|||||.+||||+.+.++||+|
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr~~---e-~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGRMK---E-KEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcccch---h-hhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeec
Confidence 9999999999999999999998765432 2 556788999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++..+.... .....+|++.|.|||++.+.+| .++.|+||+|++||-|+.|..||+...-...+
T Consensus 199 fgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------- 264 (596)
T KOG0586|consen 199 FGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------- 264 (596)
T ss_pred cccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------
Confidence 99998765333 3345689999999999988766 58999999999999999999999854321111
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+++...+.-+.. +..+..+|+++++-.+|.+|++++++.+.
T Consensus 265 ----~rvl~gk~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 ----PRVLRGKYRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----chheeeeecccce----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1222222222111 22334478999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.78 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=184.7
Q ss_pred eeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH---HhcCCCCCceeEEEEEEcCCee
Q 046311 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES---LSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
.||+|+||.||++... +++.+|+|.+...... .......+.+|..+ +...+||||+.+++++...+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccc--------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE
Confidence 4899999999999865 6899999988643211 11122334444433 3445799999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++||||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 73 ~lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 73 CFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999999999999998643 23688899999999999999999998 9999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHH
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
....... ....++..|+|||.+. +..++.++||||||+++|||++|+.||......... .+.
T Consensus 146 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~ 208 (279)
T cd05633 146 DFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EID 208 (279)
T ss_pred eccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHH
Confidence 4332211 1235899999999986 456889999999999999999999998654321110 111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
+.... .. ..........+.+++.+||+.||++|| +++|+++.
T Consensus 209 ~~~~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 RMTLT-VN--VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHhhc-CC--cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11100 00 011122345677899999999999999 69998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.22 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=207.0
Q ss_pred eeecCCceeEEeccCCCCCCcceeecCCccccCC--CCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccc
Q 046311 35 SETGNQSLVCALIPSSRPGDFSLNCSIPQLIPVN--PNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYK 112 (768)
Q Consensus 35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~ 112 (768)
++.-|+.--.+|-. +... -..|+..++. +.+++..+++|+.|+.+| +.||.||.||.|..|+|+.-.
T Consensus 72 ~~Gsn~~~eLGlg~-----de~~-~~~P~~~~~~~~d~~~i~~~acGg~hsl~l-----d~Dg~lyswG~N~~G~Lgr~~ 140 (476)
T COG5184 72 SWGSNGMNELGLGN-----DETK-VDRPQLNPFGRIDKASIIKIACGGNHSLGL-----DHDGNLYSWGDNDDGALGRDI 140 (476)
T ss_pred EEecCcceeeccCC-----chhc-ccCceecCcccccceeeEEeecCCceEEee-----cCCCCEEEeccCccccccccc
Confidence 34444444445554 2222 4558888766 677899999999999999 899999999999999995332
Q ss_pred ------------------------cccC------CCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC----------
Q 046311 113 ------------------------RIYR------GPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS---------- 152 (768)
Q Consensus 113 ------------------------~~~~------~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~---------- 152 (768)
.+.. ..+|++|+||+.++|+| +.||.||.||.+..+-++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~cg~e~svil-~~~G~V~~~gt~r~~e~~~g~~~~s~k~ 219 (476)
T COG5184 141 HKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLACGWEISVIL-TADGRVYSWGTFRCGELGQGSYKNSQKT 219 (476)
T ss_pred ccccccccccccccchhhcccCCceeeccccccCChheEEeecCCceEEEE-ccCCcEEEecCccccccccccccccccc
Confidence 2222 12699999999999999 999999999997555333
Q ss_pred ----------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCC-------------cCeEEEeccCceeEEE
Q 046311 153 ----------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPS-------------GIFRVVAAGFRHVCAI 209 (768)
Q Consensus 153 ----------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~-------------~~~~~i~~G~~h~~al 209 (768)
...++++++|.+|..+|+.+|+||.||+|..||++...-+. ..+..|+||.+|+.||
T Consensus 220 ~~~~~p~~v~~~~i~qla~G~dh~i~lt~~G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al 299 (476)
T COG5184 220 SIQFTPLKVPKKAIVQLAAGADHLIALTNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLAL 299 (476)
T ss_pred eeeeeeeecCchheeeeccCCceEEEEecCCcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEE
Confidence 12589999999999999999999999999999976432211 4567899999999999
Q ss_pred ecCCcEEEeecCCCCCCCC----------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC---
Q 046311 210 DDDQELRCWGDSVGEVPQG----------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ--- 264 (768)
Q Consensus 210 ~~~g~v~~wG~n~~gq~~~----------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~--- 264 (768)
++||+||+||.|.+||... .|.+|++|..|+.+|+.||+||.||++.++|||.+.
T Consensus 300 ~~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~~i~~is~ge~H~l~L~~~G~l~a~Gr~~~~qlg~~~~~~ 379 (476)
T COG5184 300 DEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTICSISAGESHSLILRKDGTLYAFGRGDRGQLGIQEEIT 379 (476)
T ss_pred cCCCeEEEeccchhcccccCcccccceeeccccccccCCCceEEEEecCcceEEEEecCceEEEecCCccccccCcccce
Confidence 9999999999999999321 389999999999999999999999999999999655
Q ss_pred -----------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCc
Q 046311 265 -----------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNH 300 (768)
Q Consensus 265 -----------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~ 300 (768)
...+.++++|..|+-+. +.+|+||+||.|.+++..
T Consensus 380 ~~~~~~~~ls~~~~~~~v~~gt~~~~~~-t~~gsvy~wG~ge~gnlG 425 (476)
T COG5184 380 IDVSTPTKLSVAIKLEQVACGTHHNIAR-TDDGSVYSWGWGEHGNLG 425 (476)
T ss_pred eecCCccccccccceEEEEecCccceee-ccCCceEEecCchhhhcc
Confidence 12589999999999998 899999999999776544
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.61 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=192.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|.||.||+++.+ +++.|++|.+.... ..+.....+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---------EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---------ccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 46888899999999999999876 68899999875431 112234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~D 616 (768)
....++||||++ ++|.+++..... ...++.....++.||+.||+|||+++ |+|+||||+||+++. +..+||+|
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~d 146 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLAD 146 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcc
Confidence 999999999996 588888754322 22467777889999999999999998 999999999999985 56799999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccccc-ccch
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDF-VVPY 693 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~-~~~~ 693 (768)
||++........ ......+++.|+|||.+.. ..++.++||||||+++|||+||+.||......... ..... ..+.
T Consensus 147 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 147 FGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred cccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999965432211 1112356889999998865 45789999999999999999999998643211000 00000 0000
Q ss_pred -------hhhhhHHhhhccCCCCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 -------IVRDEIHRVLDRNVPPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 -------~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
........... ...... .........+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFP-KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhccccccchhhhhhcc-cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 000000 0011123456789999999999999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=280.51 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=196.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 537 (768)
+.+.+..||.|+.|.|++.+.+ +|..+|||.+.... ..++.++++..++++... +.|+||+.+|+|..
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 3445577999999999999876 68999999986542 234567788888887666 48999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+...++.||.|.- .++.+|.... ...++...-++...++++|.||.+++ .|+|||+||+|||+|+.|++|++||
T Consensus 163 n~dV~IcMelMs~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence 9999999999853 5666665432 22455566688899999999999887 4999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++-..-... ...+..|-+.|||||.+.. .+|+-++||||||+.|+||.||+.||.....+
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------------- 300 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------------- 300 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------------
Confidence 9996433222 2234579999999999964 47889999999999999999999999754321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+.++++... +..+.....+..+.+++..||.+|+.+||...++++.
T Consensus 301 -Fe~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 301 -FEVLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -HHHHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 133455555333 3334444467788899999999999999999988753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=298.35 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=192.8
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
..+||+|+||.||++..+ +++.||||++... .......+.+|+.++++++|+||+++++++...+..+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 367999999999999875 7899999987432 1234567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..++...+.++.|++.+|+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 94 VVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred EEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEccccccee
Confidence 999999999999988532 2578888999999999999999998 99999999999999999999999999865
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
....... .....+++.|++||.+....++.++|+||||+++|||++|+.||...... +....
T Consensus 166 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----------------~~~~~ 227 (292)
T cd06657 166 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMKM 227 (292)
T ss_pred ccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 4322211 12345789999999998888899999999999999999999998532110 00011
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+....+............+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1111111111111223456789999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.24 Aligned_cols=247 Identities=25% Similarity=0.302 Sum_probs=186.5
Q ss_pred ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH-HhcCCCCCceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES-LSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
+.||+|+||.||+++.. +++.||+|.++.... ........+..|..+ ...++|+|++++++++...+..+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY 73 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEE
Confidence 56999999999999865 689999998754311 011122334455444 44558999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+||||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 74 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 74 LVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 999999999999999643 23577888899999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (768)
.... ....++..|++||.+.+..++.++||||||+++|||++|..||...... ......
T Consensus 147 ~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~ 205 (260)
T cd05611 147 GLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---------------AVFDNI 205 (260)
T ss_pred cccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---------------HHHHHH
Confidence 3321 1235788999999998888899999999999999999999998643211 001111
Q ss_pred hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
.......+..........+.+++.+||+.+|++||++.++.+.|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111111111111123466789999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.27 Aligned_cols=268 Identities=22% Similarity=0.326 Sum_probs=190.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||.||++..+ +++.||||.+..... .+.....+.+|++++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------KEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---------cCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 47889999999999999999875 689999998864311 11223456789999999999999999999866
Q ss_pred CC--------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 538 RN--------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 538 ~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
.+ ..++||||+.+ +|.+++.... ..+++...+.++.|++.||+|||+++ |+|+||||+|||++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~ 155 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKD 155 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCC
Confidence 54 35999999965 8888876432 23588899999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc--ccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 610 WTAKVSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.+||+|||++......... .......++..|+|||.+... .++.++||||||+++|||++|+.||...........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999754322211 111223568899999987654 478899999999999999999988864322100000
Q ss_pred ccc--------ccchhhhhhHHhhhccCCCCCCc--c-----hHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 687 VDF--------VVPYIVRDEIHRVLDRNVPPPTP--F-----EIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 687 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... ..+..........+ ..+.... . .......+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKM--ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhc--cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00000000000000 0000000 0 0001234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.32 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||.||+++.. +++.+++|.+..... ........+.+|++++++++||||+++++.+......+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 72 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVM 72 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEE
Confidence 689999999999976 589999998864311 11234567899999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++++|.+++.... .+++..++.++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 73 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 73 EYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9999999999997532 4588899999999999999999998 99999999999999999999999999875433
Q ss_pred CCC------cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 626 DDE------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 626 ~~~------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
... ........++..|++||.+.....+.++||||||+++|||++|+.||...... +..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------------~~~ 210 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------------EIF 210 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Confidence 211 01112345788999999998888899999999999999999999998643210 111
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
..........+. .......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 211 ~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 211 QNILNGKIEWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHhcCCcCCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 112221111111 1112466779999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.91 Aligned_cols=271 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|++.+.||+|+||.||+|..+ +++.||+|+++.... .+.....+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---------KEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---------ccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 3467889999999999999999976 588999999865321 122335678899999999999999999998
Q ss_pred EcCC----------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 536 EDRN----------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 536 ~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
.+.. ..++|+||+++ +|.+++... ...+++...+.++.|++.||+|||+.+ |+|+||||+||+
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nil 148 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNIL 148 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 7654 78999999986 777777543 224688899999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
+++++.+||+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.........
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred ECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999998754433221 1112245788999998864 45789999999999999999999998643211000
Q ss_pred ccc-cc-------ccchhhhhhHHhhhccCCC--CC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 685 NVV-DF-------VVPYIVRDEIHRVLDRNVP--PP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 685 ~~~-~~-------~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... +. ..+.+.........+.... .. .......+..+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00 0000000000000000000 00 0000012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.42 Aligned_cols=275 Identities=23% Similarity=0.346 Sum_probs=197.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||.||++... +++.||||++... ........+.+|+.++++++||||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----------EHQTFCQRTLREIKILRRFKHENIIGILDIIR 73 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----------ccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence 468999999999999999999865 6899999987532 11223456888999999999999999999875
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...+++|||+++ +|.+++.. ..+++.....++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~ 144 (336)
T cd07849 74 PPSFESFNDVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCD 144 (336)
T ss_pred cccccccceEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCC
Confidence 44 357999999975 88888754 23578888999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccc
Q 046311 612 AKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVD 688 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~ 688 (768)
+||+|||++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||.......... ..+
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~ 224 (336)
T cd07849 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224 (336)
T ss_pred EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999875432221 111123467899999998654 568999999999999999999999985422100000 000
Q ss_pred cccchhhhhhHHhhhc-------cCCCCCC--cc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHhh
Q 046311 689 FVVPYIVRDEIHRVLD-------RNVPPPT--PF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAA 752 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~-------~~~~~~~--~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~~ 752 (768)
.. .....+......+ ...+... +. .......+.+++.+||+.+|++|||+.|+++. +++..+.
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 225 VL-GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred Hc-CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00 0000000100000 0000000 00 01224567799999999999999999999987 6666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.35 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=202.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.+.|+.-++||+|+||.||-+..+ +|+.+|.|++.... +++ ...+.--++|-.+|.+++.+.||.+--.|+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-----iKk---r~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-----IKK---RKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-----HHH---hhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 366888899999999999999755 79999999886542 111 223345678999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..+|||..|.||+|.-+|.+... +.+++...+..+.+|+.||++||+.. ||.|||||+|||||+.|+++|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeec
Confidence 99999999999999999999977654 45688888899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
+|||...+...... ..+||.+|||||++.+..|+...|.|||||+||||+.|+.||........ .
T Consensus 331 LGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------~ 395 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------R 395 (591)
T ss_pred cceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------H
Confidence 99998776655432 23799999999999999999999999999999999999999976433221 1
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
+++.+.+- ..+..+....+++...|....|++||.+|.-.
T Consensus 396 eEvdrr~~---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 EEVDRRTL---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHh---cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22222211 11112233445667788899999999999643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=288.11 Aligned_cols=249 Identities=26% Similarity=0.443 Sum_probs=199.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..+.||+|.+|.||+++.. +++.+++|.+.... ..+.....+.+|++++.+++|||++++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---------IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---------cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4777899999999999999865 67899999986532 1123456899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 144 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFG 144 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccc
Confidence 9999999999999999998653 34688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....++..|+|||.+....++.++|||+||+++|||++|+.|+...... ..
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---------------~~ 207 (254)
T cd06627 145 VATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---------------AA 207 (254)
T ss_pred cceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---------------HH
Confidence 99765433321 12345788999999998777899999999999999999999988632210 00
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.......... .........+.+++.+||..+|++||++.|++.
T Consensus 208 ~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 208 LFRIVQDDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHhccCCC---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111111111 111122456778999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.59 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC-
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR- 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 538 (768)
|++.++||+|+||.||+++.. +++.+++|++.... ..+.....+.+|++++++++|||++++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 566789999999999999876 58899999987542 1123346788999999999999999999999888
Q ss_pred -CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 -NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..++||||+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||+||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccc
Confidence 889999999975 8998886532 34688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc-----
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV----- 690 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~----- 690 (768)
|++......... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......... +.+..
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 145 GLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred cceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 999754433211 1122346788999998764 467899999999999999999999986433211000 00000
Q ss_pred --cchhhhhhHHhhhccCCCCCCc---chHH-HHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 --VPYIVRDEIHRVLDRNVPPPTP---FEIE-AVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 --~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
++....-............... ...+ ....+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000000000000000 0001 2456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=293.18 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=189.4
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDR 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 538 (768)
|+..++||+|+||.||+++.. +++.+|+|+++... .........+|+..+.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 70 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----------KSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR 70 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc----------CCchhhhHHHHHHHHhhcCCCCCccceEEEEecC
Confidence 566789999999999999865 68999999875431 1112234557888898885 99999999999887
Q ss_pred --CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 539 --NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 539 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+..++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. +.+||+|
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~d 142 (282)
T cd07831 71 KTGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLAD 142 (282)
T ss_pred CCCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEe
Confidence 88999999997 58888886432 34688999999999999999999998 999999999999999 9999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++......... ....++..|+|||++. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 143 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~ 216 (282)
T cd07831 143 FGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLG 216 (282)
T ss_pred cccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcC
Confidence 9999754332221 1235788999999764 356788999999999999999999998643221 00000000000
Q ss_pred --hhhHHhhhcc------CCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 --RDEIHRVLDR------NVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 --~~~~~~~~~~------~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+...+.. ..+... ......+..+.+++.+||+.+|++||+++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 000000 001133577889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.73 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=195.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|++.+.||+|+||.||++... +++.+++|.+..... ..........|.+|++++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD------SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc------cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence 46888999999999999999865 689999998753211 11123445689999999999999999999999876
Q ss_pred C--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 538 R--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 538 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
. ...+++|||+++++|.+++.... .+++...++++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 4 45789999999999999986422 2567788899999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||+++........ .......++..|+|||++....++.++|+||||+++|||++|+.||.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------- 214 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------------- 214 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------------
Confidence 99999754321111 111234578999999999888899999999999999999999999863211
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.............+ .........+.+++.+||+ +|.+||+..++++
T Consensus 215 -~~~~~~~~~~~~~~--~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 -MAAIFKIATQPTKP--MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHHHHHcCCCCC--CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111111111111 1122344667799999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=299.37 Aligned_cols=271 Identities=19% Similarity=0.276 Sum_probs=193.0
Q ss_pred ceeccC--CceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 465 HKIGSG--SFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G--~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
+.||+| +|++||+++.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 457776 89999999875 78999999876431 1223457889999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++||||+.+++|.+++..... ..+++.....++.|++.+|+|||+.+ |+||||||+|||++.++.++++||+.+.
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 999999999999999875432 23578888899999999999999998 9999999999999999999999998653
Q ss_pred cCCCCC-Cc----ccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccc------
Q 046311 622 IGPEDD-ES----HLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVV------ 687 (768)
Q Consensus 622 ~~~~~~-~~----~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~------ 687 (768)
...... .. .......++..|+|||++.. ..++.++||||||+++|||++|+.||......... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd08226 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229 (328)
T ss_pred hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence 221111 00 00111234667999999875 35789999999999999999999998643211000 000
Q ss_pred ccccchhh--hhh-------H-----H---------hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 688 DFVVPYIV--RDE-------I-----H---------RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 688 ~~~~~~~~--~~~-------~-----~---------~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+...... ... . . .+.+... ..+........+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred Cccccccchhhhhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000 000 0 0 0000000 01122345567889999999999999999999985
Q ss_pred H--HHHHHh
Q 046311 745 S--LERALA 751 (768)
Q Consensus 745 ~--L~~~l~ 751 (768)
. ++.+.+
T Consensus 308 ~~~~~~~~~ 316 (328)
T cd08226 308 HAFFKQVKE 316 (328)
T ss_pred CHHHHHHHH
Confidence 4 555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.38 Aligned_cols=268 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred cHHHHHHHcCCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCC
Q 046311 450 SLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKN 527 (768)
Q Consensus 450 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpn 527 (768)
.++++.+.++ +.||+|+|+.|--++ +.++.++|||+++.. ......+..+|++++.+. .|+|
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----------~gHsR~RvfREVe~f~~Cqgh~n 137 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----------PGHSRSRVFREVETFYQCQGHKN 137 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-----------CchHHHHHHHHHHHHHHhcCCcc
Confidence 4555555543 679999999999886 678999999988642 234567889999999999 5999
Q ss_pred ceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 528 LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 528 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
|++|+++|++++.+|||||.|.||+|..+|+++. .+++.+.-++..+|+.+|.|||.++ |.||||||+|||..
T Consensus 138 ilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 138 ILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE 210 (463)
T ss_pred HHHHHHHhcccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence 9999999999999999999999999999997643 3567778899999999999999999 99999999999996
Q ss_pred CCC---cEEEeeccccccCCCC-C----CcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcc
Q 046311 608 ATW---TAKVSDFGLSLIGPED-D----ESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRA 674 (768)
Q Consensus 608 ~~~---~~kl~DFGla~~~~~~-~----~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p 674 (768)
... -+||+||.|..-.... + ........+|+..|||||+.. ...|+++.|.||||||||-||+|+.|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 544 4799999987422111 1 111123467899999999874 24688999999999999999999999
Q ss_pred cccCCCCCcccccccccch---hhhhh-HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 675 IHRTHNGTPRNVVDFVVPY---IVRDE-IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
|...-..+- -|..-. ...+. .+++.+..+..+.......+.+..+|+...+..|+.+|.++.++++
T Consensus 291 FvG~Cg~dC----GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 291 FVGHCGADC----GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCccCCcC----CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 975322111 111000 01112 3344444444433333445666778999999999999999999987
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.86 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=197.1
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|++|.||++... +++.+++|+++... ..+.....+.+|++++++++|+||+++++++.+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---------ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---------ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 556788999999999999875 68999999876431 11234567889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++ +|.+++.... ..+++..++.++.|++++|.|||+++ |+|+||||+||+++.++.+||+|||.
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~ 144 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGL 144 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeee
Confidence 99999999975 8888886532 34688899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc--------ccc
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV--------DFV 690 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~--------~~~ 690 (768)
+........ ......++..|+|||.+... .++.++||||||+++|+|+||+.||......+..... ...
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 145 ARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred eEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 875544321 11123578899999998766 7899999999999999999999888543221100000 000
Q ss_pred cchhh---hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYIV---RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+... ........+...........+....+.+++.+||+.||.+||+++|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0000000000000001112234677889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.41 Aligned_cols=277 Identities=21% Similarity=0.313 Sum_probs=200.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|...+.||+|+||+||+++.. +++.||||.+.... ........+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---------DNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---------cccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 457889999999999999999865 68999999876421 11223456778999999999999999999876
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...++||||+. ++|.+++... ..+++.....++.|++.+|.|||+++ ++||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~ 146 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 44 35799999996 6898888643 23678889999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF 689 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~ 689 (768)
+||+|||++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......... ..+.
T Consensus 147 ~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 224 (337)
T cd07858 147 LKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224 (337)
T ss_pred EEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 99999999975433221 1123357889999998764 468899999999999999999999986432100000 0000
Q ss_pred -------ccchhhhhhHHhhhccCCCCC----CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHhhc
Q 046311 690 -------VVPYIVRDEIHRVLDRNVPPP----TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAAC 753 (768)
Q Consensus 690 -------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~~~ 753 (768)
....+......+.+....... ..........+.+++.+||+.+|++|||++|+++. ++.+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 000001111111111100000 00111345667899999999999999999999987 76655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.90 Aligned_cols=269 Identities=20% Similarity=0.308 Sum_probs=196.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.||+|++.... ........+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---------ccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 67888999999999999999865 68999999886431 112234567789999999999999999988753
Q ss_pred ----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 538 ----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 538 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
....++||||+. ++|.+++... ..+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence 346799999996 5899998643 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCC--cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc--
Q 046311 614 VSDFGLSLIGPEDDE--SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD-- 688 (768)
Q Consensus 614 l~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~-- 688 (768)
|+|||++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||.............
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH
Confidence 999999865432221 111123468899999999865 468899999999999999999999996432110000000
Q ss_pred ------cccchhhhhhHHhhhccCCCCCCcc-----hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 ------FVVPYIVRDEIHRVLDRNVPPPTPF-----EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
........+.+.+..+. .+..... .......+.+++.+||+.+|++||++.+++..
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000001111121111 1111111 11235678899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.21 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=191.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|+..+.||+|+||.||++..++ ++.||||+++... .......+.+|+.++.++ .||||+++++++.
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----------NKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----------ChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 467888999999999999999874 8999999986431 122345667788777666 4999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+....+++|||+++ +|.+++.... ..+++..+.+++.|++++|+|||+. + |+||||||+||++++++.+||+
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEEC
Confidence 99999999999854 7777765422 2467888899999999999999974 5 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCC----CCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ----LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|||++......... ....++..|+|||.+.... ++.++||||||+++|||++|+.||......
T Consensus 158 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------- 224 (296)
T cd06618 158 DFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------- 224 (296)
T ss_pred ccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----------
Confidence 99998654322211 1234788999999987543 788999999999999999999998532110
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+.++++...+.. +........+.+|+.+||+.||++||+++++++.
T Consensus 225 ----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 ----FEVLTKILQEEPPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011222222221111 1111234567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.31 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=192.0
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~ 536 (768)
|++.+.||+|+||.||+++.+ +++.+|+|+++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 567789999999999999986 589999999864311 112234566777766655 6999999999998
Q ss_pred cCCe-----eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DRNE-----RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
..+. .+++|||+.+ +|.+++..... ..+++..++.++.|+++||.|||+.+ ++|+||||+|||++.++.
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~ 145 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQ 145 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCC
Confidence 8776 8999999975 89998865332 23688999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||++......... ....++..|+|||.+....++.++||||||+++|||++|+.||......+. ......
T Consensus 146 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~ 220 (287)
T cd07838 146 VKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFD 220 (287)
T ss_pred EEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHH
Confidence 999999998764332211 123478899999999988899999999999999999999888864322110 000000
Q ss_pred chhhhhhH---------HhhhccCC-CCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEI---------HRVLDRNV-PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~---------~~~~~~~~-~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
........ ...+.... ........+....+.+++.+||+.||++||+++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 00000000 0001111234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=293.97 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=193.9
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
+|++.+.||+|+||.||+++. .+++.||+|+++.... .......+.+.+|++++.++ +|+||+++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-------VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 73 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-------hhcchHHHHHHHHHHHHHhcccCCChhceeeE
Confidence 477789999999999999986 3689999999864311 11122345678899999999 69999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+..+...++||||+++++|.+++... ..+++.....++.|++++|.|||+.+ ++||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 74 FQTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEE
Confidence 99999999999999999999999653 23467778888899999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.|+....... ..
T Consensus 147 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~------ 217 (290)
T cd05613 147 TDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQ------ 217 (290)
T ss_pred eeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cH------
Confidence 999998754332211 1123457899999999865 346789999999999999999999986322110 00
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
.+....+.....+. .......+.+++.+||+.+|++|| +++++++.
T Consensus 218 ---~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 218 ---AEISRRILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---HHHHHHhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01111122211111 122345667899999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.79 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=199.8
Q ss_pred CCCCcC-ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 459 NNFSED-HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
++|++. ++||-|-.|.|..+..+ +++.+|+|++... ...++|+++--.. .|||||.++++|
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------------~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------------PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----------------HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 445443 57999999999999765 7899999987532 2345677765444 699999999987
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--- 608 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--- 608 (768)
+. ...+++|||+|+||.|+..+..++. ..+++.+.-.|..||..++.|||+.+ |.||||||+|+|...
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSP 199 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCC
Confidence 54 4567899999999999999987543 34678888899999999999999999 999999999999964
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
|-.+||+|||+|+...... .....+-|+.|.|||++...+|+...|+||+||++|-||.|++||.......
T Consensus 200 na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------ 270 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ 270 (400)
T ss_pred CcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------
Confidence 5579999999998644322 2234578999999999999999999999999999999999999997543311
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+..+.-.++....+..+.+...+.++...++|+.+|..+|.+|.|++|+++.
T Consensus 271 -----ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 -----ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0112223444455555556666778888999999999999999999998864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.45 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=185.9
Q ss_pred HcCCCCcCcee--ccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEE
Q 046311 457 ATNNFSEDHKI--GSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLL 532 (768)
Q Consensus 457 ~~~~~~~~~~L--G~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 532 (768)
..++|++.+.+ |+|+||.||++..+ ++..+|+|.+...... .. |+.....+ +||||++++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------------~~--e~~~~~~~~~h~~iv~~~ 75 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------------AI--EPMVHQLMKDNPNFIKLY 75 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------------hh--hHHHHHHhhcCCCEEEEE
Confidence 34566666665 99999999999865 6788999987543110 00 22222212 799999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-c
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-T 611 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~ 611 (768)
+.+...+..++||||+++++|.+++.... .+++...+.++.|+++||.|||+.+ ++||||||+||+++.++ .
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 76 YSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCe
Confidence 99999999999999999999999996532 4688999999999999999999998 99999999999999988 9
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
++|+|||++....... ...++..|+|||++....++.++||||||+++|||++|+.||....... ..
T Consensus 149 ~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~------ 215 (267)
T PHA03390 149 IYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD------ 215 (267)
T ss_pred EEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh------
Confidence 9999999986543221 2357899999999998889999999999999999999999997432211 00
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-HHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-MTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~ 744 (768)
...+......... ........+.+++.+||+.+|.+||+ ++|+++
T Consensus 216 ----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 ----LESLLKRQQKKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----HHHHHHhhcccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0111111111111 11134566789999999999999995 688874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=291.10 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=195.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|.+.+.||+|+||.||+++.. .+..+++|.++..... ........++.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG------ELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccc------ccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence 4778899999999999999865 3455666665432111 11123345677899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.........+++..++.++.|++++|.|||+.+ ++|+||||+||+++. +.+||+|||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccC
Confidence 9999999999999999998654333445788999999999999999999998 999999999999975 569999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....+++.|+|||.+....++.++|+||||+++|+|++|..|+..... ...
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---------------~~~ 213 (260)
T cd08222 151 VSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---------------LSV 213 (260)
T ss_pred ceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HHH
Confidence 98754332221 1233578899999999888889999999999999999999998853211 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.........+. ........+.+++.+||+.+|++||++.|+++
T Consensus 214 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 214 VLRIVEGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHcCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11222211111 12234566779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.01 Aligned_cols=273 Identities=25% Similarity=0.389 Sum_probs=203.4
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
+...+.||+|+||.||+++++ +|+.||||.++... .....+...+|+++|++|+|+|||+++++-+...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc----------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 344578999999999999954 89999999987532 1234567789999999999999999999765443
Q ss_pred ------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC--CCC-
Q 046311 540 ------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--ATW- 610 (768)
Q Consensus 540 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--~~~- 610 (768)
...+|||||.+|||...|++...... ++..+.+.+..++..||.|||+++ |+||||||.||++- .++
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~G-LpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYG-LPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccC-CCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCc
Confidence 56899999999999999988765544 588899999999999999999998 99999999999983 333
Q ss_pred -cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 611 -TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 611 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
.-||+|||.|+...... .....+||+.|++||++.. +.|+...|.|||||++||..||..||....... +..+
T Consensus 161 ~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~ 235 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKE 235 (732)
T ss_pred eEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccch
Confidence 46999999998765544 3345689999999999984 889999999999999999999999997653321 1111
Q ss_pred cccchhhh------------hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC--CHHHHHHHHHHHHhh
Q 046311 689 FVVPYIVR------------DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP--SMTEIVNSLERALAA 752 (768)
Q Consensus 689 ~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP--s~~evl~~L~~~l~~ 752 (768)
..+..... ++..-.....++.+.....-....+..++..+|..+|++|- ...+....+.+++..
T Consensus 236 ~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 236 IMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111110 00001111222333333333445566778888899999998 777777766666653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=322.77 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=188.4
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
...+|++.+.||+|+||.|||++.+ ||+.+|||++.... .......+.+|+..|.+|+|||||+++..+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----------s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----------SDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----------HHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 4457888899999999999999987 89999999987541 344567789999999999999999984210
Q ss_pred E------------------------------------------------------------------c------------
Q 046311 536 E------------------------------------------------------------------D------------ 537 (768)
Q Consensus 536 ~------------------------------------------------------------------~------------ 537 (768)
. .
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 0 0
Q ss_pred ---------------------------------C--------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHH
Q 046311 538 ---------------------------------R--------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576 (768)
Q Consensus 538 ---------------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia 576 (768)
+ ...|+-||||+.-.|.++++.+.... .-...++++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLF 703 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLF 703 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHH
Confidence 0 12367799999988888886543211 244668999
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCC----------------CCCCcccccccccccC
Q 046311 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP----------------EDDESHLSLRAAGTVG 640 (768)
Q Consensus 577 ~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~ 640 (768)
.+|++||.|+|+++ ||||||||.||+|+++..|||+|||+|.... ........+..+||.-
T Consensus 704 reIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal 780 (1351)
T KOG1035|consen 704 REILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL 780 (1351)
T ss_pred HHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence 99999999999999 9999999999999999999999999997511 0011112245689999
Q ss_pred ccCccccccC---CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHH
Q 046311 641 YMDPEYYRLQ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEA 717 (768)
Q Consensus 641 y~aPE~l~~~---~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (768)
|+|||++... .|+.|+|+|||||||+||+. ||.... + ...-+..+-+..++.+..+..+.
T Consensus 781 YvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----E---------Ra~iL~~LR~g~iP~~~~f~~~~ 843 (1351)
T KOG1035|consen 781 YVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-----E---------RASILTNLRKGSIPEPADFFDPE 843 (1351)
T ss_pred eecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-----H---------HHHHHHhcccCCCCCCccccccc
Confidence 9999999754 59999999999999999984 342110 0 01112223334444432333333
Q ss_pred HHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 718 VAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 718 ~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...=..+|.++++.||.+|||+.|+|+
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 333458999999999999999999886
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=295.14 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=198.2
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
+|+..+.||+|+||.||+++. .+++.||||.++.... .........+.+|++++.++ +||||+++++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~ 73 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-------VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA 73 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-------HhhhhHHHHHHHHHHHHHhccCCcchhhhhee
Confidence 367789999999999999974 2578899998864311 11123446788999999999 69999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+......++||||+++++|.+++... ..+++.....++.|++++|+|||+.+ ++||||||+||+++.++.++|
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 74 FQTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred eecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEE
Confidence 99999999999999999999998642 23577788889999999999999988 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCC--CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... ......++..|++||.+.... .+.++||||||+++|||++|+.||....... ..
T Consensus 147 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~------ 217 (288)
T cd05583 147 TDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQ------ 217 (288)
T ss_pred EECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hH------
Confidence 999998754332211 111235789999999987654 7889999999999999999999985322110 00
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.+-...+.....+.+. .....+.+++.+||+.+|++|||+.++.+.|+...
T Consensus 218 ---~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 218 ---SEISRRILKSKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred ---HHHHHHHHccCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0111122222221111 12345678999999999999999998887776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=292.68 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=191.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|...++||+|+||.||+++.. +++.|++|++.... .........+.+|++++++++|||++++++++.+.+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--------KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--------cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 555678999999999999865 68899999886431 112234467889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+. ++|.+++.... ..+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCC
Confidence 9999999996 58888775432 23578889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
+...... ....++..|+|||++. ...++.++||||||+++|||++|+.|+.......
T Consensus 168 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------------- 227 (313)
T cd06633 168 ASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------------- 227 (313)
T ss_pred CcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------
Confidence 8643221 1235788999999974 4568889999999999999999999986432110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..........+. .........+.+++.+||+.+|.+||++.++++.
T Consensus 228 -~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 228 -ALYHIAQNDSPT--LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -HHHHHHhcCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111111 1111223457789999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.42 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
++|...+.||+|+||.||+++.. +++.|++|++..... ..+.....+.+|++++++++ ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 72 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--------IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ 72 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--------cchHHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence 46888899999999999999875 789999998864311 12234567889999999998 999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..++||||+++++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 73 DEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred CCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecC
Confidence 9999999999999999999997532 4688999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCc------------------ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 617 FGLSLIGPEDDES------------------HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 617 FGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
||++......... .......++..|++||++....++.++||||||++++||++|+.|+...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998754332210 1112335789999999998888999999999999999999999998643
Q ss_pred CCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH----HHHHH
Q 046311 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM----TEIVN 744 (768)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~----~evl~ 744 (768)
... .......+.....+ ......+.+++.+||+.+|++||++ +|+++
T Consensus 226 ~~~---------------~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 226 NEY---------------LTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cHH---------------HHHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 210 11112222111111 1224557799999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.57 Aligned_cols=265 Identities=18% Similarity=0.245 Sum_probs=189.8
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEE
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 543 (768)
.+.+|.|+++.||+++. +++.||||++.... ........+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV 76 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccc---------cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEE
Confidence 34455566666666654 58999999986431 123355679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
+|||+++++|.++++.... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 77 ~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred EEeccCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence 9999999999999975422 23577888899999999999999998 999999999999999999999999988643
Q ss_pred CCCCC-----cccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc---cch
Q 046311 624 PEDDE-----SHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV---VPY 693 (768)
Q Consensus 624 ~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~ 693 (768)
..... ........++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...+.. .+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 229 (314)
T cd08216 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPC 229 (314)
T ss_pred ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCcc
Confidence 22111 111122356788999999865 358899999999999999999999986432110 000000 000
Q ss_pred hhhhh-H----Hh-------hhcc--CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDE-I----HR-------VLDR--NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~-~----~~-------~~~~--~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..... . .. ..+. ...............+.+++.+||+.+|++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0 00 0000 0001111223345667899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.90 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=184.6
Q ss_pred eeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHH---HHHHhcCCCCCceeEEEEEEcCCee
Q 046311 466 KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE---LESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
.||+|+||.||++... +++.||+|.+...... .......+.+| ++.++..+||||+++++++.+.+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccc--------cchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE
Confidence 3899999999999864 6889999988643211 01112223333 3445556899999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++||||+++++|.+++... ..+++..++.++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 73 ~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 73 SFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 9999999999999988642 24688999999999999999999998 9999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHH
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
....... ....|+..|+|||++... .++.++||||||+++|||++|+.||......... ...
T Consensus 146 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-------------~~~ 208 (278)
T cd05606 146 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EID 208 (278)
T ss_pred ccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-------------HHH
Confidence 4432211 123689999999998744 6899999999999999999999998654221110 011
Q ss_pred hhh-ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 701 RVL-DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 701 ~~~-~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
+.. ...... ....+..+.+++.+|+..+|.+|| ++.|+++.
T Consensus 209 ~~~~~~~~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 209 RMTLTMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHhhccCCCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 001111 111245677899999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=299.87 Aligned_cols=280 Identities=23% Similarity=0.321 Sum_probs=203.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|++.+.||+|+||.||+++.. +++.|+||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 5788899999999999999875 58999999886421 1133456789999999999999999999998777
Q ss_pred C-----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 539 N-----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 539 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
. ..+++|||+++ +|.+++.... .+++..++.++.|++++|+|||+++ |+|+||||+|||++.++.++
T Consensus 72 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~ 143 (330)
T cd07834 72 SPEDFNDVYIVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLK 143 (330)
T ss_pred CcccccceEEEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 5 78999999984 8999886532 4688889999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCC-cccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc
Q 046311 614 VSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~ 690 (768)
|+|||++........ ........++..|+|||++... .++.++||||||+++|+|++|+.||.......... +.+..
T Consensus 144 L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 223 (330)
T cd07834 144 ICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223 (330)
T ss_pred EcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence 999999975443321 0111233578899999999877 78999999999999999999999986443210000 00000
Q ss_pred -------cchhhhhhHHhhhccCC-CCC---CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHhhcccC
Q 046311 691 -------VPYIVRDEIHRVLDRNV-PPP---TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAACLVS 756 (768)
Q Consensus 691 -------~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~~~~~~ 756 (768)
............+.... ... .....+....+.+++.+||+.+|++||+++++++. +++........
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 00000000111111000 000 00011234567799999999999999999999985 66665544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.69 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=196.4
Q ss_pred CCcCceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|.++..||.|+||.||++..++ +-..|-|.+.. ..++...+|+-|+++|..++||+||+|++.|+.++
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----------kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----------KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 4455679999999999998764 34445666543 34567889999999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
.++++.|||.||-....+-.- ...+...++..+++|++.+|.|||+++ |||||||..|||++-+|.++|+|||.
T Consensus 103 kLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccc
Confidence 999999999999998877542 244678888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+-..... ......+.|||.|||||++. ..+|+.++||||||++|.||..+.+|-+..+.
T Consensus 177 SAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------------- 240 (1187)
T KOG0579|consen 177 SAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------------- 240 (1187)
T ss_pred cccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------------
Confidence 8532221 12223568999999999875 46899999999999999999999888654322
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..-+.++.... ++..-........+.+++.+||.++|+.||++.++++
T Consensus 241 -MRVllKiaKSe-PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 -MRVLLKIAKSE-PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -HHHHHHHhhcC-CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 01112222221 2222233456677889999999999999999999885
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=298.95 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=190.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||.||++..+ +++.++||++..... .......+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---------KDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC---------CCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 368999999999999999999865 689999999865421 1112345678999999999999999999875
Q ss_pred cCC--------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 537 DRN--------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 537 ~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
+.. ..++||||+.+ +|.+.+.... ..+++..+..++.|++++|+|||+++ |+|+||||+|||+++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~ 150 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDN 150 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 433 46999999975 7777775432 24688899999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcc---------cccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 609 TWTAKVSDFGLSLIGPEDDESH---------LSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
++.+||+|||++.......... ......+++.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 151 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 151 QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999987533221110 1112356888999998764 45889999999999999999999998643
Q ss_pred CCCCccccc--------ccccchhhhhhHHhh----hccCCCCCC-cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 679 HNGTPRNVV--------DFVVPYIVRDEIHRV----LDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 679 ~~~~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......... ....+.. ..+... .....+... .........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 231 SDIDQLHLIFKLCGTPTEETWPGW--RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CHHHHHHHHHHHhCCCChhhchhh--hhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 221100000 0000000 000000 000000000 000112256779999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=319.16 Aligned_cols=262 Identities=29% Similarity=0.417 Sum_probs=206.1
Q ss_pred CCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCcee
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVR 530 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 530 (768)
++.+.+.||+|.||.|++|... ....||||.++.. ....+.+.+..|+++|+.+ +|+||+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~----------~~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN----------ASSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccc----------cCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 3455569999999999999743 1457999987653 2235678899999999999 7999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQ---S-------SS--PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRD 598 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~-------~~--~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 598 (768)
+++.+..++..++|+||++.|+|.++|+..+ . .. ..+.....+.++.||+.||+||++.. ++|||
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRD 443 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRD 443 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchh
Confidence 9999999999999999999999999998765 0 01 12678889999999999999999998 99999
Q ss_pred CCCCCeEECCCCcEEEeeccccccCCCCCCcccc-cccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 599 IKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS-LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 599 iKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
|..+|||++++..+||+|||+++........... ....-...|||||.+....++.|||||||||+||||+| |..|+.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999865554443322 11013566999999999999999999999999999998 666664
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.... ..++.+.+....+...+. .+..++.++|+.||+.+|++||++.|+.+.|+..+.
T Consensus 524 ~~~~---------------~~~l~~~l~~G~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 524 GIPP---------------TEELLEFLKEGNRMEQPE--HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCc---------------HHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 2100 122223333333333322 234566689999999999999999999999999764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.66 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=194.5
Q ss_pred HHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 455 LEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 455 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
...+++|+..+.||+|+||.||++... +++.||||++.... ......+.+.+|++++++++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---------STPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---------cccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 346788999999999999999999865 78999999875321 11223466788999999999999999999
Q ss_pred EEEc-CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 534 FCED-RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 534 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
++.. ....+++|||+ +++|.++++.. .++......++.|++++|+|||+.+ |+||||||+|||+++++.+
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCE
Confidence 8865 56789999998 56899888542 2466777889999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFV 690 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~ 690 (768)
||+|||++....... ....++..|+|||.+.. ..++.++||||||+++|||+||+.||......... .+.+..
T Consensus 148 ~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 222 (328)
T cd07856 148 KICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL 222 (328)
T ss_pred EeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999987432211 12346889999998765 57899999999999999999999998543210000 000000
Q ss_pred -------cchhhhhhHHhhhcc-CCCCCCcch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 -------VPYIVRDEIHRVLDR-NVPPPTPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 -------~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..........+++.. ......+.. ......+.+++.+||+.+|++||++.|++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000001111110 000000111 1124567899999999999999999999776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.50 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=192.6
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDR 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 538 (768)
|++.+.||+|+||+||+|+.. +++.|+||++..... ........+|+..+++++ ||||+++++++.+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 70 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY----------SWEECMNLREVKSLRKLNEHPNIVKLKEVFREN 70 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc----------chhHHHHHHHHHHHHhccCCCCchhHHHHhhcC
Confidence 566789999999999999975 578999998754311 122334567999999998 99999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+ +++|.+++.... ...+++..++.++.|++++|.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 71 ~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 71 DELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred CcEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecc
Confidence 9999999999 789999887543 234688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc---cc-
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV---VP- 692 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~---~~- 692 (768)
++......... ....++..|+|||++. ...++.++|+||||+++|||++|+.||......+... ..... .+
T Consensus 145 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 145 LAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred cceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 98754332211 1235788999999875 4567899999999999999999998885432211000 00000 00
Q ss_pred -hhhhhhHHhhhccCCCCCCcc-----hHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 -YIVRDEIHRVLDRNVPPPTPF-----EIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 -~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..........++...+..... .......+.+++.+||+.+|++||+++|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000011111111110000 0011356779999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=292.75 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=192.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|...+.||+|+||.||+++.. +++.+++|.+.... ........++.+|+++++.++|+|++++++++...
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--------ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 3556688999999999999865 67889999876421 11223446788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+. ++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcc
Confidence 99999999996 58888775422 23578888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
++....... ...++..|+|||.+. ...++.++||||||+++|||++|+.|+......
T Consensus 161 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------- 220 (308)
T cd06634 161 SASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------- 220 (308)
T ss_pred cceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------------
Confidence 986543221 235788999999974 356788999999999999999999987532110
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+..........+. .........+.+|+.+||+.+|++||++.++++.-
T Consensus 221 -~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 221 -SALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -HHHHHHhhcCCCC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0011111111111 11112345677999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.26 Aligned_cols=205 Identities=22% Similarity=0.328 Sum_probs=165.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc---C--CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD---D--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~---~--g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
..|+...+||+|.||.||||... + ...+|||+++..+. ........-+|+.+++.|+||||+.|..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---------~tGiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---------GTGISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---------CCCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 35888899999999999999533 2 23789998865422 1122345678999999999999999999
Q ss_pred EEEc-CCeeEEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC--
Q 046311 534 FCED-RNERVLIYEYLENGTLHDHLHNPQS-SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-- 609 (768)
Q Consensus 534 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-- 609 (768)
++.. +...+|++||.+. +|...|+-++. ....++-.....|+.||+.|+.|||++. |+||||||.|||+..+
T Consensus 95 Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgp 170 (438)
T KOG0666|consen 95 VFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGP 170 (438)
T ss_pred HHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCC
Confidence 9877 7789999999987 99998865432 2234566777899999999999999999 9999999999999877
Q ss_pred --CcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccc
Q 046311 610 --WTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIH 676 (768)
Q Consensus 610 --~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~ 676 (768)
|.+||+|||+++.+...-. .......+-|..|+|||++.+ ..|+++.|||+.|||+.||||-++.|.
T Consensus 171 erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 171 ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999999999987654332 222334567999999999876 579999999999999999999877665
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=298.49 Aligned_cols=269 Identities=20% Similarity=0.303 Sum_probs=194.8
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|+..+.||+|+||.||++... ++..||||++.... ........+.+|++++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---------QSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 4678999999999999999999854 78999999875321 1122345688999999999999999999988
Q ss_pred EcCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 536 EDRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 536 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
.... +.++||||+ +++|.+++.. ..+++..++.++.|++++|+|||+.+ |+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~ 154 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNED 154 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 6543 458999998 6799888853 23578889999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc-cccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-RNVV 687 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~ 687 (768)
+.+||+|||++....... ....+++.|++||.+.. ..++.++|+||||+++|+|++|+.||........ ....
T Consensus 155 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 155 CELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred CCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999987543221 12356889999999875 4588999999999999999999999864321100 0000
Q ss_pred ccc-------cchhhhhhHHhhhccCCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH--HHHHH
Q 046311 688 DFV-------VPYIVRDEIHRVLDRNVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN--SLERA 749 (768)
Q Consensus 688 ~~~-------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~--~L~~~ 749 (768)
... ...+.......... .++... ....+....+.+++.+|++.||++|||+.++++ .++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVK-KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHH-hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000 00000000000000 000000 001122345779999999999999999999994 34443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.68 Aligned_cols=269 Identities=21% Similarity=0.304 Sum_probs=194.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|...+.||+|+||.||+|... +++.||||++.... ..+.....+.+|++++++++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---------ccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 468999999999999999999864 68999999875321 11223456889999999999999999999886
Q ss_pred cC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.. ...++|+||+.. +|.+++. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~ 154 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDC 154 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCC
Confidence 54 346899999964 7776652 13578888999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
.+||+|||++....... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .+...
T Consensus 155 ~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~ 227 (342)
T cd07879 155 ELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQI 227 (342)
T ss_pred CEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 99999999987542211 12356889999999875 468899999999999999999999996432100 00000
Q ss_pred c------cchh----hhhhHHhhhccCC-CCCCcch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHhh
Q 046311 690 V------VPYI----VRDEIHRVLDRNV-PPPTPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAA 752 (768)
Q Consensus 690 ~------~~~~----~~~~~~~~~~~~~-~~~~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~~ 752 (768)
. .+.+ ............. .+..... ......+.+++.+||+.||++||++.|++.. ++.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 0000 0000000000000 0000000 0123456799999999999999999999954 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=297.37 Aligned_cols=273 Identities=21% Similarity=0.281 Sum_probs=196.8
Q ss_pred cHHHHHHHcCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc
Q 046311 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL 528 (768)
Q Consensus 450 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 528 (768)
...++....++|...+.||+|+||.||++.. .+++.||+|+++... ......+.+.+|+.++++++||||
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~h~~i 78 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------QSIIHAKRTYRELRLLKHMKHENV 78 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---------hhhHHHHHHHHHHHHHHHcCCCcc
Confidence 3455667789999999999999999999985 478999999875321 112234568889999999999999
Q ss_pred eeEEEEEEcC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 529 VRLLGFCEDR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 529 v~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+++++++... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 149 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 149 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH
Confidence 9999987543 3467888876 77998888542 3578889999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
||++++++.+||+|||++....... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 150 NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 150 NLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred HEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999987532211 12357889999998865 56889999999999999999999998542211
Q ss_pred Ccc-ccccc-------ccchhhhhhHHhh---hccCCCCCC-cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 682 TPR-NVVDF-------VVPYIVRDEIHRV---LDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 682 ~~~-~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... ..... ..+.+........ +........ .........+.+++.+|++.||.+||++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000 0000000000011 111100000 0000123456799999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=327.81 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=197.6
Q ss_pred cCCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
+-++....+||.|.||.||-+. .++|+..|+|.++..... ....+...+|+.++..|+|||+|+++|+-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---------cccCcchHHHHHHHHhccCccccccCceee
Confidence 3467778899999999999997 457999999988754321 223456778999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+++..+|.||||++|+|.+++... ...++.....+..|++.|++|||+++ ||||||||.||||+.+|.+|++|
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeec
Confidence 999999999999999999999643 22345555567889999999999999 99999999999999999999999
Q ss_pred ccccccCCCCC--CcccccccccccCccCccccccC---CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 617 FGLSLIGPEDD--ESHLSLRAAGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 617 FGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
||.|....... .........||+-|||||++.+. ....+.||||||||++||.||++|+...+. +|.+
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI 1450 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI 1450 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH
Confidence 99997654332 11122345799999999999753 356789999999999999999999975432 1211
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
- ..+...-.|+ .+.....+=.+++.+||+.||++|.++.|+++.
T Consensus 1451 M--------y~V~~gh~Pq--~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 M--------YHVAAGHKPQ--IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred H--------hHHhccCCCC--CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 1111111111 122356666799999999999999888766553
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=293.20 Aligned_cols=266 Identities=23% Similarity=0.274 Sum_probs=189.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-C--CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-D--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~--g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
+|++.+.||+|+||.||+++.. . +..||+|++.... ......+.+.+|+++++++ +||||++++++.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---------SKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---------ccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 4777889999999999999865 3 7899999875321 1122355788899999999 599999999875
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ....++++||+. ++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~ 143 (332)
T cd07857 72 IVFPGNFNELYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCE 143 (332)
T ss_pred eeccccCCcEEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCC
Confidence 32 245788899886 5899988642 23578889999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCC--cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 612 AKVSDFGLSLIGPEDDE--SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
+||+|||++........ ........++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 144 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~ 220 (332)
T cd07857 144 LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLN 220 (332)
T ss_pred EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHH
Confidence 99999999975432211 111123468999999998765 56899999999999999999999988643210 0000
Q ss_pred ccc-----------chhhhhhHH---hhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVV-----------PYIVRDEIH---RVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~-----------~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... ..+...... ..+....... ..........+.+++.+||+.+|++|||+.|+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000000000 0000000000 00001123567799999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=315.92 Aligned_cols=148 Identities=28% Similarity=0.368 Sum_probs=129.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.++||+|+||.||++... +++.||||+++.... ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 75 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--------INKNMVHQVQAERDALALSKSPFIVHLYYSLQS 75 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence 57888999999999999999876 689999999864321 122345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....+|||||+++++|.++++... .+++...++++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeC
Confidence 999999999999999999996532 3577788999999999999999998 999999999999999999999999
Q ss_pred cccc
Q 046311 618 GLSL 621 (768)
Q Consensus 618 Gla~ 621 (768)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=287.15 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=194.6
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|+..+.||+|.||.||+++.. +++.+++|.+.... ..+.....+.+|++++++++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 456688999999999999876 58999999986532 11233466788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||++ ++|.+++.... ..+++..+++++.|++++|+|||+++ |+|+||+|+||++++++.+||+|||+
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~ 144 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGL 144 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCc
Confidence 9999999998 59999997532 24688999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccccccchhhhh
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDFVVPYIVRD 697 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~ 697 (768)
+......... ......+..|+|||.+... .++.++||||||+++|||++|+.||......... ...... ......
T Consensus 145 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 221 (282)
T cd07829 145 ARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL-GTPTEE 221 (282)
T ss_pred ccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHh-CCCcHH
Confidence 8754332211 1123457789999998765 7899999999999999999999888543211000 000000 000000
Q ss_pred hHH---hh--hccCCCCCC-----cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIH---RV--LDRNVPPPT-----PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~---~~--~~~~~~~~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... .. .+...+... .........+.+++.+||+.+|++||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 00 000010000 000112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-34 Score=280.32 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=193.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDR 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 538 (768)
.+.+..||.|.||+|+|-.++ .|+..|||+++... .+.++++|+.|.+...+- +.||||+++|.+..+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n----------~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN----------IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc----------chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 344578999999999999866 79999999997542 245677899998875554 789999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNP-QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..|+.||.|+- ||..+...- ......+++...-+|..-..++|.||.+.- .|||||+||+||||+..|.+||+||
T Consensus 136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecc
Confidence 999999999964 665543210 011223456666678888899999998865 3999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|++-.... +...+..+|-..|||||.+.. ..|+-+|||||||++|||+.||..|++.... .
T Consensus 213 GIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--------------v 275 (361)
T KOG1006|consen 213 GICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--------------V 275 (361)
T ss_pred cchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------------H
Confidence 99853221 122234578899999999964 3488999999999999999999999875432 1
Q ss_pred hhhHHhhhccCCCCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+..++....+... ....+....+.+++..|+.+|-.+||.+.++.++
T Consensus 276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2334444444333211 1223466778899999999999999999998865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=277.89 Aligned_cols=239 Identities=26% Similarity=0.325 Sum_probs=190.6
Q ss_pred eccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|+||.||++..+ +++.+++|.+..... ........+.+|++++++++||||+++++.+..+...++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--------IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVL 72 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--------cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEE
Confidence 689999999999876 589999998865321 12234567899999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
||+++++|.+++.... .+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 73 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 73 EYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 9999999999996532 3578888999999999999999988 99999999999999999999999999875433
Q ss_pred CCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhcc
Q 046311 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDR 705 (768)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (768)
... ......++..|++||.+.....+.++|+||||+++|||++|+.||..... ......+...
T Consensus 146 ~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---------------~~~~~~~~~~ 208 (250)
T cd05123 146 EGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---------------KEIYEKILKD 208 (250)
T ss_pred CCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------------HHHHHHHhcC
Confidence 221 11234578899999999888889999999999999999999999854321 0111122222
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHH
Q 046311 706 NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741 (768)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 741 (768)
....+. .....+.+++.+||..||++||++.+
T Consensus 209 ~~~~~~----~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 PLRFPE----FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCC----CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222111 12455678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=289.52 Aligned_cols=244 Identities=26% Similarity=0.323 Sum_probs=192.3
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
.+.||.|-||+||-|+.+ +|+.||||++++.. .....+..+.+|+.+|.+++||.||.|...|+..+..+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlr---------Fp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLR---------FPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeeccc---------CCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 478999999999999865 89999999987643 23344578899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCcEEEeeccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWTAKVSDFGL 619 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~~kl~DFGl 619 (768)
+|||.+.|.-|+-.|.... ..++...-..++.||+.+|.|||.++ |+|.||||+||||.. -.++||+|||+
T Consensus 640 VVMEKl~GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEehhhcchHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccc
Confidence 9999997755655554322 22455555678889999999999999 999999999999954 45799999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
|++..+.... ...+||+.|+|||+++.+.|...-|+||.|||+|.-|+|..||..+.+ +
T Consensus 714 ARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------------------I 772 (888)
T KOG4236|consen 714 ARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------------------I 772 (888)
T ss_pred eeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------------------h
Confidence 9987654433 245899999999999999999999999999999999999999964422 2
Q ss_pred Hhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 700 HRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 700 ~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
.+.++. .+..+.....+......+||...|+..=++|-|..+-+
T Consensus 773 ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 773 NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 222211 11111222334455556899999999999998877654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=296.21 Aligned_cols=266 Identities=21% Similarity=0.312 Sum_probs=194.7
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|+..+.||+|+||.||+++.. +++.||||++.... ........+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---------QSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---------chhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 3568999999999999999999876 67899999875321 1122345678899999999999999999887
Q ss_pred EcCCe------eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 536 EDRNE------RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 536 ~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|++++|+|||+.+ |+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~ 154 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNED 154 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC
Confidence 66554 89999998 5699999864 23688899999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccc
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVV 687 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~ 687 (768)
+.+||+|||++....... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......... .+.
T Consensus 155 ~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 155 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999987543221 12357889999999864 36789999999999999999999998643211000 000
Q ss_pred cc-------ccchhhhhhHHhhhccCCCCC-Ccch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 688 DF-------VVPYIVRDEIHRVLDRNVPPP-TPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 688 ~~-------~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+. ....+..+.....+....... .... ......+.+++.+||+.+|++|||+.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 000000111111111111000 0000 1124667899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=296.86 Aligned_cols=268 Identities=21% Similarity=0.304 Sum_probs=190.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
..+|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~ 72 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----------PQSVKHALREIKIIRRLDHDNIVKVYEVLG 72 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----------CchHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence 367899999999999999999865 68999999886431 133466888999999999999999998765
Q ss_pred cC--------------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 537 DR--------------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 537 ~~--------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
.. ...++||||++ ++|.+++... .+++...+.++.|++.||.|||+.+ |+||||||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~ 143 (342)
T cd07854 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143 (342)
T ss_pred ccccccccccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 43 35789999997 5898888532 3578888999999999999999998 999999999
Q ss_pred CeEEC-CCCcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 603 NVLLD-ATWTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 603 NILl~-~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
|||++ .+..+||+|||++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99997 456789999999865432111 111122357889999998654 568889999999999999999999996432
Q ss_pred CCCcccccccccchhhh-------hhHHhhhc-cCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 680 NGTPRNVVDFVVPYIVR-------DEIHRVLD-RNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
............+.... ..+...+. .......+ ........+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 224 ELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 21100000000000000 00000000 00000000 011234567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=289.27 Aligned_cols=279 Identities=18% Similarity=0.237 Sum_probs=192.0
Q ss_pred CCCCc-CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccc---cccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSE-DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIG---TKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~-~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|.. .+.||+|+||.||++... +++.||||.+........... ..........+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 467999999999999865 689999999865422110000 0000011235789999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++...+..++||||++ ++|.+++... ..+++.....++.|++.+|+|||+.+ |+|+||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999997 5999998642 23578888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCC------------CcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCC
Q 046311 614 VSDFGLSLIGPEDD------------ESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHN 680 (768)
Q Consensus 614 l~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~ 680 (768)
|+|||++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999986543110 00111123467889999998754 468999999999999999999999864432
Q ss_pred CCcc-cccccc-------cchhhhhhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 681 GTPR-NVVDFV-------VPYIVRDEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 681 ~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.... .+.... ++...............+.. ..........+.+++.+||+.+|++||+++|++..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1100 000000 00000000000000000000 00001123557799999999999999999999863
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=276.72 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=193.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|..+++||+|.||.|-+++-+ +++.+|+|+++.... -..++...-+.|-++|+..+||.+..|.-.|+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi--------iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI--------IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe--------eehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 46777899999999999999865 789999999875421 122344556778999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.++.++||||..||.|+-+|...+ .+++......-..|+.+|.|||+++ ||.||||.+|.|||.||++||+||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence 999999999999999999996532 2344444556778999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
||++..-.. ......++|||.|+|||++....|....|.|.+||++|||+.|+.||.....+. +.+ .+..+
T Consensus 313 GLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFe----LIl~e 383 (516)
T KOG0690|consen 313 GLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFE----LILME 383 (516)
T ss_pred ccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHH----HHHhh
Confidence 999753322 222346799999999999999999999999999999999999999997543221 111 11111
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
+-+++. ...++...|+...|.+||++|. .++||.+
T Consensus 384 ------d~kFPr------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 384 ------DLKFPR------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ------hccCCc------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111221 2223344678889999999995 4556554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=272.31 Aligned_cols=221 Identities=19% Similarity=0.195 Sum_probs=172.8
Q ss_pred CCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEEEec
Q 046311 470 GSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYL 548 (768)
Q Consensus 470 G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 548 (768)
|.|+.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 67 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHA 67 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecC
Confidence 889999999865 78999999886431 2234555555667999999999999999999999999
Q ss_pred cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCC
Q 046311 549 ENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628 (768)
Q Consensus 549 ~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~ 628 (768)
++++|.+++.... .+++.....++.|++++|+|||+.+ |+||||||+||+++.++.++++|||++.......
T Consensus 68 ~~~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 68 EGGKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred CCCCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 9999999986532 3678889999999999999999998 9999999999999999999999999875433221
Q ss_pred cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCC
Q 046311 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVP 708 (768)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (768)
....++..|+|||.+....++.++||||||+++|||++|+.|+....... ........+
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~ 198 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIP 198 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCCc
Confidence 12245778999999988889999999999999999999998765321100 000000011
Q ss_pred CCCcchHHHHHHHHHHHHHcccccCCCCCCHHH
Q 046311 709 PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741 (768)
Q Consensus 709 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 741 (768)
......+.+++.+|++.||++||++.+
T Consensus 199 ------~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 199 ------EWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred ------ccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 112345678999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=246.15 Aligned_cols=198 Identities=24% Similarity=0.367 Sum_probs=164.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|...++||+|.||+|||++.. +++.||+|+++.... ++......++|+-+++.++|+|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd---------degvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD---------DEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC---------CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 4666789999999999999855 689999999987532 233445678999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..-||+|||.. +|..+..... ..++......++.|+++||.|+|+++ +.|||+||.|.||+.+|++|++|||
T Consensus 74 kkltlvfe~cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfg 146 (292)
T KOG0662|consen 74 KKLTLVFEFCDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFG 146 (292)
T ss_pred ceeEEeHHHhhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccc
Confidence 999999999965 8888875432 33567777889999999999999999 8999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCccc
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
+++.+.-.-. .....+-|..|.+|.++.+. -|+...|+||.||++.|+-.-.+|.
T Consensus 147 larafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred hhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 9986543321 11234579999999998764 5788999999999999998754554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=277.81 Aligned_cols=264 Identities=26% Similarity=0.448 Sum_probs=198.7
Q ss_pred CCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-
Q 046311 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE- 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 536 (768)
++|-.+.+||+|+|+.|||+. +...+.||||+-...+. |. ..+.+...+...+|.++-+.|+||.||++++|+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~--Wr--dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN--WR--DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc--hh--hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 457778899999999999996 45678999998655432 21 1122233456678999999999999999999985
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~k 613 (768)
+.+.++-|+||++|-+|.-||+.+ ...++.+...|++||+.+|.||.+.. |+|||-||||.||||- .-|.+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 556778999999999999999754 34577888899999999999999986 7899999999999994 468899
Q ss_pred EeeccccccCCCCCCcc-----cccccccccCccCcccccc----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 614 VSDFGLSLIGPEDDESH-----LSLRAAGTVGYMDPEYYRL----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|.||||+++...+.+.. ......||..|++||.+.- .+++.|+||||.|||+|..+.|+.||...... .
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Q 691 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--Q 691 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--H
Confidence 99999998766554432 2335689999999998753 36788999999999999999999999754221 1
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+ .+.+.+.-+-.+++.... ..+...+|++||+..-++|....++..
T Consensus 692 dILq-------eNTIlkAtEVqFP~KPvV----sseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQ-------ENTILKATEVQFPPKPVV----SSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHh-------hhchhcceeccCCCCCcc----CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111 111222222223332222 233457899999999999998888765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=273.66 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=192.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
.+|..+.+||+|+||.|.++..+ +.+.+|||+++.... + +.+..+--+.|-++|... +-|.++++...|+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVi----i----QdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVI----I----QDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhcccee----e----ecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 36778899999999999999866 568899999876421 1 112223334566777666 5789999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.-+++|+||||+.||+|--++++-.. ..++..+..|..|+-||-|||+++ ||.||||.+|||||.+|++||+|
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 99999999999999999999876433 344566788999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++..-.... .....+|||.|+|||++..++|+..+|.|||||+|||||.|+.||+.... .
T Consensus 494 FGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---------------~ 556 (683)
T KOG0696|consen 494 FGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---------------D 556 (683)
T ss_pred cccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---------------H
Confidence 999975333222 23357899999999999999999999999999999999999999985432 1
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 737 (768)
+-...+++.+...++.... +...+....+.+.|.+|.
T Consensus 557 elF~aI~ehnvsyPKslSk----EAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ELFQAIMEHNVSYPKSLSK----EAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHccCcCcccccH----HHHHHHHHHhhcCCcccc
Confidence 2234556666655544444 344678888899999994
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=288.59 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=191.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
++.|.....+|.|+|+.|-++... +++..+||++.... .+-.+|+.++.+. +||||+++.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------------~~~~~e~~~~~~~~~h~niv~~~~v~ 385 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------------DDNQDEIPISLLVRDHPNIVKSHDVY 385 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---------------cccccccchhhhhcCCCcceeeccee
Confidence 456777888999999999999754 68999999986431 1123466555555 799999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE-CCCCcEEE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL-DATWTAKV 614 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl-~~~~~~kl 614 (768)
.+..+.|+|||.+.++-|.+.+..... ....+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|
T Consensus 386 ~~~~~~~~v~e~l~g~ell~ri~~~~~-----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 386 EDGKEIYLVMELLDGGELLRRIRSKPE-----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred cCCceeeeeehhccccHHHHHHHhcch-----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEE
Confidence 999999999999999998888865321 22456679999999999999998 9999999999999 68999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||.++..... ....+-|..|.|||++....|++++|+||||++||+||+|+.||.....+
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------- 519 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------- 519 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------
Confidence 999999765443 22335689999999999999999999999999999999999999765432
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++...+.. + .+....+...++|+.+||+.||.+||+|.|+...
T Consensus 520 --~ei~~~i~~---~--~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 --IEIHTRIQM---P--KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --HHHHHhhcC---C--ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 122222221 1 1224455667799999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=267.53 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=191.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|....+||+|.||.||+|+.+ +++.||+|++-... ..+.-...-++|+++|..|+|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen---------eKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc---------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 34666678999999999999865 67889998754321 112223456789999999999999999988743
Q ss_pred --------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 538 --------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 538 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
+..+||||++|+. +|.-+|.... ..++..++.+++.++..||.|+|+.. |+|||+|+.|+||+.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKD 160 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCC
Confidence 3458999999987 8998886532 33577888999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc--ccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 610 WTAKVSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.+||+|||+++.+...+.. ...+..+-|..|++||.+.+ .+|+++.|||..||++.||+|+.+-++.........+
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 99999999999754322211 11223456999999998865 6899999999999999999999877765433211111
Q ss_pred c--------ccccchhhhhhHHhhhccCCCCCCcch--HHH------HHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 V--------DFVVPYIVRDEIHRVLDRNVPPPTPFE--IEA------VAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. .-.+|....-++.+-+.....+...+. .+. .....+|+.+++..||.+|+++.++++.
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 111222222222222211100000000 011 1234589999999999999999888753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=289.59 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=206.2
Q ss_pred HHHHHHHcCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCc
Q 046311 451 LEILLEATNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNL 528 (768)
Q Consensus 451 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnI 528 (768)
++.+-..++.|++.+.||+|.+|.||+++. ++++..|||++... ++..++++.|.++|+.+ +|||+
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~------------~d~deEiE~eynil~~~~~hpnv 78 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT------------EDEEEEIELEYNMLKKYSHHPNV 78 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC------------ccccHHHHHHHHHHHhccCCCCc
Confidence 333334456788899999999999999985 47899999987643 23455677888999888 79999
Q ss_pred eeEEEEEEc-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 529 VRLLGFCED-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 529 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+.++++|.. .+.+|||||||.+||.-|++++.. ...+.|..+..|+..+++||.+||.+. ++|||||-.|
T Consensus 79 ~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~N 153 (953)
T KOG0587|consen 79 ATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQN 153 (953)
T ss_pred ceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCce
Confidence 999999854 468999999999999999998755 445688899999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
||++.++.+||.|||++...... ........||+.|||||++.. ..|+.++|+||||++..||--|.+|+...
T Consensus 154 iLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 154 VLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred EEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99999999999999998654322 223345689999999999964 35678999999999999999999988643
Q ss_pred CCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.. . + =.+-++.++.........+.+.++|..||.+|-.+||++.++++
T Consensus 232 HPmr--a-------------L-F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 HPMR--A-------------L-FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhh--h-------------h-ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 3210 0 0 01122233333345677888999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=262.37 Aligned_cols=239 Identities=31% Similarity=0.421 Sum_probs=189.5
Q ss_pred CceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEEEecc
Q 046311 471 SFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLE 549 (768)
Q Consensus 471 ~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 549 (768)
+||.||+++.. +++.+++|++..... ....+.+.+|++.+++++|+||+++++++......+++|||++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 70 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI----------KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCD 70 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc----------ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCC
Confidence 58999999987 589999999864321 1115789999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCc
Q 046311 550 NGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629 (768)
Q Consensus 550 ~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 629 (768)
+++|.+++..... .++..++.++.+++++|.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 71 ~~~L~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-- 141 (244)
T smart00220 71 GGDLFDLLKKRGR----LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-- 141 (244)
T ss_pred CCCHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence 9999999865322 578889999999999999999998 9999999999999999999999999997654332
Q ss_pred ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCC
Q 046311 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPP 709 (768)
Q Consensus 630 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (768)
......++..|++||.+....++.++|||+||+++|+|++|..|+..... .+.+.+.+......
T Consensus 142 -~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---------------~~~~~~~~~~~~~~ 205 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---------------LLELFKKIGKPKPP 205 (244)
T ss_pred -ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHhccCCC
Confidence 11234578899999999888889999999999999999999988864211 01111122111111
Q ss_pred CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 710 PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 710 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...........+.+++.+|+..+|++||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11111113456778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=272.65 Aligned_cols=265 Identities=19% Similarity=0.281 Sum_probs=196.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-C-C----Ccee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-H-K----NLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H-p----nIv~ 530 (768)
+++|.+...||+|.||.|-+.... .+..||||+++.. ....+.-+-|+++|.+|. + | -+++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------------~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------------DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------------HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 678999999999999999999754 5789999987642 122344566999999993 2 2 3788
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--- 607 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--- 607 (768)
+.++|+-.++.++|+|.+ |-|++++|..+.. ...+..++..|+.|++++++|||+.. ++|-||||+|||+.
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 889999999999999988 5699999987543 34577888999999999999999998 99999999999992
Q ss_pred -----------------CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 608 -----------------ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 608 -----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
.+..+||+|||.|........ ..+.|..|+|||++.+..++.++||||+||||+||.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 134589999999986544332 3457999999999999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccc---cchhh--hhhHHhhhccC-------------------CCCCC---cchHHHHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFV---VPYIV--RDEIHRVLDRN-------------------VPPPT---PFEIEAVAYVGY 723 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~-------------------~~~~~---~~~~~~~~~l~~ 723 (768)
|...|+...+.+...+.+.+ .|..+ +..-.+.+.+. ..+.. .........|++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 99988765432221122211 11111 11011111110 00000 012234456889
Q ss_pred HHHHcccccCCCCCCHHHHHHH
Q 046311 724 LAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 724 Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
|+.+||..||.+|+|++|+++.
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999998863
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=303.61 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=200.7
Q ss_pred HHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 453 ILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 453 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
++....++|.+.+.||+|+||.|..++.+ +++.+|.|++.... + ........|.+|-++|..-+.+-|+++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-----M---lKr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-----M---LKRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH-----H---hhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 34445578999999999999999999876 68899999886421 1 112345678999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.-.|.++.+.|||||||+||+|-.++.+.. .++.......+..|+-||.-||+.+ +|||||||+|||||.+|+
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 999999999999999999999999997643 2455555667778999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccc----c-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR----L-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+||+|||.+.....+.. -.+...+|||.|++||++. + +.|++..|.||+||++||||.|..||..+.-
T Consensus 214 ikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------ 286 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------ 286 (1317)
T ss_pred EeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------
Confidence 99999999865543332 2234568999999999996 2 5789999999999999999999999975421
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC---HHHHHH
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS---MTEIVN 744 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~evl~ 744 (768)
.+-+.++++..-....+.+.+.+....+||.+.+. +|+.|.. ++++..
T Consensus 287 ---------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 287 ---------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ---------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 12233444441111112233455666778877664 7778877 776654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=284.53 Aligned_cols=277 Identities=18% Similarity=0.240 Sum_probs=179.6
Q ss_pred cCCCCcCceeccCCceEEEEEEE-----------------cCCCeEEEEEEeeccCcc---cccccccchhhHHHHHHHH
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-----------------DDGSQVAVKRAEISSTSS---YAIGTKRQEDKDNAFINEL 517 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vaVK~~~~~~~~~---~~~~~~~~~~~~~~~~~E~ 517 (768)
.++|++.++||+|+||.||+|.+ ..++.||||++....... +...........+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999964 235689999986432110 0000000011223455678
Q ss_pred HHHhcCCCCCc-----eeEEEEEEc--------CCeeEEEEEeccCCChhhhccCCCCC--------------------C
Q 046311 518 ESLSRLHHKNL-----VRLLGFCED--------RNERVLIYEYLENGTLHDHLHNPQSS--------------------S 564 (768)
Q Consensus 518 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~ 564 (768)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++|+..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 88888877654 667777643 35689999999999999998753210 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCc
Q 046311 565 PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644 (768)
Q Consensus 565 ~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 644 (768)
...++..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||++.......... .....+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence 12366778899999999999999998 9999999999999999999999999996543222111 1122358899999
Q ss_pred cccccCC----------------------CCChhhHHHHHHHHHHHHcCCc-ccccCCCCCcccccccccchhhhhhHHh
Q 046311 645 EYYRLQQ----------------------LTEKSDVYSFGVVLLEILSGYR-AIHRTHNGTPRNVVDFVVPYIVRDEIHR 701 (768)
Q Consensus 645 E~l~~~~----------------------~s~~sDVwSlGvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (768)
|.+.... ...+.||||+||++|||++|.. |+....... .+..++ . .....+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~--~-~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQY--D-NDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhc--c-chHHHHHh
Confidence 9875322 1234799999999999999875 553211000 000000 0 00000111
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccC---CCCCCHHHHHH
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEG---RNRPSMTEIVN 744 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP---~~RPs~~evl~ 744 (768)
........ +..........+|+.++|..+| .+|+|++|+++
T Consensus 456 ~~~~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111110 1111234556689999999766 68999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=298.31 Aligned_cols=266 Identities=19% Similarity=0.230 Sum_probs=165.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-C----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-D----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
.++|+..++||+|+||.||+|++. + +..||||++.... ..+.+.+| .+.+..+.++..++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-------------~~e~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-------------AVEIWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-------------hhHHHHHH--HHHhhchhhHHHHH
Confidence 467899999999999999999875 4 6899999864321 01111111 11122222222221
Q ss_pred EE------EEcCCeeEEEEEeccCCChhhhccCCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 046311 533 GF------CEDRNERVLIYEYLENGTLHDHLHNPQSS----------------SPLKSWPARIKVALDAARGIEYLHEYA 590 (768)
Q Consensus 533 ~~------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~ia~~ia~gL~yLH~~~ 590 (768)
.. .....+.+|||||+++++|.++++..... ........+..++.|+++||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24566889999999999999998653211 001112334578999999999999998
Q ss_pred CCCeEecCCCCCCeEECC-CCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-------------------
Q 046311 591 VPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ------------------- 650 (768)
Q Consensus 591 ~~~ivHrDiKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------------------- 650 (768)
|+||||||+|||++. ++.+||+|||+++....... .......+++.|||||.+...
T Consensus 276 ---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l 351 (566)
T PLN03225 276 ---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 351 (566)
T ss_pred ---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence 999999999999985 57999999999975432221 122245689999999965322
Q ss_pred ---CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcc----hHHHHHHHHH
Q 046311 651 ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPF----EIEAVAYVGY 723 (768)
Q Consensus 651 ---~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 723 (768)
.++.++|||||||+||||+++..+.+.........+. ........+...+.....+.... .........+
T Consensus 352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLK---RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred ccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHH---hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 2345679999999999999976554311000000000 00000011111111111100000 0001123458
Q ss_pred HHHHcccccCCCCCCHHHHHHH
Q 046311 724 LAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 724 Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
|+.+||+.||++|||++|+++.
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999874
|
|
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=265.12 Aligned_cols=210 Identities=20% Similarity=0.282 Sum_probs=174.9
Q ss_pred CCCCcEEeccCCCCCccc---------ccccccCC----CCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC------
Q 046311 92 SSSSVMHCWRFSADGIIN---------DYKRIYRG----PALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS------ 152 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~---------~~~~~~~~----~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~------ 152 (768)
..-..||+||+|..+||+ .|.+.... ..+++++||+.|+.+| +.||.||.||.|..|.+|
T Consensus 65 ~~~~~v~~~Gsn~~~eLGlg~de~~~~~P~~~~~~~~d~~~i~~~acGg~hsl~l-d~Dg~lyswG~N~~G~Lgr~~~~~ 143 (476)
T COG5184 65 VKMASVYSWGSNGMNELGLGNDETKVDRPQLNPFGRIDKASIIKIACGGNHSLGL-DHDGNLYSWGDNDDGALGRDIHKD 143 (476)
T ss_pred hheeeeEEEecCcceeeccCCchhcccCceecCcccccceeeEEeecCCceEEee-cCCCCEEEeccCcccccccccccc
Confidence 556689999999999983 23333222 4799999999999999 999999999999999777
Q ss_pred ------------------------C------C-ceEEEEecCCeEEEEeeCCeEEEecCCCCCCc---------------
Q 046311 153 ------------------------I------H-NFSNIAVGEDFVCGLLENGTITCFGSRNSPTS--------------- 186 (768)
Q Consensus 153 ------------------------~------~-~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~--------------- 186 (768)
. . +|++++||+.++++|++||+||.||...-+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~cg~e~svil~~~G~V~~~gt~r~~e~~~g~~~~s~k~~~~~ 223 (476)
T COG5184 144 ICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLACGWEISVILTADGRVYSWGTFRCGELGQGSYKNSQKTSIQF 223 (476)
T ss_pred cccccccccccchhhcccCCceeeccccccCChheEEeecCCceEEEEccCCcEEEecCccccccccccccccccceeee
Confidence 1 1 48999999999999999999999997522211
Q ss_pred ccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC-------------------CeEEEeccCCeeEEEeeCC
Q 046311 187 VTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG-------------------KFKALALGENRSCALRNNQ 247 (768)
Q Consensus 187 ~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~-------------------~~~~ia~G~~h~~al~~dg 247 (768)
.|-.++...++++++|..|..+|+++|+||.||+|..||.+. .+..|++|.+|+.||++||
T Consensus 224 ~p~~v~~~~i~qla~G~dh~i~lt~~G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al~~~G 303 (476)
T COG5184 224 TPLKVPKKAIVQLAAGADHLIALTNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLALDEDG 303 (476)
T ss_pred eeeecCchheeeeccCCceEEEEecCCcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEEcCCC
Confidence 122223358999999999999999999999999999999432 5677999999999999999
Q ss_pred eEEEEecCCCCCCCCCC------------------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCcccc
Q 046311 248 KVVCWGQNGFTLPDSLQ------------------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMVF 303 (768)
Q Consensus 248 ~v~~WG~n~~gq~~~~~------------------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~~~ 303 (768)
++|+||.|.|||++.+. +..|.+|++|..|+..| +.||.||.||++.+++.....
T Consensus 304 ~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~~i~~is~ge~H~l~L-~~~G~l~a~Gr~~~~qlg~~~ 376 (476)
T COG5184 304 EIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTICSISAGESHSLIL-RKDGTLYAFGRGDRGQLGIQE 376 (476)
T ss_pred eEEEeccchhcccccCcccccceeeccccccccCCCceEEEEecCcceEEEE-ecCceEEEecCCccccccCcc
Confidence 99999999999999661 12479999999999999 899999999999887766543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=241.54 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=164.9
Q ss_pred CCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcC
Q 046311 461 FSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDR 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 538 (768)
+...+.||+|+||.|-+-++ .+|...|+|+++... ..+..++.++|+.+..+. ..|.+|.++|.+.++
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv----------n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV----------NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc----------ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 33456799999999988875 489999999987542 235667888999987666 799999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++.||.|.- ||..+-.+--......++...-+|+..+.+||.|||++- .++|||+||+||||+.+|++||+|||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 999999999965 888776543334455677788899999999999999986 49999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc----CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL----QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
++-.....-. .+...|-..|||||.+.. ..|+-||||||||+.+.||.+++.||+..
T Consensus 195 IsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 195 ISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 9864322111 122468889999999863 47899999999999999999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=284.75 Aligned_cols=246 Identities=28% Similarity=0.369 Sum_probs=184.8
Q ss_pred CCcCceeccCCceE-EEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcC
Q 046311 461 FSEDHKIGSGSFGA-VYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDR 538 (768)
Q Consensus 461 ~~~~~~LG~G~fG~-Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 538 (768)
|...+.+|.|+-|+ ||+|..+ ++.||||++-. +......+|+..|+.- +|||||++++.-.++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~ 575 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE--------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR 575 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh--------------HhHHHHHHHHHHHHhccCCCceEEEEeeccCC
Confidence 55567899999986 7999987 79999998743 2334457899999888 699999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-----CCcEE
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-----TWTAK 613 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-----~~~~k 613 (768)
...|+..|.|.. +|.|++...........-...+.+..|+++||++||+.+ ||||||||.||||+. ...++
T Consensus 576 qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 576 QFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred ceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEE
Confidence 999999999965 999999874111111111334678899999999999988 999999999999965 35789
Q ss_pred EeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC-CcccccCCCCCccccccccc
Q 046311 614 VSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG-YRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 614 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~ 691 (768)
|+|||+++........ .......||.+|+|||++....-+.++||||||||+|+.++| ..||......+.
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------- 723 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------- 723 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------
Confidence 9999999865543322 223356799999999999988888899999999999998886 889875322110
Q ss_pred chhhhhhHHhhhccCCCCCC-cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.++........ ....+. +..+||.+|++++|..||++.+|+.
T Consensus 724 ---------NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 ---------NILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---------hhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111110000 001111 4558999999999999999999973
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=272.25 Aligned_cols=263 Identities=20% Similarity=0.238 Sum_probs=200.2
Q ss_pred CCCcCceeccCCceEEEEEEEcCCC-eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGS-QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~-~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+++....||-|+||.|=+.+.++.. .+|+|.++.... .....++.+..|-.+|...+.|.||+++..|.+.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--------VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--------VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--------cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 4555677999999999999876433 488888765321 1223455677899999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
++.||+||-|-||.|+..|+..+. ++......++-.++++++|||+++ ||.|||||+|.||+.+|-+||.|||
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999987543 344445567778999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+|+....... +..++|||.|.|||++.++..+.++|.||||+++||||+|.+||...++-. . ..-
T Consensus 566 FAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-----t-------Yn~ 630 (732)
T KOG0614|consen 566 FAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-----T-------YNL 630 (732)
T ss_pred hHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-----H-------HHH
Confidence 9987654443 336799999999999999999999999999999999999999997643311 1 111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH-------HHHHHhhcccCC
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS-------LERALAACLVSP 757 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~-------L~~~l~~~~~~~ 757 (768)
+.+-+|.. .++....+...+||++.+..+|.+|.- ..+|.+. .+.+.+..+.+|
T Consensus 631 ILkGid~i-----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pP 696 (732)
T KOG0614|consen 631 ILKGIDKI-----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPP 696 (732)
T ss_pred HHhhhhhh-----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCC
Confidence 22222221 112233344558899999999999975 4555443 334444455444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=249.76 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=192.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|...++||+|+|..|..++++ +.+.+|+|+++..-. ..++...=.+.|-.+..+. +||.+|.|..+|.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--------nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--------CCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 56888899999999999999865 678899998875421 1122233345566665555 7999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+...++|.||++||+|--++++++ .+++.........|..+|.|||+++ ||.||||.+|||||..+++||.|
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecc
Confidence 9999999999999999987776532 2466666777889999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc-ccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-RNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~ 695 (768)
+|+.+..-... .....++|||.|.|||++++..|....|.|+|||+++||+.|+.||+-.....+ .+..++..+.+
T Consensus 395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi- 471 (593)
T KOG0695|consen 395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI- 471 (593)
T ss_pred cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-
Confidence 99997543322 223467999999999999999999999999999999999999999986443322 23334443333
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 737 (768)
+++.++-+...... ...+++.-|.+||++|.
T Consensus 472 -------lekqiriprslsvk----as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 -------LEKQIRIPRSLSVK----ASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------hhhcccccceeehh----hHHHHHHhhcCCcHHhc
Confidence 33333333333332 23577888999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=262.27 Aligned_cols=208 Identities=25% Similarity=0.347 Sum_probs=167.9
Q ss_pred CCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.-|..++.||-|+||+|.++. .++...+|.|.++..+.. ..........|-++|..-+.+-||+|+-.|.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl--------~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL--------MRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH--------hhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 457778899999999999996 456778999988765321 12334456778899999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++.+|+||||++||++-.+|-+. ..+++......+..+..++++.|..+ +|||||||+|||||.+|++||+||
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeec
Confidence 99999999999999999998643 23444445556678999999999999 999999999999999999999999
Q ss_pred cccccC---------CCCCCccc-------------------------------ccccccccCccCccccccCCCCChhh
Q 046311 618 GLSLIG---------PEDDESHL-------------------------------SLRAAGTVGYMDPEYYRLQQLTEKSD 657 (768)
Q Consensus 618 Gla~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~l~~~~~s~~sD 657 (768)
||+.-+ ...+.... ....+||+.|+|||++....|+...|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 997421 11100000 00126999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCcccccCCCC
Q 046311 658 VYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 658 VwSlGvll~elltG~~p~~~~~~~ 681 (768)
.||.|||||||+.|+.||.....+
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCC
Confidence 999999999999999999875544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-30 Score=250.32 Aligned_cols=267 Identities=23% Similarity=0.345 Sum_probs=190.3
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC--
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR-- 538 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 538 (768)
+..+.||-|+||.||..+.. +|+.||.|++... ...-...+++.+|+++|..++|.|++..+++..-.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchH---------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 34577999999999999864 8999999987542 22234567899999999999999999998876543
Q ss_pred ---CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 539 ---NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 539 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
++.|++.|.|.. +|+..|-.. ..++-....-+.+||++||.|||+.+ |.||||||.|.|++.+..+||+
T Consensus 127 dfFqEiYV~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence 367889999865 888887543 23445566778899999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-cccc---
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-VDFV--- 690 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~~~~--- 690 (768)
|||+++....++..+.. ..+-|..|+|||++.+ ..|+...||||.||++.|||-.+-.|+...+-...++ .++.
T Consensus 199 DFGLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 99999876554444433 4567899999999876 5799999999999999999988777765432111111 0110
Q ss_pred ----cchhhhhhHHhhhccCCCCCCc-------chHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 691 ----VPYIVRDEIHRVLDRNVPPPTP-------FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 691 ----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
.....+..-..++......+.. .......+-..+.+.++..||++|.+.++.+..+
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111112222222222110 0001112223678899999999999988877653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=234.36 Aligned_cols=259 Identities=19% Similarity=0.322 Sum_probs=192.5
Q ss_pred cCCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 535 (768)
.++|++.+++|+|.|+.||.|. ..+.+.++||.++.. ..+.+.+|+.+|..|. ||||++|+++.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------------kkkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------------KKKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------------HHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 4678899999999999999997 457899999998743 4567899999999997 99999999998
Q ss_pred EcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcE
Q 046311 536 EDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTA 612 (768)
Q Consensus 536 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~ 612 (768)
.+. ....||+||+.+.+...+.. .++...+...+.+++++|.|+|+.+ |+|||+||.|++||. ...+
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred cCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhcee
Confidence 765 46689999999977766552 2344556678899999999999999 999999999999985 5679
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCccccc-cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+|+|+|||.+..+....... +.+..|.-||++- ...|+..-|+|||||+|.+|+..+.||....+. ..+++..+
T Consensus 173 rlIDWGLAEFYHp~~eYnVR---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIa- 247 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIA- 247 (338)
T ss_pred eeeecchHhhcCCCceeeee---eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHH-
Confidence 99999999987776655443 3567789999985 457888999999999999999999998654322 11222111
Q ss_pred chhhhhh---------------HHhhhccCCCCCC-----cchHH-HHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDE---------------IHRVLDRNVPPPT-----PFEIE-AVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~---------------~~~~~~~~~~~~~-----~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....++ ...++....+.+. ..... ..++..+|+.+.|..|-++|||++|.+..
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0111111 1122211111110 00001 12455689999999999999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=233.47 Aligned_cols=211 Identities=36% Similarity=0.575 Sum_probs=179.7
Q ss_pred eccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 467 IGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
||+|.+|.||++...+ ++.+++|++..... ......+.+|++.++.++|++|+++++++......+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~ 70 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----------SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM 70 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc----------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEE
Confidence 6899999999998764 89999999864321 113467999999999999999999999999999999999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEeeccccccCC
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGP 624 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~DFGla~~~~ 624 (768)
||+++++|.+++.... ...++..++.++.+++++|+|||+.+ ++|+||+|.||+++. ++.++|+|||.+....
T Consensus 71 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 71 EYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred ecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 9999999999996532 23578899999999999999999998 999999999999999 8999999999997554
Q ss_pred CCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhh
Q 046311 625 EDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVL 703 (768)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (768)
.... ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 145 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 145 SDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred CCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------
Confidence 3321 11223578899999998876 888999999999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 704 DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 345589999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=260.38 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=167.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCc--ccccccccchhhHHHHHHHHHHHhcCC---CCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTS--SYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l 531 (768)
...|...+.||.|+||.|+.+.++ +...|+||.+.+.... .|.+ +.+.-..-.|+++|..++ |+||+++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvr-----DrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVR-----DRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhc-----ccccCccchhHHHHHHhhhcCccchhhh
Confidence 346888999999999999999876 5678999987654321 2221 112234567999999997 9999999
Q ss_pred EEEEEcCCeeEEEEEec-cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 532 LGFCEDRNERVLIYEYL-ENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
+++|++++.+||+||-. ++-+|+++|..+ +.+++.+...|++|++-|+++||+++ |||||||-+||.++.+|
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 99999999999999975 466899999753 34577888899999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIH 676 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~ 676 (768)
-+||+|||.+........ ..++||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 708 ~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999865443332 24579999999999998876 567899999999999998888774
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=238.64 Aligned_cols=131 Identities=24% Similarity=0.395 Sum_probs=109.5
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-----C---CCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-----H---KNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv 529 (768)
.+|...++||.|.|++||++.. .+.+.||+|+.+.. +.-.+.-+.||++|++++ | ..||
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA------------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA------------QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh------------hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 6899999999999999999975 46789999987642 334556778999999883 3 4699
Q ss_pred eEEEEEEc----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 530 RLLGFCED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 530 ~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
+|+++|.. ..+.+||+|++ |-+|..+|.....+ -++.....+|+.||+.||.|||+.. +|||-||||+|||
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvL 220 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVL 220 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceee
Confidence 99999965 45899999998 66999999765443 3577888999999999999999987 5999999999999
Q ss_pred E
Q 046311 606 L 606 (768)
Q Consensus 606 l 606 (768)
|
T Consensus 221 l 221 (590)
T KOG1290|consen 221 L 221 (590)
T ss_pred e
Confidence 9
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=239.48 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=188.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|...+.++.|.- .|..+... .+++||+|++... .......++-.+|+.++..++|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---------f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---------FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---------cccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 46777788888888 56555433 5899999987533 1113344567889999999999999999998843
Q ss_pred C------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 538 R------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 538 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
. .+.|+|||+|.. +|...++. .++-.....|.+|++.|+.|||+.+ |+||||||+||++..+..
T Consensus 87 ~~~l~~~~e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred cccHHHHHhHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhh
Confidence 3 367999999965 99998863 2466677899999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCC-----------
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN----------- 680 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~----------- 680 (768)
+||.|||+++..... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|..-|.....
T Consensus 157 lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred eeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 999999999864433 222345789999999999888899999999999999999999877752210
Q ss_pred CCc--cccccc---ccchhh------hhhHHhhh-ccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 681 GTP--RNVVDF---VVPYIV------RDEIHRVL-DRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 681 ~~~--~~~~~~---~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+.+ ....++ ...+.. .-...+.+ |..++...+.+.-......+++.+||-.+|++|.+.+++|+.
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 000000 000000 00011111 112222222222223456689999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=227.94 Aligned_cols=200 Identities=34% Similarity=0.494 Sum_probs=168.7
Q ss_pred CCcCceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|...+.||+|+++.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~ 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC
Confidence 4567889999999999999764 899999998643210 24568899999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++++||+++++|.+++...... .++.....++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~ 144 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGL 144 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCce
Confidence 999999999999999999753221 578888999999999999999997 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCcccc-ccCCCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYY-RLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
+......... ......++..|++||.+ ....++.++|+|+||+++|||++|+.||..
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 145 ARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 8765443210 11233577889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=226.87 Aligned_cols=255 Identities=18% Similarity=0.287 Sum_probs=184.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE-E
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF-C 535 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~ 535 (768)
+.|.+.+.||+|.||.+-++.++ +...+++|.+.. .....++|.+|...--.| .|.||+.-+++ |
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------------chhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 56888899999999999999876 577899997643 234678899998866566 69999988775 5
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC--CCCcEE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--ATWTAK 613 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--~~~~~k 613 (768)
+..+.+++++||++.|+|.+-+... .+-+....+++.|++.+|.|||+++ +||||||.+||||- +..++|
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEE
Confidence 6677888999999999999988542 2345566789999999999999999 99999999999993 345899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccC-----CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-----QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
|+|||+.+.....-.. ..-+..|.+||+.... ...+.+|||.||+++|.+|||..|++.....++
T Consensus 164 lcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----- 233 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----- 233 (378)
T ss_pred eeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----
Confidence 9999998754332211 1236679999986432 346789999999999999999999986443332
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
++..-..+..-....++. .+. .....+.++.++-+..+|++|=-..++.++....
T Consensus 234 ---~Y~~~~~w~~rk~~~~P~--~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 234 ---PYWEWEQWLKRKNPALPK--KFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ---hHHHHHHHhcccCccCch--hhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 111111111111112221 111 1223445788999999999995555555554443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=244.82 Aligned_cols=266 Identities=21% Similarity=0.244 Sum_probs=196.5
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC------CCCce
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH------HKNLV 529 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv 529 (768)
.-.+|.+....|+|-|++|.+|... .|..||||++... +...+.=++|+++|++|+ .-|++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------------E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------------EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------------hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3468988899999999999999865 5789999998753 233445568999999994 34899
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
+|+-.|...++++||||-+. .+|.+.|.+.+.. ..+........+.|+.-+|..|...+ |+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 99999999999999999885 4999999875543 33466777889999999999999998 9999999999999875
Q ss_pred -CcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-c
Q 046311 610 -WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-V 687 (768)
Q Consensus 610 -~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~ 687 (768)
..+||||||.|.......... ..-+..|.|||++.+..|+...|+||.||.||||.||+..|..........+ .
T Consensus 573 k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 467999999997655444322 2236679999999999999999999999999999999987754322110000 0
Q ss_pred -----------------------ccccchhhh------------------hhHHhhhccCCCCCCcchHHHHHHHHHHHH
Q 046311 688 -----------------------DFVVPYIVR------------------DEIHRVLDRNVPPPTPFEIEAVAYVGYLAA 726 (768)
Q Consensus 688 -----------------------~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~ 726 (768)
++..-++.. ..+...+-.. +............|.+|+.
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~-q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV-QRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-CCCCchhHHHHHHHHHHHH
Confidence 000000000 0111111100 0011234456788899999
Q ss_pred HcccccCCCCCCHHHHHH
Q 046311 727 DCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 727 ~Cl~~dP~~RPs~~evl~ 744 (768)
+||..||++|.|..+.|+
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=252.29 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=194.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|.....+|.|+||.|||++.. +++..|||.++..... ...-+++|+-+++..+||||+.+++.+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----------d~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----------DFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----------cccccccceeeeecCCCcChHHHHhhhh
Confidence 357888899999999999999865 7899999998865332 3344667999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.++..++.|||+.+|+|.+.-+.. ..+++.++-.+....++||+|||+.+ =+|||||-.|||+++.+.+|++|
T Consensus 83 r~dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecc
Confidence 999999999999999999988752 23466677788889999999999998 48999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
||.+-.....- .....+.||+.|||||+.. ...|..++|||++|+...|+-.-+.|.....+..
T Consensus 156 fgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----------- 222 (829)
T KOG0576|consen 156 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----------- 222 (829)
T ss_pred cCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----------
Confidence 99985432211 1122457999999999863 5678999999999999999977766654322210
Q ss_pred hhhhhHHhhhccCC-CCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNV-PPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...++.+.. .++ ..........+.++++.|+.++|++||+++.++.
T Consensus 223 -----~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 223 -----ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -----HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 011111111 111 1122345677889999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=232.54 Aligned_cols=200 Identities=30% Similarity=0.409 Sum_probs=163.7
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
..+.|..+++||+|.|++||++.+. ..+.||+|.+... .....+.+|+++|..+ -+.||+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-------------s~p~ri~~El~~L~~~gG~~ni~~~ 100 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-------------SSPSRILNELEMLYRLGGSDNIIKL 100 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-------------cCchHHHHHHHHHHHhccchhhhcc
Confidence 4467889999999999999999753 4688999988653 2334588999999999 59999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TW 610 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~ 610 (768)
.+++..++...+||||++.-...+++.. ++...+...+..++++|+++|.++ ||||||||+|+|.+. .+
T Consensus 101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred hhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccC
Confidence 9999999999999999999888888854 457788889999999999999999 999999999999975 56
Q ss_pred cEEEeeccccccCCCC-------C-------C----------------------------cccccccccccCccCccccc
Q 046311 611 TAKVSDFGLSLIGPED-------D-------E----------------------------SHLSLRAAGTVGYMDPEYYR 648 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~-------~-------~----------------------------~~~~~~~~gt~~y~aPE~l~ 648 (768)
.-.|.|||||...... . . ........||++|.|||++.
T Consensus 171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~ 250 (418)
T KOG1167|consen 171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF 250 (418)
T ss_pred CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence 7899999998610000 0 0 00001236999999999986
Q ss_pred c-CCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 649 L-QQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 649 ~-~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
. ...+.++||||.|||++-+++++.||....
T Consensus 251 k~~~QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 251 RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred hccCcCCccceeeccceeehhhccccccccCc
Confidence 4 567889999999999999999999997643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=269.47 Aligned_cols=198 Identities=22% Similarity=0.222 Sum_probs=136.7
Q ss_pred hcCCC-CCceeEEEEE-------EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 046311 521 SRLHH-KNLVRLLGFC-------EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVP 592 (768)
Q Consensus 521 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~ 592 (768)
+.++| +||+++++++ .+.+..+++|||+ +++|.++|+... ..+++.+++.++.||++||+|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 34556 6888888877 2334567789987 559999997532 33688899999999999999999998
Q ss_pred CeEecCCCCCCeEECCC-------------------CcEEEeeccccccCCCCCC--------------ccccccccccc
Q 046311 593 SIIHRDIKSSNVLLDAT-------------------WTAKVSDFGLSLIGPEDDE--------------SHLSLRAAGTV 639 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~ 639 (768)
|+||||||+||||+.. +.+||+|||+++....... ........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999654 4455666666543211000 00001235788
Q ss_pred CccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHH
Q 046311 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVA 719 (768)
Q Consensus 640 ~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (768)
.|||||++....++.++|||||||+||||++|..|+..... . ...+. ....++. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~---------~~~~~---~~~~~~~---~~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T---------MSSLR---HRVLPPQ---ILLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H---------HHHHH---HhhcChh---hhhcCH
Confidence 99999999989999999999999999999998877542110 0 00010 0011110 001122
Q ss_pred HHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 720 YVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 720 ~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....++.+||+.+|.+||+|.|+++.
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 34578889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=208.36 Aligned_cols=170 Identities=21% Similarity=0.192 Sum_probs=126.2
Q ss_pred CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcc
Q 046311 551 GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630 (768)
Q Consensus 551 gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 630 (768)
|+|.++++... ..+++..++.++.|+++||+|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997532 34689999999999999999999875 999999999999999 99987543321
Q ss_pred cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCC
Q 046311 631 LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP 710 (768)
Q Consensus 631 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (768)
..||+.|||||++....++.++||||||+++|||+||+.||....... . .. ..+........+..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~-----~~-~~~~~~~~~~~~~~ 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----A-----IL-EILLNGMPADDPRD 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----H-----HH-HHHHHHhccCCccc
Confidence 257899999999999999999999999999999999999985432110 0 00 00111111111111
Q ss_pred CcchHHHHH--HHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 711 TPFEIEAVA--YVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 711 ~~~~~~~~~--~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
......... .+.+++.+||+.+|++||++.|+++.+..+...
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 111222222 588999999999999999999999998877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-24 Score=207.95 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=186.8
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
...+|.+...|..|+|+++ |..+++|++..... .....++|.+|.-.|+-+.||||+++++.|.......
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~---------t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREV---------TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhccCCCccccccccc-Ccchhhhhhhhhhc---------chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 3457888999999999998 56677787764321 1234467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe--ecccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS--DFGLS 620 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~--DFGla 620 (768)
++..||+.|||+..||+.. ....+..+..++++++++|++|||+.. |-|.---|.+..|++|++.+++|+ |--++
T Consensus 264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999999999753 344577788999999999999999987 334455789999999999998885 22111
Q ss_pred ccCCCCCCcccccccccccCccCccccccCCCC---ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT---EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s---~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
.. .. ...-.|.||+||.++..+.+ ...|+|||.++||||.|...||....+.+-.- .
T Consensus 341 fq--e~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----------k 400 (448)
T KOG0195|consen 341 FQ--EV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----------K 400 (448)
T ss_pred ee--cc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------h
Confidence 11 10 11236889999999865443 57899999999999999999997654321100 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
-..+-+...+++ ..+..+.+|+.-|+..||.+||.+..|+-+||+++
T Consensus 401 ialeglrv~ipp------gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPP------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCC------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 001111111222 22455668999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=217.94 Aligned_cols=169 Identities=20% Similarity=0.178 Sum_probs=127.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCcee-EEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR-LLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~ 534 (768)
.++|.+.+.||+|+||+||+|.++ +++.+|||++..... ..........|.+|+++|++++|+|+++ +++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP------WWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc------ccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 357899999999999999999865 577789998642100 0011234567999999999999999985 443
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC-CCCCeEECCCCcEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI-KSSNVLLDATWTAK 613 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi-Kp~NILl~~~~~~k 613 (768)
.+..+|||||+++++|... .. . . ...++.+++++|+|||+++ |+|||| ||+|||++.++.+|
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~-~~----~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLA-RP----H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHh-Cc----c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 2467999999999999732 11 0 1 1467889999999999998 999999 99999999999999
Q ss_pred EeeccccccCCCCCCccc------ccccccccCccCccccccC
Q 046311 614 VSDFGLSLIGPEDDESHL------SLRAAGTVGYMDPEYYRLQ 650 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~ 650 (768)
|+|||+++.......... -....+++.|++||.+...
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999985543221111 0234678899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=212.79 Aligned_cols=265 Identities=21% Similarity=0.241 Sum_probs=193.2
Q ss_pred CCCcCceeccCCceEEEEEEEcCC--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC----CCceeEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDG--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH----KNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~ 533 (768)
+|.+.++||+|+||.||++..... ..+|+|....... .....+..|..++..+.. +++..+++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~-----------~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~ 87 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG-----------SKPSVLKIEIQVLKKLEKKNGPSHFPKLLD 87 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc-----------CCCccchhHHHHHHHHhhhcCCCCCCEEEE
Confidence 789999999999999999987643 4788887654211 111146678888888863 68899999
Q ss_pred EE-EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC---
Q 046311 534 FC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT--- 609 (768)
Q Consensus 534 ~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~--- 609 (768)
.. ......++||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++...
T Consensus 88 ~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 88 HGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred eccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCc
Confidence 88 5777899999987 779999886544 334677889999999999999999999 9999999999999754
Q ss_pred --CcEEEeeccccccCC--CCCC---c---ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 610 --WTAKVSDFGLSLIGP--EDDE---S---HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 610 --~~~kl~DFGla~~~~--~~~~---~---~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
..+.|.|||+++... .... . .......||.+|++++...+...+.+.|+||++.++.||+.|..|+....
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 469999999998322 1111 0 10123469999999999999999999999999999999999999885433
Q ss_pred CCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
..... ..+........... ........+.++...+-..+..++|....+...|+++......
T Consensus 242 ~~~~~-------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 242 MTDLK-------SKFEKDPRKLLTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred ccchH-------HHHHHHhhhhcccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 21110 00001111111110 0111123344566666668999999999999999999887643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=196.92 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=193.9
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
-.|++.++||+|.||.++.|+. -++++||||.-... .+..++..|.+.++.| ..++|...+-|..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-------------S~APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-------------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-------------CCcchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 3799999999999999999983 47899999965432 2234567788888888 4689999998889
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-----CCc
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-----TWT 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-----~~~ 611 (768)
+..+..||+|.+ |-||+|++.-..+. ++..+.+.+|.|++.-++|+|++. +|.|||||+|+||.. ...
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCce
Confidence 999999999988 77999998655433 477888999999999999999999 999999999999964 346
Q ss_pred EEEeeccccccCCCCCC-cccc----cccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDE-SHLS----LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~-~~~~----~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.|+|||+|+...+.+. .+.. ....||.+||+-....+.+.+.+-|+-|||-++.++|-|..||+........+
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~- 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE- 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-
Confidence 89999999986543321 1111 23469999999999889999999999999999999999999998653322111
Q ss_pred cccccchhhhhhHHhhhccCCCCCC-cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
..+++=+..-..+. ..-...+.++..-+.-.=..+-.+-|..+-+...+.+++..-..
T Consensus 247 -----------kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 247 -----------KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred -----------HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11111111111000 00001122233333334445677789999999888888876544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=192.33 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=187.7
Q ss_pred cCCCCcCceeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~ 535 (768)
.++|..+++||.|+||.+|.|. ..+|++||||.-... .....+..|.++.+.|+| ..|..+..|.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-------------a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-------------AKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-------------CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 3679999999999999999997 568999999975432 223456778899999976 5677788888
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCcE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWTA 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~~ 612 (768)
.++.+..||||.+ |.||++++.-... .++..+.+.++-|++.-++|+|.++ ++||||||+|+|+.- ...+
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceE
Confidence 8889999999988 7899999875433 2467788999999999999999999 999999999999953 3468
Q ss_pred EEeeccccccCCCCCC-cc----cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc
Q 046311 613 KVSDFGLSLIGPEDDE-SH----LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 613 kl~DFGla~~~~~~~~-~~----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 687 (768)
.++||||++...+... .+ ......||.+|.+-....+...+.+.|+-|+|.+|..+.-|..|++........+.
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK- 232 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK- 232 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-
Confidence 9999999976543221 11 12245699999998877777788899999999999999999999986543332221
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcc-hHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPF-EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.+++.++....+... -...+.++.-.+.-|=..--++-|...-+.+.++-++
T Consensus 233 -----------yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 233 -----------YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred -----------HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 112222222111000 0001223334555666666677777766666555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=202.08 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=194.5
Q ss_pred CCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC-CceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK-NLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~ 539 (768)
|...+.||.|.|+.||++... ..+++|.+...... .......|.+|+.++..+.|+ +|+++.+++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLES--------KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhcc--------chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence 566788999999999999877 88899988654211 112467899999999999988 7999999998777
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEEEeecc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSDFG 618 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~kl~DFG 618 (768)
..++++|++.+++|.+++...... ..........+..|++.++.|+|+.+ ++||||||+|||++... .+++.|||
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccC
Confidence 789999999999999777653221 24577788899999999999999998 99999999999999988 79999999
Q ss_pred ccccCCCCCCcc----cccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 619 LSLIGPEDDESH----LSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 619 la~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
++.......... ......++..|++||.+.. ..+....|+|++|++++++++|..|+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------- 217 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------- 217 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----------
Confidence 997443332211 2235579999999999987 57889999999999999999999996543221
Q ss_pred chhhhhhHHhhhccCCCC--CCcch----HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPP--PTPFE----IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.......+.+.....+ ..... ......+.+++..++..+|..|.++.+....
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 218 --SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0001111111111110 00001 1122456689999999999999999887775
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=184.06 Aligned_cols=229 Identities=17% Similarity=0.200 Sum_probs=176.3
Q ss_pred cCCccccCCCCCCeeEEeeC--CCeeeeeeeeccCCCCcEEeccCCCCCcccccc-------cccCC---CCeeEEecCC
Q 046311 60 SIPQLIPVNPNASFASIVSG--DGFLCTLITFSASSSSVMHCWRFSADGIINDYK-------RIYRG---PALQQLEAGN 127 (768)
Q Consensus 60 ~~~~~~~~~~~~~~~~v~~G--~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~-------~~~~~---~~~~~i~~G~ 127 (768)
|+|.+......+++.-|..| ..|+..| .-+|+.|.||+|..|||+... ++..+ .++++-++|.
T Consensus 45 ~sphR~~~l~gv~iR~VasG~~aaH~vli-----~megk~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~Gr 119 (443)
T KOG1427|consen 45 VSPHRLRPLVGVNIRFVASGCAAAHCVLI-----DMEGKCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGR 119 (443)
T ss_pred ccceeccccccceEEEEecccchhhEEEE-----ecccceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhcc
Confidence 34444443444455556655 4577777 789999999999999995431 22222 2688889999
Q ss_pred CeEEEEEeCCCcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccc-
Q 046311 128 SHICGLVNGTNDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQ- 189 (768)
Q Consensus 128 ~h~~al~~~~g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~- 189 (768)
.|+++| +++|+|+..|.|.+||+| +..+..|+||..|+.-|...+++...|--.|||++..
T Consensus 120 nHTl~l-tdtG~v~afGeNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l~~~~si~t~glp~ygqlgh~t 198 (443)
T KOG1427|consen 120 NHTLVL-TDTGQVLAFGENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWLSSTESILTAGLPQYGQLGHGT 198 (443)
T ss_pred CcEEEE-ecCCcEEEecccccccccccccccccccCCCccccCccceeeccccceEEEeecccceeecCCccccccccCc
Confidence 999999 999999999999999999 3448899999999999999999999999999987532
Q ss_pred -------------------------cCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC----------------
Q 046311 190 -------------------------KVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG---------------- 228 (768)
Q Consensus 190 -------------------------~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~---------------- 228 (768)
++....++.++||.+||.|+.++++||.||.+.+|..+-
T Consensus 199 d~~~~~~~~~~~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvavd~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd 278 (443)
T KOG1427|consen 199 DNEFNMKDSSVRLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAVDKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFD 278 (443)
T ss_pred chhhccccccceeeeecCCCccccccccceeeEEEeccCcceeeecCCccEEEeccccccccccccchhhHHHHHHHHhc
Confidence 111246788999999999999999999999998888331
Q ss_pred ----CeEEEeccCCeeEEEeeCCeEEEEecCC-CCCCCC-------CCCCCeEEEEecCCeEEEEEecCCeEEEEeCCCC
Q 046311 229 ----KFKALALGENRSCALRNNQKVVCWGQNG-FTLPDS-------LQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESF 296 (768)
Q Consensus 229 ----~~~~ia~G~~h~~al~~dg~v~~WG~n~-~gq~~~-------~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~ 296 (768)
.-.++-+|+..++.+..-|.++.||.+. .|.-.. ..+-++.-+.+|..|. .+ ..|.+.+.||...+
T Consensus 279 ~~~rg~~~~~~g~t~Sl~v~e~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h~-~v-~ad~s~i~wg~~~~ 356 (443)
T KOG1427|consen 279 RNNRGPPNAILGYTGSLNVAEGGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMHH-FV-GADSSCISWGHAQY 356 (443)
T ss_pred CCCCCCcceeeecccceeecccceeEEeeccccCcccccCCCchhhcCCccCCCcCccceee-ee-cccccccccccccc
Confidence 4568899999999999999999999885 332221 1122457777777664 44 68999999998733
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=184.19 Aligned_cols=177 Identities=17% Similarity=0.222 Sum_probs=149.4
Q ss_pred CCCeeEEecC--CCeEEEEEeCCCcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEeeCCeEEE
Q 046311 117 GPALQQLEAG--NSHICGLVNGTNDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLENGTITC 177 (768)
Q Consensus 117 ~~~~~~i~~G--~~h~~al~~~~g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~~g~v~~ 177 (768)
+.++.-|+.| ..|+..| +-+|+.|.||+|+.||+| ..++++-++|..||++|+++|+|+.
T Consensus 55 gv~iR~VasG~~aaH~vli-~megk~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~ltdtG~v~a 133 (443)
T KOG1427|consen 55 GVNIRFVASGCAAAHCVLI-DMEGKCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLTDTGQVLA 133 (443)
T ss_pred cceEEEEecccchhhEEEE-ecccceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEecCCcEEE
Confidence 3456666666 5799999 999999999999999999 2347788999999999999999999
Q ss_pred ecCCCCCCccccc------------CCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC-----------------
Q 046311 178 FGSRNSPTSVTQK------------VPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG----------------- 228 (768)
Q Consensus 178 wG~~~~g~~~~~~------------~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~----------------- 228 (768)
+|.|.+||++... +....|+.|+||..+|.-|...+++...|-.++||.+-
T Consensus 134 fGeNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l~~~~si~t~glp~ygqlgh~td~~~~~~~~~~~~~~ 213 (443)
T KOG1427|consen 134 FGENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWLSSTESILTAGLPQYGQLGHGTDNEFNMKDSSVRLAY 213 (443)
T ss_pred ecccccccccccccccccccCCCccccCccceeeccccceEEEeecccceeecCCccccccccCcchhhccccccceeee
Confidence 9999999976321 11268999999999999999999999999999999321
Q ss_pred ---------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCCC----------------CCeEEEEecCCe
Q 046311 229 ---------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQG----------------KPFVSIEAKRSV 277 (768)
Q Consensus 229 ---------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~~----------------~~~~~i~~g~~h 277 (768)
.++.+|||.+||.|+.++++||.||-..||.||.... ..-.++-+|+..
T Consensus 214 e~~pr~~~i~~~dgvqiv~~acg~nhtvavd~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~~g~t~ 293 (443)
T KOG1427|consen 214 EAQPRPKAIASLDGVQIVKVACGTNHTVAVDKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAILGYTG 293 (443)
T ss_pred ecCCCccccccccceeeEEEeccCcceeeecCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCcceeeeccc
Confidence 5788999999999999999999999999999993321 123678888877
Q ss_pred EEEEEecCCeEEEEeCCC
Q 046311 278 FCGVLTSNYSLYCWGNES 295 (768)
Q Consensus 278 ~~~l~~~~g~~~~wG~n~ 295 (768)
+..+ ..-|.+|.||.+.
T Consensus 294 Sl~v-~e~G~Lf~~g~~k 310 (443)
T KOG1427|consen 294 SLNV-AEGGQLFMWGKIK 310 (443)
T ss_pred ceee-cccceeEEeeccc
Confidence 7777 7889999999983
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=223.57 Aligned_cols=260 Identities=19% Similarity=0.233 Sum_probs=185.6
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCe
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNE 540 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 540 (768)
...+.+|.|.+|.|+..... ..+.++.|..... .. ...........+..|+-+-..|+|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~----~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK----PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC----CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 34578999999988877643 3444555543311 00 001111122236678888888999999888887777777
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.+-+|||+++ +|+.++.... .+....+.-++.|+.+|+.|||+.+ |.|||||++|++++.++.+||+|||.+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred chhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence 7777999999 9999997531 2345566788999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCc--ccccccccccCccCccccccCCCCC-hhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccccchhhh
Q 046311 621 LIGPEDDES--HLSLRAAGTVGYMDPEYYRLQQLTE-KSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFVVPYIVR 696 (768)
Q Consensus 621 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~-~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~ 696 (768)
..+....+. .......|...|+|||++...+|.+ ..||||.|+++..|.+|+.||......+... -..+.......
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 755443333 4445678999999999999988876 5799999999999999999997654433221 00000000000
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+.......+..-..+|.++|+.+|.+|.|+++|++.
T Consensus 548 -----------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 -----------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -----------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 01111222334555679999999999999999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-21 Score=219.95 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=178.9
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH--HhcCCCCCceeEEEEEEc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES--LSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~ 537 (768)
+|...+.||.+.|=.|.+++.++|. |+||++-..+. ......|.++++- ...++|||.+++..+-..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p----------~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t 92 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDP----------TISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT 92 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCC----------CCCchHHHHHHHHHHHHhhcCCcccchHHHHHh
Confidence 5677789999999999999988777 99998854321 1223334443332 455699999999888777
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|||-+|... +|+|.|. .++.+...++.-|+.|++.+|..+|+.+ |+|+|||.+||||+.-..+.|+||
T Consensus 93 ~kAAylvRqyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 93 DKAAYLVRQYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hHHHHHHHHHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcc
Confidence 7788899999866 9999995 4566777888899999999999999999 999999999999999999999999
Q ss_pred cccccC--CCCCCcccc---cccccccCccCccccccC----------C-CCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 618 GLSLIG--PEDDESHLS---LRAAGTVGYMDPEYYRLQ----------Q-LTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 618 Gla~~~--~~~~~~~~~---~~~~gt~~y~aPE~l~~~----------~-~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
-.-+.. +.+...... .....-..|+|||.+... . .+++.||||+||++.||++ |+++|...
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 876532 222221111 112234579999987431 1 5789999999999999988 56666421
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
++..|.... ......++++.- ...+++++..|++.||++|.++++.++.-+
T Consensus 243 ----QL~aYr~~~--~~~~e~~Le~Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 ----QLLAYRSGN--ADDPEQLLEKIE----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ----HHHhHhccC--ccCHHHHHHhCc----------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 111111100 111112222110 124568999999999999999999998833
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=184.27 Aligned_cols=173 Identities=17% Similarity=0.134 Sum_probs=132.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhH------HHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKD------NAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~------~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|+..+.||.|+||.||+... ++..+|||.+..... ..+... ..|.+|++.+.+++|++|..+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~--------~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVK--------RTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcC--------chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 57899999999999999999765 477899999864321 111222 236899999999999999999
Q ss_pred EEEEEcC--------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 532 LGFCEDR--------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 532 ~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
..++... ...+|+|||++|.+|.++.. .+. ....+++.+|..||+.+ ++||||||+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~N 165 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGN 165 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHH
Confidence 9886543 35789999999999988742 121 34568999999999999 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHH
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ell 669 (768)
|+++.++ ++|+|||........... ..++....+..++|+|+||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999987644221111 01333455667999999999987665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=178.18 Aligned_cols=150 Identities=17% Similarity=0.151 Sum_probs=108.0
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccc---------------ccccchhhHHHHHHHHHHHhcCCCCCc
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI---------------GTKRQEDKDNAFINELESLSRLHHKNL 528 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~---------------~~~~~~~~~~~~~~E~~~l~~l~HpnI 528 (768)
...||+|+||.||+|...+|+.||||+++......... .............+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998889999999997642211000 000000011233469999999988776
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecCCCCCCeEEC
Q 046311 529 VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL-HEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 529 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDiKp~NILl~ 607 (768)
.....+... ..+|||||+++++|...+... ..++.....+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 443333222 338999999988776553221 2356778899999999999999 6888 99999999999998
Q ss_pred CCCcEEEeeccccccC
Q 046311 608 ATWTAKVSDFGLSLIG 623 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~ 623 (768)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-19 Score=172.81 Aligned_cols=193 Identities=17% Similarity=0.165 Sum_probs=141.5
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcCCee
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDRNER 541 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 541 (768)
....|++|+||+||.+.. .+.+++.+.+...... ........|.+|+++|++|+ |+++++++++ +..
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~-------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~ 73 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW-------LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR 73 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhh-------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence 457899999999997765 5788888876543210 00111235889999999995 5889999886 356
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC-CCCCeEECCCCcEEEeecccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI-KSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi-Kp~NILl~~~~~~kl~DFGla 620 (768)
+++|||++|.+|...+.. ....++.|+.++|+++|+++ |+|||| ||+|||++.++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 999999999998764421 01356789999999999999 999999 799999999999999999999
Q ss_pred ccCCCCCCc----c---c----ccccccccCccCccccccC-CCC-ChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 621 LIGPEDDES----H---L----SLRAAGTVGYMDPEYYRLQ-QLT-EKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 621 ~~~~~~~~~----~---~----~~~~~gt~~y~aPE~l~~~-~~s-~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
......... . . ......++.|+.|+..... ..+ ...+.++-|.-+|.++|+..+...+..+
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 854433210 0 0 0112367888888764422 333 5678899999999999998887654443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=173.09 Aligned_cols=150 Identities=17% Similarity=0.146 Sum_probs=111.0
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccc-----------c----cccchhhHHHHHHHHHHHhcCCCCCc
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI-----------G----TKRQEDKDNAFINELESLSRLHHKNL 528 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~-----------~----~~~~~~~~~~~~~E~~~l~~l~HpnI 528 (768)
.+.||+|+||.||+|+..+|+.||||+++......... . ..........+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999988652210000 0 00000112335689999999999987
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEE
Q 046311 529 VRLLGFCEDRNERVLIYEYLENGTLHDH-LHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 529 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl 606 (768)
.....+... ..+|||||++++++... +.. ...+.....+++.|++.+|.+||+ .+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554444333 34899999998865443 322 123567788999999999999999 87 9999999999999
Q ss_pred CCCCcEEEeeccccccCC
Q 046311 607 DATWTAKVSDFGLSLIGP 624 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~~~ 624 (768)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 8 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=195.99 Aligned_cols=220 Identities=27% Similarity=0.389 Sum_probs=163.0
Q ss_pred HhcCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 046311 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI 599 (768)
Q Consensus 520 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 599 (768)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.|.+... ...++|.....+..+|+.||+|||.... ..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeee
Confidence 45789999999999999999999999999999999999762 3446888899999999999999998752 399999
Q ss_pred CCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-------CCCChhhHHHHHHHHHHHHcCC
Q 046311 600 KSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-------QLTEKSDVYSFGVVLLEILSGY 672 (768)
Q Consensus 600 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~sDVwSlGvll~elltG~ 672 (768)
++.|.++|..+.+||+|||+.................-..-|.|||.++.. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998655321111111111235679999999753 1467899999999999999999
Q ss_pred cccccCCCCCcc-cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 673 RAIHRTHNGTPR-NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 673 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.||+........ +++.+ +.+.-...+.+......+....+..++.+||..+|.+||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~---------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILR---------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHH---------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999764332211 11110 11100111111111111444567899999999999999999999999998876
Q ss_pred hc
Q 046311 752 AC 753 (768)
Q Consensus 752 ~~ 753 (768)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 44
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=182.47 Aligned_cols=237 Identities=19% Similarity=0.293 Sum_probs=151.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC----------CCc
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH----------KNL 528 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H----------pnI 528 (768)
.+...+.||.|+++.||.+++. +++++|||.+.... .......+++++|.-....+.+ -.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--------~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--------DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--------TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--------ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 3455688999999999999986 58999999987643 2223456677777666555433 122
Q ss_pred eeEEEEE---------EcC---C-----eeEEEEEeccCCChhhhccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 046311 529 VRLLGFC---------EDR---N-----ERVLIYEYLENGTLHDHLHN---PQSSSPLKSWPARIKVALDAARGIEYLHE 588 (768)
Q Consensus 529 v~l~~~~---------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~~~~~~~~~ia~~ia~gL~yLH~ 588 (768)
+..++.. ... . ..+++|+-+. ++|.+++.. ............++.+..|+++.+++||.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 2222221 111 1 2267788774 588887642 11112223456677888999999999999
Q ss_pred CCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc--------CCCCChhhHHH
Q 046311 589 YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--------QQLTEKSDVYS 660 (768)
Q Consensus 589 ~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwS 660 (768)
++ ++|+||||+|+|++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+
T Consensus 164 ~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp TT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred cc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 99 999999999999999999999999887653321111 234678999997743 25788999999
Q ss_pred HHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCC
Q 046311 661 FGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736 (768)
Q Consensus 661 lGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 736 (768)
||+++|.|.++..||........ .++ .+ .... ++++.+..||..+|+.+|.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~---~~~------------~f-------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEAD---PEW------------DF-------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGST---SGG------------GG-------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCcccc---ccc------------cc-------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975432111 000 00 0112 567778899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=200.91 Aligned_cols=196 Identities=26% Similarity=0.265 Sum_probs=151.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~ 534 (768)
...|.+.+.||+|+||+||+|+..+++.||+|+-+.....++-+ =.+++.||+ -+-|+.+...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI--------------~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI--------------CLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee--------------hHHHHHhhchhhhcchHHHHHH
Confidence 35688889999999999999998889999999877665544332 223344444 1233344444
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-------
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD------- 607 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~------- 607 (768)
+.-.+.-+||+||.+.|+|.++++. ....+|...+.++.|+++-+++||..+ |||+||||+|+||.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HccCCcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence 4556677899999999999999973 345678888999999999999999999 99999999999993
Q ss_pred CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcc
Q 046311 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p 674 (768)
.+.-++|+|||-+...............+.|-.+-.+|+..++.++...|.|.|..+++-||.|+..
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2346899999998532221111222245678999999999999999999999999999999999643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=198.17 Aligned_cols=234 Identities=26% Similarity=0.309 Sum_probs=176.5
Q ss_pred eccCCceEEEEEE----EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcCCee
Q 046311 467 IGSGSFGAVYKAT----LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDRNER 541 (768)
Q Consensus 467 LG~G~fG~Vy~~~----~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 541 (768)
+|+|.||.|++.. .+.+.-+|.|.++......- ... ....|..++...+ ||.++++.-.++.+...
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~--------~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl 72 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR--------DRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKL 72 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccc--------ccc-ccccHHHHHhhccCCCceeeeeeeeccccch
Confidence 7899999999874 34577888888765432211 111 3445777788886 99999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+++++|..+|.|...+.... ..+..........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++
T Consensus 73 ~l~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 73 YLILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred hHhhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhh
Confidence 99999999999999886532 2344444455667888999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHh
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHR 701 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (768)
..-..+.. +||..|||||++. .....+|.||||++++||+||-.||.. +....
T Consensus 146 e~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~ 198 (612)
T KOG0603|consen 146 EAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKR 198 (612)
T ss_pred HhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHH
Confidence 64333321 7899999999998 678899999999999999999988863 11222
Q ss_pred hhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH--HHHHHHHH
Q 046311 702 VLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM--TEIVNSLE 747 (768)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~--~evl~~L~ 747 (768)
++...+ ....+......+++..++..+|.+|--. ..+.++.+
T Consensus 199 Il~~~~----~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 199 ILKAEL----EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred Hhhhcc----CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 222222 2344556667788888899999998654 34444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=164.56 Aligned_cols=136 Identities=18% Similarity=0.227 Sum_probs=103.0
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-----CCCCceeEEEEEE
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-----HHKNLVRLLGFCE 536 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~ 536 (768)
...+.||+|+|+.||. .-++... +||++.... ....+.+.+|+++++.+ +||||++++++++
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-----------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e 71 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-----------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE 71 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-----------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence 4457899999999996 3234444 688875421 12345789999999999 5799999999998
Q ss_pred cCC---e-eEEEEEe--ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEecCCCCCCeEECC-
Q 046311 537 DRN---E-RVLIYEY--LENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI-EYLHEYAVPSIIHRDIKSSNVLLDA- 608 (768)
Q Consensus 537 ~~~---~-~~lV~E~--~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL-~yLH~~~~~~ivHrDiKp~NILl~~- 608 (768)
++. . ..+|+|| +++++|.+++.+.. ++.. ..++.+++.++ +|||+++ |+||||||+|||++.
T Consensus 72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 72 TDCGTGYVYDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRI 141 (210)
T ss_pred eCCCCeEEEEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEecc
Confidence 874 3 3378999 55799999996521 2333 35577888777 9999999 999999999999974
Q ss_pred ---CCcEEEeecccc
Q 046311 609 ---TWTAKVSDFGLS 620 (768)
Q Consensus 609 ---~~~~kl~DFGla 620 (768)
+..++|+||+.+
T Consensus 142 ~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 142 SESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCCcEEEEECCCC
Confidence 348999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=162.34 Aligned_cols=142 Identities=20% Similarity=0.281 Sum_probs=114.6
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 544 (768)
+.||+|++|.||++.. .+..+++|+........ ...........+.+|++++..++|++|.....++.+.+..+++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRH---PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcC---hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 5799999999999987 57889999765322110 0001112235688999999999999998877777777888999
Q ss_pred EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 545 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
|||++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999998542 11 67889999999999999998 99999999999999 78999999998864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.6e-17 Score=166.85 Aligned_cols=198 Identities=22% Similarity=0.270 Sum_probs=136.3
Q ss_pred CCCCceeEEEEEEc---------------------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHH
Q 046311 524 HHKNLVRLLGFCED---------------------------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576 (768)
Q Consensus 524 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia 576 (768)
+|||||++..+|.+ ....|+||..++. +|.+++-.+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999877532 2356899998865 9999995422 2444556788
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCCeEE--CCC--CcEEEeeccccccCCC----CCCcccccccccccCccCccccc
Q 046311 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLL--DAT--WTAKVSDFGLSLIGPE----DDESHLSLRAAGTVGYMDPEYYR 648 (768)
Q Consensus 577 ~~ia~gL~yLH~~~~~~ivHrDiKp~NILl--~~~--~~~kl~DFGla~~~~~----~~~~~~~~~~~gt~~y~aPE~l~ 648 (768)
.|+++++.|||+++ |.|||+|++|||| |+| ..+.|+|||.+..... ..+..-....-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 89999999999999 9999999999999 333 3578999998743221 11111112335778899999876
Q ss_pred cCC------CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHH
Q 046311 649 LQQ------LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVG 722 (768)
Q Consensus 649 ~~~------~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 722 (768)
... .-.|+|.|+.|.+.||+++...||........ + ....-+..++. .....+..+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----~----------~r~Yqe~qLPa---lp~~vpp~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----D----------TRTYQESQLPA---LPSRVPPVAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----c----------hhhhhhhhCCC---CcccCChHHH
Confidence 321 23589999999999999999999976322110 0 00111111221 1223345677
Q ss_pred HHHHHcccccCCCCCCHHHHHHHHH
Q 046311 723 YLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 723 ~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
+|+...|+.||.+|++..-..+.|.
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 8999999999999998776555543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=157.76 Aligned_cols=152 Identities=22% Similarity=0.192 Sum_probs=112.8
Q ss_pred HHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccc------------cchhhHHHHHHHHHHHh
Q 046311 454 LLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK------------RQEDKDNAFINELESLS 521 (768)
Q Consensus 454 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~------------~~~~~~~~~~~E~~~l~ 521 (768)
+......|...+.||+|+||.||++...+|+.||||+++..... +..... ........+.+|+.++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTS-FRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccch-hhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33334457788999999999999999888999999997654211 000000 00011234678999999
Q ss_pred cCCCCC--ceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 046311 522 RLHHKN--LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI 599 (768)
Q Consensus 522 ~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 599 (768)
.+.|++ +.+.++ ....++||||+++++|.++... .....++.+++.++.++|+.+ |+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 998874 444443 2456899999999999776531 123578899999999999988 999999
Q ss_pred CCCCeEECCCCcEEEeeccccccC
Q 046311 600 KSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 600 Kp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||+||++++++.++|+|||++...
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=184.05 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=113.8
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
..|...++||+|+||+||++.+.. ..+++|+....... ...........++.+|++++++++|++++....++.+.
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYR---HPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-ccceeEEEeccccc---chhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 345667899999999999998764 44555543221110 00011122346788999999999999999888888777
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999884 34678999999999999998 9999999999999 67899999999
Q ss_pred cccc
Q 046311 619 LSLI 622 (768)
Q Consensus 619 la~~ 622 (768)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.2e-18 Score=180.65 Aligned_cols=174 Identities=28% Similarity=0.402 Sum_probs=127.1
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
.+.|+.|+++...+|.++|..... ....++...+.++.|++.+++| ++ .+|||+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 357899999999999999975443 2345788889999999999999 55 7999999999999999999999999
Q ss_pred ccccCCCCC----CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC-CcccccCCCCCcccccccccch
Q 046311 619 LSLIGPEDD----ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG-YRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 619 la~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+........ .....+...||..||+||.+.+.+|+.|+||||||++|+||++- ..+++..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------------- 466 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------------- 466 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------------
Confidence 986543333 11222356799999999999999999999999999999999972 2222111
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 740 (768)
.-...+-+..+++. +..+.+.. ..|+.+++.+.|.+||++.
T Consensus 467 ---~t~~d~r~g~ip~~--~~~d~p~e-~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 467 ---ATLTDIRDGIIPPE--FLQDYPEE-YTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ---HhhhhhhcCCCChH--HhhcCcHH-HHHHHHhcCCCcccCchHH
Confidence 11122223333321 11111122 2688999999999999433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=158.50 Aligned_cols=138 Identities=21% Similarity=0.296 Sum_probs=108.1
Q ss_pred eeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEE
Q 046311 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 545 (768)
.||+|+||.||++.+. +..+++|+........ ..........++.+|++++..++|+++....-++...+..++||
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRH---PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcC---chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 3899999999999864 7899999865321110 00001122467889999999999887665555566667789999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
||+++++|.+++.... ..++.+++++|.+||+.+ ++|+|+||+|||++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999999875311 178899999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.3e-16 Score=158.77 Aligned_cols=153 Identities=16% Similarity=0.135 Sum_probs=111.5
Q ss_pred CCCCcCceeccCCceEEEEEE--EcCCCeEEEEEEeeccCcccccc------------c-ccchhhHHHHHHHHHHHhcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKAT--LDDGSQVAVKRAEISSTSSYAIG------------T-KRQEDKDNAFINELESLSRL 523 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~--~~~g~~vaVK~~~~~~~~~~~~~------------~-~~~~~~~~~~~~E~~~l~~l 523 (768)
.-|.+.+.||+|+||.||+|. ..+|+.||||+++.......... . .........+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 45899999999875432100000 0 00011123467899999999
Q ss_pred CCCC--ceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 524 HHKN--LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 524 ~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
.+.. +.+++++ ...++||||+++.+|..++... ..........++.|++.+|++||+++ +|+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 7533 4444443 2358999999998887765321 12344456789999999999999987 389999999
Q ss_pred CCeEECCCCcEEEeecccccc
Q 046311 602 SNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~ 622 (768)
+|||++ +++++|+|||++..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=182.68 Aligned_cols=208 Identities=25% Similarity=0.364 Sum_probs=138.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|..++.|..|+||.||..+++ ..+.+|+|+-+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-----------------lilRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----------------LILRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc-----------------hhhhc--cccccCCccee--------
Confidence 46778899999999999999876 4677888542211 01111 22222344333
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
|+=..++...+ . ++. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.||
T Consensus 136 -------------gDc~tllk~~g---~-lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDf 187 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIG---P-LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDF 187 (1205)
T ss_pred -------------chhhhhcccCC---C-Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccch
Confidence 44445554321 1 111 2277899999998 999999999999999999999999
Q ss_pred cccccCCCCCC-------------cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 618 GLSLIGPEDDE-------------SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 618 Gla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|+++....... .......+||+.|+|||++..+.|.+.+|.|+||+|+||++-|+.||..+.. +
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---e 264 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---E 264 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---H
Confidence 99864321110 0011235899999999999999999999999999999999999999976532 2
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 737 (768)
++....+ .+++ + ++. .......+..+++.+.|+.+|..|-
T Consensus 265 elfg~vi----sd~i-~-----wpE---~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 265 ELFGQVI----SDDI-E-----WPE---EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHhhhh----hhhc-c-----ccc---cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2211111 1110 0 010 1222335566889999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=135.95 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=112.5
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC--CCceeEEEEEEcCCe
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH--KNLVRLLGFCEDRNE 540 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~ 540 (768)
+.+.|++|.++.||+++.++ ..+++|...... . ...+.+|+..++.++| .++.+++.+....+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~------------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~ 67 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSRE------------K-GADREREVAILQLLARKGLPVPKVLASGESDGW 67 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCC------------c-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc
Confidence 35779999999999999864 789999864321 0 3568899999999976 589999998888888
Q ss_pred eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 541 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.+++|||+++..+..+ +......++.+++++|++||....++++|+||||+|||+++++.++++|||++
T Consensus 68 ~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 68 SYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred cEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 9999999998777654 34455778899999999999875455999999999999999899999999988
Q ss_pred cc
Q 046311 621 LI 622 (768)
Q Consensus 621 ~~ 622 (768)
..
T Consensus 137 ~~ 138 (155)
T cd05120 137 GY 138 (155)
T ss_pred cC
Confidence 64
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=143.40 Aligned_cols=145 Identities=21% Similarity=0.198 Sum_probs=98.3
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccc-----------c--chhhHHHHHHHHHHHhcCCCC--Cc
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK-----------R--QEDKDNAFINELESLSRLHHK--NL 528 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~-----------~--~~~~~~~~~~E~~~l~~l~Hp--nI 528 (768)
.+.||+|+||.||++...+++.||||++............. . ..........|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211000000 0 000001124566666666443 34
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEE
Q 046311 529 VRLLGFCEDRNERVLIYEYLENGTLHDH-LHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 529 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl 606 (768)
.++++. ...++||||++++++... +.... .. ....+++.+++.++.++|. .+ |+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 445443 245899999999654322 21110 01 4457889999999999999 77 9999999999999
Q ss_pred CCCCcEEEeecccccc
Q 046311 607 DATWTAKVSDFGLSLI 622 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~ 622 (768)
+ ++.++|+|||.+..
T Consensus 149 ~-~~~~~liDfg~a~~ 163 (187)
T cd05119 149 D-DGKVYIIDVPQAVE 163 (187)
T ss_pred E-CCcEEEEECccccc
Confidence 9 89999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-14 Score=145.56 Aligned_cols=145 Identities=17% Similarity=0.143 Sum_probs=107.1
Q ss_pred ceec-cCCceEEEEEEEcCCCeEEEEEEeeccCcccccc--cccchhhHHHHHHHHHHHhcCCCCCc--eeEEEEEEcCC
Q 046311 465 HKIG-SGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIG--TKRQEDKDNAFINELESLSRLHHKNL--VRLLGFCEDRN 539 (768)
Q Consensus 465 ~~LG-~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~ 539 (768)
..|| .|+.|+||+.+.. +..++||++........... ..........+.+|++++.+|+|++| ++.+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999876 78899998864321000000 00112344678899999999998875 67777644332
Q ss_pred ----eeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 540 ----ERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 540 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
..++|||++++ .+|.+++... .++. ..+.+++.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6899988542 1222 34678999999999999 999999999999999889999
Q ss_pred eecccccc
Q 046311 615 SDFGLSLI 622 (768)
Q Consensus 615 ~DFGla~~ 622 (768)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-15 Score=174.54 Aligned_cols=257 Identities=24% Similarity=0.289 Sum_probs=182.2
Q ss_pred CCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
.|...+.||+|.|+.|-..... ....+|+|.+.... ...........|..+-+.+. |+|++.+++...
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~ 91 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS 91 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------CccchhhhcCccccccccccccccccccCCccC
Confidence 4566677999999999888754 34456666544321 12223344455777777776 999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhc-cCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecCCCCCCeEECCCC-cEE
Q 046311 537 DRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVALDAARGIEYLH-EYAVPSIIHRDIKSSNVLLDATW-TAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l-~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrDiKp~NILl~~~~-~~k 613 (768)
+.+..++++||..++++++.+ +..... .+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ ..+
T Consensus 92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~---~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 92 SPRSYLLSLSYSDGGSLFSKISHPDSTG---TSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred CCcccccccCcccccccccccccCCccC---CCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCccc
Confidence 999999999999999999999 432211 122334567889999999999 777 99999999999999999 999
Q ss_pred EeeccccccCCC-CCCccccccccc-ccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 614 VSDFGLSLIGPE-DDESHLSLRAAG-TVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
++|||+|..... ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|
T Consensus 166 ~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~- 243 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW- 243 (601)
T ss_pred CCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceee-
Confidence 999999976655 333333445578 9999999998874 5567899999999999999999998754432211 1111
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....................+++.+++..+|..|.+.+++...
T Consensus 244 ------------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 244 ------------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------------cccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 1110000000011122334477888888999999998887543
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=151.00 Aligned_cols=156 Identities=17% Similarity=0.210 Sum_probs=126.9
Q ss_pred eCCCcEEEccCCCCCCCC-------------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCccc-------
Q 046311 135 NGTNDLHWWQWPDFNSTS-------------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVT------- 188 (768)
Q Consensus 135 ~~~g~~~~Wg~~~~~~~~-------------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~------- 188 (768)
+.-..||.||.|-..-+| +.-+.+|..|.+|+..+++.|.||..|.+..|.++.
T Consensus 139 d~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~~kgqvY~cGhG~GGRlG~gdeq~~~ 218 (1267)
T KOG0783|consen 139 DLPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLTEKGQVYVCGHGAGGRLGFGDEQYNF 218 (1267)
T ss_pred CCccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEecCCCcEEEeccCCCCccCcCcccccc
Confidence 666899999999666565 112788999999999999999999999886666542
Q ss_pred --ccCCC---cCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC----------------------CeEEEeccCCeeE
Q 046311 189 --QKVPS---GIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG----------------------KFKALALGENRSC 241 (768)
Q Consensus 189 --~~~~~---~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~----------------------~~~~ia~G~~h~~ 241 (768)
..+++ .++.+||+-..|+++|+++|.||.||.|..+|.+. .+..|+||..|+.
T Consensus 219 iPkrV~gL~gh~~~qisvs~~HslvLT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg~~hsV 298 (1267)
T KOG0783|consen 219 IPKRVPGLIGHKVIQISVSHTHSLVLTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAGKSHSV 298 (1267)
T ss_pred cccccccccccceEEEEeecceeEEEeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhcccceee
Confidence 22332 68999999999999999999999999999999431 4677899999999
Q ss_pred EEeeCCeEEEEecCCCCCCCCCCC--------------CCeEEEEecCCeEEEEEecCCeEEEEeC
Q 046311 242 ALRNNQKVVCWGQNGFTLPDSLQG--------------KPFVSIEAKRSVFCGVLTSNYSLYCWGN 293 (768)
Q Consensus 242 al~~dg~v~~WG~n~~gq~~~~~~--------------~~~~~i~~g~~h~~~l~~~~g~~~~wG~ 293 (768)
|-+ |-.||.||-| .||+|+..+ ..+..++|...-|..+ +..+.++|+-+
T Consensus 299 awt-~~~VY~wGlN-~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~-~~~~~i~~~ad 361 (1267)
T KOG0783|consen 299 AWT-DTDVYSWGLN-NGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCL-LQNNSIIAFAD 361 (1267)
T ss_pred eee-cceEEEeccc-CceecCCCCCceeecchhhcccccceEEEEecCccEEEE-ecCCcEEEEec
Confidence 998 5779999999 599994443 2567788888888887 56999999865
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-12 Score=150.31 Aligned_cols=224 Identities=17% Similarity=0.167 Sum_probs=147.8
Q ss_pred ccceeeeecCCceeEEeccCCCCCCcceeecC-----Ccccc-CCCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccC-
Q 046311 30 STFSVSETGNQSLVCALIPSSRPGDFSLNCSI-----PQLIP-VNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRF- 102 (768)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~- 102 (768)
.+..+.|+.|..+..++.- -|++++.... +..-. ++.|-.-.-=..|.+|+-+.. ..||.+|-.|-
T Consensus 524 ~~~IVq~SVG~D~~~~~~~---A~~G~I~~v~D~k~~~~~Rr~~P~n~rKIv~v~~s~~VY~~v----SenGkifM~G~~ 596 (3738)
T KOG1428|consen 524 PEPIVQISVGIDTIMFRSG---AGHGWIASVDDKKRNGRLRRLVPSNRRKIVHVCASGHVYGYV----SENGKIFMGGLH 596 (3738)
T ss_pred CCceEEEEeccchhheeec---cCcceEEeccCcccccchhhcCCCCcceeEEEeeeeEEEEEE----ccCCeEEeecce
Confidence 3567788888888777764 2356666553 11111 233322223347888988873 68999998886
Q ss_pred ----CCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCCC-------------------------
Q 046311 103 ----SADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTSI------------------------- 153 (768)
Q Consensus 103 ----n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~~------------------------- 153 (768)
|...|+... ..+.-|.+++.|..|+||+ +.+|.||+||-|+.+|.|-
T Consensus 597 tm~~n~SSqmln~---L~~~~isslAlGKsH~~av-~rNG~l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~ 672 (3738)
T KOG1428|consen 597 TMRVNVSSQMLNG---LDNVMISSLALGKSHGVAV-TRNGHLFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGE 672 (3738)
T ss_pred eEEecchHHHhhc---cccceeehhhccccceeEE-EeCCeEEEEecCCcccccccccccccCCcccccceeecccCCcc
Confidence 333333110 1123478899999999999 9999999999999999980
Q ss_pred Cc----------------eEEEEec-------CCeEEEEeeCCeEEEecCC--CCCCcc----------------cccC-
Q 046311 154 HN----------------FSNIAVG-------EDFVCGLLENGTITCFGSR--NSPTSV----------------TQKV- 191 (768)
Q Consensus 154 ~~----------------~~~v~~G-------~~h~~~l~~~g~v~~wG~~--~~g~~~----------------~~~~- 191 (768)
++ ...++|| .---|++-+.+-++|==.. +.++.. ++..
T Consensus 673 HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GES~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~ 752 (3738)
T KOG1428|consen 673 HTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGESTCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRST 752 (3738)
T ss_pred ceeecCCcchhhhcccccccccccccCCCCCCcccccCCCcccceeccccccccCcCCcCCCCHHHhheecccccccccc
Confidence 00 1112222 1122333333333331000 111111 1000
Q ss_pred -----------C-CcCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC------------------CeEEEeccCCeeE
Q 046311 192 -----------P-SGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG------------------KFKALALGENRSC 241 (768)
Q Consensus 192 -----------~-~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~------------------~~~~ia~G~~h~~ 241 (768)
+ ..++++|+||..||..|.+|++||.+|+|.+||.+. .++||+||.+||.
T Consensus 753 ~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL~sd~~VfTFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~ 832 (3738)
T KOG1428|consen 753 LHPSRVILSQGPHDVKVSSVSCGNFHTVLLASDRRVFTFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTI 832 (3738)
T ss_pred cCchheeeccCCcceeEEEEeccCceEEEEecCCcEEEecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceE
Confidence 0 147899999999999999999999999999999331 6889999999999
Q ss_pred EEeeCCeEEEEecCCCCCCCCCC
Q 046311 242 ALRNNQKVVCWGQNGFTLPDSLQ 264 (768)
Q Consensus 242 al~~dg~v~~WG~n~~gq~~~~~ 264 (768)
-+..||+|+.+|.-.-|||+-|.
T Consensus 833 l~~~DGsVFTFGaF~KGQL~RP~ 855 (3738)
T KOG1428|consen 833 LRANDGSVFTFGAFGKGQLARPA 855 (3738)
T ss_pred EEecCCcEEEeccccCccccCcc
Confidence 99999999999999999998544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3e-12 Score=143.18 Aligned_cols=151 Identities=22% Similarity=0.238 Sum_probs=103.2
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccc----------------c-cc--c----------chhhHHHHH
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI----------------G-TK--R----------QEDKDNAFI 514 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~----------------~-~~--~----------~~~~~~~~~ 514 (768)
.+.||.|++|.||+|++.+|+.||||+.+......... . .. . .-..+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542111000 0 00 0 001122567
Q ss_pred HHHHHHhcCC----CCCceeEEEEE-EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 046311 515 NELESLSRLH----HKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR-GIEYLHE 588 (768)
Q Consensus 515 ~E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~-gL~yLH~ 588 (768)
+|++.+.+++ |.+-+.+-.++ ......+|||||++|++|.+++...... . .+.+++.++++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence 7777776662 33333333333 3345679999999999999876432111 1 23456666666 4678898
Q ss_pred CCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 589 YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 589 ~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
.+ ++|+|+||.||+++.+++++++|||++...
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 88 999999999999999999999999998643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-12 Score=146.94 Aligned_cols=69 Identities=14% Similarity=0.183 Sum_probs=60.5
Q ss_pred CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCC--------------CCCCCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 229 KFKALALGENRSCALRNNQKVVCWGQNGFTLPDS--------------LQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 229 ~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~--------------~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
++++|++|..|+.-|.+||+||.+|.|-+||||+ +.++.++|++||.+||.-+ ..||+|+++|.=
T Consensus 768 kv~sVSCG~~HtVlL~sd~~VfTFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~-~~DGsVFTFGaF 846 (3738)
T KOG1428|consen 768 KVSSVSCGNFHTVLLASDRRVFTFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILR-ANDGSVFTFGAF 846 (3738)
T ss_pred eEEEEeccCceEEEEecCCcEEEecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceEEE-ecCCcEEEeccc
Confidence 6889999999999999999999999999999993 3344689999999999987 799999999875
Q ss_pred CCCC
Q 046311 295 SFSS 298 (768)
Q Consensus 295 ~~~~ 298 (768)
.-++
T Consensus 847 ~KGQ 850 (3738)
T KOG1428|consen 847 GKGQ 850 (3738)
T ss_pred cCcc
Confidence 4444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.6e-14 Score=141.89 Aligned_cols=205 Identities=20% Similarity=0.288 Sum_probs=140.6
Q ss_pred HHHhcCCCCCceeEEEEEEcC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 046311 518 ESLSRLHHKNLVRLLGFCEDR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVP 592 (768)
Q Consensus 518 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~ 592 (768)
..|-++.|.|||++..|+.+. .+..++.|||+.|+|..+|++.......+......+++-||+.||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345556799999999987554 3578899999999999999875544444566667899999999999999987 8
Q ss_pred CeEecCCCCCCeEECCCCcEEEeeccccccCCCCC--CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 593 SIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD--ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
+|+|+++..+-|++..++-+||.----........ .........+-++|.+||.-.....+..+|||+||+-.+||--
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999988885321111000000 0000112346789999998777778889999999999999987
Q ss_pred CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+..-.. ... .....++.+..++...-. .. =+.++.+|++.+|..||+|++++.
T Consensus 278 lEiq~t--nse---------S~~~~ee~ia~~i~~len---~l-------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQST--NSE---------SKVEVEENIANVIIGLEN---GL-------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccC--CCc---------ceeehhhhhhhheeeccC---cc-------ccCcCcccccCCCCCCcchhhhhc
Confidence 743211 100 011112222222211000 00 025788999999999999999875
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=145.39 Aligned_cols=199 Identities=15% Similarity=0.118 Sum_probs=146.2
Q ss_pred CCCCcEEeccCCCCCccc--------cccccc----CCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-------
Q 046311 92 SSSSVMHCWRFSADGIIN--------DYKRIY----RGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS------- 152 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~--------~~~~~~----~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~------- 152 (768)
+.-..||.||.|.+..|| .|.+|. .+.-+.+|..|.+|+.-+ +..|.||+-|-+..|-+|
T Consensus 139 d~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl-~~kgqvY~cGhG~GGRlG~gdeq~~ 217 (1267)
T KOG0783|consen 139 DLPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFL-TEKGQVYVCGHGAGGRLGFGDEQYN 217 (1267)
T ss_pred CCccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEe-cCCCcEEEeccCCCCccCcCccccc
Confidence 455789999999999884 333442 123467899999999999 999999999988777666
Q ss_pred ----------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCC----------------cCeEEEeccCcee
Q 046311 153 ----------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPS----------------GIFRVVAAGFRHV 206 (768)
Q Consensus 153 ----------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~----------------~~~~~i~~G~~h~ 206 (768)
++++.+||+...|+.+|+.+|.||.||-|..+|++....+. ..+..|+||..|+
T Consensus 218 ~iPkrV~gL~gh~~~qisvs~~HslvLT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg~~hs 297 (1267)
T KOG0783|consen 218 FIPKRVPGLIGHKVIQISVSHTHSLVLTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAGKSHS 297 (1267)
T ss_pred ccccccccccccceEEEEeecceeEEEeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhccccee
Confidence 67799999999999999999999999999999987433322 3567899999999
Q ss_pred EEEecCCcEEEeecCCCCCCCC------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCC------
Q 046311 207 CAIDDDQELRCWGDSVGEVPQG------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDS------ 262 (768)
Q Consensus 207 ~al~~~g~v~~wG~n~~gq~~~------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~------ 262 (768)
.|-+ |-.||.||.|. ||.+- .+.-++|-..-|..++..+.++|.-+-..-.+..
T Consensus 298 Vawt-~~~VY~wGlN~-GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~~~~~i~~~ady~~~k~~~n~~~lk 375 (1267)
T KOG0783|consen 298 VAWT-DTDVYSWGLNN-GQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLLQNNSIIAFADYNQVKLPFNVDFLK 375 (1267)
T ss_pred eeee-cceEEEecccC-ceecCCCCCceeecchhhcccccceEEEEecCccEEEEecCCcEEEEecccceecCcchhccc
Confidence 9986 56799999884 55211 5677788888888888899999997543222110
Q ss_pred ----CC-C-----CCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 263 ----LQ-G-----KPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 263 ----~~-~-----~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
.+ . ..+....+-..-..+ +|.-|.||||=.+
T Consensus 376 s~~V~gg~l~~~~~~~~k~~a~~~kll~-lte~g~Vy~w~s~ 416 (1267)
T KOG0783|consen 376 SLKVTGGPLSLTRFNVRKLLASENKLLV-LTELGEVYEWDSK 416 (1267)
T ss_pred eeEEecCccchhhhhhhhcchhhhheee-eccCCeEEEEecC
Confidence 00 0 012222232222334 5999999999876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-11 Score=138.07 Aligned_cols=156 Identities=17% Similarity=0.153 Sum_probs=97.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccc-----------------cc------------cccch
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYA-----------------IG------------TKRQE 507 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~-----------------~~------------~~~~~ 507 (768)
...|+. +.||+|++|.||+|++++ |+.||||+.+........ .. ....-
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987 999999998754211000 00 00000
Q ss_pred hhHHHHHHHHHHHhcCC----CCCceeEEEEEEc-CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 046311 508 DKDNAFINELESLSRLH----HKNLVRLLGFCED-RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582 (768)
Q Consensus 508 ~~~~~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~g 582 (768)
..+-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++-.-... ..+. ..++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~---g~d~---~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA---GTDM---KLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc---CCCH---HHHHHHHHHH
Confidence 11234666666665553 4454555455543 5577899999999999874221110 0111 1222222211
Q ss_pred -HHHHhhCCCCCeEecCCCCCCeEECCCC----cEEEeeccccccC
Q 046311 583 -IEYLHEYAVPSIIHRDIKSSNVLLDATW----TAKVSDFGLSLIG 623 (768)
Q Consensus 583 -L~yLH~~~~~~ivHrDiKp~NILl~~~~----~~kl~DFGla~~~ 623 (768)
+.-+...+ ++|+|+||.||+++.++ ++++.|||+....
T Consensus 272 ~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 272 FFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 22334566 99999999999999888 9999999998644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.8e-12 Score=137.86 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=174.3
Q ss_pred CCCcCceecc--CCceEEEEEEE---cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEE
Q 046311 460 NFSEDHKIGS--GSFGAVYKATL---DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~--G~fG~Vy~~~~---~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 533 (768)
.|...+.+|. |.+|.+|.+.. .++..+|+|+-+..- ..+.....=.+|+...+.+ .|+|.++...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~---------s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF---------SPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCC---------CCccccccccchhhcccccCccccccccCc
Confidence 4566678999 99999999986 367889999743221 1111222234566666666 5999999888
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR----GIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~----gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
.++..+..++-+|++. .+|.++.+.... .++.........+..+ ||.++|..+ |+|-|+||.||++..+
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSD 258 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccc
Confidence 8899999999999885 688888876432 2344455666677777 999999998 9999999999999999
Q ss_pred -CcEEEeeccccccCCCCCCc---ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 610 -WTAKVSDFGLSLIGPEDDES---HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 610 -~~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
...+++|||+.......... ....+..+...|++||.++ .-++..+|+|+||.++.|-.++..........
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---- 333 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS---- 333 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC----
Confidence 88999999998765444321 1122336788999999886 56789999999999999998886543211000
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.|. .++..+. +.++-......+...+..+++.+|..|++.++++..
T Consensus 334 --~W~-----------~~r~~~i-p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 --SWS-----------QLRQGYI-PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --Ccc-----------ccccccC-chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 110 0011110 011111223344458889999999999988887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-11 Score=117.79 Aligned_cols=131 Identities=18% Similarity=0.161 Sum_probs=95.8
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCce-eEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV-RLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~ 542 (768)
.+.|+.|.++.||+.+.. +..+++|...... .....+.+|++.++.+.+.+++ +++.+. ....+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~ 67 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT------------ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGV 67 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc------------ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCe
Confidence 367899999999999876 7889999764321 0123467788888888655544 444433 33458
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAV--PSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~--~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
+||||+++.++.+.. ... ..++.++++.|+.||+... ..++|+|++|.||+++ ++.++++||+.+
T Consensus 68 lv~e~i~G~~l~~~~--------~~~----~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 68 LITEFIEGSELLTED--------FSD----PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred EEEEecCCCcccccc--------ccC----HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 999999998876531 001 2456789999999999872 2369999999999999 668999999987
Q ss_pred cc
Q 046311 621 LI 622 (768)
Q Consensus 621 ~~ 622 (768)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 53
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=81.44 Aligned_cols=30 Identities=33% Similarity=0.794 Sum_probs=17.8
Q ss_pred eEEEeccCCeeEEEeeCCeEEEEecCCCCC
Q 046311 230 FKALALGENRSCALRNNQKVVCWGQNGFTL 259 (768)
Q Consensus 230 ~~~ia~G~~h~~al~~dg~v~~WG~n~~gq 259 (768)
|++|++|.+|+|||++||+|||||.|.+||
T Consensus 1 V~~ia~G~~ht~al~~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTSDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE-TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEcCCCEEEEcCCcCCC
Confidence 456666666666666666666666666665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.7e-10 Score=108.81 Aligned_cols=146 Identities=15% Similarity=0.190 Sum_probs=99.9
Q ss_pred ceeccCCceEEEEEEEcC-------CCeEEEEEEeeccC-----ccccccccc------chhhHHHHH----HHHHHHhc
Q 046311 465 HKIGSGSFGAVYKATLDD-------GSQVAVKRAEISST-----SSYAIGTKR------QEDKDNAFI----NELESLSR 522 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~-------g~~vaVK~~~~~~~-----~~~~~~~~~------~~~~~~~~~----~E~~~l~~ 522 (768)
..||.|.-+.||.|...+ +..+|||+.+.... ..|.....+ .....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47999999875421 111111111 011233344 89999999
Q ss_pred CCC--CCceeEEEEEEcCCeeEEEEEeccCCChhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecC
Q 046311 523 LHH--KNLVRLLGFCEDRNERVLIYEYLENGTLHD-HLHNPQSSSPLKSWPARIKVALDAARGIEYL-HEYAVPSIIHRD 598 (768)
Q Consensus 523 l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrD 598 (768)
+.. -++.+++++ ...+|||||+.+..+.. .+.. ..++......+..+++..|..| |+.+ |+|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 853 466677764 46789999997654422 2221 1123344567788999999998 8887 99999
Q ss_pred CCCCCeEECCCCcEEEeeccccccC
Q 046311 599 IKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 599 iKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-11 Score=79.36 Aligned_cols=30 Identities=37% Similarity=0.690 Sum_probs=17.5
Q ss_pred eEEEeccCceeEEEecCCcEEEeecCCCCC
Q 046311 196 FRVVAAGFRHVCAIDDDQELRCWGDSVGEV 225 (768)
Q Consensus 196 ~~~i~~G~~h~~al~~~g~v~~wG~n~~gq 225 (768)
|++|++|.+|+|||++||+|||||+|.+||
T Consensus 1 V~~ia~G~~ht~al~~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTSDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE-TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEcCCCEEEEcCCcCCC
Confidence 456666666666666666666666666665
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.5e-09 Score=121.02 Aligned_cols=166 Identities=16% Similarity=0.204 Sum_probs=123.1
Q ss_pred EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccC
Q 046311 480 LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN 559 (768)
Q Consensus 480 ~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 559 (768)
..++.+|.|...+... ........+-++.|+.|+||||++++..++.++..|||+|.+. .|..++.+
T Consensus 34 k~~~~~vsVF~~~~~~-----------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~ 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSN-----------GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE 100 (690)
T ss_pred eccCCceEEEEEeCCC-----------chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH
Confidence 3468888888776431 1334456778889999999999999999999999999999885 57777754
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCccccccccccc
Q 046311 560 PQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639 (768)
Q Consensus 560 ~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 639 (768)
.. .....-.+.||+.+|.|||+.+. ++|++|.-.-|+++..|+.||++|-++.......... ....--.
T Consensus 101 l~-------~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~ 169 (690)
T KOG1243|consen 101 LG-------KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIE 169 (690)
T ss_pred hH-------HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhh
Confidence 22 33445678899999999997663 9999999999999999999999998875432222100 0111233
Q ss_pred CccCccccccCCCCChhhHHHHHHHHHHHHcC
Q 046311 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 640 ~y~aPE~l~~~~~s~~sDVwSlGvll~elltG 671 (768)
.|..|+.+.... -..|.|-||++++|++.|
T Consensus 170 s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 466777554222 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=110.52 Aligned_cols=143 Identities=22% Similarity=0.341 Sum_probs=107.6
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC--CCceeEEEEEEcCC---
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH--KNLVRLLGFCEDRN--- 539 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--- 539 (768)
+.|+.|.++.+|+++..+|+.+++|....... ......+.+|+++++.+++ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~----------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL----------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCccc----------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 67899999999999887778999998643211 0123467889999999965 34677777766542
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA----------------------------- 590 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~----------------------------- 590 (768)
..++||||+++.+|.+.+.. ...+...+..++.++++.|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 56899999999988886632 12355666778888888888888521
Q ss_pred ------------------------CCCeEecCCCCCCeEECC--CCcEEEeecccccc
Q 046311 591 ------------------------VPSIIHRDIKSSNVLLDA--TWTAKVSDFGLSLI 622 (768)
Q Consensus 591 ------------------------~~~ivHrDiKp~NILl~~--~~~~kl~DFGla~~ 622 (768)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 145899999999999998 66789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=103.97 Aligned_cols=139 Identities=22% Similarity=0.312 Sum_probs=101.8
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeEEE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 544 (768)
..+.+|+-+.+|.+.+. |.++++|.-..+ .|....-...-...+-.+|++++.+++--.|.-.+=+..+.....|+
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K---~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPK---RYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCc---ccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 35789999999999776 455666643221 11111111112234567899999988766666556666778888999
Q ss_pred EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 545 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
|||++|-.|.+++... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999998653 1456777888888999999 99999999999998764 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-10 Score=127.92 Aligned_cols=252 Identities=17% Similarity=0.156 Sum_probs=172.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
..+|..+..||.+.|+.|++...+ ++..+++|.+...... ......-..|+.+...+ .|.+++.....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~---------~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT---------FASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc---------hHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 457888999999999999998644 6788999977543211 11111223455555555 58888887777
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-CcEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAK 613 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~~~k 613 (768)
+...+..|+=.||++++++...+.- ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhh
Confidence 7777777889999999998877621 122355567889999999999999887 9999999999999886 7889
Q ss_pred EeeccccccCCCCCCcccccccccccCcc--CccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYM--DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+.||+.......... .....-+++ +|+......+-.+.|+|+||.-+.|.+++..--.... .
T Consensus 408 ~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~--- 471 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q--- 471 (524)
T ss_pred ccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c---
Confidence 999998853111111 112233444 5555566778899999999999999999864332111 1
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
...+.....+.... . ...+..+...+...++..||.+.++....+...+.
T Consensus 472 -------~~~i~~~~~p~~~~-~---~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 472 -------SLTIRSGDTPNLPG-L---KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred -------ceeeecccccCCCc-h---HHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 11122222221111 1 13445677888999999999999988776665543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5e-09 Score=99.26 Aligned_cols=151 Identities=20% Similarity=0.202 Sum_probs=107.6
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
....|-+|+-+.|+++.+. |+...||.-..+.-. ...-...-...+-.+|++.|.+++--.|.-..-++.+...-.
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YR---HP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYR---HPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeeccccccc---chHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 4578899999999999887 788777743221110 001111223456778999999987666665566667777788
Q ss_pred EEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC---cEEEeecc
Q 046311 543 LIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFG 618 (768)
Q Consensus 543 lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~---~~kl~DFG 618 (768)
|+|||+++ .++.+++....... ........++.+|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeec
Confidence 99999987 47888886533221 122233678889999999999999 99999999999996543 45899999
Q ss_pred cccc
Q 046311 619 LSLI 622 (768)
Q Consensus 619 la~~ 622 (768)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.1e-10 Score=129.55 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=160.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.+.+.+-+-++.++.++.++-. .|...++|....... +.. ...+....+-.++-.-+||.++...--+..
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~----i~~----~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK----IRT----NDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchh----hcc----ccccccCCccCccccCCCCceecccCCCCC
Confidence 45666677888999999888643 344455554432210 000 011111222222222345666655444556
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....+|+++|+.+++|...|+...... ....+ .....+...++|||... +.|||+||.|+|+..++..++.||
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~s---aepaR-s~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLS---AEPAR-SPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcc---ccccc-chhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcc
Confidence 678899999999999999998754221 22233 33445678899999986 799999999999999999999999
Q ss_pred cccccCCCC-----------------------------CCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHH
Q 046311 618 GLSLIGPED-----------------------------DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEI 668 (768)
Q Consensus 618 Gla~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~el 668 (768)
+........ +.........+|+.|.+||.+.+......+|.|++|+.++|.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 843210000 000111234689999999999999999999999999999999
Q ss_pred HcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH
Q 046311 669 LSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740 (768)
Q Consensus 669 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 740 (768)
++|..||........ ...++....+ ......+......+++...+..+|.+|-.|.
T Consensus 1029 l~g~pp~na~tpq~~---------------f~ni~~~~~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQI---------------FENILNRDIP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhh---------------hhccccCCCC-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999875433210 1111111111 1122333445556788888888888887665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-07 Score=103.20 Aligned_cols=169 Identities=20% Similarity=0.254 Sum_probs=124.0
Q ss_pred ceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc----CCeeEEEEE
Q 046311 472 FGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED----RNERVLIYE 546 (768)
Q Consensus 472 fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E 546 (768)
-.+.||+..+ +|..+.+||+...... .......-++.++++.|.|+|+|.+++.. +...+|||+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-----------~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYD 357 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ-----------STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYD 357 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc-----------CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEe
Confidence 3578999755 8999999998432110 11112345778899999999999998863 346789999
Q ss_pred eccC-CChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 547 YLEN-GTLHDHLHNPQS-----------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 547 ~~~~-gsL~~~l~~~~~-----------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
|+++ ++|.++-..... .....++..++.++.|+..+|.++|+.+ +.-+-|.+.+||++.+.+++|
T Consensus 358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIri 434 (655)
T KOG3741|consen 358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRI 434 (655)
T ss_pred cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEE
Confidence 9986 678776543211 1234567788999999999999999999 788999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~ 673 (768)
+..|+......+.. |-+. --.+-|.=.||.+++.|-||..
T Consensus 435 S~C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 435 SGCGIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecccceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 98887654333220 1111 1236789999999999999954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.4e-08 Score=95.75 Aligned_cols=134 Identities=24% Similarity=0.270 Sum_probs=84.0
Q ss_pred EEEEEEEcCCCeEEEEEEeeccCccccc----------------ccccchhhHHHHHHHHHHHhcCCCC--CceeEEEEE
Q 046311 474 AVYKATLDDGSQVAVKRAEISSTSSYAI----------------GTKRQEDKDNAFINELESLSRLHHK--NLVRLLGFC 535 (768)
Q Consensus 474 ~Vy~~~~~~g~~vaVK~~~~~~~~~~~~----------------~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~ 535 (768)
.||.|...++..+|||..+.... ++.. .............+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~-~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRT-SFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S----SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCCCCEEEEEEeccCce-EEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999988899999999875421 1100 0011112234677899999999765 566666542
Q ss_pred EcCCeeEEEEEecc--CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 536 EDRNERVLIYEYLE--NGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY-LHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~y-LH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
...|||||++ +..+..+..... +......++.+++..+.. +|..+ |+|+||.+.|||++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~~------~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVDL------SPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCGG------GGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhccc------cchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999999 655555443210 012335677788885555 56887 9999999999999887 99
Q ss_pred EEeecccccc
Q 046311 613 KVSDFGLSLI 622 (768)
Q Consensus 613 kl~DFGla~~ 622 (768)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.8e-08 Score=101.24 Aligned_cols=150 Identities=16% Similarity=0.069 Sum_probs=99.7
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccc-cchhhHHHHHHHHHHHhcCCCCC--ceeEEEEEEc----
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTK-RQEDKDNAFINELESLSRLHHKN--LVRLLGFCED---- 537 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~---- 537 (768)
+.+-.-....|++..++ |+.+.||+......... .+.. ........+.+|...+.+|...+ .++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~-~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEI-FKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHH-hhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444557777664 78899997643211000 0000 00011224778988888884333 3445556543
Q ss_pred -CCeeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-------
Q 046311 538 -RNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA------- 608 (768)
Q Consensus 538 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~------- 608 (768)
...-+||||++++- +|.+++..... ...+...+..++.+++..+.-||..+ |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23568999999986 89998853211 12244566789999999999999999 999999999999975
Q ss_pred CCcEEEeeccccc
Q 046311 609 TWTAKVSDFGLSL 621 (768)
Q Consensus 609 ~~~~kl~DFGla~ 621 (768)
+..+.++||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 5789999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-07 Score=98.95 Aligned_cols=203 Identities=18% Similarity=0.209 Sum_probs=129.6
Q ss_pred eEEEEEeccCCC-hhhhccC--CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 541 RVLIYEYLENGT-LHDHLHN--PQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 541 ~~lV~E~~~~gs-L~~~l~~--~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.-++|+.+++.. ..+++.- .+.+.+..+|...++++..++.+.+-||+++ .+-+|+.++|+|+.++..+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 557788877642 3333321 2345577899999999999999999999999 889999999999999999999986
Q ss_pred cccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcC-CcccccCCCC--Cccccc-c
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSG-YRAIHRTHNG--TPRNVV-D 688 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG-~~p~~~~~~~--~~~~~~-~ 688 (768)
..-.... ......-.+|...|.+||.-. +-.-+...|.|.||++++++|.| +.||..-... .+.... +
T Consensus 162 Dsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 5433221 111222357899999999754 33457789999999999999886 8898642211 111111 1
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchH-HHHHHHHHHHHHccccc--CCCCCCHHHHHHHHHHHHh
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEI-EAVAYVGYLAADCVTLE--GRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~Li~~Cl~~d--P~~RPs~~evl~~L~~~l~ 751 (768)
...-.+... -+.... ..+.+..... -....+.-|..+|+... +.-|||++..+..|..+.+
T Consensus 239 Ia~g~f~ya-~~~~~g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYA-SDQRRG-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeec-hhccCC-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 100000000 000011 1111222222 23455667778888643 5689999999888766544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.9e-07 Score=92.14 Aligned_cols=144 Identities=23% Similarity=0.277 Sum_probs=97.9
Q ss_pred CCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccc-ccccc---------c--hhhHHHHHHHHHHHhcCCCC--
Q 046311 461 FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYA-IGTKR---------Q--EDKDNAFINELESLSRLHHK-- 526 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~-~~~~~---------~--~~~~~~~~~E~~~l~~l~Hp-- 526 (768)
..+..+||-|.-+.||.+...+|.++|||.-+.... ++. ++..+ . ......-++|.+.|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~Grt-sFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRT-SFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCch-hhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999999999999997654321 111 11000 0 11234567899999999655
Q ss_pred CceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE
Q 046311 527 NLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 527 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl 606 (768)
.+.+.+++ +...+||||+++-.|...--. ..... .++..|++-+.-+-..+ |||+|+.+-|||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~------~en~~---~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLD------VENPD---EILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCc------ccCHH---HHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 66766653 456799999998666554310 11222 33444444444444566 9999999999999
Q ss_pred CCCCcEEEeeccccc
Q 046311 607 DATWTAKVSDFGLSL 621 (768)
Q Consensus 607 ~~~~~~kl~DFGla~ 621 (768)
++|+.+.++||=-+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=85.29 Aligned_cols=143 Identities=15% Similarity=0.101 Sum_probs=103.7
Q ss_pred eccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC--CCceeEEEEEE-cC----C
Q 046311 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH--KNLVRLLGFCE-DR----N 539 (768)
Q Consensus 467 LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~-~~----~ 539 (768)
-++|+-+.|++-.++ |..+-+|+-......++. .+.....|.+|+..|.+|.. -.+.+++ ++. .. -
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r-----~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVR-----YPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCccccccc-----CCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence 567999999998877 457889986533222221 13456789999999999853 2345555 332 11 1
Q ss_pred eeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc--EEEee
Q 046311 540 ERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT--AKVSD 616 (768)
Q Consensus 540 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~--~kl~D 616 (768)
.-+||+|-+++ -+|.+++.+.... ..+...+..+..++++.|.-||+.+ +.|+|+.+.|||++.++. ++++|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 35799998764 5898888553222 2355667889999999999999999 999999999999986666 99999
Q ss_pred ccccc
Q 046311 617 FGLSL 621 (768)
Q Consensus 617 FGla~ 621 (768)
|--++
T Consensus 174 lEk~r 178 (216)
T PRK09902 174 LEKSR 178 (216)
T ss_pred hhccc
Confidence 97654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.4e-08 Score=109.91 Aligned_cols=152 Identities=20% Similarity=0.298 Sum_probs=101.2
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcc-------cccccccccCccCcccccc
Q 046311 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH-------LSLRAAGTVGYMDPEYYRL 649 (768)
Q Consensus 577 ~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~ 649 (768)
.+++.||.|+|+.. ++||++|.|++|.++.++..||+.|+++.......... ...-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999875 59999999999999999999999999876443311111 1111234568999999998
Q ss_pred CCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHc
Q 046311 650 QQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADC 728 (768)
Q Consensus 650 ~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~C 728 (768)
...+.++|+||||+++|-+.. |+.-+........ + ......+..- ...+..+.+.++.+=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~--------~~~~~~~~~~--~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----Y--------SFSRNLLNAG--AFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch-----h--------hhhhcccccc--cccccccCcHHHHHHHHHH
Confidence 888999999999999999994 4443332211110 0 0000000000 0011233445566777889
Q ss_pred ccccCCCCCCHHHHHHH
Q 046311 729 VTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 729 l~~dP~~RPs~~evl~~ 745 (768)
+..++..||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988777653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=2e-06 Score=86.56 Aligned_cols=107 Identities=25% Similarity=0.255 Sum_probs=82.8
Q ss_pred hHHHHHHHHHHHhcCCC--CCceeEEEEEEcCC----eeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 046311 509 KDNAFINELESLSRLHH--KNLVRLLGFCEDRN----ERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581 (768)
Q Consensus 509 ~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~ 581 (768)
......+|...+.+|.. =...+.+++.+... ..+||+|++++ -+|.+++..... .+......++.++++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHH
Confidence 34567888888887753 33456666665532 45899999998 479999865222 244456789999999
Q ss_pred HHHHHhhCCCCCeEecCCCCCCeEECCCC---cEEEeecccccc
Q 046311 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFGLSLI 622 (768)
Q Consensus 582 gL~yLH~~~~~~ivHrDiKp~NILl~~~~---~~kl~DFGla~~ 622 (768)
.++-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 99999999999998887 899999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=99.06 Aligned_cols=151 Identities=19% Similarity=0.189 Sum_probs=96.5
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccc----------------ccc---c----------cchhhHHHHHH
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYA----------------IGT---K----------RQEDKDNAFIN 515 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~----------------~~~---~----------~~~~~~~~~~~ 515 (768)
+-|+.++-|.||+|++++|+.||||+.+..-..... ... . +.-..+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998754221000 000 0 00012235666
Q ss_pred HHHHHhcCC-----CCCceeEEEEE-EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHHhh
Q 046311 516 ELESLSRLH-----HKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG-IEYLHE 588 (768)
Q Consensus 516 E~~~l~~l~-----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~g-L~yLH~ 588 (768)
|...+.+++ .+++ .+=.++ +-.....|+|||++|-.+.+...... ...+. ..++..+++. +..+=.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHHHHHHHHHHHHh
Confidence 766666652 3333 333334 33567899999999999988853221 11232 2333333332 222223
Q ss_pred CCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 589 YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 589 ~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
.+ ++|.|..|.||+++.++++.+.|||+.....+
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 45 89999999999999999999999999865443
|
|
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.3e-07 Score=67.65 Aligned_cols=36 Identities=17% Similarity=0.338 Sum_probs=28.8
Q ss_pred CCeEEEEecCCCCCCC-CCC--------------CCCeEEEEecCCeEEEE
Q 046311 246 NQKVVCWGQNGFTLPD-SLQ--------------GKPFVSIEAKRSVFCGV 281 (768)
Q Consensus 246 dg~v~~WG~n~~gq~~-~~~--------------~~~~~~i~~g~~h~~~l 281 (768)
||+||+||.|.+|||| ... ...+++|+||..|+++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 7899999999999998 222 12589999999999886
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=82.39 Aligned_cols=139 Identities=15% Similarity=0.212 Sum_probs=84.2
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC--ceeEEEEEEcCCeeE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN--LVRLLGFCEDRNERV 542 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~ 542 (768)
.+|++|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+.+....+...
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-------------~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~g 70 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-------------FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLG 70 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-------------CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeee
Confidence 57999999999984 2556778875421 12234678999888885433 466777877777888
Q ss_pred EEEEeccCCC-hhhh---------------------ccCCCCCCCCCCHHHHHHHH-H----------HHHH-HHHHHhh
Q 046311 543 LIYEYLENGT-LHDH---------------------LHNPQSSSPLKSWPARIKVA-L----------DAAR-GIEYLHE 588 (768)
Q Consensus 543 lV~E~~~~gs-L~~~---------------------l~~~~~~~~~~~~~~~~~ia-~----------~ia~-gL~yLH~ 588 (768)
+|||+++|.+ +... ||...... .....+..-. . .+.+ ..++|..
T Consensus 71 lv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~ 148 (226)
T TIGR02172 71 LIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE 148 (226)
T ss_pred eeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence 9999999863 2211 12110000 1111111000 0 0011 1222221
Q ss_pred C-CCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 589 Y-AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 589 ~-~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
. ..+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 1 124579999999999999888 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-06 Score=66.41 Aligned_cols=40 Identities=18% Similarity=0.344 Sum_probs=30.4
Q ss_pred CCcEEeccCCCCCccc---------ccccc--cCCCCeeEEecCCCeEEEE
Q 046311 94 SSVMHCWRFSADGIIN---------DYKRI--YRGPALQQLEAGNSHICGL 133 (768)
Q Consensus 94 ~g~~~~WG~n~~gql~---------~~~~~--~~~~~~~~i~~G~~h~~al 133 (768)
||.||+||.|.+|||+ .|.++ ....+|++|+||..|+++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 6899999999999996 22223 2233688899999998876
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.8e-05 Score=77.40 Aligned_cols=139 Identities=18% Similarity=0.204 Sum_probs=89.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHH------HHHHHHHHHhcCCCC---Cc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDN------AFINELESLSRLHHK---NL 528 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~------~~~~E~~~l~~l~Hp---nI 528 (768)
..+|...+.+-......|.+-..+ +..+++|..+... .+.+.... ...+++..+.+++.. ..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~--------~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREEN--------RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhh--------hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 457777777777777777777666 6888999765432 11111111 223444444444322 22
Q ss_pred eeEEEEEE-----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 529 VRLLGFCE-----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 529 v~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
..++.+.+ -....+|+|||++|..|.++..- +. .++..+.+.|.-||+.+ ++|+|+.|.|
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i--------~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgN 165 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDI--------DE----DLAEKIVEAIKQLHKHG---FYHGDPHPGN 165 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchhc--------CH----HHHHHHHHHHHHHHHcC---CccCCCCcCc
Confidence 22222222 22455789999999888776521 11 24456777899999999 9999999999
Q ss_pred eEECCCCcEEEeeccccc
Q 046311 604 VLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~ 621 (768)
++++++ .++++||+..+
T Consensus 166 Flv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEECC-cEEEEECcccc
Confidence 999865 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.7e-05 Score=73.50 Aligned_cols=136 Identities=25% Similarity=0.402 Sum_probs=92.8
Q ss_pred CCCCcCceeccCCc-eEEEEEEEcCCCeEEEEEEeeccCc--cccccc-ccch-------hhHHHHHHHHHHHhcCC---
Q 046311 459 NNFSEDHKIGSGSF-GAVYKATLDDGSQVAVKRAEISSTS--SYAIGT-KRQE-------DKDNAFINELESLSRLH--- 524 (768)
Q Consensus 459 ~~~~~~~~LG~G~f-G~Vy~~~~~~g~~vaVK~~~~~~~~--~~~~~~-~~~~-------~~~~~~~~E~~~l~~l~--- 524 (768)
.+++..+.||.|.- |.|||++.. |+.+|+|.++.-... .+.... ...+ .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888899999999 999999988 689999994432111 110000 0000 22347889999888874
Q ss_pred CCCc--eeEEEEEEcCC------------------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 046311 525 HKNL--VRLLGFCEDRN------------------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584 (768)
Q Consensus 525 HpnI--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~ 584 (768)
+.++ |+.+||..-.. .+.+|.||++... ....+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4566 88888873220 2246777665422 111344567888899
Q ss_pred HHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 046311 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 585 yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla 620 (768)
.+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 999998 999999999987 4589999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.3e-05 Score=75.27 Aligned_cols=162 Identities=19% Similarity=0.178 Sum_probs=100.9
Q ss_pred cccHHHHHHHcCCCCcCce---eccCCceEEEEEEEcCCCeEEEEEEeeccCcccc-----c------ccccc-hh-hHH
Q 046311 448 EFSLEILLEATNNFSEDHK---IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYA-----I------GTKRQ-ED-KDN 511 (768)
Q Consensus 448 ~~~~~~l~~~~~~~~~~~~---LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~-----~------~~~~~-~~-~~~ 511 (768)
..+++.+....++..+.+. |.+|.-..||+|...++..+|||+.+.....-.. . ..... .. ...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3455666666666655554 5567777899999888999999998765321000 0 00000 00 011
Q ss_pred HHHHHHHHHhcCC--CCCceeEEEEEEcCCeeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 046311 512 AFINELESLSRLH--HKNLVRLLGFCEDRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE 588 (768)
Q Consensus 512 ~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~ 588 (768)
=-.+|+.-|+++. +=.+.+.+.+. ...|||||+... .-.-.|.. ..+.......+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 1245777777763 34445555543 457999999653 11112211 111122445667788888887776
Q ss_pred -CCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 589 -YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 589 -~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
.+ +||+||..-|||+. ++.+.|+||+-|..
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 44 99999999999999 88999999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00012 Score=72.29 Aligned_cols=104 Identities=24% Similarity=0.289 Sum_probs=81.5
Q ss_pred HHHHHHHhcCCC-CCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 046311 514 INELESLSRLHH-KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVP 592 (768)
Q Consensus 514 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~ 592 (768)
..|.-+++.+++ +++.+++|+| ..+++.||...+++...-.. -......+|..|.+||.++++.+++|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 6999999998 34789999987766532100 00112248999999999999999999985544
Q ss_pred CeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 593 SIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
.+.-.|++++|+-+++++++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 589999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.3e-05 Score=78.39 Aligned_cols=141 Identities=16% Similarity=0.109 Sum_probs=84.0
Q ss_pred eeccCCc-eEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcCCeeEE
Q 046311 466 KIGSGSF-GAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 466 ~LG~G~f-G~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 543 (768)
.|-.|.+ ..||+...+ +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 69 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWL 69 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEE
Confidence 3445555 789999765 4788888754210 234567888887773 4446677887777667899
Q ss_pred EEEeccCCChhhhc-------------------cCCCCCCCCCC--HHHHHHHHH--------------------HHHHH
Q 046311 544 IYEYLENGTLHDHL-------------------HNPQSSSPLKS--WPARIKVAL--------------------DAARG 582 (768)
Q Consensus 544 V~E~~~~gsL~~~l-------------------~~~~~~~~~~~--~~~~~~ia~--------------------~ia~g 582 (768)
|||+++|.+|.+.. |.......... ...++.... .+...
T Consensus 70 v~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (244)
T cd05150 70 LTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEEL 149 (244)
T ss_pred EEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHH
Confidence 99999998776432 21110000000 001110000 01111
Q ss_pred HHHHhh----CCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 583 IEYLHE----YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 583 L~yLH~----~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+..|-. ...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 150 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 150 YAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 122211 123569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.8e-05 Score=89.88 Aligned_cols=80 Identities=19% Similarity=0.364 Sum_probs=56.9
Q ss_pred CceeccCCceEEEEEEEcCC---CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCc--eeEEEEEEc
Q 046311 464 DHKIGSGSFGAVYKATLDDG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNL--VRLLGFCED 537 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g---~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~ 537 (768)
.++|+.|.+..+|+....++ ..+++|+..... .......+.+|+++|+.+. |.++ .+++.++.+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~----------~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d 112 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK----------LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD 112 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc----------cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC
Confidence 46789999999999887654 367777643221 0112346889999999995 6665 777887766
Q ss_pred C---CeeEEEEEeccCCCh
Q 046311 538 R---NERVLIYEYLENGTL 553 (768)
Q Consensus 538 ~---~~~~lV~E~~~~gsL 553 (768)
. +..|+||||++|..+
T Consensus 113 ~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 113 ASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCcCCCceEEEEecCCccc
Confidence 4 467899999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=74.92 Aligned_cols=144 Identities=24% Similarity=0.347 Sum_probs=82.9
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC--CceeEEEEEEc---C
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK--NLVRLLGFCED---R 538 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~ 538 (768)
.+.|+.|..+.||+....+ ..+++|.... ......+.+|..+++.+... .+.+++.+... .
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~-------------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~ 67 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP-------------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN 67 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESS-------------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCC-------------CCCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc
Confidence 3679999999999999887 6999997532 13445677888888887433 35566664422 3
Q ss_pred CeeEEEEEeccCCChhh----------------hc---cCCC-CCCCCCCHHH--------HHHH------------HHH
Q 046311 539 NERVLIYEYLENGTLHD----------------HL---HNPQ-SSSPLKSWPA--------RIKV------------ALD 578 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~----------------~l---~~~~-~~~~~~~~~~--------~~~i------------a~~ 578 (768)
...+++|+++++..+.. .+ +... .......+.. .... ...
T Consensus 68 ~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (239)
T PF01636_consen 68 GFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEE 147 (239)
T ss_dssp SEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHH
T ss_pred ccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHH
Confidence 35689999999988877 11 1110 0011111110 0000 011
Q ss_pred HHH-HHHHHhhC----CCCCeEecCCCCCCeEEC-CCCcEEEeeccccc
Q 046311 579 AAR-GIEYLHEY----AVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLSL 621 (768)
Q Consensus 579 ia~-gL~yLH~~----~~~~ivHrDiKp~NILl~-~~~~~kl~DFGla~ 621 (768)
+.+ .++.+++. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 148 LEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 222 23333321 234599999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=9.4e-05 Score=83.46 Aligned_cols=152 Identities=20% Similarity=0.212 Sum_probs=90.6
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccc-----------------cc---------cccchhhHHHHHHHHH
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYA-----------------IG---------TKRQEDKDNAFINELE 518 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~-----------------~~---------~~~~~~~~~~~~~E~~ 518 (768)
+.|+.-+.+.||+|++++|+.||||+-+..-..... .. ....-..+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999999999999986543111000 00 0000112235666666
Q ss_pred HHhcC----CCCCc---eeEEEEE-EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 046311 519 SLSRL----HHKNL---VRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA 590 (768)
Q Consensus 519 ~l~~l----~HpnI---v~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~ 590 (768)
-..++ +|-++ |.+=.++ .......|+||||+|..+.|...-.... .+-. .++..+.++. ++..-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~---~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPH---DILNKLVEAY--LEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHH---HHHHHHHHHH--HHHHH
Confidence 44443 45551 1122233 2345789999999998887764321111 1221 3333333332 22211
Q ss_pred CCCeEecCCCCCCeEECC----CCcEEEeeccccccCC
Q 046311 591 VPSIIHRDIKSSNVLLDA----TWTAKVSDFGLSLIGP 624 (768)
Q Consensus 591 ~~~ivHrDiKp~NILl~~----~~~~kl~DFGla~~~~ 624 (768)
..+++|.|-.|.||+++. +.++.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 123899999999999983 6789999999986543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=69.21 Aligned_cols=128 Identities=16% Similarity=0.213 Sum_probs=86.0
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCcee-EEEEEEcCCee
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR-LLGFCEDRNER 541 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~ 541 (768)
..+.|++|.+|.||++.+. +..+|+|+-+ .+.....+..|+++|..+.-.++-+ ++.|- +.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr-------------~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRR-------------RDSPRRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEec-------------CCcchhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 3467999999999999988 5688998643 3345567889999999988766654 33332 22
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC-CCCeEECCCCcEEEeecccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK-SSNVLLDATWTAKVSDFGLS 620 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK-p~NILl~~~~~~kl~DFGla 620 (768)
++.|||+.|-.|.+.-... +-.+ ...+++.---|...+ |-|..|. |..++|-.+..+.|+||..|
T Consensus 88 ~i~me~i~G~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccch
Confidence 3459999998887765421 1222 233444433344455 7888876 44444445559999999888
Q ss_pred cc
Q 046311 621 LI 622 (768)
Q Consensus 621 ~~ 622 (768)
..
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 63
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00057 Score=72.92 Aligned_cols=78 Identities=18% Similarity=0.147 Sum_probs=56.5
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC---CCceeEEEEEEcC
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH---KNLVRLLGFCEDR 538 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~ 538 (768)
...+.||.|..+.||+....++ .+.+|..+.. .....|.+|.+.|+.|.. -.+.++++++...
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~-------------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~ 82 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF-------------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE 82 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc-------------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence 3456799999999999986655 4667764310 112468889999988843 3577888877543
Q ss_pred ---CeeEEEEEeccCCCh
Q 046311 539 ---NERVLIYEYLENGTL 553 (768)
Q Consensus 539 ---~~~~lV~E~~~~gsL 553 (768)
+..+||||++++.++
T Consensus 83 ~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 83 QSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcCCCeEEEEeccCCEec
Confidence 568999999998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00031 Score=72.25 Aligned_cols=31 Identities=29% Similarity=0.457 Sum_probs=26.0
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4489999999999998776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.71 E-value=2.2e-06 Score=97.43 Aligned_cols=105 Identities=17% Similarity=0.233 Sum_probs=79.8
Q ss_pred CeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEee-------CCe
Q 046311 119 ALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLE-------NGT 174 (768)
Q Consensus 119 ~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~-------~g~ 174 (768)
++.+++||..|+.|+ +.+|+++.||.|.+||++ +....+|++|..|+|++.. +|+
T Consensus 15 ~~lq~~cGn~hclal-~~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~~~~~lt~e~~ 93 (850)
T KOG0941|consen 15 HILQVGCGNNHCLAL-SCAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSSHTVLLTDEGK 93 (850)
T ss_pred hhhhhccccHHHHhh-hccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhhchhhcchhcc
Confidence 678999999999999 999999999999999888 2336678889988888776 777
Q ss_pred EEEecCCCCCCcccccCCC------------cCeEEEeccCceeEEEecC-CcEEEeecCCCC
Q 046311 175 ITCFGSRNSPTSVTQKVPS------------GIFRVVAAGFRHVCAIDDD-QELRCWGDSVGE 224 (768)
Q Consensus 175 v~~wG~~~~g~~~~~~~~~------------~~~~~i~~G~~h~~al~~~-g~v~~wG~n~~g 224 (768)
++..|....||.+...... ..+++|+||..|+.++..+ |.++..|.+..|
T Consensus 94 ~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 94 VFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred ccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 8888877777766422221 4667777777777777444 777777766555
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=7.8e-06 Score=91.08 Aligned_cols=184 Identities=17% Similarity=0.093 Sum_probs=124.5
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC-ceeEEEEEEcCCe
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN-LVRLLGFCEDRNE 540 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~ 540 (768)
...+-+++++++.+||.+-...+...+|.+... ....-++++|.+++||| .+..++-++.+..
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc----------------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 334567899999999987543344445544211 23445888999999999 6666666666777
Q ss_pred eEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 541 RVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 541 ~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
.++.++++..+ +-...... ....+...+...+...-+++|+|||+.. =+||| |||..+ ...+..||+.
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred cchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccC
Confidence 88999999876 22221110 0011112222345556678899999874 38999 887765 6889999998
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
........ ......+|+.++|||+.....+..+.|+|++++--.+|--|-.|-
T Consensus 378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 76443332 223456899999999999999999999999998766666665443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00092 Score=68.65 Aligned_cols=74 Identities=19% Similarity=0.179 Sum_probs=46.6
Q ss_pred ceeccCCceEEEEEEEcC--CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC-ceeEEEEEEcCCee
Q 046311 465 HKIGSGSFGAVYKATLDD--GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN-LVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~--g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~ 541 (768)
+.|..|-...+|+....+ ++.+++|+...... ...+..+|+.+++.+...+ ..+++.... .
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~ 67 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------------LIIDRERELRIHKLLSKHGLAPKLYATFQ----N 67 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----C
Confidence 567788888999998664 67888886543210 0112236777887774333 344444332 2
Q ss_pred EEEEEeccCCChh
Q 046311 542 VLIYEYLENGTLH 554 (768)
Q Consensus 542 ~lV~E~~~~gsL~ 554 (768)
.++|||++|.++.
T Consensus 68 ~~l~e~i~G~~l~ 80 (235)
T cd05157 68 GLIYEFIPGRTLE 80 (235)
T ss_pred cEEEEeeCCCcCC
Confidence 4799999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0018 Score=64.46 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=91.3
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEeeccCccc-----ccccccchhhHHHHHHHHHHHhcCC------CCCceeE
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSY-----AIGTKRQEDKDNAFINELESLSRLH------HKNLVRL 531 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~-----~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l 531 (768)
....||+|+.-.||.-- +.....||+........- ..+........+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 34679999999999754 345667887765430000 0001111223456777777666665 7899999
Q ss_pred EEEEEcCCeeEEEEEeccC------CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 532 LGFCEDRNERVLIYEYLEN------GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
+|+.+.+...-+|+|.+.+ -+|.+++... .++. . +...+-+-..||-+++ |+.+|++|+||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998754 2577777432 1232 2 2233334456777777 999999999999
Q ss_pred ECCC---C-cEEEee
Q 046311 606 LDAT---W-TAKVSD 616 (768)
Q Consensus 606 l~~~---~-~~kl~D 616 (768)
+..+ . .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9532 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0035 Score=69.06 Aligned_cols=82 Identities=20% Similarity=0.196 Sum_probs=53.9
Q ss_pred ceeccCCceEEEEEEEcCC-CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEcCCe
Q 046311 465 HKIGSGSFGAVYKATLDDG-SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFCEDRNE 540 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g-~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~ 540 (768)
+.||.|.+..||+....+| +.++||.-...... ....-+....++..|.+.|..+. ..++.+++.+ +.+.
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~----~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRV----VGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCccccc----ccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 5799999999999998876 58999985421100 00000123445667777777762 3456777776 4466
Q ss_pred eEEEEEeccCCC
Q 046311 541 RVLIYEYLENGT 552 (768)
Q Consensus 541 ~~lV~E~~~~gs 552 (768)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 789999998643
|
|
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.28 E-value=2.2e-05 Score=89.50 Aligned_cols=107 Identities=17% Similarity=0.290 Sum_probs=91.0
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCccccc--------ccc--cCCCCeeEEecCCCeEEEEEeC-----
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDY--------KRI--YRGPALQQLEAGNSHICGLVNG----- 136 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~--------~~~--~~~~~~~~i~~G~~h~~al~~~----- 136 (768)
...++.+|+.|..++ ..+|+++.||.|.+||++.. .++ ..+....+|++|..|+|++ ..
T Consensus 15 ~~lq~~cGn~hclal-----~~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~l-S~~~~~l 88 (850)
T KOG0941|consen 15 HILQVGCGNNHCLAL-----SCAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFAL-SSHTVLL 88 (850)
T ss_pred hhhhhccccHHHHhh-----hccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhh-hhchhhc
Confidence 356889999999999 89999999999999999433 223 2344678899999999998 66
Q ss_pred --CCcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEeeC-CeEEEecCCCCC
Q 046311 137 --TNDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLEN-GTITCFGSRNSP 184 (768)
Q Consensus 137 --~g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~~-g~v~~wG~~~~g 184 (768)
+|.+...|....+|++ +..+.+|++|-.|+.++... |.++..|.+..|
T Consensus 89 t~e~~~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 89 TDEGKVFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred chhccccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 8999999999999998 44589999999999999887 999999988776
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.003 Score=65.85 Aligned_cols=140 Identities=16% Similarity=0.121 Sum_probs=76.8
Q ss_pred eeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEcCCeeEEE
Q 046311 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCEDRNERVLI 544 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV 544 (768)
.+..|-...+|+... +++.+++|+...... ....+..+|.++++.+....+ .+++.... .++|
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~-----------~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v 66 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCK-----------ALGVDRQREYQILQALSALGLAPKPILVNE----HWLL 66 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccc-----------cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEE
Confidence 355677889999874 467888886432110 000124668888887754333 33444322 3689
Q ss_pred EEeccCCChhhh-----------------ccCCCCCCCCCCHHHHH-HHH---------HHHHHHHHHHhhC-----CCC
Q 046311 545 YEYLENGTLHDH-----------------LHNPQSSSPLKSWPARI-KVA---------LDAARGIEYLHEY-----AVP 592 (768)
Q Consensus 545 ~E~~~~gsL~~~-----------------l~~~~~~~~~~~~~~~~-~ia---------~~ia~gL~yLH~~-----~~~ 592 (768)
|||++|..+... ||.........+...++ ... ..+.+-+..+-.. ..+
T Consensus 67 ~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (256)
T TIGR02721 67 VEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPL 146 (256)
T ss_pred EEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCC
Confidence 999998766431 22221111111221111 110 0111112222211 123
Q ss_pred CeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 593 SIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
.++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999876 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0022 Score=68.37 Aligned_cols=144 Identities=19% Similarity=0.185 Sum_probs=83.2
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC--CceeEEEE------E
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK--NLVRLLGF------C 535 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~ 535 (768)
.+.|..|....+|+...++ ..+++|+... .....+..|++++..|++. .+.+++.. .
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--------------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~ 83 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--------------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLS 83 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--------------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence 4567788888999987654 5788887542 1123455677777777432 24444431 2
Q ss_pred EcCCeeEEEEEeccCCChhh--------------hccCCCC-------CCCCCCHHHHH----------HHHHHHHHHHH
Q 046311 536 EDRNERVLIYEYLENGTLHD--------------HLHNPQS-------SSPLKSWPARI----------KVALDAARGIE 584 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~-------~~~~~~~~~~~----------~ia~~ia~gL~ 584 (768)
...+..++||||++|..+.. .||.... ......|.... .....+...+.
T Consensus 84 ~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 163 (296)
T cd05153 84 ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELA 163 (296)
T ss_pred eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence 33456689999999877543 0111100 00111222111 01112233444
Q ss_pred HHhhC----CCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 585 YLHEY----AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 585 yLH~~----~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
++.+. -...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 164 RQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 54431 113489999999999999987778999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0061 Score=65.77 Aligned_cols=31 Identities=26% Similarity=0.375 Sum_probs=26.2
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
..++|+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3599999999999998765568999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0038 Score=66.82 Aligned_cols=75 Identities=31% Similarity=0.352 Sum_probs=46.3
Q ss_pred ceeccCCceEEEEEEEcC-------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEE
Q 046311 465 HKIGSGSFGAVYKATLDD-------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCE 536 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~-------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~ 536 (768)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+....+ .+++.++.
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~ 71 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------------ELLIDRERELVVFARLSERNLGPKLYGIFP 71 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------------cceechHHHHHHHHHHHhCCCCCceEEEeC
Confidence 456667777999998664 5788888864321 111234567777777743223 34555443
Q ss_pred cCCeeEEEEEeccCCChhh
Q 046311 537 DRNERVLIYEYLENGTLHD 555 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~ 555 (768)
. .+|+||++|..+..
T Consensus 72 ~----~~v~e~i~G~~l~~ 86 (302)
T cd05156 72 N----GRIEEFIPSRTLTT 86 (302)
T ss_pred C----CchhheeCCCcCCH
Confidence 2 36899999877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.011 Score=63.39 Aligned_cols=144 Identities=19% Similarity=0.228 Sum_probs=80.2
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC--CceeEEEE------E
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK--NLVRLLGF------C 535 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~ 535 (768)
.+.++.|-...+|+...+++ .+++|+.... ....+...|++++..|... .+.+++.. .
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-------------~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR-------------VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC-------------CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 45677777789999876654 5777865321 0122344566666666322 23344331 1
Q ss_pred EcCCeeEEEEEeccCCChhh--------------hccCCCCCC--------CCCCHHHHHH------------HHHHHHH
Q 046311 536 EDRNERVLIYEYLENGTLHD--------------HLHNPQSSS--------PLKSWPARIK------------VALDAAR 581 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~~--------~~~~~~~~~~------------ia~~ia~ 581 (768)
...+..+++|||++|..+.. .+|...... ....|..... ....+.+
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 22456789999999865431 112111100 0112211110 0112333
Q ss_pred HHHHHhh----CCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 582 GIEYLHE----YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 582 gL~yLH~----~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
.++++.. ...+.++|+|+.+.||+++.++...|+||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4555543 122459999999999999988777899998874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0078 Score=63.44 Aligned_cols=31 Identities=16% Similarity=0.398 Sum_probs=25.9
Q ss_pred CCeEecCCCCCCeEECCCCc-EEEeecccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWT-AKVSDFGLSLI 622 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~-~kl~DFGla~~ 622 (768)
+.++|+|+++.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.00069 Score=70.51 Aligned_cols=143 Identities=20% Similarity=0.227 Sum_probs=94.9
Q ss_pred CCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccccccc------ch-----hhHHHHHHHHHHHhcCC-CCC-
Q 046311 461 FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR------QE-----DKDNAFINELESLSRLH-HKN- 527 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~------~~-----~~~~~~~~E~~~l~~l~-Hpn- 527 (768)
+...++||-|.-+.||.+...+|.+.++|.-+.....-..++.++ .. -......+|...|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567899999999999999999999999986443221111111111 00 01224467888888883 332
Q ss_pred ceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 528 LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 528 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+.+.++ ....++|||++.+-.|...-+- .+.+ .+...+..-+.-|..++ +||+|+.-=||+++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeec-------CChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 333433 3456899999998777665432 1222 23334444455677777 99999999999999
Q ss_pred CCCcEEEeecccc
Q 046311 608 ATWTAKVSDFGLS 620 (768)
Q Consensus 608 ~~~~~kl~DFGla 620 (768)
++..++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0036 Score=75.05 Aligned_cols=198 Identities=20% Similarity=0.204 Sum_probs=130.8
Q ss_pred HHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE----EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 046311 511 NAFINELESLSRLHHKNLVRLLGFCEDRNERV----LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYL 586 (768)
Q Consensus 511 ~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yL 586 (768)
....-|+..+.++.|+|++.++.|-.++...- +.-|++..-++...+..- ...+....+.+..++.+||.|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHH
Confidence 34455777888899999999999876554332 345777777887777542 2345666777888999999999
Q ss_pred hhCCCCCeEecCCCCC---CeEECCCCcEEEe--eccccccCCCCCCcccccccccccCccCccccccCCCCC--hhhHH
Q 046311 587 HEYAVPSIIHRDIKSS---NVLLDATWTAKVS--DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTE--KSDVY 659 (768)
Q Consensus 587 H~~~~~~ivHrDiKp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~--~sDVw 659 (768)
|+.. ..|.-+..+ +...+.++.+.++ ||+.+........... ..-+..+.+||......+.. ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence 9985 455444444 4445566677777 8888875544433222 12456688888877555444 47999
Q ss_pred HHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 660 SFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 660 SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
.+|.++..+..|..+-..... ...+++... . ..+.+...+|+..++++|++.
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~~------~----~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV------------------PVSLLDVLS------T----SELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc------------------hhhhhcccc------c----hhhhhhhhhhcchhhhhccch
Confidence 999999999988543221100 011111000 0 033467789999999999999
Q ss_pred HHHHHHH
Q 046311 740 TEIVNSL 746 (768)
Q Consensus 740 ~evl~~L 746 (768)
.+++...
T Consensus 429 ~~ll~~~ 435 (1351)
T KOG1035|consen 429 LELLTHP 435 (1351)
T ss_pred hhhhhch
Confidence 9998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0002 Score=86.93 Aligned_cols=160 Identities=13% Similarity=0.013 Sum_probs=109.5
Q ss_pred HHHHHHhcCCCCCceeEEEEEE--cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--
Q 046311 515 NELESLSRLHHKNLVRLLGFCE--DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA-- 590 (768)
Q Consensus 515 ~E~~~l~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~-- 590 (768)
.|...++...|+++.....-.. +..+.+..++|+..|.+++.|-+...+.+.++..-....-.+......-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444455567888765444332 234668899999999999999766554444433222222222244444444322
Q ss_pred CCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 591 ~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
...-+|+++|+-|.+|..+..+|+.++|+.+...... .......+++.|+.|++...-+++.++|+|..++.+|++-.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 1236999999999999999999999999998322221 11123467889999999988899999999999999999988
Q ss_pred CCcccc
Q 046311 671 GYRAIH 676 (768)
Q Consensus 671 G~~p~~ 676 (768)
|..++.
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 866653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0077 Score=63.65 Aligned_cols=141 Identities=23% Similarity=0.354 Sum_probs=73.1
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEcC
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFCEDR 538 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 538 (768)
+..+.++.|....+|+.+ .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--------------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~ 84 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE--------------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD 84 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG--------------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh--------------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345678999999999988 6688999997542 12235777888887773 44577889988877
Q ss_pred CeeEEEEEeccCCCh--h------h---hccC-CCC-----------------CCCCCCHHHH-----HHHHHH------
Q 046311 539 NERVLIYEYLENGTL--H------D---HLHN-PQS-----------------SSPLKSWPAR-----IKVALD------ 578 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL--~------~---~l~~-~~~-----------------~~~~~~~~~~-----~~ia~~------ 578 (768)
+..+|||||++.+.. . . .||. ... .....+|..- +....+
T Consensus 85 ~~~fLlle~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~ 164 (288)
T PF03881_consen 85 DDAFLLLEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKG 164 (288)
T ss_dssp SCCEEEEE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCT
T ss_pred CCceEEEEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 788999999987611 0 0 1222 110 0011234321 111111
Q ss_pred --------HHHHH-HHHhhC-CCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 579 --------AARGI-EYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 579 --------ia~gL-~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+.+.+ ..|+.. -.|.++|+||-+.|++.+.++++.|.|=
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 165 GLDAELERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp SS-CHHHHHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred CchhHHHHHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence 11111 122322 2478999999999999999998999873
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.028 Score=59.87 Aligned_cols=34 Identities=26% Similarity=0.578 Sum_probs=30.2
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccccCCC
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~ 625 (768)
+.++|+|+.+.||+++.+..+=|.||+++....+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 5699999999999999988899999999976544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.094 Score=52.54 Aligned_cols=75 Identities=19% Similarity=0.357 Sum_probs=52.6
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEcCCee
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~ 541 (768)
+.+..|-.-..|.... +..++.||+-. ......|..|+.-|..|. --++.+++.+-.+..+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~--------------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s 86 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ--------------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHS 86 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc--------------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCee
Confidence 4455555555565543 35788888632 234456788887777663 35677888888999999
Q ss_pred EEEEEeccCCChh
Q 046311 542 VLIYEYLENGTLH 554 (768)
Q Consensus 542 ~lV~E~~~~gsL~ 554 (768)
||||||++-+.+.
T Consensus 87 ylVle~L~~~~~d 99 (286)
T COG3001 87 YLVLEYLPTGPLD 99 (286)
T ss_pred EEEEeeccCCCCC
Confidence 9999999987665
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.062 Score=58.62 Aligned_cols=142 Identities=15% Similarity=0.201 Sum_probs=77.3
Q ss_pred ceeccCCceEEEEEEEcC-----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEcC
Q 046311 465 HKIGSGSFGAVYKATLDD-----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCEDR 538 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~-----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~ 538 (768)
+.|-.|-.-.+|+....+ ++.+++|+...... ..-+-.+|..+++.+..-++ .++++.+...
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~------------~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g 109 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE------------LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG 109 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC------------eeechHHHHHHHHHHHHcCCCCceEEEECCc
Confidence 456567778899987542 36788887643210 11112457777777743333 3455655332
Q ss_pred CeeEEEEEeccCCChhhh-----------------ccCCCCCC-C-CCCHHHHHHHHHH-----------------HHHH
Q 046311 539 NERVLIYEYLENGTLHDH-----------------LHNPQSSS-P-LKSWPARIKVALD-----------------AARG 582 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~-----------------l~~~~~~~-~-~~~~~~~~~ia~~-----------------ia~g 582 (768)
.|+||+++.+|... +|...... . ...|....++..+ +..-
T Consensus 110 ----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 110 ----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred ----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 58999988776421 22211111 1 1112222122111 1111
Q ss_pred HHHH----hh-CCCCCeEecCCCCCCeEECC-CCcEEEeecccccc
Q 046311 583 IEYL----HE-YAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLI 622 (768)
Q Consensus 583 L~yL----H~-~~~~~ivHrDiKp~NILl~~-~~~~kl~DFGla~~ 622 (768)
+..| .. .....++|+|+++.|||+++ ++.++++||..+..
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2222 11 11234899999999999976 46899999987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.19 Score=55.51 Aligned_cols=84 Identities=18% Similarity=0.197 Sum_probs=52.1
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccC---cccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEc
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISST---SSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFCED 537 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 537 (768)
.+.||.|-...||+.... +..++||+-..... .+|. ....+-..|++.|+.+. ..++.+++.++.
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wp-------l~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de- 107 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWP-------MTKERAYFEATALREHGRLCPDHVPEVYHFDR- 107 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCcccc-------CCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence 467899999999998865 56799998653211 0111 11222333455555543 357778888776
Q ss_pred CCeeEEEEEeccC--CChhhhc
Q 046311 538 RNERVLIYEYLEN--GTLHDHL 557 (768)
Q Consensus 538 ~~~~~lV~E~~~~--gsL~~~l 557 (768)
+..+++||++++ ..+.+.+
T Consensus 108 -d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 108 -TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred -CCCEEEEeecCCcceehhhhh
Confidence 456789999977 3344443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.24 Score=53.06 Aligned_cols=29 Identities=28% Similarity=0.346 Sum_probs=25.0
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+.++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 768 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-53 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-48 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-28 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-27 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-26 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-25 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-25 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-25 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-25 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-25 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-25 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-24 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-133
Identities = 125/303 (41%), Positives = 178/303 (58%), Gaps = 16/303 (5%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED 508
L L EATNNF IG G FG VYK L DG++VA+KR S Q
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---------SQGI 79
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
++ F E+E+LS H +LV L+GFC++RNE +LIY+Y+ENG L HL+ + S
Sbjct: 80 EE--FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
W R+++ + AARG+ YLH +IIHRD+KS N+LLD + K++DFG+S G E D+
Sbjct: 138 WEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
+HLS GT+GY+DPEY+ +LTEKSDVYSFGVVL E+L AI ++ N+ +
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ V ++ +++D N+ E++ G A C+ L +RPSM +++ LE
Sbjct: 255 WAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 749 ALA 751
AL
Sbjct: 313 ALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-120
Identities = 114/306 (37%), Positives = 176/306 (57%), Gaps = 15/306 (4%)
Query: 444 GRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT 503
G+L+ FSL L A++NFS + +G G FG VYK L DG+ VAVKR + T G
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GG 70
Query: 504 KRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
+ Q F E+E +S H+NL+RL GFC ER+L+Y Y+ NG++ L S
Sbjct: 71 ELQ------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
P WP R ++AL +ARG+ YLH++ P IIHRD+K++N+LLD + A V DFGL+ +
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI--HRTHNG 681
D +H++ GT+G++ PEY + +EK+DV+ +GV+LLE+++G RA R N
Sbjct: 185 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741
++D+V + ++ ++D ++ ++ E V + +A C RP M+E
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 742 IVNSLE 747
+V LE
Sbjct: 302 VVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-118
Identities = 109/316 (34%), Positives = 165/316 (52%), Gaps = 25/316 (7%)
Query: 444 GRLEEFSLEILLEATNNFSE------DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTS 497
R FS L TNNF E +K+G G FG VYK ++ + VAVK+ +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKL-----A 63
Query: 498 SYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL 557
+ T + + F E++ +++ H+NLV LLGF D ++ L+Y Y+ NG+L D L
Sbjct: 64 AMVDITTEELKQQ--FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 558 HNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
+ PL SW R K+A AA GI +LHE IHRDIKS+N+LLD +TAK+SDF
Sbjct: 122 SCLDGTPPL-SWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDF 177
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
GL+ + ++ ++ R GT YM PE R ++T KSD+YSFGVVLLEI++G A+
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 678 THNGTPRNVVDFVVPYIV-RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736
P+ ++D I +D + +V + +A+ C+ + R
Sbjct: 237 HRE--PQLLLDIKEEIEDEEKTIEDYID---KKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 737 PSMTEIVNSLERALAA 752
P + ++ L+ A+
Sbjct: 292 PDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-82
Identities = 78/320 (24%), Positives = 123/320 (38%), Gaps = 38/320 (11%)
Query: 448 EFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE 507
+ E L + G FG V+KA L VAVK I S+
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ------- 64
Query: 508 DKDNAFINELESLSRLHHKNLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSS 563
E+ SL + H+N+++ +G + + LI + E G+L D L
Sbjct: 65 -----NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--- 116
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAV-------PSIIHRDIKSSNVLLDATWTAKVSD 616
+ SW +A ARG+ YLHE P+I HRDIKS NVLL TA ++D
Sbjct: 117 -VV-SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSG 671
FGL+L + + GT YM PE + + D+Y+ G+VL E+ S
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD----RNVPPPTPFEIEAVAYVGYLAAD 727
A + + + + +++ V+ R V + +A + +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 728 CVTLEGRNRPSMTEIVNSLE 747
C + R S + +
Sbjct: 295 CWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 6e-76
Identities = 101/342 (29%), Positives = 156/342 (45%), Gaps = 48/342 (14%)
Query: 428 PVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSE---DHKIGSGSFGAVYKATLDDGS 484
P+ + + ++ G ++ ++I + + KIG+GSFG V++A GS
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDI------PWCDLNIKEKIGAGSFGTVHRAEWH-GS 61
Query: 485 QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLI 544
VAVK ++ N F+ E+ + RL H N+V +G ++
Sbjct: 62 DVAVKILMEQDFH---------AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112
Query: 545 YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNV 604
EYL G+L+ LH + L R+ +A D A+G+ YLH P I+HR++KS N+
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQL-DERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNL 170
Query: 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664
L+D +T KV DFGLS + + S AAGT +M PE R + EKSDVYSFGV+
Sbjct: 171 LVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 665 LLEILSG---YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYV 721
L E+ + + ++ P VV V R EI P ++ A
Sbjct: 229 LWELATLQQPWGNLN------PAQVVAAVGFKCKRLEI--------PRNLNPQVAA---- 270
Query: 722 GYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISRSA 763
+ C T E RPS I++ L + + + P +RS
Sbjct: 271 --IIEGCWTNEPWKRPSFATIMDLLRPLIKSAV--PPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-72
Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 45/294 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ +G G+FG V KA VA+K+ E + AFI EL
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI-------------ESESERKAFIVELR 53
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
LSR++H N+V+L G C N L+ EY E G+L++ LH + + + L
Sbjct: 54 QLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWCLQ 110
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT-AKVSDFGLSLIGPEDDESHLSLRAAG 637
++G+ YLH ++IHRD+K N+LL A T K+ DFG + D G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 165
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVDFVVPYI 694
+ +M PE + +EK DV+S+G++L E+++ + I F + +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFRIMWA 216
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
V + L +N+P P + L C + + RPSM EIV +
Sbjct: 217 VHNGTRPPLIKNLPKP----------IESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-68
Identities = 80/322 (24%), Positives = 137/322 (42%), Gaps = 47/322 (14%)
Query: 438 ASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISST 496
+MG + + + + +IG G FG V+K + D S VA+K + +
Sbjct: 1 GAMGGSEFPKSRLPTLADN---EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 497 SSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDH 556
++ ++ F E+ +S L+H N+V+L G N ++ E++ G L+
Sbjct: 58 EGETEMIEKFQE----FQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHR 111
Query: 557 LHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-----ATWT 611
L + + P+ W ++++ LD A GIEY+ P I+HRD++S N+ L A
Sbjct: 112 LLDK--AHPI-KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL--TEKSDVYSFGVVLLEIL 669
AKV+DFGLS H G +M PE ++ TEK+D YSF ++L IL
Sbjct: 168 AKVADFGLS-----QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 670 SG---YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAA 726
+G + + ++ + +R I P P + +
Sbjct: 223 TGEGPFDEY----SYGKIKFINMIREEGLRPTI--------PEDCPPRLRN------VIE 264
Query: 727 DCVTLEGRNRPSMTEIVNSLER 748
C + + + RP + IV L
Sbjct: 265 LCWSGDPKKRPHFSYIVKELSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-68
Identities = 80/339 (23%), Positives = 126/339 (37%), Gaps = 63/339 (18%)
Query: 448 EFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE 507
E + +N IG G +GAVYK +LD VAVK ++ +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQN--------- 51
Query: 508 DKDNAFINELE--SLSRLHHKNLVRLLGFCE-----DRNERVLIYEYLENGTLHDHLHNP 560
FINE + + H N+ R + E R E +L+ EY NG+L +L
Sbjct: 52 -----FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106
Query: 561 QSSSPLKSWPARIKVALDAARGIEYLHE------YAVPSIIHRDIKSSNVLLDATWTAKV 614
S W + ++A RG+ YLH + P+I HRD+ S NVL+ T +
Sbjct: 107 TSD-----WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
Query: 615 SDFGLSLI------GPEDDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSF 661
SDFGLS+ +E + ++ GT+ YM PE + ++ D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 662 GVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--------IVRDEIHRVLDRNVPPPTP- 712
G++ EI T +V ++ + + D V P P
Sbjct: 222 GLIYWEIFMR-----CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276
Query: 713 ---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
AV + DC + R + +
Sbjct: 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-67
Identities = 87/311 (27%), Positives = 131/311 (42%), Gaps = 57/311 (18%)
Query: 451 LEILLEATNNFSE---DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE 507
LEI +F+E + IG G FG VY+A G +VAVK A + +
Sbjct: 2 LEI------DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIE--- 51
Query: 508 DKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
E + + L H N++ L G C L+ E+ G L+ L +
Sbjct: 52 ----NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----I 102
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--------ATWTAKVSDFGL 619
+ A+ ARG+ YLH+ A+ IIHRD+KSSN+L+ + K++DFGL
Sbjct: 103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162
Query: 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIH 676
+ + +S AAG +M PE R ++ SDV+S+GV+L E+L+G +R I
Sbjct: 163 ARE--WHRTTKMS--AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI- 217
Query: 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736
V + V + P P L DC + +R
Sbjct: 218 -----DGLAV------------AYGVAMNKLALPIPSTCPEP--FAKLMEDCWNPDPHSR 258
Query: 737 PSMTEIVNSLE 747
PS T I++ L
Sbjct: 259 PSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 5e-66
Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 40/290 (13%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IGSGSFG VYK VAVK +++ + + AF NE+ L +
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT---------PQQLQAFKNEVGVLRKTR 78
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N++ +G+ ++ ++ E +L+ HLH ++ I +A ARG++
Sbjct: 79 HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFE---MKKLIDIARQTARGMD 134
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH SIIHRD+KS+N+ L T K+ DFGL+ SH + +G++ +M P
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 645 EYYRLQQL---TEKSDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVDFVVPYIVRDE 698
E R+Q + +SDVY+FG+VL E+++G Y I R+ + +V
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI------NNRDQIIEMVGRGSL-- 243
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
V P ++ L A+C+ + RPS I+ +E
Sbjct: 244 --SPDLSKVRSNCPKRMKR------LMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-64
Identities = 65/317 (20%), Positives = 118/317 (37%), Gaps = 56/317 (17%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G FG VY +VA++ +I + ED+ AF E+ + +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN---------EDQLKAFKREVMAYRQTR 87
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H+N+V +G C +I + TL+ + + + ++A + +G+
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD---VNKTRQIAQEIVKGMG 144
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR---AAGTVGY 641
YLH I+H+D+KS NV D ++DFGL I + G + +
Sbjct: 145 YLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 642 MDPEYYRLQQL---------TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692
+ PE R ++ SDV++ G + E+ + P
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR------------------EWP 242
Query: 693 Y--IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
+ + I + + P +I + + C E RP+ T++++ LE+ L
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLS-QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK-L 300
Query: 751 AACLVSPS----ISRSA 763
S +SA
Sbjct: 301 PKRNRRLSHPGHFWKSA 317
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-63
Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 51/300 (17%)
Query: 460 NFSE---DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
+F + K+ G ++K G+ + VK ++ S K F E
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS---------TRKSRDFNEE 57
Query: 517 LESLSRLHHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
L H N++ +LG C+ LI ++ G+L++ LH + +K
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV--DQSQAVK 115
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
ALD ARG+ +LH P I + S +V++D TA++S +
Sbjct: 116 FALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------ 168
Query: 635 AAGTVGYMDPEYYRLQQL---TEKSDVYSFGVVLLEILSG---YRAIHRTHNGTPRNVVD 688
++ PE + + +D++SF V+L E+++ + + +
Sbjct: 169 -MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGM 221
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
V +R I PP + L C+ + RP IV LE+
Sbjct: 222 KVALEGLRPTI--------PPGISPHVSK------LMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-63
Identities = 77/296 (26%), Positives = 119/296 (40%), Gaps = 46/296 (15%)
Query: 465 HKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G G FG K T + G + +K + E+ F+ E++ + L
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELI-----------RFDEETQRTFLKEVKVMRCL 64
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H N+++ +G I EY++ GTL + + S W R+ A D A G+
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQY-PWSQRVSFAKDIASGM 121
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA-------- 635
YLH +IIHRD+ S N L+ V+DFGL+ + ++ LR+
Sbjct: 122 AYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 636 ----AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
G +M PE + EK DV+SFG+VL EI+ A + PR +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTMD---- 231
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ LDR PP P + C L+ RPS ++ + LE
Sbjct: 232 ---FGLNVRGFLDRYCPPNCPPSFFP------ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-61
Identities = 65/314 (20%), Positives = 116/314 (36%), Gaps = 58/314 (18%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE--SLSR 522
+G G +G V++ + G VAVK +++K + E E +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIF------------SSRDEKS--WFRETELYNTVM 58
Query: 523 LHHKNLVRLLGFC----EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L H+N++ + + LI Y E G+L+D+L + +++ L
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLS 113
Query: 579 AARGIEYLHEYAV-----PSIIHRDIKSSNVLLDATWTAKVSDFGLSLI--GPEDDESHL 631
A G+ +LH P+I HRD+KS N+L+ ++D GL+++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 632 SLRAAGTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685
+ GT YM PE ++ D+++FG+VL E+ +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGI 225
Query: 686 VVDFVVPY--------IVRDEIHRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGR 734
V D+ P+ D V P P F + + L +C
Sbjct: 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 735 NRPSMTEIVNSLER 748
R + I +L +
Sbjct: 286 ARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-61
Identities = 75/354 (21%), Positives = 130/354 (36%), Gaps = 61/354 (17%)
Query: 425 PSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGS 484
P L + Q S G+ L + + +IG G +G V+ G
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKWR-GE 61
Query: 485 QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE--SLSRLHHKNLVRLLGFCEDRNERV 542
+VAVK E+ + E E + H+N++ +
Sbjct: 62 KVAVKVF------------FTTEEAS--WFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 543 ----LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAV-----PS 593
LI +Y ENG+L+D+L + + +K+A + G+ +LH P+
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLI--GPEDDESHLSLRAAGTVGYMDPE------ 645
I HRD+KS N+L+ T ++D GL++ ++ GT YM PE
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--------IVRD 697
Q +D+YSFG++L E+ + V ++ +PY D
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCV--------SGGIVEEYQLPYHDLVPSDPSYED 274
Query: 698 EIHRVLDRNVPPPTPFEI---EAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
V + + P P E + +G L +C +R + + +L +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-60
Identities = 79/363 (21%), Positives = 136/363 (37%), Gaps = 62/363 (17%)
Query: 417 QPPMPPPPPSP-PVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAV 475
P + P S L+ + + + G+ L + IG G FG V
Sbjct: 2 DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIAR---TIVLQESIGKGRFGEV 58
Query: 476 YKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE--SLSRLHHKNLVRLLG 533
++ G +VAVK ++ ++ E E L H+N++ +
Sbjct: 59 WRGKWR-GEEVAVKIFS--------------SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 534 FCEDRNERV----LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY 589
N L+ +Y E+G+L D+L+ + IK+AL A G+ +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 590 AV-----PSIIHRDIKSSNVLLDATWTAKVSDFGLSLI--GPEDDESHLSLRAAGTVGYM 642
V P+I HRD+KS N+L+ T ++D GL++ D GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 643 DPE------YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--- 693
PE + + +++D+Y+ G+V EI D+ +PY
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS--------IGGIHEDYQLPYYDL 270
Query: 694 -----IVRDEIHRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745
V + V ++ + P P EA+ + + +C G R + I +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 746 LER 748
L +
Sbjct: 331 LSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 39/262 (14%)
Query: 464 DHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
D +IG GSF VYK + +VA + + + + F E E L
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---------KSERQRFKEEAEMLKG 81
Query: 523 LHHKNLVRLLGFCEDRNER----VLIYEYLENGTLHDHL--HNPQSSSPLKSWPARIKVA 576
L H N+VR E + VL+ E + +GTL +L L+SW +I
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI--- 138
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRA 635
+G+++LH P IIHRD+K N+ + T + K+ D GL+ + +
Sbjct: 139 ---LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---- 190
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---------YRAIHR-THNGTPRN 685
GT +M PE Y ++ E DVY+FG+ +LE+ + I+R +G
Sbjct: 191 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249
Query: 686 VVDFVVPYIVRDEIHRVLDRNV 707
D V V++ I + +N
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNK 271
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 44/290 (15%)
Query: 465 HKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+IG G+FG V+ L D + VAVK + D F+ E L +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP----------DLKAKFLQEARILKQY 169
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H N+VRL+G C + ++ E ++ G L + +K+ +++ DAA G+
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT---LLQMVGDAAAGM 226
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYL IHRD+ + N L+ K+SDFG+S + + V +
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
PE + + +SDV+SFG++L E S Y + + + +FV ++
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL------SNQQTREFV------EKG 331
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
R L P P + + L C E RPS + I L+
Sbjct: 332 GR-LPC--PELCPDAV-------FRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 77/341 (22%), Positives = 129/341 (37%), Gaps = 61/341 (17%)
Query: 409 AEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIG 468
E PP+P P + ++ NF + KIG
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYN--TL------------------ANFRIEKKIG 41
Query: 469 SGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN 527
G F VY+A L DG VA+K+ +I + + + I E++ L +L+H N
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMD-------AKARADC-IKEIDLLKQLNHPN 93
Query: 528 LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH 587
+++ + NE ++ E + G L + + + L K + +E++H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 588 EYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG---YMDP 644
++HRDIK +NV + AT K+ D GL S + A VG YM P
Sbjct: 154 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-----FSSKTTAAHSLVGTPYYMSP 205
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD 704
E KSD++S G +L E+ + + G N+ + I + +
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYS-LCKKIEQCDY----- 255
Query: 705 RNVPPPTPFEIEAVAY---VGYLAADCVTLEGRNRPSMTEI 742
PP P + Y + L C+ + RP +T +
Sbjct: 256 ----PPLPSDH----YSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 68/299 (22%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ-----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+GSG+FG VYK + VA+K T + +K+ ++E
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--------ELREATSPKANKE--ILDEAY 69
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
++ + + ++ RLLG C + LI + + G L D++ + + + +
Sbjct: 70 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQ 125
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
A+G+ YL + ++HRD+ + NVL+ K++DFGL+ L+G E+ E H A G
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH----AEG 178
Query: 638 T---VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFV 690
+ +M E + T +SDV+S+GV + E+++ G Y I + +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSIL 232
Query: 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
++ R L + PP ++ Y + C ++ +RP E++ +
Sbjct: 233 ------EKGER-LPQ--PPICTIDV-------YMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 84/304 (27%), Positives = 135/304 (44%), Gaps = 54/304 (17%)
Query: 463 EDHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
D IG G FG VY D +Q A+K S + T+ Q+ + F+ E
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--------SLSRITEMQQVEA--FLREGL 74
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+ L+H N++ L+G + Y+ +G L + +PQ + +K I L
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGL 131
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA 636
ARG+EYL A +HRD+ + N +LD ++T KV+DFGL+ I D E + +
Sbjct: 132 QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHR 186
Query: 637 GT---VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDF 689
V + E + + T KSDV+SFGV+L E+L+ G YR I P ++ F
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI------DPFDLTHF 240
Query: 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ + R L + P P + Y + C + RP+ +V +E+
Sbjct: 241 L------AQGRR-LPQ--PEYCPDSL-------YQVMQQCWEADPAVRPTFRVLVGEVEQ 284
Query: 749 ALAA 752
++A
Sbjct: 285 IVSA 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 38/297 (12%)
Query: 465 HKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++G G+FG+V D G+ VAVK+ + S D+ F E++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-----------DQQRDFQREIQI 77
Query: 520 LSRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L LH +V+ G + L+ EYL +G L D L ++ + +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSS 134
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA 636
+G+EYL +HRD+ + N+L+++ K++DFGL+ L+ + D +
Sbjct: 135 QICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
+ + PE + +SDV+SFGVVL E+ + Y + + ++
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 697 DEIHRVLDRNV----PPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ +L+ PP P E+ + L C ++RPS + + L+
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEV-------HELMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 50/319 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGS------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++G GSFG VY+ +VA+K +++ +E + F+NE
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--------RERIE--FLNEAS 80
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR---- 572
+ + ++VRLLG ++I E + G L +L P ++ P
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
I++A + A G+ YL+ +HRD+ + N ++ +T K+ DFG++ E D
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVD 688
+ V +M PE + T SDV+SFGVVL EI + Y+ + + V+
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLR 251
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
FV E LD+ P P + L C + RPS EI++S++
Sbjct: 252 FV------MEGGL-LDK--PDNCPDMLFE------LMRMCWQYNPKMRPSFLEIISSIKE 296
Query: 749 ALAACLVSPSISRSATSSS 767
+ S S +
Sbjct: 297 EMEPGFREVSFYYSEENKL 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 16/221 (7%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
++ + IG+GS+G K DG + K E+ G+ + +K ++E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWK--ELD------YGSMTEAEKQML-VSEV 56
Query: 518 ESLSRLHHKNLVRLLG-FCEDRNERVLIY-EYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L L H N+VR + N + I EY E G L + ++V
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 576 ALDAARGIEYLHE--YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
++ H +++HRD+K +NV LD K+ DFGL+ I + ++ +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAK 174
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674
GT YM PE EKSD++S G +L E+ +
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 57/247 (23%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
++F E +G G+FG V KA D A+K+ + E+K + ++E
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK------------IRHTEEKLSTILSE 52
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVL----------IY---EYLENGTLHDHLHN-PQS 562
+ L+ L+H+ +VR +R V ++ EY ENGTL+D +H+ +
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 563 SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+ W ++ + Y+H IIHRD+K N+ +D + K+ DFGL+
Sbjct: 113 QQRDEYW----RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 623 GPEDDESHLSLRAA------------GTVGYMDPE------YYRLQQLTEKSDVYSFGVV 664
+ GT Y+ E +Y EK D+YS G++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGII 220
Query: 665 LLEILSG 671
E++
Sbjct: 221 FFEMIYP 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 37/297 (12%)
Query: 465 HKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+G G FG V D G QVAVK + G D E+E
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVK------SLKPESGGNHIAD----LKKEIEI 76
Query: 520 LSRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L L+H+N+V+ G C + LI E+L +G+L ++L ++ L ++K A+
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAV 133
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA 636
+G++YL +HRD+ + NVL+++ K+ DFGL+ I + + +
Sbjct: 134 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
V + PE + SDV+SFGV L E+L+ Y + ++ +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 697 DEIHRVLDRN----VPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ L PP P E+ Y L C + NR S ++ E
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEV-------YQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-37
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G FG V G++VAVK + + AF+ E +++L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVK-------------CIKNDATAQAFLAEASVMTQLR 244
Query: 525 HKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H NLV+LLG + + ++ EY+ G+L D+L + S +K +LD +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAM 302
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYL + +HRD+ + NVL+ AKVSDFGL+ + S V +
Sbjct: 303 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTA 354
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
PE R ++ + KSDV+SFG++L EI S Y I ++VV V ++
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV------EKG 402
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
++ +D P P + Y + +C L+ RP+ ++ LE
Sbjct: 403 YK-MDA--PDGCPPAV-------YDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 76/290 (26%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
HK+G G +G VY+ S VAVK + + E+ F+ E + +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEE----FLKEAAVMKEI 273
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H NLV+LLG C +I E++ G L D+L S + +A + +
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSAM 331
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYL + + IHR++ + N L+ KV+DFGLS + D A + +
Sbjct: 332 EYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 387
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
PE + + KSDV++FGV+L EI + Y I V + + ++
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELL------EKD 435
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+R ++R P P ++ Y L C +RPS EI + E
Sbjct: 436 YR-MER--PEGCPEKV-------YELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 37/234 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+F +G G FG V++A D A+KR I +E + E+
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR----------IRLPNRELAREKVMREV 54
Query: 518 ESLSRLHHKNLVRLLGFCEDRNE---------RVLIY---EYLENGTLHDHLHNPQSSSP 565
++L++L H +VR ++N +V +Y + L D ++ + +
Sbjct: 55 KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIE 113
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIG 623
+ + + L A +E+LH ++HRD+K SN+ KV DFGL +
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 624 PEDDESHLSLRAA--------GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
E++++ L+ A GT YM PE + K D++S G++L E+L
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 87/314 (27%), Positives = 131/314 (41%), Gaps = 67/314 (21%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ---VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
IG G+FG V KA + A+KR + ++ + +D F ELE L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRD--FAGELEVL 79
Query: 521 SRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR----- 572
+L HH N++ LLG CE R L EY +G L D L + P +
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 573 -----IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ A D ARG++YL + IHRD+ + N+L+ + AK++DFGLS +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQE 193
Query: 628 ESHLSLRAAGTVGYMDPE--YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP-- 683
V +M E Y + T SDV+S+GV+L EI+ + GTP
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV--------SLGGTPYC 243
Query: 684 ----RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPS 738
+ + + + +R L++ P E+ Y L C + RPS
Sbjct: 244 GMTCAELYEKL------PQGYR-LEK--PLNCDDEV-------YDLMRQCWREKPYERPS 287
Query: 739 MTEIVNSLERALAA 752
+I+ SL R L
Sbjct: 288 FAQILVSLNRMLEE 301
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 71/297 (23%), Positives = 112/297 (37%), Gaps = 48/297 (16%)
Query: 464 DHKIGSGSFGAVYKATLDDGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
K+G GSFG V + D S VAVK Q + + FI E+ +
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--------CLKPDVLSQPEAMDDFIREVNA 74
Query: 520 LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ L H+NL+RL G + ++ E G+L D L Q L + A+
Sbjct: 75 MHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQ 129
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
A G+ YL IHRD+ + N+LL K+ DFGL + DD +
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPY 693
+ PE + + + SD + FGV L E+ + + + ++ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKE 240
Query: 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERA 749
R L R P P +I Y + C + +RP+ + + L A
Sbjct: 241 GER------LPR--PEDCPQDI-------YNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+IGSG FG V+ + +VA+K + S +ED FI E E + +L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--------EED----FIEEAEVMMKLS 61
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H LV+L G C ++ L+ E++E+G L D+L + + + LD G+
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMA 118
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT---VGY 641
YL E +IHRD+ + N L+ KVSDFG++ +D + + GT V +
Sbjct: 119 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKW 171
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
PE + + + KSDV+SFGV++ E+ S G N VV+ +
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI------STGF 222
Query: 701 RVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERALAACL 754
R L + P + Y + C +RP+ + ++ L + L
Sbjct: 223 R-LYK--PRLASTHV-------YQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 72/301 (23%), Positives = 118/301 (39%), Gaps = 47/301 (15%)
Query: 465 HKIGSGSFGAVYKATLDD-----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+G G FG V D G VAVK G + + + E++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------ALKADAGPQHRSG----WKQEIDI 86
Query: 520 LSRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSP-LKSWPARIKVA 576
L L+H+++++ G CED L+ EY+ G+L D+L L + A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------A 140
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRA 635
G+ YLH IHRD+ + NVLLD K+ DFGL+ + + +
Sbjct: 141 QQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY- 693
V + PE + + SDV+SFGV L E+L+ + + + + +
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELIGIAQG 253
Query: 694 -IVRDEIHRVLDRN----VPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLE 747
+ + +L+R P P E+ Y L +C E RP+ ++ L+
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEV-------YHLMKNCWETEASFRPTFENLIPILK 306
Query: 748 R 748
Sbjct: 307 T 307
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 49/304 (16%)
Query: 465 HKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
+G G FG+V +A L VAVK + + F+ E +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA---------SSDIEEFLREAACM 79
Query: 521 SRLHHKNLVRLLGFCEDRNERV------LIYEYLENGTLHDHL--HNPQSSSPLKSWPAR 572
H ++ +L+G + +I ++++G LH L +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
++ +D A G+EYL + + IHRD+ + N +L T V+DFGLS D
Sbjct: 140 VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVD 688
+ V ++ E T SDV++FGV + EI++ G Y I + +
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI------ENAEIYN 250
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
++ +R L + PP E+ L C + + + RPS T + LE
Sbjct: 251 YL------IGGNR-LKQ--PPECMEEVYD------LMYQCWSADPKQRPSFTCLRMELEN 295
Query: 749 ALAA 752
L
Sbjct: 296 ILGH 299
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ KIG GSFG +DG Q +K EI+ I ++++ + E+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK--EIN------ISRMSSKEREES-RREV 74
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI-KVA 576
L+ + H N+V+ E+ ++ +Y E G L + N Q + +I
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQ--EDQILDWF 131
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ ++++H+ I+HRDIKS N+ L T ++ DFG++ + E +
Sbjct: 132 VQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--I 186
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA 674
GT Y+ PE + KSD+++ G VL E+ + A
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG FG V VAVK + S S +++ F E +++ +L
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--------EDE----FFQEAQTMMKLS 61
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H LV+ G C ++ EY+ NG L ++L +S +++ D G+
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT---VGY 641
+L + IHRD+ + N L+D KVSDFG++ +D + GT V +
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKW 171
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
PE + + + KSDV++FG+++ E+ S G N VV V + H
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKV------SQGH 222
Query: 701 RVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLE 747
R L R P I Y + C RP+ ++++S+E
Sbjct: 223 R-LYR--PHLASDTI-------YQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 78/305 (25%), Positives = 124/305 (40%), Gaps = 58/305 (19%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ IG G FG VY TL D AVK S T E F+ E
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--------SLNRITDIGEVSQ--FLTEGII 79
Query: 520 LSRLHHKNLVRLLGFCEDRNERVL-IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ H N++ LLG C L + Y+++G L + + N + +K I L
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQ 136
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A+G++YL +HRD+ + N +LD +T KV+DFGL+ D
Sbjct: 137 VAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEYYSVHNK 189
Query: 639 VG------YMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVD 688
G +M E + Q+ T KSDV+SFGV+L E+++ G Y + ++
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITV 243
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLE 747
++ + R L + P P + Y + C + RPS +E+V+ +
Sbjct: 244 YL------LQGRR-LLQ--PEYCPDPL-------YEVMLKCWHPKAEMRPSFSELVSRIS 287
Query: 748 RALAA 752
+
Sbjct: 288 AIFST 292
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 41/299 (13%)
Query: 465 HKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++G G+FG+V D G VAVK+ + S+ E+ F E+E
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----------EEHLRDFEREIEI 64
Query: 520 LSRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L L H N+V+ G C R LI EYL G+L D+L + ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTS 121
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAA 636
+G+EYL IHRD+ + N+L++ K+ DFGL+ ++ + + +
Sbjct: 122 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--I 694
+ + PE + + SDV+SFGVVL E+ + R + + +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQM 236
Query: 695 VRDEIHRVLDRNV----PPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ + +L N P P EI Y + +C RPS ++ +++
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPDEI-------YMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 79/317 (24%), Positives = 122/317 (38%), Gaps = 63/317 (19%)
Query: 464 DHKIGSGSFGAVYKATL--------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+G G+FG V A + VAVK + +T ++ D ++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--------KDLSD--LVS 89
Query: 516 ELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR 572
E+E + + HKN++ LLG C +I EY G L ++L P
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 573 ----------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+ ARG+EYL A IHRD+ + NVL+ K++DFGL+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
D + V +M PE + T +SDV+SFGV++ EI T G+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--------TLGGS 258
Query: 683 P------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736
P + + E HR +D+ P E+ + DC R
Sbjct: 259 PYPGIPVEELFKLL------KEGHR-MDK--PANCTNELYM------MMRDCWHAVPSQR 303
Query: 737 PSMTEIVNSLERALAAC 753
P+ ++V L+R L
Sbjct: 304 PTFKQLVEDLDRILTLT 320
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 41/302 (13%)
Query: 466 KIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
++G G+FG+V D G VAVK+ + S+ E+ F E+E L
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----------EEHLRDFEREIEIL 96
Query: 521 SRLHHKNLVRLLGFCEDRNERV--LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L H N+V+ G C R LI EYL G+L D+L + ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQ 153
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
+G+EYL IHRD+ + N+L++ K+ DFGL+ ++ + + +
Sbjct: 154 ICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY--IV 695
+ + PE + + SDV+SFGVVL E+ + R + + ++
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMI 268
Query: 696 RDEIHRVLDRNV----PPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERAL 750
+ +L N P P EI Y + +C RPS ++ +++
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEI-------YMIMTECWNNNVNQRPSFRDLALRVDQIR 321
Query: 751 AA 752
Sbjct: 322 DQ 323
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 74/306 (24%), Positives = 128/306 (41%), Gaps = 54/306 (17%)
Query: 465 HKIGSGSFGAVYKATLDDGS----QVAVK--RAEISSTSSYAIGTKRQEDKDNAFINELE 518
+G G FG+V + L +VAVK + + SS + + F++E
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-----------QREIEEFLSEAA 88
Query: 519 SLSRLHHKNLVRLLGFCEDRNERV-----LIYEYLENGTLHDHL--HNPQSSSPLKSWPA 571
+ H N++RLLG C + + + +I +++ G LH +L ++
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+K +D A G+EYL + + +HRD+ + N +L T V+DFGLS D
Sbjct: 149 LLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVV 687
A V ++ E + T KSDV++FGV + EI + G Y + +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV------QNHEMY 259
Query: 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSL 746
D++ HR L + P E+ Y + C + +RP+ + + L
Sbjct: 260 DYL------LHGHR-LKQ--PEDCLDEL-------YEIMYSCWRTDPLDRPTFSVLRLQL 303
Query: 747 ERALAA 752
E+ L +
Sbjct: 304 EKLLES 309
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 82/320 (25%), Positives = 129/320 (40%), Gaps = 70/320 (21%)
Query: 464 DHKIGSGSFGAVYKATLDDG------SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+G G FG V KAT + VAVK + +++ S E +D ++E
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--------ELRD--LLSEF 77
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR--- 572
L +++H ++++L G C +LI EY + G+L L L S +R
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 573 ---------------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
I A ++G++YL A ++HRD+ + N+L+ K+SDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
GLS E+D + V +M E T +SDV+SFGV+L EI+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV-------- 246
Query: 678 THNGTP------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVT 730
T G P + + + HR ++R P E+ Y L C
Sbjct: 247 TLGGNPYPGIPPERLFNLL------KTGHR-MER--PDNCSEEM-------YRLMLQCWK 290
Query: 731 LEGRNRPSMTEIVNSLERAL 750
E RP +I LE+ +
Sbjct: 291 QEPDKRPVFADISKDLEKMM 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 79/316 (25%), Positives = 121/316 (38%), Gaps = 63/316 (19%)
Query: 464 DHKIGSGSFGAVYKATL--------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+G G FG V A + VAVK + +T ++ D ++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--------KDLSD--LVS 135
Query: 516 ELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR 572
E+E + + HKN++ LLG C +I EY G L ++L P
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 573 ----------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+ ARG+EYL A IHRD+ + NVL+ K++DFGL+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
D + V +M PE + T +SDV+SFGV++ EI T G+
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--------TLGGS 304
Query: 683 P------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR 736
P + + E HR +D+ P E+ + DC R
Sbjct: 305 PYPGIPVEELFKLL------KEGHR-MDK--PANCTNELYM------MMRDCWHAVPSQR 349
Query: 737 PSMTEIVNSLERALAA 752
P+ ++V L+R L
Sbjct: 350 PTFKQLVEDLDRILTL 365
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 76/290 (26%), Positives = 119/290 (41%), Gaps = 46/290 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGSQ-VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
HK+G G +G VY+ S VAVK + + F+ E + +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------------EEFLKEAAVMKEI 66
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H NLV+LLG C +I E++ G L D+L S + +A + +
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSAM 124
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYL + + IHRD+ + N L+ KV+DFGLS + D A + +
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 180
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
PE + + KSDV++FGV+L EI + Y I V + + ++
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELL------EKD 228
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+R ++R P P ++ Y L C +RPS EI + E
Sbjct: 229 YR-MER--PEGCPEKV-------YELMRACWQWNPSDRPSFAEIHQAFET 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 82/293 (27%), Positives = 128/293 (43%), Gaps = 58/293 (19%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G FG V G++VAVK + + AF+ E +++L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVK-------------CIKNDATAQAFLAEASVMTQLR 72
Query: 525 HKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H NLV+LLG + + I EY+ G+L D+L + S +K +LD +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAM 130
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT---VG 640
EYL + +HRD+ + NVL+ AKVSDFGL+ ++ S V
Sbjct: 131 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASS----TQDTGKLPVK 179
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHNGTPRNVVDFVVPYIVR 696
+ PE R ++ + KSDV+SFG++L EI S Y I ++VV V
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV------ 227
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
++ ++ +D P P + Y + +C L+ RPS ++ LE
Sbjct: 228 EKGYK-MDA--PDGCPPAV-------YEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G+G FG V VA+K + S S +++ FI E + + L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--------EDE----FIEEAKVMMNLS 77
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H+ LV+L G C + +I EY+ NG L ++L + +++ D +E
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAME 134
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT---VGY 641
YL +HRD+ + N L++ KVSDFGLS +D+ + + G+ V +
Sbjct: 135 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRW 187
Query: 642 MDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
PE + + KSD+++FGV++ EI S G R N + + +
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHI------AQGL 238
Query: 701 RVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
R L R P ++ Y + C + RP+ +++++
Sbjct: 239 R-LYR--PHLASEKV-------YTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ IG G FG VY TL D AVK S T E F+ E
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--------SLNRITDIGEVSQ--FLTEGII 143
Query: 520 LSRLHHKNLVRLLGFCEDRNERVL-IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ H N++ LLG C L + Y+++G L + + N + +K I L
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQ 200
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
A+G+++L +HRD+ + N +LD +T KV+DFGL+ + D E G
Sbjct: 201 VAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTG 255
Query: 638 T---VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFV 690
V +M E + Q+ T KSDV+SFGV+L E+++ G Y + ++ ++
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYL 309
Query: 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERA 749
+ R L + P P + Y + C + RPS +E+V+ +
Sbjct: 310 ------LQGRR-LLQ--PEYCPDPL-------YEVMLKCWHPKAEMRPSFSELVSRISAI 353
Query: 750 LAA 752
+
Sbjct: 354 FST 356
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 68/299 (22%), Positives = 130/299 (43%), Gaps = 57/299 (19%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ-----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+GSG+FG VYK + VA+K T + +K+ ++E
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--------ELREATSPKANKE--ILDEAY 69
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
++ + + ++ RLLG C + LI + + G L D++ + + + + +
Sbjct: 70 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQ 125
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
A+G+ YL + ++HRD+ + NVL+ K++DFGL+ L+G E+ E H A G
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH----AEG 178
Query: 638 T---VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFV 690
+ +M E + T +SDV+S+GV + E+++ G Y I + +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASEISSIL 232
Query: 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
++ R L + PP ++ Y + C ++ +RP E++ +
Sbjct: 233 ------EKGER-LPQ--PPICTIDV-------YMIMVKCWMIDADSRPKFRELIIEFSK 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 42/287 (14%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G G FG V+ T + ++VA+K + + S E F+ E + + +L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--------PEA----FLQEAQVMKKLR 237
Query: 525 HKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H+ LV+L + E + I EY+ G+L D L P + +A A G+
Sbjct: 238 HEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGM 293
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
Y+ + +HRD++++N+L+ KV+DFGL+ + ED+E A + +
Sbjct: 294 AYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 349
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
PE + T KSDV+SFG++L E+ + G N R V+D V + +R
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV------ERGYR- 399
Query: 703 LDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ PP P + + L C E RP+ + LE
Sbjct: 400 MPC--PPECPESL-------HDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 65/318 (20%)
Query: 464 DHKIGSGSFGAVYKATL--------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+G G+FG V A + ++VAVK + +T ++ D I+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--------KDLSD--LIS 123
Query: 516 ELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR 572
E+E + + HKN++ LLG C +I EY G L ++L P +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 573 ----------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+ A ARG+EYL A IHRD+ + NVL+ K++DFGL+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
D + V +M PE + T +SDV+SFGV+L EI T G+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF--------TLGGS 292
Query: 683 P------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRN 735
P + + E HR +D+ P E+ Y + DC
Sbjct: 293 PYPGVPVEELFKLL------KEGHR-MDK--PSNCTNEL-------YMMMRDCWHAVPSQ 336
Query: 736 RPSMTEIVNSLERALAAC 753
RP+ ++V L+R +A
Sbjct: 337 RPTFKQLVEDLDRIVALT 354
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ-----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+GSG FG V+K + V +K G + + + +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIK------VIEDKSGRQSFQA----VTDHML 67
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
++ L H ++VRLLG C + L+ +YL G+L DH+ + + + +
Sbjct: 68 AIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP---QLLLNWGVQ 123
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A+G+ YL E+ ++HR++ + NVLL + +V+DFG++ + P DD+ L A
Sbjct: 124 IAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFVVPYI 694
+ +M E + T +SDV+S+GV + E+++ G Y + V D +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------RLAEVPDLL---- 230
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERAL 750
++ R L + P ++ Y + C ++ RP+ E+ N R
Sbjct: 231 --EKGER-LAQ--PQICTIDV-------YMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 56/311 (18%)
Query: 464 DHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+G+G+FG V +AT D +VAVK + ++ + E + ++EL
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--------DEKEA--LMSEL 100
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--------HNPQSSSPLKS 568
+ +S L H+N+V LLG C ++I EY G L + L +P + +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 569 WPAR--IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
R + + A+G+ +L A + IHRD+ + NVLL AK+ DFGL+ D
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGT 682
+ A V +M PE T +SDV+S+G++L EI S G Y I
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-----V 272
Query: 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTE 741
V + ++ + + P P I Y + C LE +RP+ +
Sbjct: 273 NSKFYKLV------KDGYQ-MAQ--PAFAPKNI-------YSIMQACWALEPTHRPTFQQ 316
Query: 742 IVNSLERALAA 752
I + L+
Sbjct: 317 ICSFLQEQAQE 327
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 79/317 (24%), Positives = 122/317 (38%), Gaps = 65/317 (20%)
Query: 464 DHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+G G+FG V +A VAVK + +T E + ++EL
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRA--LMSEL 81
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHL--HNPQSSSPLKSWPAR- 572
+ L + HH N+V LLG C + +I E+ + G L +L + +
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 573 ---------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623
I + A+G+E+L A IHRD+ + N+LL K+ DFGL+
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683
+D + A + +M PE + T +SDV+SFGV+L EI + +P
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF--------SLGASP 250
Query: 684 -------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRN 735
+ E R + P T E+ Y DC E
Sbjct: 251 YPGVKIDEEFCRRL------KEGTR-MRA--PDYTTPEM-------YQTMLDCWHGEPSQ 294
Query: 736 RPSMTEIVNSLERALAA 752
RP+ +E+V L L A
Sbjct: 295 RPTFSELVEHLGNLLQA 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 40/239 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+F E IGSG FG V+KA DG +KR + ++ + E+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----------VKYNNEKAE-----REV 55
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERV----------------LIYEYLENGTLHDHLHNPQ 561
++L++L H N+V G + + + E+ + GTL + +
Sbjct: 56 KALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-R 114
Query: 562 SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621
L A ++ +G++Y+H +I+RD+K SN+ L T K+ DFGL
Sbjct: 115 RGEKLDKVLAL-ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN 680
D + R+ GT+ YM PE Q ++ D+Y+ G++L E+L T
Sbjct: 171 SLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G+G FG V+ + ++VAVK + S S +AF+ E + +L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------------DAFLAEANLMKQLQ 66
Query: 525 HKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H+ LVRL E + I EY+ENG+L D L P + + +A A G+
Sbjct: 67 HQRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAEGM 122
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT---VG 640
++ E + IHRD++++N+L+ T + K++DFGL+ + +++ + G +
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----AREGAKFPIK 175
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
+ PE T KSDV+SFG++L EI++ G N V+ + +
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNL------ERG 226
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+R + R P P E+ Y L C +RP+ + + LE
Sbjct: 227 YR-MVR--PDNCPEEL-------YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 32/229 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + +G G+ V++ G A+K + + E
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK----------VFNNISFLRPVDVQMREF 58
Query: 518 ESLSRLHHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
E L +L+HKN+V+L E+ R VLI E+ G+L+ L P ++ L V
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IV 117
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSLIGPEDDESHL 631
D G+ +L E I+HR+IK N++ D K++DFG + +D+
Sbjct: 118 LRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF 172
Query: 632 SLRAAGTVGYMDPEYYRLQQL--------TEKSDVYSFGVVLLEILSGY 672
GT Y+ P+ Y L D++S GV +G
Sbjct: 173 V-SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 463 EDHKIGSGSFGAVYKATLDDGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
D ++G G+FG+V + VA+K GT++ + ++ + E +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK--------VLKQGTEKADTEE--MMREAQI 63
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ +L + +VRL+G C+ +L+ E G LH L + P+ ++
Sbjct: 64 MHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPV---SNVAELLHQV 119
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
+ G++YL E + +HRD+ + NVLL AK+SDFGLS +G +D
Sbjct: 120 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697
+ + PE ++ + +SDV+S+GV + E LS G + + V+ F+ +
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI------E 227
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ R ++ PP P E+ Y L +DC + +RP + +
Sbjct: 228 QGKR-MEC--PPECPPEL-------YALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 85/319 (26%), Positives = 128/319 (40%), Gaps = 65/319 (20%)
Query: 464 DHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+GSG+FG V AT QVAVK + + SS E + ++EL
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--------EREA--LMSEL 99
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR-- 572
+ +++L H+N+V LLG C LI+EY G L ++L + S + +
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 573 ---------------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
+ A A+G+E+L S +HRD+ + NVL+ K+ DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YR 673
GL+ D + A V +M PE T KSDV+S+G++L EI S G Y
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 674 AIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLE 732
I N + + +D+ P EI Y + C +
Sbjct: 277 GIP-----VDANFYKLI------QNGFK-MDQ--PFYATEEI-------YIIMQSCWAFD 315
Query: 733 GRNRPSMTEIVNSLERALA 751
R RPS + + L LA
Sbjct: 316 SRKRPSFPNLTSFLGCQLA 334
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 75/259 (28%), Positives = 110/259 (42%), Gaps = 33/259 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFI 514
+F +G G FG VY A +A+K +A++ E +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--------GVEHQ---LR 57
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E+E S L H N++RL G+ D LI EY GT++ L Q S
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATY 114
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
+ A + Y H +IHRDIK N+LL + K++DFG S+ P L
Sbjct: 115 ITE-LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL- 167
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH-RTHNGTPRNV--VDFVV 691
GT+ Y+ PE + EK D++S GV+ E L G T+ T + + V+F
Sbjct: 168 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 226
Query: 692 P-YI---VRDEIHRVLDRN 706
P ++ RD I R+L N
Sbjct: 227 PDFVTEGARDLISRLLKHN 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 63/318 (19%), Positives = 112/318 (35%), Gaps = 53/318 (16%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++ K+G G F V L DG A+KR Q+D++ A E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----------QQDREEA-QREAD 78
Query: 519 SLSRLHHKNLVRLLGFCEDR----NERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARI 573
+H N++RL+ +C +E L+ + + GTL + + + L +I
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT--EDQI 136
Query: 574 -KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
+ L RG+E +H HRD+K +N+LL + D G E
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 633 LRAA-------GTVGYMDPE---YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
T+ Y PE + E++DV+S G VL ++ G
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE---------G 244
Query: 683 PRNVVDFVVPYIVRDEIHRVLDRNV--PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740
P + + + D + + + P L +T++ RP +
Sbjct: 245 P-----YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIP 295
Query: 741 EIVNSLERALAACLVSPS 758
+++ LE +
Sbjct: 296 LLLSQLEALQPPAPGQHT 313
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 74/309 (23%), Positives = 125/309 (40%), Gaps = 56/309 (18%)
Query: 465 HKIGSGSFGAVYKATLDDGS------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++G G+FG V+ A + VAVK + ++ F E E
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVK--------ALKEASESARQD---FQREAE 95
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR---- 572
L+ L H+++VR G C + ++++EY+ +G L+ L H P +
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 573 -----IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ VA A G+ YL +HRD+ + N L+ K+ DFG+S D
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTP 683
+ R + +M PE ++ T +SDV+SFGVVL EI + G + + +
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SN 266
Query: 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743
+D + + L+R P P E+ A + C E + R S+ ++
Sbjct: 267 TEAIDCI------TQGRE-LER--PRACPPEVYA------IMRGCWQREPQQRHSIKDVH 311
Query: 744 NSLERALAA 752
L+ A
Sbjct: 312 ARLQALAQA 320
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 61/308 (19%)
Query: 465 HKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++G G+FG V+ A D VAVK R++ F E E
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVK------ALKDPTLAARKD-----FQREAE 69
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR---- 572
L+ L H+++V+ G C D + ++++EY+++G L+ L H P + + P +
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 573 ------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
+ +A A G+ YL +HRD+ + N L+ A K+ DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP--- 683
D + + +M PE ++ T +SDV+SFGV+L EI T+ P
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF--------TYGKQPWFQ 238
Query: 684 ---RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740
V++ + RVL+R P P E+ + C E + R ++
Sbjct: 239 LSNTEVIECI-------TQGRVLER--PRVCPKEVYD------VMLGCWQREPQQRLNIK 283
Query: 741 EIVNSLER 748
EI L
Sbjct: 284 EIYKILHA 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 77/323 (23%), Positives = 123/323 (38%), Gaps = 66/323 (20%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
N S +G+G+FG V +AT D VAVK + S+ E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--------TEREA-- 72
Query: 513 FINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSW 569
++EL+ LS L +H N+V LLG C ++I EY G L + L S
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 570 PAR------------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
+ + A+G+ +L + IHRD+ + N+LL K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDF 189
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
GL+ D + A V +M PE T +SDV+S+G+ L E+
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF-------- 241
Query: 678 THNGTP-------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCV 729
+ +P + E R + P P E+ Y + C
Sbjct: 242 SLGSSPYPGMPVDSKFYKMI------KEGFR-MLS--PEHAPAEM-------YDIMKTCW 285
Query: 730 TLEGRNRPSMTEIVNSLERALAA 752
+ RP+ +IV +E+ ++
Sbjct: 286 DADPLKRPTFKQIVQLIEKQISE 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G+G FG V+ AT + ++VAVK + S S AF+ E + L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------------EAFLAEANVMKTLQ 241
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H LV+L + +I E++ G+L D L + + S P I + A G+
Sbjct: 242 HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ--PLPKLIDFSAQIAEGMA 298
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGTVGYMD 643
++ + + IHRD++++N+L+ A+ K++DFGL+ +I ED+E A + +
Sbjct: 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTA 353
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILS----GYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
PE T KSDV+SFG++L+EI++ Y + + V+ + +
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRAL------ERG 401
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+R + R P P E+ Y + C RP+ I + L+
Sbjct: 402 YR-MPR--PENCPEEL-------YNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVK---------RAEISSTSSYAIGTKRQEDKDNAFINE 516
+ G F + D A+K + + + +++ I K + D F NE
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD---FKNE 93
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
L+ ++ + ++ + G + +E +IYEY+EN ++ + I+V
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 577 LDAAR----GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
+ Y+H +I HRD+K SN+L+D K+SDFG S +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----- 206
Query: 633 LR-AAGTVGYMDPE-------YYRLQQLTEKSDVYSFGVVLLEILSGY 672
++ + GT +M PE Y K D++S G+ L +
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNV 249
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 32/229 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + +G G+ V++ G A+K + + E
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK----------VFNNISFLRPVDVQMREF 58
Query: 518 ESLSRLHHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
E L +L+HKN+V+L E+ R VLI E+ G+L+ L P ++ L V
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IV 117
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSLIGPEDDESHL 631
D G+ +L E I+HR+IK N++ D K++DFG + +D+
Sbjct: 118 LRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF 172
Query: 632 SLRAAGTVGYMDPEYYRLQQL--------TEKSDVYSFGVVLLEILSGY 672
GT Y+ P+ Y L D++S GV +G
Sbjct: 173 V-SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 42/292 (14%)
Query: 463 EDHKIGSGSFGAVYKATLDDGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
ED ++GSG+FG V K VAVK + + + + E
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---------PALKDELLAEANV 71
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ +L + +VR++G CE +L+ E E G L+ +L + I++
Sbjct: 72 MQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD----KNIIELVHQV 126
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
+ G++YL E + +HRD+ + NVLL AK+SDFGLS + +++
Sbjct: 127 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697
V + PE + + KSDV+SFGV++ E S G + V + +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAML------E 234
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ R + P P E+ Y L C T + NRP + L
Sbjct: 235 KGER-MGC--PAGCPREM-------YDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 77/318 (24%), Positives = 121/318 (38%), Gaps = 64/318 (20%)
Query: 465 HKIGSGSFGAVYKATLDDG------SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
IG G+FG V++A + VAVK + +++ D F E
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--------DMQAD--FQREAA 102
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLKSWPAR---- 572
++ + N+V+LLG C L++EY+ G L++ L +P + L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 573 --------------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618
+ +A A G+ YL E +HRD+ + N L+ K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRA 674
LS D A + +M PE + T +SDV+++GVVL EI S G Y
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 675 IHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGR 734
+ V+ +V +L P P E+ L C +
Sbjct: 280 M------AHEEVIYYV-------RDGNILAC--PENCPLELYN------LMRLCWSKLPA 318
Query: 735 NRPSMTEIVNSLERALAA 752
+RPS I L+R
Sbjct: 319 DRPSFCSIHRILQRMCER 336
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-34
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 42/287 (14%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G G FG V+ T + ++VA+K + + S AF+ E + + +L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------------EAFLQEAQVMKKLR 320
Query: 525 HKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H+ LV+L + E + I EY+ G+L D L P + +A A G+
Sbjct: 321 HEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGM 376
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
Y+ + +HRD++++N+L+ KV+DFGL+ + ED+E A + +
Sbjct: 377 AYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 432
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
PE + T KSDV+SFG++L E+ + G N R V+D V + +R
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV------ERGYR- 482
Query: 703 LDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ PP P + + L C E RP+ + LE
Sbjct: 483 MPC--PPECPESL-------HDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G++G VY L + ++A+K EI +R E+ L H
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK--EIP---------ERDSRYSQPLHEEIALHKHLKH 78
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV-ALDAARGIE 584
KN+V+ LG + + E + G+L L + PLK I G++
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLK 136
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
YLH+ I+HRDIK NVL++ + K+SDFG S + + GT+ YM
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMA 191
Query: 644 PEYYRLQQL--TEKSDVYSFGVVLLEILSGYR 673
PE + +D++S G ++E+ +G
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 76/328 (23%), Positives = 124/328 (37%), Gaps = 67/328 (20%)
Query: 444 GRLEEFSLE-ILLEATNNFSEDHKIGSGSFGAVYKATLDDGS------QVAVKRAEISST 496
G+L+E SL + ++G FG VYK L + VA+K + +
Sbjct: 1 GKLKEISLSAVRFM--------EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 52
Query: 497 SSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDH 556
++ F +E +RL H N+V LLG +I+ Y +G LH+
Sbjct: 53 G--------PLREE--FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
Query: 557 L--HNPQSSSPLKSWPAR----------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNV 604
L +P S + + A G+EYL + ++H+D+ + NV
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNV 159
Query: 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664
L+ K+SD GL D L + + +M PE + + SD++S+GVV
Sbjct: 160 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
Query: 665 LLEILS-G---YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAY 720
L E+ S G Y + ++VV+ + L P P +
Sbjct: 220 LWEVFSYGLQPYCGY------SNQDVVEMI------RNRQV-LPC--PDDCPAWV----- 259
Query: 721 VGY-LAADCVTLEGRNRPSMTEIVNSLE 747
Y L +C RP +I + L
Sbjct: 260 --YALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 83/308 (26%), Positives = 125/308 (40%), Gaps = 48/308 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGS------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+G G+FG VY+ + QVAVK + Q++ D F+ E
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--------QDELD--FLMEAL 85
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLK-SWPARIKV 575
+S+ +H+N+VR +G R ++ E + G L L P+ S P + + V
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFGLSLIGPEDDESHLS 632
A D A G +YL E IHRDI + N LL AK+ DFG++
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691
A V +M PE + T K+D +SFGV+L EI S GY N + V++FV
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV- 258
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751
R +D P P + + C + +RP+ I+ +E
Sbjct: 259 -----TSGGR-MDP--PKNCPGPVYR------IMTQCWQHQPEDRPNFAIILERIEY--- 301
Query: 752 ACLVSPSI 759
C P +
Sbjct: 302 -CTQDPDV 308
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 28/223 (12%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
E + + ++G GSFG V++ G Q AVK+ +
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV---------------- 98
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
EL + + L +V L G + + E LE G+L + + L A
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALY- 154
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKVSDFGLSLIGPEDDESHLSL 633
A G+EYLH I+H D+K+ NVLL + A + DFG +L D L
Sbjct: 155 YLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 634 RAA---GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
GT +M PE + K D++S ++L +L+G
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 46/311 (14%)
Query: 464 DHKIGSGSFGAVYKATLDDGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ IGSG G V L VA+K + G ++ +D F++E
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--------ALKAGYTERQRRD--FLSEASI 103
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + H N++RL G +++ EY+ENG+L L ++ + + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGV 160
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
G+ YL + +HRD+ + NVL+D+ KVSDFGLS ++ + D ++ +
Sbjct: 161 GAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697
+ + PE + + SDV+SFGVV+ E+L+ G R N R+V+ V +
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSV------E 268
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERALAACLVS 756
E +R L P P + + L DC + RP ++IV+ L+ + S
Sbjct: 269 EGYR-LPA--PMGCPHAL-------HQLMLDCWHKDRAQRPRFSQIVSVLDA----LIRS 314
Query: 757 PSISRSATSSS 767
P R+ + S
Sbjct: 315 PESLRATATVS 325
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 31/222 (13%)
Query: 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+F +G G+ G + + D VAVKR I + D E++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR----------ILPECFSFAD----REVQL 70
Query: 520 LSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L H N++R +DR + + E TL +++ + I +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQ 126
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLL-----DATWTAKVSDFGLSLIGPEDDESHLSL 633
G+ +LH +I+HRD+K N+L+ A +SDFGL S
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 634 R-AAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSG 671
GT G++ PE + T D++S G V ++S
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 63/327 (19%), Positives = 119/327 (36%), Gaps = 75/327 (22%)
Query: 464 DHKIGSGSFGAVYKATLDDGS--------QVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+ +G G+F ++K + +V +K + + + +F
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-----------NYSESFFE 61
Query: 516 ELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
+S+L HK+LV G C +E +L+ E+++ G+L +L ++ + +++V
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI---LWKLEV 118
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT--------AKVSDFGLSLIGPEDD 627
A A + +L E ++IH ++ + N+LL K+SD G+S+ D
Sbjct: 119 AKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 628 ESHLSLRAAGTVGYMDPE---YYRLQQLTEKSDVYSFGVVLLEILSG----YRAIHRTHN 680
+ ++ PE + L +D +SFG L EI SG A+
Sbjct: 176 ILQERIP------WVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLSAL----- 222
Query: 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740
+ + F E L P + L +C+ E +RPS
Sbjct: 223 -DSQRKLQFY-------EDRHQLPA--PKAAE--------LANLINNCMDYEPDHRPSFR 264
Query: 741 EIVNSLERALAACLVSPSISRSATSSS 767
I+ L + R +
Sbjct: 265 AIIRDLNS----LFTPDLVPRGSHHHH 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 83/308 (26%), Positives = 125/308 (40%), Gaps = 48/308 (15%)
Query: 465 HKIGSGSFGAVYKATLDDGS------QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+G G+FG VY+ + QVAVK + Q++ D F+ E
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--------QDELD--FLMEAL 126
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL--HNPQSSSPLK-SWPARIKV 575
+S+ +H+N+VR +G R ++ E + G L L P+ S P + + V
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFGLSLIGPEDDESHLS 632
A D A G +YL E IHRDI + N LL AK+ DFG++
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691
A V +M PE + T K+D +SFGV+L EI S GY N + V++FV
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV- 299
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751
R +D P P + + C + +RP+ I+ +E
Sbjct: 300 -----TSGGR-MDP--PKNCPGPVYR------IMTQCWQHQPEDRPNFAIILERIEY--- 342
Query: 752 ACLVSPSI 759
C P +
Sbjct: 343 -CTQDPDV 349
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 48/227 (21%), Positives = 91/227 (40%), Gaps = 31/227 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+S +IGSG V++ + A+K + + + +++ NE+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---------DSYRNEIA 78
Query: 519 SLSRLHHKNL--VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
L++L + +RL + ++ E N L+ L +S + W +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERK-SYW 133
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ + +H++ I+H D+K +N L+ K+ DFG++ D S +
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 637 GTVGYMDPE-----------YYRLQQLTEKSDVYSFGVVLLEILSGY 672
GTV YM PE +++ KSDV+S G +L + G
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 55/296 (18%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+IGSG V++ + A+K + + + +++ NE+ L++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---------DSYRNEIAYLNKLQQ 66
Query: 526 KNL--VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
+ +RL + ++ E N L+ L +S + W + + +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERK-SYWKNMLEAV 121
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
+H++ I+H D+K +N L+ K+ DFG++ D S + GTV YM
Sbjct: 122 HTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 644 PE-----------YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692
PE +++ KSDV+S G +L + G TP F
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------TP-----FQQI 223
Query: 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAAD----CVTLEGRNRPSMTEIVN 744
++H ++D N P D C+ + + R S+ E++
Sbjct: 224 INQISKLHAIIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 57/298 (19%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ +G G FG VY+ + VAVK + + F++E
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK--------TCKKDCTLDNKEK--FMSEAVI 66
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLI-YEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ L H ++V+L+G E+ E I E G L +L ++S + + +L
Sbjct: 67 MKNLDHPHIVKLIGIIEE--EPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQ 121
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+ + YL + +HRDI N+L+ + K+ DFGLS ++D +A+ T
Sbjct: 122 ICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVT 174
Query: 639 ---VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFVV 691
+ +M PE ++ T SDV+ F V + EILS G + + ++V+ +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL------ENKDVIGVL- 227
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
++ R L + P P + Y L C + +RP TE+V SL
Sbjct: 228 -----EKGDR-LPK--PDLCPPVL-------YTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 70/293 (23%), Positives = 112/293 (38%), Gaps = 49/293 (16%)
Query: 465 HKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL 520
IG G FG V++ VA+K + ++ + F+ E ++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----------DSVREKFLQEALTM 70
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
+ H ++V+L+G N +I E G L L + S L + I A +
Sbjct: 71 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL---ASLILYAYQLS 126
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT-- 638
+ YL +HRDI + NVL+ + K+ DFGLS + +A+
Sbjct: 127 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL 179
Query: 639 -VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696
+ +M PE ++ T SDV+ FGV + EIL G + N +V+ +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI------ 230
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ R L PP P + Y L C + RP TE+ L
Sbjct: 231 ENGER-LPM--PPNCPPTL-------YSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-33
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
+ + ++G+G FG V + D G QVA+K + +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK----------QCRQELSPKNRERWC 60
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNE------RVLIYEYLENGTLHDHLHNPQSSSPLKS 568
E++ + +L+H N+V + + +L EY E G L +L+ ++ LK
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTAKVSDFGLSLIGPE 625
P R ++ D + + YLHE IIHRD+K N++L K+ D G + +
Sbjct: 121 GPIRTLLS-DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
+ + GT+ Y+ PE ++ T D +SFG + E ++G+R
Sbjct: 177 GELCTEFV---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 50/278 (17%), Positives = 100/278 (35%), Gaps = 31/278 (11%)
Query: 408 EAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKI 467
+ M + + S + + + E + +S +I
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQI 64
Query: 468 GSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN 527
GSG V++ + A+K + + + +++ NE+ L++L +
Sbjct: 65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---------DSYRNEIAYLNKLQQHS 115
Query: 528 L--VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
+RL + ++ E N L+ L +S + W + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERK-SYWKNMLEAVHT 170
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
+H++ I+H D+K +N L+ K+ DFG++ D S + G V YM PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 646 -----------YYRLQQLTEKSDVYSFGVVLLEILSGY 672
+++ KSDV+S G +L + G
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 49/286 (17%), Positives = 91/286 (31%), Gaps = 35/286 (12%)
Query: 411 AQAQSAQPPMPPP--PPSPPVLEKKLS----QLASMGN----AGRLEEFSLEILLEATNN 460
+ + P P ++ K LS ++S N +L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 461 -FSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAI--GTKRQEDKDNAFINEL 517
H +G G+F VY+AT D + K+ + + + +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK-------FVLKVQKPANPWEFYIGTQLM 118
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVA 576
E L ++ +N VL+ E GTL + + + + I A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA-----------KVSDFGLSLIGPE 625
+ IE +H+ IIH DIK N +L + + D G S+
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+ + T G+ E + + D + + +L G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 33/251 (13%)
Query: 467 IGSGSFGAVYKA-TLDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G FG VY A + +A+K ++++ E + E+E S
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE--------GVEHQ---LRREIEIQSH 70
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
L H N++R+ + DR L+ E+ G L+ L Q + + + A
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME-ELADA 126
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ Y HE +IHRDIK N+L+ K++DFG S+ P S GT+ Y+
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDYL 179
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH-RTHNGTPRNV--VDFVVPYIV---- 695
PE + EK D++ GV+ E L G +H T R + VD P +
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 696 RDEIHRVLDRN 706
+D I ++L +
Sbjct: 240 KDLISKLLRYH 250
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 48/260 (18%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G GSF VY+A + G +VA+K + + + NE++ +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--------GMVQR---VQNEVKIHCQ 67
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
L H +++ L + ED N L+ E NG ++ +L P AR + G
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMH-QIITG 124
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+ YLH + I+HRD+ SN+LL K++DFGL+ E H +L GT Y+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYI 179
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSG------------YRAIHRTHNGTPRNVVDFV 690
PE +SDV+S G + +L G + D+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------ADYE 230
Query: 691 VPYIV----RDEIHRVLDRN 706
+P + +D IH++L RN
Sbjct: 231 MPSFLSIEAKDLIHQLLRRN 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 22/291 (7%)
Query: 384 VSAFFGYKHCKCKGCRVHDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNA 443
S H R+D + + +P P P + S +
Sbjct: 262 ASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVF-ESPFS 320
Query: 444 GRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGS---QVAVKRAEISSTSSYA 500
E ++ L+ N D ++G G+FG+V + VA+K
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK--------VLK 372
Query: 501 IGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNP 560
GT++ + ++ + E + + +L + +VRL+G C+ +L+ E G LH L
Sbjct: 373 QGTEKADTEE--MMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK 429
Query: 561 QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ P+ ++ + G++YL E + +HR++ + NVLL AK+SDFGLS
Sbjct: 430 REEIPV---SNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 621 -LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670
+G +D + + PE ++ + +SDV+S+GV + E LS
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 80/312 (25%), Positives = 144/312 (46%), Gaps = 46/312 (14%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
D +G+G FG V L S+ VA+K + +G ++ +D F+ E
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK--------TLKVGYTEKQRRD--FLGEASI 99
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + H N++RL G +++ EY+ENG+L L + + + +
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGI 156
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
A G++YL + +HRD+ + N+L+++ KVSDFGL ++ + + ++ +
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697
+ + PE ++ T SDV+S+G+VL E++S G R N ++V+ V D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV------D 264
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERALAACLVS 756
E +R L P P + Y L DC + NRP +IV+ L++ + +
Sbjct: 265 EGYR-LPP--PMDCPAAL-------YQLMLDCWQKDRNNRPKFEQIVSILDK----LIRN 310
Query: 757 PSISRSATSSSA 768
P + TS++A
Sbjct: 311 PGSLKIITSAAA 322
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 64/315 (20%), Positives = 108/315 (34%), Gaps = 73/315 (23%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
T F E KIGSG FG+V+K DG A+KR++ S D+ NA + E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--------VDEQNA-LRE 60
Query: 517 LESLSRL-HHKNLVRLLGFCEDRNERVLIY-EYLENGTLHDHLHNPQSSSPLKSWPARIK 574
+ + + L H ++VR ++ +LI EY G+L D +
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-------------------ATWTAKVS 615
+ L RG+ Y+H S++H DIK SN+ + K+
Sbjct: 120 LLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 616 DFGLSLIGPEDDESHLSLRAA--GTVGYMDPEYYRLQQL---TEKSDVYSFGVVLLEILS 670
D G + +S G ++ E LQ+ K+D+++ + ++
Sbjct: 177 DLGHV--------TRISSPQVEEGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAG 226
Query: 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCV 729
D+ H + +P P E + +
Sbjct: 227 AEP------------------LPRNGDQWHEIRQGRLPRIPQVLSQEFTELL----KVMI 264
Query: 730 TLEGRNRPSMTEIVN 744
+ RPS +V
Sbjct: 265 HPDPERRPSAMALVK 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-32
Identities = 57/239 (23%), Positives = 85/239 (35%), Gaps = 44/239 (18%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
N + +G GS G V G VAVKR I D + + E++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--------------DFCDIALMEIK 60
Query: 519 SLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS---PLKSWPARIK 574
L+ H N++R + E L D + + S L+ I
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-------------WTAKVSDFGLSL 621
+ A G+ +LH IIHRD+K N+L+ + +SDFGL
Sbjct: 120 LLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 622 IGPEDDESHLSLR--AAGTVGYMDPE-------YYRLQQLTEKSDVYSFGVVLLEILSG 671
S + +GT G+ PE ++LT D++S G V ILS
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 7e-32
Identities = 53/354 (14%), Positives = 100/354 (28%), Gaps = 52/354 (14%)
Query: 401 HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNN 460
G + E + Q + L + S L E
Sbjct: 17 QGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESE--LGERPRT 74
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVK---------RAEISSTSSYAIGTKRQEDKD 510
+G A +AT + G V I + +
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 511 NA--------FINELESLSRLHHKNLVRLLGFCEDRN--ERVLIYEYLE--NGTLHDHLH 558
N FI + + K ++R+ D R +Y ++ T + L
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 559 NPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618
+ S+ AR+++ L R + LH Y ++H ++ +++LD ++ F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPEY-----------YRLQQLTEKSDVYSFGVVLLE 667
+ D +S + + G+ PE R +T D ++ G+V+
Sbjct: 252 HLV---RDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 668 ILSGYRA-IHRTHNGTPRNVVDFV--VPYIVRDEIHRVLDRNVPP---PTPFEI 715
I G + +P VR + L P +
Sbjct: 306 IWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP--KEDRLLPLQA 357
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 464 DHKIGSGSFGAVYKATLDDGS-----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
IG+G FG VYK L S VA+K + G ++ D F+ E
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK--------TLKAGYTEKQRVD--FLGEAG 98
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ + H N++RL G ++I EY+ENG L L + S + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRG 155
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAG 637
A G++YL + +HRD+ + N+L+++ KVSDFGLS ++ + + ++ +
Sbjct: 156 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696
+ + PE ++ T SDV+SFG+V+ E+++ G R N V+ +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAI------ 263
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERALAA 752
++ R L P P I Y L C E RP +IV+ L++ + A
Sbjct: 264 NDGFR-LPT--PMDCPSAI-------YQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 64/278 (23%), Positives = 100/278 (35%), Gaps = 37/278 (13%)
Query: 401 HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNN 460
H S +D P E + + + R E F + +
Sbjct: 6 HHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ-------S 58
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F ++G GS+G V+K +DG AVKR+ +D+ + E+ S
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--------KDRARK-LAEVGS 109
Query: 520 LSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK-VAL 577
++ H VRL E+ L E +L H +S P A++
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLP----EAQVWGYLR 164
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRA 635
D + +LH ++H D+K +N+ L K+ DFGL L E
Sbjct: 165 DTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---- 217
Query: 636 AGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGY 672
G YM PE LQ +DV+S G+ +LE+
Sbjct: 218 -GDPRYMAPEL--LQGSYGTAADVFSLGLTILEVACNM 252
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 51/295 (17%)
Query: 464 DHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
IG G FG V++ VA+K + T + F+ E +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK--------TCKNCTSDSVREK--FLQEALT 444
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ + H ++V+L+G N +I E G L L + S L S I A
Sbjct: 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQL 500
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
+ + YL +HRDI + NVL+ + K+ DFGLS + ED + + +
Sbjct: 501 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLP 555
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFVVPYI 694
+ +M PE ++ T SDV+ FGV + EIL G ++ + +V+ +
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------KNNDVIGRI---- 605
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLER 748
+ R L PP P + Y L C + RP TE+ L
Sbjct: 606 --ENGER-LPM--PPNCPPTL-------YSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 50/275 (18%)
Query: 417 QPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSED----HKIGSGSF 472
+ + + E K+GSG++
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGM-------------YVRKKEGKIGESYFKVRKLGSGAY 49
Query: 473 GAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL 528
G V + S+ A+K +++ ++ + NE+ L L H N+
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE-IYNEISLLKSLDHPNI 108
Query: 529 VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR------- 581
++L ED+ L+ E+ E G L + + N DAA
Sbjct: 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-----------ECDAANIMKQILS 157
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
GI YLH++ +I+HRDIK N+LL ++ K+ DFGLS +D + GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGT 211
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
Y+ PE + ++ EK DV+S GV++ +L GY
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 58/264 (21%), Positives = 98/264 (37%), Gaps = 39/264 (14%)
Query: 434 LSQLASMGNAGRLEEFSL--EILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR 490
++ S+G A ++ + + + G F VY+A + G + A+KR
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 491 AEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNER-------V 542
+ + +E I E+ + +L H N+V+ E
Sbjct: 61 ----------LLSNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARI-KVALDAARGIEYLHEYAVPSIIHRDIKS 601
L+ L G L + L +S PL + K+ R ++++H P IIHRD+K
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLS--CDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKV 166
Query: 602 SNVLLDATWTAKVSDFGLS---LIGPEDDESHLSLRAA-------GTVGYMDPE---YYR 648
N+LL T K+ DFG + P+ S T Y PE Y
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 649 LQQLTEKSDVYSFGVVLLEILSGY 672
+ EK D+++ G +L +
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 66/315 (20%), Positives = 108/315 (34%), Gaps = 55/315 (17%)
Query: 409 AEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIG 468
A A A P P +P + + + L G
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFL------------G 50
Query: 469 SGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN 527
G F ++ + D A K I S + Q +K E+ L H++
Sbjct: 51 KGGFAKCFEISDADTKEVFAGK---IVPKSL--LLKPHQREK---MSMEISIHRSLAHQH 102
Query: 528 LVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH 587
+V GF ED + ++ E +L + + L AR G +YLH
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQYLH 158
Query: 588 EYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYY 647
+IHRD+K N+ L+ K+ DFGL+ D E L GT Y+ PE
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVL 213
Query: 648 RLQQLTEKSDVYSFGVVLLEILSG------------YRAIHRTHNGTPRNVVDFVVP-YI 694
+ + + DV+S G ++ +L G Y I + ++ +P +I
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------NEYSIPKHI 264
Query: 695 ---VRDEIHRVLDRN 706
I ++L +
Sbjct: 265 NPVAASLIQKMLQTD 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 73/260 (28%), Positives = 116/260 (44%), Gaps = 41/260 (15%)
Query: 466 KIGSGSFGAVYKAT---LDDGSQVAVK--RAEISSTSSYAIGTKRQEDKDNAFINELESL 520
K+G G VY A L+ +VA+K KR F E+ +
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEET---LKR-------FEREVHNS 65
Query: 521 SRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAA 580
S+L H+N+V ++ E+ + L+ EY+E TL +++ S PL S I
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPL-SVDTAINFTNQIL 121
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA--GT 638
GI++ H+ I+HRDIK N+L+D+ T K+ DFG++ E+ L+ GT
Sbjct: 122 DGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGT 175
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR----------AIHRTHNGTPRNVVD 688
V Y PE + + E +D+YS G+VL E+L G AI + P D
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235
Query: 689 FV--VPYIVRDEIHRVLDRN 706
+P + + I R +++
Sbjct: 236 VRKDIPQSLSNVILRATEKD 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 43/257 (16%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G F ++ + D A K I S + Q +K E+ L H
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGK---IVPKSL--LLKPHQREK---MSMEISIHRSLAH 74
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
+++V GF ED + ++ E +L + + L AR G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQY 130
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE 645
LH V IHRD+K N+ L+ K+ DFGL+ D E L GT Y+ PE
Sbjct: 131 LHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE 185
Query: 646 YYRLQQLTEKSDVYSFGVVLLEILSG------------YRAIHRTHNGTPRNVVDFVVP- 692
+ + + DV+S G ++ +L G Y I + ++ +P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------NEYSIPK 236
Query: 693 YI---VRDEIHRVLDRN 706
+I I ++L +
Sbjct: 237 HINPVAASLIQKMLQTD 253
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 59/295 (20%)
Query: 402 DSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNF 461
+SG D ++ + ++ K + ++ F I+
Sbjct: 26 NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85
Query: 462 SED------HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
+ +G G FG V+K G ++A K I T+ +DK+
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK----------IIKTRGMKDKEE-VK 134
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
NE+ +++L H NL++L E +N+ VL+ EY++ G L D RI
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD----------------RI- 177
Query: 575 VA-------LDAAR-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFG 618
+ LD GI ++H+ I+H D+K N+L K+ DFG
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 619 LSLIGPEDDESHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
L+ ++ L+ GT ++ PE ++ +D++S GV+ +LSG
Sbjct: 235 LARRYKPREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 453 ILLEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQE 507
+ + SE K+GSG++G V + A+K I
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI----------IRKTSVS 76
Query: 508 DKDNA-FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPL 566
N+ + E+ L L H N+++L F ED+ L+ E + G L D + + + +
Sbjct: 77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV 136
Query: 567 KSWPARI-KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLI 622
+ A I K L + YLH++ +I+HRD+K N+LL + K+ DFGLS +
Sbjct: 137 DA--AVIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 623 GPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
+ GT Y+ PE R ++ EK DV+S GV+L +L+GY
Sbjct: 189 FENQKKMK---ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 33/231 (14%)
Query: 453 ILLEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQE 507
+ +T FS+ +G GSFG V G + AVK I ++ +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKV----------ISKRQVK 65
Query: 508 DKDN--AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP 565
K + + + E++ L +L H N+++L F ED+ L+ E G L D + + + S
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 566 LKSWPARI-KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSL 621
+ + ARI + L I Y+H+ I+HRD+K N+LL ++ DFGLS
Sbjct: 126 VDA--ARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ GT Y+ PE EK DV+S GV+L +LSG
Sbjct: 178 HFEASKKMK---DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 69/235 (29%), Positives = 101/235 (42%), Gaps = 44/235 (18%)
Query: 455 LEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDK 509
L F+E +G GSFG V K + AVK I ++K
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV----------INKASAKNK 63
Query: 510 DN-AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
D + E+E L +L H N+++L ED + ++ E G L D + + S
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS---- 119
Query: 569 WPARIKVALDAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFG 618
DAAR GI Y+H++ +I+HRD+K N+LL + K+ DFG
Sbjct: 120 -------EHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
LS ++ + GT Y+ PE R EK DV+S GV+L +LSG
Sbjct: 170 LSTCFQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 62/290 (21%), Positives = 105/290 (36%), Gaps = 56/290 (19%)
Query: 411 AQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSG 470
+ + + L + G+ L KIG G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLL--------------LDSYVKIGEG 56
Query: 471 SFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529
S G V A G QVAVK + ++Q+ ++ NE+ + H N+V
Sbjct: 57 STGIVCLAREKHSGRQVAVKM----------MDLRKQQRREL-LFNEVVIMRDYQHFNVV 105
Query: 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALDAARGIEYLHE 588
+ E ++ E+L+ G L D + L A + + + YLH
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATV--CEAVLQALAYLHA 159
Query: 589 YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRA--AGTVGYMDP 644
+IHRDIKS ++LL K+SDFG + + R GT +M P
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKDVPKRKSLVGTPYWMAP 210
Query: 645 EYYRLQQLTEKSDVYSFGVVLLEILSGY---------RAIHR-THNGTPR 684
E + D++S G++++E++ G +A+ R + P+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 464 DHKIGSGSFGAVYKAT---LDDGSQVAVK--RAEISSTSSYAIGTKRQEDKDNAFINELE 518
+G G V+ A VAVK RA+++ S+ R F E +
Sbjct: 17 GEILGFGGMSEVHLARDLRDH--RDVAVKVLRADLARDPSF---YLR-------FRREAQ 64
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIY----EYLENGTLHDHLHNPQSSSPLKSWPARIK 574
+ + L+H +V + E + EY++ TL D +H + P+ + I+
Sbjct: 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPM-TPKRAIE 120
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
V DA + + + H+ IIHRD+K +N+++ AT KV DFG++ D + ++
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVTQT 176
Query: 635 AA--GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
AA GT Y+ PE R + +SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 26/332 (7%), Positives = 77/332 (23%), Gaps = 31/332 (9%)
Query: 402 DSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNF 461
++G + + + + + + + E +L +
Sbjct: 5 EAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKL 64
Query: 462 SEDHKIGSGSFGAVYKAT-LDDGSQVAVK----------------RAEISSTSSYAIGTK 504
+ G V+ ++ A+K + + +
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN--ERVLIYEYL--ENGTLHDHLHNP 560
+ + ++++ +L +D +L+ + L L
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 561 QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ A + R L ++H N+ + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 621 LIGPEDDESHLSLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSGYRAIHRT 678
+ ++ V Y E+ T + + G+ + + +
Sbjct: 242 WKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP 710
G + + D + +P
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 55/301 (18%)
Query: 401 HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNN 460
HD Q A PMP + + + +++L + +L
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-------------- 55
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
FS+ +IG GSFGAVY A + + VA+K+ S S +K I E+
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--------NEKWQDIIKEVRF 107
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALD 578
L +L H N ++ G + L+ EY + + PL+ A +
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAV--THG 162
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA--A 636
A +G+ YLH + ++IHRD+K+ N+LL K+ DFG + S ++
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFV 211
Query: 637 GTVGYMDPEYYRLQQLTE---KSDVYSFGVVLLEILSG---YRAIH--R-----THNGTP 683
GT +M PE + K DV+S G+ +E+ ++ N +P
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271
Query: 684 R 684
Sbjct: 272 A 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 34/236 (14%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
++ KIG G+ G VY A + G +VA+++ + ++Q K+ INE+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQ----------MNLQQQPKKEL-IINEILV 70
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALD 578
+ + N+V L +E ++ EYL G+L D + + + A + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAV--CRE 124
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+ +E+LH +IHRDIKS N+LL + K++DFG + ++ GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGT 179
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY---------RAIHR-THNGTPR 684
+M PE + K D++S G++ +E++ G RA++ NGTP
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK--------RAEISSTSSYAIGTKRQEDKDNAFINEL 517
IG GS+G V A +D + A+K R GT+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 518 ESLSR-------LHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHNPQSSSPLKS 568
E + + L H N+V+L+ +D NE L ++E + G + + PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSE 136
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
AR D +GIEYLH IIHRDIK SN+L+ K++DFG+S + +
Sbjct: 137 DQAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSD 191
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLT---EKSDVYSFGVVLLEILSGY 672
+ LS GT +M PE + + DV++ GV L + G
Sbjct: 192 ALLS-NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 456 EATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
+T+ F E+ +G G V + + AVK I T + + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKI--IDVTGGGSFSAEEVQELR 67
Query: 511 NAFINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSW 569
A + E++ L ++ H N+++L E L+++ ++ G L D
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-------------- 113
Query: 570 PARI--KVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
+ KV L + + I LH+ +I+HRD+K N+LLD K++DF
Sbjct: 114 --YLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSG 671
G S D L GT Y+ PE ++ D++S GV++ +L+G
Sbjct: 169 GFSCQ--LDPGEKLR-EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 672 Y 672
Sbjct: 226 S 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+GSG+F V+ G A+K I K +D++ NE+ L ++
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKC--IK---------KSPAFRDSSLENEIAVLKKIK 64
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL------D 578
H+N+V L E L+ + + G L D RI + D
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFD----------------RI-LERGVYTEKD 107
Query: 579 AAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDE 628
A+ ++YLHE I+HRD+K N+L + ++DFGLS + +
Sbjct: 108 ASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQN 161
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+S A GT GY+ PE + ++ D +S GV+ +L GY
Sbjct: 162 GIMS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG+FG V++ G K I T DK NE+ +++LH
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAK----------FINTPYPLDKYT-VKNEISIMNQLH 106
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA-------L 577
H L+ L ED+ E VLI E+L G L D RI A
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFD----------------RI-AAEDYKMSEA 149
Query: 578 DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFGLSLIGPEDDE 628
+ G++++HE+ SI+H DIK N++ + + K+ DFGL+ D+
Sbjct: 150 EVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ T + PE + + +D+++ GV+ +LSG
Sbjct: 207 VKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 60/270 (22%), Positives = 93/270 (34%), Gaps = 56/270 (20%)
Query: 450 SLEILLEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTK 504
+L + + IG GS+G V A + A+K I + +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK---IMNKNKIRQINP 69
Query: 505 RQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSS 564
+ ++ E+ + +LHH N+ RL ED L+ E G L D L+ S
Sbjct: 70 KDVER---IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 565 PLKSWPARIKVAL-----------------------------DAAR-------GIEYLHE 588
K +K + + + YLH
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 589 YAVPSIIHRDIKSSNVLL--DATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGYMDP 644
I HRDIK N L + ++ K+ DFGLS + E + AGT ++ P
Sbjct: 187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 645 E--YYRLQQLTEKSDVYSFGVVLLEILSGY 672
E + K D +S GV+L +L G
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 53/259 (20%), Positives = 106/259 (40%), Gaps = 27/259 (10%)
Query: 421 PPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSE----DHKIGSGSFGAVY 476
+ +S +++ + + ++ + ++G+G+FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 477 KAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535
+ T G+ A K + T + DK+ E++++S L H LV L
Sbjct: 175 RVTERATGNNFAAK----------FVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 223
Query: 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSII 595
ED NE V+IYE++ G L + + + + ++ G+ ++HE + +
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHEN---NYV 277
Query: 596 HRDIKSSNVLLDATWTA--KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT 653
H D+K N++ + K+ DFGL+ + GT + PE + +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVG 334
Query: 654 EKSDVYSFGVVLLEILSGY 672
+D++S GV+ +LSG
Sbjct: 335 YYTDMWSVGVLSYILLSGL 353
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 53/286 (18%)
Query: 408 EAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKI 467
A A++ + P + + + + + + +EF + I
Sbjct: 51 SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVI 102
Query: 468 GSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-H 525
G G V + G + AVK I ++ + ++ E+ A E L ++ H
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVK---IMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVAL---DAA 580
+++ L+ E + L+++ + G L D + KVAL +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFD----------------YLTEKVALSEKETR 203
Query: 581 R-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+ +LH +I+HRD+K N+LLD ++SDFG S + L
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR- 257
Query: 634 RAAGTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSGYR 673
GT GY+ PE ++ D+++ GV+L +L+G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 464 DHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
K+GSG+FG V+ G + +K I R + E+E L
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIK----------TINKDRSQVPMEQIEAEIEVLKS 76
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDH-LHNPQSSSPLKSWPAR--IKVALDA 579
L H N++++ ED + ++ E E G L + + L +K ++A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ Y H ++H+D+K N+L K+ DFGL+ + D+ S AA
Sbjct: 137 ---LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---NAA 187
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
GT YM PE ++ + +T K D++S GVV+ +L+G
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 42/282 (14%), Positives = 82/282 (29%), Gaps = 39/282 (13%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---------RAEISSTSSYAIGTKRQEDKDNA---- 512
+G A +AT + G V I + + N
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 513 ----FINELESLSRLHHKNLVRLLGFCEDRN--ERVLIYEYLE--NGTLHDHLHNPQSSS 564
FI + + K ++R+ D R +Y ++ T + L + S+
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 565 PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624
AR+++ L R + LH Y ++H ++ +++LD ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 625 EDDESHLSLRAAGTVGYMDPEYYRLQQ-----LTEKSDVYSFGVVLLEILSGYRAIHR-T 678
S + R Q +T D ++ G+ + I
Sbjct: 263 ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 679 HNGTPRNVVDFV--VPYIVRDEIHRVLDRNVPP---PTPFEI 715
G + +P VR + L P +
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRALLEGFLRYP--KEDRLLPLQA 361
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 40/225 (17%), Positives = 81/225 (36%), Gaps = 52/225 (23%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+G G FG V++ K + + D+ E+ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKF--VK---------VKGTDQVL-VKKEISILNIAR 59
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA-------L 577
H+N++ L E E V+I+E++ + + RI
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFE----------------RI-NTSAFELNER 102
Query: 578 DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFGLSLIGPEDDE 628
+ +++LH + +I H DI+ N++ ++ K+ +FG + D
Sbjct: 103 EIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
L Y PE ++ ++ +D++S G ++ +LSG
Sbjct: 160 FRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
++F + ++G+G+ G V+K + V A K I + + N I EL
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL----------IHLEIKPAIRNQIIREL 82
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KV 575
+ L + +V G E + E+++ G+L L P +I KV
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA------GRIPEQILGKV 136
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSL 633
++ +G+ YL E I+HRD+K SN+L+++ K+ DFG+S LI S+
Sbjct: 137 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------SM 186
Query: 634 RA--AGTVGYMDPEYYRLQQL--TEKSDVYSFGVVLLEILSG 671
GT YM PE RLQ + +SD++S G+ L+E+ G
Sbjct: 187 ANSFVGTRSYMSPE--RLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 65/303 (21%), Positives = 112/303 (36%), Gaps = 58/303 (19%)
Query: 464 DHKIGSGSFGAVYKATLDD---GSQVAVK--RAEISSTSSYAIGTKRQEDKDNAFINELE 518
+G G G VY+A D VA+K +SS + R E
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFR---TR-------MQREAR 86
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ RL ++V + F E + + + L L + PL + P + +
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPL-APPRAVAIVRQ 142
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA-- 636
++ H HRD+K N+L+ A A + DFG I + L+
Sbjct: 143 IGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTV 196
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
GT+ YM PE + T ++D+Y+ VL E L+G + G +V
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTG----SPPYQGDQLSV---------- 242
Query: 697 DEIHRVLDRNVPPPT------PFEIEAVAYVGYLAADCVTLEGRNR-PSMTEIVNSLERA 749
+ +++ +P P+ P +AV G +A + +R + ++ + A
Sbjct: 243 --MGAHINQAIPRPSTVRPGIPVAFDAVIARG-MAKN-----PEDRYVTCGDLSAAAHAA 294
Query: 750 LAA 752
LA
Sbjct: 295 LAT 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 44/224 (19%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG F V K G + A K + ++R ++ E+ L ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAK----FIKKRQSRASRRGVSREE-IEREVSILRQVL 73
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVAL---DA 579
H N++ L E+R + VLI E + G L D + K +L +A
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFD----------------FLAQKESLSEEEA 117
Query: 580 AR-------GIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSLIGPEDDE 628
G+ YLH I H D+K N++L K+ DFGL+ +D
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG 172
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
GT ++ PE + L ++D++S GV+ +LSG
Sbjct: 173 VEFKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+GSG+ G V A +VA++ I S +AIG+ R+ D E+E L +L
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIR---IISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 524 HHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
+H ++++ F + + ++ E +E G L D + + LK +
Sbjct: 198 NHPCIIKIKNFFDAED--YYIVLELMEGGELFDKV---VGNKRLKEATCK-LYFYQMLLA 251
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
++YLHE IIHRD+K NVLL + K++DFG S I + S + GT
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR-TLCGTP 305
Query: 640 GYMDPE---YYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE D +S GV+L LSGY
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 45/256 (17%)
Query: 464 DHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKD--NAFINELE 518
I G G +Y A D +G V +K G D + + E +
Sbjct: 85 KGCIAHGGLGWIYLAL-DRNVNGRPVVLK------------GLVHSGDAEAQAMAMAERQ 131
Query: 519 SLSRLHHKNLVRLLGFCE--DRNERVLIY---EYLENGTLHDHLHNPQSSSPLKSWPARI 573
L+ + H ++V++ F E DR+ + Y EY+ +L I
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP------VAEAI 185
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL--SLIGPEDDESHL 631
L+ + YLH +++ D+K N++L K+ D G + + +L
Sbjct: 186 AYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYL 237
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA-IHRTHNGTPRNVVDFV 690
GT G+ PE R T +D+Y+ G L + R +G P +
Sbjct: 238 ----YGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
Query: 691 VPYIVRDEIHRVLDRN 706
+ R +D +
Sbjct: 293 TYDSYGRLLRRAIDPD 308
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 437 LASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISS 495
+AS A L+E L L + F +G+G++G VYK + G A+K +++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT- 60
Query: 496 TSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLG------FCEDRNERVLIYEYL 548
D++ E+ L + HH+N+ G ++ L+ E+
Sbjct: 61 -----------GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 549 ENGTLHDHLHNPQSSSPLK-SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607
G++ D L + LK W A I + RG+ +LH+ +IHRDIK NVLL
Sbjct: 110 GAGSVTD-LIKNTKGNTLKEEWIAYI--CREILRGLSHLHQ---HKVIHRDIKGQNVLLT 163
Query: 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAA------GTVGYMDPEYYRLQQLTE-----KS 656
K+ DFG+S + L GT +M PE + + KS
Sbjct: 164 ENAEVKLVDFGVS--------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 657 DVYSFGVVLLEILSG 671
D++S G+ +E+ G
Sbjct: 216 DLWSLGITAIEMAEG 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 46/225 (20%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG F V K G + A K + + + G R+E E+ L ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-----IEREVSILRQVL 73
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVAL---DA 579
H N++ L E+R + VLI E + G L D + K +L +A
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFD----------------FLAQKESLSEEEA 117
Query: 580 AR-------GIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSLIGPEDDE 628
G+ YLH I H D+K N++L K+ DFGL+ + E
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 629 SHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ GT ++ PE + L ++D++S GV+ +LSG
Sbjct: 175 ----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/345 (17%), Positives = 106/345 (30%), Gaps = 82/345 (23%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR--------------------------- 490
+F +G G FG V++A D A+KR
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 491 --------------------AEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR 530
EI +A ++ + KN V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA 590
L + + + L D ++ S + + + A +E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL-HIFIQIAEAVEFLHS-- 182
Query: 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAA--------GTVG 640
++HRD+K SN+ KV DFGL + E++++ L+ A GT
Sbjct: 183 -KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
YM PE + K D++S G++L E+L + R I
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------------------ERVRII 283
Query: 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745
+ P + + + D ++ RP T+I+ +
Sbjct: 284 TDVRNLKFPLLFTQKYPQEH--MMVQDMLSPSPTERPEATDIIEN 326
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 50/243 (20%), Positives = 90/243 (37%), Gaps = 51/243 (20%)
Query: 452 EILLEATNNFSE-----DHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKR 505
+ ++ NF+ ++G G F V + G + A K + +R
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK----------FLKKRR 66
Query: 506 QEDKD-NAFINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
+ ++E+ L ++ L E+ +E +LI EY G +
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC------ 120
Query: 564 SPLKSWPARIKVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATW 610
+ + D R G+ YLH+ +I+H D+K N+LL
Sbjct: 121 ------LPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171
Query: 611 TAKVSDFGLSLIGPEDDESHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
K+ DFG+S E LR GT Y+ PE +T +D+++ G++ +L
Sbjct: 172 DIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227
Query: 670 SGY 672
+
Sbjct: 228 THT 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 73/318 (22%), Positives = 128/318 (40%), Gaps = 52/318 (16%)
Query: 439 SMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTS 497
S+ ++G+L+ + + + +IG G++G+V K G +AVKR I ST
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR--IRSTV 59
Query: 498 SYAIGTKRQEDKDNAFINELE-SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDH 556
E + + +L+ + +V+ G + + E + + +
Sbjct: 60 D--------EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKF 110
Query: 557 LHNPQSSSPLKSWPARI--KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614
S P I K+ L + + +L E IIHRDIK SN+LLD + K+
Sbjct: 111 YKYVYSVLD-DVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKL 167
Query: 615 SDFGLS--LIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL------TEKSDVYSFGVVLL 666
DFG+S L+ +S R AG YM PE R+ +SDV+S G+ L
Sbjct: 168 CDFGISGQLV-----DSIAKTRDAGCRPYMAPE--RIDPSASRQGYDVRSDVWSLGITLY 220
Query: 667 EILSG---YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY 723
E+ +G Y + + + + +V+ + ++ + F + +V
Sbjct: 221 ELATGRFPYPKWN-----SVFDQLT----QVVKGDPPQLSN---SEEREFSPSFINFV-- 266
Query: 724 LAADCVTLEGRNRPSMTE 741
C+T + RP E
Sbjct: 267 --NLCLTKDESKRPKYKE 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG F V K G + A K ++R ++ E+ L +
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAK----FIKKRRLSSSRRGVSREE-IEREVNILREIR 66
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--KVAL---DA 579
H N++ L E++ + VLI E + G L D + K +L +A
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFD----------------FLAEKESLTEDEA 110
Query: 580 AR-------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTA----KVSDFGLSLIGPEDDE 628
+ G+ YLH I H D+K N++L K+ DFG++ +E
Sbjct: 111 TQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 629 SHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ GT ++ PE + L ++D++S GV+ +LSG
Sbjct: 168 ----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG F V K G Q A K I ++R +++ E+ L +
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKF--IKKRR--TKSSRRGVSRED-IEREVSILKEIQ 72
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA------LD 578
H N++ L E++ + +LI E + G L D + +
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFD----------------FL-AEKESLTEEE 115
Query: 579 AAR-------GIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSLIGPEDD 627
A G+ YLH I H D+K N++L K+ DFGL+ +
Sbjct: 116 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 628 ESHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
E + GT ++ PE + L ++D++S GV+ +LSG
Sbjct: 173 E----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IGSG+ V A +VA+KR I ++ + + + E++++S+ H
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKR----------INLEKCQTSMDELLKEIQAMSQCH 71
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP---ARIKVAL-DAA 580
H N+V ++E L+ + L G++ D + + + KS + I L +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRA--AG 637
G+EYLH+ IHRD+K+ N+LL + +++DFG+S + D + +R G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 638 TVGYMDPEYYRLQQLT---EKSDVYSFGVVLLEILSG 671
T +M PE ++Q+ K+D++SFG+ +E+ +G
Sbjct: 189 TPCWMAPEV--MEQVRGYDFKADIWSFGITAIELATG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 52/226 (23%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD-NAFINELESLSRL 523
+G GSFG V K + AVK I ++KD + + E+E L +L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKV----------INKASAKNKDTSTILREVELLKKL 78
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL------ 577
H N+++L ED + ++ E G L D I +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFD----------------EI-IKRKRFSEH 121
Query: 578 DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDD 627
DAAR GI Y+H++ +I+HRD+K N+LL + K+ DFGLS ++
Sbjct: 122 DAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
+ GT Y+ PE R EK DV+S GV+L +LSG
Sbjct: 179 KMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 48/237 (20%), Positives = 84/237 (35%), Gaps = 19/237 (8%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
IG G F V + + G Q AVK + + ++ E L
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKI--VDVA---KFTSSPGLSTED-LKREASICHML 83
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
H ++V LL +++E+++ L + + + S +
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 584 EYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
Y H+ +IIHRD+K VLL + + K+ FG+++ E GT
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPH 198
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV----VDFVVPY 693
+M PE + + + DV+ GV+L +LSG + T +
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQ 255
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G GS+G V + + + AVK + ++ + K+ E++ L R
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----------EIQLLRR 62
Query: 523 LHHKNLVRLLG--FCEDRNERVLIYEYLENGT--LHDHLHNPQSSSPLKSWPAR------ 572
L HKN+++L+ + E++ + ++ EY G + D + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV----PEKRFPVCQAHGYFCQL 118
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
I G+EYLH I+H+DIK N+LL T K+S G++
Sbjct: 119 I-------DGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 633 LRAAGTVGYMDPEYYRLQQLTE--KSDVYSFGVVLLEILSGY 672
+ G+ + PE K D++S GV L I +G
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 64/229 (27%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+GSG+ G V A +VA+K I S +AIG+ R+ D E+E L +L+
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIK---IISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 525 HKNLVRLLGFCEDRNERVLIY---EYLENGTLHDHLHNPQSSSPLKSWPARI--KVAL-- 577
H ++++ F + + Y E +E G L D ++ L
Sbjct: 74 HPCIIKIKNFFDAED----YYIVLELMEGGELFD----------------KVVGNKRLKE 113
Query: 578 -DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTAKVSDFGLSLIGPED 626
++YLHE IIHRD+K NVLL + K++DFG S I
Sbjct: 114 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LG 168
Query: 627 DESHLSLRAAGTVGYMDPE---YYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ S + GT Y+ PE D +S GV+L LSGY
Sbjct: 169 ETSLMR-TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 53/236 (22%)
Query: 458 TNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD-N 511
+ FS++ ++G G+F V + G + A K I TK+ +D
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI----------INTKKLSARDFQ 50
Query: 512 AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
E +L H N+VRL ++ + L+++ + G L +
Sbjct: 51 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE---------------- 94
Query: 572 RI--KVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSD 616
I + DA+ I Y H I+HR++K N+LL K++D
Sbjct: 95 DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
FGL++ + + H AGT GY+ PE + ++ D+++ GV+L +L GY
Sbjct: 152 FGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
+ ++G G+FG VYKA + G+ A K E S E++ +I E+E
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----------EEELEDYIVEIEI 69
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALD 578
L+ H +V+LLG + ++ E+ G + + + L +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVV--CRQ 125
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA-- 636
+ +LH IIHRD+K+ NVL+ +++DFG+S +
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQKR 174
Query: 637 ----GTVGYMDPEYYRLQQLTE-----KSDVYSFGVVLLEILSG 671
GT +M PE + + + K+D++S G+ L+E+
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 30/214 (14%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG GS+G V A + A K+ I ED D F E+E + L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKK----------IPKYFVEDVD-RFKQEIEIMKSLD 64
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR--IKVALDAARG 582
H N++RL ED + L+ E G L + + + + A +K L A
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD---AARIMKDVLSA--- 118
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
+ Y H+ ++ HRD+K N L K+ DFGL+ + GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMR-TKVGTP 172
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
Y+ P+ + D +S GV++ +L GY
Sbjct: 173 YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYP 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 62/245 (25%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
F K+G GS+G+VYKA + G VA+K+ + E I E
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------------ESDLQEIIKE 74
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKV 575
+ + + ++V+ G + ++ EY G++ D + + L A I
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATI-- 130
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
+G+EYLH IHRDIK+ N+LL+ AK++DFG++ L+
Sbjct: 131 LQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--------GQLTDTM 179
Query: 636 A------GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG---YRAIHR-------TH 679
A GT +M PE + +D++S G+ +E+ G Y IH
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239
Query: 680 NGTPR 684
N P
Sbjct: 240 NPPPT 244
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F++ KIG GSFG V+K VA+K I + ED+ E+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI----------IDLEEAEDEIEDIQQEITV 73
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALD 578
LS+ + + G + +I EYL G+ D L PL + A I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATI--LRE 127
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA-- 636
+G++YLH IHRDIK++NVLL K++DFG++ L+
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQIKR 176
Query: 637 ----GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT +M PE + K+D++S G+ +E+ G
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 53/252 (21%)
Query: 442 NAGRLEEFSLEILLEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISST 496
G+ E ++ A+ FS++ ++G G+F V + G + A K
Sbjct: 8 TGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI------ 61
Query: 497 SSYAIGTKRQEDKD-NAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHD 555
I TK+ +D E +L H N+VRL ++ + L+++ + G L +
Sbjct: 62 ----INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117
Query: 556 HLHNPQSSSPLKSWPARI--KVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSN 603
I + DA+ I Y H I+HR++K N
Sbjct: 118 ----------------DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPEN 158
Query: 604 VLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYS 660
+LL K++DFGL++ + + H AGT GY+ PE + ++ D+++
Sbjct: 159 LLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 661 FGVVLLEILSGY 672
GV+L +L GY
Sbjct: 216 CGVILYILLVGY 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 32/220 (14%)
Query: 466 KIGSG--SFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELESLS 521
IG G V A G V V+R I + ++ F+ EL
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRR----------INLEACSNEMVTFLQGELHVSK 81
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-SWPARIKVALDAA 580
+H N+V NE ++ ++ G+ D L + A I
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYI--LQGVL 138
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGT 638
+ ++Y+H +HR +K+S++L+ +S + +I + + +
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 639 VG---YMDPEYYRLQQL----TEKSDVYSFGVVLLEILSG 671
V ++ PE LQQ KSD+YS G+ E+ +G
Sbjct: 196 VKVLPWLSPEV--LQQNLQGYDAKSDIYSVGITACELANG 233
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 64/289 (22%), Positives = 94/289 (32%), Gaps = 64/289 (22%)
Query: 401 HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNN 460
H S +D +P N L +F
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF----------- 54
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
F + ++G G+ VY+ A+K + + E+
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALK----------VLKKTVDKKI---VRTEIGV 101
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-- 577
L RL H N+++L E E L+ E + G L D RI V
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD----------------RI-VEKGY 144
Query: 578 ----DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIG 623
DAA + YLHE I+HRD+K N+L K++DFGLS I
Sbjct: 145 YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
Query: 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
GT GY PE R + D++S G++ +L G+
Sbjct: 202 EHQVLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF 247
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G++G V A VAVK ++ K+ E+ L+H
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----------EICINKMLNH 64
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR---- 581
+N+V+ G + N + L EY G L D + I + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFH 112
Query: 582 ----GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
G+ YLH I HRDIK N+LLD K+SDFGL+ + ++ L + G
Sbjct: 113 QLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 638 TVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
T+ Y+ PE + ++ E DV+S G+VL +L+G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 56/238 (23%)
Query: 458 TNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDN- 511
F+E+ ++G G+F V + + G + A I TK+ +D+
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI----------INTKKLSARDHQ 55
Query: 512 AFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
E L H N+VRL + LI++ + G L +
Sbjct: 56 KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE---------------- 99
Query: 572 RI--------KVALDAAR----GIEYLHEYAVPSIIHRDIKSSNVLL-----DATWTAKV 614
I A + + + H+ ++HR++K N+LL A K+
Sbjct: 100 DIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA--AVKL 154
Query: 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+DFGL++ + ++ AGT GY+ PE R + D+++ GV+L +L GY
Sbjct: 155 ADFGLAIEVEGEQQAWFGF--AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 66/314 (21%), Positives = 105/314 (33%), Gaps = 57/314 (18%)
Query: 409 AEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIG 468
+ PP PP P+PP K + + +G
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEA--------------------EYRLGPLLG 40
Query: 469 SGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--- 524
G FG V+ L D QVA+K + + E+ L ++
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNR-----VLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 525 -HKNLVRLLGFCEDRNERVLIYEYLENGT-LHDHLHNPQSSSPLKSWPARIKVALDAARG 582
H ++RLL + E + +L+ E L D++ PL P+R
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSR-CFFGQVVAA 151
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
I++ H V +HRDIK N+L+D AK+ DFG + + + GT Y
Sbjct: 152 IQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYT-DFDGTRVY 204
Query: 642 MDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY---RAIHRTHNGTPRNVVDFVVPYIV-- 695
PE+ Q + V+S G++L +++ G + P V
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA------ELHFPAHVSP 258
Query: 696 --RDEIHRVLDRNV 707
I R L
Sbjct: 259 DCCALIRRCLAPKP 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG G+F V A + G +VA+K + +++ TS + R E+ +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL--FR----------EVRIMKI 70
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
L+H N+V+L E LI EY G + D+L + +K AR
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEAR-SKFRQIVSA 126
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
++Y H+ I+HRD+K+ N+LLDA K++DFG S L G Y
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLD-AFCGAPPYA 180
Query: 643 DPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
PE ++ ++ + DV+S GV+L ++SG
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 54/290 (18%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE-SLSRL 523
++G G++G V K + G +AVKR I +T + + + +L+ S+ +
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKR--IRATVN--------SQEQKRLLMDLDISMRTV 63
Query: 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
V G + + E + + +L K+A+ + +
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLRAAGTVGY 641
E+LH S+IHRD+K SNVL++A K+ DFG+S L+ + AG Y
Sbjct: 123 EHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-----DDVAKDIDAGCKPY 175
Query: 642 MDPE----YYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
M PE + + KSD++S G+ ++E+ AI PY
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIEL-----AI-----LRF--------PYDSWG 217
Query: 698 EIHRVLDR--NVPPPT----PFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741
+ L + P P F E V + + C+ + RP+ E
Sbjct: 218 TPFQQLKQVVEEPSPQLPADKFSAEFVDFT----SQCLKKNSKERPTYPE 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 67/303 (22%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N+ ++GSG+ G V+K V AVK+ + ++++ + +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ----------MRRSGNKEENKRILMDL 74
Query: 518 ESLSRLH-HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI--- 573
+ + + H +V+ G + + E + K I
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL----------KKRMQGPIPER 124
Query: 574 ---KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDE 628
K+ + + + YL E +IHRD+K SN+LLD K+ DFG+S L+ +
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-----D 177
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQL-------TEKSDVYSFGVVLLEILSG---YRAIHRT 678
R+AG YM PE R+ ++DV+S G+ L+E+ +G Y+
Sbjct: 178 DKAKDRSAGCAAYMAPE--RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-- 233
Query: 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS 738
T V+ ++++E +P F + ++V DC+T + R RP
Sbjct: 234 ---TDFEVLT----KVLQEEPPL-----LPGHMGFSGDFQSFV----KDCLTKDHRKRPK 277
Query: 739 MTE 741
+
Sbjct: 278 YNK 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G++G V A VAVK ++ K+ E+ L+H
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----------EICINKMLNH 64
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR---- 581
+N+V+ G + N + L EY G L D + I + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFH 112
Query: 582 ----GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
G+ YLH I HRDIK N+LLD K+SDFGL+ + ++ L + G
Sbjct: 113 QLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 638 TVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
T+ Y+ PE + ++ E DV+S G+VL +L+G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/311 (20%), Positives = 106/311 (34%), Gaps = 46/311 (14%)
Query: 409 AEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIG 468
+ + +P P + ++LA LE + + +G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE-----------SQYQVGPLLG 52
Query: 469 SGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK- 526
SG FG+VY + D VA+K E I + E+ L ++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDR-----ISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 527 -NLVRLLGFCEDRNERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
++RLL + E + VLI E E L D + L+ AR +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELAR-SFFWQVLEAVR 163
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
+ H ++HRDIK N+L+D K+ DFG + ++ + GT Y
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYT-DFDGTRVYSP 216
Query: 644 PEYYRLQQLT-EKSDVYSFGVVLLEILSGY---RAIHRTHNGTPRNVVDFVVPYIV---- 695
PE+ R + + V+S G++L +++ G G V
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG------QVFFRQRVSSEC 270
Query: 696 RDEIHRVLDRN 706
+ I L
Sbjct: 271 QHLIRWCLALR 281
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 38/235 (16%)
Query: 458 TNNFSEDHKI-----GSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDN 511
+ F + +++ G G+ V L + AVK I + +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK----------IIEKQPGHIRSR 56
Query: 512 AFINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP 570
F E+E L + H+N++ L+ F E+ + L++E + G++ H+H + + L+
Sbjct: 57 VF-REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE--- 112
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLS-LIGPED 626
A V D A +++LH I HRD+K N+L + K+ DF L I
Sbjct: 113 AS-VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 627 DESHLSLR----AAGTVGYMDPEYYRLQQLTEKS-----DVYSFGVVLLEILSGY 672
D S +S G+ YM PE D++S GV+L +LSGY
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 28/214 (13%)
Query: 464 DHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
D +G GSF K AVK I + + + E+ +L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK----------IISKRMEANTQK----EITALKL 61
Query: 523 L-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
H N+V+L D+ L+ E L G L + + + S + A +
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE---AS-YIMRKLVS 117
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+ ++H+ ++HRD+K N+L + K+ DFG + + P D++ + T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ Y PE E D++S GV+L +LSG
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 29/251 (11%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+GSG+FG V+ A + +V VK I + E+ LSR+ H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKF--IKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEH 88
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGT-LHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
N++++L E++ L+ E +G L + L A + +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLAS-YIFRQLVSAVG 144
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YL IIHRDIK N+++ +T K+ DFG + + GT+ Y P
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFCGTIEYCAP 198
Query: 645 EYYRLQQLT-EKSDVYSFGVVLLEILSGY---RAIHRTHNGTPRNVVDFVVPYIVRDE-- 698
E + +++S GV L ++ + T PY+V E
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA------AIHPPYLVSKELM 252
Query: 699 --IHRVLDRNV 707
+ +L
Sbjct: 253 SLVSGLLQPVP 263
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 34/231 (14%)
Query: 452 EILLEATNNFSED----HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQ 506
+ L + F++ IG GS+ + + AVK I K +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-----------IIDKSK 59
Query: 507 EDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP 565
D E+E L R H N++ L +D ++ E ++ G L D + + S
Sbjct: 60 RDPTE----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWTAKVSDFGLSL 621
+ A V + +EYLH ++HRD+K SN+L + ++ DFG +
Sbjct: 116 RE---AS-AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
++ ++ T ++ PE Q D++S GV+L +L+GY
Sbjct: 169 QLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 47/341 (13%), Positives = 89/341 (26%), Gaps = 86/341 (25%)
Query: 418 PPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYK 477
P S P + +L A + GR LL G ++
Sbjct: 6 LREPDRESSAPPDDVQLVPGARIA-NGRYR------LLI---------FHGGVPPLQFWQ 49
Query: 478 AT---LDDGSQVAVK--RAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532
A LD QVA+ + ++ LSR+ + R+L
Sbjct: 50 ALDTALDR--QVALTFVDPQGVLPDDVL----------QETLSRTLRLSRIDKPGVARVL 97
Query: 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR-IKVALDAARGIEYLHEYAV 591
R +++ E++ G+L + S P I+ A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPS-------PVGAIRAMQSLAAAADAAHRAG- 149
Query: 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ 651
+ S V + ++ M
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179
Query: 652 LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPT 711
+ D+ G L +L + + R P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQPIEPA 226
Query: 712 PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752
+ + + +AA V +G R + + ++N +++A A
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAV 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 62/294 (21%)
Query: 406 LDEAEAQAQSAQPPMPPPPPSP--PVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSE 463
L ++ Q+ P P PPP P P L +Q + L N +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 464 DHK-----IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
D+K +G G G V + + A+K + E+
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM----------L------QDCPKARREV 105
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERV----LIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
E R ++VR++ E+ ++ E L+ G L + R
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ------------DR 153
Query: 573 IKVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKVSDFGL 619
A +A+ I+YLH +I HRD+K N+L K++DFG
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 620 SLIGPEDDESHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ + SL T Y+ PE ++ + D++S GV++ +L GY
Sbjct: 211 AKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G+FG V G +VAVK R +I S KR E+++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG-KIKR----------EIQNLKL 67
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR- 581
H ++++L + ++ EY+ G L D++ +V AR
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARR 115
Query: 582 -------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
++Y H + ++HRD+K NVLLDA AK++DFGLS + + + S
Sbjct: 116 LFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170
Query: 635 AAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
G+ Y PE + + D++S GV+L +L G
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 48/233 (20%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+ ++ IG+GSFG V++A L + +VA+K+ Q+ + F N
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-------------LQDKR---FKN 80
Query: 516 -ELESLSRLHHKNLVRLLGF----CEDRNERV--LIYEYLENGTLHDHL-HNPQSSSPLK 567
EL+ + + H N+V L F + ++E L+ EY+ T++ H + +
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139
Query: 568 SWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPE 625
IK+ + R + Y+H I HRDIK N+LLD + K+ DFG + I
Sbjct: 140 --MLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 626 DDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
+ + V Y+ YYR T D++S G V+ E++ G
Sbjct: 195 GEPN---------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
E + + F + G G+FG V G VA+K+ + + +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRELQ----- 68
Query: 511 NAFINELESLSRLHHKNLVRLLGF-----CEDRNER--VLIYEYLENGTLHDHL-HNPQS 562
++ L+ LHH N+V+L + DR + ++ EY+ + TLH + +
Sbjct: 69 -----IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR 122
Query: 563 SSPLKSWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLS 620
P IKV L R I LH +V ++ HRDIK NVL++ A T K+ DFG +
Sbjct: 123 QVAPP--PILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 621 LIGPEDDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
+ + V Y+ YYR Q T D++S G + E++ G
Sbjct: 180 KKLSPSEPN---------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 59/290 (20%)
Query: 403 SGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQ---LASMGNAGRLEEFSLEILLEATN 459
SGR + A+S +P P + + + G+ + E+
Sbjct: 2 SGRP-RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV------ 54
Query: 460 NFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN-EL 517
++++ IG+GSFG VY+A L D G VA+K+ Q+ + F N EL
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------------LQDKR---FKNREL 98
Query: 518 ESLSRLHHKNLVRLLGF----CEDRNERVL--IYEYLENGTLHDHL-HNPQSSSPLKSWP 570
+ + +L H N+VRL F E ++E L + +Y+ T++ H ++ L
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP--V 155
Query: 571 ARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDE 628
+K+ + R + Y+H + I HRDIK N+LLD T K+ DFG + +
Sbjct: 156 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 629 SHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
+ V Y+ YYR T DV+S G VL E+L G
Sbjct: 213 N---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G GSFG V AT +VA+K R + S + +R E+ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVER----------EISYLKL 65
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR- 581
L H ++++L + V++ EY G L D++ + ++ D R
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRR 112
Query: 582 -------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
IEY H + I+HRD+K N+LLD K++DFGLS I + + S
Sbjct: 113 FFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 635 AAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
G+ Y PE + + DV+S G+VL +L G
Sbjct: 168 -CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G+FG V G +VAVK R +I S +R E+++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRR----------EIQNLKL 72
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR- 581
H ++++L ++ ++ EY+ G L D++ ++ +R
Sbjct: 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRR 120
Query: 582 -------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
G++Y H + ++HRD+K NVLLDA AK++DFGLS + + + S
Sbjct: 121 LFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175
Query: 635 AAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
G+ Y PE + + D++S GV+L +L G
Sbjct: 176 -CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 57/218 (26%), Positives = 82/218 (37%), Gaps = 42/218 (19%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IGSG+FG VAVK + +N E+ + L H
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK-----------YIERGAAIDENVQ-REIINHRSLRH 75
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR---- 581
N+VR +I EY G L++ + N + + D AR
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICN------------AGRFSEDEARFFFQ 123
Query: 582 ----GIEYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFGLSLIGPEDDESHLSLRA 635
G+ Y H I HRD+K N LLD + K+ DFG S + ++
Sbjct: 124 QLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 178
Query: 636 AGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGY 672
GT Y+ PE Q+ + +DV+S GV L +L G
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 29/170 (17%)
Query: 463 EDHKIGSGSFGAVYKA---TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
E K+G G++G VYKA D A+K+ E + S A E+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------------EIAL 71
Query: 520 LSRLHHKNLVRLLGFCEDRNER--VLIYEYLEN---GTLHDHLHNPQSSSPLKSWPARIK 574
L L H N++ L +R L+++Y E+ + H + + P++ +K
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 575 -VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA----KVSDFGL 619
+ GI YLH ++HRD+K +N+L+ K++D G
Sbjct: 132 SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 61/259 (23%), Positives = 102/259 (39%), Gaps = 40/259 (15%)
Query: 421 PPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATL 480
P P + +Q R E+F +L G GSF V A
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKIL------------GEGSFSTVVLARE 51
Query: 481 -DDGSQVAVKRAEISSTSSYAIGTKR---QEDKDNAFINELESLSRLHHKNLVRLLGFCE 536
+ A+K I KR +E+K E + +SRL H V+L +
Sbjct: 52 LATSREYAIK-----------ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 537 DRNERVLIYEYLENGTLHDHLHNPQS-SSPLKSWPARIKVA--LDAARGIEYLHEYAVPS 593
D + Y +NG L ++ S R A + A +EYLH
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVSA---LEYLHGK---G 150
Query: 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT 653
IIHRD+K N+LL+ +++DFG + + + + + GT Y+ PE +
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 654 EKSDVYSFGVVLLEILSGY 672
+ SD+++ G ++ ++++G
Sbjct: 211 KSSDLWALGCIIYQLVAGL 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 455 LEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR----AE--ISSTSSYAIGTKRQE 507
+ +++ F + K+G+G++ VYK G VA+K +E ST+
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA---------- 50
Query: 508 DKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSP 565
I E+ + L H+N+VRL N+ L++E+++N D +
Sbjct: 51 ------IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG 104
Query: 566 LKSWPARIK-VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
L+ +K +G+ + HE I+HRD+K N+L++ K+ DFGL+
Sbjct: 105 LE--LNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 6e-20
Identities = 78/362 (21%), Positives = 124/362 (34%), Gaps = 103/362 (28%)
Query: 464 DHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+G G+FG V +A VAVK + +T S A ++EL
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----------RALMSEL 76
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHN---------------P 560
+ L + HH N+V LLG C + +I E+ + G L +L +
Sbjct: 77 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136
Query: 561 QSSSPLKSWPARIKVALD--------------AARGIEYLHEYAVPSIIHRDIKSSNVLL 606
Q + + P +K LD + + + E P +++D + L+
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 607 DATW------------------------------TAKVSDFGLSLIGPEDDESHLSLRAA 636
++ K+ DFGL+ +D + A
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G---YRAIHRTHNGTPRNVVDFVVP 692
+ +M PE + T +SDV+SFGV+L EI S G Y + +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----IDEEFCRRL-- 309
Query: 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEGRNRPSMTEIVNSLERALA 751
E R + P T E+ Y DC E RP+ +E+V L L
Sbjct: 310 ----KEGTR-MRA--PDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
Query: 752 AC 753
A
Sbjct: 356 AN 357
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 46/240 (19%), Positives = 91/240 (37%), Gaps = 61/240 (25%)
Query: 458 TNNFSEDHKI-----GSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDN 511
++D+++ G G G V + G + A+K +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL----------L------YDSP 66
Query: 512 AFINELESLSRL-HHKNLVRLLGFCEDRNERV----LIYEYLENGTLHDHLHNPQSSSPL 566
E++ + ++V +L E+ + +I E +E G L +
Sbjct: 67 KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-------- 118
Query: 567 KSWPARIKVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAK 613
R A +AA I++LH + +I HRD+K N+L + K
Sbjct: 119 ----ERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171
Query: 614 VSDFGLSLIGPEDDESHLSLR-AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
++DFG + ++ +L+ T Y+ PE ++ + D++S GV++ +L G+
Sbjct: 172 LTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----I 514
+ KIG G++G VYKA + G A+K+ R E +D I
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-------------RLEKEDEGIPSTTI 48
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPAR 572
E+ L L H N+V+L + VL++E+L+ L D S KS+ +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ GI Y H+ ++HRD+K N+L++ K++DFGL+
Sbjct: 109 L------LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 28/168 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----I 514
+ + K+G G++G VYKA G VA+KR R + +D I
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-------------RLDAEDEGIPSTAI 67
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPAR 572
E+ L LHH N+V L+ L++E++E + D S +K + +
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+ RG+ + H++ I+HRD+K N+L+++ K++DFGL+
Sbjct: 128 L------LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF---- 513
+ + KIG G++G V+KA + VA+KR R +D D
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------------RLDDDDEGVPSSA 48
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPA 571
+ E+ L L HKN+VRL + L++E+ + D + +KS+
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
++ +G+ + H +++HRD+K N+L++ K+++FGL+
Sbjct: 109 QL------LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 30/170 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF---- 513
NF + KIG G++G VYKA G VA+K+ R + +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-------------RLDTETEGVPSTA 49
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN---GTLHDHLHNPQSSSPLKSWP 570
I E+ L L+H N+V+LL N+ L++E+L + +KS+
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
++ +G+ + H + ++HRD+K N+L++ K++DFGL+
Sbjct: 110 FQL------LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF---- 513
+ + + KIG G+FG V+KA G +VA+K+ E++ F
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------------LMENEKEGFPITA 63
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERV--------LIYEYLEN--GTLHDHLHNPQSS 563
+ E++ L L H+N+V L+ C + L++++ E+ L ++ +
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123
Query: 564 SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
S +K G+ Y+H I+HRD+K++NVL+ K++DFGL
Sbjct: 124 SEIKRV------MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVK---RAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
IG GSFG V +D ++ A+K + + + + N EL+ +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC----------VERNEVRNV-FKELQIMQG 71
Query: 523 LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAA 580
L H LV L +D + ++ + L G L HL +K + + +AL
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL--- 128
Query: 581 RGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
+YL IIHRD+K N+LLD ++DF ++ + P + + ++ AGT
Sbjct: 129 ---DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TM--AGTKP 179
Query: 641 YMDPEYYRLQQLTE--KS-DVYSFGVVLLEILSGYR 673
YM PE + ++ + D +S GV E+L G R
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 31/170 (18%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF---- 513
+ +G GS+G V K D G VA+K+ + D D
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK-------------FLESDDDKMVKKIA 71
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLH---DHLHNPQSSSPLKSWP 570
+ E++ L +L H+NLV LL C+ + L++E++++ T+ + N ++ +
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL 130
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
+I GI + H + +IIHRDIK N+L+ + K+ DFG +
Sbjct: 131 FQI------INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 46/220 (20%), Positives = 82/220 (37%), Gaps = 54/220 (24%)
Query: 415 SAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGA 474
+ +S +++ +A ++ + + K+G G++G
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMS-VSAAPSATSIDRY--RRI----------TKLGEGTYGE 49
Query: 475 VYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF----INELESLSRLHHKNLV 529
VYKA VA+KR R E ++ I E+ L L H+N++
Sbjct: 50 VYKAIDTVTNETVAIKRI-------------RLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 530 RLLGFCEDRNERVLIYEYLENGTLHD-----HLHNPQSSSPLKSWPARIKVALDAARGIE 584
L + LI+EY E +D + S +KS+ ++ G+
Sbjct: 97 ELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQL------INGVN 146
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTA-----KVSDFGL 619
+ H +HRD+K N+LL + + K+ DFGL
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + +G G F VYKA + VA+K+ ++ S G R A + E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT-----A-LREI 63
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPARIKV 575
+ L L H N++ LL ++ L+++++E + + S +K++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY------ 117
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
L +G+EYLH++ I+HRD+K +N+LLD K++DFGL
Sbjct: 118 MLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 47/247 (19%), Positives = 84/247 (34%), Gaps = 38/247 (15%)
Query: 65 IPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQ--- 121
+P + +I G L V+ W G N ++ A Q
Sbjct: 18 VPAEAQSGVDAIAGGYFHGLAL-----KGGKVL-GW-----GA-NLNGQLTMPAATQSGV 65
Query: 122 -QLEAGNSHICGLVNGTNDLHWWQWPDF-----NSTSIHNFSNIAVGEDFVCGLLENGTI 175
+ AGN H L +G + W + + + IA G L ++G +
Sbjct: 66 DAIAAGNYHSLALKDGE--VIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYAL-KDGKV 122
Query: 176 TCFGS-RNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGD------SVGEVPQG 228
+G + T+V + SG+ + G A+ + + WGD +V Q
Sbjct: 123 IAWGDDSDGQTTVPAEAQSGV-TALDGGVYTALAVKNG-GVIAWGDNYFGQTTVPAEAQS 180
Query: 229 KFKALALGENRSCALRNNQKVVCWGQNGF-TLPDSLQG-KPFVSIEAKRSVFCGVLTSNY 286
+A G S AL++ + V+ WG N + + +I + + N
Sbjct: 181 GVDDVAGGIFHSLALKDGK-VIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLAL--KNG 237
Query: 287 SLYCWGN 293
+ WG+
Sbjct: 238 KVIAWGS 244
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 33/155 (21%), Positives = 55/155 (35%), Gaps = 23/155 (14%)
Query: 155 NFSNIAVGEDFVCGLLENGTITCFGSRNS------PTSVTQKVPSGIFRVVAAGFRHVCA 208
IA G L + G + +G N P + V + +AAG H A
Sbjct: 25 GVDAIAGGYFHGLAL-KGGKVLGWG-ANLNGQLTMPAATQSGVDA-----IAAGNYHSLA 77
Query: 209 IDDDQELRCWGD------SVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGF-TLPD 261
+ D E+ WG +V + A+A G S AL++ KV+ WG +
Sbjct: 78 LKDG-EVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKDG-KVIAWGDDSDGQTTV 135
Query: 262 SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESF 296
+ + V+ + + + WG+ F
Sbjct: 136 PAEAQSGVTALDGGVYTALAVKNG-GVIAWGDNYF 169
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 27/208 (12%)
Query: 63 QL-IPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQ 121
QL +P + +I +G+ L V+ W + DG G
Sbjct: 54 QLTMPAATQSGVDAIAAGNYHSLAL-----KDGEVI-AWGGNEDGQTTVPAEARSGVD-- 105
Query: 122 QLEAGNSHICGLVNGTNDLHWWQWPDFNSTSI-----HNFSNIAVGEDFVCGLLENGTIT 176
+ AG L +G + W T++ + + G + ++NG +
Sbjct: 106 AIAAGAWASYALKDGK--VIAWGDDSDGQTTVPAEAQSGVTALDGG-VYTALAVKNGGVI 162
Query: 177 CFGSRNS-PTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGD-SVGEVPQG-----K 229
+G T+V + SG+ VA G H A+ D + + WGD +
Sbjct: 163 AWGDNYFGQTTVPAEAQSGV-DDVAGGIFHSLALKDGK-VIAWGDNRYKQTTVPTEALSG 220
Query: 230 FKALALGENRSCALRNNQKVVCWGQNGF 257
A+A GE S AL+N KV+ WG +
Sbjct: 221 VSAIASGEWYSLALKNG-KVIAWGSSRT 247
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 122 QLEAGNSHICGLVNGTNDLHWWQWPDFNST-----SIHNFSNIAVGEDFVCGLLENGTIT 176
+ G H L +G + W + T ++ S IA GE + L +NG +
Sbjct: 184 DVAGGIFHSLALKDGK--VIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLAL-KNGKVI 240
Query: 177 CFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDD 212
+G + + V SG+ + AG A+
Sbjct: 241 AWG-SSRTAPSS--VQSGVSSI-EAGPNAAYALKGG 272
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD----NAF 513
+ + KIG GS+G V+K D G VA+K+ ED A
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKK------------FLESEDDPVIKKIA- 49
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLH--DHLHNPQSSSPLKSWPA 571
+ E+ L +L H NLV LL + L++EY ++ LH D +KS
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+ + + + H++ + IHRD+K N+L+ K+ DFG
Sbjct: 110 QT------LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 55/248 (22%), Positives = 94/248 (37%), Gaps = 35/248 (14%)
Query: 440 MGNAGRLEEFSL-EILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSS 498
M G L L + ++ I SGS+GAV +G VA+KR + +T S
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKR--VFNTVS 59
Query: 499 YAIGTKRQEDKDNA--FINELESLSRLHHKNLVRLL-----GFCEDRNERVLIYEYLENG 551
D + E+ L+ HH N++ L ++ L+ E +
Sbjct: 60 DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT- 118
Query: 552 TLHDHLHNPQSSSPLKSWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610
L +H+ + + P I+ + G+ LHE ++HRD+ N+LL
Sbjct: 119 DLAQVIHDQRI--VIS--PQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNN 171
Query: 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGV 663
+ DF L+ D T Y+ +YR + T+ D++S G
Sbjct: 172 DITICDFNLAREDTADANK--------T-HYVTHRWYRAPELVMQFKGFTKLVDMWSAGC 222
Query: 664 VLLEILSG 671
V+ E+ +
Sbjct: 223 VMAEMFNR 230
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 22/165 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + K+G G++ VYK + VA+K I + +E I E+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKE----------IRLEHEEGAPCTAIREV 51
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLEN--GTLHDHLHNPQSSSPLKSWPARIKV 575
L L H N+V L L++EYL+ D N + +K + ++
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS 620
RG+ Y H ++HRD+K N+L++ K++DFGL+
Sbjct: 110 ----LRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 42/239 (17%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
I+ +++F +G G++G V AT G VA+K+ E +A+ T R
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----- 58
Query: 511 NAFINELESLSRLHHKNLVRLL-----GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSP 565
E++ L H+N++ + E+ NE +I E ++ D LH S+
Sbjct: 59 -----EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT----D-LHRVISTQM 108
Query: 566 LKSWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGP 624
L I+ + R ++ LH ++IHRD+K SN+L+++ KV DFGL+ I
Sbjct: 109 LS--DDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII- 162
Query: 625 EDDESHLSLRAAGTVGYMDPEY-----YR-------LQQLTEKSDVYSFGVVLLEILSG 671
D+ + + G M E+ YR + + DV+S G +L E+
Sbjct: 163 -DESAADNSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 45/266 (16%)
Query: 403 SGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFS 462
+ + + Q + K + + + ++ + + +
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHS-----DW------QIPDRYE 56
Query: 463 EDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAFINELESL 520
H IG+GS+G V +A + VA+K+ + R E+ L
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----------EIAIL 106
Query: 521 SRLHHKNLVRLL-----GFCEDRNERVLIYEYLENGT-LHDHLHNPQSSSPLKSWPARIK 574
+RL+H ++V++L E +E ++ E + + P L IK
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLFRTPV---YLT--ELHIK 159
Query: 575 VAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-----LIGPEDDE 628
L + G++Y+H I+HRD+K +N L++ + KV DFGL+
Sbjct: 160 TLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 629 SHLSLRAAGTVGYMDPEYYRLQQLTE 654
+ +QLT
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 457 ATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF-- 513
AT+ + +IG G++G VYKA G VA+K +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS----------VRVPNGGGGGGGLPI 56
Query: 514 -----INELESLSRLHHKNLVRLL----GFCEDRNERV-LIYEYLEN--GTLHDHLHNPQ 561
+ L L H N+VRL+ DR +V L++E+++ T D P
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 562 SSSPL-KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+ K + RG+++LH I+HRD+K N+L+ + T K++DFGL
Sbjct: 117 LPAETIKDLMRQF------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 39/178 (21%)
Query: 459 NNFSEDHKIGSGSFGAVYKA--TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAF--- 513
+ +IG G++G V+KA + G VA+KR R + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------------RVQTGEEGMPLS 57
Query: 514 ----INELESLSRLHHKNLVRLL----GFCEDRNERV-LIYEYLEN--GTLHDHLHNPQS 562
+ L L H N+VRL DR ++ L++E+++ T D + P
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 563 SSPL-KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619
+ K ++ RG+++LH + ++HRD+K N+L+ ++ K++DFGL
Sbjct: 118 PTETIKDMMFQL------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 459 NNFSEDHK-IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT------KRQEDKDN 511
+ F D + +G G FG V+ + ++ YA K+++
Sbjct: 185 DWF-LDFRVLGRGGFGEVFACQMKATGKL------------YACKKLNKKRLKKRKGYQG 231
Query: 512 AFINELESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWP 570
A + E + L+++H + +V L + + + L+ + G + H++N +P P
Sbjct: 232 A-MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 571 -ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
A A G+E+LH+ +II+RD+K NVLLD ++SD GL++
Sbjct: 290 RAIFYTA-QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
AGT G+M PE ++ D ++ GV L E+++
Sbjct: 346 TKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 50/256 (19%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAF 513
+N+ H IG GS+G VY A + VA+K+ + R
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-------- 74
Query: 514 INELESLSRLHHKNLVRLL-----GFCEDRNERVLIYEYLENGT-LHDHLHNPQSSSPLK 567
E+ L+RL ++RL +E ++ E + + L P L
Sbjct: 75 --EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--SDLKKLFKTPI---FLT 127
Query: 568 SWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
IK L + G ++HE IIHRD+K +N LL+ + KV DFGL+ +
Sbjct: 128 --EEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTE--------------------KS-DVYSFGVVL 665
++++ +QLT KS D++S G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 666 LEILSGYRAIHRTHNG 681
E+L+ ++
Sbjct: 243 AELLNMLQSHINDPTN 258
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-17
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 459 NNFSEDHK-IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR-----QEDKDNA 512
N+F H+ IG G FG VY D ++ YA+ + +
Sbjct: 189 NDF-SVHRIIGRGGFGEVYGCRKADTGKM------------YAMKCLDKKRIKMKQGETL 235
Query: 513 FINE---LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLK 567
+NE L +S +V + ++ I + + G LH HL S + ++
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
+ A I + L E++H +++RD+K +N+LLD ++SD GL+ +
Sbjct: 296 FYAAEIILGL------EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKS-DVYSFGVVLLEILSGY 672
GT GYM PE + + S D +S G +L ++L G+
Sbjct: 347 PHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 66/270 (24%)
Query: 420 MPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKAT 479
M PPP+ G + + E + + +GSG++GAV A
Sbjct: 1 MSSPPPARS---------------GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV 45
Query: 480 -LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL----- 532
G++VA+K+ + +A R EL L + H+N++ LL
Sbjct: 46 DGRTGAKVAIKKLYRPFQSELFAKRAYR----------ELRLLKHMRHENVIGLLDVFTP 95
Query: 533 -GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL-DAARGIEYLHEYA 590
+D + L+ ++ D L L RI+ + +G+ Y+H
Sbjct: 96 DETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLG--EDRIQFLVYQMLKGLRYIHA-- 146
Query: 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV--GYMDPEYYR 648
IIHRD+K N+ ++ K+ DFGL+ R A + GY+ +YR
Sbjct: 147 -AGIIHRDLKPGNLAVNEDCELKILDFGLA-------------RQADSEMTGYVVTRWYR 192
Query: 649 -------LQQLTEKSDVYSFGVVLLEILSG 671
+ T+ D++S G ++ E+++G
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
+ ++ IG G++G V A + +VA+K+ +Y T R
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR--------- 74
Query: 515 NELESLSRLHHKNLVRLL-----GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSW 569
E++ L R H+N++ + E + ++ + +E D L+ + L
Sbjct: 75 -EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET----D-LYKLLKTQHLS-- 126
Query: 570 PARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDE 628
I L RG++Y+H +++HRD+K SN+LL+ T K+ DFGL+ + D +
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 629 SHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
L T Y+ +YR + T+ D++S G +L E+LS
Sbjct: 184 HTGFL----T-EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-16
Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT------KRQEDKDNA 512
N F + +G G FG V + ++ YA K+++ + A
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKM------------YACKKLEKKRIKKRKGEAMA 231
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
+NE + L +++ + +V L + + + + L+ + G L H+++ + A
Sbjct: 232 -LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARA 288
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
A + G+E LH I++RD+K N+LLD ++SD GL++ PE
Sbjct: 289 VFYAA-EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GTVGYM PE + ++ T D ++ G +L E+++G
Sbjct: 345 R---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 54/264 (20%), Positives = 97/264 (36%), Gaps = 81/264 (30%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN- 515
+ +S +G+GSFG V + ++ G + A+K+ D + N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ----------------DPRYKNR 49
Query: 516 ELESLSRLHHKNLVRLLGFCEDRNERV--------------------------------- 542
EL+ + L H N+++L+ + +
Sbjct: 50 ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109
Query: 543 -----LIYEYLENGTLHDHL-HNPQSSSPLKSWPARIKVAL-DAARGIEYLHEYAVPSII 595
+I EY+ + TLH L +S + I + + R + ++H I
Sbjct: 110 NKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP--MNLISIYIYQLFRAVGFIHSL---GIC 163
Query: 596 HRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR------ 648
HRDIK N+L+++ T K+ DFG + + S V Y+ +YR
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---------VAYICSRFYRAPELML 214
Query: 649 -LQQLTEKSDVYSFGVVLLEILSG 671
+ T D++S G V E++ G
Sbjct: 215 GATEYTPSIDLWSIGCVFGELILG 238
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 54/218 (24%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQ----EDKDNA-FINELESLS 521
IG G+F V + QV YA+ + + + + F E + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQV------------YAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+ + +L +D N L+ EY G L L P + AR +A +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM--ARFYLA-EIVM 173
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
I+ +H +HRDIK N+LLD +++DFG L D SL A GT Y
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDY 229
Query: 642 MDPEYYRLQQLTEKSDVY-------SFGVVLLEILSGY 672
+ PE + + Y + GV E+ G
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 36/190 (18%), Positives = 59/190 (31%), Gaps = 61/190 (32%)
Query: 159 IAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRV--VAAGF 203
IA G+ + G + +G P + + GI R+ VAAG
Sbjct: 126 IACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKI--QAFEGI-RIKMVAAGA 182
Query: 204 RHVCAIDDDQELRCWGD------------------SVGEVPQGKFKALALGENRSCALRN 245
H A+ +D +L WG V K +A G + ++
Sbjct: 183 EHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSY 242
Query: 246 NQKVVCWGQNGF-----------TLP---DSLQGKPFVSIEAKRSVFCG-----VLTSNY 286
+ + +G + + +P ++L I G LTS+
Sbjct: 243 SGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQIS------GGWRHTMALTSDG 296
Query: 287 SLYCWGNESF 296
LY WG F
Sbjct: 297 KLYGWGWNKF 306
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 35/186 (18%), Positives = 54/186 (29%), Gaps = 58/186 (31%)
Query: 159 IAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRVVAAGFRH 205
I+ G LL + +G R SPT ++ I V G H
Sbjct: 21 ISAGASHSVALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQI-VSVTCGADH 79
Query: 206 VCAIDDD-QELRCWGD-SVGE----------VPQ-------GKFKALALGENRSCALRNN 246
A E+ WG G P + K +A G++ A+
Sbjct: 80 TVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVTME 139
Query: 247 QKVVCWGQNGF-----------TLP---DSLQGKPFVSIEAKRSVFCG-----VLTSNYS 287
+V WG+N +P + +G + G +T +
Sbjct: 140 GEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVA------AGAEHTAAVTEDGD 193
Query: 288 LYCWGN 293
LY WG
Sbjct: 194 LYGWGW 199
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 30/197 (15%), Positives = 59/197 (29%), Gaps = 60/197 (30%)
Query: 149 NSTSIHNFSNIAVGEDFVCGLLENGT-ITCFG-------------SRNSPTSVTQKVPSG 194
++ H ++ G D ++G + +G +P + K G
Sbjct: 63 SALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPI--KALHG 120
Query: 195 IFRV-VAAGFRHVCAIDDDQELRCWGD------------------SVGEVPQGKFKALAL 235
I +A G H A+ + E++ WG + + K +A
Sbjct: 121 IRIKQIACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAA 180
Query: 236 GENRSCALRNNQKVVCWGQNGF--------------TLPDSLQGKPFVSIEAKRSVFCG- 280
G + A+ + + WG + S G+ V CG
Sbjct: 181 GAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMS------MVACGW 234
Query: 281 ----VLTSNYSLYCWGN 293
++ + +LY +G
Sbjct: 235 RHTISVSYSGALYTYGW 251
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 31/185 (16%), Positives = 52/185 (28%), Gaps = 47/185 (25%)
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRVVA 200
S +A G + +G + +G P + S I ++ +
Sbjct: 225 EKMSMVACGWRHTISVSYSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQI-S 283
Query: 201 AGFRHVCAIDDDQELRCWGDS------------------VGEVPQGKFKALALGENRSCA 242
G+RH A+ D +L WG + V K ++ G + A
Sbjct: 284 GGWRHTMALTSDGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLA 343
Query: 243 LRNNQKVVCWGQNGF------TLPDSLQGKPFVSIEA-KRSVFCG-----VLTSNYSLYC 290
+ V WG+ D + P IEA G S
Sbjct: 344 VTERNNVFAWGRGTNGQLGIGESVD--RNFP-KIIEALSVDGASGQHIESSNIDPSSGKS 400
Query: 291 WGNES 295
W + +
Sbjct: 401 WVSPA 405
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 21/147 (14%), Positives = 41/147 (27%), Gaps = 35/147 (23%)
Query: 180 SRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDS------------------ 221
+ + P + +++AG H A+ + WG
Sbjct: 3 AEDMAADEVTAPPRKV-LIISAGASHSVALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQ 61
Query: 222 VGEVPQGKFKALALGENRSCALRNN-QKVVCWGQNGF--------------TLPDSLQGK 266
+ + + ++ G + + A + +V WG F +L G
Sbjct: 62 LSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGI 121
Query: 267 PFVSIEAKRSVFCGVLTSNYSLYCWGN 293
I S C +T + WG
Sbjct: 122 RIKQIACGDS-HCLAVTMEGEVQSWGR 147
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 19/85 (22%), Positives = 27/85 (31%), Gaps = 14/85 (16%)
Query: 226 PQGKFKALALGENRSCALRNNQKVVCWGQNGF--------------TLPDSLQGKPFVSI 271
P K ++ G + S AL + V WG+ T +L G VS+
Sbjct: 14 PPRKVLIISAGASHSVALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSV 73
Query: 272 EAKRSVFCGVLTSNYSLYCWGNESF 296
S +Y WG F
Sbjct: 74 TCGADHTVAYSQSGMEVYSWGWGDF 98
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT--KRQ--EDKDNA-FINELESLS 521
IG G+FG V L + +V +A+ K + + + A F E + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKV------------FAMKILNKWEMLKRAETACFREERDVLV 129
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
K + L +D N L+ +Y G L L + P + AR +A +
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM--ARFYLA-EMVI 186
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
I+ +H+ +HRDIK N+L+D +++DFG L ED S A GT Y
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDY 242
Query: 642 MDPEYYRLQQLTEKS-----DVYSFGVVLLEILSGY 672
+ PE + + + D +S GV + E+L G
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 49/238 (20%), Positives = 96/238 (40%), Gaps = 52/238 (21%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDK 509
+ E + +GSG++G+V A G +VA+K+ + + +A R
Sbjct: 17 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---- 72
Query: 510 DNAFINELESLSRLHHKNLVRLL------GFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
EL L + H+N++ LL + + L+ +++ L + S
Sbjct: 73 ------ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS- 124
Query: 564 SPLKSWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622
+I+ + +G++Y+H ++HRD+K N+ ++ K+ DFGL+
Sbjct: 125 ------EEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA-- 173
Query: 623 GPEDDESHLSLRAAGTV--GYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
R A GY+ +YR + D++S G ++ E+L+G
Sbjct: 174 -----------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 51/234 (21%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAF 513
E + +GSG++G+V A G +VAVK+ + + +A T R
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-------- 77
Query: 514 INELESLSRLHHKNLVRLL------GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
EL L + H+N++ LL E+ N+ L+ + D L+N L
Sbjct: 78 --ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQKLT 130
Query: 568 SWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
++ + RG++Y+H IIHRD+K SN+ ++ K+ DFGL+
Sbjct: 131 --DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA------ 179
Query: 627 DESHLSLRAAGTV--GYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSG 671
R GY+ +YR + D++S G ++ E+L+G
Sbjct: 180 -------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 33/225 (14%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAF 513
+ IGSG+ G V A VA+K+ + ++A R
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-------- 73
Query: 514 INELESLSRLHHKNLVRLL------GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
EL + ++HKN++ LL E+ + ++ E ++ L +
Sbjct: 74 --ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD----- 125
Query: 568 SWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
R+ L GI++LH IIHRD+K SN+++ + T K+ DFGL+
Sbjct: 126 --HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTA 177
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
S + T Y PE E D++S G ++ E++ G
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 30/181 (16%), Positives = 52/181 (28%), Gaps = 47/181 (25%)
Query: 159 IAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRV-VAAGFR 204
+A G + G + +G + P V + + +G
Sbjct: 164 VAAGGAHSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDA 223
Query: 205 HVCAIDDDQELRCWGD------------------SVGEVPQGKFKALALGENRSCALRNN 246
+ DD + WGD + + + G S AL +
Sbjct: 224 QTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKS 283
Query: 247 QKVVCWGQNGF--------------TLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWG 292
V WG+ + LQGK ++I S+ C T + +Y WG
Sbjct: 284 GAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIAT-GSLHCVCCTEDGEVYTWG 342
Query: 293 N 293
+
Sbjct: 343 D 343
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 32/195 (16%), Positives = 65/195 (33%), Gaps = 55/195 (28%)
Query: 150 STSIHNFSNIAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIF 196
+ + + GE + + +G + G S ++PT + I
Sbjct: 49 ALATLRPVQLIGGEQTLFAVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIK 108
Query: 197 RV-VAAGFRHVCAIDDDQELRCWGD------------------SVGEVPQGKFKALALGE 237
+V V +G +H A+ + E+ WG+ + + + +A G
Sbjct: 109 KVAVNSGGKHCLALSSEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGG 168
Query: 238 NRSCALRNNQKVVCWGQNGF--------------TLPDSLQGKPFVSIEAKRSVFCG--- 280
S + + WG+ + L ++LQG V I + G
Sbjct: 169 AHSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDI----ACGSGDAQ 224
Query: 281 --VLTSNYSLYCWGN 293
LT + +++ WG+
Sbjct: 225 TLCLTDDDTVWSWGD 239
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 37/191 (19%), Positives = 58/191 (30%), Gaps = 61/191 (31%)
Query: 159 IAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRV-VAAGFR 204
+ G L G + +G + P + + GI V VAAG
Sbjct: 112 VNSGGKHCLALSSEGEVYSWGEAEDGKLGHGNRSPCDRPRVI--ESLRGIEVVDVAAGGA 169
Query: 205 HVCAIDDDQELRCWGD------------------SVGEVPQGKFKALALGENR--SCALR 244
H + +L WG V + + +A G + L
Sbjct: 170 HSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCLT 229
Query: 245 NNQKVVCWGQNGF-----------TLP---DSLQGKPFVSIEAKRSVFCG-----VLTSN 285
++ V WG + +P DSL G V +E CG LT +
Sbjct: 230 DDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVE------CGSQFSVALTKS 283
Query: 286 YSLYCWGNESF 296
++Y WG +
Sbjct: 284 GAVYTWGKGDY 294
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 31/183 (16%), Positives = 51/183 (27%), Gaps = 49/183 (26%)
Query: 158 NIAVGEDFVCGLLENGTITCFGS-------------RNSPTSVTQKVPSGIFRVVAAGFR 204
+ +GTI +G PT + G +
Sbjct: 5 HHHSSGRENLYFQGSGTIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRP-VQLIGGEQ 63
Query: 205 HVCAIDDDQELRCWGD-SVGE----------VPQ---------GKFKALALGENRSCALR 244
+ A+ D +L G + G P K A+ G AL
Sbjct: 64 TLFAVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALS 123
Query: 245 NNQKVVCWGQNGF--------------TLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYC 290
+ +V WG+ + +SL+G V + A + +T+ LY
Sbjct: 124 SEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGA-HSACVTAAGDLYT 182
Query: 291 WGN 293
WG
Sbjct: 183 WGK 185
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 25/172 (14%), Positives = 46/172 (26%), Gaps = 47/172 (27%)
Query: 159 IAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRVVAAGFRH 205
G+ L ++ T+ +G P + G+ +V G +
Sbjct: 218 CGSGDAQTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKV-ECGSQF 276
Query: 206 VCAIDDDQELRCWGD------------------SVGEVPQGKFKALALGENRSCALRNNQ 247
A+ + WG V + K A+A G +
Sbjct: 277 SVALTKSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTEDG 336
Query: 248 KVVCWGQNGF--------------TLPDSLQGKPFVSIEAKRSVFCGVLTSN 285
+V WG N L +LQGK + + +++
Sbjct: 337 EVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSA-HTLAWSTS 387
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 20/125 (16%), Positives = 35/125 (28%), Gaps = 32/125 (25%)
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFGS-------------RNSPTSVTQKVPSGIFRVVA 200
+ G F L ++G + +G P V + +A
Sbjct: 265 LGVVKVECGSQFSVALTKSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKV-IAIA 323
Query: 201 AGFRHVCAIDDDQELRCWGDS------------------VGEVPQGKFKALALGENRSCA 242
G H +D E+ WGD+ V + K +A G + A
Sbjct: 324 TGSLHCVCCTEDGEVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSAHTLA 383
Query: 243 LRNNQ 247
++
Sbjct: 384 WSTSK 388
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 12/98 (12%), Positives = 22/98 (22%), Gaps = 21/98 (21%)
Query: 199 VAAGFRHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGFT 258
+ R + WG L E + T
Sbjct: 6 HHSSGRENLYFQGSGTIYGWGH-------NHRGQLGGIEGAKVKV-------------PT 45
Query: 259 LPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNESF 296
++L V + +T++ LY G +
Sbjct: 46 PCEALATLRPVQLIGGEQTLF-AVTADGKLYATGYGAG 82
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 51/241 (21%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEIS-STSSYAIGTKRQEDKDNAF 513
+ + + + +G G G V+ A D +VA+K+ I + R
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVKHALR-------- 57
Query: 514 INELESLSRLHHKNLVRLL--------------GFCEDRNERVLIYEYLENGTLHDHLHN 559
E++ + RL H N+V++ G + N ++ EY+E D L N
Sbjct: 58 --EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LAN 110
Query: 560 PQSSSPLKSWPARIKVAL-DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSDF 617
PL ++ + RG++Y+H +++HRD+K +N+ ++ K+ DF
Sbjct: 111 VLEQGPLL--EEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILS 670
GL+ I L + + ++YR T+ D+++ G + E+L+
Sbjct: 166 GLARIMDPHYSHKGHL----S-EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 671 G 671
G
Sbjct: 221 G 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 51/282 (18%)
Query: 408 EAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKI 467
E + A + K + S + + + I
Sbjct: 11 EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70
Query: 468 GSGSFGAVYKAT-LDDGSQVAVKR-AEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
GSG+ G V A VA+K+ + ++A R EL + ++H
Sbjct: 71 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----------ELVLMKCVNH 120
Query: 526 KNLVRLL------GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
KN++ LL E+ + L+ E ++ L + + ++
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------ 173
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
GI++LH IIHRD+K SN+++ + T K+ DFGL+ R AGT
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------RTAGTS 217
Query: 640 GYMDPE----YYR------LQQLTEKSDVYSFGVVLLEILSG 671
M P YYR E D++S G ++ E++
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 50/248 (20%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
+ + K+G G++G V+K+ G VAVK+ I + +R
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRT---- 55
Query: 511 NAFINELESLSRLH-HKNLVRLLGFC--EDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
E+ L+ L H+N+V LL ++ + L+++Y+E D LH ++ L+
Sbjct: 56 ---FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET----D-LHAVIRANILE 107
Query: 568 SWPARIKVAL-DAARGIEYLHEYAVPS--IIHRDIKSSNVLLDATWTAKVSDFGLS---- 620
P + + + I+YLH S ++HRD+K SN+LL+A KV+DFGLS
Sbjct: 108 --PVHKQYVVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 621 -----LIGPEDDESHLSLRAAGTVGYMDPEY-----YR-------LQQLTEKSDVYSFGV 663
+ + + +Y YR + T+ D++S G
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPIL-TDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 664 VLLEILSG 671
+L EIL G
Sbjct: 220 ILGEILCG 227
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 32/182 (17%), Positives = 53/182 (29%), Gaps = 51/182 (28%)
Query: 159 IAVGEDFVCGLLENGTITCFGS--------------RNSPTSVTQKVPSGIFRVVAAGFR 204
V E G + G R P V +P + AG
Sbjct: 13 KKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALV--SIPEDV-VQAEAGGM 69
Query: 205 HVCAIDDDQELRCWGD-----------------SVGEVPQG-KFKALALGENRSCALRNN 246
H + ++ +G G+V K ++ G++ + AL ++
Sbjct: 70 HTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDD 129
Query: 247 QKVVCWG-------QNGFTLPDSLQGKPFVSIEAK---RSVFCG-----VLTSNYSLYCW 291
+V WG G P P V ++ V G +LT++ LY
Sbjct: 130 GRVFLWGSFRDNNGVIGLLEPMKKSMVP-VQVQLDVPVVKVASGNDHLVMLTADGDLYTL 188
Query: 292 GN 293
G
Sbjct: 189 GC 190
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 29/207 (14%), Positives = 58/207 (28%), Gaps = 66/207 (31%)
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFGS-RNS-----------PTSVTQKVPSGIFRV--V 199
++ G+ L ++G + +GS R++ + V +V + V V
Sbjct: 111 EKVVQVSAGDSHTAALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDV-PVVKV 169
Query: 200 AAGFRHVCAIDDDQELRCWGD----------------------------------SVGEV 225
A+G H+ + D +L G S G
Sbjct: 170 ASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSR 229
Query: 226 PQGKFKALALGENRSCALRNNQKVVCWGQNGF-----------TLPDSLQGKPFVSIEAK 274
+F+ G + A+ + V +G + + +P +L +
Sbjct: 230 GHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWV 289
Query: 275 RSVFCG-----VLTSNYSLYCWGNESF 296
G + S Y G +
Sbjct: 290 -GFSGGQHHTVCMDSEGKAYSLGRAEY 315
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 30/200 (15%), Positives = 56/200 (28%), Gaps = 70/200 (35%)
Query: 159 IAVGEDFVCGLLENGTITCFG------------------------SRNSPTSVTQKVPSG 194
+A G D + L +G + G P V K
Sbjct: 169 VASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGS 228
Query: 195 IFRV----VAAGFRHVCAIDDDQELRCWGD-SVGE----------VPQ---------GKF 230
V G AI + + +G + + +PQ +
Sbjct: 229 RGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSW 288
Query: 231 KALALGENRSCALRNNQKVVCWGQNGF------------TLPDSLQGKPFVSIEAKRSVF 278
+ G++ + + + K G+ + ++P + P VS SV
Sbjct: 289 VGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVS-----SVA 343
Query: 279 CG-----VLTSNYSLYCWGN 293
CG +T + ++ WG
Sbjct: 344 CGASVGYAVTKDGRVFAWGM 363
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 21/131 (16%), Positives = 38/131 (29%), Gaps = 30/131 (22%)
Query: 193 SGIFRVVAAGFRHVCAIDDDQELRCWGD-SVGEVPQG----------------KFKALAL 235
I + H + + G VG++ G
Sbjct: 7 DAIPKSKKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEA 66
Query: 236 GENRSCALRNNQKVVCWGQNGF------TLPDSLQGKP-FVSIEAK-RSVFCG-----VL 282
G + L + +V +G N T + + P V ++ K V G L
Sbjct: 67 GGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL 126
Query: 283 TSNYSLYCWGN 293
T + ++ WG+
Sbjct: 127 TDDGRVFLWGS 137
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 22/145 (15%), Positives = 39/145 (26%), Gaps = 31/145 (21%)
Query: 144 QWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQK 190
S F + G F + G + FG S P ++T
Sbjct: 222 MLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSF 281
Query: 191 VPSGI-FRVVAAGFRHVCAIDDDQELRCWGD------------SVGEVPQ-----GKFKA 232
S + + G H +D + + G +P +
Sbjct: 282 KNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSS 341
Query: 233 LALGENRSCALRNNQKVVCWGQNGF 257
+A G + A+ + +V WG
Sbjct: 342 VACGASVGYAVTKDGRVFAWGMGTN 366
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 10/82 (12%), Positives = 21/82 (25%), Gaps = 12/82 (14%)
Query: 227 QGKFKALALGENRSCALRNNQKVVCWGQN-------GFTLPDSLQGKPFVSIEAKRSVFC 279
K+ + + V+ GQ G + + + E
Sbjct: 7 DAIPKSKKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEA 66
Query: 280 G-----VLTSNYSLYCWGNESF 296
G L+ + +Y +G
Sbjct: 67 GGMHTVCLSKSGQVYSFGCNDE 88
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQED----KDNA-FINELESLS 521
IG G+FG V +V YA+ + + D+A F E + ++
Sbjct: 77 IGRGAFGEVQLVRHKSTRKV------------YAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 522 RLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+ +V+L +D ++ EY+ G L + + N AR A +
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTA-EVVL 179
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
++ +H IHRD+K N+LLD + K++DFG + ++ A GT Y
Sbjct: 180 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDY 235
Query: 642 MDPEYYRLQQLTEK----SDVYSFGVVLLEILSGY 672
+ PE + Q D +S GV L E+L G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 48/245 (19%), Positives = 80/245 (32%), Gaps = 79/245 (32%)
Query: 452 EILLEATNNFSEDHK-----IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKR 505
L N +D+K +G G G V + + A+K +
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK----------ML---- 51
Query: 506 QEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERV----LIYEYLENGTLHDHLHNP 560
E+E R ++VR++ E+ ++ E L+ G L +
Sbjct: 52 --QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-- 107
Query: 561 QSSSPLKSWPARIKVAL---DAAR-------GIEYLHEYAVPSIIHRDIKSSNVLL---D 607
R A +A+ I+YLH +I HRD+K N+L
Sbjct: 108 ----------DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR 154
Query: 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLE 667
K++DFG + E E Y + D++S GV++
Sbjct: 155 PNAILKLTDFGFA---KE----------------TTGEKY-----DKSCDMWSLGVIMYI 190
Query: 668 ILSGY 672
+L GY
Sbjct: 191 LLCGY 195
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 50/248 (20%), Positives = 93/248 (37%), Gaps = 53/248 (21%)
Query: 442 NAGRLEEF----SLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISST 496
N R E+ S + +++ K+G G + V++A + + +V VK
Sbjct: 15 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----- 69
Query: 497 SSYAIGTKRQEDKDNAF--INELESLSRLHHKNLVRLLGFCEDRNER--VLIYEYLENGT 552
+ K I LE+L N++ L +D R L++E++ N
Sbjct: 70 --------KPVKKKKIKREIKILENLR--GGPNIITLADIVKDPVSRTPALVFEHVNNTD 119
Query: 553 LHDHLHNPQSSSPLKSWPAR--IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610
L + R + L + ++Y H I+HRD+K NV++D
Sbjct: 120 FKQLYQ------TLTDYDIRFYMYEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEH 167
Query: 611 TA-KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPE------YYRLQQLTEKSDVYSFGV 663
++ D+GL+ E ++R A + + PE Y D++S G
Sbjct: 168 RKLRLIDWGLAEFYHPGQE--YNVRVA-SRYFKGPELLVDYQMY-----DYSLDMWSLGC 219
Query: 664 VLLEILSG 671
+L ++
Sbjct: 220 MLASMIFR 227
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 29/200 (14%), Positives = 56/200 (28%), Gaps = 55/200 (27%)
Query: 152 SIHNFSNIAVGEDFVCGLLENGTITCFG-----------SRNSPTSVTQKVPSGI-FRVV 199
I + +I+ G L ++G I FG S + S + +
Sbjct: 73 GIPDAVDISAGGMHNLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCI 132
Query: 200 AAGFRHVCAIDDDQELRCWGDSVG-----------------EVPQG-KFKALALGENRSC 241
+AG H + +D + WG ++ +G ++A G +
Sbjct: 133 SAGDSHSACLLEDGRVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLV 192
Query: 242 ALRNNQKVVCWGQNGF-----------------TLPDSLQGKPFVSIEAKR--SVFCG-- 280
L KV G D L+ + AK +++
Sbjct: 193 ILTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNY 252
Query: 281 ----VLTSNYSLYCWGNESF 296
+ ++ G +F
Sbjct: 253 CTFMRESQTQVIWATGLNNF 272
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 27/181 (14%), Positives = 51/181 (28%), Gaps = 50/181 (27%)
Query: 159 IAVGEDFVCGLLENGTITCFGS--------------RNSPTSVTQKVPSGIFRVVAAGFR 204
IA + G + G+ R + V ++AG
Sbjct: 29 IAFHLELPKRRTVLGNVLVCGNGDVGQLGLGEDILERKRLSPV--AGIPDA-VDISAGGM 85
Query: 205 HVCAIDDDQELRCWGD-----------------SVGEVPQG-KFKALALGENRSCALRNN 246
H + ++ +G + K ++ G++ S L +
Sbjct: 86 HNLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLED 145
Query: 247 QKVVCWG-------QNGFTLPDSLQGKPFVSIEAKR--SVFCG-----VLTSNYSLYCWG 292
+V WG G T D + P +E S+ G +LT+ ++ G
Sbjct: 146 GRVFAWGSFRDSHGNMGLT-IDGNKRTPIDLMEGTVCCSIASGADHLVILTTAGKVFTVG 204
Query: 293 N 293
Sbjct: 205 C 205
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 27/194 (13%), Positives = 48/194 (24%), Gaps = 54/194 (27%)
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFGS--------------------RNSPTSVTQKVPS 193
+IA G D + L G + G ++
Sbjct: 179 TVCCSIASGADHLVILTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLII 238
Query: 194 GI---FRVVAAGFRHVCAI-DDDQELRCWGD-SVGE----------------VPQGKFKA 232
F + A Q + G + + +
Sbjct: 239 TRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRH 298
Query: 233 LALGENRSCALRNNQKVVCWGQN-------GFTLPDSLQGKPFVSIEAK-RSVFCG---- 280
+A G++ + L + K G+ G + + K SV CG
Sbjct: 299 IAGGQHHTVILTTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVCS 358
Query: 281 -VLTSNYSLYCWGN 293
+T + LY WG+
Sbjct: 359 YAVTIDGKLYSWGS 372
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 21/145 (14%), Positives = 43/145 (29%), Gaps = 30/145 (20%)
Query: 179 GSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGD-SVGEVPQG--------- 228
+ N+ Q+ P +A + G+ VG++ G
Sbjct: 9 TNNNNAGEAEQQPPKAKRARIAFHLELPKRRTVLGNVLVCGNGDVGQLGLGEDILERKRL 68
Query: 229 -------KFKALALGENRSCALRNNQKVVCWGQNGF------TLPDSLQGKP-FVSIEAK 274
++ G + L + + +G N T D + KP + + K
Sbjct: 69 SPVAGIPDAVDISAGGMHNLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGK 128
Query: 275 -RSVFCG-----VLTSNYSLYCWGN 293
+ G L + ++ WG+
Sbjct: 129 ALCISAGDSHSACLLEDGRVFAWGS 153
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 22/140 (15%), Positives = 35/140 (25%), Gaps = 30/140 (21%)
Query: 148 FNSTSIHNFSNIAVGEDFVCGLL-ENGTITCFGSRN---------SPTSVTQKVPSGIFR 197
T F I + I G N + + +
Sbjct: 236 LIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKD 295
Query: 198 V--VAAGFRHVCAIDDDQELRCWG------------DSVGEVPQ------GKFKALALGE 237
+ +A G H + D + G V E P K ++ GE
Sbjct: 296 IRHIAGGQHHTVILTTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGE 355
Query: 238 NRSCALRNNQKVVCWGQNGF 257
S A+ + K+ WG
Sbjct: 356 VCSYAVTIDGKLYSWGSGVN 375
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+GSFG V + A+K + + +Q + NE L ++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQ-----KVVKLKQIEHTL---NEKRILQAVNF 100
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGI 583
LV+L +D + ++ EY+ G + HL S + + A+I +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------ 154
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
EYLH +I+RD+K N+L+D +V+DFG + +L GT +
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTL--CGTPEALA 206
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
PE + + D ++ GV++ E+ +GY
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 33/200 (16%), Positives = 58/200 (29%), Gaps = 60/200 (30%)
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGIFRVVA 200
+N +A G+D + L E G + +G T + + +A
Sbjct: 204 YNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIA 263
Query: 201 AGFRHVCAIDDDQELRCWGD---------------SVGEVPQ-------GKFKALALGEN 238
+G H A+ D +L WG ++ P+ +++A GE+
Sbjct: 264 SGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIAAGEH 323
Query: 239 RSCALRNNQKVVCWGQNGF------------TLPDSLQGKPFVSIEAKR--------SVF 278
S L + + G+ + GK + SV
Sbjct: 324 HSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFKSVA 383
Query: 279 CG-----VLTSNYSLYCWGN 293
G + N Y WG
Sbjct: 384 AGSHHSVAVAQNGIAYSWGF 403
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 37/229 (16%), Positives = 51/229 (22%), Gaps = 87/229 (37%)
Query: 147 DFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGS-------------------------- 180
F + AVG L E + +G
Sbjct: 60 PFLPRDEAKIISFAVGGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSS 119
Query: 181 ------RNSPTSVTQKVPSGIFRV---------VAAGFRHVCAIDDDQELRCWGDS---- 221
N S K+P F +AA CA+ + E+ WG
Sbjct: 120 DDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALFSNGEVYAWGTFRCNE 179
Query: 222 ------------------VGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGF------ 257
V + LA G++ L V WG
Sbjct: 180 GILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRK 239
Query: 258 --------TLPDSLQGKPFVSIEAKRSVFCG-----VLTSNYSLYCWGN 293
TL G V + + G LT + L WG
Sbjct: 240 VMERFRLKTLDPRPFGLRHV-----KYIASGENHCFALTKDNKLVSWGL 283
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 35/226 (15%), Positives = 55/226 (24%), Gaps = 93/226 (41%)
Query: 158 NIAVGEDFVCGLLENGTITCFGS----------------RNSPTSVTQKVPSGIFRV-VA 200
N + ++ I C+G+ P + A
Sbjct: 14 NAQEDYKHMYLSVQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFA 73
Query: 201 AGFRHVCAIDDDQELRCWG----------------------------------------- 219
G H A+D++ + WG
Sbjct: 74 VGGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTP 133
Query: 220 -----DSVGEVPQG-KFKALALGENRSCALRNNQKVVCWGQN-------GFT-------- 258
+S + +G K LA +N SCAL +N +V WG GF
Sbjct: 134 AKIPRESFPPLAEGHKVVQLAATDNMSCALFSNGEVYAWGTFRCNEGILGFYQDKIKIQK 193
Query: 259 LP---DSLQGKPFVSIEAKRSVFCG-----VLTSNYSLYCWGNESF 296
P + V + G L ++ WGN
Sbjct: 194 TPWKVPTFSKYNIVQLA------PGKDHILFLDEEGMVFAWGNGQQ 233
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 26/152 (17%), Positives = 45/152 (29%), Gaps = 46/152 (30%)
Query: 152 SIHNFSNIAVGEDFVCGLLENGTITCFG-------------SRNSPTSVTQKVPSGI--- 195
+ + IA GE+ L ++ + +G + + +++
Sbjct: 255 GLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVV 314
Query: 196 FRVVAAGFRHVCAIDDDQELRCWGD-----------------------SVGEVPQ----- 227
R +AAG H + D +L G VP
Sbjct: 315 IRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLN 374
Query: 228 --GKFKALALGENRSCALRNNQKVVCWGQNGF 257
KFK++A G + S A+ N WG
Sbjct: 375 NVPKFKSVAAGSHHSVAVAQNGIAYSWGFGET 406
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 23/165 (13%), Positives = 40/165 (24%), Gaps = 65/165 (39%)
Query: 199 VAAGFRHVCAIDDDQELRCWGD-SVGE----------------------VPQGKFKALAL 235
++H+ ++ CWG S+ E + K + A+
Sbjct: 15 AQEDYKHMYLSVQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAV 74
Query: 236 GENRSCALRNNQKVVCWGQNGF----------------------------------TLPD 261
G + AL V WG N + P
Sbjct: 75 GGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPA 134
Query: 262 SLQGKPFVSIEAKR---SVFCG-----VLTSNYSLYCWGNESFSS 298
+ + F + + L SN +Y WG +
Sbjct: 135 KIPRESFPPLAEGHKVVQLAATDNMSCALFSNGEVYAWGTFRCNE 179
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 49/276 (17%)
Query: 407 DEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHK 466
D + QA + P E+ LA + + EF LL
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL----------- 156
Query: 467 IGSGSFGAVYKATLDDGSQV-AVK---------RAEISSTSSYAIGTKRQEDKDNAFINE 516
G G+FG V + A+K + E++ T + E
Sbjct: 157 -GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-----------------LTE 198
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L H L L + ++R+ + EY G L HL + AR
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYG 254
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A + ++YLH ++++RD+K N++LD K++DFGL G +D + +
Sbjct: 255 A-EIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-- 309
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE D + GVV+ E++ G
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G+GSFG V+ + A+K + + +Q + N +E LS + H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKE-----IVVRLKQVEHTN---DERLMLSIVTH 65
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHL------HNPQSSSPLKSWPARIKVALDA 579
++R+ G +D + +I +Y+E G L L NP + K + A + +AL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAAEVCLAL-- 119
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
EYLH II+RD+K N+LLD K++DFG + + +L GT
Sbjct: 120 ----EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTL--CGTP 167
Query: 640 GYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
Y+ PE + + D +SFG+++ E+L+GY
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 29/200 (14%), Positives = 51/200 (25%), Gaps = 44/200 (22%)
Query: 457 ATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR------QEDKD 510
T KIG G FG V++ D + VA+K I ++ E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 511 NAFINELESLSRLHHKNLVRLLGFC------------------------------EDRNE 540
+ ++ L + + L ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 541 RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
++ E+ G + + L S + + HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLH 189
Query: 601 SSNVLLDATWTAKVSDFGLS 620
NVLL T K+
Sbjct: 190 WGNVLLKKTSLKKLHYTLNG 209
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 50/225 (22%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSS-YAIGTKRQEDKDN--AFINELES---- 519
+G G +G V++ V++ ++T +A+ + K +
Sbjct: 25 LGKGGYGKVFQ----------VRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAE 71
Query: 520 ---LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L + H +V L+ + ++ LI EYL G L L
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG------------IF 118
Query: 576 ALDAAR--------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
D A + +LH+ II+RD+K N++L+ K++DFGL D
Sbjct: 119 MEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ GT+ YM PE D +S G ++ ++L+G
Sbjct: 176 TVTHTF--CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 38/216 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVK---------RAEISSTSSYAIGTKRQEDKDNAFINE 516
+G G+FG V + A+K + E++ T + E
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-----------------VTE 55
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L H L L + ++R+ + EY G L HL AR
Sbjct: 56 SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG 111
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A + +EYLH +++RDIK N++LD K++DFGL G D + +
Sbjct: 112 A-EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-- 165
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE D + GVV+ E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR----QEDKDNAFINELESLSR 522
+G GSFG V+ + K + + YA+ + + E + L
Sbjct: 32 LGQGSFGKVF---------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 523 LHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
++H +V+L + ++ LI ++L G L L + + +
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK------------EVMFTEEDVK 129
Query: 582 --------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+++LH II+RD+K N+LLD K++DFGLS + ++ S
Sbjct: 130 FYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GTV YM PE + T+ +D +SFGV++ E+L+G
Sbjct: 187 --CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 3e-12
Identities = 69/376 (18%), Positives = 125/376 (33%), Gaps = 44/376 (11%)
Query: 308 PGPCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRM 367
P P P + E + + ++ + R
Sbjct: 195 PYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRN 254
Query: 368 VALLVVGCLGSLVVVLVSAFFGYKHCKCKGCRVHDSGR--LDEAEAQAQSAQPPMPPPPP 425
+ + S + + + +G + E + +
Sbjct: 255 DFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQG 314
Query: 426 SPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQ 485
+ EK + ++ N G + L +F+ +G GSFG V + +
Sbjct: 315 TKAPEEKTANTISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 486 VAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELESL--------SRLHHKNLVRLLGFCE 536
+ YA+ + KD +++E L +L C
Sbjct: 368 L------------YAVKILK---KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCF 411
Query: 537 DRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSII 595
+R+ + EY+ G L H+ Q K A A + A G+ +L II
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAA-EIAIGLFFLQSK---GII 464
Query: 596 HRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEK 655
+RD+K NV+LD+ K++DFG+ D + + GT Y+ PE Q +
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTPDYIAPEIIAYQPYGKS 522
Query: 656 SDVYSFGVVLLEILSG 671
D ++FGV+L E+L+G
Sbjct: 523 VDWWAFGVLLYEMLAG 538
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 52/225 (23%), Positives = 86/225 (38%), Gaps = 34/225 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N + KIGSGSFG +Y T + G +VA+K + + K E
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------------ECVKTKHPQLHIES 55
Query: 518 ESLSRLHHKNLV-RLLGFCEDRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKV 575
+ + + + + + V++ E L G +L D + LK+ + +
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKT---VLLL 110
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK---VSDFGLSL--IGPEDDESH 630
A IEY+H + IHRD+K N L+ + DFGL+ + H
Sbjct: 111 ADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ-H 166
Query: 631 LSLRAA----GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+ R GT Y + + + + D+ S G VL+ G
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELES------ 519
IG GS+ V L ++ YA+ + K+ +++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRI------------YAMKVVK---KELVNDDEDIDWVQTEKH 61
Query: 520 --LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+H LV L C R+ + EY+ G L H+ Q L AR A
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSA 117
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ + + YLHE II+RD+K NVLLD+ K++D+G+ G ++ +
Sbjct: 118 -EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--C 171
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE R + D ++ GV++ E+++G
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 47/288 (16%)
Query: 401 HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNN 460
H +E + A L +L + G E+ +E N
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-------N 55
Query: 461 FSEDHK-IGSGSFGAVY---KATLDDGSQV-AVK---RAEISSTSSYAIGTKRQEDKDNA 512
F E K +G+G++G V+ K + D ++ A+K +A I ++ + ++
Sbjct: 56 F-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI---------VQKAKTTEHT 105
Query: 513 FINE---LESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKS 568
E LE + LV L + ++ LI +Y+ G L HL
Sbjct: 106 -RTERQVLEHIR--QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTE 158
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPED 626
+I V + +E+LH+ II+RDIK N+LLD+ ++DFGLS + E
Sbjct: 159 HEVQIYVG-EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQL-TEKS-DVYSFGVVLLEILSGY 672
+ ++ GT+ YM P+ R +K+ D +S GV++ E+L+G
Sbjct: 215 ERAY-DF--CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELES------ 519
IG GS+ V L ++ YA+ + K+ +++
Sbjct: 60 IGRGSYAKVLLVRLKKTDRI------------YAMRVVK---KELVNDDEDIDWVQTEKH 104
Query: 520 --LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+H LV L C R+ + EY+ G L H+ Q L AR A
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSA 160
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ + + YLHE II+RD+K NVLLD+ K++D+G+ G ++ +
Sbjct: 161 -EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--C 214
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE R + D ++ GV++ E+++G
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
++ +IG GSFG +++ T L + QVA+K + + +E
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------------EPRRSDAPQLRDEY 56
Query: 518 ESLSRLHHKNLV-RLLGFCEDRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKV 575
+ L + + F ++ VL+ + L G +L D L +K+
Sbjct: 57 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT---VAMA 111
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK-----VSDFGLSL--IGPEDDE 628
A ++ +HE S+++RDIK N L+ + V DFG+ P +
Sbjct: 112 AKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 629 SHLSLRA----AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
H+ R +GT YM + ++ + + D+ + G V + L G
Sbjct: 169 -HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 62/269 (23%), Positives = 98/269 (36%), Gaps = 55/269 (20%)
Query: 418 PPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHK-IGSGSFGAVY 476
M P PP ++++ S + +F K IG GSFG V
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHF-------------LKVIGKGSFGKVL 55
Query: 477 KATLDDGSQV-AVK---------RAEISSTSSYAIGTKR--QEDKDNAFINELESLSRLH 524
A AVK + E + + ++ + F L LH
Sbjct: 56 LARHKAEEVFYAVKVLQKKAILKKKEEKHI----MSERNVLLKNVKHPF------LVGLH 105
Query: 525 HKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGI 583
F +++ + +Y+ G L HL + + AR A + A +
Sbjct: 106 ---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR---ARFYAA-EIASAL 152
Query: 584 EYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMD 643
YLH +I++RD+K N+LLD+ ++DFGL E + + + GT Y+
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEYLA 207
Query: 644 PEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
PE Q D + G VL E+L G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 28/169 (16%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 466 KIGSGSFGAVYKAT---------LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
+ G +Y+A + ++K + + Q +N+
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 517 LESLSRLHHKNLVRLLGF-CEDRNERVLIYEYLENGT-LHDHL-HNPQSSSPLKSWPARI 573
+ L + +GF R L+ L G L L +P+ +S +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS---VL 162
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV--SDFGLS 620
+VA +E+LHE +H ++ + N+ +D ++V + +G +
Sbjct: 163 QVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 53/224 (23%)
Query: 467 IGSGSFGAVYKATL-DDGSQVAVK---------RAEISSTSSYAIGTKRQEDKDNAFINE 516
+G GSFG V+ A A+K ++ T + KR +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT----MVEKR--------VLS 72
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L H L + E + + EYL G L H+ + K
Sbjct: 73 LAW----EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH------------KF 115
Query: 576 ALDAAR--------GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
L A G+++LH I++RD+K N+LLD K++DFG+ D
Sbjct: 116 DLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+ GT Y+ PE Q+ D +SFGV+L E+L G
Sbjct: 173 AKTNTF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 467 IGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI-NELES------ 519
+G GSFG V A + + + YA+ + KD +++E
Sbjct: 31 LGKGSFGKVMLARVKETGDL------------YAVKVLK---KDVILQDDDVECTMTEKR 75
Query: 520 --LSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+H L +L C +R+ + E++ G L H+ Q S AR A
Sbjct: 76 ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAA 131
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ + +LH+ II+RD+K NVLLD K++DFG+ G + + +
Sbjct: 132 -EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--C 185
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE + D ++ GV+L E+L G
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 36/170 (21%), Positives = 61/170 (35%), Gaps = 29/170 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
NF KIG G+FG + L VA+K E + + E
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LE------------PMKSRAPQLHLEY 55
Query: 518 ESLSRLHH-KNLVRLLGFCEDRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKV 575
+L + ++ F ++ E L G +L D + LK+ + +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKT---VLMI 110
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS-----DFGLS 620
A+ +EY+H ++I+RD+K N L+ DF L+
Sbjct: 111 AIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 467 IGSGSFGAVYKATLDDGSQV-AVK---------RAEISSTSSYAIGTKRQEDKDNAFINE 516
+G GSFG V + ++ AVK ++ T ++
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-----VEK---------RV 73
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERV-LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKV 575
L + L +L C +R+ + EY+ G L H+ Q K A
Sbjct: 74 LALPGK--PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYA 127
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRA 635
A + A G+ +L II+RD+K NV+LD+ K++DFG+ D + +
Sbjct: 128 A-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-- 181
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
GT Y+ PE Q + D ++FGV+L E+L+G
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 21/169 (12%)
Query: 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
IG G FG +Y A ++ V + G E K + E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 525 HKNLVRLLGFC----------EDRNERVLIYEYLENGT-LHDHLHNPQSSSPLKSWPARI 573
++ LG ++ R +I + G+ L K+ +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKT---VL 155
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV--SDFGLS 620
+++L +EY+HE+ +H DIK+SN+LL+ +V D+GL+
Sbjct: 156 QLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 32/224 (14%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N F KIGSGSFG +Y T + +VA+K + + K + E
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------ENVKTKHPQLLYES 53
Query: 518 ESLSRLHHKNLV-RLLGFCEDRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKV 575
+ L + + F + + VL+ + L G +L D + LK+ + +
Sbjct: 54 KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKT---VLML 108
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK---VSDFGLS-LIGPEDDESHL 631
A +E++H S +HRDIK N L+ A + DFGL+ H+
Sbjct: 109 ADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 632 SLRAA----GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
R GT Y + + + + D+ S G VL+ L G
Sbjct: 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDK------DNAFINELE 518
KIGSG FG +Y A + + A ++ + G E K I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN---GPLFSELKFYQRVAKKDCIKKWI 100
Query: 519 SLSRLHHKNLVRLLGF----CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
+L + + G + R+ R ++ E L G + + + ++
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST---VLQ 155
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV--SDFGLS 620
+ + +EY+HE +H DIK++N+LL +V +D+GLS
Sbjct: 156 LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/240 (20%), Positives = 91/240 (37%), Gaps = 66/240 (27%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
K+G G F V+ A + + + VA+K + Y A +E++ L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYT----------EAAEDEIKLLQRVN 73
Query: 525 -----------HKNLVRLLGFCEDRNER----VLIYEYL-ENGTLHDHL----HNPQSSS 564
++++LL + V+++E L EN L + H
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLI 131
Query: 565 PLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD------ATWTAKVSDFG 618
+K ++ + LD Y+H IIH DIK NVL++ K++D G
Sbjct: 132 YVKQISKQLLLGLD------YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSGY 672
+ E + + R Y PE + +D++S ++ E+++G
Sbjct: 184 NACWYDEHYTNSIQTRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 52/225 (23%)
Query: 467 IGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG GSFG V KA VA+K + + + E+ L L
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKM--VRNEKRFH----------RQAAEEIRILEHLRK 152
Query: 526 K------NLVRLLGFCEDRNERVLIYEYLENGTLHDHL----HNPQSSSPLKSWPARIKV 575
+ N++ +L RN + +E L L++ + S ++ + I
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 576 ALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA--KVSDFGLSLIGPEDDESHLSL 633
LD LH+ IIH D+K N+LL + KV DFG S + +++
Sbjct: 212 CLD------ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
Query: 634 RAAGTVGYMDPEYYR----LQQL--TEKSDVYSFGVVLLEILSGY 672
R +YR + D++S G +L E+L+GY
Sbjct: 263 R-----------FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 67/518 (12%), Positives = 146/518 (28%), Gaps = 144/518 (27%)
Query: 257 FTLPDSLQG--KPFVSIEAKRS----VFCG-VLTSNYSLYCWGNESFSSNHMVFERVLPG 309
D++ G + F ++ +K+ F VL NY + + E+ P
Sbjct: 55 IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK---FLMSPIKT-----EQRQPS 106
Query: 310 PCTNTCPCPMLPGSGNVCGEGQIICQPCFEKTSVT-PSPTPQPQQPPESGSRGGWSGRMV 368
T + + + Q+ F K +V+ P + +Q
Sbjct: 107 MMTRM----YIEQRDRLYNDNQV-----FAKYNVSRLQPYLKLRQALLELRPAKN----- 152
Query: 369 ALLVVGCLGS----LVVVLVSAFFGYKHCKCKGCRVH--DSGRLDEAEA-----QAQSAQ 417
+L+ G LGS + + + + YK ++ + + E Q Q
Sbjct: 153 -VLIDGVLGSGKTWVALDVCLS---YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 418 PPMPPPPPSPPVLEKKLSQLASMGNAGRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYK 477
++ + + + +L + + + Y+
Sbjct: 209 ------------IDPNWTSRSDHSSNIKLR---IHSIQAELRRLLKSKP---------YE 244
Query: 478 ATL---DDGSQVAVKRAEISSTSSYAIG-----TKRQEDKDNAFINELESLSRLHHKNLV 529
L + V+ A+ +++ + T R + L + + H
Sbjct: 245 NCLLVLLN-----VQNAKA--WNAFNLSCKILLTTR----FKQVTDFLSAATTTHISLDH 293
Query: 530 RLLGFCEDRNERVLIYEYLENGTLHD-----HLHNPQSSS----PLKSWPAR-------- 572
+ D + +L+ +YL + D NP+ S ++ A
Sbjct: 294 HSMTLTPDEVKSLLL-KYL-DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 573 -------IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPE 625
I+ +L+ EY + S+ +LL W +
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD------VM 405
Query: 626 DDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685
+ L + + +Y + L L A+HR+
Sbjct: 406 VVVNKLHKYSL-VEKQPKESTISIP------SIY---LELKVKLENEYALHRS------- 448
Query: 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY 723
+VD I + D + P + +++G+
Sbjct: 449 IVD-------HYNIPKTFDSDDLIPPYLDQYFYSHIGH 479
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 95/709 (13%), Positives = 198/709 (27%), Gaps = 247/709 (34%)
Query: 147 DFNSTSI-HNFSNI------AVGEDFVCGLLENGTITCFGSR------NSPTSVTQ---- 189
DF + + + +I A ++F C +++ + S +V+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 190 ------KVPSGIFRVV-----------AAGFRHVC-------AIDDDQELRCWGDSV--- 222
K + + V + + + +Q R + D+
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 223 -GEVPQGK-FKAL--ALGENRSCALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVF 278
V + + + L AL E LR + V+ G G GK +V+++ S
Sbjct: 128 KYNVSRLQPYLKLRQALLE-----LRPAKNVLIDGVLGS-------GKTWVALDVCLSY- 174
Query: 279 CGVLTS-NYSLYCW---GNESFSSNHMVFERVLPGPCTNTCPCPMLPGSGNVCGEGQIIC 334
V ++ ++ W N +S V E ML Q +
Sbjct: 175 -KVQCKMDFKIF-WLNLKNC--NSPETVLE--------------ML----------QKLL 206
Query: 335 QPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLV----VGCLGSLVV--V----LV 384
+ + + S + LL CL LV+ V
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHS-----IQAELRRLLKSKPYENCL--LVLLNVQNAKAW 259
Query: 385 SAFFGYKHCKCKGCRV----HDSGRLDEAEAQAQSAQPPMPPPPPSPPVLEKKLSQLASM 440
+AF C++ D A + L+ L
Sbjct: 260 NAFNL-------SCKILLTTRFKQVTDFLSAATT-----------THISLDHHSMTLT-- 299
Query: 441 GNAGRLEEFSLEILLEATNNFSED--HKIGSGS------FGAVYK---ATLDDGSQVAVK 489
+ +LL+ + +D ++ + + + AT D+ V
Sbjct: 300 ------PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 490 R-AEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG-FCEDRN--ERVL-I 544
+ I +S L L ++ + L F + +L +
Sbjct: 354 KLTTIIESS-------------------LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394
Query: 545 Y----EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600
+ + + LH S ++ P + + + + + +
Sbjct: 395 IWFDVIKSDVMVVVNKLHK---YSLVEKQPKESTI---------SIPSIYLELKVKLENE 442
Query: 601 SS--NVLLDATWTAKVSDFGLSLIGPEDDE---SHLSLRAAGTVGYMDPEYYRLQQLTEK 655
+ ++D K D LI P D+ SH+ G+ + + + E+
Sbjct: 443 YALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHI--------GH----HLKNIEHPER 489
Query: 656 SDVYSFGVVLLEILSGYRAIHRT--HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPF 713
+ F +V L+ +R + + H+ T N ++ + + +
Sbjct: 490 MTL--FRMVFLD----FRFLEQKIRHDSTAWNASGSILNTLQQLKF-------------- 529
Query: 714 EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSISRS 762
Y Y+ N P +VN++ L ++ S
Sbjct: 530 ------YKPYIC--------DNDPKYERLVNAILDFLPKI--EENLICS 562
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 52/227 (22%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL- 523
IG GSFG V KA + VA+K I + ++ N E+ L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKI--IKNKKAFL----------NQAQIEVRLLELMN 108
Query: 524 -----HHKNLVRLLGFCEDRNERVLIYEYLE-NGTLHDHL----HNPQSSSPLKSWPARI 573
+V L RN L++E L N L+D L S + + + ++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL--DATWTAKVSDFGLSLIGPEDDESHL 631
AL +L + SIIH D+K N+LL K+ DFG S + ++
Sbjct: 167 CTALL------FLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 632 SLRAAGTVGYMDPE------YYRLQQLTEKSDVYSFGVVLLEILSGY 672
R Y PE Y D++S G +L+E+ +G
Sbjct: 220 QSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 47/282 (16%), Positives = 84/282 (29%), Gaps = 89/282 (31%)
Query: 465 HKIGSGSFGAVYKA-TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
K+G G F V+ + + VA+K + + + A ++E+ L +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK-----------VVKSAEHYTETA-LDEIRLLKSV 90
Query: 524 H--------HKNLVRLLG-FCEDRNE---RVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
+ +V+LL F +++E L HL S + P
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-----VLGHHLLKWIIKSNYQGLPL 145
Query: 572 RI--KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----------------------- 606
K+ +G++YLH IIH DIK N+LL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 607 --------------------------DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVG 640
K++D G + + + T
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQ 258
Query: 641 YMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682
Y E +D++S + E+ +G + H+G
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEPHSGE 299
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 28/157 (17%), Positives = 55/157 (35%), Gaps = 20/157 (12%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G AV+ + + VK ++ TS + KR + D F +R
Sbjct: 97 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKR-DYGDLHFSVLAIRSARNEF 155
Query: 526 KNLVRLLGFC----EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+ L +L G ++ E ++ L+ + +P +
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELID----AKELYRVRVENPDEVL----------DM 201
Query: 582 GIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618
+E + ++ I+H D+ NVL+ + DF
Sbjct: 202 ILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 50/257 (19%), Positives = 87/257 (33%), Gaps = 81/257 (31%)
Query: 466 KIGSGSFGAVYKA--TLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
+G G+FG V + SQVA+K I + Y ++ A + E+ L ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKI--IRNVGKY---------REAARL-EINVLKKI 73
Query: 524 HHK------NLVRLLGFCEDRNERVLIYEYLENGTLHDHL----HNPQSSSPLKSWPARI 573
K V + + + +E L + L P ++ ++
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA-------------------KV 614
AL +LHE + H D+K N+L + +V
Sbjct: 133 CHALR------FLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 615 SDFGLSLIGPEDDESHLSL------RAAGTVGYMDPE-----YYRLQQLTEKSDVYSFGV 663
+DFG + D E H ++ R PE + + DV+S G
Sbjct: 184 ADFGSATF---DHEHHTTIVATRHYRP--------PEVILELGW-----AQPCDVWSIGC 227
Query: 664 VLLEILSGYRAIHRTHN 680
+L E G+ + +TH
Sbjct: 228 ILFEYYRGF-TLFQTHE 243
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 83/260 (31%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL- 523
K+G G+FG V +D+ AVK + + Y + E + L ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV--VRNIKKYT----------RSAKIEADILKKIQ 89
Query: 524 ----HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHL-HNPQSSSPLKSWPARIK-VAL 577
++ N+V+ G + LI+E L +L++ + N + ++ IK +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIE----DIKLYCI 144
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA------------------------- 612
+ + + YL + S+ H D+K N+LLD +
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 613 KVSDFGLSLIGPEDDESHLSL------RAAGTVGYMDPE------YYRLQQLTEKSDVYS 660
K+ DFG + + H S+ RA PE + SD++S
Sbjct: 202 KLIDFGCATF---KSDYHGSIINTRQYRA--------PEVILNLGW------DVSSDMWS 244
Query: 661 FGVVLLEILSGYRAIHRTHN 680
FG VL E+ +G + RTH
Sbjct: 245 FGCVLAELYTGS-LLFRTHE 263
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.28 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 96.13 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 96.09 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.71 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 95.64 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.37 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 95.33 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 94.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.7 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 94.6 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.53 | |
| 2zwa_A | 695 | Leucine carboxyl methyltransferase 2; HET: SAH CIT | 91.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.28 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.91 | |
| 3v7d_B | 464 | Cell division control protein 4; WD 40 domain, pho | 90.31 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.02 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.98 | |
| 1k3i_A | 656 | Galactose oxidase precursor; blade beta propeller, | 88.5 | |
| 3k26_A | 366 | Polycomb protein EED; WD40, structural genomics, N | 87.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.05 | |
| 3i2n_A | 357 | WD repeat-containing protein 92; WD40 repeats, str | 86.05 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.23 | |
| 3sfz_A | 1249 | APAF-1, apoptotic peptidase activating factor 1; a | 84.83 | |
| 3v7d_B | 464 | Cell division control protein 4; WD 40 domain, pho | 84.59 | |
| 3odt_A | 313 | Protein DOA1; ubiquitin, nuclear protein; HET: MSE | 83.7 | |
| 4g56_B | 357 | MGC81050 protein; protein arginine methyltransfera | 82.78 | |
| 3mkq_A | 814 | Coatomer beta'-subunit; beta-propeller, alpha-sole | 81.19 | |
| 3mkq_A | 814 | Coatomer beta'-subunit; beta-propeller, alpha-sole | 81.16 | |
| 1vyh_C | 410 | Platelet-activating factor acetylhydrolase IB alph | 81.07 | |
| 1gxr_A | 337 | ESG1, transducin-like enhancer protein 1; transcri | 81.07 | |
| 2zwa_A | 695 | Leucine carboxyl methyltransferase 2; HET: SAH CIT | 81.03 | |
| 4aez_A | 401 | CDC20, WD repeat-containing protein SLP1; cell cyc | 80.53 | |
| 3k26_A | 366 | Polycomb protein EED; WD40, structural genomics, N | 80.01 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=449.97 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=212.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|.+.++||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++|+|||||+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------~~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------SDNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----------ChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 46778899999999999999864 4678999998632 234567899999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQ---------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+++.+++..+|||||+++|+|.++|+... .....++|..+++++.||++||+|||+++ |+||||||+|
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~N 158 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 158 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhh
Confidence 99999999999999999999999997532 23345799999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCC
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGT 682 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~ 682 (768)
|||++++.+||+|||+|+...............||+.|||||++....++.++|||||||+||||+| |+.||......
T Consensus 159 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~- 237 (299)
T 4asz_A 159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 237 (299)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred EEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999999986544333333334568999999999999999999999999999999999 89998643210
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+-+..+.+...++ . ....+..+.+|+.+||+.||++||||+||++.|+++.++.
T Consensus 238 --------------~~~~~i~~~~~~~-~--p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 238 --------------EVIECITQGRVLQ-R--PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp --------------HHHHHHHHTCCCC-C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred --------------HHHHHHHcCCCCC-C--CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111222222111 1 1123456779999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=451.37 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=205.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|.+.++||+|+||+||+|++. +++.||||+++.. .+...++|.+|+++|++|+|||||+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------~~~~~~~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------SESARQDFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----------SHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35677789999999999999864 4788999998532 234567899999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS-----------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
+++.+.+..+|||||+++|+|.++|+.... ....++|..+++|+.||++||+|||+++ |+||||||
T Consensus 110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp 186 (329)
T 4aoj_A 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLAT 186 (329)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccH
Confidence 999999999999999999999999976432 1234789999999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
+||||++++.+||+|||+++...............||+.|||||++....++.++|||||||+||||+| |+.||.....
T Consensus 187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999986554444444445679999999999999999999999999999999999 8999864321
Q ss_pred CCcccccccccchhhhhhHHhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
. +-+..+... +++.+ ...+..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 267 ~---------------~~~~~i~~g~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 T---------------EAIDCITQGRELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H---------------HHHHHHHHTCCCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H---------------HHHHHHHcCCCCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 011112111 11111 12345678999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=443.57 Aligned_cols=260 Identities=31% Similarity=0.498 Sum_probs=203.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+|+++ ..||||+++... ......++|.+|++++++++|||||++++++.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~---------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD---------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS---------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 46788899999999999999876 369999886431 223456789999999999999999999998864
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+|||||+++|+|.++|+... ..+++..+++|+.||++||+|||+++ ||||||||+||||++++.+||+|||
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCS
T ss_pred CeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeecc
Confidence 56899999999999999997543 34689999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
+|+...............||+.|||||++.. ..|+.++|||||||+||||+||+.||......
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------------- 243 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------------- 243 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------------
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------------
Confidence 9986544333333345689999999999864 35899999999999999999999999643221
Q ss_pred hhhHHhhhccCCCC--CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 696 RDEIHRVLDRNVPP--PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 696 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
..+...+...... ......+.+..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 244 -~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 244 -DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111112111111 111222345667899999999999999999999999987753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=446.08 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=208.0
Q ss_pred CCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++++.++||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||++++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----------~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----------EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----------CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----------ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 4566789999999999999863 46789999986431 2234578999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
++.+.+..+|||||+++|+|.++|+.... ....++|..+++|+.||++||+|||+++ ||||||||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~ 173 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 173 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccc
Confidence 99999999999999999999999965321 1234789999999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHN 680 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~ 680 (768)
+||||++++++||+|||+++.....+.........||+.|||||++....++.++|||||||+||||+| |+.||.....
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544433333345679999999999999999999999999999999999 8999864321
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
. +-...+.+...++ . ..+.+..+.+|+.+||+.||++||||+||++.|+.
T Consensus 254 ---~------------~~~~~i~~~~~~~-~--p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 ---Q------------DVVEMIRNRQVLP-C--PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---H------------HHHHHHHTTCCCC-C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---H------------HHHHHHHcCCCCC-C--cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0 1111222222111 1 12334567899999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=438.00 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=205.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|+..++||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-----------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 142 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-----------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV 142 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-----------CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-----------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46888999999999999999976 79999999986432 1223457899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..||||||+++|+|.+++... .+++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecC
Confidence 99999999999999999999642 3688899999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+....... .....+||+.|||||++....|+.++|||||||+||||++|+.||...... +
T Consensus 215 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---------------~ 277 (346)
T 4fih_A 215 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---------------K 277 (346)
T ss_dssp TTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------H
T ss_pred cCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------------H
Confidence 99986543322 223458999999999999999999999999999999999999999643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+..+.+ ..++........+..+.+|+.+||+.||++|||++|+++.
T Consensus 278 ~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 278 AMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHH-SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHc-CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1222222223445677899999999999999999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=439.64 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=202.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+++.. +++.||||+++... ......+.|.+|+++|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---------MSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---------CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 57999999999999999999875 78999999987542 123446789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..||||||+++|+|.++|.... ...+++...+.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECST
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccc
Confidence 999999999999999999996532 234577888899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+
T Consensus 170 Gla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---------------~~ 232 (350)
T 4b9d_A 170 GIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---------------KN 232 (350)
T ss_dssp TEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------------HH
T ss_pred ccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------------HH
Confidence 9998643221 122345799999999999999999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
-+.+++....++. ....+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~i~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 233 LVLKIISGSFPPV---SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCCC---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223333333221 1223456789999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=432.84 Aligned_cols=277 Identities=25% Similarity=0.351 Sum_probs=204.8
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.+|.+.++||+|+||+||+|+++ |+.||||+++.. ......++.|+..+.+++|||||++++++.++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~------------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc------------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 35777899999999999999985 899999998532 11223344567777889999999999999765
Q ss_pred C----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecCCCCCCeEECCC
Q 046311 539 N----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA-----VPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 539 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDiKp~NILl~~~ 609 (768)
+ ..+|||||+++|+|.++|+.. .++|..+++++.|+++||+|||++. .++|+||||||+||||+.+
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 4 579999999999999999752 3689999999999999999999871 2459999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc--ccccccccccCccCccccccC------CCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 610 WTAKVSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
+++||+|||+++........ .......||+.|||||++.+. .++.++|||||||+||||+||+.|+......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999754332221 122245799999999998754 4678999999999999999998887643322
Q ss_pred CcccccccccchhhhhhH-HhhhccCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 682 TPRNVVDFVVPYIVRDEI-HRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.. ...++.......+.+ ..+.+....+..+ ...+....+.+|+.+||+.||++||||.||++.|+++.+.+.
T Consensus 225 ~~-p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 225 QL-PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CC-TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cc-cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 11 011111000011122 2233333333222 233566788899999999999999999999999999887553
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=435.23 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=205.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|+..++||+|+||+||+|+.+ +|+.||||+++.... +.+|+.++++|+|||||++++++.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45778889999999999999975 689999999864311 2369999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~kl~D 616 (768)
++..||||||+++|+|.++|+.. ..+++.....++.||+.||+|||+++ |+||||||+||||+.++ ++||+|
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECC
T ss_pred CCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEee
Confidence 99999999999999999999753 23688999999999999999999998 99999999999999987 699999
Q ss_pred ccccccCCCCCCcc---cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 617 FGLSLIGPEDDESH---LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 617 FGla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
||+|+......... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||....... +.
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~------ 265 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LC------ 265 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CH------
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH------
Confidence 99998654332211 1223579999999999999999999999999999999999999997543221 10
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..+.....+ ........+..+.+|+.+||+.||++|||+.|+++.|.++++..
T Consensus 266 ------~~i~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 266 ------LKIASEPPP-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ------HHHHHSCCG-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------HHHHcCCCC-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 111111110 00111233456779999999999999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=438.73 Aligned_cols=267 Identities=28% Similarity=0.375 Sum_probs=213.6
Q ss_pred HcCCCCcCceeccCCceEEEEEEEcC------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCce
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLV 529 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv 529 (768)
..++|++.++||+|+||+||+|++.. ++.||||+++.. ......++|.+|+++|.+++| ||||
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~----------~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc----------cChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 35689999999999999999998642 357999988643 123445789999999999965 9999
Q ss_pred eEEEEEEcC-CeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 046311 530 RLLGFCEDR-NERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIH 596 (768)
Q Consensus 530 ~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 596 (768)
+++++|.+. +..+||||||++|+|.++|+.... ....+++..++.++.||++||+|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999998664 568999999999999999975321 1234689999999999999999999998 999
Q ss_pred cCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCccc
Q 046311 597 RDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAI 675 (768)
Q Consensus 597 rDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~ 675 (768)
|||||+||||++++.+||+|||+|+...............||+.|||||++....|+.++|||||||+||||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986655444333445678999999999999999999999999999999998 89999
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
...... +.+.+.+.....++.+ ...+..+.+||.+||+.||++|||+.||++.|++++++.
T Consensus 289 ~~~~~~---------------~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 289 PGVKID---------------EEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TTCCCS---------------HHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCHH---------------HHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 643211 1112222222111111 123456779999999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=421.28 Aligned_cols=248 Identities=28% Similarity=0.448 Sum_probs=196.8
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc---
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED--- 537 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 537 (768)
++.++||+|+||+||+|.+. ++..||||++.... ......+.|.+|+++|++|+|||||++++++.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 55678999999999999875 68999999986432 223445789999999999999999999999865
Q ss_pred -CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEe
Q 046311 538 -RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVS 615 (768)
Q Consensus 538 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~ 615 (768)
++..||||||+++|+|.++|++. ..+++.....++.||++||+|||+++ ++|+||||||+||||+. ++.+||+
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEE
Confidence 34579999999999999999753 34688899999999999999999987 56999999999999984 7999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....
T Consensus 175 DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--------------- 234 (290)
T 3fpq_A 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--------------- 234 (290)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------------
T ss_pred eCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---------------
Confidence 99999754322 2234579999999999874 699999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+.+.+.....+ .......+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 235 AAQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111222221111 1112222345779999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=431.37 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=207.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+++.. +++.||||++..... ..+...+.+.+|+++|++|+|||||++++++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 36889999999999999999875 789999999874311 122345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..||||||+++|+|.++|.+. ..+++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEc
Confidence 99999999999999999999753 23688888999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+..............+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------------~~ 241 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------GL 241 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 999876544433334456899999999999999999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
-..+++...+..+. ..+..+.+|+.+||+.||++|||++|++
T Consensus 242 ~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 242 IFAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12223333332222 2334577999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=437.47 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=204.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-----------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 219 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-----------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV 219 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-----------CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-----------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence 46899999999999999999976 79999999987532 1223458899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..|||||||++|+|.++++.. .+++.....++.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 220 ~~~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 220 GDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecC
Confidence 99999999999999999999642 2688899999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+....... .....+||+.|||||++....|+.++|||||||+||||++|+.||..... . +
T Consensus 292 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~------------~ 354 (423)
T 4fie_A 292 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---L------------K 354 (423)
T ss_dssp TTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H------------H
T ss_pred ccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---H------------H
Confidence 99986543322 22345799999999999999999999999999999999999999964321 0 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+..+.+. ..+........+..+.+|+.+||+.||++|||++|+++.
T Consensus 355 ~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 355 AMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111 111111122334567799999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=413.27 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=190.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.. +++.||||++..... ........+.+|++++++++|||||++++++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--------AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--------CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 58999999999999999999865 789999999875321 122345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..|+||||+ +|+|.+++.+. ..+++.....++.||+.||+|||+++ |+||||||+||||+.++++||+||
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCS
T ss_pred CCEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeec
Confidence 99999999999 67999999653 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+|+....... .....||+.|||||++.+..+ +.++|||||||+||||+||+.||..... .
T Consensus 157 Gla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~------------ 218 (275)
T 3hyh_A 157 GLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---P------------ 218 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H------------
T ss_pred CCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---H------------
Confidence 99976443222 224579999999999988776 5899999999999999999999964321 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.-...+.......+. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 219 ~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 VLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111122222222222 23455778999999999999999999987
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=424.95 Aligned_cols=263 Identities=17% Similarity=0.218 Sum_probs=222.7
Q ss_pred ccccceeeeecCCceeEEeccCCCCCCcceeecC-----------------CccccCCCCCCeeEEeeCCCeeeeeeeec
Q 046311 28 SLSTFSVSETGNQSLVCALIPSSRPGDFSLNCSI-----------------PQLIPVNPNASFASIVSGDGFLCTLITFS 90 (768)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~v~~G~~~~c~l~~~~ 90 (768)
+....+++|++|..|+|||.. ++.++||+ |.+++..++..+.+|++|..|+|+|
T Consensus 13 ~~~~~v~~ia~G~~hs~al~~-----~g~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al---- 83 (406)
T 4d9s_A 13 APPRKVLIISAGASHSVALLS-----GDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAY---- 83 (406)
T ss_dssp --CCCEEEEEECSSEEEEEET-----TTEEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEE----
T ss_pred CCccceEEEecCCCeEEEEEe-----CCEEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEE----
Confidence 345578999999999999997 56788884 2223334455789999999999999
Q ss_pred cCCC-CcEEeccCCCCCccccc--------ccc--cCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-------
Q 046311 91 ASSS-SVMHCWRFSADGIINDY--------KRI--YRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS------- 152 (768)
Q Consensus 91 ~~~~-g~~~~WG~n~~gql~~~--------~~~--~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~------- 152 (768)
+.+ ++||+||.|.+|||+.. .++ ..+.+|++|+||..|+||| +.||+||+||.|.+||+|
T Consensus 84 -~~~gg~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~al-t~~G~v~~wG~n~~GqLG~g~~~~~ 161 (406)
T 4d9s_A 84 -SQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAV-TMEGEVQSWGRNQNGQLGLGDTEDS 161 (406)
T ss_dssp -ETTTTEEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSSSCCCE
T ss_pred -ECCCCEEEEEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEE-cCCCcEEEeCCCCCccCCCCCCCCc
Confidence 565 59999999999999532 222 2345799999999999999 999999999999999998
Q ss_pred ----------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCccc---------ccCC---CcCeEEEeccCceeEEEe
Q 046311 153 ----------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVT---------QKVP---SGIFRVVAAGFRHVCAID 210 (768)
Q Consensus 153 ----------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~---------~~~~---~~~~~~i~~G~~h~~al~ 210 (768)
..++++|+||.+|+|||++||+||+||.|.+||++. ..+. ..++++|+||.+|+++|+
T Consensus 162 ~~p~~v~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~ 241 (406)
T 4d9s_A 162 LVPQKIQAFEGIRIKMVAAGAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVS 241 (406)
T ss_dssp EEEEECGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEE
T ss_pred ccceEecccCCCcEEEEecCCCeEEEEeCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEc
Confidence 236999999999999999999999999999998752 1221 257999999999999999
Q ss_pred cCCcEEEeecCCCCCCCC------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC--------
Q 046311 211 DDQELRCWGDSVGEVPQG------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ-------- 264 (768)
Q Consensus 211 ~~g~v~~wG~n~~gq~~~------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~-------- 264 (768)
+||+||+||.|.+||.+. .|++|++|.+|++||++||+||+||.|.+||||...
T Consensus 242 ~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt~~G~v~~wG~n~~GqLG~g~~~~~~~p~ 321 (406)
T 4d9s_A 242 YSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTSDGKLYGWGWNKFGQVGVGNNLDQCSPV 321 (406)
T ss_dssp TTCCEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSSCEEEEE
T ss_pred CCCCEEEeeCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEcCCCeEEEeeCCCCCCCCCCCCCCCccCE
Confidence 999999999999999431 499999999999999999999999999999998432
Q ss_pred ------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCccc
Q 046311 265 ------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMV 302 (768)
Q Consensus 265 ------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~~ 302 (768)
...+++|+||.+|+++| ++||+||+||+|.+++....
T Consensus 322 ~v~~~~~~~v~~va~G~~hs~al-t~~G~v~~wG~n~~GqLG~g 364 (406)
T 4d9s_A 322 QVRFPDDQKVVQVSCGWRHTLAV-TERNNVFAWGRGTNGQLGIG 364 (406)
T ss_dssp EECCGGGCCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSS
T ss_pred EEeccCCCcEEEEEeCCCeEEEE-eCCCCEEEecCCCCCccCCC
Confidence 23689999999999999 89999999999988776643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=415.32 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||+||+++.. +++.||||+++..... ......+.+|+++|++++|||||+++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK---------VRDRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE---------EEECC------CCCCCCCCTTEECEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC---------hHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 46899999999999999999852 4688999998653211 1122357889999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+++..||||||+++|+|.++|.+. ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 167 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKL 167 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEe
Confidence 99999999999999999999999753 23688889999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||+|+....... .....+||+.|||||++....|+.++|||||||+||||+||+.||.....
T Consensus 168 ~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------------- 231 (304)
T 3ubd_A 168 TDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------------- 231 (304)
T ss_dssp ESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred cccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------------
Confidence 99999975433222 12245799999999999999999999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 744 (768)
.+-...++...+..+. ..+..+.+|+.+||+.||++|||+ +|+++
T Consensus 232 -~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 232 -KETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -HHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112223333332222 234557799999999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=409.27 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=189.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+|+.+ +++.||||+++... .+...+.+.+|+++|++|+|||||++++++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----------RELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 35888999999999999999875 78999999986531 23345679999999999999999999999865
Q ss_pred CC------------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 538 RN------------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 538 ~~------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
.+ ..|+||||+++|+|.++++..... ...++...+.++.||++||+|||+++ |+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NIL 150 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIF 150 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeE
Confidence 44 368999999999999999764322 23456677899999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcc----------cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESH----------LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
|+.++.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||+||||++ ||
T Consensus 151 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf 227 (299)
T 4g31_A 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227 (299)
T ss_dssp ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence 9999999999999997654322111 1123479999999999999999999999999999999996 55
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.... +. ...+..+.+...+ +...+....+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~-----~~---------~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 228 STQM-----ER---------VRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp SSHH-----HH---------HHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc-----HH---------HHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3210 00 0111222222221 122333455678999999999999999999987
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=387.09 Aligned_cols=214 Identities=17% Similarity=0.249 Sum_probs=195.4
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST 151 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~ 151 (768)
.+.+|++|..|+|+| + ||+||+||.|.+|||+.|.... .+|++|++|..|+++| + ||+||+||.|.+||+
T Consensus 25 ~i~~ia~G~~h~~~l-----~-~G~v~~wG~n~~Gqlg~p~~~~--~~i~~ia~G~~hs~~l-~-~G~v~~wG~n~~Gql 94 (282)
T 3qhy_B 25 GVDAIAGGYFHGLAL-----K-GGKVLGWGANLNGQLTMPAATQ--SGVDAIAAGNYHSLAL-K-DGEVIAWGGNEDGQT 94 (282)
T ss_dssp SCCEEEECSSEEEEE-----E-TTEEEEEECCSSSTTSCCGGGG--SCCCEEEECSSEEEEE-E-TTEEEEEECCTTSTT
T ss_pred CCcEEEeCCCeEEEE-----E-CCEEEEEeCCCCCCCCCCccCC--CCEEEEEeCCCEEEEE-E-CCEEEEeeCCCCCCC
Confidence 789999999999999 7 9999999999999998776553 4799999999999999 7 999999999999999
Q ss_pred C-----CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCC
Q 046311 152 S-----IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVP 226 (768)
Q Consensus 152 ~-----~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~ 226 (768)
| ..++++|+||..|+++|+ ||+||+||.|.+||++.......+|++|+||.+|+|+|+ ||+||+||.|.+||.
T Consensus 95 g~P~~~~~~v~~ia~G~~hs~al~-~G~v~~wG~n~~gqlg~~~~~~~~i~~i~~G~~~~~~l~-~G~v~~wG~n~~gql 172 (282)
T 3qhy_B 95 TVPAEARSGVDAIAAGAWASYALK-DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVK-NGGVIAWGDNYFGQT 172 (282)
T ss_dssp CCCGGGSSSEEEEEEETTEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSEEEEEE-TTEEEEEECCTTSTT
T ss_pred CCCcccCCCeEEEECcCCEEEEEe-CCeEEEecCCCCCcCCCCccCCCCeEEEEcccCEEEEEE-CCEEEEecCCCCCCC
Confidence 8 347999999999999999 999999999999998754444578999999999999999 899999999999994
Q ss_pred C------CCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC--CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCC
Q 046311 227 Q------GKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ--GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSS 298 (768)
Q Consensus 227 ~------~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~--~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~ 298 (768)
. .+|++|++|.+|++|| +||+||+||.|.+|||+.+. ...+++|++|..|+++| + ||+||+||.|.+.+
T Consensus 173 g~p~~~~~~v~~i~~G~~hs~al-~~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G~~h~~al-~-~g~v~~wG~n~~gq 249 (282)
T 3qhy_B 173 TVPAEAQSGVDDVAGGIFHSLAL-KDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLAL-K-NGKVIAWGSSRTAP 249 (282)
T ss_dssp SCCGGGGSSEEEEEECSSEEEEE-ETTEEEEEECCTTSTTCCCGGGGSSCCEEEECSSCEEEE-E-TTEEEEESTTCCCC
T ss_pred CCceecCCCeEEEEecCCEEEEE-ECCeEEEEECCCCCCCCCCcccCCCceEEEcCCCEEEEE-E-CCEEEEecCCCCcc
Confidence 3 3799999999999999 89999999999999999765 35799999999999999 8 99999999998765
Q ss_pred Cc
Q 046311 299 NH 300 (768)
Q Consensus 299 ~~ 300 (768)
..
T Consensus 250 ~~ 251 (282)
T 3qhy_B 250 SS 251 (282)
T ss_dssp GG
T ss_pred cc
Confidence 44
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=408.51 Aligned_cols=261 Identities=16% Similarity=0.085 Sum_probs=216.8
Q ss_pred cccceeeeecCCceeEEeccCCCCCCcceeecC----C------------ccccCCCCCCeeEEeeCCCeeeeeeeeccC
Q 046311 29 LSTFSVSETGNQSLVCALIPSSRPGDFSLNCSI----P------------QLIPVNPNASFASIVSGDGFLCTLITFSAS 92 (768)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------------~~~~~~~~~~~~~v~~G~~~~c~l~~~~~~ 92 (768)
.......|++|..|+|+|.. ++.++||+ + .+.++...-.+.+|++|..|+|+| +
T Consensus 22 ~~~~~~~ia~g~~~~~~l~~-----~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~v~~va~G~~h~~~l-----~ 91 (423)
T 3mvd_K 22 PKAKRARIAFHLELPKRRTV-----LGNVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVL-----T 91 (423)
T ss_dssp -------CCCCCCCCCCCCC-----CEEEEEEEECTTSTTCSCSSCCEEEEEEECCSCSSEEEEEECSSEEEEE-----E
T ss_pred ccceeeEEecCCccceeecC-----CCcEEEEeCCCCCCCCCCCCCccCcCCeEccCCCCceEEeeCCCeEEEE-----e
Confidence 34456679999999999997 67888884 1 122233333579999999999999 8
Q ss_pred CCCcEEeccCCCCCccccc----------ccccCCCCeeEEecCCCeEEEEEeCCCcEEEccC--CCCCCCC--------
Q 046311 93 SSSVMHCWRFSADGIINDY----------KRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQW--PDFNSTS-------- 152 (768)
Q Consensus 93 ~~g~~~~WG~n~~gql~~~----------~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~--~~~~~~~-------- 152 (768)
.||+||+||.|.+|||+.. ..+....+|++|+||..|+||| +.||+||+||. |.+||+|
T Consensus 92 ~~G~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al-~~~G~v~~wG~~~n~~GqlG~~~~~~~~ 170 (423)
T 3mvd_K 92 KSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACL-LEDGRVFAWGSFRDSHGNMGLTIDGNKR 170 (423)
T ss_dssp TTSCEEEEECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEE-ETTSCEEEEECEECSSSEEESBTTBCEE
T ss_pred CCCeEEEeECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEE-eCCCeEEEEeCCCCCCCCcCcCCCCCCc
Confidence 9999999999999999532 2333344799999999999999 99999999999 8999987
Q ss_pred -------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccC-----------------------CCcCeEEEecc
Q 046311 153 -------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKV-----------------------PSGIFRVVAAG 202 (768)
Q Consensus 153 -------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~-----------------------~~~~~~~i~~G 202 (768)
..+|++|+||..|++||++||+||+||.|.+||++.... ....|++|+||
T Consensus 171 ~p~~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~p~~v~~~~~~~v~~i~~g 250 (423)
T 3mvd_K 171 TPIDLMEGTVCCSIASGADHLVILTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWAT 250 (423)
T ss_dssp EEEESSTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTTTSSCEEECCTTCCCEEEEEEE
T ss_pred eeeEecCCCcEEEEecCCCeEEEEecCCeEEEeeCCcCCccCCCcccccccccccccccccCCeEEeecCCccEEEEEEC
Confidence 346999999999999999999999999999999864221 11478999999
Q ss_pred CceeEEE-ecCCcEEEeecCCCCCCCC-----------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC
Q 046311 203 FRHVCAI-DDDQELRCWGDSVGEVPQG-----------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ 264 (768)
Q Consensus 203 ~~h~~al-~~~g~v~~wG~n~~gq~~~-----------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~ 264 (768)
.+|++++ ++||+||+||.|.+||.+. +|++|++|.+|+|||++||+||+||.|.+||||...
T Consensus 251 ~~~~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~alt~~G~v~~wG~n~~GqLG~g~ 330 (423)
T 3mvd_K 251 NYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILTTDLKCSVVGRPEYGRLGLGD 330 (423)
T ss_dssp TTEEEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEEETTCCEEEEECCGGGTTCSSS
T ss_pred CcEEEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEEeCCCcEEEEECCCCCCCCCCC
Confidence 9999999 6899999999999999432 699999999999999999999999999999998433
Q ss_pred CC--------------CeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCcc
Q 046311 265 GK--------------PFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHM 301 (768)
Q Consensus 265 ~~--------------~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~ 301 (768)
.. .+++|+||.+|+++| ++||+||+||.|.+++...
T Consensus 331 ~~~~~~~p~~v~~l~~~v~~ia~G~~hs~al-t~~G~v~~wG~n~~GqLG~ 380 (423)
T 3mvd_K 331 VKDVVEKPTIVKKLTEKIVSVGCGEVCSYAV-TIDGKLYSWGSGVNNQLGV 380 (423)
T ss_dssp CCSCEEEEEECTTCCSCEEEEEEETTEEEEE-ETTSCEEEEECCTTSCSSS
T ss_pred ccccccCceEeccCCCCEEEEEcCCCeEEEE-cCCCCEEEECCCCCCCCCC
Confidence 21 589999999999999 9999999999998877654
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=405.93 Aligned_cols=254 Identities=15% Similarity=0.125 Sum_probs=213.5
Q ss_pred eeecCCceeEEeccCCCCCCcceeecC----Cc------------cccCCCCCCeeEEeeCCCeeeeeeeeccCCCCcEE
Q 046311 35 SETGNQSLVCALIPSSRPGDFSLNCSI----PQ------------LIPVNPNASFASIVSGDGFLCTLITFSASSSSVMH 98 (768)
Q Consensus 35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~------------~~~~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~ 98 (768)
+...+..|+|+|.. ++.+++|+ +| |..+.....+.+|++|..|+|+| +.||+||
T Consensus 12 ~~~~~~~h~~~l~~-----~g~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~va~G~~hs~~l-----~~~G~v~ 81 (413)
T 1a12_A 12 SKKVKVSHRSHSTE-----PGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCL-----SKSGQVY 81 (413)
T ss_dssp -CCCCCCCTTCCCC-----CBEEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEE-----ETTSCEE
T ss_pred hhhhccccceeecC-----CCcEEEEECCCCCcCCCCCCccccccceEccCCCCeEEEEeCCCeEEEE-----cCCCCEE
Confidence 45666789999997 56777774 11 11123335789999999999999 8999999
Q ss_pred eccCCCCCccccc----------ccccCCCCeeEEecCCCeEEEEEeCCCcEEEccC--CCCCCCC--------------
Q 046311 99 CWRFSADGIINDY----------KRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQW--PDFNSTS-------------- 152 (768)
Q Consensus 99 ~WG~n~~gql~~~----------~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~--~~~~~~~-------------- 152 (768)
+||.|.+|||+.. ..+....+|++|+||..|+||| +.||+||+||. |.+||+|
T Consensus 82 ~wG~n~~GqLG~~~~~~~~~~~P~~v~l~~~i~~va~G~~hs~al-t~~G~v~~wG~~~n~~GqlG~~~~~~~~~~P~~v 160 (413)
T 1a12_A 82 SFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL-TDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQV 160 (413)
T ss_dssp EEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEE-ETTSCEEEEECEEETTEEEESSBBTBCEEEEEEE
T ss_pred EEECCCCCCCCCCCCCCccccCCeEecCCCcEEEEecCCCeEEEE-cCCCcEEEeeCCcCCCCccCcCCccccccCCEEe
Confidence 9999999999643 2232234799999999999999 99999999999 8889887
Q ss_pred --CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCccccc--------------------C--------CCcCeEEEecc
Q 046311 153 --IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQK--------------------V--------PSGIFRVVAAG 202 (768)
Q Consensus 153 --~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~--------------------~--------~~~~~~~i~~G 202 (768)
..+|++|+||..|+++|++||+||+||.|.+||++... + ...+|++|+||
T Consensus 161 ~~~~~i~~ia~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G 240 (413)
T 1a12_A 161 QLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCG 240 (413)
T ss_dssp CCSSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEE
T ss_pred cCCCCEEEEEecCceEEEEcCCCCEEEeeCCCCCccCCCccccccccccccccccccCceEeeccccccCCccEEEEEeC
Confidence 23589999999999999999999999999999975311 1 12579999999
Q ss_pred CceeEEEecCCcEEEeecCCCCCCCC--------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCC
Q 046311 203 FRHVCAIDDDQELRCWGDSVGEVPQG--------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDS 262 (768)
Q Consensus 203 ~~h~~al~~~g~v~~wG~n~~gq~~~--------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~ 262 (768)
.+|++||++||+||+||.|.+||.+. .|++|++|.+|++||++||+||+||+|.+||||.
T Consensus 241 ~~hs~alt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ia~G~~hs~al~~~G~v~~wG~n~~GqLG~ 320 (413)
T 1a12_A 241 AYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGL 320 (413)
T ss_dssp TTEEEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEETTSCEEEEECCGGGTTCS
T ss_pred CCEEEEEeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEEEecccceEEEEeCCCCEEEeeCCCCCccCC
Confidence 99999999999999999999999321 3999999999999999999999999999999985
Q ss_pred CC-------------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCc
Q 046311 263 LQ-------------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNH 300 (768)
Q Consensus 263 ~~-------------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~ 300 (768)
.. ...+++|+||.+|+++| ++||+||+||.|.+++..
T Consensus 321 g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~al-t~~G~v~~wG~n~~gqLG 370 (413)
T 1a12_A 321 GEGAEEKSIPTLISRLPAVSSVACGASVGYAV-TKDGRVFAWGMGTNYQLG 370 (413)
T ss_dssp CTTCCCEEEEEECCSSSSEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTC
T ss_pred CCCCccccCCEEecccCceeEEEECcceEEEE-eCCCCEEEecCCCCCCCC
Confidence 42 12789999999999999 899999999999776654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=409.55 Aligned_cols=270 Identities=20% Similarity=0.304 Sum_probs=199.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||+||+|+.. +|+.||||+++.. .......+.+.+|+++|++|+|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---------~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---------FDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---------ccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 357999999999999999999875 7999999998543 122334567899999999999999999999875
Q ss_pred c------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 D------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
. .+..||||||++ |+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~ 195 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENC 195 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCC
Confidence 4 367899999996 6899999753 34688899999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCC--CcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc
Q 046311 611 TAKVSDFGLSLIGPEDD--ESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 687 (768)
.+||+|||+++...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||............
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I 275 (398)
T 4b99_A 196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275 (398)
T ss_dssp CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999997543321 12223356899999999998765 5699999999999999999999999643221100000
Q ss_pred -c-------cccchhhhhhHHhhhccCCCCCCcch-----HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 688 -D-------FVVPYIVRDEIHRVLDRNVPPPTPFE-----IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 688 -~-------~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. ..............+.. ++...+.. ......+.+|+.+||+.||++|||++|+++.
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000000111111111 11111111 1123556799999999999999999998873
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=409.75 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=213.2
Q ss_pred ceeeeecCCceeEEeccCCCCCCcceeecC--------------------CccccCC--CCCCeeEEeeCCCeeeeeeee
Q 046311 32 FSVSETGNQSLVCALIPSSRPGDFSLNCSI--------------------PQLIPVN--PNASFASIVSGDGFLCTLITF 89 (768)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~--~~~~~~~v~~G~~~~c~l~~~ 89 (768)
..+.+.++-.|+|++.. +..++||+ |..++.. ....+.+|++|..|+|+|
T Consensus 11 ~~~~~~~~~~h~~~~~~-----~g~v~~wG~n~~GqLG~G~~~~~~~~~~P~~~~~~~~~~~~i~~va~G~~Ht~al--- 82 (473)
T 3of7_A 11 HIINAQEDYKHMYLSVQ-----PLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAVGGMHTLAL--- 82 (473)
T ss_dssp TCCCCGGGGHHHHCCSS-----CCEEEEEEECTTSTTCSCSCGGGGEEEEEEECTTSCTTTTCEEEEEECSSEEEEE---
T ss_pred hhhhhcccccccccCCC-----CccEEEEcCCCCCccCCCCCcccccccCcccccccccCCCCEEEEEeCCCeEEEE---
Confidence 34556667778888886 56777774 1122222 345789999999999999
Q ss_pred ccCCCCcEEeccCCCCCccccc-------------------------------cccc--------CCCCeeEEecCCCeE
Q 046311 90 SASSSSVMHCWRFSADGIINDY-------------------------------KRIY--------RGPALQQLEAGNSHI 130 (768)
Q Consensus 90 ~~~~~g~~~~WG~n~~gql~~~-------------------------------~~~~--------~~~~~~~i~~G~~h~ 130 (768)
+.+|+|||||.|.+|||+.. ..+. .+.+|++|+||..|+
T Consensus 83 --t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~~~~~~~i~~va~G~~hs 160 (473)
T 3of7_A 83 --DEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMS 160 (473)
T ss_dssp --ETTCCEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHHHHTTCCEEEEEECSSEE
T ss_pred --ecCCeEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCcccCCCcEEEEEccCCEE
Confidence 89999999999999999642 2222 246899999999999
Q ss_pred EEEEeCCCcEEEccC--CCCCCCCC-------------------CceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccc
Q 046311 131 CGLVNGTNDLHWWQW--PDFNSTSI-------------------HNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQ 189 (768)
Q Consensus 131 ~al~~~~g~~~~Wg~--~~~~~~~~-------------------~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~ 189 (768)
||| +.||+||+||. |.+||+|. .+|++|+||..|+|||+++|+||+||.|.+||++..
T Consensus 161 ~al-t~~G~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~ 239 (473)
T 3of7_A 161 CAL-FSNGEVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRK 239 (473)
T ss_dssp EEE-ETTSCEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTSSC
T ss_pred EEE-eCCCeEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEEeCCCeEEEEeCCCCCCCCCC
Confidence 999 99999999998 46777762 239999999999999999999999999999997632
Q ss_pred c-------------CCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCC----------------------CCeEEEe
Q 046311 190 K-------------VPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ----------------------GKFKALA 234 (768)
Q Consensus 190 ~-------------~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~----------------------~~~~~ia 234 (768)
. +...+|++|+||.+|+|||++||+||+||.|.+||.+ ..|++|+
T Consensus 240 ~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~alt~~G~v~~wG~n~~GqlG~~~~~~~~~~~~~P~~v~~~~~~~i~~ia 319 (473)
T 3of7_A 240 VMERFRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIA 319 (473)
T ss_dssp CCGGGTTTTCSCEECSCCSEEEEEECSSEEEEEETTSCEEEEEECTTSTTCCCSCCCTTCEEEEEEECCCCTTCCEEEEE
T ss_pred ccccccccccCceecCCcceEEEecCCCeEEEEecCCCEEEeCCCCCCCcCCCCcccCCceeeccccccccCCccEEEEE
Confidence 1 1125799999999999999999999999999999932 1599999
Q ss_pred ccCCeeEEEeeCCeEEEEecCCCCCCCCCCC--------------------------CCeEEEEecCCeEEEEEecCCeE
Q 046311 235 LGENRSCALRNNQKVVCWGQNGFTLPDSLQG--------------------------KPFVSIEAKRSVFCGVLTSNYSL 288 (768)
Q Consensus 235 ~G~~h~~al~~dg~v~~WG~n~~gq~~~~~~--------------------------~~~~~i~~g~~h~~~l~~~~g~~ 288 (768)
||.+|+++|++||+||+||.|.+||||.+.. ..|++|+||.+|+++| ++||+|
T Consensus 320 ~G~~hs~~lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~~Ia~G~~hs~al-~~~G~v 398 (473)
T 3of7_A 320 AGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFKSVAAGSHHSVAV-AQNGIA 398 (473)
T ss_dssp ECSSEEEEEETTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEEEEEECSSEEEEE-ETTSCE
T ss_pred eCCCeEEEEeCCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceEEEEeCCCeEEEE-eCCCcE
Confidence 9999999999999999999999999985321 1689999999999999 899999
Q ss_pred EEEeCCCCCCCc
Q 046311 289 YCWGNESFSSNH 300 (768)
Q Consensus 289 ~~wG~n~~~~~~ 300 (768)
|+||.|.+++..
T Consensus 399 y~wG~n~~GqLG 410 (473)
T 3of7_A 399 YSWGFGETYAVG 410 (473)
T ss_dssp EEEECCTTCTTC
T ss_pred EEeeCCCCCCCC
Confidence 999999766544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=392.15 Aligned_cols=283 Identities=43% Similarity=0.713 Sum_probs=229.4
Q ss_pred HHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 455 LEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 455 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
....++|+..+.||+|+||.||++++++++.||||++... .....+.|.+|++++++++||||++++++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----------SSQGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----------CSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3456799999999999999999999888999999986532 12345679999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.+++.........+++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEE
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999775544445789999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++................||+.|+|||++....++.++||||||+++|||++|+.||.............|.....
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 99999976443333223334468999999999988899999999999999999999999997654433333333322222
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
....+...++..... ....+....+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 261 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 261 NNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 222222333333222 234567788999999999999999999999999999998754
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=376.78 Aligned_cols=237 Identities=19% Similarity=0.195 Sum_probs=205.9
Q ss_pred ccceeeeecCCceeEEeccCCCCCCcceeecC----Ccc-ccCCCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCCC
Q 046311 30 STFSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQL-IPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSA 104 (768)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~ 104 (768)
...+++|++|..|+|+|. ++.+++|+ ++. +|......+.+|++|..|+|+| + ||+||+||.|.
T Consensus 23 ~~~i~~ia~G~~h~~~l~------~G~v~~wG~n~~Gqlg~p~~~~~~i~~ia~G~~hs~~l-----~-~G~v~~wG~n~ 90 (282)
T 3qhy_B 23 QSGVDAIAGGYFHGLALK------GGKVLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLAL-----K-DGEVIAWGGNE 90 (282)
T ss_dssp SSSCCEEEECSSEEEEEE------TTEEEEEECCSSSTTSCCGGGGSCCCEEEECSSEEEEE-----E-TTEEEEEECCT
T ss_pred cCCCcEEEeCCCeEEEEE------CCEEEEEeCCCCCCCCCCccCCCCEEEEEeCCCEEEEE-----E-CCEEEEeeCCC
Confidence 346899999999999997 46788886 211 2222233789999999999999 6 99999999999
Q ss_pred CCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEecCCeEEEEeeCCeEEEec
Q 046311 105 DGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAVGEDFVCGLLENGTITCFG 179 (768)
Q Consensus 105 ~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~G~~h~~~l~~~g~v~~wG 179 (768)
+|||+.|.++. .+|++|+||..|+++| + ||+||+||.|.+||++ ..++++|++|..|+++|+ ||+||+||
T Consensus 91 ~Gqlg~P~~~~--~~v~~ia~G~~hs~al-~-~G~v~~wG~n~~gqlg~~~~~~~~i~~i~~G~~~~~~l~-~G~v~~wG 165 (282)
T 3qhy_B 91 DGQTTVPAEAR--SGVDAIAAGAWASYAL-K-DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVK-NGGVIAWG 165 (282)
T ss_dssp TSTTCCCGGGS--SSEEEEEEETTEEEEE-E-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSEEEEEE-TTEEEEEE
T ss_pred CCCCCCCcccC--CCeEEEECcCCEEEEE-e-CCeEEEecCCCCCcCCCCccCCCCeEEEEcccCEEEEEE-CCEEEEec
Confidence 99999888774 4799999999999999 8 9999999999999998 457999999999999999 89999999
Q ss_pred CCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCC------CCeEEEeccCCeeEEEeeCCeEEEEe
Q 046311 180 SRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ------GKFKALALGENRSCALRNNQKVVCWG 253 (768)
Q Consensus 180 ~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~------~~~~~ia~G~~h~~al~~dg~v~~WG 253 (768)
.|.+||++.......+|++|+||.+|+||| +||+||+||.|.+||.+ .+|++|++|.+|+|||+ ||+||+||
T Consensus 166 ~n~~gqlg~p~~~~~~v~~i~~G~~hs~al-~~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G~~h~~al~-~g~v~~wG 243 (282)
T 3qhy_B 166 DNYFGQTTVPAEAQSGVDDVAGGIFHSLAL-KDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALK-NGKVIAWG 243 (282)
T ss_dssp CCTTSTTSCCGGGGSSEEEEEECSSEEEEE-ETTEEEEEECCTTSTTCCCGGGGSSCCEEEECSSCEEEEE-TTEEEEES
T ss_pred CCCCCCCCCceecCCCeEEEEecCCEEEEE-ECCeEEEEECCCCCCCCCCcccCCCceEEEcCCCEEEEEE-CCEEEEec
Confidence 999999874333347899999999999999 89999999999999943 27999999999999999 99999999
Q ss_pred cCCCCCCCCCCCCCeEEEEecCCeEEEEEecCCeE
Q 046311 254 QNGFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSL 288 (768)
Q Consensus 254 ~n~~gq~~~~~~~~~~~i~~g~~h~~~l~~~~g~~ 288 (768)
.|.+||++++ ..+++|+||..|+||| +.++..
T Consensus 244 ~n~~gq~~v~--~~v~~iaaG~~h~~al-~~~~~~ 275 (282)
T 3qhy_B 244 SSRTAPSSVQ--SGVSSIEAGPNAAYAL-KGGSGS 275 (282)
T ss_dssp TTCCCCGGGS--SCEEEEEECSSCEEEE-EC----
T ss_pred CCCCccccCC--CCcEEEEECcCeEEEE-ecCCCC
Confidence 9999999986 4799999999999999 666643
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=393.58 Aligned_cols=227 Identities=19% Similarity=0.316 Sum_probs=196.2
Q ss_pred CCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccc--------cccc--cCCCCeeEEecCCCeEEEEEeCC
Q 046311 68 NPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIIND--------YKRI--YRGPALQQLEAGNSHICGLVNGT 137 (768)
Q Consensus 68 ~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~--------~~~~--~~~~~~~~i~~G~~h~~al~~~~ 137 (768)
.+...+.+|++|..|+|+| +.||+||+||.|.+|||+. |.++ ....+|++|+||..|+||| +.+
T Consensus 13 ~~~~~v~~ia~G~~hs~al-----~~~g~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al-~~~ 86 (406)
T 4d9s_A 13 APPRKVLIISAGASHSVAL-----LSGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAY-SQS 86 (406)
T ss_dssp --CCCEEEEEECSSEEEEE-----ETTTEEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEE-ETT
T ss_pred CCccceEEEecCCCeEEEE-----EeCCEEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEE-ECC
Confidence 3445899999999999999 8999999999999999953 2233 2334799999999999999 766
Q ss_pred -CcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccc---------c
Q 046311 138 -NDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQ---------K 190 (768)
Q Consensus 138 -g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~---------~ 190 (768)
|+||+||.|.+||+| ..++++|+||..|++||++||+||+||.|.+||++.. .
T Consensus 87 gg~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~alt~~G~v~~wG~n~~GqLG~g~~~~~~~p~~ 166 (406)
T 4d9s_A 87 GMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQK 166 (406)
T ss_dssp TTEEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSCCCEEEEEE
T ss_pred CCEEEEEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEEcCCCcEEEeCCCCCccCCCCCCCCcccceE
Confidence 599999999999998 2369999999999999999999999999999997532 1
Q ss_pred CC---CcCeEEEeccCceeEEEecCCcEEEeecCCCCCCC------------------CCeEEEeccCCeeEEEeeCCeE
Q 046311 191 VP---SGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ------------------GKFKALALGENRSCALRNNQKV 249 (768)
Q Consensus 191 ~~---~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~------------------~~~~~ia~G~~h~~al~~dg~v 249 (768)
+. ..+|++|+||.+|+|||++||+||+||.|.+||.+ .++++|++|.+|+++|++||+|
T Consensus 167 v~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~~~G~v 246 (406)
T 4d9s_A 167 IQAFEGIRIKMVAAGAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSYSGAL 246 (406)
T ss_dssp CGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEETTCCE
T ss_pred ecccCCCcEEEEecCCCeEEEEeCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEcCCCCE
Confidence 11 24799999999999999999999999999999932 2699999999999999999999
Q ss_pred EEEecCCCCCCCCCC--------------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCcc
Q 046311 250 VCWGQNGFTLPDSLQ--------------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHM 301 (768)
Q Consensus 250 ~~WG~n~~gq~~~~~--------------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~ 301 (768)
|+||.|.+||||... ...+++|++|.+|+++| ++||+||+||.|.+++...
T Consensus 247 ~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~al-t~~G~v~~wG~n~~GqLG~ 311 (406)
T 4d9s_A 247 YTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMAL-TSDGKLYGWGWNKFGQVGV 311 (406)
T ss_dssp EEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCS
T ss_pred EEeeCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEE-cCCCeEEEeeCCCCCCCCC
Confidence 999999999998432 23589999999999999 8999999999998877553
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=398.64 Aligned_cols=228 Identities=15% Similarity=0.198 Sum_probs=195.8
Q ss_pred CCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCccccc--------ccccC--CC--CeeEEecCCCeEEEEEe
Q 046311 68 NPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDY--------KRIYR--GP--ALQQLEAGNSHICGLVN 135 (768)
Q Consensus 68 ~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~--------~~~~~--~~--~~~~i~~G~~h~~al~~ 135 (768)
.++..+.+|++|..|+|+| +.||+||+||.|.+|||+.. ..+.. .. ++++|++|..|++|| +
T Consensus 50 ~~~~~i~~i~~G~~~~~~l-----~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al-~ 123 (389)
T 3kci_A 50 LATLRPVQLIGGEQTLFAV-----TADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLAL-S 123 (389)
T ss_dssp HHHTCEEEEEEETTEEEEE-----ETTSCEEEEECCGGGTTSSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEE-E
T ss_pred ccCCceEEEEeCCCeEEEE-----cCCCcEEEEECCCCCCCCCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEE-c
Confidence 3445688999999999999 89999999999999999532 22211 11 457899999999999 9
Q ss_pred CCCcEEEccCCCCCCCC-----------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccc---------
Q 046311 136 GTNDLHWWQWPDFNSTS-----------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQ--------- 189 (768)
Q Consensus 136 ~~g~~~~Wg~~~~~~~~-----------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~--------- 189 (768)
.||+||+||.|.+||+| ..++++|+||..|++||++||+||+||.|.+||++..
T Consensus 124 ~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~p~ 203 (389)
T 3kci_A 124 SEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPK 203 (389)
T ss_dssp TTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTSCEEEEECCGGGTTCSSSCCCEEEEE
T ss_pred CCCCEEEEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEEEeCcCeEEEEeCCCeEEEeCCCCCCCcCCCCCcccccce
Confidence 99999999999999998 2369999999999999999999999999999987522
Q ss_pred cCC---CcCeEEEeccC--ceeEEEecCCcEEEeecCCCCCCCC------------------CeEEEeccCCeeEEEeeC
Q 046311 190 KVP---SGIFRVVAAGF--RHVCAIDDDQELRCWGDSVGEVPQG------------------KFKALALGENRSCALRNN 246 (768)
Q Consensus 190 ~~~---~~~~~~i~~G~--~h~~al~~~g~v~~wG~n~~gq~~~------------------~~~~ia~G~~h~~al~~d 246 (768)
.++ ..++++|+||. .|+++|++||+||+||.|.+||.+. .|++|++|.+|++||++|
T Consensus 204 ~v~~~~~~~v~~ia~G~g~~~t~~l~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~~ 283 (389)
T 3kci_A 204 LVEALQGHRVVDIACGSGDAQTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKS 283 (389)
T ss_dssp ECGGGTTSCEEEEEECCSSCEEEEEETTTEEEEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEETT
T ss_pred EecccCCCeEEEEEEcCCCcEEEEEccCCEEEEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeCC
Confidence 121 25799999995 8999999999999999999999431 599999999999999999
Q ss_pred CeEEEEecCCCCCCCCCC--------------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCccc
Q 046311 247 QKVVCWGQNGFTLPDSLQ--------------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMV 302 (768)
Q Consensus 247 g~v~~WG~n~~gq~~~~~--------------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~~ 302 (768)
|+||+||.|.+||||... +..+++|++|.+|+++| ++||+||+||.|.+++....
T Consensus 284 G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~G~~h~~al-~~~G~v~~wG~n~~GqLG~g 352 (389)
T 3kci_A 284 GAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCC-TEDGEVYTWGDNDEGQLGDG 352 (389)
T ss_dssp SCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEE-ETTCCEEEEECCTTSTTCSS
T ss_pred CeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEeccCeEEEE-CCCCCEEEeeCCCCCcCCCC
Confidence 999999999999998432 23689999999999999 99999999999988876653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=393.32 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=168.1
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
..++|++.++||+|+||+||+|+.+ +++.||||++... ....++.+|+++|+.+ +||||+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-------------~~~~~~~~E~~~l~~~~~h~nIv~l 85 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-------------SHPIRIAAELQCLTVAGGQDNVMGV 85 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-------------SCHHHHHHHHHHHHHTCSBTTBCCC
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-------------cCHHHHHHHHHHHHHhcCCCCCceE
Confidence 4578999999999999999999753 4678999987532 1234678999999998 69999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-C
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-W 610 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~ 610 (768)
++++.+.++.||||||+++|+|.++++. +++.....++.|++.||+|||+++ |+||||||+|||++.+ +
T Consensus 86 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 86 KYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp SEEEEETTEEEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EEEEEECCEEEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCC
Confidence 9999999999999999999999999942 578888999999999999999999 9999999999999876 7
Q ss_pred cEEEeeccccccCCCCCCc--------------------------ccccccccccCccCccccccC-CCCChhhHHHHHH
Q 046311 611 TAKVSDFGLSLIGPEDDES--------------------------HLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGV 663 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGv 663 (768)
.+||+|||+|+........ ......+||+.|||||++.+. .++.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 9999999999754322110 011234799999999998765 5899999999999
Q ss_pred HHHHHHcCCcccccC
Q 046311 664 VLLEILSGYRAIHRT 678 (768)
Q Consensus 664 ll~elltG~~p~~~~ 678 (768)
++|||+||+.||...
T Consensus 236 il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHTCSSSSCC
T ss_pred HHHHHHHCCCCCCCC
Confidence 999999999999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=412.97 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=206.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++..+ +|+.||||++... .....+.+.+|+++|+.|+|||||++++++.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 225 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----------chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 57999999999999999999875 7999999998642 12345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC--CcEEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT--WTAKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~--~~~kl~ 615 (768)
.+..||||||+++|+|.++|.... ..+++.....++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 226 ~~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~ 299 (573)
T 3uto_A 226 DNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 299 (573)
T ss_dssp SSEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred CCEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEe
Confidence 999999999999999999996532 23678889999999999999999999 9999999999999854 899999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++....... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.....
T Consensus 300 DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------------- 361 (573)
T 3uto_A 300 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------------- 361 (573)
T ss_dssp CCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------------
T ss_pred eccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------------
Confidence 9999987544332 2245799999999999999999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..+.......+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 362 ~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 362 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223332222222222234556779999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=383.92 Aligned_cols=293 Identities=38% Similarity=0.659 Sum_probs=233.4
Q ss_pred CccccccHHHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC
Q 046311 444 GRLEEFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523 (768)
Q Consensus 444 ~~~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 523 (768)
+....+++.++....++|+..+.||+|+||.||+++.++++.||||++..... ......|.+|+++++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT----------QGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------------CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC----------chHHHHHHHHHHHHHhc
Confidence 34567888999999999999999999999999999988899999999864321 11223689999999999
Q ss_pred CCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 524 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+||||+++++++.+.+..++||||+++++|.++++........+++..++.++.|++.||+|||++..++|+||||||+|
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 99999999999999999999999999999999998766555668999999999999999999999922239999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCC--CC
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTH--NG 681 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~--~~ 681 (768)
||++.++.+||+|||++........ .......||+.|+|||++....++.++||||||+++|||++|+.||.... ..
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999976543322 22233468999999999988889999999999999999999999996321 11
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
......++..............+..... ....+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1112222222222222233333333322 34456678899999999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=410.16 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=200.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.. +|+.||||+++.... .............+++.+++.++|||||+++++|.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i-----~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-----KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHc-----chhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 57999999999999999999876 799999999975421 111112222333455778888999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..||||||++||+|.++|... ..+++.....++.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccc
Confidence 99999999999999999999753 23688888999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+|+....... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||.........
T Consensus 337 GlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~------------ 400 (689)
T 3v5w_A 337 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------------ 400 (689)
T ss_dssp TTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH------------
T ss_pred ceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------------
Confidence 99986543322 24589999999999964 57999999999999999999999999754322110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~ 744 (768)
.-...++...+..+. ..+..+.+|+.+||+.||++|++ ++||++
T Consensus 401 ~i~~~i~~~~~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 401 EIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHhhcCCCCCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 001122222222222 23455679999999999999998 688776
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=382.27 Aligned_cols=245 Identities=15% Similarity=0.190 Sum_probs=206.9
Q ss_pred cceeeeecCCceeEEeccCCCCCCcceeecC----Cc-----------ccc--CCCCCCeeEEeeCCCeeeeeeeeccCC
Q 046311 31 TFSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQ-----------LIP--VNPNASFASIVSGDGFLCTLITFSASS 93 (768)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----------~~~--~~~~~~~~~v~~G~~~~c~l~~~~~~~ 93 (768)
..+++|++|..|+|+|.. ++.+++|+ +| .+| +.-...+.+|++|..|+|+| +.
T Consensus 59 ~~i~~va~G~~hs~~l~~-----~G~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~l~~~i~~va~G~~hs~al-----t~ 128 (413)
T 1a12_A 59 EDVVQAEAGGMHTVCLSK-----SGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL-----TD 128 (413)
T ss_dssp SCEEEEEECSSEEEEEET-----TSCEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEE-----ET
T ss_pred CCeEEEEeCCCeEEEEcC-----CCCEEEEECCCCCCCCCCCCCCccccCCeEecCCCcEEEEecCCCeEEEE-----cC
Confidence 568899999999999997 56777774 11 111 11122689999999999999 89
Q ss_pred CCcEEeccC--CCCCcccc---------cccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCCC---------
Q 046311 94 SSVMHCWRF--SADGIIND---------YKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTSI--------- 153 (768)
Q Consensus 94 ~g~~~~WG~--n~~gql~~---------~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~~--------- 153 (768)
||.||+||. |.+|||+. |.++....+|++|+||..|+++| +.||+||+||.|.+||+|.
T Consensus 129 ~G~v~~wG~~~n~~GqlG~~~~~~~~~~P~~v~~~~~i~~ia~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~~ 207 (413)
T 1a12_A 129 DGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVML-TADGDLYTLGCGEQGQLGRVPELFANRG 207 (413)
T ss_dssp TSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSCGGGTSSSC
T ss_pred CCcEEEeeCCcCCCCccCcCCccccccCCEEecCCCCEEEEEecCceEEEE-cCCCCEEEeeCCCCCccCCCcccccccc
Confidence 999999999 99999952 44555556899999999999999 9999999999999999872
Q ss_pred ------------------------CceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccc---------cCCC-----cC
Q 046311 154 ------------------------HNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQ---------KVPS-----GI 195 (768)
Q Consensus 154 ------------------------~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~---------~~~~-----~~ 195 (768)
.+|++|+||.+|+++|++||+||+||.|.+||++.. .+.. .+
T Consensus 208 ~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~hs~alt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~ 287 (413)
T 1a12_A 208 GRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKS 287 (413)
T ss_dssp GGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCC
T ss_pred ccccccccccCceEeeccccccCCccEEEEEeCCCEEEEEeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCce
Confidence 348899999999999999999999999999997532 1211 34
Q ss_pred eEEEeccCceeEEEecCCcEEEeecCCCCCCC-----------------CCeEEEeccCCeeEEEeeCCeEEEEecCCCC
Q 046311 196 FRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ-----------------GKFKALALGENRSCALRNNQKVVCWGQNGFT 258 (768)
Q Consensus 196 ~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~-----------------~~~~~ia~G~~h~~al~~dg~v~~WG~n~~g 258 (768)
|++|+||.+|+|||++||+||+||.|.+||.+ ..|++|++|.+|++||++||+||+||.|.+|
T Consensus 288 v~~ia~G~~hs~al~~~G~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt~~G~v~~wG~n~~g 367 (413)
T 1a12_A 288 WVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNY 367 (413)
T ss_dssp EEEEEECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEETTSCEEEEECCTTS
T ss_pred EEEEecccceEEEEeCCCCEEEeeCCCCCccCCCCCCccccCCEEecccCceeEEEECcceEEEEeCCCCEEEecCCCCC
Confidence 99999999999999999999999999999832 1699999999999999999999999999999
Q ss_pred CCCCCC----------------CCCeEEEEecCCeEEEEEecCCe
Q 046311 259 LPDSLQ----------------GKPFVSIEAKRSVFCGVLTSNYS 287 (768)
Q Consensus 259 q~~~~~----------------~~~~~~i~~g~~h~~~l~~~~g~ 287 (768)
|||... ...+++|+||.+|+++| +.||+
T Consensus 368 qLG~g~~~~~~~P~~v~~~~~~~~~v~~v~~G~~ht~~l-~~~g~ 411 (413)
T 1a12_A 368 QLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLL-VKDKE 411 (413)
T ss_dssp TTCSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEE-EEECS
T ss_pred CCCCCCCCCcccCeEccccccCCCeEEEEeeCCCcEEEE-EecCC
Confidence 998432 23589999999999999 67775
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=379.65 Aligned_cols=242 Identities=19% Similarity=0.238 Sum_probs=201.8
Q ss_pred ceeeeecCCceeEEeccCCCCCCcceeecC-----------------CccccCCCCC--CeeEEeeCCCeeeeeeeeccC
Q 046311 32 FSVSETGNQSLVCALIPSSRPGDFSLNCSI-----------------PQLIPVNPNA--SFASIVSGDGFLCTLITFSAS 92 (768)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~--~~~~v~~G~~~~c~l~~~~~~ 92 (768)
.+++|++|..|+|+|.. ++.++||+ |..++...++ .+.+|++|..|+|+| +
T Consensus 54 ~i~~i~~G~~~~~~l~~-----~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al-----~ 123 (389)
T 3kci_A 54 RPVQLIGGEQTLFAVTA-----DGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLAL-----S 123 (389)
T ss_dssp CEEEEEEETTEEEEEET-----TSCEEEEECCGGGTTSSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEE-----E
T ss_pred ceEEEEeCCCeEEEEcC-----CCcEEEEECCCCCCCCCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEE-----c
Confidence 57789999999999997 56788874 1222222333 336889999999999 8
Q ss_pred CCCcEEeccCCCCCccccc--------ccc--cCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC----------
Q 046311 93 SSSVMHCWRFSADGIINDY--------KRI--YRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS---------- 152 (768)
Q Consensus 93 ~~g~~~~WG~n~~gql~~~--------~~~--~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~---------- 152 (768)
.||+||+||.|.+|||+.. ..+ ..+.+|++|+||..|++|| +.||+||+||.|.+||+|
T Consensus 124 ~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~p 202 (389)
T 3kci_A 124 SEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACV-TAAGDLYTWGKGRYGRLGHSDSEDQLKP 202 (389)
T ss_dssp TTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEE-ETTSCEEEEECCGGGTTCSSSCCCEEEE
T ss_pred CCCCEEEEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEEEeCcCeEEEE-eCCCeEEEeCCCCCCCcCCCCCcccccc
Confidence 9999999999999999532 222 2334799999999999999 999999999999999998
Q ss_pred -------CCceEEEEecC--CeEEEEeeCCeEEEecCCCCCCccc---------ccCC---CcCeEEEeccCceeEEEec
Q 046311 153 -------IHNFSNIAVGE--DFVCGLLENGTITCFGSRNSPTSVT---------QKVP---SGIFRVVAAGFRHVCAIDD 211 (768)
Q Consensus 153 -------~~~~~~v~~G~--~h~~~l~~~g~v~~wG~~~~g~~~~---------~~~~---~~~~~~i~~G~~h~~al~~ 211 (768)
..++++|+||. .|+++|++||+||+||.|.+||++. ..++ ..++++|+||.+|++||++
T Consensus 203 ~~v~~~~~~~v~~ia~G~g~~~t~~l~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~ 282 (389)
T 3kci_A 203 KLVEALQGHRVVDIACGSGDAQTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTK 282 (389)
T ss_dssp EECGGGTTSCEEEEEECCSSCEEEEEETTTEEEEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEET
T ss_pred eEecccCCCeEEEEEEcCCCcEEEEEccCCEEEEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeC
Confidence 23589999995 8999999999999999999999752 1222 2469999999999999999
Q ss_pred CCcEEEeecCCCCCCC------------------CCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC---------
Q 046311 212 DQELRCWGDSVGEVPQ------------------GKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ--------- 264 (768)
Q Consensus 212 ~g~v~~wG~n~~gq~~------------------~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~--------- 264 (768)
||+||+||.|.+||.+ .+|++|++|.+|++||++||+||+||.|.+||||...
T Consensus 283 ~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~G~~h~~al~~~G~v~~wG~n~~GqLG~g~~~~~~~P~~ 362 (389)
T 3kci_A 283 SGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTEDGEVYTWGDNDEGQLGDGTTNAIQRPRL 362 (389)
T ss_dssp TSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEETTCCEEEEECCTTSTTCSSSCCCEEEEEE
T ss_pred CCeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEeccCeEEEECCCCCEEEeeCCCCCcCCCCCCCCccCcEE
Confidence 9999999999999943 1599999999999999999999999999999999432
Q ss_pred -----CCCeEEEEecCCeEEEEEecC
Q 046311 265 -----GKPFVSIEAKRSVFCGVLTSN 285 (768)
Q Consensus 265 -----~~~~~~i~~g~~h~~~l~~~~ 285 (768)
+..+++|+||..|+++| +++
T Consensus 363 v~~~~~~~v~~va~G~~ht~al-~~~ 387 (389)
T 3kci_A 363 VAALQGKKVNRVACGSAHTLAW-STS 387 (389)
T ss_dssp CGGGTTSCCCEEEEETTEEEEE-CC-
T ss_pred ecccCCCCEEEEEecCCcEEEE-ecC
Confidence 23689999999999999 544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.55 Aligned_cols=274 Identities=27% Similarity=0.340 Sum_probs=210.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+++.. ++.||||++... ......+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------------chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 57899999999999999999877 799999998532 22344567799999999999999999999875
Q ss_pred C----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeEecCCCCCCe
Q 046311 539 N----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY----------AVPSIIHRDIKSSNV 604 (768)
Q Consensus 539 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~----------~~~~ivHrDiKp~NI 604 (768)
. ..++||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+||
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Ni 162 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNV 162 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhE
Confidence 4 469999999999999999652 268999999999999999999998 6 99999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 605 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
|++.++.+||+|||+++...............||+.|+|||++.. ..++.++||||||+++|||+||+.||....
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999976544333322334578999999999876 355678999999999999999999997543
Q ss_pred CCCcccccccccchhhhhhHHh-hhccCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHR-VLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
...................+.+ .......+... ........+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 3222111111011111112222 22222222111 12244566889999999999999999999999999987643
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=379.76 Aligned_cols=243 Identities=14% Similarity=0.069 Sum_probs=205.8
Q ss_pred ceeeeecCCceeEEeccCCCCCCcceeecC----Cc-------------cccCCCCCCeeEEeeCCCeeeeeeeeccCCC
Q 046311 32 FSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQ-------------LIPVNPNASFASIVSGDGFLCTLITFSASSS 94 (768)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-------------~~~~~~~~~~~~v~~G~~~~c~l~~~~~~~~ 94 (768)
.+++|++|..|+|+|.. ++.++||+ +| +..+.-...+.+|++|..|+|+| +.|
T Consensus 76 ~v~~va~G~~h~~~l~~-----~G~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al-----~~~ 145 (423)
T 3mvd_K 76 DAVDISAGGMHNLVLTK-----SGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACL-----LED 145 (423)
T ss_dssp SEEEEEECSSEEEEEET-----TSCEEEEECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEE-----ETT
T ss_pred CceEEeeCCCeEEEEeC-----CCeEEEeECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEE-----eCC
Confidence 47899999999999997 56788884 11 11122223689999999999999 899
Q ss_pred CcEEeccC--CCCCcccc--------cccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCCC-----------
Q 046311 95 SVMHCWRF--SADGIIND--------YKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTSI----------- 153 (768)
Q Consensus 95 g~~~~WG~--n~~gql~~--------~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~~----------- 153 (768)
|+||+||. |.+|||+. |.++....+|++|+||..|+||| +.+|+||+||.|.+||+|.
T Consensus 146 G~v~~wG~~~n~~GqlG~~~~~~~~~p~~~~~~~~i~~va~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~ 224 (423)
T 3mvd_K 146 GRVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVIL-TTAGKVFTVGCAEQGQLGRLSERSISGEGR 224 (423)
T ss_dssp SCEEEEECEECSSSEEESBTTBCEEEEEESSTTCCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTSSCCTTTTTSCST
T ss_pred CeEEEEeCCCCCCCCcCcCCCCCCceeeEecCCCcEEEEecCCCeEEEE-ecCCeEEEeeCCcCCccCCCcccccccccc
Confidence 99999999 99999953 33455566899999999999999 9999999999999999983
Q ss_pred -----------------CceEEEEecCCeEEEE-eeCCeEEEecCCCCCCcccc-----------cCCCcCeEEEeccCc
Q 046311 154 -----------------HNFSNIAVGEDFVCGL-LENGTITCFGSRNSPTSVTQ-----------KVPSGIFRVVAAGFR 204 (768)
Q Consensus 154 -----------------~~~~~v~~G~~h~~~l-~~~g~v~~wG~~~~g~~~~~-----------~~~~~~~~~i~~G~~ 204 (768)
..|++|++|.+|++++ +++|+||+||.|.+||++.. .....+|++|+||.+
T Consensus 225 ~~~~~~~~p~~v~~~~~~~v~~i~~g~~~~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ 304 (423)
T 3mvd_K 225 RGKRDLLRPTQLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQH 304 (423)
T ss_dssp TTTTTTSSCEEECCTTCCCEEEEEEETTEEEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSS
T ss_pred cccccccCCeEEeecCCccEEEEEECCcEEEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccC
Confidence 2479999999999999 58899999999999998641 112358999999999
Q ss_pred eeEEEecCCcEEEeecCCCCCCCC------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCC---
Q 046311 205 HVCAIDDDQELRCWGDSVGEVPQG------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSL--- 263 (768)
Q Consensus 205 h~~al~~~g~v~~wG~n~~gq~~~------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~--- 263 (768)
|+|||++||+||+||.|.+||.+. .|++|++|.+|++||++||+||+||.|.+||||..
T Consensus 305 ht~alt~~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~~v~~ia~G~~hs~alt~~G~v~~wG~n~~GqLG~g~~~ 384 (423)
T 3mvd_K 305 HTVILTTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVCSYAVTIDGKLYSWGSGVNNQLGVGDGD 384 (423)
T ss_dssp EEEEEETTCCEEEEECCGGGTTCSSSCCSCEEEEEECTTCCSCEEEEEEETTEEEEEETTSCEEEEECCTTSCSSSSSSC
T ss_pred eEEEEeCCCcEEEEECCCCCCCCCCCccccccCceEeccCCCCEEEEEcCCCeEEEEcCCCCEEEECCCCCCCCCCCCCC
Confidence 999999999999999999998321 58999999999999999999999999999999832
Q ss_pred -------------CCCCeEEEEecCCeEEEEEecCC
Q 046311 264 -------------QGKPFVSIEAKRSVFCGVLTSNY 286 (768)
Q Consensus 264 -------------~~~~~~~i~~g~~h~~~l~~~~g 286 (768)
.+..+++|+||..|+++| +.++
T Consensus 385 ~~~~P~~v~~~~~~~~~v~~va~G~~ht~~l-~~~~ 419 (423)
T 3mvd_K 385 DELEPIVVVSKNTQGKHMLLASGGGQHAIFL-VKAD 419 (423)
T ss_dssp CEEEEEECCSTTTTTCCEEEEEECSSEEEEE-EECC
T ss_pred CcccCeEEeCcccCCCEEEEEEECCCcEEEE-Eccc
Confidence 233689999999999999 5555
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=373.01 Aligned_cols=268 Identities=33% Similarity=0.493 Sum_probs=203.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.++||+|+||+||+++.+ ++.||||++.... ......++|.+|++++++++||||+++++++.+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQD---------FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCC---------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCC---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 357888999999999999999874 7899999986431 223455789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++...... ..+++..++.++.|+++||+|||+++ ++|+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHH-HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999999763211 22688899999999999999999987 45899999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||...... +
T Consensus 184 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---------------~ 246 (309)
T 3p86_A 184 GLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---------------Q 246 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---------------H
T ss_pred CCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Confidence 99975432221 122346899999999999999999999999999999999999998643210 0
Q ss_pred hHHhh--hccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 698 EIHRV--LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 698 ~~~~~--~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
....+ .......+ ......+.+|+.+||+.||++|||++|+++.|+.+++....++.
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 247 VVAAVGFKCKRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp HHHHHHHSCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred HHHHHHhcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 11111 11111111 12345577999999999999999999999999999977655443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=379.26 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=211.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
++|++.+.||+|+||.||+++.. ++..||||+++.. ..+...+++.+|+++++++ +||||+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----------CBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----------cCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 57888999999999999999852 3457999987532 2234567899999999999 899999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++.+.+..++||||+++|+|.+++..... ....+++..++.++.||++||+|||+++ |+||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 227 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 227 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 999999999999999999999999999975432 1234688899999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||+++...............+|+.|+|||++....++.++||||||+++|||+| |+.||.
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999986544333233334467889999999998999999999999999999999 999986
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..... ++...+........ .......+.+|+.+||+.||++||++.|+++.|++++...
T Consensus 308 ~~~~~----------------~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 308 GIPVE----------------ELFKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp TCCGG----------------GHHHHHHTTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHH----------------HHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 43211 11111111111111 1123456778999999999999999999999999999765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.49 Aligned_cols=288 Identities=37% Similarity=0.602 Sum_probs=227.1
Q ss_pred cccccHHHHHHHcCCCCcC------ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH
Q 046311 446 LEEFSLEILLEATNNFSED------HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519 (768)
Q Consensus 446 ~~~~~~~~l~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 519 (768)
...|++.++..++++|... +.||+|+||.||++.. +++.||||++..... ...+...+.|.+|+++
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~~E~~~ 83 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD-------ITTEELKQQFDQEIKV 83 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTT-------SCTTTHHHHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccC-------cchHHHHHHHHHHHHH
Confidence 4578899999999988877 8999999999999986 478999999864311 1223456789999999
Q ss_pred HhcCCCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 046311 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDI 599 (768)
Q Consensus 520 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 599 (768)
+++++||||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+++ |+||||
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 159 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDI 159 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCC
Confidence 9999999999999999999999999999999999999975332 234689999999999999999999998 999999
Q ss_pred CCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 600 KSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 600 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999976544333222334568999999998864 58999999999999999999999997543
Q ss_pred CCCcccccccccchh-hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 680 NGTPRNVVDFVVPYI-VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
... ....+..... ....+...+++... .........+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 239 EPQ--LLLDIKEEIEDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSS--BTTHHHHHHHTTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chH--HHHHHHHHhhhhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 221 1111100000 01113334444332 2344567788899999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.55 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=209.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||+++.. +++.||+|++.. ......+.|.+|++++++++||||+++++++.+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----------FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----------CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 46888999999999999999875 689999998742 224556789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCC
T ss_pred CCeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeec
Confidence 999999999999999999997532 34688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcc------------cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 618 GLSLIGPEDDESH------------LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 618 Gla~~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
|++.......... ......||+.|+|||++....++.++||||||+++|||++|..|+..........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 9997543322111 1113468999999999999999999999999999999999998886433211110
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.. .....++...+.. .+..+.+|+.+||+.||++|||++|+++.|+++.....
T Consensus 233 ------~~----~~~~~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 ------GL----NVRGFLDRYCPPN------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ------SB----CHHHHHHHTCCTT------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------hh----hhhccccccCCCC------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0111111111211 12346689999999999999999999999999887543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=369.24 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=207.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||++.+. .+..||||+++.. ..+...+.|.+|++++++++||||++++++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----------YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 57888999999999999999875 3445999998632 223456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 192 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEE
Confidence 999999999999999999999996532 24688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... .......+|+.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------ 260 (325)
T 3kul_A 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------------ 260 (325)
T ss_dssp CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------
T ss_pred CCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------------
Confidence 999999865433221 11223346788999999998899999999999999999999 9999864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.++...+......+ .....+..+.+|+.+||+.||++|||++||++.|+++++..
T Consensus 261 ----~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 261 ----RDVISSVEEGYRLP--APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ----HHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ----HHHHHHHHcCCCCC--CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 11111111111111 11123456779999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.56 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------QPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-----------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-----------ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 5799999999999999999986 478999999986431 1234568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 160 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999652 3578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....||+.|+|||++....++.++||||||+++|||++|+.||...... .
T Consensus 161 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~ 223 (297)
T 3fxz_A 161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---------------R 223 (297)
T ss_dssp TTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------H
T ss_pred CCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Confidence 998765433222 22347999999999999999999999999999999999999998643210 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.....+ ...........+.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 224 ALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHCSC-CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhCCCC-CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111111111 111122344567799999999999999999999873
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=378.29 Aligned_cols=240 Identities=18% Similarity=0.173 Sum_probs=202.8
Q ss_pred cceeeeecCCceeEEeccCCCCCCcceeecC----Cc----------------------------------cccCC----
Q 046311 31 TFSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQ----------------------------------LIPVN---- 68 (768)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----------------------------------~~~~~---- 68 (768)
..+++|++|..|+|||.. ++.++||+ +| |..++
T Consensus 67 ~~i~~va~G~~Ht~alt~-----~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l 141 (473)
T 3of7_A 67 AKIISFAVGGMHTLALDE-----ESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESF 141 (473)
T ss_dssp TCEEEEEECSSEEEEEET-----TCCEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGC
T ss_pred CCEEEEEeCCCeEEEEec-----CCeEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccC
Confidence 468999999999999997 56778874 10 11121
Q ss_pred ----CCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccC--CCCCcccc----------cccccC--CCCeeEEecCCCeE
Q 046311 69 ----PNASFASIVSGDGFLCTLITFSASSSSVMHCWRF--SADGIIND----------YKRIYR--GPALQQLEAGNSHI 130 (768)
Q Consensus 69 ----~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~--n~~gql~~----------~~~~~~--~~~~~~i~~G~~h~ 130 (768)
.+..+.+|++|..|+|+| +.+|+||+||. |.+|||+. |..+.. +.+|++|+||..|+
T Consensus 142 ~~~~~~~~i~~va~G~~hs~al-----t~~G~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs 216 (473)
T 3of7_A 142 PPLAEGHKVVQLAATDNMSCAL-----FSNGEVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHI 216 (473)
T ss_dssp HHHHTTCCEEEEEECSSEEEEE-----ETTSCEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEE
T ss_pred CcccCCCcEEEEEccCCEEEEE-----eCCCeEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeE
Confidence 246789999999999999 89999999998 68899953 223322 23599999999999
Q ss_pred EEEEeCCCcEEEccCCCCCCCCC------------------CceEEEEecCCeEEEEeeCCeEEEecCCCCCCccccc--
Q 046311 131 CGLVNGTNDLHWWQWPDFNSTSI------------------HNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQK-- 190 (768)
Q Consensus 131 ~al~~~~g~~~~Wg~~~~~~~~~------------------~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~-- 190 (768)
||| +.+|+||+||.|.+||+|. .+|++|+||.+|+|||+++|+||+||.|.+||++...
T Consensus 217 ~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~alt~~G~v~~wG~n~~GqlG~~~~~ 295 (473)
T 3of7_A 217 LFL-DEEGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDV 295 (473)
T ss_dssp EEE-ETTSCEEEEECCTTSTTSSCCCGGGTTTTCSCEECSCCSEEEEEECSSEEEEEETTSCEEEEEECTTSTTCCCSCC
T ss_pred EEE-eCCCeEEEEeCCCCCCCCCCccccccccccCceecCCcceEEEecCCCeEEEEecCCCEEEeCCCCCCCcCCCCcc
Confidence 999 9999999999999999982 3589999999999999999999999999999975321
Q ss_pred -----------CC---CcCeEEEeccCceeEEEecCCcEEEeecCCCCCCCC----------------------------
Q 046311 191 -----------VP---SGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQG---------------------------- 228 (768)
Q Consensus 191 -----------~~---~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~~---------------------------- 228 (768)
+. ..+|++|+||.+|+|+|++||+||+||.|.+||.+.
T Consensus 296 ~~~~~~~~P~~v~~~~~~~i~~ia~G~~hs~~lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~ 375 (473)
T 3of7_A 296 EDGALVTKPKRLALPDNVVIRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNN 375 (473)
T ss_dssp CTTCEEEEEEECCCCTTCCEEEEEECSSEEEEEETTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCS
T ss_pred cCCceeeccccccccCCccEEEEEeCCCeEEEEeCCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCC
Confidence 11 147999999999999999999999999999998431
Q ss_pred --CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC-C----------------CCeEEEEecCCeEEEE
Q 046311 229 --KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ-G----------------KPFVSIEAKRSVFCGV 281 (768)
Q Consensus 229 --~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~-~----------------~~~~~i~~g~~h~~~l 281 (768)
.|++|++|.+|++||++||+||+||.|.+||||... . ..+++|+||..|++++
T Consensus 376 ~~~v~~Ia~G~~hs~al~~~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~~~~~v~~v~cG~~~s~~~ 447 (473)
T 3of7_A 376 VPKFKSVAAGSHHSVAVAQNGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQDHNIILVGCGGQFSVSG 447 (473)
T ss_dssp SCCEEEEEECSSEEEEEETTSCEEEEECCTTCTTCCCSCCSCEEEEEECCCTTTTTEEEEEEEECSSEEEEE
T ss_pred CCceEEEEeCCCeEEEEeCCCcEEEeeCCCCCCCCCCCCCccccCCeEecccccCCCeEEEEeeCCCeEEEE
Confidence 689999999999999999999999999999999543 1 1489999999999999
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=372.90 Aligned_cols=272 Identities=28% Similarity=0.358 Sum_probs=212.6
Q ss_pred HHHHHHcCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-C
Q 046311 452 EILLEATNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-H 524 (768)
Q Consensus 452 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 524 (768)
.......++|++.+.||+|+||.||++++. +++.||||+++.. ......+.|.+|++++.++ +
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGH 84 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCC
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----------CCHHHHHHHHHHHHHHHhhcC
Confidence 333344578999999999999999999742 4578999998532 1233456799999999999 8
Q ss_pred CCCceeEEEEEEcCCe-eEEEEEeccCCChhhhccCCCCC----------------------------------------
Q 046311 525 HKNLVRLLGFCEDRNE-RVLIYEYLENGTLHDHLHNPQSS---------------------------------------- 563 (768)
Q Consensus 525 HpnIv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------- 563 (768)
||||+++++++.+.+. .++||||+++|+|.++++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 9999999999987654 89999999999999999764321
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 564 ----------------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 564 ----------------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEecccee
Confidence 112688899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhHH
Q 046311 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700 (768)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (768)
...............+|+.|+|||++....++.++||||||+++|||+| |+.||...... +...
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------~~~~ 306 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------------EEFC 306 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------------HHHH
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------------HHHH
Confidence 6544333333334568999999999998999999999999999999999 99998643221 1111
Q ss_pred hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..+........ .......+.+++.+||+.||++|||++|+++.|++++++.
T Consensus 307 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 307 RRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11111111110 1112345778999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.81 Aligned_cols=261 Identities=28% Similarity=0.495 Sum_probs=199.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|++. ++..||||+++.. ..+...++|.+|+.++++++||||++++++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----------YTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999865 5778999987532 123455789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 188 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEE
Confidence 999999999999999999999997532 34688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcc-cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESH-LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||+++......... ......+++.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------------ 256 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------------ 256 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------------
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 9999997654322211 1112245788999999998999999999999999999998 9999864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.++.+.+......+. ....+..+.+|+.+||+.||++||+++||++.|++++...
T Consensus 257 ----~~~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 257 ----QDVIKAVDEGYRLPP--PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----HHHHHHHHTTEECCC--CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----HHHHHHHHcCCCCCC--CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111111111111111 1123456779999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.84 Aligned_cols=269 Identities=26% Similarity=0.366 Sum_probs=210.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ...+...+.|.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--------REKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--------SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--------cccHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 357999999999999999999865 68999999986432 123345678999999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999653 23688999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ .......||+.|+|||++....++.++||||||+++|||+||+.||......
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------------- 218 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--------------- 218 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---------------
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---------------
Confidence 999976433221 1122346899999999999999999999999999999999999999643210
Q ss_pred hhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCC-CHHHHHHHHHHHHhhcccCC
Q 046311 697 DEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRP-SMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 697 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~~l~~~~~~~ 757 (768)
....+.+....+.. .....+.+..+.+++.+||+.||++|| +++++.+.|+.++.......
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 219 SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 11111222211110 011122346678999999999999998 99999999998876554433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=359.45 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=201.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCC
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRN 539 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 539 (768)
|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-----------QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-----------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 666789999999999999976 79999999986431 234567889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGL 619 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGl 619 (768)
..++||||+++++|.+++... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 187 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGF 187 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeee
Confidence 999999999999999998642 3689999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+......... .....||+.|+|||++....++.++||||||+++|||++|+.||...... ...
T Consensus 188 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---------------~~~ 250 (321)
T 2c30_A 188 CAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAM 250 (321)
T ss_dssp CEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------HHH
T ss_pred eeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Confidence 9765432221 22457999999999999889999999999999999999999998643210 011
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+.+.. .+...........+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 KRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 11111122334567799999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=376.82 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=208.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||+|++. +++.||||.++.. .......+|.+|++++++++||||+++++++.+
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 46888899999999999999986 7899999987532 122344578899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999999997432 23578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+++...............+++.|+|||++....++.++||||||+++|||+| |+.||.....
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------------- 321 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------------- 321 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----------------
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------
Confidence 99975433222111112235778999999998899999999999999999998 9888864321
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.+..+.+......+.+ ...+..+.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 322 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 322 QQTREFVEKGGRLPCP--ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112222222111111 12245677899999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=353.57 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=208.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc------------cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 5688889999999999999999888999999986431 2335789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTT
T ss_pred CceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccc
Confidence 99999999999999999997533 34688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ .......+|+.|+|||++....++.++||||||+++|||++ |+.||...... +
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---------------~ 215 (269)
T 4hcu_A 152 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---------------E 215 (269)
T ss_dssp GGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------H
T ss_pred cccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---------------H
Confidence 9975433221 11223456788999999998999999999999999999999 89888643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
....+... ..... .......+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 216 ~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 216 VVEDISTG-FRLYK--PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHTT-CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcC-ccCCC--CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11111111 11111 111235577899999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=371.20 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=214.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNL 528 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnI 528 (768)
.++|.+.++||+|+||.||+++.. .+..||||+++.. ..+....++.+|+++++++ +||||
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----------cCHHHHHHHHHHHHHHHHhcCCchh
Confidence 357888999999999999999853 2357999988542 2234557899999999999 99999
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 046311 529 VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIH 596 (768)
Q Consensus 529 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 596 (768)
+++++++.+.+..++||||+++|+|.+++..... ....+++..+++++.|+++||+|||+++ |+|
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 214 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 214 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 9999999999999999999999999999975431 1234789999999999999999999998 999
Q ss_pred cCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCccc
Q 046311 597 RDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAI 675 (768)
Q Consensus 597 rDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~ 675 (768)
|||||+||||+.++.+||+|||+++...............+|+.|+|||++....++.++||||||+++|||++ |+.||
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986544333333334467899999999999999999999999999999999 99988
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
..... .++.+.+........+ ......+.+|+.+||+.||++|||++||++.|+++++....
T Consensus 295 ~~~~~----------------~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 295 PGVPV----------------EELFKLLKEGHRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp TTCCH----------------HHHHHHHHTTCCCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCCCH----------------HHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 64321 1111222211111111 12345677899999999999999999999999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.59 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||||++...... .......+.+.+|+++++.++||||+++++++.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT------SSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------TSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcc------ccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46889999999999999999875 6899999998643210 1112235679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc---EEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT---AKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~---~kl 614 (768)
.+..++||||+++++|.+++.........+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEE
Confidence 99999999999999999888643323334688899999999999999999998 999999999999986654 999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ ......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 175 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 238 (351)
T 3c0i_A 175 GGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------------- 238 (351)
T ss_dssp CCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------------
T ss_pred ecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------------
Confidence 99999976543322 12234699999999999988999999999999999999999999964210
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....+...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 --RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111122222221111111123456789999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.53 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=206.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||||.++...... .......+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----SRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT-----CSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc-----ccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 357899999999999999999876 68999999987643211 111224567999999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC----cE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----TA 612 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----~~ 612 (768)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCE
Confidence 999999999999999999999653 24688999999999999999999998 99999999999998776 79
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
||+|||++........ .....||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 159 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------------ 223 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------ 223 (361)
T ss_dssp EECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------
T ss_pred EEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------------
Confidence 9999999976543322 1234699999999999988999999999999999999999999964321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+....+.......+.......+..+.+|+.+||..||++|||+.|+++
T Consensus 224 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 ---QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111222222222111111223456779999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=361.16 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=204.4
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 35799999999999999999987 479999999986431 22345567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..++||||+++++|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEee
Confidence 999999999999999999999653 23578889999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCC-ChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++........ .....||+.|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------------- 219 (328)
T 3fe3_A 158 FGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------------- 219 (328)
T ss_dssp TTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred ccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---------------
Confidence 999975443322 2345799999999999887765 799999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.......+. ..+..+.+|+.+||+.||++|||++|+++.
T Consensus 220 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 220 KELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112222232222222 123456789999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=362.24 Aligned_cols=252 Identities=17% Similarity=0.250 Sum_probs=205.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+++++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 71 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------GTDQVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------THHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------------cccHHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence 367999999999999999999876 6889999987532 234457889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--CCcEEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--TWTAKV 614 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--~~~~kl 614 (768)
+.+..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++. ++.+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 72 SMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred cCCEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEE
Confidence 9999999999999999999996532 24688899999999999999999998 999999999999987 789999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ .....+|+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 146 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 208 (321)
T 1tki_A 146 IEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------------- 208 (321)
T ss_dssp CCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------------
T ss_pred EECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------------
Confidence 99999986543332 1234689999999999988889999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.............+.+..+.+|+.+||+.||++|||+.|+++.
T Consensus 209 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 209 -QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122233322222111112334667899999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.41 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=211.1
Q ss_pred cCCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|.+.+.||+|+||.||+++. .+++.||||++... ......+.+.+|++++++++||||+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----------ASPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----------CCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 35788899999999999999986 24578999987532 223455789999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS--------------------SSPLKSWPARIKVALDAARGIEYLHEYAV 591 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~ 591 (768)
++++.+.+..++||||+++++|.+++..... ....+++..+++++.|+++||+|||+++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 170 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999999999999999975432 1123678899999999999999999998
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS- 670 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt- 670 (768)
|+||||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||++
T Consensus 171 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp --EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976544333222234457889999999998889999999999999999999
Q ss_pred CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
|+.||...... ++...+....... .....+..+.+|+.+||+.||++||++.|+++.|++++
T Consensus 249 g~~p~~~~~~~----------------~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 249 GGNPYPGIPPE----------------RLFNLLKTGHRME--RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp SCCSSTTCCGG----------------GHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH----------------HHHHHhhcCCcCC--CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99998643221 1111111111111 11123456779999999999999999999999999998
Q ss_pred hh
Q 046311 751 AA 752 (768)
Q Consensus 751 ~~ 752 (768)
..
T Consensus 311 ~~ 312 (314)
T 2ivs_A 311 VK 312 (314)
T ss_dssp HT
T ss_pred hh
Confidence 65
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=366.76 Aligned_cols=266 Identities=29% Similarity=0.404 Sum_probs=210.1
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCcee
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR 530 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 530 (768)
..++|++.+.||+|+||.||+++.. +++.||||+++.. ......+.|.+|++++++++||||++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3468999999999999999999875 3478999987532 12345678999999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS--------------------SPLKSWPARIKVALDAARGIEYLHEYA 590 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~~ia~~ia~gL~yLH~~~ 590 (768)
+++++.+.+..++||||+++++|.+++...... ...+++..++.++.||++||+|||+++
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999753211 145688999999999999999999998
Q ss_pred CCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 591 VPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 591 ~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
|+||||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||+|
T Consensus 195 ---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 195 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 99999999999999999999999999975433222222234467899999999998899999999999999999999
Q ss_pred -CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 671 -GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 671 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
|+.||..... .+....+.+...... ....+..+.+|+.+||+.||++||++.|+++.|+++
T Consensus 272 ~g~~p~~~~~~---------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 272 YGLQPYYGMAH---------------EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTCCTTTTSCH---------------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCCcCCCCCh---------------HHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9988864321 011112222222111 112335677999999999999999999999999998
Q ss_pred Hhhc
Q 046311 750 LAAC 753 (768)
Q Consensus 750 l~~~ 753 (768)
....
T Consensus 334 ~~~~ 337 (343)
T 1luf_A 334 CERA 337 (343)
T ss_dssp TC--
T ss_pred Hhhh
Confidence 7543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.97 Aligned_cols=275 Identities=25% Similarity=0.384 Sum_probs=205.1
Q ss_pred CCCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.++||+|+||+||++++ .+++.||||++... .....+.|.+|++++++++||||+++++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 5788899999999999999984 26889999987532 2344568999999999999999999999
Q ss_pred EEEcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 534 FCEDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 534 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++... ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~ 152 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCe
Confidence 98653 56899999999999999997532 23688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++......... .......++..|+|||++....++.++||||||+++|||+||..|+...............
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence 999999999765433221 1222345778899999999899999999999999999999999887532110000000000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
..........+.+......+. ....+..+.+|+.+||+.||++|||++|+++.|+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchhHHHHHHHHhccCcCCC--CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000111112222222222111 122345678999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=360.22 Aligned_cols=272 Identities=25% Similarity=0.361 Sum_probs=195.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC-C---CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD-G---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.++|++.+.||+|+||.||+++... + ..||||+++... ......+.|.+|++++++++||||+++++
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---------IASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---------cCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 4579999999999999999998653 2 279999886431 12344678999999999999999999999
Q ss_pred EEEcCCee------EEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 534 FCEDRNER------VLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 534 ~~~~~~~~------~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
++...+.. ++||||+++++|.+++.... .....+++..+++++.|+++||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIl 169 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCM 169 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEE
Confidence 99887665 99999999999999985432 12224688999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPR 684 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 684 (768)
++.++.+||+|||++................+++.|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--- 246 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--- 246 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---
Confidence 99999999999999976544333222333457889999999998999999999999999999999 89888643221
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCCC
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSI 759 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~~ 759 (768)
+....+........ .......+.+|+.+||+.||++|||+.|+++.|++++......+..
T Consensus 247 ------------~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 247 ------------EIYNYLIGGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp ------------GHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred ------------HHHHHHhcCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 11111121111111 1123356779999999999999999999999999999866554433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=359.09 Aligned_cols=265 Identities=28% Similarity=0.389 Sum_probs=212.6
Q ss_pred CCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|+..+.||+|+||.||+++. .+++.||||+++.. ......+.+.+|+++++++ +||||+++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------AHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----------hhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 5788899999999999999985 24678999998642 1223457899999999999 99999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSS--------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++.+.+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 169 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 99999999999999999999999999754321 124688999999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||+| |+.||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986554433333334457889999999998899999999999999999999 999886
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..... ....+.+........ ....+..+.+|+.+||+.||++|||+.|+++.|++++..+
T Consensus 250 ~~~~~---------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 250 GMPVD---------------SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TCCSS---------------HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cccch---------------hHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 43221 111111111111111 1123456779999999999999999999999999999765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=373.21 Aligned_cols=266 Identities=28% Similarity=0.381 Sum_probs=209.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|++.+.||+|+||.||+|++. +++.||||+++.. .......++.+|+.++++++||||++++
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------CSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----------cChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 57888999999999999999843 4678999987532 2234556799999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQS---SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
+++.+....++||||+++|+|.+++..... ....+++..++.++.||++||+|||+++ |+||||||+|||++.+
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecC
Confidence 999999999999999999999999975331 2234688999999999999999999998 9999999999999955
Q ss_pred C---cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccc
Q 046311 610 W---TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRN 685 (768)
Q Consensus 610 ~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 685 (768)
+ .+||+|||+++...............+|+.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----- 292 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----- 292 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 4 599999999964322222222223467899999999998999999999999999999998 9999864321
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.++.+.+........ ....+..+.+|+.+||+.||++||++.||++.|+.+.+....
T Consensus 293 -----------~~~~~~i~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 293 -----------QEVLEFVTSGGRMDP--PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp -----------HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred -----------HHHHHHHHcCCCCCC--CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111111111111111 112234577999999999999999999999999998875544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.14 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=204.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.||||.+....... .......+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----SRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTT-----CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccc-----ccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46888999999999999999876 68999999987543211 1112245679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC----cEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----TAK 613 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----~~k 613 (768)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEE
Confidence 99999999999999999999653 34688999999999999999999998 99999999999998877 899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 159 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------ 223 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------ 223 (326)
T ss_dssp ECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------------
T ss_pred EEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------------
Confidence 9999999765433221 2346899999999999889999999999999999999999998643210
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....+...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 224 ---ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111111111123456779999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.10 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=204.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++..+ +++.||+|++.... ......+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 357999999999999999999876 68999999986432 12334567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC---CcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~---~~~k 613 (768)
+.+..++||||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEE
Confidence 999999999999999999999653 23688899999999999999999998 9999999999999865 4599
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++........ .....||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 172 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------------- 235 (362)
T 2bdw_A 172 LADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------------- 235 (362)
T ss_dssp ECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------
T ss_pred EeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------
Confidence 999999976543322 1234799999999999988999999999999999999999999864321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.......+..........+.+|+.+||+.||++||++.|+++.
T Consensus 236 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 236 --HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111222222222222222345667899999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=359.94 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=201.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 75 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----------VDCPENIKKEICINKMLNHENVVKFYGHRR 75 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----------cchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 357999999999999999999876 789999999864321 123356889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~D 148 (323)
T 3tki_A 76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148 (323)
T ss_dssp CSSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEE
Confidence 999999999999999999999753 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++................||+.|+|||++....+ +.++||||||+++|||++|+.||........
T Consensus 149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------ 216 (323)
T 3tki_A 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------------ 216 (323)
T ss_dssp CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------------
T ss_pred eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------------
Confidence 999975433332222334579999999999987665 7799999999999999999999975432110
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
............. ........+.+|+.+||+.||++|||++|+++.
T Consensus 217 --~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 217 --EYSDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --HHHHHHTTCTTST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --HHHHHhcccccCC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0111111111111 112234556789999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=362.22 Aligned_cols=259 Identities=23% Similarity=0.412 Sum_probs=198.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCe----EEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|+..++||+|+||+||+|++. +++. ||+|.+... ......++|.+|+.++++++||||+++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----------cCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 46888999999999999999864 4554 466665422 12334578999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.+.. .++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 85 ICLTST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp EEESSS-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEE
T ss_pred EEecCC-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEE
Confidence 998764 789999999999999997533 33688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............+|+.|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------- 226 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------- 226 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------
Confidence 999999976544333333334457889999999999999999999999999999999 99998643221
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
++...+........ .......+.+|+.+||+.||++||+++|+++.|+++...
T Consensus 227 -----~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 227 -----EISSILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----GHHHHHHTTCCCCC--CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----HHHHHHHcCCCCCC--CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11222222111111 112334577899999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.83 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=204.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---------LSARDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---------CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 457899999999999999999865 78999999986532 12334567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~k 613 (768)
+.+..++||||+++|+|.+++... ..+++.....++.||++||+|||+++ |+||||||+|||++ .++.+|
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEE
Confidence 999999999999999999998753 23688899999999999999999998 99999999999998 567899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... .....||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 154 L~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------------- 218 (444)
T 3soa_A 154 LADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------------- 218 (444)
T ss_dssp ECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------
T ss_pred EccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------------
Confidence 9999999765433221 2235799999999999988999999999999999999999999864321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.......+.+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 219 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 219 --HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11112222222222222222334567799999999999999999999873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.94 Aligned_cols=272 Identities=21% Similarity=0.302 Sum_probs=211.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+++.. +++.||||++.... .....+.+.+|++++++++||||+++++++..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----------ccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 57889999999999999999876 58999999986431 12235678899999999999999999999987
Q ss_pred CC--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE----CCCCc
Q 046311 538 RN--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWT 611 (768)
Q Consensus 538 ~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl----~~~~~ 611 (768)
.. ..++||||+++++|.+++...... ..+++..++.++.|+++||+|||+++ |+||||||+|||+ +.++.
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCce
Confidence 65 779999999999999999764332 22688999999999999999999998 9999999999999 88888
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccc--------cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR--------LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
+||+|||+++........ ....||+.|+|||++. ...++.++||||||+++|||+||+.||........
T Consensus 155 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred EEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 999999999765443322 2346899999999986 46789999999999999999999999975332110
Q ss_pred ccccccccchhhhhhH-------------HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 684 RNVVDFVVPYIVRDEI-------------HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
..+... .+..... ........+............+.+|+.+||+.||++|||++|+++...+..
T Consensus 232 --~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 232 --NKEVMY-KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp --CHHHHH-HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred --hHHHHH-HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000000 0000000 000111223333455677888999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.98 Aligned_cols=269 Identities=22% Similarity=0.324 Sum_probs=199.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.++||+|+||+||+++..+++.||||++.... ..+.....+.+|++++++++||||+++++++.+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---------EDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 35789999999999999999999889999999986431 122345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccC
Confidence 9999999999985 8888886532 33678889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-cccc---cc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-VDFV---VP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~~~~---~~ 692 (768)
|++......... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .... .+
T Consensus 164 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 164 GLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp TTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred cCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 999765322221 223468999999999875 5689999999999999999999999975433221000 0000 00
Q ss_pred h--hhhhhHHhhhccCCCC--CCcc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 Y--IVRDEIHRVLDRNVPP--PTPF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~--~~~~~~~~~~~~~~~~--~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
. ....+.....+..... .... .......+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000000011111110 0000 0112356779999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.14 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=206.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||.||+++++++..||||+++... ...+++.+|++++++++||||+++++++.+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS------------MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC------------CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 4788899999999999999999988899999986431 1235689999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred CCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccc
Confidence 99999999999999999997532 23688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ .......+|+.|+|||++....++.++||||||+++|||+| |+.||...... +
T Consensus 166 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---------------~ 229 (283)
T 3gen_A 166 LSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---------------E 229 (283)
T ss_dssp GGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---------------H
T ss_pred cccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---------------H
Confidence 9975433221 11123356788999999998899999999999999999998 99998643211 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
....+... ..... .......+.+|+.+||+.||++|||++|+++.|++++...
T Consensus 230 ~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 230 TAEHIAQG-LRLYR--PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHHHTT-CCCCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcc-cCCCC--CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111111 11100 0112345778999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.98 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=196.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc--CCCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR--LHHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||+||+++. +++.||||++... ....+.+|.+++.. ++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------------DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------------GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------------cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 35799999999999999999988 4899999987532 23445566666655 7999999999986
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecCCCCCC
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH--------EYAVPSIIHRDIKSSN 603 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDiKp~N 603 (768)
.+ ....++||||+++|+|.++++. ..+++..+++++.|+++||+||| +.+ |+||||||+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 143 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKN 143 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGG
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHh
Confidence 54 3457899999999999999954 23688999999999999999999 766 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcc--cccccccccCccCccccccC------CCCChhhHHHHHHHHHHHHcC----
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESH--LSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVLLEILSG---- 671 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltG---- 671 (768)
||++.++.+||+|||+++......... ......||+.|+|||++... .++.++||||||+++|||+||
T Consensus 144 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~ 223 (301)
T 3q4u_A 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223 (301)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCc
Confidence 999999999999999996533222111 11234689999999999866 455799999999999999999
Q ss_pred ------CcccccCCCCCcccccccccchhhhhhHHhhhc-cCCCCC---CcchHHHHHHHHHHHHHcccccCCCCCCHHH
Q 046311 672 ------YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLD-RNVPPP---TPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741 (768)
Q Consensus 672 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 741 (768)
+.||........ ........+. ....+. ..........+.+|+.+||+.||++|||+.|
T Consensus 224 ~~~~~~~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 224 GIVEDYKPPFYDVVPNDP-----------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp TBCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cccccccccccccCCCCc-----------chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 555543221110 0111111111 111111 1123456778899999999999999999999
Q ss_pred HHHHHHHH
Q 046311 742 IVNSLERA 749 (768)
Q Consensus 742 vl~~L~~~ 749 (768)
|++.|+++
T Consensus 293 i~~~L~~i 300 (301)
T 3q4u_A 293 IKKTLTKI 300 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcc
Confidence 99999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.91 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=207.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.+.||+|+||.||+++.+++..||||+++... ...+++.+|++++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS------------MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT------------BCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC------------CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 35788899999999999999999888899999986431 233568999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCT
T ss_pred CCceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccC
Confidence 999999999999999999996532 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++......... ......+|+.|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 149 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------- 212 (268)
T 3sxs_A 149 GMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------------- 212 (268)
T ss_dssp TCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---------------
T ss_pred ccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---------------
Confidence 999765433221 1223356788999999998899999999999999999999 99998643211
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
+....+......... ...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 213 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 213 EVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111111111111110 1123457789999999999999999999999987753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.63 Aligned_cols=267 Identities=19% Similarity=0.217 Sum_probs=209.9
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+|+++++++ +|+|++++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------------TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-------------ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 5799999999999999999986 478999999875321 123477899999999 8999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc-----
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT----- 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~----- 611 (768)
+....++||||+ +++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCe
Confidence 999999999999 999999997532 23688999999999999999999998 999999999999987776
Q ss_pred EEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+||+|||++......... .......||+.|+|||++....++.++||||||+++|||++|+.||...........
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 999999999754432221 112345699999999999988999999999999999999999999976433221111
Q ss_pred cccccchhhhhhHHhhhccCCCCC-CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCC
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPP-TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~ 757 (768)
. ..+.......+ .......+..+.+|+.+||+.||++||++++|++.|++++.......
T Consensus 230 ~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 230 Y------------ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp H------------HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred H------------HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 0 00000000000 00001224567799999999999999999999999999998765444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.50 Aligned_cols=266 Identities=29% Similarity=0.412 Sum_probs=208.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 530 (768)
.++|++.+.||+|+||.||+++.. ++..||||++.... .....+.+.+|+.+++++ +||||++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------DSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 357889999999999999999862 45689999986421 123446799999999999 8999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-------------------SPLKSWPARIKVALDAARGIEYLHEYAV 591 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~ 591 (768)
+++++...+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 192 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS- 192 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 999999999999999999999999999764321 123688899999999999999999998
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS- 670 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt- 670 (768)
|+||||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||+|
T Consensus 193 --ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 193 --CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp --EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999975443333222334457889999999988899999999999999999998
Q ss_pred CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
|+.||...... ......+........+ ......+.+|+.+||+.||++|||+.|+++.|+.++
T Consensus 271 g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 271 GVNPYPGIPVD---------------ANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp SCCSSTTCCCS---------------HHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCcccCCcH---------------HHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 99998643221 1111222222211111 122456778999999999999999999999999988
Q ss_pred hhc
Q 046311 751 AAC 753 (768)
Q Consensus 751 ~~~ 753 (768)
+..
T Consensus 334 ~~~ 336 (344)
T 1rjb_A 334 ADA 336 (344)
T ss_dssp ---
T ss_pred HHH
Confidence 654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.21 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=195.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.++||+|+||+||+++.+ ..||||+++... ......+.|.+|++++++++||||++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS---------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC---------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 357999999999999999999865 469999986432 2234567899999999999999999999965 5
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccc
Confidence 567899999999999999996532 34688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++................||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------- 231 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------- 231 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------------
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------------
Confidence 9997544322222223456899999999986 567888999999999999999999999643221
Q ss_pred hhhhHHhhhcc-CCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 695 VRDEIHRVLDR-NVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 695 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
+.+.+.+.. ...+ ........+..+.+|+.+||+.||++|||++|+++.|+++.+
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 232 --DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111111111 1111 111122334667899999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=367.33 Aligned_cols=285 Identities=18% Similarity=0.220 Sum_probs=209.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|++.++||+|+||.||++.+.. ++.||||++.....................+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3578999999999999999998764 4789999986532110000000011122345667778889999999999
Q ss_pred EEEEEcC----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 532 LGFCEDR----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 532 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
++++... ...+|||||+ +++|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 999999997532 34689999999999999999999998 99999999999998
Q ss_pred --CCCcEEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCC
Q 046311 608 --ATWTAKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN 680 (768)
Q Consensus 608 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~ 680 (768)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||++||||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999754322111 111234599999999999988999999999999999999999999975322
Q ss_pred CCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCC
Q 046311 681 GTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~ 757 (768)
.. ..... ........+..+++..++.. ..+..+.+++..||+.+|++||++++|++.|++++.......
T Consensus 267 ~~--~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 267 DP--KYVRD-SKIRYRENIASLMDKCFPAA-----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp CH--HHHHH-HHHHHHHCHHHHHHHHSCTT-----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CH--HHHHH-HHHHhhhhHHHHHHHhcccc-----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 11 11100 01111122333333322111 123457789999999999999999999999999998765544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.88 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.+ +++.||||+++... .+...+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----------RELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 46888999999999999999986 78999999986431 23455789999999999999999999999865
Q ss_pred CC---------------------------------------------------------eeEEEEEeccCCChhhhccCC
Q 046311 538 RN---------------------------------------------------------ERVLIYEYLENGTLHDHLHNP 560 (768)
Q Consensus 538 ~~---------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~ 560 (768)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 379999999999999999865
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCc----------c
Q 046311 561 QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES----------H 630 (768)
Q Consensus 561 ~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~ 630 (768)
... ...++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++......... .
T Consensus 156 ~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 156 CSL-EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CSG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred cCc-cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 432 33466678899999999999999998 999999999999999999999999999765433211 1
Q ss_pred cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCC
Q 046311 631 LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP 710 (768)
Q Consensus 631 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (768)
......||+.|+|||++....++.++||||||+++|||++|..|+... ............
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----------------~~~~~~~~~~~~--- 291 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----------------VRIITDVRNLKF--- 291 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----------------HHHHHHHHTTCC---
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----------------HHHHHHhhccCC---
Confidence 122346999999999999899999999999999999999987654211 001111111111
Q ss_pred CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 711 TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 711 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..........+.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 1122334456679999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=361.72 Aligned_cols=264 Identities=17% Similarity=0.199 Sum_probs=207.6
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-------------RAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-------------SSCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-------------chHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 5789999999999999999986 478999999876431 122478899999999 9999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc-----
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT----- 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~----- 611 (768)
+.+..++||||+ +++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~ 148 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQV 148 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTS
T ss_pred cCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCce
Confidence 999999999999 89999999753 234689999999999999999999998 999999999999998887
Q ss_pred EEEeeccccccCCCCCCcc-----cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDESH-----LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 9999999997543322111 12345799999999999999999999999999999999999999975432221111
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcc-hHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPF-EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
...+.+.....+... ....+ .+.+++..||+.||.+||++++|++.|++++.....
T Consensus 229 ------------~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 229 ------------YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp ------------HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------------HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 011100000000000 00112 678999999999999999999999999999876533
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.35 Aligned_cols=266 Identities=24% Similarity=0.275 Sum_probs=203.6
Q ss_pred HHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 456 EATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 456 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
...++|++.+.||+|+||.||++... +++.||+|++...... .......+.+.+|++++++++||||++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR------QINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------C---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc------ccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 34567999999999999999999875 6889999998653210 1123456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCC------------------------------------CCCCCHHHHHHHHHH
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSS------------------------------------SPLKSWPARIKVALD 578 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~~~~~~~~~ia~~ 578 (768)
+.+.+..++||||+++|+|.+++...... ...+++..+..++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 99999999999999999999998521000 111245667789999
Q ss_pred HHHHHHHHhhCCCCCeEecCCCCCCeEECCCC--cEEEeeccccccCCCCC--CcccccccccccCccCcccccc--CCC
Q 046311 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATW--TAKVSDFGLSLIGPEDD--ESHLSLRAAGTVGYMDPEYYRL--QQL 652 (768)
Q Consensus 579 ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~--~~~ 652 (768)
+++||+|||+++ |+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.. ..+
T Consensus 177 i~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 177 IFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 999999999998 99999999999998776 89999999997532211 1111224568999999999865 678
Q ss_pred CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHccccc
Q 046311 653 TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLE 732 (768)
Q Consensus 653 s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~d 732 (768)
+.++||||||+++|||++|+.||..... .+....++........+........+.+|+.+||+.|
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVND---------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCh---------------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999864321 1223334444433333333334567889999999999
Q ss_pred CCCCCCHHHHHHH
Q 046311 733 GRNRPSMTEIVNS 745 (768)
Q Consensus 733 P~~RPs~~evl~~ 745 (768)
|++||++.|+++.
T Consensus 319 p~~Rps~~~~l~h 331 (345)
T 3hko_A 319 VDERFDAMRALQH 331 (345)
T ss_dssp TTTSCCHHHHHHS
T ss_pred hhHCCCHHHHhcC
Confidence 9999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=358.19 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=210.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
++|++.+.||+|+||.||+++.. ++..||||+++.. ..+.....+.+|+++++++ +||||+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----------CcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 57888999999999999999863 4678999987532 1234567899999999999 899999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++.+.+..++||||+++++|.+++...... ...+++..++.++.|+++||+|||+++ |+||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 181 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 9999999999999999999999999999764321 123688899999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||++ |+.||.
T Consensus 182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999999976544333222333457889999999988889999999999999999999 999886
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.... .++.+.+........ .......+.+++.+||+.||++||+++|+++.|++++....
T Consensus 262 ~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 262 GIPV----------------EELFKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp TCCH----------------HHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cCCH----------------HHHHHHHhcCCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 4321 111111111111111 11233557789999999999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=354.94 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=203.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.+ +++.||||+++.... ........+.+|+++++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--------hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 57888999999999999999876 689999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999642 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||..... ..
T Consensus 150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------------~~ 212 (337)
T 1o6l_A 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------ER 212 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---------------HH
Confidence 99975332221 12245799999999999999999999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
....++......+. .....+.+|+.+||+.||++|| +++|+++.
T Consensus 213 ~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 213 LFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11122222222221 2235567899999999999999 89999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=379.43 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=207.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||+|.++++..||||+++.. ....+.|.+|+++|++++||||+++++++. .
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT------------SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC------------CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 467888999999999999999988899999998642 123568999999999999999999999986 5
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.++++.... ...++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCC
Confidence 678999999999999999975321 23578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+++....... .......+|+.|+|||++....++.++||||||++||||+| |+.||..... .
T Consensus 330 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----------------~ 392 (454)
T 1qcf_A 330 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------------P 392 (454)
T ss_dssp GGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------H
T ss_pred CceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----------------H
Confidence 9986533211 11122346789999999998899999999999999999999 9999864221 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
++.+.+......+. ....+..+.+||.+||+.||++|||+++|++.|++++.+..
T Consensus 393 ~~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 393 EVIRALERGYRMPR--PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HHHHHHHcCCCCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 11111111111111 11234567799999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=360.60 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=199.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCe----EEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|+..+.||+|+||.||++++. +++. ||+|.+.... .......+.+|+.++++++||||+++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----------GRQSFQAVTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----------SCSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----------cHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 47888999999999999999865 4555 6667654321 1122235678999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++. .+..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEE
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEE
Confidence 886 456889999999999999997542 23577888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............+|..|+|||++....++.++||||||+++|||+| |+.||.......
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------- 225 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------- 225 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----------
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----------
Confidence 999999987654443333344567889999999998999999999999999999999 999987532211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
+...+........ .......+.+|+.+||+.||++||+++|+++.|+++...
T Consensus 226 ------~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 226 ------VPDLLEKGERLAQ--PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------HHHHHHTTCBCCC--CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------HHHHHHcCCCCCC--CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111000 001223456899999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=353.33 Aligned_cols=280 Identities=23% Similarity=0.332 Sum_probs=202.5
Q ss_pred HHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC--CCCCceeE
Q 046311 454 LLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL--HHKNLVRL 531 (768)
Q Consensus 454 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l 531 (768)
.....++|++.++||+|+||.||+++.+ ++.||||++... ....+.+|.+++..+ +||||+++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~~~h~~i~~~ 96 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--------------EEASWFRETEIYQTVLMRHENILGF 96 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--------------GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--------------ccchhhhHHHHHHHHhhcCCCeeeE
Confidence 3344568999999999999999999887 899999987532 223445555555554 99999999
Q ss_pred EEEEEcC----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecCCCCC
Q 046311 532 LGFCEDR----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA-----VPSIIHRDIKSS 602 (768)
Q Consensus 532 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDiKp~ 602 (768)
++++.+. ...++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. .++|+||||||+
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp EEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGG
T ss_pred EEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchH
Confidence 9999877 7889999999999999999642 3688899999999999999999981 112999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcc--cccccccccCccCccccccCCCCCh------hhHHHHHHHHHHHHcCCcc
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESH--LSLRAAGTVGYMDPEYYRLQQLTEK------SDVYSFGVVLLEILSGYRA 674 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~------sDVwSlGvll~elltG~~p 674 (768)
|||++.++.+||+|||++.......... ......||+.|+|||++.....+.+ +||||||+++|||+||..|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999997543322211 1123468999999999987666554 9999999999999999555
Q ss_pred cccCCCCCcccccccccchhhhhhHHhhh-ccCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 675 IHRTHNGTPRNVVDFVVPYIVRDEIHRVL-DRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
+........ ..................+ .....+..+ ...+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 252 ~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 252 GGIVEEYQL-PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTBCCCCCC-TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccccccc-cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 432111000 0000000000011111111 111111111 12366778899999999999999999999999999998
Q ss_pred hhcc
Q 046311 751 AACL 754 (768)
Q Consensus 751 ~~~~ 754 (768)
+...
T Consensus 331 ~~~~ 334 (337)
T 3mdy_A 331 ESQD 334 (337)
T ss_dssp HTTT
T ss_pred hhcc
Confidence 7653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=372.16 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=204.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||+++++ ++.||||+++.. ...+.|.+|++++++++||||+++++++.+.
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC-------------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc-------------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 46888899999999999999987 789999998532 1346799999999999999999999998766
Q ss_pred C-eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 N-ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 ~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+ ..++||||+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence 5 7899999999999999997532 223578889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+++...... ....+++.|+|||++....++.++||||||++||||+| |+.||.......
T Consensus 334 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------------- 394 (450)
T 1k9a_A 334 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------- 394 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------------
T ss_pred CCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence 9997543221 12256889999999999999999999999999999999 999986432211
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+...+........ ....+..+.+||.+||+.||++|||+.|+++.|+++....
T Consensus 395 --~~~~i~~~~~~~~--p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 395 --VVPRVEKGYKMDA--PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp --HHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --HHHHHHcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 1111111111111 1123456779999999999999999999999999988654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.14 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||+++.+ ++.||||++.... ......+.|.+|+.++++++||||+++++++.+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD---------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT---------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc---------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 47888999999999999999986 8899999986531 2234556799999999999999999999999887
Q ss_pred --CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 539 --NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 539 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
...++||||+++++|.++++.... ..+++..++.++.|+++||+|||+++ ++|+||||||+|||++.++.++|.|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred CCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence 788999999999999999976432 24689999999999999999999976 4589999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCC---hhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTE---KSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
||+....... ...+|+.|+|||++....++. ++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------- 216 (271)
T 3kmu_A 157 ADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------------- 216 (271)
T ss_dssp GGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------------
T ss_pred ccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------------
Confidence 9987542221 235799999999998665544 89999999999999999999864321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.+...........+.. ....+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 217 --~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 217 --MEIGMKVALEGLRPTI--PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --HHHHHHHHHSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0111122222111111 11234567799999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.44 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=195.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||.||++.+. ++.||||+++.... .......+.+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPD-------EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCc-------ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57888999999999999999976 89999998764321 11123456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--------CC
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--------TW 610 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--------~~ 610 (768)
+..++||||+++++|.+++.. ..+++..++.++.|++++|+|||+++..+|+||||||+|||++. ++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence 999999999999999999953 23688899999999999999999998556899999999999986 77
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
.+||+|||++........ ....||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 154 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------- 220 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------- 220 (271)
T ss_dssp CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---------
T ss_pred ceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------
Confidence 899999999975433222 1346899999999999889999999999999999999999998643210
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.............. .....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 221 ------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ------AVAYGVAMNKLALP--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------HHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------HHHHhhhcCCCCCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111111111111 1112345677999999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.86 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeE----EEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQV----AVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~v----aVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.++||+|+||.||++.+. +++.+ ++|.+... ......+.+.+|+.++++++||||+++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----------SSCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----------cCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 57899999999999999999864 56655 55554321 22345678999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.... .++|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 157 (327)
T 3lzb_A 85 ICLTST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp EEESSS-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEE
T ss_pred EEecCC-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEE
Confidence 998765 789999999999999997532 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------- 226 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------- 226 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------
Confidence 999999976543333222233457889999999999999999999999999999999 99998643221
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
++...+......+. .......+.+|+.+||+.||++||++.|+++.|+++..
T Consensus 227 -----~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 227 -----EISSILEKGERLPQ--PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----GHHHHHHTTCCCCC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----HHHHHHHcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11122222111111 11223457789999999999999999999999999885
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.64 Aligned_cols=273 Identities=25% Similarity=0.349 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||||++.... ........++.+|++++++++||||+++++++.+
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS--------SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh--------ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 46888999999999999999874 78999999986421 1223456788999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.........+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEec
Confidence 99999999999999999998643222344688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+++.|+|||++....++.++||||||+++|||++|+.||...... . ..
T Consensus 181 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~---------~~ 245 (310)
T 2wqm_A 181 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L---------YS 245 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----H---------HH
T ss_pred cceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----H---------HH
Confidence 998754332211 12346899999999999889999999999999999999999998643211 0 00
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCCC
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPSI 759 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~~ 759 (768)
....+.....+... .......+.+|+.+||+.||++|||++||++.|+++.+....+++.
T Consensus 246 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~ 305 (310)
T 2wqm_A 246 LCKKIEQCDYPPLP--SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305 (310)
T ss_dssp HHHHHHTTCSCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred HHHHhhcccCCCCc--ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence 11111111111111 1123456779999999999999999999999999999887666653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.02 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=202.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|++++++++||||+++++++.+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 119 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----------chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence 57899999999999999999876 6889999988642 12234578999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--CCcEEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--TWTAKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--~~~~kl~ 615 (768)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 120 ~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 120 KYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEE
Confidence 999999999999999999997532 23688899999999999999999998 999999999999974 5789999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||++......... ....||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 194 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------------- 256 (387)
T 1kob_A 194 DFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------------- 256 (387)
T ss_dssp CCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------------
T ss_pred ecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------------
Confidence 99999865433221 2346899999999999889999999999999999999999999643210
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+.+..+..................+.+|+.+||+.||++|||+.|+++.
T Consensus 257 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 257 -ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111111111111111112234567799999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.52 Aligned_cols=268 Identities=28% Similarity=0.379 Sum_probs=211.1
Q ss_pred HcCCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
..++|++.+.||+|+||.||+++. .+++.||||++... ........+.+|++++.++ +||||+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----------CCcHHHHHHHHHHHHHHhcccCCCee
Confidence 456899999999999999999974 24688999998642 1233456799999999999 799999
Q ss_pred eEEEEEEcCC-eeEEEEEeccCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 046311 530 RLLGFCEDRN-ERVLIYEYLENGTLHDHLHNPQSS------------SPLKSWPARIKVALDAARGIEYLHEYAVPSIIH 596 (768)
Q Consensus 530 ~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 596 (768)
++++++...+ ..++||||+++++|.+++...... ...+++..++.++.|+++||+|||+++ |+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999987754 589999999999999999764431 122578899999999999999999998 999
Q ss_pred cCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCccc
Q 046311 597 RDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAI 675 (768)
Q Consensus 597 rDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~ 675 (768)
|||||+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||+| |+.||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999976544333223334467899999999998899999999999999999998 99998
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
...... +.....+........ .......+.+++.+||+.||++|||+.|+++.|++++++..
T Consensus 252 ~~~~~~---------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKID---------------EEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCS---------------HHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchh---------------HHHHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 643211 011111111111100 11123457789999999999999999999999999997653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.81 Aligned_cols=281 Identities=27% Similarity=0.390 Sum_probs=200.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHH--HHHHhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE--LESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E--~~~l~~l~HpnIv~l~~~~~ 536 (768)
++|++.++||+|+||.||+++. +++.||||++... ....+.+| +..+..++||||+++++.+.
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--------------NRQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG--------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc--------------chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 5788899999999999999987 4799999998632 12233444 44455689999999998653
Q ss_pred c-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeEecCCCCC
Q 046311 537 D-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY---------AVPSIIHRDIKSS 602 (768)
Q Consensus 537 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~---------~~~~ivHrDiKp~ 602 (768)
. ....++||||+++|+|.+++.... .++..+++++.|+++||+|||+. + |+||||||+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~ 149 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSR 149 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGG
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccc
Confidence 2 235689999999999999996432 37888899999999999999998 6 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCC------cccccccccccCccCcccccc-------CCCCChhhHHHHHHHHHHHH
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDE------SHLSLRAAGTVGYMDPEYYRL-------QQLTEKSDVYSFGVVLLEIL 669 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~ell 669 (768)
|||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|||+
T Consensus 150 Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 99999999999999999975433211 111223469999999999876 45667999999999999999
Q ss_pred cCCcccccCCCCCccccccc--ccchhhhhhHHhhhc-----cCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHH
Q 046311 670 SGYRAIHRTHNGTPRNVVDF--VVPYIVRDEIHRVLD-----RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742 (768)
Q Consensus 670 tG~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 742 (768)
+|..|+.............. .......+.....+. ..++............+.+|+.+||+.||++|||++|+
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 99888754332211100000 000000111111111 11122222233456778899999999999999999999
Q ss_pred HHHHHHHHhhcccCCCCccc
Q 046311 743 VNSLERALAACLVSPSISRS 762 (768)
Q Consensus 743 l~~L~~~l~~~~~~~~~~~~ 762 (768)
++.|++++..-......+.+
T Consensus 310 l~~L~~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 310 EERMAELMMIWERNKSVSPT 329 (336)
T ss_dssp HHHHHHHHHCCCC-------
T ss_pred HHHHHHHHHHHHhcccCCCc
Confidence 99999999877665544443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=347.77 Aligned_cols=259 Identities=25% Similarity=0.307 Sum_probs=194.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCccccc---------------ccccchhhHHHHHHHHHHHhc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAI---------------GTKRQEDKDNAFINELESLSR 522 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~---------------~~~~~~~~~~~~~~E~~~l~~ 522 (768)
++|++.+.||+|+||.||+++.. +++.||||++.......... .........+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57899999999999999999875 68899999987543211000 000011234578999999999
Q ss_pred CCCCCceeEEEEEEc--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 046311 523 LHHKNLVRLLGFCED--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600 (768)
Q Consensus 523 l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK 600 (768)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.|+++||+|||+++ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 999999999999987 5688999999999999987643 24688999999999999999999998 9999999
Q ss_pred CCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCC---CCChhhHHHHHHHHHHHHcCCccccc
Q 046311 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 601 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
|+|||++.++.+||+|||++........ ......||+.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999976543322 122346899999999997654 47889999999999999999999864
Q ss_pred CCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... . .....+.......+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~------~---------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------M---------CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------H---------HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------H---------HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 0 001111111111111 1122355779999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=358.16 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=189.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||||+++.. ...+.+.+|++++++++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------------VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------hhHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 467899999999999999999986 5789999998642 12346788999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~~k 613 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++. ++.+|
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~k 191 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLK 191 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEE
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEE
Confidence 999999999999999999999753 23688899999999999999999998 999999999999975 88999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 192 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------ 256 (349)
T 2w4o_A 192 IADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------------ 256 (349)
T ss_dssp ECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------------
T ss_pred EccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------------
Confidence 999999975433221 12346899999999999889999999999999999999999998643221
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+.........+...+....+.+|+.+||+.||++|||+.|+++
T Consensus 257 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 257 --QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011222222222222222234456779999999999999999999886
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=361.20 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=195.4
Q ss_pred cCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 463 EDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
..+.||+|+||.||++... +++.||+|+++.. .....+.|.+|++++++++||||+++++++.+.+..
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----------GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3578999999999999875 6899999998643 123456799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE--CCCCcEEEeeccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL--DATWTAKVSDFGL 619 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl--~~~~~~kl~DFGl 619 (768)
+|||||+++++|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 99999999999999886422 23578889999999999999999998 9999999999999 6778999999999
Q ss_pred cccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhH
Q 046311 620 SLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
+......... ....||+.|+|||++....++.++||||||+++|||++|+.||..... .+.+
T Consensus 236 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------------~~~~ 297 (373)
T 2x4f_A 236 ARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---------------AETL 297 (373)
T ss_dssp CEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HHHH
T ss_pred ceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHH
Confidence 9865433322 234689999999999988999999999999999999999999864321 1112
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..++.................+.+|+.+||+.||++|||+.|+++
T Consensus 298 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 223332222222222234566789999999999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.25 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=200.0
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||++.. .+++.||||++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--------KKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--------cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 5799999999999999999997 4789999999864311 112234578999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+ +|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCS
T ss_pred CCEEEEEEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEe
Confidence 99999999999 68999988643 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++......... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... .
T Consensus 153 G~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~-------- 218 (336)
T 3h4j_B 153 GLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---K-------- 218 (336)
T ss_dssp SCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---C--------
T ss_pred ccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---H--------
Confidence 999765433222 23469999999999987766 78999999999999999999999754322111 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.......+ ...+..+.+|+.+||+.||++|||++|+++.
T Consensus 219 ----~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 ----KVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----CCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----HHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0001111111 1123456789999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=358.34 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=200.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||+++.+ +++.||||+++... .........+.+|.+++..+ +||||+++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--------~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--------ILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--------HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--------hcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 368999999999999999999876 68999999986431 11223456788999999988 799999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999999653 23688889999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 167 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------------- 229 (353)
T 3txo_A 167 DFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------------- 229 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred cccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---------------
Confidence 9999975332221 12245799999999999988999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH------HHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM------TEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~ 744 (768)
.+....++......+.. ....+.+|+.+||+.||++||++ +|+++
T Consensus 230 ~~~~~~i~~~~~~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 230 DDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHHcCCCCCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11122333333322222 23456789999999999999998 77765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.50 Aligned_cols=274 Identities=26% Similarity=0.372 Sum_probs=206.2
Q ss_pred CCCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|+..++||+|+||.||++++ .+++.||||++.... .......+.+|++++++++||||+++++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------GGNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----------cchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 3578889999999999999984 368899999986431 2234567899999999999999999999
Q ss_pred EEEcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 534 FCEDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 534 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++.+. ...++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 164 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 164 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCC
Confidence 99876 66899999999999999995432 23688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++......... .......+|..|+|||++....++.++||||||+++|||+||..|+........ ......
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~ 243 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL-KMIGPT 243 (302)
T ss_dssp EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSC
T ss_pred EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh-hccCCc
Confidence 999999999765443321 222344678889999999988999999999999999999999988643210000 000000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
........+...+....... .....+..+.+|+.+||+.||++|||++|+++.|+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 244 HGQMTVTRLVNTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CGGGHHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ccccCHHHHHHHHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 00001111222222222111 111234567799999999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=379.00 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=208.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|++.++||+|+||.||+|+++ ++..||||+++.. ....++|.+|+++|++++||||+++++++.+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc------------ccchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45788899999999999999987 4789999987532 1235679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..+|||||+++|+|.++++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999999975322 33688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+++....... .......+++.|+|||++....++.++||||||++||||+| |+.||.....
T Consensus 363 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---------------- 425 (495)
T 1opk_A 363 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------- 425 (495)
T ss_dssp TCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----------------
T ss_pred ccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----------------
Confidence 99986543221 11223346789999999998899999999999999999999 8888864321
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.++.+.+........ ....+..+.+||.+||+.||++|||+.||++.|++++..
T Consensus 426 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 426 SQVYELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp GGHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111122222222111 112345677899999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.91 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=196.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.++|++.+.||+|+||.||++.... +..||+|+++.. ......+.|.+|+.++++++||||+++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 3578889999999999999998642 456999986432 12345568999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++. .+..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEE
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEE
Confidence 984 567899999999999999997532 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++......... ......+|+.|+|||++....++.++||||||+++|||++ |+.||.......
T Consensus 157 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---------- 225 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------- 225 (281)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------
T ss_pred ECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----------
Confidence 9999999765432221 1123356789999999998899999999999999999997 888986432210
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
....+......+ .....+..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 226 -----~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 226 -----VIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -----HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111111 11123456778999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=346.95 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=201.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||||++....... ........+.|.+|++++++++||||+++++++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG----ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC----CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc----chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 57888999999999999999875 78999999986532210 00011122679999999999999999999999866
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc-----E
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT-----A 612 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~-----~ 612 (768)
.. ++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ ++|+||||||+|||++.++. +
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred CC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeE
Confidence 55 69999999999999886532 34688999999999999999999987 45899999999999988776 9
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCccccc--cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR--LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
||+|||++...... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........
T Consensus 169 kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------- 236 (287)
T 4f0f_A 169 KVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------- 236 (287)
T ss_dssp EECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-------
T ss_pred EeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-------
Confidence 99999999743321 22346899999999984 45678999999999999999999999965432110
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
............+. .....+..+.+|+.+||+.||++|||++|+++.|++
T Consensus 237 ------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 237 ------KFINMIREEGLRPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ------HHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ------HHHHHHhccCCCCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00111111111111 111234567899999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=348.20 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=196.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||+||+++.++++.||||++.... ..+.....+.+|++++++++||||+++++++.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc---------cccccchhHHHHHHHHHhcCCCCEeeeeeEEccC
Confidence 4788899999999999999998889999999986432 1122346788999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++ +|.+++.... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 73 KRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SCEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CeEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECc
Confidence 999999999986 9999987532 23578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh--
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV-- 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 695 (768)
++........ ......+|+.|+|||++.. ..++.++||||||+++|||++|+.||........ +.. ......
T Consensus 146 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~ 220 (288)
T 1ob3_A 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTP 220 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC
T ss_pred cccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHHCCC
Confidence 9975432211 1123468999999999875 4689999999999999999999999864321100 000 000000
Q ss_pred -h---hhHHh--hhccCCCCC--C---cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 -R---DEIHR--VLDRNVPPP--T---PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 -~---~~~~~--~~~~~~~~~--~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
. ....+ ..+...... . .........+.+|+.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 001011000 0 001123456679999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.30 Aligned_cols=273 Identities=26% Similarity=0.398 Sum_probs=210.6
Q ss_pred CCcCceeccCCceEEEEEEEc-----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 461 FSEDHKIGSGSFGAVYKATLD-----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 461 ~~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
|++.++||+|+||+||++.++ +++.||||+++.. ........|.+|++++++++||||+++++++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----------AGPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----------cChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 488899999999999998643 6789999998642 1234567799999999999999999999999
Q ss_pred EcC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 536 EDR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 536 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
.+. ...++||||+++++|.+++... .+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~k 174 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVK 174 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEE
Confidence 874 6789999999999999999653 2688999999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++......... .......+|+.|+|||++....++.++||||||+++|||+||+.||....... .....+...
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~ 253 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQG 253 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCH
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhccccc
Confidence 9999999865443221 12233467889999999998889999999999999999999999986421100 000011111
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
......+.+.+........ ....+..+.+|+.+||+.||++|||++|+++.|+++.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 254 QMTVLRLTELLERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHhcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 1111223333333322211 12334567899999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.15 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=204.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+.+|++++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---------CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 468999999999999999999876 68999999986532 12344567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc---EE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT---AK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~---~k 613 (768)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +|
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEE
Confidence 999999999999999999988643 23688899999999999999999998 999999999999986655 99
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....+|+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 149 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------ 213 (284)
T 3kk8_A 149 LADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------ 213 (284)
T ss_dssp ECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred EeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------------
Confidence 9999999765433221 2346899999999999989999999999999999999999998643210
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+.......+.+........+.+|+.+||+.||++|||++|+++.
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 214 ---RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111112222211111112334567799999999999999999999884
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=364.93 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=190.0
Q ss_pred CCCCcC-ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh-cCCCCCceeEEEEE
Q 046311 459 NNFSED-HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS-RLHHKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~ 535 (768)
++|... +.||+|+||+||++... +++.||||+++.. ..+.+|++++. ..+||||+++++++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------------~~~~~E~~~~~~~~~hp~iv~l~~~~ 124 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------------PKARREVELHWRASQCPHIVRIVDVY 124 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------------hhHHHHHHHHHHhcCCCCcceEeEEE
Confidence 456555 68999999999999876 6899999988521 34667888774 45899999999998
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--- 608 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--- 608 (768)
.. ....+|||||+++|+|.+++.... ...+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 199 (400)
T 1nxk_A 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 199 (400)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSST
T ss_pred eecccCCcEEEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCC
Confidence 75 567899999999999999997643 234688999999999999999999998 999999999999987
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
++.+||+|||+++....... .....||+.|+|||++....++.++||||||++||||++|+.||......... .
T Consensus 200 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~ 273 (400)
T 1nxk_A 200 NAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P 273 (400)
T ss_dssp TCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---C
T ss_pred CccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---H
Confidence 78999999999976443221 12456899999999999899999999999999999999999999754322110 0
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+.......+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 274 --------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 274 --------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --------SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011111111111111112334567799999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=341.87 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=207.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|+..+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4688889999999999999999888999999986431 1235789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTT
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccc
Confidence 99999999999999999997532 23578899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ .......+++.|+|||++....++.++||||||+++|||++ |+.||...... +
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------------~ 213 (267)
T 3t9t_A 150 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---------------E 213 (267)
T ss_dssp GGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------H
T ss_pred cccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---------------H
Confidence 9975433211 11123356789999999998899999999999999999999 88888643210 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
....+... ..... .......+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 214 ~~~~i~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 214 VVEDISTG-FRLYK--PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHTT-CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcC-CcCCC--CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111111 11100 011235577899999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.47 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||+|+++.... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 46888999999999999999876 789999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeec
Confidence 99999999999999999999753 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...... ....||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 151 g~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------------~~ 210 (318)
T 1fot_A 151 GFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------------MK 210 (318)
T ss_dssp SSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred CcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 9997643321 234799999999999999999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
...+++......+.. ....+.+|+.+||+.||++|| +++|+++.
T Consensus 211 ~~~~i~~~~~~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 211 TYEKILNAELRFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhCCCCCCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 122333333322222 234567899999999999999 89998853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.24 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=197.6
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++. .+++.||||++.... ...+.....|.+|++++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--------TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--------cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 5799999999999999999986 478999999986431 1223445689999999999999999999999876
Q ss_pred CCe----eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 538 RNE----RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 538 ~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
... .++||||+++++|.++++.. ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEE
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEE
Confidence 543 49999999999999999643 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++......... .......||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------- 225 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------- 225 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------
Confidence 9999999754332211 1222346899999999999889999999999999999999999998643210
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHH-HHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE-IVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e-vl~~L~~~l~~ 752 (768)
+.....+.....+........+..+.+|+.+||+.||++||++.+ +...|.++...
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 226 ----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 111111221111111111123456779999999999999996555 44556666543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.63 Aligned_cols=280 Identities=24% Similarity=0.354 Sum_probs=208.2
Q ss_pred CCCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.+.||+|+||.||++++ .+++.||||++... .....+.|.+|++++++++||||+++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----------GPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----------CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 5788899999999999999984 36789999988532 2344567999999999999999999999
Q ss_pred EEE--cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 534 FCE--DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 534 ~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++. +....++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~ 165 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 165 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCC
Confidence 886 4567899999999999999996532 23688999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++......... .......+|+.|+|||++....++.++||||||+++|||++|+.||......... .....
T Consensus 166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~ 244 (327)
T 3lxl_A 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCE 244 (327)
T ss_dssp EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC--
T ss_pred EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccc
Confidence 999999999865433321 1222345788899999999888999999999999999999999998642211000 00000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
........+.+.+........ ....+..+.+|+.+||+.||++|||++|+++.|+++......+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred cccccHHHHHHHhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 000011122222222222211 123345678999999999999999999999999999876655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.69 Aligned_cols=274 Identities=18% Similarity=0.267 Sum_probs=202.5
Q ss_pred cCCCCcCceeccC--CceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 458 TNNFSEDHKIGSG--SFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G--~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.++|++.++||+| +||.||+++.. +++.||||++.... ........+.+|++++++++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---------CSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---------cChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3578999999999 99999999976 78999999987532 223456778899999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.+++..... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl 169 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYL 169 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999975422 23688899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCC-----CcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cc
Q 046311 615 SDFGLSLIGPEDD-----ESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NV 686 (768)
Q Consensus 615 ~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~ 686 (768)
+|||++....... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ..
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999985432111 1111123468999999999987 67999999999999999999999999753322110 00
Q ss_pred cccccchhhh------h-------------hHHhhhcc-------CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH
Q 046311 687 VDFVVPYIVR------D-------------EIHRVLDR-------NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT 740 (768)
Q Consensus 687 ~~~~~~~~~~------~-------------~~~~~~~~-------~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 740 (768)
.....+.... . .....+.. ......+........+.+|+.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 0000000000 0 00000000 00000112223446688999999999999999999
Q ss_pred HHHHH
Q 046311 741 EIVNS 745 (768)
Q Consensus 741 evl~~ 745 (768)
|+++.
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=363.08 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|++.++||+|+||.||+++.+ +++.||||+++.... ........+.+|..++.++ +||||+++++++.
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--------C----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--------cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 57889999999999999999976 678999999875421 1122334678899998877 8999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEee
Confidence 999999999999999999999753 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ....
T Consensus 197 FGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~------~~~~ 268 (396)
T 4dc2_A 197 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------NTED 268 (396)
T ss_dssp CTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------------CCHH
T ss_pred cceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch------hhHH
Confidence 999975322221 22345799999999999999999999999999999999999999964322111000 0000
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
.-...+....+..+.. ....+.+|+.+||+.||++||++
T Consensus 269 ~~~~~i~~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVILEKQIRIPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHhccccCCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112223333322222 33456789999999999999995
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.03 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=212.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... ++..||||.+... ....+.+.+|++++++++||||+++++++.
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------------STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 457888999999999999999976 4889999988532 234567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++..... ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~D 154 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEcc
Confidence 99999999999999999999975332 34688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++........ .......+|+.|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 155 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-------------- 219 (288)
T 3kfa_A 155 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------- 219 (288)
T ss_dssp CCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------------
T ss_pred CccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence 999976543322 22223456889999999998899999999999999999999 88888643211
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccC
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVS 756 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~ 756 (768)
...+.+........ ....+..+.+|+.+||+.||++|||++|+++.|++++.....+
T Consensus 220 --~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 220 --QVYELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp --GHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred --HHHHHHhccCCCCC--CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 11111111111111 1123456779999999999999999999999999998876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=349.86 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=198.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.++|.+.+.||+|+||.||++... ++..||||+++... ......+.|.+|+.++++++||||+++++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---------SSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---------CCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---------cchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 457888999999999999999764 34579999986431 22344567999999999999999999999
Q ss_pred EEEcCCe-----eEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE
Q 046311 534 FCEDRNE-----RVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 534 ~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl 606 (768)
++.+.+. .++||||+++++|.+++.... .....+++..+++++.|+++||.|||+++ |+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 9987653 499999999999999984322 22345688999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccc
Q 046311 607 DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRN 685 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 685 (768)
+.++.+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 256 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---- 256 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----
Confidence 9999999999999976543332222233457889999999998899999999999999999999 88888643221
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+....+....... .....+..+.+++.+||+.||++|||+.|+++.|+++++..
T Consensus 257 -----------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 257 -----------EMYDYLLHGHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -----------GHHHHHHTTCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------HHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0011111111111 11123456779999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=373.77 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=202.8
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++.+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 4678889999999999999999888889999876421 124579999999999999999999999876
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCc
Confidence 67899999999999999996421 123688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+++....... .......+++.|+|||++....++.++||||||++||||+| |+.||..... .
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~ 388 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------R 388 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------H
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------------H
Confidence 9976543221 11223356889999999998899999999999999999999 8988863221 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
++.+.+......+. ....+..+.+|+.+||+.||++|||+++|++.|++++....
T Consensus 389 ~~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 389 EVLDQVERGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHHHTTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHcCCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11111112111111 11234567799999999999999999999999999886543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=342.68 Aligned_cols=266 Identities=19% Similarity=0.281 Sum_probs=197.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||+++.. +++.||||++.... ........+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---------CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 47889999999999999999876 68999999987542 223445678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Df 145 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANF 145 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 9999999999986 666655432 233688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCC-CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh--
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI-- 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 694 (768)
|++......... .....+|+.|+|||++.+.. ++.++||||||+++|||++|..|+....... ..........
T Consensus 146 g~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~ 221 (292)
T 3o0g_A 146 GLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGT 221 (292)
T ss_dssp TTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCC
T ss_pred ccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCC
Confidence 999765332221 22346899999999987665 7999999999999999999988864322110 0000000000
Q ss_pred -hhh---hHHhhhccC-------CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 -VRD---EIHRVLDRN-------VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 -~~~---~~~~~~~~~-------~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+ ...+..+.. ..............+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000000 00000111123456779999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.44 Aligned_cols=266 Identities=29% Similarity=0.410 Sum_probs=209.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC-C-----CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD-G-----SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 530 (768)
.++|+..+.||+|+||.||++.... + ..||+|.+... ......+.+.+|+++++++ +||||++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----------AHADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----------cChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3578889999999999999998652 2 47999987542 1234557799999999999 8999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQS----------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIK 600 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiK 600 (768)
+++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+|||||
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 191 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcc
Confidence 99999999999999999999999999864211 1234588899999999999999999998 9999999
Q ss_pred CCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCC
Q 046311 601 SSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTH 679 (768)
Q Consensus 601 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~ 679 (768)
|+|||++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||+| |..||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999975433332222233457889999999998899999999999999999999 888886432
Q ss_pred CCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.. ....+.+........+ ...+..+.+|+.+||+.||++|||+.||++.|+++....
T Consensus 272 ~~---------------~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 272 VN---------------SKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp SS---------------HHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hh---------------HHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 21 1111122111111111 112355778999999999999999999999999988654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=350.74 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=197.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||+++.. ++.||||++.. +...+.|.+|++++++++||||+++++++.+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------------ESERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 46888899999999999999886 78999998742 2345679999999999999999999998763
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc-EEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT-AKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~-~kl~DF 617 (768)
..++||||+++++|.++++.... ....++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+||
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 -PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp -TTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred -CcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 47999999999999999976432 234578888999999999999999932123999999999999988876 799999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++....... ....||+.|+|||++....++.++||||||+++|||++|+.||........ .
T Consensus 151 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------~ 212 (307)
T 2eva_A 151 GTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-------------R 212 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-------------H
T ss_pred cccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-------------H
Confidence 9997543221 123589999999999988999999999999999999999999864322100 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..........+. .....+..+.+|+.+||+.||++|||++|+++.|+++....
T Consensus 213 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 213 IMWAVHNGTRPP---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHTTCCCC---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHhcCCCCC---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 001111111111 11123455778999999999999999999999999987644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.01 Aligned_cols=276 Identities=20% Similarity=0.302 Sum_probs=213.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+++.. +++.||||++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----------ccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 57889999999999999999876 58999999986421 12235678899999999999999999999987
Q ss_pred CC--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE----CCCCc
Q 046311 538 RN--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL----DATWT 611 (768)
Q Consensus 538 ~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl----~~~~~ 611 (768)
.+ ..++||||+++++|.+++...... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCcee
Confidence 65 779999999999999999764322 22688999999999999999999998 9999999999999 78888
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCcccccc--------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
+||+|||+++....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||........
T Consensus 155 ~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred EEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 99999999976543322 123468999999999864 5678899999999999999999999975332111
Q ss_pred ccccccccchhhhhh------HH------hhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 684 RNVVDFVVPYIVRDE------IH------RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~------~~------~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
. .+.......... .. .......+............+.+++.+||+.||++||+++|+++.+++++.
T Consensus 232 ~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 232 N--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp C--HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred h--HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 0 000000000000 00 001112233334456778889999999999999999999999999999997
Q ss_pred hc
Q 046311 752 AC 753 (768)
Q Consensus 752 ~~ 753 (768)
..
T Consensus 310 ~~ 311 (396)
T 4eut_A 310 RM 311 (396)
T ss_dssp CE
T ss_pred ce
Confidence 54
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.73 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=202.8
Q ss_pred HHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 454 LLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 454 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
+....++|++.++||+|+||+||+++.+ +++.||+|+++.... ........+.+|+.+++.++||||++++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--------IKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh--------hhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3334578999999999999999999976 688999999864211 0112234578899999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
+++.+.+..+|||||+++|+|.++++.. .+++.....++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~i 207 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 207 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCE
Confidence 9999999999999999999999999642 2578888999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCccccccCC----CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ----LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
||+|||+++........ ......||+.|+|||++.... ++.++||||||++||||++|+.||......
T Consensus 208 kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------- 279 (410)
T 3v8s_A 208 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------- 279 (410)
T ss_dssp EECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------
T ss_pred EEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------
Confidence 99999999765433221 122457999999999997655 789999999999999999999999643210
Q ss_pred cccchhhhhhHHhhhcc----CCCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDR----NVPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
+...+++.. ..+... ..+..+.+|+.+||+.+|++ ||+++||++.
T Consensus 280 --------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 --------GTYSKIMNHKNSLTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------HHHHHHHTHHHHCCCCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------hHHHHHHhccccccCCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111112111 111111 22355678999999999988 9999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.55 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=207.6
Q ss_pred CCCCcCc-eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDH-KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|.+.+ .||+|+||.||++... ++..||||+++.. ......+.+.+|++++++++||||++++++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----------cchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3455555 8999999999999853 5778999998642 123456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+ ..+..++||||+++++|.+++... ...+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||
T Consensus 79 ~-~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl 151 (287)
T 1u59_A 79 C-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKI 151 (287)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEE
T ss_pred e-cCCCcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEE
Confidence 9 455689999999999999999653 234688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... .......+|+.|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------- 220 (287)
T 1u59_A 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------- 220 (287)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------
T ss_pred CcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----------
Confidence 999999765433221 11223356899999999988889999999999999999999 99998643211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccC
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVS 756 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~ 756 (768)
++...+....... .....+..+.+++.+||+.||++||++.|+++.|++++.+....
T Consensus 221 -----~~~~~i~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 221 -----EVMAFIEQGKRME--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -----HHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -----HHHHHHhcCCcCC--CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1111111111111 11123456779999999999999999999999999998866443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.05 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=206.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||++..+++..||||.+... ....+.|.+|++++++++||||+++++++.+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC------------cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 578889999999999999999888889999988532 1234678999999999999999999999864
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++++|.+++.... ...+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCc
Confidence 56899999999999999996421 113688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
++........ .......+++.|+|||++....++.++||||||+++|||++ |+.||..... .
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------------~ 217 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------P 217 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------H
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----------------H
Confidence 9976543221 11223356889999999988889999999999999999999 8888864321 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
++...+........ ....+..+.+|+.+||+.||++|||+.++++.|++++....
T Consensus 218 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 218 EVIQNLERGYRMVR--PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcccCCCC--cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11111111111111 11223567799999999999999999999999999987653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.84 Aligned_cols=263 Identities=28% Similarity=0.474 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcC-----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD-----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|+..+.||+|+||.||+|.... +..||||+++.. ..+.....|.+|++++++++||||+++++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----------YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 467778999999999999998652 235999988532 12344567999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.+.+..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 187 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCK 187 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEE
Confidence 9999999999999999999999997532 34688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcc-cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccccccc
Q 046311 614 VSDFGLSLIGPEDDESH-LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 691 (768)
|+|||++.......... ......+|+.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------- 256 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------- 256 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----------
Confidence 99999997644322111 1122346789999999998899999999999999999999 9999854321
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.++.+.+......+. .......+.+|+.+||+.||++||++.|+++.|++++.....
T Consensus 257 -----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 257 -----HEVMKAINDGFRLPT--PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -----HHHHHHHHTTCCCCC--CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -----HHHHHHHHCCCcCCC--cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 111111111111111 112345677999999999999999999999999999876544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.24 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=204.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||.+....... .......+.+.+|+.++++++||||+++++++.+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----SRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----cccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46888999999999999999976 68999999987643211 1112245779999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC----cEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----TAK 613 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----~~k 613 (768)
.+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence 99999999999999999999753 23578899999999999999999998 99999999999999887 799
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 160 l~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------- 223 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------- 223 (321)
T ss_dssp ECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------------
T ss_pred EccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------------
Confidence 9999999765433221 234689999999999988999999999999999999999999864321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+....+.......+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 --QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111112221111111111123456779999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=347.04 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=195.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.++||+|+||.||++... ++..||+|++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR----------SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----------CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc----------cchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 46888899999999999999875 68999999986431 12345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCcEEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~~kl 614 (768)
.+..++||||+++++|.+++.........+++..++.++.|+++||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEE
Confidence 99999999999999999998643222344688899999999999999999998 9999999999999 45688999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ .....+|+.|+|||++. ..++.++||||||+++|||++|+.||....... .
T Consensus 169 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~-------- 233 (285)
T 3is5_A 169 IDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---V-------- 233 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------
T ss_pred EeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---H--------
Confidence 99999975443222 12346899999999986 578999999999999999999999986432100 0
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. ............ .......+.+|+.+||+.||++|||++|+++
T Consensus 234 -~~-~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 234 -QQ-KATYKEPNYAVE---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HH-HHHHCCCCCCC-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -Hh-hhccCCcccccc---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000111111110 0012345678999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.04 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=196.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~ 536 (768)
.+|++.+.||+|+||.||++...+++.||||++.... ........|.+|++++++++ ||||+++++++.
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc---------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 3588999999999999999998889999999986531 22345678999999999996 599999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
..+..++||| +.+++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++ ++.+||+|
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEe
Confidence 9999999999 56889999997532 3577888999999999999999998 99999999999995 58999999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc-----------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
||+++...............||+.|+|||++.. ..++.++||||||++||||++|+.||......
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---- 273 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 273 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----
Confidence 999986544332222334579999999999864 36889999999999999999999999643210
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+..+++.......+. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 274 ----------~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ----------ISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----------HHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------HHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112233333322211111 113456789999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.01 Aligned_cols=270 Identities=21% Similarity=0.248 Sum_probs=204.2
Q ss_pred HcCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+|+++++.++|++++..+.++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------KHPQLHIESKIYKMMQGGVGIPTIRWC 73 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------------CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-------------cchHHHHHHHHHHHhcCCCCCCeeeee
Confidence 457899999999999999999986 478999999865431 112478899999999888777666655
Q ss_pred -EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCc
Q 046311 536 -EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWT 611 (768)
Q Consensus 536 -~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~ 611 (768)
.+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.
T Consensus 74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 74 GAEGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTC
T ss_pred cCCCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCe
Confidence 6777889999999 899999997432 23688999999999999999999998 9999999999999 78899
Q ss_pred EEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+||+|||++......... .......||+.|+|||++....++.++||||||+++|||++|+.||...........
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 999999999754433221 112245689999999999998999999999999999999999999975433222111
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCC
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~ 757 (768)
... +.... +.... .......+..+.+|+.+||+.||++|||++||++.|++++.....+.
T Consensus 227 ~~~----~~~~~----~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 227 YER----ISEKK----MSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHH----HHHHH----HHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhh----hhccc----ccchh---hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 110 00000 00000 00001123567799999999999999999999999999998765443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.97 Aligned_cols=264 Identities=19% Similarity=0.266 Sum_probs=200.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++.... ...+...+.+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--------SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--------GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--------ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 468999999999999999999976 68899999875421 112334578999999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred eCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEec
Confidence 999999999999999999999753 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++......... ......+|+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 178 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------- 240 (309)
T 2h34_A 178 FGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------------- 240 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----------------
T ss_pred CccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----------------
Confidence 9998754432211 11234689999999999988999999999999999999999999864211
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-CHHHHHHHHHHHHhhc
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-SMTEIVNSLERALAAC 753 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~~l~~~ 753 (768)
..+...+....+.........+..+.+|+.+||+.||++|| +++++++.|+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 241 SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 01111122222111111222345577899999999999999 9999999999887655
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.99 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=196.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC--CCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH--KNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||++...+++.||||++.... ......+.|.+|++++++++| |||+++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 35689999999999999999998889999999986531 223455789999999999976 9999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||| +.+++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++ ++.+||+
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEEC
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEe
Confidence 99999999999 5678999999753 23578889999999999999999998 99999999999997 6789999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-----------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|||++................||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 9999986544333323334579999999999864 67889999999999999999999999642210
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
...+...++.......+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 227 -----------~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 -----------ISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----------HHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11223333322221111 1112456789999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.76 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=209.3
Q ss_pred cccHHHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc--CCC
Q 046311 448 EFSLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR--LHH 525 (768)
Q Consensus 448 ~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~H 525 (768)
..++.......++|++.+.||+|+||.||+++.+ ++.||||++... ....+.+|++++.. ++|
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~l~h 95 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--------------EERSWFREAEIYQTVMLRH 95 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--------------GHHHHHHHHHHHHHSCCCC
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--------------hHHHHHHHHHHHHHhhcCC
Confidence 3444444455678999999999999999999985 899999987421 23567788888877 799
Q ss_pred CCceeEEEEEEcCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCC
Q 046311 526 KNLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH--------EYAVPS 593 (768)
Q Consensus 526 pnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH--------~~~~~~ 593 (768)
|||+++++++.... ..++||||+++|+|.+++... .+++..+++++.|+++||+||| +.+
T Consensus 96 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--- 167 (342)
T 1b6c_B 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--- 167 (342)
T ss_dssp TTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---
T ss_pred CcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---
Confidence 99999999998876 789999999999999999642 3688999999999999999999 666
Q ss_pred eEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcc--cccccccccCccCccccccC------CCCChhhHHHHHHHH
Q 046311 594 IIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH--LSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVL 665 (768)
Q Consensus 594 ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll 665 (768)
|+||||||+|||++.++.+||+|||++.......... ......||+.|+|||++... .++.++||||||+++
T Consensus 168 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 9999999999999999999999999997543322110 12234689999999998765 234689999999999
Q ss_pred HHHHcC----------CcccccCCCCCcccccccccchhhhhhHH-hhhccCCCCCCc---chHHHHHHHHHHHHHcccc
Q 046311 666 LEILSG----------YRAIHRTHNGTPRNVVDFVVPYIVRDEIH-RVLDRNVPPPTP---FEIEAVAYVGYLAADCVTL 731 (768)
Q Consensus 666 ~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~ 731 (768)
|||+|| +.||........ ..+.+. .+......+..+ ...+....+.+|+.+||+.
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSDP-----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS
T ss_pred HHHHhccCcCCcccccccCccccCcCcc-----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhcc
Confidence 999999 445543221110 011111 222222222211 2235667889999999999
Q ss_pred cCCCCCCHHHHHHHHHHHHhhc
Q 046311 732 EGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 732 dP~~RPs~~evl~~L~~~l~~~ 753 (768)
||++|||++||++.|+++.+..
T Consensus 317 dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 317 NGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTT
T ss_pred ChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.25 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=198.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CC-------CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCcee
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DG-------SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR 530 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g-------~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 530 (768)
++|++.+.||+|+||.||++... ++ ..||+|++... .....+.|.+|++++++++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----------HRNYSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----------GGGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----------cHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 57888999999999999999865 23 46999987532 2234567999999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
+++++.+.+..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREE 150 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECC
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCC
Confidence 9999999999999999999999999997532 22588889999999999999999998 99999999999998887
Q ss_pred c--------EEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 611 T--------AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 611 ~--------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
. +||+|||++...... ....+|+.|+|||++.. ..++.++||||||+++|||++|..|+......
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 7 999999998643221 12357899999999987 67899999999999999999965554322110
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.............+... ...+.+|+.+||+.||++|||++|+++.|++++....
T Consensus 225 ---------------~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 225 ---------------QRKLQFYEDRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ---------------HHHHHHHHTTCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ---------------HHHHHHhhccCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 01111111111111111 2346689999999999999999999999998886443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=369.66 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=204.1
Q ss_pred HHHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCcee
Q 046311 452 EILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVR 530 (768)
Q Consensus 452 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 530 (768)
.++....++|++.++||+|+||+||+++.+ +++.||||+++.... ........+.+|..++..++||||++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--------LKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--------HHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--------hhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 334445678999999999999999999976 578999999864311 11122334889999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
+++++.+.+..+|||||+++|+|.+++.... ..+++.....++.|++.||+|||+++ |+||||||+||||+.++
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCC
Confidence 9999999999999999999999999997632 33688899999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
.+||+|||+++........ ......||+.|+|||++. ...++.++||||||++||||++|+.||......
T Consensus 213 ~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---- 287 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---- 287 (437)
T ss_dssp CEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----
T ss_pred CEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh----
Confidence 9999999999765433221 222357999999999987 467899999999999999999999999643210
Q ss_pred ccccccchhhhhhHHhhhc----cCCCCCCcchHHHHHHHHHHHHHcccccCCC--CCCHHHHHHH
Q 046311 686 VVDFVVPYIVRDEIHRVLD----RNVPPPTPFEIEAVAYVGYLAADCVTLEGRN--RPSMTEIVNS 745 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 745 (768)
+...+++. ...+... ......+.+|+.+||..+|++ ||+++|+++.
T Consensus 288 -----------~~~~~i~~~~~~~~~p~~~---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 -----------ETYGKIMNHKERFQFPTQV---TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -----------HHHHHHHTHHHHCCCCSSC---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -----------HHHHhhhhccccccCCccc---ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 01111111 1111110 112345678999999888888 9999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.53 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=204.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CC---CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DG---SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g---~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
.|...++||+|+||+||++.+. ++ ..||+|.+... ......+.|.+|+.++++++||||+++++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------TEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4556689999999999999854 22 26999987532 2234557899999999999999999999999
Q ss_pred EcCCee-EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 536 EDRNER-VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 536 ~~~~~~-~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
.+.+.. ++||||+.+++|.+++.... ...++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCSSSCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred ecCCCCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence 876655 99999999999999997632 34588899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCC--cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDE--SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++........ ........+|+.|+|||.+....++.++||||||+++|||++|..|+......
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----------- 234 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----------- 234 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----------
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----------
Confidence 99999975433221 11122346789999999999889999999999999999999976665432110
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.++...+........ ....+..+.+|+.+||+.||++|||++|+++.|++++.....
T Consensus 235 ----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 235 ----FDLTHFLAQGRRLPQ--PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----GGHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----HHHHHHhhcCCCCCC--CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 011111111111111 112235677999999999999999999999999999987644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.66 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=181.4
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcCCee
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDRNER 541 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 541 (768)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++++++ ||||+++++++.+....
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 478999999999999876 6899999997531 3456788999999997 99999999999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC---cEEEeecc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFG 618 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~---~~kl~DFG 618 (768)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999999999999999753 34688999999999999999999998 99999999999997655 89999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
++......... .....+|+.|+|||++....++.++||||||+++|||++|+.||........... ..+.
T Consensus 155 ~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------~~~~ 224 (325)
T 3kn6_A 155 FARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS--------AVEI 224 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC--------HHHH
T ss_pred cceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc--------HHHH
Confidence 99764433221 1234689999999999989999999999999999999999999975432111000 0111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+...............+..+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2233333333322222344567889999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.72 Aligned_cols=266 Identities=21% Similarity=0.354 Sum_probs=186.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..++||+|+||.||++... +++.||||+++... .+.....+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 73 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----------EEGTPSTAIREISLMKELKHENIVRLYDVIH 73 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS----------TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc----------ccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence 357889999999999999999865 68999999986532 1223456889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQ--SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+..++||||++ ++|.+++.... .....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEE
Confidence 9999999999998 59999886422 12234688889999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc---
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF--- 689 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~--- 689 (768)
+|||++......... .....+|+.|+|||++.. ..++.++||||||+++|||++|+.||.......... +.+.
T Consensus 150 ~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 150 GDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp CCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred CcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999764322211 123468999999999875 468999999999999999999999996432210000 0000
Q ss_pred ----ccchhh-------------hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 ----VVPYIV-------------RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ----~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++... ...+.+.+..... ......+.+|+.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK------EPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS------SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhccccc------ccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 0000000000000 0123467799999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.30 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=191.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|+..++||+|+||+||+|+.. +++.||||++.... .......++.+|+..+.++ +||||+++++++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF---------RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC---------CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc---------cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 46889999999999999999986 78999999875321 1223344555666655555 9999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcc
Confidence 999999999999 669999886532 34689999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+...
T Consensus 201 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------------------ 258 (311)
T 3p1a_A 201 FGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------------------ 258 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------------------
T ss_pred ceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------------------
Confidence 999876543222 223468999999999875 7999999999999999999997665421
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....+.....++ .........+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 EGWQQLRQGYLPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHTTTCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cHHHHHhccCCCc--ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111111110 111223466789999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.49 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||||++..... ........+.+|++++++++||||+++++++.+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 47888999999999999999976 689999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccc
Confidence 99999999999999999999753 23578889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...... ....||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 186 g~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------------~~ 245 (350)
T 1rdq_E 186 GFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQ 245 (350)
T ss_dssp TTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred ccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---------------HH
Confidence 9997643321 234689999999999989999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
....+.......+. .....+.+|+.+||+.||++||+ ++||++.
T Consensus 246 ~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 246 IYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 12223333222222 23455779999999999999998 8888763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.02 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=199.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 536 (768)
++|+..+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..++.++ +||||+++++++.
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--------CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--------cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 46888999999999999999976 688999999875321 1234456788999999988 8999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999643 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||........... ....
T Consensus 154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~ 225 (345)
T 3a8x_A 154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ------NTED 225 (345)
T ss_dssp GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------CHH
T ss_pred ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc------ccHH
Confidence 999975332221 12345799999999999999999999999999999999999999964322110000 0000
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM 739 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 739 (768)
.-...+.......+. .....+.+|+.+||+.||++||++
T Consensus 226 ~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 226 YLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111122222222222 234557789999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.02 Aligned_cols=269 Identities=21% Similarity=0.295 Sum_probs=197.2
Q ss_pred CCCCcC-ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 459 NNFSED-HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
+.|++. +.||+|+||.||++... +++.||||++.... ......+.+|++++.++ +||||+++++++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-----------GHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-----------SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-----------chhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 467774 78999999999999864 78999999986431 23456789999999985 799999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc---E
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT---A 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~---~ 612 (768)
.+.+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSE
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCce
Confidence 9999999999999999999999753 23578889999999999999999998 999999999999988776 9
Q ss_pred EEeeccccccCCCCCC-----cccccccccccCccCcccccc-----CCCCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 613 KVSDFGLSLIGPEDDE-----SHLSLRAAGTVGYMDPEYYRL-----QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 613 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
||+|||++........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 9999999875432111 111123458999999999875 468899999999999999999999997543322
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.........+.....-...+.......+..........+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 234 CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp SCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110000000000011112222222222111111234567899999999999999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.98 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||+|++..... ........+.+|+++++.++||||+++++++.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--------VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--------ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46888999999999999999876 688999999864311 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEecc
Confidence 99999999999999999999753 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++........ .....||+.|+|||++.. ..++.++||||||+++|||++|+.||.........
T Consensus 160 G~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---------- 226 (384)
T 4fr4_A 160 NIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---------- 226 (384)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH----------
T ss_pred ceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH----------
Confidence 99986543322 224579999999999864 45899999999999999999999999754322110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-HHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-MTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~ 744 (768)
.....+.......+. .....+.+|+.+||+.||++||+ ++++++
T Consensus 227 --~~~~~~~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 227 --EIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --HHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --HHHHHHhhcccCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111111111122111 23456779999999999999998 777765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.71 Aligned_cols=270 Identities=20% Similarity=0.247 Sum_probs=207.3
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE-
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC- 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~- 535 (768)
.++|++.+.||+|+||.||+++. .+++.||||++.... ...++.+|+++++.++|++++..+.++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------KHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-------------SCCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-------------chhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 46899999999999999999996 478999999876431 123588999999999988866666554
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTA 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~ 612 (768)
.+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCE
T ss_pred CCCCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeE
Confidence 6677889999999 899999997422 23688999999999999999999998 99999999999994 78899
Q ss_pred EEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc
Q 046311 613 KVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 687 (768)
||+|||++......... .......||+.|+|||++....++.++||||||+++|||++|+.||............
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 99999999754433221 1123456899999999999989999999999999999999999999764332221111
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
... .... +.... .......+..+.+|+.+||+.||++|||++||++.|++++.....+.+
T Consensus 228 ~~~----~~~~----~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 228 ERI----SEKK----MSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHH----HHHH----HHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred hhh----cccc----cCCch---HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 110 0000 00000 000011235577999999999999999999999999999987755443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.53 Aligned_cols=262 Identities=33% Similarity=0.472 Sum_probs=205.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCe--EEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQ--VAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~--vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+++.. ++.. ++||+++.. ......+.+.+|+++++++ +||||++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----------cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 47888999999999999999865 5554 488987632 1123345689999999999 99999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQ------------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+.+.+..++||||+++++|.+++.... .....+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 171 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 171 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccc
Confidence 999999999999999999999997643 22335688999999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~ 681 (768)
|||++.++.+||+|||++........ .....+++.|+|||++....++.++||||||+++|||+| |+.||.....
T Consensus 172 NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~- 247 (327)
T 1fvr_A 172 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 247 (327)
T ss_dssp GEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred eEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence 99999999999999999874322111 122356889999999988889999999999999999998 9999864321
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.++...+........ .......+.+|+.+||+.||++|||++|+++.|++++....
T Consensus 248 ---------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 248 ---------------AELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---------------HHHHHHGGGTCCCCC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------------HHHHHHhhcCCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111111111111 11223567799999999999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.73 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=181.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||++..... ........+.+|++++++++||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--------YKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--------hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 56888999999999999999874 789999999864311 112334678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEee
Confidence 999999999999999999997532 34688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+|+.|+|||++....++.++||||||+++|||++|+.||........
T Consensus 157 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------- 220 (278)
T 3cok_A 157 GLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------------- 220 (278)
T ss_dssp TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred cceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------
Confidence 999764432221 1234689999999999988899999999999999999999999865322110
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..+........+. .....+.+|+.+||+.||++|||++|+++
T Consensus 221 -~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 -LNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCSSCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHhhcccCCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111111111111 12345678999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.86 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=204.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----------VEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-----------cchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 356889999999999999999876 57789999886431 123567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~~k 613 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+|
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~ 149 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLK 149 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred cCCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEE
Confidence 999999999999999999998643 23688899999999999999999998 9999999999999 7889999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....+|+.|+|||++.+ .++.++||||||+++|||++|+.||.....
T Consensus 150 l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------- 212 (277)
T 3f3z_A 150 LIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------------- 212 (277)
T ss_dssp ECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------------
T ss_pred EEecccceeccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-------------
Confidence 9999999765433221 23468999999999875 489999999999999999999999864321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERAL 750 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l 750 (768)
.+....+.......+..........+.+|+.+||+.||++|||+.|+++. +++.+
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 213 --SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp --HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred --HHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 11122222222222111111234667899999999999999999999863 55544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.63 Aligned_cols=256 Identities=18% Similarity=0.208 Sum_probs=204.5
Q ss_pred cCCCCcCceeccCCceEEEEEE------EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKAT------LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNL 528 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~------~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnI 528 (768)
.++|.+.++||+|+||+||+|. ..+++.||||+++.. ...++.+|++++++++ |+||
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------------NPWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--------------CHHHHHHHHHHHHHSCGGGGGGB
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--------------ChhHHHHHHHHHHHhhhhhhhhh
Confidence 4578899999999999999994 446899999987532 2346778888888886 9999
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 529 VRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS-SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 529 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+++++++...+..+|||||+++|+|.++++.... ....+++..++.++.||++||+|||+++ |+||||||+||||+
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG 206 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEec
Confidence 9999999999999999999999999999964221 2344789999999999999999999998 99999999999999
Q ss_pred C-----------CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccc
Q 046311 608 A-----------TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIH 676 (768)
Q Consensus 608 ~-----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~ 676 (768)
. ++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999965332222223334579999999999999899999999999999999999999986
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCC-CCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNR-PSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Ps~~evl~~L~~~l~~~ 753 (768)
....... . +....... . ....+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus 287 ~~~~~~~------~------------~~~~~~~~-~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 287 KNEGGEC------K------------PEGLFRRL-P----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEETTEE------E------------ECSCCTTC-S----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCce------e------------echhcccc-C----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 4322110 0 00111110 1 13345688999999999998 78999999999988764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=352.06 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=208.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|++.+.||+|+||.||+|+.. +++.||||++... ........|.+|++++++++||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----------cCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 467899999999999999999754 3678999987532 122345679999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQ------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
++++.+.+..++||||+++++|.+++.... ......++..+++++.|+++||+|||+++ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999986421 11234578899999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcc
Q 046311 606 LDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPR 684 (768)
Q Consensus 606 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 684 (768)
++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 246 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---- 246 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----
Confidence 99999999999999975433322222233457889999999998899999999999999999999 8888754321
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.+....+........ ....+..+.+|+.+||+.||++|||+.|+++.|++++.
T Consensus 247 -----------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 -----------EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -----------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 011112222222111 11234557789999999999999999999999998765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.09 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=196.2
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLLG 533 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~ 533 (768)
.++|++.++||+|+||+||+++. .+++.||||++...... .........+.+|+++++++ +||||+++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG------GGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCC------TTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccc------ccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 56899999999999999999986 47899999998754221 11112234566777776666 5999999999
Q ss_pred EEEcCC-----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 534 FCEDRN-----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 534 ~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
++.... ..++||||+. ++|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 997765 5789999997 599999976432 23688999999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
++.+||+|||++........ .....||+.|+|||++....++.++||||||+++|||++|+.||....... ...
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~ 229 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLG 229 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHH
T ss_pred CCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99999999999976543222 124468999999999998999999999999999999999999996432210 000
Q ss_pred cccchhh---hhhH-------HhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIV---RDEI-------HRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~---~~~~-------~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....... .... ...+....+. ......+....+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 0000 0000000000 00001123456779999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=342.50 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=200.6
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.+|++.++||+|+||.||+|+..+ ...+|+|.+... ......+.|.+|+.++++++||||++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 357888999999999999998642 235888877532 223455789999999999999999999998
Q ss_pred EE-cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 535 CE-DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 535 ~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
+. .++..++||||+++++|.+++.... ...++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEE
Confidence 64 4567899999999999999997532 33578899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCc--ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCC-cccccCCCCCcccccccc
Q 046311 614 VSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY-RAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~ 690 (768)
|+|||++......... .......+|+.|+|||.+....++.++||||||+++|||++|. .|+.......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------- 240 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------- 240 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------
Confidence 9999999754432211 1122345788999999999899999999999999999999954 4443322111
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
............. ....+..+.+++.+||+.||++|||++|+++.|++++...
T Consensus 241 -------~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 241 -------ITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------HHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0111111111110 0112345779999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.93 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=204.2
Q ss_pred CCCCcCc-eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDH-KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|.+.+ .||+|+||.||++.+. +++.||||+++... ......++|.+|++++++++||||++++++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4677777 9999999999999643 46889999986431 123345789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+ ..+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEE
Confidence 9 566789999999999999999753 23678899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... .......+++.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------ 226 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------ 226 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------------
Confidence 999999765433221 11222346789999999988889999999999999999999 9999864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.++.+.+........ ....+..+.+++.+||+.||++||++.|+++.|++++...-
T Consensus 227 ----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 227 ----SEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ----HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111111111111111 11234567799999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.48 Aligned_cols=277 Identities=19% Similarity=0.212 Sum_probs=198.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||++... ++..+|||++.....................+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999875 57899999987542110000000111123457889999999999999999999
Q ss_pred EEc----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 535 CED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 535 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
+.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 987 67899999999 999999997532 4688999999999999999999998 99999999999998877
Q ss_pred --cEEEeeccccccCCCCCC-----cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 611 --TAKVSDFGLSLIGPEDDE-----SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 611 --~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
.+||+|||+++....... ........||+.|+|||++....++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999975432211 1111344789999999999988999999999999999999999999964322110
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.... ... .....+...+....+ ....+..+.+++.+||+.||++||+++||++.|+++..
T Consensus 269 -~~~~-~~~-~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 -AVQT-AKT-NLLDELPQSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHH-HHH-HHHHTTTHHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHH-HHH-hhcccccHHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0000 000 000000000000000 00233467899999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=375.23 Aligned_cols=263 Identities=23% Similarity=0.384 Sum_probs=203.0
Q ss_pred CCCcCc-eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 460 NFSEDH-KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
++.+.+ +||+|+||.||+|.+. ++..||||+++.. ......++|.+|+++|++++||||+++++++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC----------CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC----------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 333344 7999999999999864 4567999998643 1223457899999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.. +..++||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEe
Confidence 76 5689999999999999999753 234688999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 616 DFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 616 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|||+++........ .......+|+.|+|||++....++.++||||||++||||+| |+.||......
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------------ 546 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------ 546 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------------
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------------
Confidence 99999865432211 11122345789999999998999999999999999999998 99998643221
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCC
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~ 757 (768)
++...+........ ....+..+.+||.+||+.||++||++++|++.|+.++.......
T Consensus 547 ----~~~~~i~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 547 ----EVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp ----HHHHHHHTTCCCCC--CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred ----HHHHHHHcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 11111211111111 11234567799999999999999999999999999887664433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.77 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=194.1
Q ss_pred CCCcCceeccCCceEEEEEEEc--CC--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD--DG--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~--~g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
.|+..+.||+|+||.||+|++. ++ ..||||.++.. ......++|.+|+.++++++||||+++++++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 159 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4667789999999999999864 22 35888876532 2234567899999999999999999999987
Q ss_pred Ec-CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 536 ED-RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 536 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
.+ ++..++||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 160 LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CCCSSCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EcCCCCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence 54 557899999999999999997532 33578889999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc--ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccccccc
Q 046311 615 SDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 615 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 691 (768)
+|||+++........ .......+|+.|+|||++....++.++||||||+++|||+| |..||....... .
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~----- 305 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----- 305 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---H-----
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---H-----
Confidence 999999754332211 11123457889999999999999999999999999999999 566665432211 0
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
...+........ ....+..+.+++.+||+.||++||+++|+++.|++++....
T Consensus 306 -------~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 306 -------TVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------HHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------HHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011111111110 11223457789999999999999999999999999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=370.93 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=206.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...+.||+|+||.||+++.+ +++.||+|++..... ........+.+|++++++++||||+++++++.+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--------KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--------hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 57888899999999999999976 689999999864311 112345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++.........+++...+.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeec
Confidence 99999999999999999999765444455788899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++........ .....||+.|+|||++.+..++.++|||||||+||||++|+.||........ . .+
T Consensus 334 Gla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~---------~~ 400 (543)
T 3c4z_A 334 GLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N---------KE 400 (543)
T ss_dssp TTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--H---------HH
T ss_pred ceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--H---------HH
Confidence 999865433221 2234799999999999999999999999999999999999999975432110 0 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 744 (768)
-...++......+. ..+..+.+|+.+||+.||++||++ +||++
T Consensus 401 ~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 401 LKQRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHhhcccCCCc----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11222222222221 234566789999999999999975 66664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=347.18 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=192.2
Q ss_pred CCCCcCceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+++. .+++.||+|+++.... .........+.+|++++++++||||++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-------VRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-------hhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 4688899999999999999987 4789999999864321 1112334567889999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++++|.+++... ..+++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl 162 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKL 162 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEE
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEE
Confidence 99999999999999999999999642 23578888999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 163 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------- 226 (327)
T 3a62_A 163 TDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------------- 226 (327)
T ss_dssp CCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------------
T ss_pred EeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------------
Confidence 99999875332221 12234689999999999988999999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
.+....++......+. .....+.+|+.+||+.||++|| ++.|+++
T Consensus 227 -~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 227 -KKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -HHHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1112222222222211 2235577899999999999999 7778876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.05 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=200.9
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
..++|++.+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..++..+ +||||++++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~ 86 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--------hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 3468999999999999999999976 689999999864311 1123445678899998876 99999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 87 FQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEE
Confidence 99999999999999999999999642 23588899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------- 223 (345)
T 1xjd_A 160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------------- 223 (345)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------------
Confidence 99999975432221 12345799999999999998999999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH-HHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT-EIV 743 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl 743 (768)
.+-...+.......+. .....+.+|+.+||+.||++||++. |++
T Consensus 224 -~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 224 -EELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -HHHHHHHHhCCCCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0111122222221111 2335577899999999999999997 665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=337.59 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=199.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||||++.... .........+.+|++++++++||||+++++++.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--------cchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 57889999999999999999876 57799999986431 1112335678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEec
Confidence 99999999999999999998643 23578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ....+|+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 154 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------------~~ 214 (279)
T 3fdn_A 154 GWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------------QE 214 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred cccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---------------HH
Confidence 99865433221 234689999999999988999999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.......+. .....+.+|+.+||+.||++|||++|+++.
T Consensus 215 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 215 TYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHTCCCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHhCCCCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111111111 123456789999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.69 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=201.8
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+++..+ +..||||.+... ......+.|.+|++++++++||||++++++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----------CTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----------SCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----------cCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 578889999999999999998642 235999987532 123456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+ +..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKL 154 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEE
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEe
Confidence 865 45689999999999999996532 23578899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||++......... ......+|+.|+|||++....++.++||||||+++|||+| |+.||....... .
T Consensus 155 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~------- 223 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---V------- 223 (281)
T ss_dssp CCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---H-------
T ss_pred CccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---H-------
Confidence 999999765432221 1123356889999999998899999999999999999998 999986432211 0
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
...+... ...+.+. .....+.+++.+||+.||++||++.|+++.|+++++..
T Consensus 224 --~~~~~~~--~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 224 --IGVLEKG--DRLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --HHHHHHT--CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHhcC--CCCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 0011110 1111111 12355779999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.20 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------AVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----------CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----------chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 57889999999999999999876 78999999986431 12345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeC
Confidence 99999999999999999999653 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++................+|+.|+|||++....+ +.++||||||+++|||++|+.||........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------- 216 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------------- 216 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------------
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------------
Confidence 99975433222222234568999999999987665 7799999999999999999999975432110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
............ .........+.+|+.+||+.||++|||++|+++
T Consensus 217 -~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 217 -EYSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -HHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHhhhccccc--CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011111111111 011123456778999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=339.10 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=205.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||+|.++...... .......+.|.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS-----SRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccc-----cccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 46888999999999999999976 68999999987643211 1122345789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC----cEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----TAK 613 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----~~k 613 (768)
.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++ .+|
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEE
T ss_pred CCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceE
Confidence 99999999999999999999642 23688999999999999999999998 99999999999998877 899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....+|+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 153 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------ 217 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------------ 217 (283)
T ss_dssp ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------------
T ss_pred EEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------------
Confidence 9999999764432221 2346899999999999889999999999999999999999998643210
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH--HHHHHHh
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN--SLERALA 751 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~--~L~~~l~ 751 (768)
+....+..................+.+|+.+||+.||++||++.|+++ .++++..
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 218 ---ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---HHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 111111111111111111123456779999999999999999999998 3555543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.07 Aligned_cols=266 Identities=28% Similarity=0.385 Sum_probs=204.4
Q ss_pred CCCCcCceeccCCceEEEEEEE------cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|++.+.||+|+||.||+++. .+++.||||++... ..+....++.+|+.++++++||||++++
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------CSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----------cchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 5799999999999999999983 25778999987532 2234556899999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSS---SPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA- 608 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~- 608 (768)
+++.+.+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence 9999999999999999999999999754321 234688899999999999999999998 999999999999984
Q ss_pred --CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccc
Q 046311 609 --TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRN 685 (768)
Q Consensus 609 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 685 (768)
+..+||+|||++................+|+.|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 252 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---- 252 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----
Confidence 45699999999864332222222223467899999999988899999999999999999998 88888643210
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
+....+........ .......+.+|+.+||+.||++||++.|+++.|+.+......
T Consensus 253 -----------~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 253 -----------EVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp -----------HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred -----------HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 00111111111110 112235677899999999999999999999999998875543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.91 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=203.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ........+.+|+++++.++||||+++++++.+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--------RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--------HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 57889999999999999999976 799999999864311 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEec
Confidence 99999999999999999999653 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------------~ 222 (476)
T 2y94_A 161 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------------P 222 (476)
T ss_dssp SSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---------------H
T ss_pred cchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---------------H
Confidence 99986543322 223479999999999987765 6899999999999999999999964321 1
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....++.+.....+.. ....+.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~i~~~~~~~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 223 TLFKKICDGIFYTPQY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHHTTCCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcCCcCCCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1122233332222211 2345678999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=349.84 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=202.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..++..+ +||||+++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 467999999999999999999976 478999999875311 1123456788999999988 899999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||||+++|+|.+++... ..+++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEE
Confidence 9999999999999999999999643 23678899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 164 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------------- 226 (353)
T 2i0e_A 164 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------------- 226 (353)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred eCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---------------
Confidence 9999975332221 12245799999999999999999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS 745 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 745 (768)
.+-...++...+..+. .....+.+|+.+||+.||++||+ ++|+++.
T Consensus 227 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 227 DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112233333332222 23456778999999999999995 5777653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=377.93 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=206.3
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||.||+++++++..||||+++... ...++|.+|+++|++++||||+++++++.+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4678889999999999999999888889999986431 124579999999999999999999999876
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+|||||+++|+|.++|+... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTT
T ss_pred ccceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccc
Confidence 67899999999999999996421 123688899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+++....... .......++..|+|||++....++.++||||||++||||+| |+.||..... .
T Consensus 409 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------------~ 471 (535)
T 2h8h_A 409 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------R 471 (535)
T ss_dssp STTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------------H
T ss_pred cceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------H
Confidence 9976542211 11122346789999999998899999999999999999999 8988864221 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
++.+.+......+. .......+.+||.+||+.||++|||+++|++.|++++...
T Consensus 472 ~~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 472 EVLDQVERGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111212211111 1123456779999999999999999999999999887544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.10 Aligned_cols=269 Identities=21% Similarity=0.314 Sum_probs=197.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||.||++... +++.||||++... .......+.+.+|++++++++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---------EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---------CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---------ccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 57899999999999999999976 5899999988543 1223445678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeC
Confidence 99999999999999999988653 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++......... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 147 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 147 GFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 999765432221 123468999999999875 67899999999999999999999998643221110000000000000
Q ss_pred hh-----HHhhh-ccCCCCCCc---c---hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DE-----IHRVL-DRNVPPPTP---F---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~-----~~~~~-~~~~~~~~~---~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. ....+ ....+.+.. . ..+.+..+.+|+.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000 001111000 0 01234557799999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=352.89 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=192.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.. +++.||||++.... .....+.+|+.++++++||||+++++++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA------------AIDENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST------------TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc------------cccHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 57889999999999999999976 78999999986431 123568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc--EEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT--AKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~--~kl~ 615 (768)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEEC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEe
Confidence 99999999999999999999642 23688899999999999999999998 999999999999987765 9999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCCh-hhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEK-SDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||+++....... .....||+.|+|||++....++.+ +||||||+++|||++|+.||........
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------- 226 (361)
T 3uc3_A 161 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----------- 226 (361)
T ss_dssp CCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-----------
T ss_pred ecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-----------
Confidence 9999974322221 123468999999999988777655 8999999999999999999975332110
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+..++......+. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 227 YRKTIQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 01122233332222111 11223556789999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=347.05 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=200.7
Q ss_pred cCCCCcC-ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 458 TNNFSED-HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
.++|.+. +.||+|+||.||++... +++.||||+++... ........+.+|+.++.++ +||||++++++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---------RGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE---------TTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh---------cchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4567766 88999999999999876 68999999986532 1223456789999999999 56999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCc
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWT 611 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~ 611 (768)
+.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999986532 234688999999999999999999998 999999999999987 789
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||++......... ....||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 173 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------- 239 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---------- 239 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred EEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------
Confidence 999999999765432221 2346899999999999899999999999999999999999998643210
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+....+..................+.+|+.+||+.||++|||++|+++.
T Consensus 240 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 -----ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111111111111122334567799999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.79 Aligned_cols=275 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred CCCCcCceeccCCceEEEEEEE-----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
++|++.+.||+|+||.||+++. .+++.||||++... .....+.|.+|++++++++||||+++++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------TEEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----------CSHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4688889999999999999984 36889999988532 2345568999999999999999999999
Q ss_pred EEEcCC--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 534 FCEDRN--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 534 ~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++...+ ..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 183 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 183 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTE
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCc
Confidence 986654 7899999999999999997532 23688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++......... .......++..|+|||++....++.++||||||+++|||+||..|+...............
T Consensus 184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTC
T ss_pred EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcccc
Confidence 999999999765433221 1122335678899999999888999999999999999999999887532100000000000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
........+.+.+......+. ....+..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHhhcCCCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000011122223322221111 112345677999999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.10 Aligned_cols=199 Identities=24% Similarity=0.298 Sum_probs=172.3
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-----CCCcee
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-----HKNLVR 530 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~ 530 (768)
..++|++.++||+|+||.||+++.. +++.||||+++.. ......+.+|+++++.++ ||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------------KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------------HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------------hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 4578999999999999999999874 6899999988531 234456788999999986 999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-- 608 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-- 608 (768)
+++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 999999999999999999 8899999975432 23688899999999999999999998 999999999999975
Q ss_pred -----------------------CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHH
Q 046311 609 -----------------------TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVL 665 (768)
Q Consensus 609 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll 665 (768)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7899999999997543322 234689999999999999999999999999999
Q ss_pred HHHHcCCcccccC
Q 046311 666 LEILSGYRAIHRT 678 (768)
Q Consensus 666 ~elltG~~p~~~~ 678 (768)
|||++|+.||...
T Consensus 250 ~ell~g~~pf~~~ 262 (360)
T 3llt_A 250 AELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHSSCSCCCS
T ss_pred HHHHHCCCCCCCC
Confidence 9999999999643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=358.21 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=191.4
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|.+.++||+|+||.||+|... +++.||||++...... ............+.+|+++|++++||||+++++++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFA---IGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGT---TC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhc---ccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3578999999999999999999875 6899999998754221 11111222334688999999999999999999998
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC---CcE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTA 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~---~~~ 612 (768)
.. +..++||||+++++|.+++... ..+++.....++.|+++||+|||+++ |+||||||+|||++.+ ..+
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred ec-CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 54 5679999999999999998653 23688899999999999999999998 9999999999999654 459
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
||+|||+++....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||....... .+
T Consensus 282 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~--- 353 (419)
T 3i6u_A 282 KITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SL--- 353 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CH---
T ss_pred EEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HH---
Confidence 9999999986543221 223568999999999853 567889999999999999999999996432211 00
Q ss_pred ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+.............+....+.+|+.+||+.||++|||++|+++
T Consensus 354 ---------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 ---------KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0011111111111111123456779999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.92 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=202.8
Q ss_pred HHHHHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCce
Q 046311 451 LEILLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529 (768)
Q Consensus 451 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 529 (768)
+++.....++|++.+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..++..++||||+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--------~~~~~~~~~~~E~~il~~~~hp~Iv 124 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--------LKRGEVSCFREERDVLVNGDRRWIT 124 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--------hhHHHHHHHHHHHHHHHhcCCCCee
Confidence 3334444678999999999999999999975 789999999864211 1112334588899999999999999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
++++++.+.+..||||||+++|+|.+++.... ..+++.....++.||+.||+|||+++ |+||||||+||||+.+
T Consensus 125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC 198 (412)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCC
Confidence 99999999999999999999999999996532 23678888999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCcccccccccccCccCccccc-------cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 610 WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-------LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
+++||+|||+++........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 199 g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~- 276 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA- 276 (412)
T ss_dssp SCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred CCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-
Confidence 99999999999765433221 122357999999999987 357899999999999999999999999643211
Q ss_pred cccccccccchhhhhhHHhhhcc--CCCCCCcchHHHHHHHHHHHHHcccccCCCC---CCHHHHHHH
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDR--NVPPPTPFEIEAVAYVGYLAADCVTLEGRNR---PSMTEIVNS 745 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R---Ps~~evl~~ 745 (768)
+...+++.. .+..+ ......+..+.+|+.+||. +|++| |+++|+++.
T Consensus 277 --------------~~~~~i~~~~~~~~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 --------------ETYGKIVHYKEHLSLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --------------HHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --------------HHHHHHHhcccCcCCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 001111110 00000 0111234567789999999 99998 588888753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.76 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=197.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||++..+ +++.||||+++.... .+.+|++++.++ +||||+++++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------------~~~~E~~~l~~~~~hp~iv~~~~~~ 85 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------------DPTEEIEILLRYGQHPNIITLKDVY 85 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------------CCHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------------ChHHHHHHHHHhcCCCCcCeEEEEE
Confidence 356889999999999999999876 688999999864311 134688888887 799999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC----Cc
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT----WT 611 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~----~~ 611 (768)
.+.+..++||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||+.++ +.
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~ 158 (342)
T 2qr7_A 86 DDGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPES 158 (342)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGG
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCe
Confidence 9999999999999999999999753 23688899999999999999999998 9999999999998543 35
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||++........ ......+|+.|+|||++....++.++||||||+++|||++|+.||.........
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------- 229 (342)
T 2qr7_A 159 IRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE------- 229 (342)
T ss_dssp EEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH-------
T ss_pred EEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH-------
Confidence 99999999976433222 122457899999999998888899999999999999999999999753222111
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
+-...+...............+..+.+|+.+||+.||++||++.|+++.
T Consensus 230 -----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 230 -----EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -----HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112222222222211222334567799999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.13 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=190.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHH-HhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES-LSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||+++.+ +++.||||+++.... ........+.+|..+ ++.++||||+++++++.
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--------~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI--------LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGB--------C-------------CCBCCCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 46888999999999999999976 588999999875421 112234456677776 57789999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..|+||||+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEee
Confidence 999999999999999999999653 23577888899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++....... ......||+.|+|||++....++.++||||||+++|||++|+.||..... .
T Consensus 183 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------------~ 245 (373)
T 2r5t_A 183 FGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------------A 245 (373)
T ss_dssp CCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---------------H
T ss_pred CccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------------H
Confidence 999975322221 12245799999999999999999999999999999999999999964321 1
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 742 (768)
+....++......+. .....+.+|+.+||+.||++||++.+.
T Consensus 246 ~~~~~i~~~~~~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 246 EMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp HHHHHHHHSCCCCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred HHHHHHHhcccCCCC----CCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 112233333222221 223456789999999999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.83 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=193.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.. +++.||||++..... ........+.+|++++++++||||+++++++.+
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------C-------------CCCCCSCTTSCCEEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--------hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 57889999999999999999875 689999999864311 122344567889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+..++||||+++++|.+++... ..+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999643 236888999999999999999998 77 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++....... ......||+.|+|||++....++.++||||||++||||++|+.||..... .
T Consensus 293 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------------~ 355 (446)
T 4ejn_A 293 FGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------E 355 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred CCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---------------H
Confidence 999975332221 12245799999999999999999999999999999999999999964321 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
.....+.......+.. ....+.+|+.+||+.||++|| +++|+++
T Consensus 356 ~~~~~i~~~~~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 356 KLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHhCCCCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1112222222222221 235577899999999999999 9999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=349.93 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=198.5
Q ss_pred CCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
..|+..+.||+|+||.||+++. .+++.||||++.... .......++|.+|++++++++||||+++++++.+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 125 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--------SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--------ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3588889999999999999986 478999999986432 1223445689999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeec
Confidence 999999999997 68888885322 34688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|++...... ....||+.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 199 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------------- 258 (348)
T 1u5q_A 199 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------- 258 (348)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------------
T ss_pred cCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------------
Confidence 999754322 1346899999999984 56789999999999999999999999864321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+..+.....+... .......+.+|+.+||+.||++|||++|+++.
T Consensus 259 -~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 259 -MSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -HHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111122222111111 11223557789999999999999999999853
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.45 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=201.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE- 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 536 (768)
++|++.+.||+|+||.||+++.. +++.||+|++.... ..+...+.+.+|++++++++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 57888999999999999999876 68999999987532 12345678999999999999999999999874
Q ss_pred -cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEecCCCCCCeEECCCCcEE
Q 046311 537 -DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAV--PSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 537 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~--~~ivHrDiKp~NILl~~~~~~k 613 (768)
.....++||||+++++|.+++.........+++..++.++.|++.+|+|||+.+. .+|+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence 3568899999999999999997543333446899999999999999999999761 2389999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++........ ......+|+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------ 222 (279)
T 2w5a_A 157 LGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------------ 222 (279)
T ss_dssp ECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred EecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------------
Confidence 999999976443221 112346899999999999888999999999999999999999998643210
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 746 (768)
+....+........ .......+.+++.+||+.||++||++.||++.+
T Consensus 223 ---~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 223 ---ELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---HHHHHHhhcccccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 00111111111111 112345677999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.27 Aligned_cols=264 Identities=21% Similarity=0.330 Sum_probs=202.3
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----------EQQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 35799999999999999999997 47899999988542 2345567899999999999999999999986
Q ss_pred ----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 537 ----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 537 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
.....++||||+++++|.+++.........+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCE
Confidence 334789999999999999999753333445689999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCcc-------cccccccccCccCccccccCC---CCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 613 KVSDFGLSLIGPEDDESH-------LSLRAAGTVGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
||+|||++.......... ......||+.|+|||++.... ++.++||||||+++|||++|+.||.......
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 999999986543211100 001235799999999987543 6899999999999999999999986421110
Q ss_pred cccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
. .....+......+ ........+.+|+.+||+.||++|||++|+++.|+++..
T Consensus 254 ~--------------~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 D--------------SVALAVQNQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp S--------------CHHHHHHCC--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred c--------------hhhHHhhccCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0011111111111 011223567799999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=350.05 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=200.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++......... .........+.+|++++++++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC---WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS---EEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc---ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 457999999999999999999865 6899999998764321100 001123345778999999999999999999999
Q ss_pred cCCeeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENG-TLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+.+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 999999999999777 9999997532 3688999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|||++......... ....||+.|+|||++....+ +.++||||||+++|||++|+.||.....
T Consensus 173 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------- 235 (335)
T 3dls_A 173 DFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------- 235 (335)
T ss_dssp CCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred ecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence 99999765433221 23468999999999987776 7899999999999999999999863211
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
........+.. ....+.+|+.+||+.||++|||++|+++.
T Consensus 236 -------~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------TVEAAIHPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------GTTTCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HHhhccCCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111 23456789999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.81 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=201.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||+++.. +++.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------------EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------------GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------------HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 46889999999999999999986 78999999986431 246789999999999999999998854
Q ss_pred ----------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 046311 538 ----------------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKS 601 (768)
Q Consensus 538 ----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp 601 (768)
....++||||+++++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp 150 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKP 150 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCH
Confidence 345799999999999999996432 234688899999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 602 SNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 602 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
+|||++.++.+||+|||++......... ....+|+.|+|||++....++.++||||||+++|||++|..|+....
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 225 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-- 225 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--
T ss_pred HHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--
Confidence 9999999999999999999765433221 23468999999999998899999999999999999999988764210
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.......+...+. .....+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 226 ---------------~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 ---------------KFFTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------------HHHHHHHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------------HHHHHhhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111111222221 122446789999999999999999999999998875543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.21 Aligned_cols=269 Identities=17% Similarity=0.238 Sum_probs=206.5
Q ss_pred CCCCcCceeccCCceEEEEEEEcC---------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD---------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~---------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 529 (768)
++|++.+.||+|+||.||+++... ++.||||++... ..+.+|++++++++||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------------STHHHHHHHHHHHCCHHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------------chHHHHHHHHHHhcccchh
Confidence 578899999999999999998763 789999987532 2478899999999999988
Q ss_pred e---------------EEEEEEc-CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 046311 530 R---------------LLGFCED-RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPS 593 (768)
Q Consensus 530 ~---------------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ 593 (768)
+ +++++.. ....++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+++
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--- 179 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE--- 179 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 7 6777765 77889999999 999999997532 234689999999999999999999998
Q ss_pred eEecCCCCCCeEECCCC--cEEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHH
Q 046311 594 IIHRDIKSSNVLLDATW--TAKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLL 666 (768)
Q Consensus 594 ivHrDiKp~NILl~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ 666 (768)
|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++....++.++||||||++||
T Consensus 180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999988 9999999999754322111 1112347899999999999889999999999999999
Q ss_pred HHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCC--CCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 667 EILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNV--PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 667 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
||++|+.||....... ..+ ............ ..........+..+.+|+.+||+.||++||+++||++
T Consensus 260 el~~g~~pf~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNT-EDI---------MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHSCCTTGGGTTCH-HHH---------HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCcccCCcCH-HHH---------HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9999999997543211 000 000111111110 0000001122356779999999999999999999999
Q ss_pred HHHHHHhhcccCCCC
Q 046311 745 SLERALAACLVSPSI 759 (768)
Q Consensus 745 ~L~~~l~~~~~~~~~ 759 (768)
.|+++++....+++.
T Consensus 330 ~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 330 NLEALLQDLRVSPYD 344 (352)
T ss_dssp HHHHHHHHTTCCTTS
T ss_pred HHHHHHHhcCCCcCc
Confidence 999999887665443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=337.08 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=197.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||++... +++.||||++.... .......++.+|+..+.++ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---------AGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---------TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---------cccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 357889999999999999999976 78999999987531 1233456788999999999 999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-------
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA------- 608 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~------- 608 (768)
.+.+..++||||+++++|.+++.........+++..++.++.|+++||+|||+++ |+||||||+|||++.
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence 9999999999999999999999754322244688999999999999999999998 999999999999984
Q ss_pred ------------CCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCccc
Q 046311 609 ------------TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 609 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
...+||+|||++....... ...+|+.|+|||++... .++.++||||||+++|||++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 4479999999997654322 23589999999998765 5668999999999999999998765
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... +....+.....+... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~------------------~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNG------------------DQWHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSS------------------HHHHHHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cch------------------hHHHHHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 321 011112222221111 1123557789999999999999999999763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.10 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=196.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc-
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED- 537 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 537 (768)
.|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---------hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 4677889999999999999875 67899999986432 223456789999999999999999999999865
Q ss_pred ---CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCcEE
Q 046311 538 ---RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAK 613 (768)
Q Consensus 538 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~~k 613 (768)
....++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ ++|+||||||+|||++ .++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEE
Confidence 35689999999999999999642 23578899999999999999999986 4589999999999997 789999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++........ ....||+.|+|||++. ..++.++||||||+++|||++|+.||......
T Consensus 173 l~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------ 235 (290)
T 1t4h_A 173 IGDLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------------ 235 (290)
T ss_dssp ECCTTGGGGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------
T ss_pred EeeCCCccccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------------
Confidence 999999975433221 2346899999999887 56999999999999999999999998643211
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+.+.....+ ..........+.+|+.+||+.||++|||++|+++
T Consensus 236 ---~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 236 ---AQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---HHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHhccCCc-cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111111111 1111222345779999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.10 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=197.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||.||+++.+ ++.||||+++.. ...+.|.+|++++++++||||+++++++.+.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-------------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 57888999999999999999876 789999987532 2346789999999999999999999987554
Q ss_pred -CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 539 -NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 539 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..++||||+++++|.+++.... ...+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeec
Confidence 47899999999999999996432 112577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........ ...+++.|+|||++....++.++||||||+++|||+| |+.||......
T Consensus 162 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------------- 221 (278)
T 1byg_A 162 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------- 221 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---------------
T ss_pred ccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---------------
Confidence 99875432211 2357889999999998899999999999999999998 99988643211
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+....+....... .....+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 222 -~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 222 -DVVPRVEKGYKMD--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -GHHHHHTTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -HHHHHHhcCCCCC--CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111111111111 11123456779999999999999999999999999988654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=354.83 Aligned_cols=204 Identities=29% Similarity=0.415 Sum_probs=161.9
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 534 (768)
..++|++.+.||+|+||.||++... +++.||||++... .........+.+|+.+++++. ||||++++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---------~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---------ccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 3468999999999999999999865 7899999988532 122345567889999999997 9999999999
Q ss_pred EEcCC--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 535 CEDRN--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 535 ~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
+...+ ..++||||++ ++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCE
Confidence 97554 6899999997 5999998642 3578888999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCC-------------------CcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCC
Q 046311 613 KVSDFGLSLIGPEDD-------------------ESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGY 672 (768)
Q Consensus 613 kl~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~ 672 (768)
||+|||+++...... .........||+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999997543211 0111223579999999999876 67899999999999999999999
Q ss_pred cccccC
Q 046311 673 RAIHRT 678 (768)
Q Consensus 673 ~p~~~~ 678 (768)
.||...
T Consensus 229 ~pf~~~ 234 (388)
T 3oz6_A 229 PIFPGS 234 (388)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.97 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=204.8
Q ss_pred HHHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 454 LLEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 454 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
.....++|++.+.||+|+||.||++++. +|+.||||++....... .....+...+.+.+|+.+++++ +||||+++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL---SPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC---CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc---CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344567999999999999999999986 79999999987542110 0011123356788999999999 89999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999999999999642 23688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCcccccc------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
+||+|||++......... ....||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 239 ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----- 310 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----- 310 (365)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred EEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----
Confidence 999999999765433221 23568999999999863 3588999999999999999999999864211
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+.........+........+.+|+.+||+.||++|||++|+++
T Consensus 311 ----------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ----------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----------HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111112222222111111122455779999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=368.98 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=205.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||+++.+ +++.||||++..... ........+.+|+++|++++||||+++++++.
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--------hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 356889999999999999999876 789999999864311 11234567889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence 99999999999999999999976432 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ .....||+.|+|||++....++.++||||||+++|||++|+.||........ .
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~------------~ 394 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK------------R 394 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC------------H
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh------------H
Confidence 999976543322 1234799999999999988999999999999999999999999975432111 1
Q ss_pred hhHHhhhc-cCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 697 DEIHRVLD-RNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
.++.+.+. ..... .......+.+|+.+||+.||++|| +++||++.
T Consensus 395 ~~i~~~i~~~~~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 395 EEVERLVKEVPEEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHhhcccccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11111111 11111 112345677999999999999999 78888763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.09 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=205.0
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~ 535 (768)
.++|++.++||+|+||.||+++. .+++.||||++.... ...++.+|+++++.|+| ++|..+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------~~~~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------------KHPQLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-------------SSCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------------ccHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 36799999999999999999986 478999999876431 11247889999999976 5666666777
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCcE
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTA 612 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~~ 612 (768)
.+.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+
T Consensus 73 ~~~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~v 145 (483)
T 3sv0_A 73 VEGDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQV 145 (483)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCE
T ss_pred eeCCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeE
Confidence 8888999999999 899999997432 23689999999999999999999998 9999999999999 588999
Q ss_pred EEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc
Q 046311 613 KVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 687 (768)
||+|||+++........ .......||+.|+|||++....++.++||||||++||||++|+.||............
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence 99999999764433221 1122457999999999999999999999999999999999999999764432211111
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+..........+..+. ...+..+.+|+..||+.+|++||++.+|++.|++++...
T Consensus 226 ~~i~~~~~~~~~~~l~-----------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 226 EKISEKKVATSIEALC-----------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHHSCHHHHH-----------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhhccccccHHHHh-----------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1100000000011110 112356779999999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.51 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=153.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||||++... .......+++.+|+++|++++||||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECST---------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh---------hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 57999999999999999999865 7899999988532 1223456789999999999999999999999843
Q ss_pred -----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 538 -----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 538 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
....|+||||+. ++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp SCTTTCCCEEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred CCcccCceEEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCE
Confidence 357899999984 6999999653 34688899999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCc-------------------------ccccccccccCccCcccc-ccCCCCChhhHHHHHHHHH
Q 046311 613 KVSDFGLSLIGPEDDES-------------------------HLSLRAAGTVGYMDPEYY-RLQQLTEKSDVYSFGVVLL 666 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~ 666 (768)
||+|||+++........ .......||+.|+|||++ ....++.++|||||||+||
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999764322110 112234689999999986 5567999999999999999
Q ss_pred HHHcCC
Q 046311 667 EILSGY 672 (768)
Q Consensus 667 elltG~ 672 (768)
||++|.
T Consensus 276 elltg~ 281 (458)
T 3rp9_A 276 ELLNMI 281 (458)
T ss_dssp HHHTTS
T ss_pred HHHHhc
Confidence 999953
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=361.70 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=195.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||.||++... +++.||||++... .......+++.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 468999999999999999999865 6899999998643 122345678899999999999999999999996
Q ss_pred cC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.. ...+|||||+++ +|.+.+.. .+++..+..++.||++||+|||+++ |+||||||+||||+.++
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCC
Confidence 54 457999999976 57777643 2578888999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~ 689 (768)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||||++||||++|+.||.......... +.+.
T Consensus 202 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp CEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999976443221 224578999999999999999999999999999999999999996432110000 0000
Q ss_pred c---cchh---hhhhHHhhhccCC----------------CCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 V---VPYI---VRDEIHRVLDRNV----------------PPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ~---~~~~---~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. .+.. ........++... +............+.+|+.+||+.||++|||++|+++.
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 0001111111111 11111122235678899999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.61 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=189.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
.+|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----------chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 47889999999999999999975 7899999988532 2344567899999999996 999999999984
Q ss_pred --------cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 537 --------DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 537 --------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
.....++||||++ |+|.+++...... ..+++..++.++.|++.||+|||+++ ++|+||||||+|||++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSN 173 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT-CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECC
Confidence 3345789999996 6999988642222 23689999999999999999999986 45899999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcc----------cccccccccCccCcccc---ccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESH----------LSLRAAGTVGYMDPEYY---RLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
++.+||+|||++.......... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 9999999999997654322111 11133589999999998 5667889999999999999999999998
Q ss_pred ccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 676 HRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
....... .+......+. .......+.+|+.+||+.||++|||+.|+++.|+++.+....
T Consensus 254 ~~~~~~~-------------------~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 254 EDGAKLR-------------------IVNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp -------------------------------CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred cchhHHH-------------------hhcCcccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 6432110 0001010000 001112356899999999999999999999999999886655
Q ss_pred CC
Q 046311 756 SP 757 (768)
Q Consensus 756 ~~ 757 (768)
.+
T Consensus 313 ~~ 314 (337)
T 3ll6_A 313 NP 314 (337)
T ss_dssp CT
T ss_pred CC
Confidence 44
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=372.61 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=198.3
Q ss_pred ceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 465 HKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
++||+|+||.||+|.+. .++.||||+++... ......++|.+|++++++++||||+++++++.+ +..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 47999999999999653 46789999986431 223345789999999999999999999999965 458
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 445 ~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~ 517 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 517 (635)
T ss_dssp EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcc
Confidence 8999999999999999643 33688999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCC-cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhH
Q 046311 622 IGPEDDE-SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 622 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
....... ........+|+.|+|||++....++.++||||||++||||++ |+.||..... .++
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~ 581 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEV 581 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHH
T ss_pred ccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence 6543322 122223456889999999999999999999999999999998 9999864321 112
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
...+........ ....+..+.+||.+||+.||++||++++|++.|++++..
T Consensus 582 ~~~i~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 582 TAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222222221111 112345677999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.15 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=199.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----------AFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----------ccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 46888999999999999999876 78999999986431 1233568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCcEEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~~kl 614 (768)
.+..++||||+++++|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEB
T ss_pred CCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEE
Confidence 99999999999999999998642 23578889999999999999999998 9999999999999 78899999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++....... .....||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 151 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------- 213 (304)
T 2jam_A 151 TDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------------- 213 (304)
T ss_dssp CSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------
T ss_pred ccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence 9999987543221 12346899999999999889999999999999999999999998643210
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....+.........+.....+..+.+|+.+||+.||++|||++|+++
T Consensus 214 --~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 214 --KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122222222111222233456789999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.54 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|...+.||+|+||.||++... +++.||+|++.... .......+.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh--------ccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 46888999999999999999976 57899999986432 1223456778999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999998642 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+|+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~ 222 (294)
T 2rku_A 160 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KE 222 (294)
T ss_dssp TTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred cCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HH
Confidence 999764322221 1234689999999999988899999999999999999999999864321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.......+. .....+.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 223 TYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhhccCCCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11222222222111 223456789999999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.64 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=203.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+.+|+.++++++||||+++++++.+
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh--------hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 57888999999999999999876 57899999986432 1223456778999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeec
Confidence 99999999999999999998642 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....||+.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 186 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------~~ 248 (335)
T 2owb_A 186 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KE 248 (335)
T ss_dssp TTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred cCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---------------HH
Confidence 999765422221 1234689999999999988899999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.......+. .....+.+|+.+||+.||++||+++|+++.
T Consensus 249 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 249 TYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhcCCCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112222222111 123456789999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.78 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=193.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++...... ............+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFA---IGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhh---hcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 357899999999999999999875 6789999998653211 011112233456889999999999999999999987
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc---EE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT---AK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~---~k 613 (768)
..+ .++||||+++++|.+++... ..+++...+.++.|+++||+|||+++ |+||||||+|||++.++. +|
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 665 89999999999999998653 23688889999999999999999998 999999999999987654 99
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
|+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+.
T Consensus 158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~--- 229 (322)
T 2ycf_A 158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLK--- 229 (322)
T ss_dssp ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHH---
T ss_pred EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHH---
Confidence 99999997653322 112346899999999974 4678999999999999999999999996533211 000
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
. .+.............+....+.+|+.+||+.||++||++.|+++
T Consensus 230 ------~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 ------D---QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ------H---HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------H---HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 01111111100111123456779999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=362.14 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=202.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+++.. +++.||||++.... ........+.+|++++++++||||+++++++.+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 92 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---------AKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH---------HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc---------ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence 46888999999999999999876 78999999986431 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcEEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTAKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~kl 614 (768)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence 99999999999999999988643 23688899999999999999999998 99999999999995 4668999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.....
T Consensus 166 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 227 (486)
T 3mwu_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------------- 227 (486)
T ss_dssp CSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred EECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------
Confidence 99999975543322 123468999999999875 589999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+..+.........+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 228 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 228 -YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122223333322222223345667899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.73 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=188.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||+||++... +++.||||+++... ........+.+|++++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---------EEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---------cccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 357899999999999999999865 78999999986431 12233456789999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE-----CCCCc
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL-----DATWT 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl-----~~~~~ 611 (768)
+.+..++||||+++ +|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.
T Consensus 104 ~~~~~~lv~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 104 HNHRLHLIFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCE
T ss_pred cCCEEEEEEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccce
Confidence 99999999999985 9999997532 3688899999999999999999998 9999999999999 45566
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++........ ......+|+.|+|||++... .++.++||||||+++|||++|+.||........ +....
T Consensus 176 ~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~ 251 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIF 251 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHH
Confidence 99999999975432221 11234679999999998764 589999999999999999999999864321100 00000
Q ss_pred ----cchh-hhhhHHh--hhccCCCCCCcc------hHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 ----VPYI-VRDEIHR--VLDRNVPPPTPF------EIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ----~~~~-~~~~~~~--~~~~~~~~~~~~------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.. ....... ......+..... .......+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0000000 000000000000 0012356779999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=361.70 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||+++.. ++..||||++..... .......+.+|+.++++++||||+++++++.+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV---------STSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc---------CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 46889999999999999999976 689999999875321 12234678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCcEEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWTAKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~~kl 614 (768)
....++||||+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEE
Confidence 99999999999999999988643 23578889999999999999999998 999999999999976 455999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ .....||+.|+|||++. ..++.++||||||+++|||++|+.||.....
T Consensus 181 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 242 (494)
T 3lij_A 181 VDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------------- 242 (494)
T ss_dssp CCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred EECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------------
Confidence 99999976543322 12346999999999986 5799999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHHHh
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALA 751 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~ 751 (768)
.+....+.........+.....+..+.+|+.+||+.||++|||+.|+++. |++...
T Consensus 243 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 243 -QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp -HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred -HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 11122222222222222222345667799999999999999999999864 555443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.03 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=205.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||||++..... ........+.+|++++++++||||+++++++.+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--------KQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--------ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46888999999999999999976 789999999864321 122345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---CCCCcEEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---DATWTAKV 614 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---~~~~~~kl 614 (768)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999999999753 23688899999999999999999998 9999999999999 56789999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.....
T Consensus 171 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 232 (484)
T 3nyv_A 171 IDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------------- 232 (484)
T ss_dssp CCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred EeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 99999976543322 123469999999999875 699999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.........+.....+..+.+|+.+||+.||++|||++|+++.
T Consensus 233 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 233 -YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11122233333332223233445667899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.50 Aligned_cols=270 Identities=21% Similarity=0.286 Sum_probs=193.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||+++.. +++.||||++...... ...+.....+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------EAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc------hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 468999999999999999999875 6899999998653211 111122346889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred eCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999986 8999886532 23567788999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
||++........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|..||....... ..........
T Consensus 156 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~ 230 (346)
T 1ua2_A 156 FGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLG 230 (346)
T ss_dssp CGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred cccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcC
Confidence 999976533222 1223468999999999865 458899999999999999999998886432110 0000000000
Q ss_pred ---hhh---HH---hhhccCCCCCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 696 ---RDE---IH---RVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 696 ---~~~---~~---~~~~~~~~~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+. .. ..+.....+..+ ........+.+|+.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00 000000000000 001223567899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.77 Aligned_cols=286 Identities=20% Similarity=0.249 Sum_probs=202.3
Q ss_pred cHHHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCce
Q 046311 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLV 529 (768)
Q Consensus 450 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 529 (768)
...++....++|++.+.||+|+||.||++...+++.||||++...................+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35566777899999999999999999999988899999999865432211111122233457899999999999999999
Q ss_pred eEEEEEEc-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCe
Q 046311 530 RLLGFCED-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNV 604 (768)
Q Consensus 530 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NI 604 (768)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 99999844 336799999998 58888887532 34688999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 605 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
|++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++||||||+++|||++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999974332222 123468999999999876 6789999999999999999999999964321100
Q ss_pred c-cccccc-cc------hhhhhhHHhhhccCCCCCCc-----chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 684 R-NVVDFV-VP------YIVRDEIHRVLDRNVPPPTP-----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 684 ~-~~~~~~-~~------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. .+.+.. .+ ..........+......... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 000000 00 00000111111111111000 011224567799999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.15 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=188.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||||+++... ........+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 357889999999999999999874 78999999986431 12223344555666688899999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+.+..++||||+++ +|.+++.........+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBC
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999974 88888754222334568999999999999999999998 7 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccc----ccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYY----RLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|||++......... ....||+.|+|||++ ....++.++||||||+++|||++|+.||......
T Consensus 153 Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------- 219 (290)
T 3fme_A 153 DFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------- 219 (290)
T ss_dssp CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----------
T ss_pred ecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----------
Confidence 99999754332221 223689999999996 4567899999999999999999999998642110
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+...+....+... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 220 ----~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 220 ----FQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----HHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1112222222222111 1123456779999999999999999999988
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.82 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=198.8
Q ss_pred CCCCcCceeccCCceEEEEEEE----cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 533 (768)
++|++.+.||+|+||.||+++. .+++.||||+++..... ........+.+|+++++++ +||||+++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-------EEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-------hhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 5788999999999999999987 36899999998643210 0112234566799999999 6999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++...+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+||||+.++.+|
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEE
Confidence 999999999999999999999999653 23578889999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|+|||+++....... .......||+.|+|||++.. ..++.++||||||++||||++|+.||........ .
T Consensus 200 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~----- 271 (355)
T 1vzo_A 200 LTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--Q----- 271 (355)
T ss_dssp ESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--H-----
T ss_pred EeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--H-----
Confidence 999999975432221 12224569999999999975 4578999999999999999999999975432111 0
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 745 (768)
..-...+.......+ .+....+.+|+.+||+.||++|| +++|+++.
T Consensus 272 ----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 272 ----AEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----HHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 001111222211111 12345577899999999999999 99999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.52 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=202.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||++..... ..+.....+.+|++++++++||||+++++++.+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--------EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--------chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 47888999999999999999876 578899999864311 112234678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecc
Confidence 999999999999999999996532 3578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++........ ....+++.|+|||++....++.++||||||+++|||++|+.||..... .+
T Consensus 159 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------~~ 219 (284)
T 2vgo_A 159 GWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---------------TE 219 (284)
T ss_dssp TTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred cccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---------------hH
Confidence 99865433221 234689999999999988999999999999999999999999864321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.......+. .....+.+++.+||+.||++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 220 THRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHTTCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHhccccCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11222222222111 223456789999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.95 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=204.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||++... +++.||||+++........ ....+...+.+.+|++++++++ ||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS--AEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCC--HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccC--HHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 367899999999999999999976 6899999998754321110 0111233567889999999995 99999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||||+++++|.+++... ..+++..++.++.|++.+|+|||+++ |+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 9999999999999999999999642 23688899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccc------cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR------LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
|||++......... ....+|+.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 167 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------- 234 (298)
T 1phk_A 167 DFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------- 234 (298)
T ss_dssp CCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------
T ss_pred cccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---------
Confidence 99999765433221 2346899999999985 45688999999999999999999999864321
Q ss_pred ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+.........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 ------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0111122222222222222234566789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.82 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=201.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|+..+.||+|+||.||++... +++.||||++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT----------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc----------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 46888899999999999999865 68999999986432 12345779999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+++++|.+++.. ..+++..++.++.|++++|+|||+++ |+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df 163 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADF 163 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeec
Confidence 9999999999999999999964 23688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|++......... .....+|+.|+|||++....++.++||||||+++|||++|+.||...... .
T Consensus 164 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~ 226 (303)
T 3a7i_A 164 GVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---------------K 226 (303)
T ss_dssp TTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------H
T ss_pred ccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---------------H
Confidence 999754332211 12346899999999999889999999999999999999999998643210 0
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
....+.....+. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 227 VLFLIPKNNPPT---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHSCCCC---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHhhcCCCCC---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011111111111 111223457789999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.69 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=196.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+|+.++++++||||+++++++.
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-------------SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-------------SCCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-------------HHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 467999999999999999999876 5899999998642 12356889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred eCCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEee
Confidence 999999999999999999998632 234688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||++........ ......+|+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 169 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------- 231 (314)
T 3com_A 169 FGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------------- 231 (314)
T ss_dssp CTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---------------
T ss_pred cccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---------------
Confidence 999975433221 112346899999999999889999999999999999999999998643210
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
........ ...+...........+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 232 RAIFMIPT-NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHH-SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhc-CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111111 111111112223456779999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=346.04 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=191.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||+++.. +++.||||++..... ......+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----------EGAPCTAIREVSLLKDLKHANIVTLHDIIHT 71 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----------cccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence 47889999999999999999976 789999999864321 1111234579999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 144 (324)
T 3mtl_A 72 EKSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADF 144 (324)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSS
T ss_pred CCEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccC
Confidence 999999999997 59999886532 34688889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc--------c
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV--------D 688 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~--------~ 688 (768)
|++........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .
T Consensus 145 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 145 GLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222 (324)
T ss_dssp SEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99975432221 1123468999999999876 57899999999999999999999999653211100000 0
Q ss_pred cccchhhhh-hHHhhhccCCCCCC--cchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIVRD-EIHRVLDRNVPPPT--PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..++..... +............. .........+.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 00100000000000 000122356779999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=354.13 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=167.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++... .......+++.+|+++|++++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---------FEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST---------TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch---------hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 468999999999999999999875 6889999998632 122345678999999999999999999999987
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...++||||++ ++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~ 167 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCS 167 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCC
Confidence 66 57899999986 5999999753 33688999999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc--------------------ccccccccccCccCcccc-ccCCCCChhhHHHHHHHHHHHHc
Q 046311 612 AKVSDFGLSLIGPEDDES--------------------HLSLRAAGTVGYMDPEYY-RLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~ellt 670 (768)
+||+|||+++........ .......||+.|+|||++ ....++.++|||||||+||||++
T Consensus 168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 999999999865432211 112345789999999986 55679999999999999999999
Q ss_pred CCcccc
Q 046311 671 GYRAIH 676 (768)
Q Consensus 671 G~~p~~ 676 (768)
|..|+.
T Consensus 248 g~~p~~ 253 (432)
T 3n9x_A 248 MLQSHI 253 (432)
T ss_dssp TCTTTC
T ss_pred cccccc
Confidence 766654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=359.85 Aligned_cols=262 Identities=27% Similarity=0.357 Sum_probs=200.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCccc--ccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSY--AIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~--~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.++|++.++||+|+||+||+++.. +++.||||++........ .......+...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999976 678999999875432110 00011112345789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC---c
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---T 611 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~---~ 611 (768)
+.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998643 23688999999999999999999998 99999999999998765 6
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|||++|+.||.....
T Consensus 188 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------- 252 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND----------- 252 (504)
T ss_dssp EEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------
T ss_pred EEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----------
Confidence 999999999765433221 2346999999999987 5699999999999999999999999964321
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+.+..+.........+.....+..+.+|+.+||+.||++|||++|+++.
T Consensus 253 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 ----QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11122222222221111112234667899999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.35 Aligned_cols=269 Identities=23% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+.+|++++++++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 57889999999999999999876 58999999986431 223345678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeC
Confidence 99999999999999999887543 23688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccccc---c
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFVV---P 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~~---~ 692 (768)
|++........ ......+|+.|+|||++... .++.++||||||+++|||++|+.||.......... ...... +
T Consensus 169 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 169 GFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 99975433221 11234689999999998765 78999999999999999999999986532211000 000000 0
Q ss_pred h----hhhhhH-HhhhccCCCCCCcc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 Y----IVRDEI-HRVLDRNVPPPTPF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 ~----~~~~~~-~~~~~~~~~~~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. +..... .............. ....+..+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 00000000000000 01234668899999999999999999998863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=339.10 Aligned_cols=257 Identities=17% Similarity=0.273 Sum_probs=196.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
++|++.++||+|+||.||++... +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------------KKKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--------------chHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 57899999999999999999864 7899999987532 2457889999999997 999999999998
Q ss_pred c--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEE
Q 046311 537 D--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAK 613 (768)
Q Consensus 537 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~k 613 (768)
+ ....++||||+++++|.+++.. ++...+..++.|+++||+|||+++ |+||||||+|||++.++ .+|
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~k 171 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR 171 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred cCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEE
Confidence 8 6678999999999999999853 577888999999999999999998 99999999999999776 899
Q ss_pred EeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||++......... ....+|+.|+|||++.. ..++.++||||||+++|||++|+.||....... ..+.. ...
T Consensus 172 l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~-~~~ 246 (330)
T 3nsz_A 172 LIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVR-IAK 246 (330)
T ss_dssp ECCCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHH-HHH
T ss_pred EEeCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHH-HHH
Confidence 9999999765433322 23468999999999876 678999999999999999999999985432210 00000 000
Q ss_pred hhhhhhHHhhhcc---------------CCCCC------CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDR---------------NVPPP------TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~---------------~~~~~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..........++. ..... ..........+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001111111110 00000 0011113466789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.54 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=194.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||++.... .........+.+|++++++++||||+++++++.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 57899999999999999999976 78999999986431 1122345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+|+||||+|||++.++.+||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999999653 23578899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|++........ .....+|+.|+|||++....+ +.++||||||+++|||++|+.||..... .
T Consensus 156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~ 217 (276)
T 2h6d_A 156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------------P 217 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------H
T ss_pred ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---------------H
Confidence 99976543322 123468999999999987665 6899999999999999999999864211 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+.......+. .....+.+++.+||+.||++|||++|+++.
T Consensus 218 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 TLFKKIRGGVFYIPE----YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhcCcccCch----hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111111111111 123457789999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.85 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=197.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++..... .........+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-------RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-------HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-------cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 468999999999999999999875 688999999864311 111234578999999999999999999999984
Q ss_pred --cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 537 --DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 537 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+....++||||++++ |.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 445789999999876 777775432 234688899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCC--CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++................+|+.|+|||++.... ++.++||||||+++|||++|+.||.....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------ 218 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------------ 218 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------------
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------------
Confidence 9999997654333322333456899999999987643 37799999999999999999999864311
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+....+.......+. .....+.+|+.+||+.||++|||++|+++.
T Consensus 219 ---~~~~~~i~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 219 ---YKLFENIGKGSYAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---HHHHHHHHHCCCCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHHHhcCCCCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111112222222111 223456789999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.42 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=195.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc--CCC--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--DGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+++++ +++ .||||+++... ...+...+.|.+|++++++++||||++++++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--------LSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--------cCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 47888999999999999999864 233 68999876431 1123456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.. .++||||+++++|.+++.... ..+++..+++++.|++++|+|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred EccCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEE
Confidence 98765 889999999999999996532 23578899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||++......... .......+|..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------ 230 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------ 230 (291)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------
T ss_pred ccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------------
Confidence 999999765433221 11223457889999999988889999999999999999999 9999864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.+....+.......+ .....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 231 ---~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 231 ---SQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---HHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---HHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 011112222111111 1112345678999999999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.96 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=194.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|.....||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----------C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 4555668999999999999864 68899999886431 23446789999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEEEeec
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDF 617 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~kl~DF 617 (768)
+..++||||+++++|.+++..... ....++..+..++.|+++||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999999999975432 223467888899999999999999998 999999999999987 899999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccC--CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|++........ ......||+.|+|||++... .++.++||||||+++|||++|+.||........ ..
T Consensus 168 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~- 235 (295)
T 2clq_A 168 GTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AM- 235 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------HH-
T ss_pred ccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---------HH-
Confidence 99976443221 11234689999999998764 378999999999999999999999864321100 00
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. .......... .......+.+|+.+||+.||++||+++|+++
T Consensus 236 ~~--~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 236 FK--VGMFKVHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HH--HHHHCCCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred Hh--hccccccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0011111111 1123455778999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.70 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=192.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... +++.||||++... ...+...+++.+|++++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---------TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---------ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 467999999999999999999875 7899999987532 122344567899999999999999999999997
Q ss_pred cCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
..+ ..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 165 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDC 165 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCC
Confidence 653 469999999 7899999964 23578889999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVD 688 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~ 688 (768)
.+||+|||+++...... ....+|+.|+|||++.. ..++.++||||||+++|||++|+.||......... .+..
T Consensus 166 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 166 ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999998643321 23468999999999876 68999999999999999999999999643211000 0000
Q ss_pred c-------ccchhhhhhHHhhhcc---CCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 F-------VVPYIVRDEIHRVLDR---NVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~-------~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. ..+.+........+.. .... ...........+.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 0000000011111110 0000 000111234567799999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=357.08 Aligned_cols=246 Identities=15% Similarity=0.202 Sum_probs=188.3
Q ss_pred cCCCCcCceeccCCceEEEEEEE-cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHH---HHHhcCCCCCceeEE-
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL---ESLSRLHHKNLVRLL- 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~HpnIv~l~- 532 (768)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .......+.|.+|+ +++++++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecc--------ccchHHHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 35788899999999999999996 468999999987532 11233557899999 555666899999998
Q ss_pred ------EEEEcCCe-----------------eEEEEEeccCCChhhhccCCCCC---CCCCCHHHHHHHHHHHHHHHHHH
Q 046311 533 ------GFCEDRNE-----------------RVLIYEYLENGTLHDHLHNPQSS---SPLKSWPARIKVALDAARGIEYL 586 (768)
Q Consensus 533 ------~~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~---~~~~~~~~~~~ia~~ia~gL~yL 586 (768)
+++.+.+. .+|||||+ +|+|.+++...... ...+++..++.++.||++||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 77766542 78999999 67999999753211 11223577888999999999999
Q ss_pred hhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-----------CCCCh
Q 046311 587 HEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-----------QLTEK 655 (768)
Q Consensus 587 H~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~ 655 (768)
|+++ |+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++... .++.+
T Consensus 223 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 223 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 9998 99999999999999999999999999985322 1223457 999999999877 89999
Q ss_pred hhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCC
Q 046311 656 SDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRN 735 (768)
Q Consensus 656 sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~ 735 (768)
+||||||++||||++|+.||........ .. .+... .. ..+..+.+|+.+||+.||++
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~---~~------------~~~~~-~~-------~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGG---SE------------WIFRS-CK-------NIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CC---SG------------GGGSS-CC-------CCCHHHHHHHHHHTCSSGGG
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccc---hh------------hhhhh-cc-------CCCHHHHHHHHHHcCCCchh
Confidence 9999999999999999999965332111 01 11110 00 11245678999999999999
Q ss_pred CCCHHHHHH
Q 046311 736 RPSMTEIVN 744 (768)
Q Consensus 736 RPs~~evl~ 744 (768)
|||+.|+++
T Consensus 351 Rpt~~e~l~ 359 (377)
T 3byv_A 351 RLLPLQAME 359 (377)
T ss_dssp CCCHHHHHT
T ss_pred CCCHHHHhh
Confidence 999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.28 Aligned_cols=271 Identities=22% Similarity=0.323 Sum_probs=197.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.. +++.||||++.... ........+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS---------CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc---------ccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 57889999999999999999974 78999999885432 112334568899999999999999999999877
Q ss_pred --------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 538 --------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 538 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
.+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD 160 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCC
Confidence 3468999999985 7877776532 23688999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCC--cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 610 WTAKVSDFGLSLIGPEDDE--SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999975442221 112234568999999999875 4689999999999999999999999875322110000
Q ss_pred cc--------cccchhhhhhHHhhhccCCCCCCcchHH-----HHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 VD--------FVVPYIVRDEIHRVLDRNVPPPTPFEIE-----AVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. ...+.....+..+.+............. ....+.+|+.+||+.||++|||++|+++.
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000000000000000000000011111 13457799999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.88 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=193.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... +++.||||++.... ......+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---------CChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 368999999999999999999865 68899999986431 22345567899999999999999999999997
Q ss_pred cCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
..+ ..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~ 164 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTS
T ss_pred cccccccccceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCC
Confidence 665 78999999975 88888853 2578888999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-ccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~ 689 (768)
.+||+|||++....... ......||+.|+|||++....++.++||||||+++|||++|+.||......... .+...
T Consensus 165 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 165 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp CEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred CEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997543221 112346899999999999889999999999999999999999999653211000 00000
Q ss_pred c---cchhh---hhhHHhhhccC----------------CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 V---VPYIV---RDEIHRVLDRN----------------VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ~---~~~~~---~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. .+... .......+... .+............+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 00000 00001111110 011111223346678899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=368.94 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=204.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||+++.. +++.||||+++.... ..+.....+.+|..++..+ +||||+++++++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--------HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--------ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 467999999999999999999876 678899999874311 1223456788899999988 799999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..||||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999753 23688899999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++....... ......||+.|+|||++....++.++||||||++||||++|+.||.....
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------------- 547 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------------- 547 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---------------
Confidence 9999975332222 12345799999999999999999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCH-----HHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSM-----TEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 744 (768)
.+-...++...+..+. .....+.+|+.+||+.||++||++ +||++
T Consensus 548 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 548 DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122334444333322 234567799999999999999998 67665
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.69 Aligned_cols=255 Identities=9% Similarity=0.046 Sum_probs=180.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHH---HHHhcCCCCCceeEE--
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL---ESLSRLHHKNLVRLL-- 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~HpnIv~l~-- 532 (768)
.+|+..+.||+|+||.||++++. +++.||||++..... ........+.+|+ ..|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~ 132 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--------NSRSELERLHEATFAAARLLG-ESPEEARDRRR 132 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--------THHHHHHHHHHHHHHHHHHHC-----------C
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--------ccccHHHHHHHHHHHHHHhcc-cChhhhhhcee
Confidence 35888899999999999999975 789999999875421 1234455677884 45555 799988855
Q ss_pred -----EEEEcC-----------------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHH------HHHHHHHHHHHH
Q 046311 533 -----GFCEDR-----------------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPAR------IKVALDAARGIE 584 (768)
Q Consensus 533 -----~~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~------~~ia~~ia~gL~ 584 (768)
+++... ...+|||||++ ++|.+++..... ...+..+ +.++.||++||+
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHH
Confidence 444433 33799999999 899999975321 1244455 788899999999
Q ss_pred HHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccccc--CCCCChhhHHHHH
Q 046311 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFG 662 (768)
Q Consensus 585 yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlG 662 (768)
|||+++ |+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.. ..++.++||||||
T Consensus 209 ~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 209 NLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp HHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred HHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 999998 9999999999999999999999999998643211 13356799999999987 6899999999999
Q ss_pred HHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHH
Q 046311 663 VVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEI 742 (768)
Q Consensus 663 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 742 (768)
++||||++|+.||............... ........... +.....+..+.+|+.+||+.||++|||+.|+
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPS--------LRVPGTDSLAF--GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTCCCBCC--------TTSCCCCSCCC--TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHHHhCCCCCCCcCcccccchhhhh--------hhhccccccch--hhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999999999999765332211110000 00000011111 0011234567789999999999999999999
Q ss_pred HH
Q 046311 743 VN 744 (768)
Q Consensus 743 l~ 744 (768)
++
T Consensus 351 l~ 352 (371)
T 3q60_A 351 ME 352 (371)
T ss_dssp TT
T ss_pred hc
Confidence 75
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.77 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=192.8
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
..++|++.+.||+|+||.||+++.. +++.||||++.... .....+.+|+.+++++ +||||++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------------DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------------STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc------------ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 4578999999999999999999974 78999999986431 2345788999999999 89999999999
Q ss_pred EEc------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC
Q 046311 535 CED------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA 608 (768)
Q Consensus 535 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~ 608 (768)
+.. .+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE 164 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcC
Confidence 976 467899999999999999997532 234578888999999999999999998 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTP 683 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~ 683 (768)
++.+||+|||++........ ......+|+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-- 240 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-- 240 (326)
T ss_dssp TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred CCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--
Confidence 99999999999875432211 112346899999999986 467899999999999999999999998543210
Q ss_pred ccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 684 RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.....+.....+.. ........+.+|+.+||+.||++||+++|+++
T Consensus 241 -------------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 -------------RALFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------------HHHHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------------HHHHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00111111111110 01122356778999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=336.26 Aligned_cols=259 Identities=23% Similarity=0.387 Sum_probs=183.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++.... ......++.+|++++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------------CCCCCCCTTBCCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 468999999999999999999854 68999999875431 1223457889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNP----QSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~----~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
..+..++||||+++++|.+++... ......+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCE
Confidence 999999999999999999998631 112334688999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCC---cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 613 KVSDFGLSLIGPEDDE---SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 613 kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
||+|||++........ ........+|+.|+|||++.. ..++.++||||||+++|||++|+.||....... .
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~-- 235 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---V-- 235 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H--
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---H--
Confidence 9999999875433211 111223468999999999875 568999999999999999999999986532211 0
Q ss_pred cccchhhhhhHHhhhccCCCCC------CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPP------TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+....+.. ..........+.+|+.+||+.||++||++.|+++
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 ----------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----------HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----------HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000111000000 0000112345778999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.46 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=201.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||++... +++.||+|++... ......+.+.+|++++++++||||+++++++.+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----------cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 57889999999999999999876 7899999998643 123445789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+..++||||+++++|.+++.... .+++..+..++.|++.+|+|||+. + |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~D 175 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCD 175 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEE
Confidence 999999999999999999996532 357888999999999999999986 7 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc---------
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV--------- 687 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~--------- 687 (768)
||++...... ......||+.|+|||++....++.++||||||+++|||++|+.||............
T Consensus 176 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3eqc_A 176 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251 (360)
T ss_dssp CCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred CCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence 9998643211 112346899999999999889999999999999999999999999643211000000
Q ss_pred --------------ccc----cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 688 --------------DFV----VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 688 --------------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+. .+....+....+.....+.. ........+.+|+.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00000011111222211111 111234567799999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.33 Aligned_cols=263 Identities=20% Similarity=0.262 Sum_probs=201.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccc------cccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIG------TKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|++.+.||+|+||.||++.. +++.||||++........... ..........|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 799999999875422110000 00011122789999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhh------ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCCe
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDH------LHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSNV 604 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~NI 604 (768)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ ++ |+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 9999999999999999999999999 5432 13456899999999999999999999 87 99999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCC-hhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 605 LLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTE-KSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 605 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
|++.++.+||+|||++...... ......+|+.|+|||++... .++. ++||||||+++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999764332 12234689999999999876 5666 9999999999999999999997543210
Q ss_pred cccccccccchhhhhhHHhhhccCCCCC---------------CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 683 PRNVVDFVVPYIVRDEIHRVLDRNVPPP---------------TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. ...+.......+ ..........+.+|+.+||+.||++|||++|+++
T Consensus 260 --~~------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 --EL------------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HH------------HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HH------------HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 011111111000 0001223456789999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=349.94 Aligned_cols=198 Identities=27% Similarity=0.311 Sum_probs=168.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC------CCCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL------HHKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~ 530 (768)
..+|++.++||+|+||.||++... +++.||||+++.. ......+.+|+++++.+ +|+||++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~ 163 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------------KRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------------cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence 357899999999999999999865 5899999998532 22345667777777766 5789999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
+++++...+..++||||+. ++|.+++..... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++
T Consensus 164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 164 MLENFTFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQG 237 (429)
T ss_dssp EEEEEEETTEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTT
T ss_pred EEeecccCCeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCC
Confidence 9999999999999999996 599999875432 23688999999999999999999998 99999999999999988
Q ss_pred c--EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 611 T--AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 611 ~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
. +||+|||++....... ....+|+.|+|||++....++.++|||||||+||||+||+.||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 9999999997543222 1346899999999999999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.95 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=195.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|++++++++||||+++++++.
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------SEEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 357899999999999999999986 5899999987543 1234567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..++||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECC
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEE
Confidence 9999999999999999999986422 23688899999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
||++....... .......+|+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 161 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------- 228 (302)
T 2j7t_A 161 FGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------- 228 (302)
T ss_dssp CHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------
T ss_pred CCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----------
Confidence 99875321100 0111346899999999983 567899999999999999999999998643210
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...........+ ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 -----RVLLKIAKSDPP-TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----HHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----HHHHHHhccCCc-ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111111111111 11112233456779999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.79 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=200.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||||++.... ........+.+|++++++++||||+++++++.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---------AKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------BSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 357999999999999999999976 78999999986432 11234567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC---CcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT---WTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~---~~~k 613 (768)
+.+..++||||+++++|.+++... ..+++..++.++.|++++|+|||+++ |+||||||+|||++.+ ..+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEE
Confidence 999999999999999999988642 23588899999999999999999998 9999999999999754 4799
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....+|+.|+|||++.+ .++.++||||||+++|||++|+.||......
T Consensus 165 L~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------ 228 (287)
T 2wei_A 165 IIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------------ 228 (287)
T ss_dssp ECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred EeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------------
Confidence 9999999765433221 12358999999999875 5899999999999999999999998643210
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+....+.........+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 ---DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111122222222221222233456779999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.35 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=189.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||+++.. +++.||||++... ......+.+|++++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------------EEKLSTILSEVMLLASLNHQYVVRYYAAWL 72 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------------HHHHHHHHHHHHHHHhcCchHHHHHHHHHH
Confidence 457889999999999999999975 7899999998532 234567899999999999999999999886
Q ss_pred c-------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 537 D-------------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 537 ~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+ ....++||||+++++|.+++.... ...++..++.++.|+++||+|||+++ |+||||||+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~N 146 (303)
T 1zy4_A 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMN 146 (303)
T ss_dssp ECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred hhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHh
Confidence 5 356789999999999999997532 23467888999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCC------------cccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHc
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDE------------SHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~ellt 670 (768)
||++.++.+||+|||++........ ........+|+.|+|||++... .++.++||||||+++|||++
T Consensus 147 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999975432210 1111234689999999998754 78999999999999999998
Q ss_pred CCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 671 GYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 671 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
|+..... . .+....+.......+..........+.+|+.+||+.||++|||++|+++
T Consensus 227 ---p~~~~~~-----~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 ---PFSTGME-----R---------VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---CCSSHHH-----H---------HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCchh-----H---------HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 3321100 0 0111111111111112222333456779999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=344.38 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=196.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.+.||+|+||.||+++.+. .+|+|+++.... .+...+.|.+|+.++++++||||+++++++.+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD---------NEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC---------CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC---------CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4678999999999999999998763 599998865321 11223456789999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++ ++.+||+||
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCC
T ss_pred CCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeec
Confidence 999999999999999999997532 34678899999999999999999998 99999999999998 679999999
Q ss_pred cccccCCCCC---CcccccccccccCccCcccccc---------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc
Q 046311 618 GLSLIGPEDD---ESHLSLRAAGTVGYMDPEYYRL---------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN 685 (768)
Q Consensus 618 Gla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~---------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 685 (768)
|++....... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 249 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---- 249 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 9986532211 1111223458999999999864 35788999999999999999999998643210
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcc
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACL 754 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~ 754 (768)
.....+.....+... .......+.+|+.+||+.||++|||+.|+++.|+++.....
T Consensus 250 -----------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 250 -----------AIIWQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp -----------HHHHHHHTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred -----------HHHHHhccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001111111111110 01123446789999999999999999999999999886553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.35 Aligned_cols=269 Identities=21% Similarity=0.274 Sum_probs=193.7
Q ss_pred HcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 457 ATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 457 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
..++|++.+.||+|+||.||++... +++.||||++..... .+.+|+++++.++||||+++++++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------------~~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------------YKNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------------SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------------hHHHHHHHHHHcCCCCccchhhee
Confidence 4578999999999999999999864 789999998864311 123699999999999999999998
Q ss_pred Ec--------------------------------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHH
Q 046311 536 ED--------------------------------------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577 (768)
Q Consensus 536 ~~--------------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~ 577 (768)
.. ....++||||++ ++|.+.+.........+++..+..++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 43 334789999998 488877754222234568889999999
Q ss_pred HHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCCh
Q 046311 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEK 655 (768)
Q Consensus 578 ~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~ 655 (768)
|+++||+|||+++ |+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||++.+. .++.+
T Consensus 149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcc
Confidence 9999999999998 99999999999997 6889999999999765433222 234689999999998764 58999
Q ss_pred hhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh---hhhhHHhh----hccCCCCC--Cc----chHHHHHHHH
Q 046311 656 SDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI---VRDEIHRV----LDRNVPPP--TP----FEIEAVAYVG 722 (768)
Q Consensus 656 sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~--~~----~~~~~~~~l~ 722 (768)
+||||||+++|||++|+.||......+ .+... .... ..+.+... .+...+.. .. .....+..+.
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSID--QLVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChHH--HHHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHH
Confidence 999999999999999999997432111 00000 0000 00000000 00000000 00 0111235577
Q ss_pred HHHHHcccccCCCCCCHHHHHHH--HHHHH
Q 046311 723 YLAADCVTLEGRNRPSMTEIVNS--LERAL 750 (768)
Q Consensus 723 ~Li~~Cl~~dP~~RPs~~evl~~--L~~~l 750 (768)
+|+.+||+.||++|||+.|+++. ++++.
T Consensus 300 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 99999999999999999999853 44443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.74 Aligned_cols=264 Identities=19% Similarity=0.287 Sum_probs=195.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|...+.||+|+||.||++... +++.||||++.... ..+...+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---------cchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 468999999999999999999875 68999999986431 22344678899999999999999999999998
Q ss_pred cCCee------EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRNER------VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
..+.. ++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~ 181 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDC 181 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCC
Confidence 77654 99999997 589888843 2688899999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc-cccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR-NVVD 688 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~ 688 (768)
.+||+|||++....... ....+|+.|+|||++.. ..++.++||||||+++|||++|+.||......... .+..
T Consensus 182 ~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 182 ELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp CEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999997543221 23468999999999876 68899999999999999999999999643211000 0000
Q ss_pred c-------ccchhhhhhHHhhhccCCCCCCc----chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 F-------VVPYIVRDEIHRVLDRNVPPPTP----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~-------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. ....+........+......... ........+.+|+.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 00000000011111111111100 011224667899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.07 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=198.3
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||++... +++.||||++... ........+.+|++++++++||||+++++++.
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 95 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----------EHQTYCQRTLREIKILLRFRHENIIGINDIIR 95 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence 457999999999999999999875 6889999998532 12334577899999999999999999999986
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...++||||++ ++|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 96 APTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp CSSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred cCCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCC
Confidence 54 46899999997 5999998642 3688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCc-ccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-cc
Q 046311 612 AKVSDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV-VD 688 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-~~ 688 (768)
+||+|||++......... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........... ..
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 999999999765432211 11234578999999998754 4589999999999999999999999965432111000 00
Q ss_pred cc-------cchhhhhhHHhhhccCCC-CCCcc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FV-------VPYIVRDEIHRVLDRNVP-PPTPF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~-------~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. .................. ...+. .......+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000000000 00000 01223567799999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.64 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=194.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~ 535 (768)
.++|++.+.||+|+||.||++..++++.||||++.... ........+.+|++++++++ ||||+++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS---------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc---------ccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 35688999999999999999998889999999986531 22345678999999999997 59999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 536 EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
.+.+..++||| +.+++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++ ++.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEe
Confidence 99999999999 5688999999753 23578889999999999999999998 99999999999996 4899999
Q ss_pred eccccccCCCCCCcccccccccccCccCcccccc-----------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-----------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR 684 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 684 (768)
|||++................||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence 9999976543332222234468999999999865 46888999999999999999999998643210
Q ss_pred cccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 685 NVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.......++.......+ ......+.+|+.+||+.||++||++.|+++.
T Consensus 246 -----------~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 -----------ISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----------HHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHHHhcccccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11122333322221111 0113457789999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.85 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=182.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... +++.||||++... .......+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 468999999999999999999864 6899999987532 122345578889999999999999999999986
Q ss_pred cC------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DR------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.. ...++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~ 169 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 169 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCC
Confidence 54 5679999999 6899999864 23688899999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVD 688 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~ 688 (768)
.+||+|||+++..... .....+|+.|+|||++.. ..++.++||||||+++|||++|+.||.......... +..
T Consensus 170 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 170 ELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999754322 123468999999999876 678999999999999999999999996432110000 000
Q ss_pred c-------ccchhhhhhHHhhhccCCCCC-Ccch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 F-------VVPYIVRDEIHRVLDRNVPPP-TPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~-------~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. ..+.+........+......+ .... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000000111111111111100 0110 1123567799999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.12 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=178.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..+.||+|+||.||++... +++.||||++.... ..+...+.+.++..+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 57888899999999999999976 78999999986431 112233445555567888899999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
.+..++||||+ ++.+..++... ...+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECC
T ss_pred CCcEEEEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEE
Confidence 99999999999 44555554321 12357889999999999999999995 7 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
||++........ .....+|+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 169 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------- 235 (318)
T 2dyl_A 169 FGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---------- 235 (318)
T ss_dssp CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred CCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----------
Confidence 999965433221 12346899999999984 457889999999999999999999998642210
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..++....+. .+........+.+|+.+||+.||++||+++|+++
T Consensus 236 ----~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 236 ----FEVLTKVLQEEPPL-LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----HHHHHHHHHSCCCC-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----HHHHHHHhccCCCC-CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01112222221111 1111123355778999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.34 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=188.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.+|+..+.||+|+||.||++++. +++.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~il~~l~hpniv~l~~~~~~ 118 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------RFKNRELQIMRKLDHCNIVRLRYFFYS 118 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------------TSCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------------hhHHHHHHHHHHcCCCCccceeeEEec
Confidence 35888899999999999999986 68999999885421 112369999999999999999998853
Q ss_pred C----C--eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC-C
Q 046311 538 R----N--ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-W 610 (768)
Q Consensus 538 ~----~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~-~ 610 (768)
. + ..++||||+++ +|.+++.........+++..+..++.||++||+|||+++ |+||||||+||||+.+ +
T Consensus 119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~ 194 (420)
T 1j1b_A 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTA 194 (420)
T ss_dssp EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTT
T ss_pred cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCC
Confidence 2 2 36789999986 676665432222344688899999999999999999998 9999999999999965 6
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
.+||+|||+++........ ....+|+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+.+.
T Consensus 195 ~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i 269 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEI 269 (420)
T ss_dssp EEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH
T ss_pred eEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 7899999999864332221 234689999999998754 79999999999999999999999997532110 01000
Q ss_pred cc--chhhhhhHHhhhccCC-----CCCC--c----chHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VV--PYIVRDEIHRVLDRNV-----PPPT--P----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~--~~~~~~~~~~~~~~~~-----~~~~--~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.. ..-..+.+.+ ++... +... + +.......+.+|+.+||+.||++||++.|+++
T Consensus 270 ~~~lg~p~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 270 IKVLGTPTREQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCHHHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCHHHHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 0000011111 11111 1000 0 01122456779999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.28 Aligned_cols=269 Identities=22% Similarity=0.260 Sum_probs=183.5
Q ss_pred HHHcCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 455 LEATNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 455 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
....++|++.+.||+|+||.||+++.. +++.||||++.... .....+.+|++.+..++||||+++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT------------TCCCHHHHHHHHHHHHCCTTBCCEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc------------cccHHHHHHHHHHHhcCCCCcccHHH
Confidence 345578999999999999999999975 68999999885431 11234667888889999999999999
Q ss_pred EEEcCCe-------eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEecCCCCCCe
Q 046311 534 FCEDRNE-------RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH--EYAVPSIIHRDIKSSNV 604 (768)
Q Consensus 534 ~~~~~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH--~~~~~~ivHrDiKp~NI 604 (768)
++..... .++||||+++ +|.+.+..........++..+..++.|++.+|.||| +++ |+||||||+||
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NI 162 (360)
T 3e3p_A 87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNV 162 (360)
T ss_dssp EEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGE
T ss_pred hhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHE
Confidence 9865433 7899999986 555444321122334678888999999999999999 877 99999999999
Q ss_pred EECC-CCcEEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 605 LLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 605 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
|++. ++.+||+|||++......... ....||+.|+|||++... .++.++||||||+++|||++|+.||.......
T Consensus 163 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 239 (360)
T 3e3p_A 163 LVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239 (360)
T ss_dssp EEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence 9986 899999999999865433322 234689999999998654 48999999999999999999999997532210
Q ss_pred cccccccccchhh--hhhHHhhhccCCC-------CCC-------cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 683 PRNVVDFVVPYIV--RDEIHRVLDRNVP-------PPT-------PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 683 ~~~~~~~~~~~~~--~~~~~~~~~~~~~-------~~~-------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.......... ..+....++.... ... ....+....+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 240 ---QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp ---HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 0000000100000 000 0011135668899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=364.54 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=202.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.++|++.+.||+|+||.||+|.+.. +..||||+++.. ..+...+.|.+|+.++++++||||+++++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----------TCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578889999999999999998742 456899986532 12344578999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++. ++..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|
T Consensus 459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vk 531 (656)
T 2j0j_A 459 VIT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 531 (656)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEE
T ss_pred EEe-cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEE
Confidence 985 456899999999999999997532 23688899999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++........ ......+|+.|+|||++....++.++||||||+++|||++ |..||......
T Consensus 532 L~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----------- 599 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------- 599 (656)
T ss_dssp ECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------
T ss_pred EEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----------
Confidence 9999999765433221 1123456789999999998899999999999999999997 98888643211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+....+......+ .....+..+.+|+.+||+.||++|||+.||++.|++++...
T Consensus 600 ----~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 600 ----DVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1111111111111 11123456779999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.16 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=197.9
Q ss_pred CCCCcCceeccCCceEEEEEEE-c-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC------Ccee
Q 046311 459 NNFSEDHKIGSGSFGAVYKATL-D-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK------NLVR 530 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~-~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~ 530 (768)
++|++.+.||+|+||.||++.. + +++.||||+++.. ......+.+|+++++.++|+ ++++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------------CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 5799999999999999999986 3 6889999987532 23456788899998888665 4999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-- 608 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-- 608 (768)
+++++.+.+..++||||+ +++|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSD 155 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCC
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccc
Confidence 999999999999999999 8899999975432 23578899999999999999999998 999999999999987
Q ss_pred -----------------CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC
Q 046311 609 -----------------TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 609 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG 671 (768)
++.+||+|||++....... ....||+.|+|||++....++.++||||||+++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 6689999999997643322 134689999999999988999999999999999999999
Q ss_pred CcccccCCCCCccccccccc---ch-----------------------hhhhhHHhhhccCCCCCCcchHHHHHHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVV---PY-----------------------IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLA 725 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~---~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li 725 (768)
+.||................ +. .......+... ...............+.+|+
T Consensus 231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHH
Confidence 99996432211000000000 00 00000000000 00000111224467788999
Q ss_pred HHcccccCCCCCCHHHHHHH
Q 046311 726 ADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 726 ~~Cl~~dP~~RPs~~evl~~ 745 (768)
.+||+.||++|||+.|+++.
T Consensus 310 ~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhCcCcccccCHHHHhcC
Confidence 99999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.48 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=196.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--------CCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--------HKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv 529 (768)
++|++.++||+|+||+||+++.. +++.||||+++.. ......+.+|++++++++ |+||+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------------EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------------CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 67999999999999999999865 6889999998532 234567889999999985 78899
Q ss_pred eEEEEEE----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCe
Q 046311 530 RLLGFCE----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNV 604 (768)
Q Consensus 530 ~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NI 604 (768)
++++++. +....++||||+ +++|.+++.... ...+++..++.++.||++||+|||++ + |+||||||+||
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NI 178 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENI 178 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGE
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHe
Confidence 9999987 556889999999 556666664322 13368899999999999999999998 7 99999999999
Q ss_pred EECCCC-------------------------------------------------cEEEeeccccccCCCCCCccccccc
Q 046311 605 LLDATW-------------------------------------------------TAKVSDFGLSLIGPEDDESHLSLRA 635 (768)
Q Consensus 605 Ll~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~ 635 (768)
||+.++ .+||+|||++....... ...
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~ 253 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TED 253 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSC
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccC
Confidence 999775 79999999997643321 234
Q ss_pred ccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc---cch--------hhhhh-HHhhh
Q 046311 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV---VPY--------IVRDE-IHRVL 703 (768)
Q Consensus 636 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~---~~~--------~~~~~-~~~~~ 703 (768)
.||+.|+|||++....++.++||||||++||||+||+.||............+.. ... +.... ....+
T Consensus 254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 6899999999999889999999999999999999999999754332211000000 000 00000 00000
Q ss_pred ccC-----CCC------------CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 704 DRN-----VPP------------PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 704 ~~~-----~~~------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... ... ......+....+.+|+.+||+.||++|||++|+++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 000 01123456678889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.49 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=194.9
Q ss_pred cCCCCcCceeccCCceEEEEEEE--cCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATL--DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLL 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~--~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~ 532 (768)
.++|++.+.||+|+||.||+++. .+++.||||++...... ......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---------EGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---------TSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc---------ccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 46899999999999999999997 36789999998754221 11122455676666655 899999999
Q ss_pred EEEE-----cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 533 GFCE-----DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 533 ~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+++. .....++||||++ ++|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~ 154 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT 154 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEc
Confidence 9987 5567899999998 599999975432 23688899999999999999999998 99999999999999
Q ss_pred CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc
Q 046311 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 687 (768)
.++.+||+|||++....... ......+|+.|+|||++....++.++||||||+++|||++|+.||....... ..
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~ 228 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QL 228 (326)
T ss_dssp TTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred CCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HH
Confidence 99999999999997543221 1223468999999999998899999999999999999999999986432110 00
Q ss_pred ccccchhh---hhhH-------Hhhhcc-CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 688 DFVVPYIV---RDEI-------HRVLDR-NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 688 ~~~~~~~~---~~~~-------~~~~~~-~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
........ .... ...+.. ...+...........+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0000 000000 000000111123456778999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.47 Aligned_cols=261 Identities=19% Similarity=0.274 Sum_probs=195.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|...+.||+|+||.||++... +++.||||++... ...+...+.+.+|+.++++++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---------ccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 357889999999999999999875 6899999998542 122344567899999999999999999999998
Q ss_pred cCCe------eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRNE------RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
.... .++||||++ ++|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~ 163 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDC 163 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTC
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCC
Confidence 7654 499999997 599888843 2688899999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
.+||+|||++....... ....+|+.|+|||++.. ..++.++||||||+++|||++|+.||....... ....
T Consensus 164 ~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~ 235 (353)
T 3coi_A 164 ELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQ 235 (353)
T ss_dssp CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHH
T ss_pred cEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 99999999997543221 23468999999999876 678999999999999999999999997532110 0000
Q ss_pred cc-----------chhhhhhHHhhhcc---CCC-CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 VV-----------PYIVRDEIHRVLDR---NVP-PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 ~~-----------~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. ..+........++. ... ............+.+|+.+||+.||++|||++|+++.
T Consensus 236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000000111110 000 0001112334667899999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.96 Aligned_cols=268 Identities=19% Similarity=0.321 Sum_probs=190.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|+..+.||+|+||.||++... +++.||||++... .....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----------DPQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----------ChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 367999999999999999999976 5899999988642 2345578899999999999999999999874
Q ss_pred --------------cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 537 --------------DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 537 --------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+....++||||++ ++|.+++.. ..+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 149 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 3467899999998 599999964 23578889999999999999999998 999999999
Q ss_pred CeEEC-CCCcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCC
Q 046311 603 NVLLD-ATWTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTH 679 (768)
Q Consensus 603 NILl~-~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~ 679 (768)
|||++ +++.+||+|||++........ ........+|..|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99997 577999999999976432211 111223457999999998865 678999999999999999999999997532
Q ss_pred CCCcccccccccchhhhhhHHhhhc-------cCCC-CCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 680 NGTPRNVVDFVVPYIVRDEIHRVLD-------RNVP-PPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
............+....+...+... .... +..+ ........+.+|+.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 2100000000000000000111000 0000 0000 011234667899999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.51 Aligned_cols=269 Identities=22% Similarity=0.281 Sum_probs=197.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||.||+++.. +++.||||++... ........+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------DKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 467899999999999999999976 6899999998532 12344567889999999999999999999876
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~ 150 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCD 150 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCC
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCc
Confidence 54 67899999997 599999864 23688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcc--------cccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCC
Q 046311 612 AKVSDFGLSLIGPEDDESH--------LSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGT 682 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~ 682 (768)
+||+|||++.......... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......
T Consensus 151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 230 (353)
T 2b9h_A 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230 (353)
T ss_dssp EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999997544222110 1123468999999998764 678999999999999999999999996432110
Q ss_pred cccc-c--------ccccchhhhhhHHhhhccCCC-CCCc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 683 PRNV-V--------DFVVPYIVRDEIHRVLDRNVP-PPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 683 ~~~~-~--------~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.... . +............+.+..... +... ........+.+|+.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 000000000111111111000 0000 001234567799999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=344.20 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=185.7
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 537 (768)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------------FCDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------------HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 345566889999999998777778999999987532 234578899999876 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC------
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPL---KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA------ 608 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~---~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~------ 608 (768)
.+..++||||++ |+|.+++......... ..+..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHS
T ss_pred CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccc
Confidence 999999999996 6999999765332211 123345789999999999999998 999999999999965
Q ss_pred -------CCcEEEeeccccccCCCCCCcc--cccccccccCccCcccccc-------CCCCChhhHHHHHHHHHHHHc-C
Q 046311 609 -------TWTAKVSDFGLSLIGPEDDESH--LSLRAAGTVGYMDPEYYRL-------QQLTEKSDVYSFGVVLLEILS-G 671 (768)
Q Consensus 609 -------~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~ellt-G 671 (768)
++.+||+|||++.......... ......||+.|+|||++.. ..++.++||||||+++|||+| |
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 4589999999998654332211 1123469999999999865 578999999999999999999 8
Q ss_pred CcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+.||....... .......... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~Pf~~~~~~~-------------~~i~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 237 KHPFGDKYSRE-------------SNIIRGIFSL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCTTCSTTTHH-------------HHHHHTCCCC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCchhhH-------------HHHhcCCCCc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99986432100 0000001110 01111223456677889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.27 Aligned_cols=201 Identities=23% Similarity=0.338 Sum_probs=152.2
Q ss_pred CCc-CceeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 461 FSE-DHKIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 461 ~~~-~~~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
|++ .++||+|+||.||+++.+ +++.||||++... .....+.+|+++|++++||||+++++++.
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-------------GISMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-------------SCCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-------------CCCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 544 468999999999999865 5789999987532 12246789999999999999999999995
Q ss_pred c--CCeeEEEEEeccCCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE---
Q 046311 537 D--RNERVLIYEYLENGTLHDHLHNPQ-----SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL--- 606 (768)
Q Consensus 537 ~--~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl--- 606 (768)
. ....++||||+++ +|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~ 164 (405)
T 3rgf_A 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE 164 (405)
T ss_dssp ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCS
T ss_pred cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecC
Confidence 4 6789999999975 8888775211 12223688899999999999999999998 9999999999999
Q ss_pred -CCCCcEEEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 607 -DATWTAKVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 607 -~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
+.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp STTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 6788999999999976543211 112224578999999999876 45899999999999999999999999643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.60 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=176.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHH-HHhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE-SLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~ 536 (768)
++|+..+.||+|+||.||++... +++.||||++.... ......++.+|+. +++.++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 57888999999999999999975 78999999986431 1233445666666 777889999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQ-SSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+..++||||+++ +|.+++.... .....+++..+.+++.|+++||.|||+. + |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence 99999999999985 8888775210 1123468889999999999999999998 8 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCcccc----ccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYY----RLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+|||++........ .....||+.|+|||++ ....++.++||||||+++|||++|+.||....... +
T Consensus 168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-- 237 (327)
T 3aln_A 168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----D-- 237 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----H--
Confidence 99999975433221 1233689999999998 45678999999999999999999999986432110 0
Q ss_pred cchhhhhhHHhhhccCCCC-CCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPP-PTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+...+....+. ...........+.+|+.+||+.||++||++.|+++
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 -------QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111111110 00111123456779999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=333.42 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=170.7
Q ss_pred cCCCCcCc-eeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 046311 458 TNNFSEDH-KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFC 535 (768)
Q Consensus 458 ~~~~~~~~-~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 535 (768)
.++|.+.+ .||+|+||.||++... +++.||||++... . ....+....++.++||||+++++++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~---~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------------P---KARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------------H---HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------------H---HHHHHHHHHHHhcCCCChHHHHHHH
Confidence 35777754 6999999999999876 6899999998532 1 1112223345667999999999998
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--- 608 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--- 608 (768)
.. ....++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~ 166 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEK 166 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSST
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCC
Confidence 76 4458999999999999999976432 34688999999999999999999998 999999999999976
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
++.+||+|||++........ ....+|+.|+|||++....++.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 239 (336)
T 3fhr_A 167 DAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--- 239 (336)
T ss_dssp TCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred CceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---
Confidence 45599999999975433221 23468999999999988889999999999999999999999996543221100
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.....+.......+.+........+.+|+.+||+.||++|||++|+++.
T Consensus 240 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 240 --------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000011111111111112234567799999999999999999999983
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.22 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=189.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.+|+..++||+|+||.||+++...+..+|+|++..... ...+|+++++.++||||+++++++...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---------------~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---------------FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---------------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 46889999999999999999988777799998754211 112699999999999999999998554
Q ss_pred C------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCc
Q 046311 539 N------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWT 611 (768)
Q Consensus 539 ~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~ 611 (768)
. ..++||||++++ |.+.+.........+++..+..++.|+++||+|||+++ |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCc
Confidence 3 378999999874 43333211112234688889999999999999999998 99999999999998 7999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||+++........ ....+|+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+....
T Consensus 181 ~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~ 255 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEII 255 (394)
T ss_dssp EEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 999999999765333221 234689999999998654 58999999999999999999999997532110 000000
Q ss_pred cchh---hhhhH----HhhhccCCCCCC--c----chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 691 VPYI---VRDEI----HRVLDRNVPPPT--P----FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 691 ~~~~---~~~~~----~~~~~~~~~~~~--~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
... ..+.+ ........+... + ........+.+|+.+||+.||++|||+.|+++.
T Consensus 256 -~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 256 -KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp -HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 00000 001111111110 0 011134567899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.59 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-----------CC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-----------HK 526 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------Hp 526 (768)
++|++.+.||+|+||.||+++.. +++.||||++... ......+.+|++++++++ ||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------------ccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 57899999999999999999874 7899999987532 234466888999988886 89
Q ss_pred CceeEEEEEEcCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCC
Q 046311 527 NLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKS 601 (768)
Q Consensus 527 nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp 601 (768)
||+++++++...+ ..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp 160 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKP 160 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSG
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCh
Confidence 9999999987654 789999999 8899999975332 2368889999999999999999998 8 99999999
Q ss_pred CCeEE------CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 602 SNVLL------DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 602 ~NILl------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
+|||+ +.++.+||+|||++....... ....+|+.|+|||++.+..++.++||||||+++|||+||+.||
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred HHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99999 445589999999997643221 2346899999999999889999999999999999999999999
Q ss_pred ccCCCCCccccccccc---------chhh--hh----------------------hHHhhhccCCCCCCcchHHHHHHHH
Q 046311 676 HRTHNGTPRNVVDFVV---------PYIV--RD----------------------EIHRVLDRNVPPPTPFEIEAVAYVG 722 (768)
Q Consensus 676 ~~~~~~~~~~~~~~~~---------~~~~--~~----------------------~~~~~~~~~~~~~~~~~~~~~~~l~ 722 (768)
............+... +... .. .....+... ..........+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 311 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK----YKFSKDEAKEIS 311 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT----TCCCHHHHHHHH
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc----ccCCcchHHHHH
Confidence 7543221100000000 0000 00 000000000 112345677888
Q ss_pred HHHHHcccccCCCCCCHHHHHHH--HHHHHh
Q 046311 723 YLAADCVTLEGRNRPSMTEIVNS--LERALA 751 (768)
Q Consensus 723 ~Li~~Cl~~dP~~RPs~~evl~~--L~~~l~ 751 (768)
+|+.+||+.||++|||++|+++. +++.+.
T Consensus 312 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 99999999999999999999883 555443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.24 Aligned_cols=200 Identities=28% Similarity=0.274 Sum_probs=166.8
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CC-----Ccee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HK-----NLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~ 530 (768)
.++|++.+.||+|+||+||++... +++.||||+++.. .....++.+|+++++.++ |+ +|++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------------KAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------------HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 468999999999999999999876 6789999998532 223456778888888774 55 4999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC--C
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--A 608 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--~ 608 (768)
+++++...+..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||.+. .+|+||||||+||||+ .
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTT
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCC
Confidence 9999999999999999996 499999975432 23688999999999999999999532 2399999999999994 5
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
++.+||+|||+++...... ....+|+.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 197 ~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7889999999997653321 2346899999999999889999999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.90 Aligned_cols=238 Identities=15% Similarity=0.117 Sum_probs=184.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.. +++.||||++.... ...+...+.|.+|+..+.+++||||+++++++.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG--------VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC--------CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc--------ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 57899999999999999999976 58999999986431 1123455789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++++|.++++.. ......++++.|+++||+|||+++ |+||||||+|||++.++.+||+++
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred CCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence 99999999999999999999542 244567889999999999999998 999999999999999999999744
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+ |++| ++.++||||||++||||+||+.||........... ...
T Consensus 174 ~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~----- 216 (286)
T 3uqc_A 174 A----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AER----- 216 (286)
T ss_dssp C----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCB-----
T ss_pred c----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHH-----
Confidence 2 4443 68899999999999999999999975433211100 000
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
.+..............+..+.+|+.+||+.||++| |+.|+++.|+++......
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 217 ----DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp ----CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred ----HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 00000000000111234557799999999999999 999999999998876553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=328.27 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=187.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC----CCCCceeEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL----HHKNLVRLL 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~HpnIv~l~ 532 (768)
.++|++.+.||+|+||.||+++.. +++.||||++........ ........+.+|+.++.++ +||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW-----SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-------------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc-----ccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 468999999999999999999864 688999999865422110 0111223456788888888 899999999
Q ss_pred EEEEcCCeeEEEEEe-ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCC
Q 046311 533 GFCEDRNERVLIYEY-LENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATW 610 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~ 610 (768)
+++.+.+..++|||| +.+++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 999999999999999 7899999999753 23688999999999999999999998 99999999999998 889
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCC-ChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLT-EKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 689 (768)
.+||+|||++........ ....+|+.|+|||++....+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred eEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence 999999999976543322 234689999999998876664 58999999999999999999985321
Q ss_pred ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+..+.....+. .....+.+|+.+||+.||++|||++|+++
T Consensus 244 -----------~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -----------EILEAELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----------HHHHTCCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------HHhhhccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111111 12345678999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.21 Aligned_cols=262 Identities=19% Similarity=0.274 Sum_probs=194.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CC-CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC------cee
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DG-SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN------LVR 530 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g-~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~ 530 (768)
++|++.+.||+|+||.||++... ++ +.||||+++.. ......+.+|++++++++|++ ++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------------GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------------ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 57999999999999999999875 34 68999998532 234567888999999887665 999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE----
Q 046311 531 LLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL---- 606 (768)
Q Consensus 531 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl---- 606 (768)
+++++...+..++||||+ +++|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSE 160 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCC
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccc
Confidence 999999999999999999 567777775432 123688999999999999999999998 9999999999999
Q ss_pred ---------------CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC
Q 046311 607 ---------------DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 607 ---------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG 671 (768)
+.++.+||+|||++....... ....||+.|+|||++....++.++||||||+++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 567899999999997643322 234689999999999988999999999999999999999
Q ss_pred CcccccCCCCCcccccccc---cchhh-----------------------hhhHHhhhccCCCCCCcchHHHHHHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFV---VPYIV-----------------------RDEIHRVLDRNVPPPTPFEIEAVAYVGYLA 725 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li 725 (768)
+.||............... .+... ........ ................+.+|+
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC-KPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC-CcccccccccchhHHHHHHHH
Confidence 9999753221100000000 00000 00000000 000000011223456788999
Q ss_pred HHcccccCCCCCCHHHHHH
Q 046311 726 ADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 726 ~~Cl~~dP~~RPs~~evl~ 744 (768)
.+||+.||++|||++|+++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHhcCChhhCcCHHHHhc
Confidence 9999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.48 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=183.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 537 (768)
.+|...++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--------------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--------------FSFADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--------------EEECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--------------HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 4588889999999999766556678999999985321 11245799999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-----CCcE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-----TWTA 612 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-----~~~~ 612 (768)
....++||||++ |+|.+++...... ......+.++.||++||+|||+++ |+||||||+|||++. ...+
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCE
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeE
Confidence 999999999996 5999999764422 223345789999999999999998 999999999999953 3468
Q ss_pred EEeeccccccCCCCCC-cccccccccccCccCccccc---cCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCccccc
Q 046311 613 KVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYR---LQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVV 687 (768)
Q Consensus 613 kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~ 687 (768)
||+|||+++....... ........||+.|+|||++. ...++.++||||||+++|||++ |+.||......
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------ 236 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------ 236 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------
Confidence 8999999976543221 11223456999999999997 4567889999999999999999 88888532210
Q ss_pred ccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.....+.................+.+|+.+||+.||++|||++|+++
T Consensus 237 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 ----------QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----------HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111111111111112234455779999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.19 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=195.9
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGF 534 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~ 534 (768)
.++|++.+.||+|+||.||++... +++.||||+++........ .......+.+|+.++++++ ||||++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-----ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEE-----ECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhh-----hhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 467999999999999999999864 6899999998765322111 0112234667999999996 5999999999
Q ss_pred EEcCCeeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCcE
Q 046311 535 CEDRNERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTA 612 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~~ 612 (768)
+.+.+..++|||++.+ ++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 8999999652 23578889999999999999999998 99999999999998 78999
Q ss_pred EEeeccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 613 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
||+|||++........ ....||+.|+|||++....+ +.++||||||+++|||++|+.||....
T Consensus 190 kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------ 253 (320)
T 3a99_A 190 KLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 253 (320)
T ss_dssp EECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------
Confidence 9999999976543221 23468999999999887665 688999999999999999999985321
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
........... .....+.+|+.+||+.||++|||++|+++.
T Consensus 254 ---------~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ---------EIIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------HHHHCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------hhhcccccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111111 123456789999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=349.52 Aligned_cols=274 Identities=22% Similarity=0.333 Sum_probs=205.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||++... +++.||||++... ........|.+|++++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 57999999999999999999874 6899999987532 123456779999999999999999999998765
Q ss_pred ------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 538 ------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 538 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.+..++||||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~-~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC-CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT-TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSS
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCC
Confidence 66789999999999999999764432 23577888999999999999999998 999999999999987654
Q ss_pred ---EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 612 ---AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 612 ---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
+||+|||++......... ....||+.|+|||++....++.++||||||+++|||++|+.||...... ..
T Consensus 160 ~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~ 231 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQ 231 (676)
T ss_dssp SCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HH
T ss_pred ceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hh
Confidence 999999999765433221 2346899999999999999999999999999999999999999643110 00
Q ss_pred cccchhhh--------hhH--HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHH-----HHHHHHHHHhhc
Q 046311 689 FVVPYIVR--------DEI--HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE-----IVNSLERALAAC 753 (768)
Q Consensus 689 ~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e-----vl~~L~~~l~~~ 753 (768)
|....... +.. ...+....+.+..........+.+|+.+||+.||++|||++| ..+.+++++...
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000000 000 001111222222333445677889999999999999999998 667788888654
Q ss_pred c
Q 046311 754 L 754 (768)
Q Consensus 754 ~ 754 (768)
.
T Consensus 312 i 312 (676)
T 3qa8_A 312 L 312 (676)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=354.05 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=193.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc--CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||.||++.+. +++.||||++... ........|.+|++++++++||||+++++++.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----------GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----------CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 57999999999999999999875 5899999987532 12344567899999999999999999999998
Q ss_pred cCCe-----eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DRNE-----RVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
..+. .||||||+++++|.+++.. .+++..++.++.||+++|+|||+++ |+||||||+|||++.+ .
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~ 219 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-Q 219 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-C
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-c
Confidence 7665 6999999999999988753 3689999999999999999999998 9999999999999986 9
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+||+|||+++..... ....||+.|+|||++... ++.++||||||++||||++|..|+.......
T Consensus 220 ~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------- 283 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------- 283 (681)
T ss_dssp EEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------
T ss_pred EEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------
Confidence 999999999765432 234689999999998754 4899999999999999999988875321100
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-CHHHHHHHHHHHHh
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-SMTEIVNSLERALA 751 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~~l~ 751 (768)
++ ...........+.+|+.+||+.||++|| +++++...|..++.
T Consensus 284 ---------------~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ---------------LP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---------------CC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---------------cc-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 0111122345677999999999999999 57777777777654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.42 Aligned_cols=231 Identities=22% Similarity=0.316 Sum_probs=175.9
Q ss_pred CCCCcC-ceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHH-hcCCCCCceeEEEEE
Q 046311 459 NNFSED-HKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESL-SRLHHKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~ 535 (768)
++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|++++ +.++||||+++++++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------------PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------------HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 456666 77999999999999874 7899999987531 3467788887 566999999999998
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--- 608 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--- 608 (768)
.. ....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCC
Confidence 76 6678999999999999999976432 24688999999999999999999998 999999999999998
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
++.+||+|||++.... ...++.++||||||+++|||++|+.||...........
T Consensus 156 ~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-- 209 (299)
T 3m2w_A 156 NAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-- 209 (299)
T ss_dssp TCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--
T ss_pred CCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--
Confidence 7899999999985422 13467899999999999999999999965332110000
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.. ..........+..........+.+|+.+||+.||++|||+.|+++.
T Consensus 210 -~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 -MK--------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -SC--------CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HH--------HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0000000111101111234667899999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=325.92 Aligned_cols=245 Identities=16% Similarity=0.178 Sum_probs=175.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCc--------
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNL-------- 528 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnI-------- 528 (768)
.+|...+.||+|+||.||+|++. +++.||||++..... ......+.|.+|+.+++.++| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--------~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--------ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 34777889999999999999954 789999998863321 122335679999999999987 221
Q ss_pred -e------------eEEEEEEc-----CCeeEEEEEeccCCChhhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046311 529 -V------------RLLGFCED-----RNERVLIYEYLENGTLHDHLHNP---QSSSPLKSWPARIKVALDAARGIEYLH 587 (768)
Q Consensus 529 -v------------~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~~~~ia~~ia~gL~yLH 587 (768)
+ .++.++.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1 11111111 12456777765 67999988411 112233567788999999999999999
Q ss_pred hCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCcccc----------ccCCCCChhh
Q 046311 588 EYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYY----------RLQQLTEKSD 657 (768)
Q Consensus 588 ~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~~sD 657 (768)
+++ |+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|
T Consensus 229 ~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 229 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred hCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 998 999999999999999999999999998754322 223467 999999999 5556888999
Q ss_pred HHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC
Q 046311 658 VYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737 (768)
Q Consensus 658 VwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 737 (768)
|||||++||||+||+.||....... .. ..++.... ..+..+.+|+.+||+.||++||
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~---~~------------~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALG---GS------------EWIFRSCK--------NIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGS---CS------------GGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhh---hH------------HHHHhhcc--------cCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999999996432211 10 11111111 1124577899999999999999
Q ss_pred CHHHHHH
Q 046311 738 SMTEIVN 744 (768)
Q Consensus 738 s~~evl~ 744 (768)
++.|+++
T Consensus 357 t~~~~l~ 363 (413)
T 3dzo_A 357 LPLQAME 363 (413)
T ss_dssp CHHHHTT
T ss_pred CHHHHHh
Confidence 9877743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.32 Aligned_cols=249 Identities=16% Similarity=0.216 Sum_probs=185.2
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---------CCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---------HKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------HpnIv 529 (768)
++|++.++||+|+||+||+++. +++.||||++........ ........+.+.+|+++++.++ ||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV---NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCB---TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCcccc---ccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4578889999999999999988 589999999976532110 0112233467888888888875 88888
Q ss_pred eEEEEEE------------------------------cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 046311 530 RLLGFCE------------------------------DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579 (768)
Q Consensus 530 ~l~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~i 579 (768)
++.+.+. +.+..+|||||+++|+|.+.+.+ ..+++..+..++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 8877643 26789999999999987777743 235889999999999
Q ss_pred HHHHHHHh-hCCCCCeEecCCCCCCeEECCCC--------------------cEEEeeccccccCCCCCCcccccccccc
Q 046311 580 ARGIEYLH-EYAVPSIIHRDIKSSNVLLDATW--------------------TAKVSDFGLSLIGPEDDESHLSLRAAGT 638 (768)
Q Consensus 580 a~gL~yLH-~~~~~~ivHrDiKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt 638 (768)
+.||+||| +++ |+||||||+||||+.++ .+||+|||+++..... ...||
T Consensus 171 ~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred HHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence 99999999 888 99999999999999887 8999999999754321 23689
Q ss_pred cCccCccccccCCCCChhhHHHHHHH-HHHHHcCCcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHH
Q 046311 639 VGYMDPEYYRLQQLTEKSDVYSFGVV-LLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEA 717 (768)
Q Consensus 639 ~~y~aPE~l~~~~~s~~sDVwSlGvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (768)
+.|+|||++.+.. +.++|||||+++ .+++++|..||.... |. . ...+.+..................
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WL-H-YLTDKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HH-H-HHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hh-h-HHHHhhhhhhccCcccchhhhhhc
Confidence 9999999998665 889999998777 778899988874210 00 0 001111111111112222334567
Q ss_pred HHHHHHHHHHcccccCCCCCCHHHHH
Q 046311 718 VAYVGYLAADCVTLEGRNRPSMTEIV 743 (768)
Q Consensus 718 ~~~l~~Li~~Cl~~dP~~RPs~~evl 743 (768)
+..+.+|+.+||+.| |++|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 788999999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-30 Score=294.62 Aligned_cols=196 Identities=17% Similarity=0.114 Sum_probs=134.1
Q ss_pred eeccCCceEEEEEE-EcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEcCCeeEE
Q 046311 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGFCEDRNERVL 543 (768)
Q Consensus 466 ~LG~G~fG~Vy~~~-~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 543 (768)
.++.|.+|.+..++ ..-|+.+++|.+........ ....+.+...++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGI-LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTC-SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEeccccccc-chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 35667777666654 23589999999875432211 11123344557899999999999 79999999999999999999
Q ss_pred EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 544 IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 544 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
||||++|++|.++|.... .++. .+|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+..
T Consensus 320 VMEyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999997642 2233 358899999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 624 PEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
...... .....||+.|||||++.+ .+..++|+|++|+++++|.++..++
T Consensus 390 ~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 433221 224579999999999975 5678899999999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=265.00 Aligned_cols=193 Identities=16% Similarity=0.214 Sum_probs=146.1
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
...+.||+|+||.||+++.. ++.+++|+........ .........++|.+|++++++++||||+++..++...+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~---~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRD---ERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK 414 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSC---HHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccc---hhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence 34578999999999999544 7899999875432110 0111122346789999999999999999666666677788
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+|||||+++++|.++++. ++.++.|++++|+|||+++ |+||||||+|||++. ++||+|||+++
T Consensus 415 ~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp EEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCE
Confidence 999999999999999964 3589999999999999998 999999999999998 99999999998
Q ss_pred cCCCCCCcc-----cccccccccCccCcccccc--CCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 622 IGPEDDESH-----LSLRAAGTVGYMDPEYYRL--QQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 622 ~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
......... ......||+.|||||++.. ..|+..+|+|+..+-.++.+..+.+|
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 764432211 1124579999999999986 56888899999998888888776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.8e-23 Score=214.42 Aligned_cols=162 Identities=16% Similarity=0.124 Sum_probs=121.9
Q ss_pred HHHHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccch--------hhHHHHHHHHHHHhcC
Q 046311 452 EILLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQE--------DKDNAFINELESLSRL 523 (768)
Q Consensus 452 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l 523 (768)
..+......|.+.+.||+|+||.||++...+++.||||.++.......... ...+ .....+.+|+++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~-~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVK-EKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCC-C-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhh-hhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344444556777899999999999999987799999999864321110000 0000 2356799999999999
Q ss_pred CCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 524 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
+| +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||+|||+++ |+||||||+|
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 95 445554433 45699999999999999 521 123479999999999999998 9999999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccc
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYR 648 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 648 (768)
||++ ++.+||+|||+++. +..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999862 44578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.4e-18 Score=175.85 Aligned_cols=147 Identities=20% Similarity=0.208 Sum_probs=106.7
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCCe--EEEEEEeeccCcc-----cccc--------cccchhhHHHHHHHHHHHhcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATL-DDGSQ--VAVKRAEISSTSS-----YAIG--------TKRQEDKDNAFINELESLSRL 523 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~--vaVK~~~~~~~~~-----~~~~--------~~~~~~~~~~~~~E~~~l~~l 523 (768)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... +... ..........+.+|++.|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 67888 9999875432100 0000 000112234688999999999
Q ss_pred CCCCc--eeEEEEEEcCCeeEEEEEeccC-C----ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeE
Q 046311 524 HHKNL--VRLLGFCEDRNERVLIYEYLEN-G----TLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLH-EYAVPSII 595 (768)
Q Consensus 524 ~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH-~~~~~~iv 595 (768)
+|+++ ..++.+ ...+|||||+.+ | +|.+++.. .++.....++.|++.+|.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88754 444442 356899999942 4 66665432 123345789999999999999 887 99
Q ss_pred ecCCCCCCeEECCCCcEEEeecccccc
Q 046311 596 HRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 596 HrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
||||||+|||++. .++|+|||++..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.6e-16 Score=167.57 Aligned_cols=147 Identities=16% Similarity=0.208 Sum_probs=103.2
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccccccc---chhh--------HHHHHHHHHHHhcCCCCC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKR---QEDK--------DNAFINELESLSRLHHKN 527 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~---~~~~--------~~~~~~E~~~l~~l~Hpn 527 (768)
.-|++.++||+|+||.||+|...+|+.||||+++........+...+ .... .....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988999999999864321100000000 0000 111245777777775554
Q ss_pred ce--eEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeE
Q 046311 528 LV--RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVL 605 (768)
Q Consensus 528 Iv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NIL 605 (768)
+. ..+++ . ..+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||||||.|||
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 32 22322 2 23799999999998776532 112467899999999999998 999999999999
Q ss_pred ECCCC----------cEEEeecccccc
Q 046311 606 LDATW----------TAKVSDFGLSLI 622 (768)
Q Consensus 606 l~~~~----------~~kl~DFGla~~ 622 (768)
+++++ .+.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 98776 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.8e-11 Score=123.40 Aligned_cols=143 Identities=15% Similarity=0.106 Sum_probs=110.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
...|+....++.|+.+.||+.... ++.+++|+...... .....+.+|+++++.+. |..+.++++++.
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-----------~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 80 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-----------GTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-----------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-----------CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence 356777788898999999999755 68999998753210 11234788999999884 677889999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA-------------------------- 590 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~-------------------------- 590 (768)
+.+..|+||||++|.+|.+.+.. ......++.++++.|..||+..
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred cCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 88899999999999999886421 1122477889999999999821
Q ss_pred ------------------------------CCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 591 ------------------------------VPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 591 ------------------------------~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=118.99 Aligned_cols=128 Identities=16% Similarity=0.105 Sum_probs=95.6
Q ss_pred ccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC--ceeEEEEEEcCCeeEEEE
Q 046311 468 GSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN--LVRLLGFCEDRNERVLIY 545 (768)
Q Consensus 468 G~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~ 545 (768)
+.|..+.||+....+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--------------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--------------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--------------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 456669999998777888999986421 1134678888888885444 556888888888899999
Q ss_pred EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 046311 546 EYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA----------------------------------- 590 (768)
Q Consensus 546 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~----------------------------------- 590 (768)
||++|.+|. ... .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999998884 211 11 1356778888888888743
Q ss_pred --------------------CCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 591 --------------------VPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 591 --------------------~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.5e-09 Score=115.91 Aligned_cols=144 Identities=22% Similarity=0.315 Sum_probs=105.8
Q ss_pred cCceeccCCceEEEEEEEcCCCeEEEEEEe--eccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEEEEcC
Q 046311 463 EDHKIGSGSFGAVYKATLDDGSQVAVKRAE--ISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGFCEDR 538 (768)
Q Consensus 463 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~--~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~ 538 (768)
..+.|+.|.++.||+.+.. +..+++|+.. ... .......+.+|+++++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~----------~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK----------LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC--------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC----------CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 4578999999999999876 4678888654 211 0012346778999999886 45678899888776
Q ss_pred ---CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------
Q 046311 539 ---NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA------------------------- 590 (768)
Q Consensus 539 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~------------------------- 590 (768)
+..++||||++|..|.+... ..++...+..++.++++.|+.||+..
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 45899999999988755221 12466777889999999999999731
Q ss_pred ------------------------------CCCeEecCCCCCCeEECCCCc--EEEeeccccccC
Q 046311 591 ------------------------------VPSIIHRDIKSSNVLLDATWT--AKVSDFGLSLIG 623 (768)
Q Consensus 591 ------------------------------~~~ivHrDiKp~NILl~~~~~--~kl~DFGla~~~ 623 (768)
.+.++|+|+++.|||++.++. +.|+||+.+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.4e-09 Score=113.33 Aligned_cols=187 Identities=19% Similarity=0.210 Sum_probs=119.4
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCC--ceeEEEEEEcCC-
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKN--LVRLLGFCEDRN- 539 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpn--Iv~l~~~~~~~~- 539 (768)
.+.++.|.+..||+.. ..+++|+... ......+.+|.++|+.+ ++.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~ 87 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET 87 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-------------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC
Confidence 4668999999999873 5788887431 12346788999999887 3333 344554443333
Q ss_pred --eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------
Q 046311 540 --ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA--------------------------- 590 (768)
Q Consensus 540 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~--------------------------- 590 (768)
..|+|||+++|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 88 ~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 88 YQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp CSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred CCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 3478999999988875332 11345566777788888888887511
Q ss_pred ----------------------------CCCeEecCCCCCCeEECC--CCcEEEeeccccccCCCCCCcccccc------
Q 046311 591 ----------------------------VPSIIHRDIKSSNVLLDA--TWTAKVSDFGLSLIGPEDDESHLSLR------ 634 (768)
Q Consensus 591 ----------------------------~~~ivHrDiKp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~------ 634 (768)
.+.++|+|++|.|||+++ +..+.|+||+.+..............
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~ 241 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYG 241 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCC
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccC
Confidence 145899999999999988 45678999999865432211000000
Q ss_pred ------cccccCccC-ccccccCCCCChhhHHHHHHHHHHHHcCCccc
Q 046311 635 ------AAGTVGYMD-PEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI 675 (768)
Q Consensus 635 ------~~gt~~y~a-PE~l~~~~~s~~sDVwSlGvll~elltG~~p~ 675 (768)
.....++.. ||... ......+.|+++.++|++.+|..++
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000001112 22221 1122368999999999999997765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2e-06 Score=88.80 Aligned_cols=135 Identities=16% Similarity=0.163 Sum_probs=96.4
Q ss_pred ceeccCCce-EEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEcCCee
Q 046311 465 HKIGSGSFG-AVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG-~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 541 (768)
+.+..|..+ .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+.+++.++.+.+..
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG--------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET--------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC--------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 345556555 68998765 467889997542 23456788999988874 33467788999999999
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA------------------------------- 590 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~------------------------------- 590 (768)
++|||++++.++.+.... .......+..++++.|..||+..
T Consensus 96 ~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF 167 (272)
T ss_dssp EEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred EEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence 999999999888775532 11122355666667777777421
Q ss_pred ------------------------CCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 591 ------------------------VPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 591 ------------------------~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999987777799998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=5.4e-06 Score=87.49 Aligned_cols=136 Identities=16% Similarity=0.206 Sum_probs=93.1
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC---CceeEEEEEE-cCC
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK---NLVRLLGFCE-DRN 539 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~ 539 (768)
.+.++.|....||+. +..+++|+-. .......+.+|.++|+.|.+. .+.+++.+.. ..+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g 86 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG 86 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC
Confidence 466888998999998 5788888632 122346788999999999652 3566777664 445
Q ss_pred eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 046311 540 ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY------------------------------ 589 (768)
Q Consensus 540 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~------------------------------ 589 (768)
..++||||++|.+|.+..-. .++...+..++.++++.|+.||+.
T Consensus 87 ~~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 87 NPFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp CEEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 67899999999888763211 012333444455555555555532
Q ss_pred ---------------------------CCCCeEecCCCCCCeEECC---CCc-EEEeecccccc
Q 046311 590 ---------------------------AVPSIIHRDIKSSNVLLDA---TWT-AKVSDFGLSLI 622 (768)
Q Consensus 590 ---------------------------~~~~ivHrDiKp~NILl~~---~~~-~kl~DFGla~~ 622 (768)
..+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-05 Score=87.23 Aligned_cols=84 Identities=10% Similarity=0.064 Sum_probs=54.5
Q ss_pred Ccee-ccCCceEEEEEEEc-------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-C--CCceeEE
Q 046311 464 DHKI-GSGSFGAVYKATLD-------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-H--KNLVRLL 532 (768)
Q Consensus 464 ~~~L-G~G~fG~Vy~~~~~-------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H--pnIv~l~ 532 (768)
.+.| +.|....+|+.... +++.+++|+....... .......+.+|+++++.|. + -.+.+++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~--------~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV--------PVFPTYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC--------CSSSCCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc--------ccCchhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 3567 88989999998764 2567888865322100 0000124667888877773 2 3467788
Q ss_pred EEEEcC---CeeEEEEEeccCCChhh
Q 046311 533 GFCEDR---NERVLIYEYLENGTLHD 555 (768)
Q Consensus 533 ~~~~~~---~~~~lV~E~~~~gsL~~ 555 (768)
.+..+. +..++||||++|..|.+
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEccCCCccCCceEEEEecCCCChhh
Confidence 877655 35689999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.5e-05 Score=80.57 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=26.9
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00013 Score=76.83 Aligned_cols=141 Identities=21% Similarity=0.242 Sum_probs=92.8
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEcC
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH---HKNLVRLLGFCEDR 538 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 538 (768)
...+.|+.|.+..+|+.... +..+++|+... .....|.+|.+.|+.|. ...+.+++.+....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~--------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~ 103 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINER--------------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ 103 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEG--------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCc--------------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC
Confidence 34567999999999999864 67888997542 12456788988888883 35688889888888
Q ss_pred CeeEEEEEeccCCChhh-----------hccCCCC--C----------------CCCCCHHHHH---HHH--H-------
Q 046311 539 NERVLIYEYLENGTLHD-----------HLHNPQS--S----------------SPLKSWPARI---KVA--L------- 577 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~-----------~l~~~~~--~----------------~~~~~~~~~~---~ia--~------- 577 (768)
+..++||||+++..+.. .||.... . ....+|.... ++. .
T Consensus 104 g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g 183 (312)
T 3jr1_A 104 GHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKG 183 (312)
T ss_dssp SEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHT
T ss_pred CceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcC
Confidence 88999999999876521 2232111 0 0112454321 111 1
Q ss_pred -------HHHHH-HHHHhh-CCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 578 -------DAARG-IEYLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 578 -------~ia~g-L~yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
.+..- ...|.. ...|.++|+|+.+.|+|++.++ +.|+||.
T Consensus 184 ~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 184 LIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223432 2347799999999999999887 8888873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=9e-05 Score=81.01 Aligned_cols=82 Identities=17% Similarity=0.121 Sum_probs=49.1
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC--CC-ceeEEEEEEcCC
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH--KN-LVRLLGFCEDRN 539 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pn-Iv~l~~~~~~~~ 539 (768)
.+.||.|.++.||+++.. +++.++||....... ...........++..|.++++.+.. +. +.+++.+ +.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r----~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK----VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-----------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhc----ccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 467999999999999754 468899998653210 0000001122356678888877632 33 4455543 345
Q ss_pred eeEEEEEeccCC
Q 046311 540 ERVLIYEYLENG 551 (768)
Q Consensus 540 ~~~lV~E~~~~g 551 (768)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 568999999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00015 Score=75.39 Aligned_cols=79 Identities=20% Similarity=0.280 Sum_probs=55.2
Q ss_pred CCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC---CCceeEEEEEE
Q 046311 460 NFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH---KNLVRLLGFCE 536 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~ 536 (768)
.+...+.+|.|..+.||+.++.+|+.+.+|+..... ......|..|++.|+.|.- --+.+++++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-----------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-----------PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-----------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-----------cchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 455567899999999999999999999999754221 1112357789988888742 1244555542
Q ss_pred cCCeeEEEEEeccCCCh
Q 046311 537 DRNERVLIYEYLENGTL 553 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL 553 (768)
..++||||++++..
T Consensus 84 ---~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 ---DRTLAMEWVDERPP 97 (288)
T ss_dssp ---TTEEEEECCCCCCC
T ss_pred ---CceEEEEeecccCC
Confidence 34789999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00068 Score=74.60 Aligned_cols=79 Identities=15% Similarity=0.153 Sum_probs=49.6
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccC---CCCChhhHHHHHHHHHHH
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ---QLTEKSDVYSFGVVLLEI 668 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~el 668 (768)
+.++|+|+++.|||++.++ ++|+||+.+............. ..-...|++|+..... ......++..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 9999999887543211110000 0012346666654311 112245667888888888
Q ss_pred HcCC
Q 046311 669 LSGY 672 (768)
Q Consensus 669 ltG~ 672 (768)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0015 Score=68.91 Aligned_cols=143 Identities=17% Similarity=0.178 Sum_probs=76.9
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC--ceeEEE------EEE
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN--LVRLLG------FCE 536 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~------~~~ 536 (768)
+.|+.|....+|+....++ .+++|+.... ....++..|++++..|.... +.+++. +..
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-------------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~ 93 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-------------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 93 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-------------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence 4577788899999987755 6888876531 01123445666666553211 222321 112
Q ss_pred cCCeeEEEEEeccCCChhh--------------hccCC----CCCC----CCCCHHHHHH------------HHHHHHHH
Q 046311 537 DRNERVLIYEYLENGTLHD--------------HLHNP----QSSS----PLKSWPARIK------------VALDAARG 582 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~----~~~~~~~~~~------------ia~~ia~g 582 (768)
..+..+++|||++|..+.. .+|.. .... ....|...+. +...+.+.
T Consensus 94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~ 173 (322)
T 2ppq_A 94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 173 (322)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence 3456789999999866432 01211 0000 0011322111 00123445
Q ss_pred HHHHhhC----CCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 583 IEYLHEY----AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 583 L~yLH~~----~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++++++. ..+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 174 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5555532 12359999999999999887656899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0024 Score=67.45 Aligned_cols=144 Identities=13% Similarity=0.105 Sum_probs=79.7
Q ss_pred ceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCC--CceeEEEE-----EEc
Q 046311 465 HKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHK--NLVRLLGF-----CED 537 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~-----~~~ 537 (768)
+.|+ |....||+....+|+.+++|+..... .....+..|..++..|... .+.+++.. ...
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~------------~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~ 98 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER------------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH 98 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC------------CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE
Confidence 4576 78889999887777789999874210 1223456677777666321 23334332 122
Q ss_pred CCeeEEEEEeccCCChhh--------------hccC----CCC-CCCCCCHHHH----HHH---------------HHHH
Q 046311 538 RNERVLIYEYLENGTLHD--------------HLHN----PQS-SSPLKSWPAR----IKV---------------ALDA 579 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~--------------~l~~----~~~-~~~~~~~~~~----~~i---------------a~~i 579 (768)
.+..+++|||++|..+.. .+|. ... .....++... ..+ ...+
T Consensus 99 ~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 178 (328)
T 1zyl_A 99 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT 178 (328)
T ss_dssp TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHH
Confidence 456688999998865431 0111 000 0111122111 000 0011
Q ss_pred HHHHHHHhhC----CCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 580 ARGIEYLHEY----AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 580 a~gL~yLH~~----~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
-+.++.+.+. ..+.++|+|+++.|||++ + .+.|+||+.+...
T Consensus 179 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 179 DELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1122333221 224589999999999999 5 8999999887543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0017 Score=68.82 Aligned_cols=33 Identities=27% Similarity=0.354 Sum_probs=28.2
Q ss_pred CCeEecCCCCCCeEECCC----CcEEEeeccccccCC
Q 046311 592 PSIIHRDIKSSNVLLDAT----WTAKVSDFGLSLIGP 624 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~----~~~kl~DFGla~~~~ 624 (768)
+.++|+|+.+.|||++.+ ..+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 459999999999999875 689999999887543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0026 Score=66.38 Aligned_cols=140 Identities=18% Similarity=0.139 Sum_probs=74.3
Q ss_pred CceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~ 542 (768)
.+.|..|....+|+. ..+++|+...... ...+..+|+..++.+....+ .+++.+ +.+.-+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~------------~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~ 83 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE------------EYINRANEAVAAREAAKAGVSPEVLHV--DPATGV 83 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----------------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc------------ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence 578999999999999 6688887643210 00112346666666532222 455543 344457
Q ss_pred EEEEec-cCCChhh------------------hccCCCCCCC-CCCHHHHH-HHHH--------------HHHHHHH---
Q 046311 543 LIYEYL-ENGTLHD------------------HLHNPQSSSP-LKSWPARI-KVAL--------------DAARGIE--- 584 (768)
Q Consensus 543 lV~E~~-~~gsL~~------------------~l~~~~~~~~-~~~~~~~~-~ia~--------------~ia~gL~--- 584 (768)
+++||+ ++.+|.. .||....... .......+ .... .+.+.+.
T Consensus 84 ~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 84 MVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp EEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred EEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 899999 6655532 1122111000 00111111 0000 0111111
Q ss_pred -HHhh-CCCCCeEecCCCCCCeEECCCCcEEEeeccccccC
Q 046311 585 -YLHE-YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIG 623 (768)
Q Consensus 585 -yLH~-~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~ 623 (768)
.|.. ...+.++|+|+.+.||| ..++.+.|+||..+...
T Consensus 164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 1211 12245899999999999 55667899999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0054 Score=66.22 Aligned_cols=142 Identities=14% Similarity=0.159 Sum_probs=79.6
Q ss_pred CceeccCCceEEEEEEEc--------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEE
Q 046311 464 DHKIGSGSFGAVYKATLD--------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGF 534 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 534 (768)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|. +.-..+++++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~------------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI------------LQGVDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc------------cchHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 356777888899999864 2467888874211 112345668888888773 3333566666
Q ss_pred EEcCCeeEEEEEeccCCChhhh-----------------ccCCCCC-CCCCC--HHHHHHHHHHHH--------------
Q 046311 535 CEDRNERVLIYEYLENGTLHDH-----------------LHNPQSS-SPLKS--WPARIKVALDAA-------------- 580 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~-----------------l~~~~~~-~~~~~--~~~~~~ia~~ia-------------- 580 (768)
+.+ .+||||++|..|..- ||..... ..... |....++..++-
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 543 299999998665421 1221111 11112 233333332221
Q ss_pred -----HHHHHH----hhCC-CCCeEecCCCCCCeEECCC----CcEEEeeccccc
Q 046311 581 -----RGIEYL----HEYA-VPSIIHRDIKSSNVLLDAT----WTAKVSDFGLSL 621 (768)
Q Consensus 581 -----~gL~yL----H~~~-~~~ivHrDiKp~NILl~~~----~~~kl~DFGla~ 621 (768)
+.+..| .... ...++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 122333 2222 2359999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0046 Score=68.10 Aligned_cols=73 Identities=15% Similarity=0.234 Sum_probs=48.2
Q ss_pred CceeccCCceEEEEEEEcC--------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC-ceeEEEE
Q 046311 464 DHKIGSGSFGAVYKATLDD--------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN-LVRLLGF 534 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~ 534 (768)
.+.|+.|-...+|+....+ ++.+++|+.... .....+.+|..+++.|...+ ..++++.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------------~~~~~li~E~~~l~~L~~~g~~P~l~~~ 144 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------------ETESHLVAESVIFTLLSERHLGPKLYGI 144 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------------CCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------------CcHHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence 4578888889999998753 478888875211 01134557888888774333 3567765
Q ss_pred EEcCCeeEEEEEeccCCCh
Q 046311 535 CEDRNERVLIYEYLENGTL 553 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL 553 (768)
+.+ .+||||++|.+|
T Consensus 145 ~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 145 FSG----GRLEEYIPSRPL 159 (429)
T ss_dssp ETT----EEEECCCCEEEC
T ss_pred eCC----CEEEEEeCCccc
Confidence 532 389999987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.015 Score=64.34 Aligned_cols=75 Identities=16% Similarity=0.081 Sum_probs=46.9
Q ss_pred CceeccCCceEEEEEEEcC-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEcCCee
Q 046311 464 DHKIGSGSFGAVYKATLDD-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCEDRNER 541 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~ 541 (768)
.+.|+.|-...+|+....+ +..+++|+...... ...+..+|..+++.|...++ .++++++. +
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~------------~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~-- 176 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD------------EIINREREKKISCILYNKNIAKKIYVFFT--N-- 176 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC------------SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh------------hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--
Confidence 4578888889999998764 47788887532210 00012468888888864444 56777662 2
Q ss_pred EEEEEeccCCChh
Q 046311 542 VLIYEYLENGTLH 554 (768)
Q Consensus 542 ~lV~E~~~~gsL~ 554 (768)
.+||||++|.+|.
T Consensus 177 G~v~e~I~G~~l~ 189 (458)
T 2qg7_A 177 GRIEEFMDGYALS 189 (458)
T ss_dssp EEEEECCCSEECC
T ss_pred eEEEEeeCCccCC
Confidence 3599999986553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0069 Score=65.17 Aligned_cols=73 Identities=21% Similarity=0.205 Sum_probs=41.7
Q ss_pred ceeccCCceEEEEEEEcC---------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCC-ceeEEEE
Q 046311 465 HKIGSGSFGAVYKATLDD---------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKN-LVRLLGF 534 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~---------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~ 534 (768)
+.|+.|..-.+|+....+ +..+++|+..... ....+..+|.++++.+...+ ..++++.
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~------------~~~~~~~~E~~~l~~L~~~g~~P~~~~~ 106 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV------------DELYNTISEFEVYKTMSKYKIAPQLLNT 106 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG------------GGTSCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc------------cceecHHHHHHHHHHHHhcCCCCceEEe
Confidence 567888888999998754 2678888653210 00012346777777764223 3466654
Q ss_pred EEcCCeeEEEEEeccCCCh
Q 046311 535 CEDRNERVLIYEYLENGTL 553 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL 553 (768)
. . -++||||++|..|
T Consensus 107 ~--~--~~~v~e~i~G~~l 121 (369)
T 3c5i_A 107 F--N--GGRIEEWLYGDPL 121 (369)
T ss_dssp E--T--TEEEEECCCSEEC
T ss_pred c--C--CcEEEEEecCCcC
Confidence 4 2 3689999998654
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=96.13 E-value=1.2 Score=48.10 Aligned_cols=212 Identities=9% Similarity=0.095 Sum_probs=127.6
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCccccccccc--CCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCC
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIY--RGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFN 149 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~--~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~ 149 (768)
.+.+++--+.+...- ..||+|..|-.+. |+. .... ....|..++..+...+.- ..||+|..|-.....
T Consensus 135 ~v~~~~~d~~~l~~g-----~~dg~i~iwd~~~-~~~---~~~~~~h~~~v~~l~~~~~~l~sg-~~dg~i~vwd~~~~~ 204 (435)
T 1p22_A 135 GVYCLQYDDQKIVSG-----LRDNTIKIWDKNT-LEC---KRILTGHTGSVLCLQYDERVIITG-SSDSTVRVWDVNTGE 204 (435)
T ss_dssp CEEEEECCSSEEEEE-----ESSSCEEEEESSS-CCE---EEEECCCSSCEEEEECCSSEEEEE-ETTSCEEEEESSSCC
T ss_pred cEEEEEECCCEEEEE-----eCCCeEEEEeCCC-CeE---EEEEcCCCCcEEEEEECCCEEEEE-cCCCeEEEEECCCCc
Confidence 345555544443333 5789999996543 332 1111 233577887744444443 889999999654222
Q ss_pred CC-----CCCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcc---cccCCCcCeEEEeccCceeEEEecCCcEEEeecC
Q 046311 150 ST-----SIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSV---TQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDS 221 (768)
Q Consensus 150 ~~-----~~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~---~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n 221 (768)
.. ....+..++.-....+.-..||+|..|=-....... ........+..++....+.+.-..||+|..|=-.
T Consensus 205 ~~~~~~~h~~~v~~l~~~~~~l~s~s~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~~~dg~i~vwd~~ 284 (435)
T 1p22_A 205 MLNTLIHHCEAVLHLRFNNGMMVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTS 284 (435)
T ss_dssp EEEEECCCCSCEEEEECCTTEEEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETT
T ss_pred EEEEEcCCCCcEEEEEEcCCEEEEeeCCCcEEEEeCCCCCCceeeeEecCCCCcEEEEEeCCCEEEEEeCCCeEEEEECC
Confidence 11 134577777666666667788999999643322211 1111235677777766676677889999999644
Q ss_pred CCCC------CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCC--CCCCCCeEEEEecCCeEEEEEecCCeEEEEeC
Q 046311 222 VGEV------PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPD--SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGN 293 (768)
Q Consensus 222 ~~gq------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~ 293 (768)
.... ....+..++....+-..-..||+|..|=-.....+. ......+..++..+.+...- ..||+|..|--
T Consensus 285 ~~~~~~~~~~~~~~v~~~~~~~~~l~~g~~dg~i~iwd~~~~~~~~~~~~h~~~v~~~~~~~~~l~sg-~~dg~i~vwd~ 363 (435)
T 1p22_A 285 TCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIECGACLRVLEGHEELVRCIRFDNKRIVSG-AYDGKIKVWDL 363 (435)
T ss_dssp TCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTTCCEEEEECCCSSCEEEEECCSSEEEEE-ETTSCEEEEEH
T ss_pred cCcEEEEEcCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCCCCEEEEEeCCcCcEEEEEecCCEEEEE-eCCCcEEEEEC
Confidence 3211 123577777666666666689999999755322211 11234577777755555554 78999999954
Q ss_pred C
Q 046311 294 E 294 (768)
Q Consensus 294 n 294 (768)
.
T Consensus 364 ~ 364 (435)
T 1p22_A 364 V 364 (435)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=96.09 E-value=1.9 Score=46.45 Aligned_cols=214 Identities=12% Similarity=0.171 Sum_probs=124.7
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST 151 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~ 151 (768)
.+.+++- ++...+. -..||+|..|-... |+.... .......|..++.-....+.- ..||+|..|-.......
T Consensus 175 ~v~~l~~-~~~~l~s----g~~dg~i~vwd~~~-~~~~~~-~~~h~~~v~~l~~~~~~l~s~-s~dg~i~vwd~~~~~~~ 246 (435)
T 1p22_A 175 SVLCLQY-DERVIIT----GSSDSTVRVWDVNT-GEMLNT-LIHHCEAVLHLRFNNGMMVTC-SKDRSIAVWDMASPTDI 246 (435)
T ss_dssp CEEEEEC-CSSEEEE----EETTSCEEEEESSS-CCEEEE-ECCCCSCEEEEECCTTEEEEE-ETTSCEEEEECSSSSCC
T ss_pred cEEEEEE-CCCEEEE----EcCCCeEEEEECCC-CcEEEE-EcCCCCcEEEEEEcCCEEEEe-eCCCcEEEEeCCCCCCc
Confidence 5666666 3333333 15799999996543 332110 011233577777665555555 89999999966432222
Q ss_pred -------C-CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCC
Q 046311 152 -------S-IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVG 223 (768)
Q Consensus 152 -------~-~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~ 223 (768)
+ ...+..++....+.+.-..||+|..|=-...............+..++........-..||+|..|=-...
T Consensus 247 ~~~~~~~~~~~~v~~~~~~~~~l~s~~~dg~i~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~l~~g~~dg~i~iwd~~~~ 326 (435)
T 1p22_A 247 TLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTSTCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIECG 326 (435)
T ss_dssp EEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTTC
T ss_pred eeeeEecCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCcCcEEEEEcCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCCC
Confidence 1 33467777766777777788999999643321111111123467777766666666688999999975432
Q ss_pred CC------CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCC-----------CCCCCCeEEEEecCCeEEEEEecCC
Q 046311 224 EV------PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPD-----------SLQGKPFVSIEAKRSVFCGVLTSNY 286 (768)
Q Consensus 224 gq------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~-----------~~~~~~~~~i~~g~~h~~~l~~~~g 286 (768)
.. ....+..|+....+-..-..||+|..|--....... ......+..++..+.+.+.. ..||
T Consensus 327 ~~~~~~~~h~~~v~~~~~~~~~l~sg~~dg~i~vwd~~~~~~~~~~~~~~~~~~~~~h~~~v~~l~~~~~~l~s~-s~Dg 405 (435)
T 1p22_A 327 ACLRVLEGHEELVRCIRFDNKRIVSGAYDGKIKVWDLVAALDPRAPAGTLCLRTLVEHSGRVFRLQFDEFQIVSS-SHDD 405 (435)
T ss_dssp CEEEEECCCSSCEEEEECCSSEEEEEETTSCEEEEEHHHHTSTTSCTTTTEEEEECCCSSCCCCEEECSSCEEEC-CSSS
T ss_pred CEEEEEeCCcCcEEEEEecCCEEEEEeCCCcEEEEECCCCCCccccccchheeeccCCCCCeEEEEeCCCEEEEE-eCCC
Confidence 11 123677888766665556689999999532211000 01122344555444444444 6899
Q ss_pred eEEEEeCC
Q 046311 287 SLYCWGNE 294 (768)
Q Consensus 287 ~~~~wG~n 294 (768)
+|..|--.
T Consensus 406 ~i~iwd~~ 413 (435)
T 1p22_A 406 TILIWDFL 413 (435)
T ss_dssp EEEEEC--
T ss_pred EEEEEECC
Confidence 99999544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.034 Score=59.01 Aligned_cols=31 Identities=23% Similarity=0.368 Sum_probs=27.5
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
+.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.71 E-value=0.027 Score=55.02 Aligned_cols=100 Identities=13% Similarity=0.069 Sum_probs=64.3
Q ss_pred CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCc
Q 046311 550 NGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629 (768)
Q Consensus 550 ~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 629 (768)
.-||.+.|... ...+++.+.+.++.|.++.|.-+-....+ ..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 34788888653 34568999999999999988766221111 1334457899999999998764 1110
Q ss_pred ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc
Q 046311 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS 670 (768)
Q Consensus 630 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt 670 (768)
.....+.+||... ...+.+.=|||||++||.-+-
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123467888763 455788999999999999885
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=95.64 E-value=1.7 Score=46.99 Aligned_cols=199 Identities=10% Similarity=0.104 Sum_probs=117.8
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC-----CCCceEEEEecCCeE
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST-----SIHNFSNIAVGEDFV 166 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~-----~~~~~~~v~~G~~h~ 166 (768)
..||+|..|-....-.+... ......|..++.-+...+.- ..||+|..|-....... ....+..++.....-
T Consensus 136 ~~dg~i~vwd~~~~~~~~~~--~~h~~~v~~~~~~~~~l~s~-~~dg~i~vwd~~~~~~~~~~~~h~~~v~~~~~~~~~l 212 (445)
T 2ovr_B 136 SDDNTLKVWSAVTGKCLRTL--VGHTGGVWSSQMRDNIIISG-STDRTLKVWNAETGECIHTLYGHTSTVRCMHLHEKRV 212 (445)
T ss_dssp ETTSCEEEEETTTCCEEEEC--CCCSSCEEEEEEETTEEEEE-ETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTEE
T ss_pred ECCCcEEEEECCCCcEEEEE--cCCCCCEEEEEecCCEEEEE-eCCCeEEEEECCcCcEEEEECCCCCcEEEEEecCCEE
Confidence 57999999976532222110 01223466666544444444 78999999965422111 133466777666666
Q ss_pred EEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC------CCCCeEEEeccCCee
Q 046311 167 CGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV------PQGKFKALALGENRS 240 (768)
Q Consensus 167 ~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ia~G~~h~ 240 (768)
+.-..||+|..|=-...............+..++....+.+.-..||+|..|=...... ....+..++....+-
T Consensus 213 ~s~s~dg~i~~wd~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~v~~~~~~~~~l 292 (445)
T 2ovr_B 213 VSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHV 292 (445)
T ss_dssp EEEETTSEEEEEESSSCCEEEEEECCSSCEEEEEECSSCEEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSEE
T ss_pred EEEeCCCEEEEEECCCCcEEEEEcCCcccEEEEEECCCEEEEEcCCCEEEEEECCCCcEeEEecCCCCceEEEEECCCEE
Confidence 66677899999964432111111122346677776666666668899999996432111 123577777766666
Q ss_pred EEEeeCCeEEEEecCCCCCCC--CCCCCCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 241 CALRNNQKVVCWGQNGFTLPD--SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 241 ~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
+.-..||+|..|=-.....+. ......+..++..+.+...- ..||.|..|=-.
T Consensus 293 ~~~~~d~~i~i~d~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~-~~dg~i~vwd~~ 347 (445)
T 2ovr_B 293 VSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNILVSG-NADSTVKIWDIK 347 (445)
T ss_dssp EEEETTSCEEEEETTTCCEEEEECCCCSCEEEEEEETTEEEEE-ETTSCEEEEETT
T ss_pred EEEeCCCeEEEEECCCCCEEEEEcCCcccEEEEEEeCCEEEEE-eCCCeEEEEECC
Confidence 666689999999754322211 11223456666655555554 789999999543
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=95.33 E-value=3.9 Score=44.05 Aligned_cols=198 Identities=10% Similarity=0.120 Sum_probs=119.1
Q ss_pred CCCCcEEeccCCCCCcccccccc-cCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC-----CCCceEEEEecCCe
Q 046311 92 SSSSVMHCWRFSADGIINDYKRI-YRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST-----SIHNFSNIAVGEDF 165 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~-~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~-----~~~~~~~v~~G~~h 165 (768)
..||+|..|-... |+.. ... .....|..++..+.....- ..||+|..|-....... ....+..++....+
T Consensus 176 ~~dg~i~vwd~~~-~~~~--~~~~~h~~~v~~~~~~~~~l~s~-s~dg~i~~wd~~~~~~~~~~~~~~~~v~~~~~~~~~ 251 (445)
T 2ovr_B 176 STDRTLKVWNAET-GECI--HTLYGHTSTVRCMHLHEKRVVSG-SRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRR 251 (445)
T ss_dssp ETTSCEEEEETTT-TEEE--EEECCCSSCEEEEEEETTEEEEE-ETTSEEEEEESSSCCEEEEEECCSSCEEEEEECSSC
T ss_pred eCCCeEEEEECCc-CcEE--EEECCCCCcEEEEEecCCEEEEE-eCCCEEEEEECCCCcEEEEEcCCcccEEEEEECCCE
Confidence 5799999996543 3320 111 1223566676655555444 88999999965432211 13346666665566
Q ss_pred EEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC------CCCCeEEEeccCCe
Q 046311 166 VCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV------PQGKFKALALGENR 239 (768)
Q Consensus 166 ~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ia~G~~h 239 (768)
.+.-..||+|..|=-...............+.+++....+.+.-..||+|..|=-..... ....+..++.....
T Consensus 252 l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~~~~~~~v~~~~~~~~~ 331 (445)
T 2ovr_B 252 VVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNI 331 (445)
T ss_dssp EEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSEEEEEETTSCEEEEETTTCCEEEEECCCCSCEEEEEEETTE
T ss_pred EEEEcCCCEEEEEECCCCcEeEEecCCCCceEEEEECCCEEEEEeCCCeEEEEECCCCCEEEEEcCCcccEEEEEEeCCE
Confidence 666677899999953321111111112256777777666666668899999996443221 11256666666666
Q ss_pred eEEEeeCCeEEEEecCCCCCCC---C--CCCCCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 240 SCALRNNQKVVCWGQNGFTLPD---S--LQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 240 ~~al~~dg~v~~WG~n~~gq~~---~--~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
-..-..||+|..|=-.....+. . .....+..++....+...- ..||.|..|--+
T Consensus 332 l~~~~~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~-~~dg~v~iwd~~ 390 (445)
T 2ovr_B 332 LVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITS-SDDGTVKLWDLK 390 (445)
T ss_dssp EEEEETTSCEEEEETTTCCEEEEECSTTSCSSCEEEEEECSSEEEEE-ETTSEEEEEETT
T ss_pred EEEEeCCCeEEEEECCCCcEEEEEccCCCCCCCEEEEEECCCEEEEE-eCCCeEEEEECC
Confidence 6666689999999754322111 1 1234577777766666555 789999999654
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.031 Score=54.64 Aligned_cols=65 Identities=12% Similarity=0.228 Sum_probs=59.0
Q ss_pred CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCCC-CCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 229 KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQG-KPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 229 ~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~~-~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
.+.+|+.-+.|+.-+--|++++.+|+|..||+.++.. ..|.++.||..+|.-+ ..-..|--||+.
T Consensus 310 ~i~~VsG~y~H~vvi~gd~el~sFG~~sNGQ~~ip~tagPfla~~AG~~fTVTV-n~~nyv~FWGDS 375 (400)
T 4gbf_A 310 PIGGVSGLYTHYTVMYGDGQIAFFGNNDNGQCDVDDHAGPYIQLAAGHNFTVTV-NTLNQVMFWGDS 375 (400)
T ss_dssp CCCCCBCSSSEEEC-CTTTCCCEEECCTTSTTCCCGGGCCEEEEEECSSEEEEE-ETTCCEEEEECC
T ss_pred ccccccccccceEEEecCceeEEeccCCCCceecCCCcchHHhHhccCCeEEEE-eceeeEEEecCC
Confidence 6889999999999999999999999999999998874 4799999999999999 888899999985
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.05 Score=59.52 Aligned_cols=74 Identities=14% Similarity=0.086 Sum_probs=45.9
Q ss_pred CceeccCCceEEEEEEEcC--------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEE
Q 046311 464 DHKIGSGSFGAVYKATLDD--------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGF 534 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 534 (768)
.+.|..|-...+|+....+ ++.+++|+..... . ...+..+|.++++.+. +.-..++++.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~----------~~idR~~E~~~l~~L~~~gi~P~l~~~ 142 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--G----------KFYDSKVELDVFRYLSNINIAPNIIAD 142 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-------------CCCCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--c----------hhcCHHHHHHHHHHHHhcCCCCCEEEE
Confidence 4567778889999998763 5778888753211 0 0011245777776663 2224456653
Q ss_pred EEcCCeeEEEEEeccCCCh
Q 046311 535 CEDRNERVLIYEYLENGTL 553 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL 553 (768)
+ . -++||||++|..|
T Consensus 143 ~--~--~~~I~efI~G~~l 157 (424)
T 3mes_A 143 F--P--EGRIEEFIDGEPL 157 (424)
T ss_dssp E--T--TEEEEECCCSEEC
T ss_pred c--C--CCEEEEEeCCccC
Confidence 3 2 3789999998765
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=94.60 E-value=0.036 Score=54.20 Aligned_cols=78 Identities=19% Similarity=0.296 Sum_probs=61.7
Q ss_pred cCeEEEeccCceeEEEecCCcEEEeecCCCCCCC-----CCeEEEeccCCeeEEEeeCCeEEEEecCC-CCCCCCCCCCC
Q 046311 194 GIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ-----GKFKALALGENRSCALRNNQKVVCWGQNG-FTLPDSLQGKP 267 (768)
Q Consensus 194 ~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~-----~~~~~ia~G~~h~~al~~dg~v~~WG~n~-~gq~~~~~~~~ 267 (768)
..+.+||.-+.|+..+--|++++.+|+|..||.. +.+.+++||.++|.-+..-..|-.||+.- ...|-.....+
T Consensus 309 n~i~~VsG~y~H~vvi~gd~el~sFG~~sNGQ~~ip~tagPfla~~AG~~fTVTVn~~nyv~FWGDSPDNSLLwnGr~t~ 388 (400)
T 4gbf_A 309 NPIGGVSGLYTHYTVMYGDGQIAFFGNNDNGQCDVDDHAGPYIQLAAGHNFTVTVNTLNQVMFWGDSPDNSLLWNGRGTR 388 (400)
T ss_dssp SCCCCCBCSSSEEEC-CTTTCCCEEECCTTSTTCCCGGGCCEEEEEECSSEEEEEETTCCEEEEECCTTSTTCCTTCCSB
T ss_pred CccccccccccceEEEecCceeEEeccCCCCceecCCCcchHHhHhccCCeEEEEeceeeEEEecCCCCcceeecCccce
Confidence 5678899999999999999999999999999932 48999999999999999999999999653 33333333344
Q ss_pred eEEE
Q 046311 268 FVSI 271 (768)
Q Consensus 268 ~~~i 271 (768)
+++|
T Consensus 389 ~~~~ 392 (400)
T 4gbf_A 389 VKHI 392 (400)
T ss_dssp CCCC
T ss_pred eeec
Confidence 4443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.53 E-value=0.009 Score=40.92 Aligned_cols=32 Identities=19% Similarity=0.312 Sum_probs=23.0
Q ss_pred CCCccceEEEeehHHHHHHHHHHHHHHHhhhh
Q 046311 361 GGWSGRMVALLVVGCLGSLVVVLVSAFFGYKH 392 (768)
Q Consensus 361 ~~~s~~~i~~ivv~~~~~lv~l~~l~~~~~~~ 392 (768)
++.+...++.|++++++.+++++.+++|++||
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 45667778888888888777777766666543
|
| >2zwa_A Leucine carboxyl methyltransferase 2; HET: SAH CIT; 1.70A {Saccharomyces cerevisiae} PDB: 2zw9_A* 2zzk_A* | Back alignment and structure |
|---|
Probab=91.36 E-value=3.8 Score=47.59 Aligned_cols=199 Identities=13% Similarity=0.008 Sum_probs=107.3
Q ss_pred CCCcEEeccCCCCCccccccccc--CCCCeeEEe-c---------CCCeEEEEEeC-CCcEEEccCCCCCC--CC-----
Q 046311 93 SSSVMHCWRFSADGIINDYKRIY--RGPALQQLE-A---------GNSHICGLVNG-TNDLHWWQWPDFNS--TS----- 152 (768)
Q Consensus 93 ~~g~~~~WG~n~~gql~~~~~~~--~~~~~~~i~-~---------G~~h~~al~~~-~g~~~~Wg~~~~~~--~~----- 152 (768)
.++.||..|......+. ...++ ....+..+. . =..|++++ .. +|++|..|...... +.
T Consensus 396 ~~~~iyv~GG~~~~~~~-~v~~yd~~~~~W~~~~~~~p~~~~p~~R~~hs~~~-~~~~~~lyv~GG~~~~~~~~~dv~~y 473 (695)
T 2zwa_A 396 AGNDVFYMGGSNPYRVN-EILQLSIHYDKIDMKNIEVSSSEVPVARMCHTFTT-ISRNNQLLLIGGRKAPHQGLSDNWIF 473 (695)
T ss_dssp CSSCEEEECCBSSSBCC-CEEEEEECSSCEEEEECCCCCSCCCCCCBSCEEEE-ETTTTEEEEECCBSSTTCBCCCCEEE
T ss_pred ECCEEEEECCCCCCCcC-cEEEEECCCCeEEEeccCCCCCCCCccccceEEEE-EccCCEEEEEcCCCCCCCccccEEEE
Confidence 36778888864332221 11111 122466666 2 13688887 55 89999998643221 11
Q ss_pred ---CCceEEEE----ecCCeEEEEeeCCeEEEecCCCCCC-cccccCCCcCeEEEec-------cCceeEEE-ecC-CcE
Q 046311 153 ---IHNFSNIA----VGEDFVCGLLENGTITCFGSRNSPT-SVTQKVPSGIFRVVAA-------GFRHVCAI-DDD-QEL 215 (768)
Q Consensus 153 ---~~~~~~v~----~G~~h~~~l~~~g~v~~wG~~~~g~-~~~~~~~~~~~~~i~~-------G~~h~~al-~~~-g~v 215 (768)
...+..++ .=..|++++..+|.+|..|...... .-.-......|..++. -..|++++ ..+ |++
T Consensus 474 d~~t~~W~~~~~~p~~R~~h~~~~~~~~~iyv~GG~~~~~~v~~yd~~t~~W~~~~~~g~~p~~r~~~~a~v~~~~~~~i 553 (695)
T 2zwa_A 474 DMKTREWSMIKSLSHTRFRHSACSLPDGNVLILGGVTEGPAMLLYNVTEEIFKDVTPKDEFFQNSLVSAGLEFDPVSKQG 553 (695)
T ss_dssp ETTTTEEEECCCCSBCCBSCEEEECTTSCEEEECCBCSSCSEEEEETTTTEEEECCCSSGGGGSCCBSCEEEEETTTTEE
T ss_pred eCCCCcEEECCCCCCCcccceEEEEcCCEEEEECCCCCCCCEEEEECCCCceEEccCCCCCCCcccceeEEEEeCCCCEE
Confidence 22355542 2346888876699999999543222 1111122356777663 23566344 544 899
Q ss_pred EEeecCC-CC-C---------C-CCC------eEEEec-----cCCeeEEEeeCCeEEEEecCC-CCC---CC-----CC
Q 046311 216 RCWGDSV-GE-V---------P-QGK------FKALAL-----GENRSCALRNNQKVVCWGQNG-FTL---PD-----SL 263 (768)
Q Consensus 216 ~~wG~n~-~g-q---------~-~~~------~~~ia~-----G~~h~~al~~dg~v~~WG~n~-~gq---~~-----~~ 263 (768)
|.+|... .+ . + ... |..+.. -..|++++..||.+|..|-.. .+. .. -+
T Consensus 554 yv~GG~~~~~~~~~~~v~~yd~~~~~w~~~~~W~~~~~~p~~~R~~~~~~~~~~~~iyv~GG~~~~~~~~~~~~v~~yd~ 633 (695)
T 2zwa_A 554 IILGGGFMDQTTVSDKAIIFKYDAENATEPITVIKKLQHPLFQRYGSQIKYITPRKLLIVGGTSPSGLFDRTNSIISLDP 633 (695)
T ss_dssp EEECCBCTTSSCBCCEEEEEEECTTCSSCCEEEEEEEECGGGCCBSCEEEEEETTEEEEECCBCSSCCCCTTTSEEEEET
T ss_pred EEECCcCCCCCeeeCcEEEEEccCCccccceEEEEcCCCCCCCcccceEEEeCCCEEEEECCccCCCCCCCCCeEEEEEC
Confidence 9999542 22 1 1 114 677643 356888887779999998532 211 11 01
Q ss_pred CCCCeEEEEe-----------cCCeEEEEEecCCeEEEEeCC
Q 046311 264 QGKPFVSIEA-----------KRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 264 ~~~~~~~i~~-----------g~~h~~~l~~~~g~~~~wG~n 294 (768)
....+..+.. -..|++.+ ..+|.++..|.+
T Consensus 634 ~t~~W~~~~~p~~~~~~~~p~~~gh~~~~-~~~g~i~v~GGg 674 (695)
T 2zwa_A 634 LSETLTSIPISRRIWEDHSLMLAGFSLVS-TSMGTIHIIGGG 674 (695)
T ss_dssp TTTEEEECCCCHHHHHHSCCCCSSCEEEC-C---CEEEECCE
T ss_pred CCCeEEEeeccccccCCCCccceeeeEEE-eCCCEEEEEeCC
Confidence 1223443321 11376665 567789999885
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.28 E-value=0.72 Score=49.88 Aligned_cols=29 Identities=28% Similarity=0.375 Sum_probs=24.5
Q ss_pred eEecCCCCCCeEE------CCCCcEEEeecccccc
Q 046311 594 IIHRDIKSSNVLL------DATWTAKVSDFGLSLI 622 (768)
Q Consensus 594 ivHrDiKp~NILl------~~~~~~kl~DFGla~~ 622 (768)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999987753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.91 E-value=0.1 Score=36.88 Aligned_cols=7 Identities=29% Similarity=0.809 Sum_probs=3.2
Q ss_pred eehHHHH
Q 046311 371 LVVGCLG 377 (768)
Q Consensus 371 ivv~~~~ 377 (768)
|++++++
T Consensus 13 IA~gVVg 19 (44)
T 2ks1_B 13 IATGMVG 19 (44)
T ss_dssp STHHHHH
T ss_pred EEeehhH
Confidence 4444444
|
| >3v7d_B Cell division control protein 4; WD 40 domain, phospho-peptide complex, E3 ubiquitin ligase, cell cycle, phospho binding protein, phosphorylation; HET: SEP; 2.31A {Saccharomyces cerevisiae} PDB: 1nex_B* 3mks_B* | Back alignment and structure |
|---|
Probab=90.31 E-value=22 Score=38.09 Aligned_cols=197 Identities=12% Similarity=0.184 Sum_probs=110.9
Q ss_pred CCCCcEEeccCCCCCccccccccc--CCCCeeEEec---CCCeEEEEEeCCCcEEEccCCCCCCCC--------------
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIY--RGPALQQLEA---GNSHICGLVNGTNDLHWWQWPDFNSTS-------------- 152 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~--~~~~~~~i~~---G~~h~~al~~~~g~~~~Wg~~~~~~~~-------------- 152 (768)
..||++..|-... |+. .... ....|..++. ......+.-..||++..|-........
T Consensus 180 s~dg~i~vwd~~~-~~~---~~~~~~h~~~v~~l~~~~~~~~~~l~s~s~d~~i~vwd~~~~~~~~~~~~~~~~~~~~~~ 255 (464)
T 3v7d_B 180 STDRTVRVWDIKK-GCC---THVFEGHNSTVRCLDIVEYKNIKYIVTGSRDNTLHVWKLPKESSVPDHGEEHDYPLVFHT 255 (464)
T ss_dssp ETTSCEEEEETTT-TEE---EEEECCCSSCEEEEEEEESSSCEEEEEEETTSCEEEEECCCCCCC------CCSSEEESC
T ss_pred eCCCCEEEEECCC-CcE---EEEECCCCCccEEEEEecCCCCCEEEEEcCCCcEEEeeCCCCcccccccccCCcceEeec
Confidence 5799999996543 322 1111 2234555543 233334333789999999664322110
Q ss_pred --------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEec--cCceeEEEecCCcEE
Q 046311 153 --------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAA--GFRHVCAIDDDQELR 216 (768)
Q Consensus 153 --------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~--G~~h~~al~~~g~v~ 216 (768)
...+..++.-..+...-..||+|..|--...............+..++. -+...+.-..||+|+
T Consensus 256 ~~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~sg~~dg~i~ 335 (464)
T 3v7d_B 256 PEENPYFVGVLRGHMASVRTVSGHGNIVVSGSYDNTLIVWDVAQMKCLYILSGHTDRIYSTIYDHERKRCISASMDTTIR 335 (464)
T ss_dssp GGGCTTEEEEECCCSSCEEEEEEETTEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTTTEEEEEETTSCEE
T ss_pred cCCCeEEEEEccCccceEEEEcCCCCEEEEEeCCCeEEEEECCCCcEEEEecCCCCCEEEEEEcCCCCEEEEEeCCCcEE
Confidence 2235566655666666677899999964321111111111234555443 334555557889999
Q ss_pred EeecCCCCC------CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCC---CCCCCCeEEEEecCCeEEEEEecCCe
Q 046311 217 CWGDSVGEV------PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPD---SLQGKPFVSIEAKRSVFCGVLTSNYS 287 (768)
Q Consensus 217 ~wG~n~~gq------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~---~~~~~~~~~i~~g~~h~~~l~~~~g~ 287 (768)
.|=-..... ....+..++....+-..-..||+|..|=-+...+.- ......+..++..+....+- .||.
T Consensus 336 vwd~~~~~~~~~~~~h~~~v~~~~~~~~~l~s~s~dg~v~vwd~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~dg~ 413 (464)
T 3v7d_B 336 IWDLENGELMYTLQGHTALVGLLRLSDKFLVSAAADGSIRGWDANDYSRKFSYHHTNLSAITTFYVSDNILVSG--SENQ 413 (464)
T ss_dssp EEETTTTEEEEEECCCSSCEEEEEECSSEEEEEETTSEEEEEETTTCCEEEEEECTTCCCEEEEEECSSEEEEE--ETTE
T ss_pred EEECCCCcEEEEEeCCCCcEEEEEEcCCEEEEEeCCCcEEEEECCCCceeeeecCCCCccEEEEEeCCCEEEEe--cCCe
Confidence 996432111 123577777777777777799999999766433221 12223455666665544443 4889
Q ss_pred EEEEeCC
Q 046311 288 LYCWGNE 294 (768)
Q Consensus 288 ~~~wG~n 294 (768)
+..|=-.
T Consensus 414 i~iwd~~ 420 (464)
T 3v7d_B 414 FNIYNLR 420 (464)
T ss_dssp EEEEETT
T ss_pred EEEEECC
Confidence 9999543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.11 Score=36.66 Aligned_cols=7 Identities=29% Similarity=0.904 Sum_probs=3.2
Q ss_pred eehHHHH
Q 046311 371 LVVGCLG 377 (768)
Q Consensus 371 ivv~~~~ 377 (768)
|++++++
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 4444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.98 E-value=1 Score=43.86 Aligned_cols=118 Identities=12% Similarity=0.145 Sum_probs=80.1
Q ss_pred CCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCC
Q 046311 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603 (768)
Q Consensus 524 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~N 603 (768)
.||++++. .+-.+++...+.|+.-+.+-=+..++ ..+...+++++.+|+....+++.. +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68988876 56667777666666544222222232 247788999999999888666543 788999999
Q ss_pred eEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccC
Q 046311 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678 (768)
Q Consensus 604 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~ 678 (768)
|+++.++.+++.-.|+-.. ++|. ..++..=.-.+=+++..+++++..|+..
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999987776432 2222 1122222346678889999998888643
|
| >1k3i_A Galactose oxidase precursor; blade beta propeller, prosequence form, precursor of copper enzyme., oxidoreductase; 1.40A {Fusarium SP} SCOP: b.1.18.2 b.18.1.1 b.69.1.1 PDB: 1gof_A 1gog_A 1goh_A 2eie_A 2jkx_A 2vz1_A 2vz3_A 2eic_A 2eib_A 1t2x_A 2eid_A 2wq8_A | Back alignment and structure |
|---|
Probab=88.50 E-value=10 Score=43.49 Aligned_cols=50 Identities=12% Similarity=0.085 Sum_probs=32.6
Q ss_pred EEEEEeCCCcEEEccCCCCCCCC-----CCceEEEE----ecCCeEEEEeeCCeEEEecC
Q 046311 130 ICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIA----VGEDFVCGLLENGTITCFGS 180 (768)
Q Consensus 130 ~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~----~G~~h~~~l~~~g~v~~wG~ 180 (768)
+.++ ..||++|..|.......- ...+..++ .=.+|++++..||++++.|.
T Consensus 247 ~~~~-~~~g~lyv~GG~~~~~v~~yd~~t~~W~~~~~~~~~R~~~s~~~~~dg~iyv~GG 305 (656)
T 1k3i_A 247 GISM-DGNGQIVVTGGNDAKKTSLYDSSSDSWIPGPDMQVARGYQSSATMSDGRVFTIGG 305 (656)
T ss_dssp EEEE-CTTSCEEEECSSSTTCEEEEEGGGTEEEECCCCSSCCSSCEEEECTTSCEEEECC
T ss_pred cccC-CCCCCEEEeCCCCCCceEEecCcCCceeECCCCCccccccceEEecCCeEEEEeC
Confidence 3455 689999999874332111 22344442 22468888888999999996
|
| >3k26_A Polycomb protein EED; WD40, structural genomics, NPPSFA, national project on prote structural and functional analysis, structural genomics CON SGC; HET: M3L; 1.58A {Homo sapiens} PDB: 3jzn_A* 3k27_A* 3jpx_A* 3jzg_A* 3jzh_A* 3iiw_A* 3ijc_A* 3iiy_A* 3ij0_A* 3ij1_A* 2qxv_A | Back alignment and structure |
|---|
Probab=87.00 E-value=27 Score=35.41 Aligned_cols=164 Identities=7% Similarity=0.069 Sum_probs=86.4
Q ss_pred CCCCcEEeccCCCCCccccccccc---CCCCeeEEecCC-----CeEEEEEeCCCcEEEccCCCCCCCC-----CCceEE
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIY---RGPALQQLEAGN-----SHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSN 158 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~---~~~~~~~i~~G~-----~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~ 158 (768)
.+++.|..|-......+....... ....|..++--. ...++.-..||+|..|......... ...+..
T Consensus 41 ~~~~~v~vw~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~l~~~~~dg~i~v~d~~~~~~~~~~~~~~~~i~~ 120 (366)
T 3k26_A 41 VGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINE 120 (366)
T ss_dssp EETTEEEEEEECGGGCEEEEEEEECSCTTCCEEEEEEEECTTTCCEEEEEEETTCEEEEECTTTCCEEEEEESCCSCEEE
T ss_pred CCCCEEEEEEcCCCcEEEeeeeccccCCCCcEEEEEeccCCCCCCCEEEEecCCCEEEEEEchhceEeeeecCCCCcEEE
Confidence 456678888665444431111111 123355544321 1233333789999999754322111 334666
Q ss_pred EEe---cCCeEEEEeeCCeEEEecCCCCCCcccc----cCCCcCeEEEec--cCceeEEEecCCcEEEeecCCCCC----
Q 046311 159 IAV---GEDFVCGLLENGTITCFGSRNSPTSVTQ----KVPSGIFRVVAA--GFRHVCAIDDDQELRCWGDSVGEV---- 225 (768)
Q Consensus 159 v~~---G~~h~~~l~~~g~v~~wG~~~~g~~~~~----~~~~~~~~~i~~--G~~h~~al~~~g~v~~wG~n~~gq---- 225 (768)
++. ....-+.-..||+|..|=-... +.... ......+..++- -..+-+.-..||+|..|=-.....
T Consensus 121 ~~~~~~~~~~l~s~~~dg~i~iwd~~~~-~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~ 199 (366)
T 3k26_A 121 LKFHPRDPNLLLSVSKDHALRLWNIQTD-TLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAI 199 (366)
T ss_dssp EEECSSCTTEEEEEETTSCEEEEETTTT-EEEEEECSTTSCSSCEEEEEECTTSSEEEEEETTSCEEEEESCSHHHHHHH
T ss_pred EEECCCCCCEEEEEeCCCeEEEEEeecC-eEEEEecccccccCceeEEEECCCCCEEEEecCCCCEEEEECCCCcccccc
Confidence 654 3444555566899999964322 22111 112346666653 234444557789999996432110
Q ss_pred ------------------------------CCCCeEEEeccCCeeEEEeeCCeEEEEecCC
Q 046311 226 ------------------------------PQGKFKALALGENRSCALRNNQKVVCWGQNG 256 (768)
Q Consensus 226 ------------------------------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~ 256 (768)
....+..|+--..+-+.-..||.|..|=-..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~~wd~~~ 260 (366)
T 3k26_A 200 KESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGK 260 (366)
T ss_dssp HHHHTCCGGGCSSCCCCEEECCCSEEECSSCSSCCCEEEEETTEEEEECSSSEEEEEEESS
T ss_pred ceeEEecCCCCcccccceeeccCccccccCCcceEEEEEEcCCEEEEEecCCEEEEEeCCC
Confidence 1113444443345555556899999997554
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.05 E-value=0.24 Score=34.83 Aligned_cols=7 Identities=43% Similarity=0.591 Sum_probs=3.3
Q ss_pred EEEeehH
Q 046311 368 VALLVVG 374 (768)
Q Consensus 368 i~~ivv~ 374 (768)
++.++++
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4444555
|
| >3i2n_A WD repeat-containing protein 92; WD40 repeats, structural genomics, structural genomic consortium, SGC, apoptosis, transcription; 1.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.05 E-value=31 Score=34.84 Aligned_cols=200 Identities=14% Similarity=0.136 Sum_probs=105.3
Q ss_pred CCcEEeccCCCCCcccccccccCCCCeeEEecCCC----eEEEEEeCCCcEEEccCCCCC-CCC-----CCceEEEE---
Q 046311 94 SSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNS----HICGLVNGTNDLHWWQWPDFN-STS-----IHNFSNIA--- 160 (768)
Q Consensus 94 ~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~----h~~al~~~~g~~~~Wg~~~~~-~~~-----~~~~~~v~--- 160 (768)
||+|..|-.+. +++...........|..++-... ..++....||+|..|-..... ... ...+..+.
T Consensus 43 d~~v~iw~~~~-~~~~~~~~~~~~~~v~~~~~~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~~v~~~~~~~ 121 (357)
T 3i2n_A 43 TGVIQLYEIQH-GDLKLLREIEKAKPIKCGTFGATSLQQRYLATGDFGGNLHIWNLEAPEMPVYSVKGHKEIINAIDGIG 121 (357)
T ss_dssp CEEEEEEEECS-SSEEEEEEEEESSCEEEEECTTCCTTTCCEEEEETTSCEEEECTTSCSSCSEEECCCSSCEEEEEEES
T ss_pred CcEEEEEeCCC-CcccceeeecccCcEEEEEEcCCCCCCceEEEecCCCeEEEEeCCCCCccEEEEEecccceEEEeecc
Confidence 78888886553 33211111123345667765432 333333789999999765333 111 23355552
Q ss_pred -----ecCCeEEEEeeCCeEEEecCCCCCCcccc--cCC---CcCeEEEe------ccCceeEEEecCCcEEEeecCCCC
Q 046311 161 -----VGEDFVCGLLENGTITCFGSRNSPTSVTQ--KVP---SGIFRVVA------AGFRHVCAIDDDQELRCWGDSVGE 224 (768)
Q Consensus 161 -----~G~~h~~~l~~~g~v~~wG~~~~g~~~~~--~~~---~~~~~~i~------~G~~h~~al~~~g~v~~wG~n~~g 224 (768)
....+-+.-..||+|..|--......... ... ...+.+++ ....+.+.-..||+|+.|--....
T Consensus 122 ~~~~s~~~~~l~~~~~d~~i~vwd~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~ 201 (357)
T 3i2n_A 122 GLGIGEGAPEIVTGSRDGTVKVWDPRQKDDPVANMEPVQGENKRDCWTVAFGNAYNQEERVVCAGYDNGDIKLFDLRNMA 201 (357)
T ss_dssp GGGCC-CCCEEEEEETTSCEEEECTTSCSSCSEEECCCTTSCCCCEEEEEEECCCC-CCCEEEEEETTSEEEEEETTTTE
T ss_pred ccccCCCccEEEEEeCCCeEEEEeCCCCCCcceeccccCCCCCCceEEEEEEeccCCCCCEEEEEccCCeEEEEECccCc
Confidence 23345555566899999965433211110 001 12566665 344455555778999999654322
Q ss_pred C-----CCCCeEEEecc-----CCeeEEEeeCCeEEEEecCCCCCCCC-------CCCCCeEEEEecCCe--EEEEEecC
Q 046311 225 V-----PQGKFKALALG-----ENRSCALRNNQKVVCWGQNGFTLPDS-------LQGKPFVSIEAKRSV--FCGVLTSN 285 (768)
Q Consensus 225 q-----~~~~~~~ia~G-----~~h~~al~~dg~v~~WG~n~~gq~~~-------~~~~~~~~i~~g~~h--~~~l~~~~ 285 (768)
. ....+..++-- ...-++-..||+|+.|--........ .....+..++.-... ..+.-..|
T Consensus 202 ~~~~~~~~~~v~~~~~~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~d 281 (357)
T 3i2n_A 202 LRWETNIKNGVCSLEFDRKDISMNKLVATSLEGKFHVFDMRTQHPTKGFASVSEKAHKSTVWQVRHLPQNRELFLTAGGA 281 (357)
T ss_dssp EEEEEECSSCEEEEEESCSSSSCCEEEEEESTTEEEEEEEEEEETTTEEEEEEEECCSSCEEEEEEETTEEEEEEEEETT
T ss_pred eeeecCCCCceEEEEcCCCCCCCCEEEEECCCCeEEEEeCcCCCcccceeeeccCCCcCCEEEEEECCCCCcEEEEEeCC
Confidence 1 12356666543 33444445899999996443222210 223456655543332 22223689
Q ss_pred CeEEEEeCC
Q 046311 286 YSLYCWGNE 294 (768)
Q Consensus 286 g~~~~wG~n 294 (768)
|.++.|=-+
T Consensus 282 g~i~iwd~~ 290 (357)
T 3i2n_A 282 GGLHLWKYE 290 (357)
T ss_dssp SEEEEEEEE
T ss_pred CcEEEeecC
Confidence 999999544
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.23 E-value=2.1 Score=41.79 Aligned_cols=114 Identities=8% Similarity=0.106 Sum_probs=77.0
Q ss_pred CCCCceeEEEEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEecCCCCC
Q 046311 524 HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE-YLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 524 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~-yLH~~~~~~ivHrDiKp~ 602 (768)
.||++ -..+-.+++...+.|+.-+++.=+..++. .+...+++++.+|+.... +++.. +|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 68887 44455777777777776544333334432 477889999999887666 55543 78899999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhh-HHHHHHHHHHHHcCCcccc
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSD-VYSFGVVLLEILSGYRAIH 676 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sD-VwSlGvll~elltG~~p~~ 676 (768)
||+++.++.++|.-.|+-. -++|.-+ + ..| .-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE-------------------SLPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT-------------------TBSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998776532 2333321 1 223 2356678888888877664
|
| >3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* | Back alignment and structure |
|---|
Probab=84.83 E-value=82 Score=38.63 Aligned_cols=196 Identities=13% Similarity=0.146 Sum_probs=95.4
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEecCC-CeEEEEEeCCCcEEEccCCCCCCCC-----CCceEE--EEecC
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGN-SHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSN--IAVGE 163 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~-~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~--v~~G~ 163 (768)
..||++..|-... |+... .......+..++.-. ....+. ..||++..|......... ...+.. ++.-.
T Consensus 1022 ~~dg~i~vwd~~~-~~~~~--~~~~~~~v~~~~~~~~~~l~~~-~~dg~v~vwd~~~~~~~~~~~~~~~~v~~~~~s~d~ 1097 (1249)
T 3sfz_A 1022 SEDSVIQVWNWQT-GDYVF--LQAHQETVKDFRLLQDSRLLSW-SFDGTVKVWNVITGRIERDFTCHQGTVLSCAISSDA 1097 (1249)
T ss_dssp CSSSBEEEEETTT-TEEEC--CBCCSSCEEEEEECSSSEEEEE-ESSSEEEEEETTTTCCCEEEECCSSCCCCEEECSSS
T ss_pred cCCCEEEEEECCC-CceEE--EecCCCcEEEEEEcCCCcEEEE-ECCCcEEEEECCCCceeEEEcccCCcEEEEEECCCC
Confidence 5788999996543 33211 111223455554332 333344 789999999664222111 112322 33333
Q ss_pred CeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEe--ccCceeEEEecCCcEEEeecCCCCC---------------C
Q 046311 164 DFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVA--AGFRHVCAIDDDQELRCWGDSVGEV---------------P 226 (768)
Q Consensus 164 ~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~--~G~~h~~al~~~g~v~~wG~n~~gq---------------~ 226 (768)
.+-+.-..||+|..|--...............+..++ .-+..-..-..||+|+.|--..... .
T Consensus 1098 ~~l~s~s~d~~v~iwd~~~~~~~~~l~~h~~~v~~~~~s~dg~~lat~~~dg~i~vwd~~~~~~~~~~~~~~~~~~~~~~ 1177 (1249)
T 3sfz_A 1098 TKFSSTSADKTAKIWSFDLLSPLHELKGHNGCVRCSAFSLDGILLATGDDNGEIRIWNVSDGQLLHSCAPISVEEGTATH 1177 (1249)
T ss_dssp SSCEEECCSSCCCEECSSSSSCSBCCCCCSSCEEEEEECSSSSEEEEEETTSCCCEEESSSSCCCCCCCCCC-------C
T ss_pred CEEEEEcCCCcEEEEECCCcceeeeeccCCCcEEEEEECCCCCEEEEEeCCCEEEEEECCCCceEEEecccccccccccc
Confidence 3444455678999996433222211111124455554 3333333446789999996432111 0
Q ss_pred CCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCC--CCCCe--EEEEecCCeEEEEEecCCeEEEEe
Q 046311 227 QGKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSL--QGKPF--VSIEAKRSVFCGVLTSNYSLYCWG 292 (768)
Q Consensus 227 ~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~--~~~~~--~~i~~g~~h~~~l~~~~g~~~~wG 292 (768)
...+.+++--.+....+..+|+|..|--.....+... ....+ ..++..+.+.... ..||.++.|=
T Consensus 1178 ~~~v~~l~fs~dg~~l~s~~g~v~vwd~~~g~~~~~~~~~~~~i~~~~~s~dg~~l~~~-~~dg~v~vw~ 1246 (1249)
T 3sfz_A 1178 GGWVTDVCFSPDSKTLVSAGGYLKWWNVATGDSSQTFYTNGTNLKKIHVSPDFRTYVTV-DNLGILYILQ 1246 (1249)
T ss_dssp CSCCCEEEECTTSSCEEEESSSEEEBCSSSCBCCCCCCCSSCCCCCCEECSSSCCEEEE-CTTCCEEEEC
T ss_pred CceEEEEEECCCCCEEEECCCeEEEEECCCCceeeeeeccCCcccEEEECCCCCEEEEe-cCCcEEEEEe
Confidence 1134455443333333344588888864432222211 11222 3344444444554 7889999984
|
| >3v7d_B Cell division control protein 4; WD 40 domain, phospho-peptide complex, E3 ubiquitin ligase, cell cycle, phospho binding protein, phosphorylation; HET: SEP; 2.31A {Saccharomyces cerevisiae} PDB: 1nex_B* 3mks_B* | Back alignment and structure |
|---|
Probab=84.59 E-value=45 Score=35.46 Aligned_cols=171 Identities=8% Similarity=0.064 Sum_probs=95.2
Q ss_pred CeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEe--cCCeEEEEeeCCeEEEecCCCCCCcccc-c
Q 046311 119 ALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAV--GEDFVCGLLENGTITCFGSRNSPTSVTQ-K 190 (768)
Q Consensus 119 ~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~--G~~h~~~l~~~g~v~~wG~~~~g~~~~~-~ 190 (768)
.+..++.-+.+...- ..||+|..|......... ...+..++. -....+.-..||+|..|=-.. ++.... .
T Consensus 272 ~v~~~~~~~~~l~~~-~~d~~i~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~sg~~dg~i~vwd~~~-~~~~~~~~ 349 (464)
T 3v7d_B 272 SVRTVSGHGNIVVSG-SYDNTLIVWDVAQMKCLYILSGHTDRIYSTIYDHERKRCISASMDTTIRIWDLEN-GELMYTLQ 349 (464)
T ss_dssp CEEEEEEETTEEEEE-ETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTTTEEEEEETTSCEEEEETTT-TEEEEEEC
T ss_pred eEEEEcCCCCEEEEE-eCCCeEEEEECCCCcEEEEecCCCCCEEEEEEcCCCCEEEEEeCCCcEEEEECCC-CcEEEEEe
Confidence 456665544444444 789999999654222111 233555543 233455556689999996432 222111 1
Q ss_pred CCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC-------CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCC--
Q 046311 191 VPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV-------PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPD-- 261 (768)
Q Consensus 191 ~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq-------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~-- 261 (768)
.....+..++....+-+.-..||+|..|=-+...+ ....+..++..... ++...||+|..|=-.....+.
T Consensus 350 ~h~~~v~~~~~~~~~l~s~s~dg~v~vwd~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~dg~i~iwd~~~g~~~~~~ 428 (464)
T 3v7d_B 350 GHTALVGLLRLSDKFLVSAAADGSIRGWDANDYSRKFSYHHTNLSAITTFYVSDNI-LVSGSENQFNIYNLRSGKLVHAN 428 (464)
T ss_dssp CCSSCEEEEEECSSEEEEEETTSEEEEEETTTCCEEEEEECTTCCCEEEEEECSSE-EEEEETTEEEEEETTTCCEEESC
T ss_pred CCCCcEEEEEEcCCEEEEEeCCCcEEEEECCCCceeeeecCCCCccEEEEEeCCCE-EEEecCCeEEEEECCCCcEEehh
Confidence 12356777776677777778999999997654333 11144455554443 333458999999654322221
Q ss_pred -CCCCCCeEEEEecCCeEEEEEecCCeEEEEe
Q 046311 262 -SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWG 292 (768)
Q Consensus 262 -~~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG 292 (768)
......+..|+.-+....+....||.++.|-
T Consensus 429 ~~~~~~~v~~v~~~~~~l~~~~~~~g~~~i~~ 460 (464)
T 3v7d_B 429 ILKDADQIWSVNFKGKTLVAAVEKDGQSFLEI 460 (464)
T ss_dssp TTTTCSEEEEEEEETTEEEEEEEETTEEEEEE
T ss_pred hccCCCcEEEEEecCCEEEEEEEeCCeEEEEE
Confidence 2223456666544443333336788777764
|
| >3odt_A Protein DOA1; ubiquitin, nuclear protein; HET: MSE MES; 1.35A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=83.70 E-value=36 Score=33.57 Aligned_cols=196 Identities=8% Similarity=0.014 Sum_probs=101.9
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEe--cCCCeEEEEEeCCCcEEEccCCCCC--C-C-----CCCceEEEEe
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLE--AGNSHICGLVNGTNDLHWWQWPDFN--S-T-----SIHNFSNIAV 161 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~--~G~~h~~al~~~~g~~~~Wg~~~~~--~-~-----~~~~~~~v~~ 161 (768)
..||.|..|-... +++..... .....+..++ -.+.+.+.- ..||.+..|--.... . . ....+..++.
T Consensus 36 ~~dg~v~vw~~~~-~~~~~~~~-~~~~~v~~~~~~~~~~~l~~~-~~dg~i~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 112 (313)
T 3odt_A 36 SRDGTVRLWSKDD-QWLGTVVY-TGQGFLNSVCYDSEKELLLFG-GKDTMINGVPLFATSGEDPLYTLIGHQGNVCSLSF 112 (313)
T ss_dssp ETTSEEEEEEESS-SEEEEEEE-ECSSCEEEEEEETTTTEEEEE-ETTSCEEEEETTCCTTSCC-CEECCCSSCEEEEEE
T ss_pred EcCCcEEEEECCC-CEEEEEee-cCCccEEEEEECCCCCEEEEe-cCCCeEEEEEeeecCCCCcccchhhcccCEEEEEe
Confidence 5789999997633 22211000 1122344443 333344443 789999988543221 1 1 1345677777
Q ss_pred cCCeEEEEeeCCeEEEecCCCCCCccc-ccCCCcCeEEEec---cCceeEEEecCCcEEEeecCCCCC-----CCCCeEE
Q 046311 162 GEDFVCGLLENGTITCFGSRNSPTSVT-QKVPSGIFRVVAA---GFRHVCAIDDDQELRCWGDSVGEV-----PQGKFKA 232 (768)
Q Consensus 162 G~~h~~~l~~~g~v~~wG~~~~g~~~~-~~~~~~~~~~i~~---G~~h~~al~~~g~v~~wG~n~~gq-----~~~~~~~ 232 (768)
-...-+.-..||+|..|= .++... .......+..+.. .....+.-..||+|..|=....-+ ....+..
T Consensus 113 ~~~~l~~~~~d~~i~~~d---~~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~~~~~~i~~ 189 (313)
T 3odt_A 113 QDGVVISGSWDKTAKVWK---EGSLVYNLQAHNASVWDAKVVSFSENKFLTASADKTIKLWQNDKVIKTFSGIHNDVVRH 189 (313)
T ss_dssp ETTEEEEEETTSEEEEEE---TTEEEEEEECCSSCEEEEEEEETTTTEEEEEETTSCEEEEETTEEEEEECSSCSSCEEE
T ss_pred cCCEEEEEeCCCCEEEEc---CCcEEEecccCCCceeEEEEccCCCCEEEEEECCCCEEEEecCceEEEEeccCcccEEE
Confidence 666666677789999995 112111 1111234444432 445555567889999995221100 1124444
Q ss_pred EeccCC-eeEEEeeCCeEEEEecCCCCCCCC--CCCCCeEEEEecCC-eEEEEEecCCeEEEEeCC
Q 046311 233 LALGEN-RSCALRNNQKVVCWGQNGFTLPDS--LQGKPFVSIEAKRS-VFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 233 ia~G~~-h~~al~~dg~v~~WG~n~~gq~~~--~~~~~~~~i~~g~~-h~~~l~~~~g~~~~wG~n 294 (768)
++.-.+ .-++-..||+|+.|=-+....+.. .....+..++.-.. +.... ..||.|+.|--.
T Consensus 190 ~~~~~~~~~~~~~~dg~i~i~d~~~~~~~~~~~~~~~~i~~~~~~~~~~l~~~-~~dg~v~iwd~~ 254 (313)
T 3odt_A 190 LAVVDDGHFISCSNDGLIKLVDMHTGDVLRTYEGHESFVYCIKLLPNGDIVSC-GEDRTVRIWSKE 254 (313)
T ss_dssp EEEEETTEEEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEECTTSCEEEE-ETTSEEEEECTT
T ss_pred EEEcCCCeEEEccCCCeEEEEECCchhhhhhhhcCCceEEEEEEecCCCEEEE-ecCCEEEEEECC
Confidence 433211 233445899999997654322211 11234555554322 33333 689999999543
|
| >4g56_B MGC81050 protein; protein arginine methyltransferase, protein complexes, histo methylation, transferase; HET: SAH; 2.95A {Xenopus laevis} | Back alignment and structure |
|---|
Probab=82.78 E-value=47 Score=34.27 Aligned_cols=171 Identities=7% Similarity=0.074 Sum_probs=85.6
Q ss_pred CeeEEecC-CCeEEEEEeCCCcEEEccCCCCCCC--------C-CCceEEEEe--cCCeEEEEeeCCeEEEecCCCCCCc
Q 046311 119 ALQQLEAG-NSHICGLVNGTNDLHWWQWPDFNST--------S-IHNFSNIAV--GEDFVCGLLENGTITCFGSRNSPTS 186 (768)
Q Consensus 119 ~~~~i~~G-~~h~~al~~~~g~~~~Wg~~~~~~~--------~-~~~~~~v~~--G~~h~~~l~~~g~v~~wG~~~~g~~ 186 (768)
.|.+|+-- .....+- ..||+|..|--...... + ...|..|+. -..+-+.-..||+|..|=.+. ++.
T Consensus 96 ~V~~~~~s~d~~~l~~-s~dg~v~lWd~~~~~~~~~~~~~~~~h~~~V~~v~~spdg~~l~sgs~dg~v~iwd~~~-~~~ 173 (357)
T 4g56_B 96 GVTDVAWVSEKGILVA-SDSGAVELWEILEKESLLVNKFAKYEHDDIVKTLSVFSDGTQAVSGGKDFSVKVWDLSQ-KAV 173 (357)
T ss_dssp CEEEEEEETTTEEEEE-ETTSCEEEC--------CCCCEEECCCSSCEEEEEECSSSSEEEEEETTSCEEEEETTT-TEE
T ss_pred CEEEEEEcCCCCEEEE-ECCCEEEEeeccccceeEEEeeccCCCCCCEEEEEECCCCCEEEEEeCCCeEEEEECCC-CcE
Confidence 46666522 2333333 78999999954321111 1 223555543 333434445679999995332 222
Q ss_pred ccc-cCCCcCeEEEec---cCceeEEEecCCcEEEeecCCCCC--------CCCCeEEEecc--CCeeEEE-eeCCeEEE
Q 046311 187 VTQ-KVPSGIFRVVAA---GFRHVCAIDDDQELRCWGDSVGEV--------PQGKFKALALG--ENRSCAL-RNNQKVVC 251 (768)
Q Consensus 187 ~~~-~~~~~~~~~i~~---G~~h~~al~~~g~v~~wG~n~~gq--------~~~~~~~ia~G--~~h~~al-~~dg~v~~ 251 (768)
... ......+..|+. |....+.-..||+|..|=-..... ....+..|+.- ..+..|. ..||+|+.
T Consensus 174 ~~~~~~h~~~v~~v~~s~~~~~~~~s~~~dg~v~~wd~~~~~~~~~~~~~~~~~~v~~v~~sp~~~~~la~g~~d~~i~~ 253 (357)
T 4g56_B 174 LKSYNAHSSEVNCVAACPGKDTIFLSCGEDGRILLWDTRKPKPATRIDFCASDTIPTSVTWHPEKDDTFACGDETGNVSL 253 (357)
T ss_dssp EEEECCCSSCEEEEEECTTCSSCEEEEETTSCEEECCTTSSSCBCBCCCTTCCSCEEEEEECTTSTTEEEEEESSSCEEE
T ss_pred EEEEcCCCCCEEEEEEccCCCceeeeeccCCceEEEECCCCceeeeeeeccccccccchhhhhcccceEEEeecccceeE
Confidence 111 111245666653 333444557899999994322111 11246666642 2233333 57999999
Q ss_pred EecCCCCCCC--CCCCCCeEEEEe---cCCeEEEEEecCCeEEEEe
Q 046311 252 WGQNGFTLPD--SLQGKPFVSIEA---KRSVFCGVLTSNYSLYCWG 292 (768)
Q Consensus 252 WG~n~~gq~~--~~~~~~~~~i~~---g~~h~~~l~~~~g~~~~wG 292 (768)
|=-.....+. ......+..|+. |......- ..||+|+.|=
T Consensus 254 wd~~~~~~~~~~~~~~~~v~~l~~sp~~~~~lasg-s~D~~i~iwd 298 (357)
T 4g56_B 254 VNIKNPDSAQTSAVHSQNITGLAYSYHSSPFLASI-SEDCTVAVLD 298 (357)
T ss_dssp EESSCGGGCEEECCCSSCEEEEEECSSSSCCEEEE-ETTSCEEEEC
T ss_pred EECCCCcEeEEEeccceeEEEEEEcCCCCCEEEEE-eCCCEEEEEE
Confidence 9644322221 112235666653 33333333 6899999993
|
| >3mkq_A Coatomer beta'-subunit; beta-propeller, alpha-solenoid, transport protein; 2.50A {Saccharomyces cerevisiae} PDB: 2ynp_A | Back alignment and structure |
|---|
Probab=81.19 E-value=34 Score=39.68 Aligned_cols=200 Identities=9% Similarity=0.050 Sum_probs=98.8
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEe--cCCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEe--c
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLE--AGNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAV--G 162 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~--~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~--G 162 (768)
..||+|..|-... |+....-. .....|..++ ..+..-+.- ..||+|..|-.+...... ...+..++- -
T Consensus 32 ~~~g~v~iwd~~~-~~~~~~~~-~~~~~v~~~~~s~~~~~l~~~-~~dg~i~vw~~~~~~~~~~~~~~~~~v~~~~~s~~ 108 (814)
T 3mkq_A 32 LYSGRVEIWNYET-QVEVRSIQ-VTETPVRAGKFIARKNWIIVG-SDDFRIRVFNYNTGEKVVDFEAHPDYIRSIAVHPT 108 (814)
T ss_dssp ETTSEEEEEETTT-TEEEEEEE-CCSSCEEEEEEEGGGTEEEEE-ETTSEEEEEETTTCCEEEEEECCSSCEEEEEECSS
T ss_pred eCCCEEEEEECCC-CceEEEEe-cCCCcEEEEEEeCCCCEEEEE-eCCCeEEEEECCCCcEEEEEecCCCCEEEEEEeCC
Confidence 3678888886543 33211000 1222344443 222333333 789999999764332211 233555543 3
Q ss_pred CCeEEEEeeCCeEEEecCCCCCCcccc-cCCCcCeEEEec---cCceeEEEecCCcEEEeecCCCCC-------CCCCeE
Q 046311 163 EDFVCGLLENGTITCFGSRNSPTSVTQ-KVPSGIFRVVAA---GFRHVCAIDDDQELRCWGDSVGEV-------PQGKFK 231 (768)
Q Consensus 163 ~~h~~~l~~~g~v~~wG~~~~g~~~~~-~~~~~~~~~i~~---G~~h~~al~~~g~v~~wG~n~~gq-------~~~~~~ 231 (768)
..+-+.-..||+|..|--......... ......+..++- ....-+.-..||+|+.|--..... ....+.
T Consensus 109 ~~~l~~~~~dg~i~vw~~~~~~~~~~~~~~~~~~v~~~~~~p~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~~v~ 188 (814)
T 3mkq_A 109 KPYVLSGSDDLTVKLWNWENNWALEQTFEGHEHFVMCVAFNPKDPSTFASGCLDRTVKVWSLGQSTPNFTLTTGQERGVN 188 (814)
T ss_dssp SSEEEEEETTSEEEEEEGGGTSEEEEEEECCSSCEEEEEEETTEEEEEEEEETTSEEEEEETTCSSCSEEEECCCTTCCC
T ss_pred CCEEEEEcCCCEEEEEECCCCceEEEEEcCCCCcEEEEEEEcCCCCEEEEEeCCCeEEEEECCCCcceeEEecCCCCCEE
Confidence 334444556799999964322121111 111234555543 334445557889999996432221 112333
Q ss_pred EEec----cCCeeEEEeeCCeEEEEecCCCCCCC--CCCCCCeEEEEe--cCCeEEEEEecCCeEEEEeCCC
Q 046311 232 ALAL----GENRSCALRNNQKVVCWGQNGFTLPD--SLQGKPFVSIEA--KRSVFCGVLTSNYSLYCWGNES 295 (768)
Q Consensus 232 ~ia~----G~~h~~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i~~--g~~h~~~l~~~~g~~~~wG~n~ 295 (768)
.++. ....-+.-..||+|..|=......+. ......+..++. .+.+.+.. ..||+|+.|-.+.
T Consensus 189 ~~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~-~~dg~v~vwd~~~ 259 (814)
T 3mkq_A 189 YVDYYPLPDKPYMITASDDLTIKIWDYQTKSCVATLEGHMSNVSFAVFHPTLPIIISG-SEDGTLKIWNSST 259 (814)
T ss_dssp EEEECCSTTCCEEEEECTTSEEEEEETTTTEEEEEEECCSSCEEEEEECSSSSEEEEE-ETTSCEEEEETTT
T ss_pred EEEEEECCCCCEEEEEeCCCEEEEEECCCCcEEEEEcCCCCCEEEEEEcCCCCEEEEE-eCCCeEEEEECCC
Confidence 3332 33444444589999999644321111 011234544433 23333333 6799999996553
|
| >3mkq_A Coatomer beta'-subunit; beta-propeller, alpha-solenoid, transport protein; 2.50A {Saccharomyces cerevisiae} PDB: 2ynp_A | Back alignment and structure |
|---|
Probab=81.16 E-value=85 Score=36.15 Aligned_cols=197 Identities=7% Similarity=0.095 Sum_probs=97.7
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEecC--CCeEEEEEeCCCcEEEccCCCCCCCC------CCceEEEEe--
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAG--NSHICGLVNGTNDLHWWQWPDFNSTS------IHNFSNIAV-- 161 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G--~~h~~al~~~~g~~~~Wg~~~~~~~~------~~~~~~v~~-- 161 (768)
..||++..|-.+....+... ......|..++-- +.+.+. ...||+|..|-........ ...+..++-
T Consensus 74 ~~dg~i~vw~~~~~~~~~~~--~~~~~~v~~~~~s~~~~~l~~-~~~dg~i~vw~~~~~~~~~~~~~~~~~~v~~~~~~p 150 (814)
T 3mkq_A 74 SDDFRIRVFNYNTGEKVVDF--EAHPDYIRSIAVHPTKPYVLS-GSDDLTVKLWNWENNWALEQTFEGHEHFVMCVAFNP 150 (814)
T ss_dssp ETTSEEEEEETTTCCEEEEE--ECCSSCEEEEEECSSSSEEEE-EETTSEEEEEEGGGTSEEEEEEECCSSCEEEEEEET
T ss_pred eCCCeEEEEECCCCcEEEEE--ecCCCCEEEEEEeCCCCEEEE-EcCCCEEEEEECCCCceEEEEEcCCCCcEEEEEEEc
Confidence 47899999976543333111 0122345555532 223333 3789999999653221110 233555543
Q ss_pred -cCCeEEEEeeCCeEEEecCCCCCCcccccC---CCcCeEEEec--cCceeEEEecCCcEEEeecCCCCC------CCCC
Q 046311 162 -GEDFVCGLLENGTITCFGSRNSPTSVTQKV---PSGIFRVVAA--GFRHVCAIDDDQELRCWGDSVGEV------PQGK 229 (768)
Q Consensus 162 -G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~---~~~~~~~i~~--G~~h~~al~~~g~v~~wG~n~~gq------~~~~ 229 (768)
....-+.-..||+|+.|--........... ........+. ....-+.-..||+|+.|=...... ....
T Consensus 151 ~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~~~~~~ 230 (814)
T 3mkq_A 151 KDPSTFASGCLDRTVKVWSLGQSTPNFTLTTGQERGVNYVDYYPLPDKPYMITASDDLTIKIWDYQTKSCVATLEGHMSN 230 (814)
T ss_dssp TEEEEEEEEETTSEEEEEETTCSSCSEEEECCCTTCCCEEEECCSTTCCEEEEECTTSEEEEEETTTTEEEEEEECCSSC
T ss_pred CCCCEEEEEeCCCeEEEEECCCCcceeEEecCCCCCEEEEEEEECCCCCEEEEEeCCCEEEEEECCCCcEEEEEcCCCCC
Confidence 233444456689999996432211111111 1123334443 444555557889999996432211 1224
Q ss_pred eEEEecc--CCeeEEEeeCCeEEEEecCCCCCCC--CCCCCCeEEEEecCCe---EEEEEecCCeEEEEe
Q 046311 230 FKALALG--ENRSCALRNNQKVVCWGQNGFTLPD--SLQGKPFVSIEAKRSV---FCGVLTSNYSLYCWG 292 (768)
Q Consensus 230 ~~~ia~G--~~h~~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i~~g~~h---~~~l~~~~g~~~~wG 292 (768)
+..++.. ...-+.-..||+|+.|-.+....+. ......+..++..... ..+. ..++.+..|-
T Consensus 231 v~~~~~~~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~-~~~~~~~~~~ 299 (814)
T 3mkq_A 231 VSFAVFHPTLPIIISGSEDGTLKIWNSSTYKVEKTLNVGLERSWCIATHPTGRKNYIAS-GFDNGFTVLS 299 (814)
T ss_dssp EEEEEECSSSSEEEEEETTSCEEEEETTTCSEEEEECCSSSSEEEEEECTTCGGGEEEE-EETTEEEEEE
T ss_pred EEEEEEcCCCCEEEEEeCCCeEEEEECCCCcEEEEeecCCCcEEEEEEccCCCceEEEE-EeCCCEEEEE
Confidence 5555433 3333444478999999655422211 1112355555533221 2444 4566677664
|
| >1vyh_C Platelet-activating factor acetylhydrolase IB alpha subunit; lissencephaly, platelet activacting factor, regulator of cytoplasmic dynein; 3.4A {Mus musculus} SCOP: b.69.4.1 | Back alignment and structure |
|---|
Probab=81.07 E-value=59 Score=34.24 Aligned_cols=196 Identities=12% Similarity=0.234 Sum_probs=98.5
Q ss_pred CCCCcEEeccCCCCCccccccccc--CCCCeeEEecC-CCeEEEEEeCCCcEEEccCCCCCCC----C-CCceEEEEe--
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIY--RGPALQQLEAG-NSHICGLVNGTNDLHWWQWPDFNST----S-IHNFSNIAV-- 161 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~--~~~~~~~i~~G-~~h~~al~~~~g~~~~Wg~~~~~~~----~-~~~~~~v~~-- 161 (768)
..||+|..|-... |++ .... ....|..|+-- ....++.-..||+|..|-......+ + ...+..++.
T Consensus 127 s~Dg~i~vwd~~~-~~~---~~~l~~h~~~V~~v~~~~~~~~l~sgs~D~~i~iwd~~~~~~~~~~~~h~~~V~~v~~~p 202 (410)
T 1vyh_C 127 SEDATIKVWDYET-GDF---ERTLKGHTDSVQDISFDHSGKLLASCSADMTIKLWDFQGFECIRTMHGHDHNVSSVSIMP 202 (410)
T ss_dssp ESSSCEEEEETTT-CCC---CEEECCCSSCEEEEEECTTSSEEEEEETTSCCCEEETTSSCEEECCCCCSSCEEEEEECS
T ss_pred eCCCeEEEEECCC-CcE---EEEEeccCCcEEEEEEcCCCCEEEEEeCCCeEEEEeCCCCceeEEEcCCCCCEEEEEEeC
Confidence 5789999996543 332 1121 12345555532 2223333378999999965432211 1 233555543
Q ss_pred cCCeEEEEeeCCeEEEecCCCCCCcccc-cCCCcCeEEEe--ccCceeEEEecCCcEEEeecCCCCC------CCCCeEE
Q 046311 162 GEDFVCGLLENGTITCFGSRNSPTSVTQ-KVPSGIFRVVA--AGFRHVCAIDDDQELRCWGDSVGEV------PQGKFKA 232 (768)
Q Consensus 162 G~~h~~~l~~~g~v~~wG~~~~g~~~~~-~~~~~~~~~i~--~G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ 232 (768)
...+-+.-..||+|..|--.. ++.... ......+..++ ..+..-..-..||+|..|=-..... ....+..
T Consensus 203 ~~~~l~s~s~D~~i~~wd~~~-~~~~~~~~~h~~~v~~~~~~~~g~~l~s~s~D~~v~vwd~~~~~~~~~~~~h~~~v~~ 281 (410)
T 1vyh_C 203 NGDHIVSASRDKTIKMWEVQT-GYCVKTFTGHREWVRMVRPNQDGTLIASCSNDQTVRVWVVATKECKAELREHRHVVEC 281 (410)
T ss_dssp SSSEEEEEETTSEEEEEETTT-CCEEEEEECCSSCEEEEEECTTSSEEEEEETTSCEEEEETTTCCEEEEECCCSSCEEE
T ss_pred CCCEEEEEeCCCeEEEEECCC-CcEEEEEeCCCccEEEEEECCCCCEEEEEcCCCeEEEEECCCCceeeEecCCCceEEE
Confidence 344555556789999996432 221111 11112344433 2333344446789999995332111 1113444
Q ss_pred Eecc----------------------CCeeEEEeeCCeEEEEecCCCCCCC--CCCCCCeEEE--EecCCeEEEEEecCC
Q 046311 233 LALG----------------------ENRSCALRNNQKVVCWGQNGFTLPD--SLQGKPFVSI--EAKRSVFCGVLTSNY 286 (768)
Q Consensus 233 ia~G----------------------~~h~~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i--~~g~~h~~~l~~~~g 286 (768)
|+-. +.+-..-..||+|..|--.....+. ......+..+ +..+.+...- ..||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~~l~sgs~D~~i~iwd~~~~~~~~~~~~h~~~v~~v~~~~~g~~l~s~-s~D~ 360 (410)
T 1vyh_C 282 ISWAPESSYSSISEATGSETKKSGKPGPFLLSGSRDKTIKMWDVSTGMCLMTLVGHDNWVRGVLFHSGGKFILSC-ADDK 360 (410)
T ss_dssp EEECCSCGGGGGGGCCSCC-------CCEEEEEETTSEEEEEETTTTEEEEEEECCSSCEEEEEECSSSSCEEEE-ETTT
T ss_pred EEEcCcccccchhhhccccccccCCCCCEEEEEeCCCeEEEEECCCCceEEEEECCCCcEEEEEEcCCCCEEEEE-eCCC
Confidence 4321 2233334579999999754321111 0112234444 3344455444 6899
Q ss_pred eEEEEeC
Q 046311 287 SLYCWGN 293 (768)
Q Consensus 287 ~~~~wG~ 293 (768)
+|+.|=.
T Consensus 361 ~i~vwd~ 367 (410)
T 1vyh_C 361 TLRVWDY 367 (410)
T ss_dssp EEEEECC
T ss_pred eEEEEEC
Confidence 9999944
|
| >1gxr_A ESG1, transducin-like enhancer protein 1; transcriptional CO-repressor, WD40, transcription repressor, WD repeat; 1.65A {Homo sapiens} SCOP: b.69.4.1 PDB: 2ce8_A 2ce9_A | Back alignment and structure |
|---|
Probab=81.07 E-value=46 Score=33.06 Aligned_cols=212 Identities=8% Similarity=0.035 Sum_probs=101.8
Q ss_pred EeeCCCeeeeeeeeccCCCCcEEeccCCCCCccc--ccc------cccCCCCeeEEecC-CCeEEEEEeCCCcEEEccCC
Q 046311 76 IVSGDGFLCTLITFSASSSSVMHCWRFSADGIIN--DYK------RIYRGPALQQLEAG-NSHICGLVNGTNDLHWWQWP 146 (768)
Q Consensus 76 v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~--~~~------~~~~~~~~~~i~~G-~~h~~al~~~~g~~~~Wg~~ 146 (768)
+..+.-..+++ ..||.+...+....+.+. .+. .......|..++-- ....++. ..||++..|-..
T Consensus 7 ~~~~~v~~~~~-----s~dg~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~v~~~~~~~~~~~l~~-~~dg~i~iw~~~ 80 (337)
T 1gxr_A 7 MGSKPAYSFHV-----TADGQMQPVPFPPDALIGPGIPRHARQINTLNHGEVVCAVTISNPTRHVYT-GGKGCVKVWDIS 80 (337)
T ss_dssp EEEEECCEEEE-----CSSSCEEECCCCTTSSSSTTCCSEEEEEEEECCSSCCCEEEECSSSSEEEE-ECBSEEEEEETT
T ss_pred ccCCceeEEEE-----CCCCCEEEeecCCCcEeccccCCccccceeccCCCceEEEEEecCCcEEEE-cCCCeEEEEECC
Confidence 33444455666 677777777665444331 000 11122345555432 2233344 349999999664
Q ss_pred CCCCC----------CCCceEEEEe--cCCeEEEEeeCCeEEEecCCCCCC-c-ccccCCCcCeEEEe--ccCceeEEEe
Q 046311 147 DFNST----------SIHNFSNIAV--GEDFVCGLLENGTITCFGSRNSPT-S-VTQKVPSGIFRVVA--AGFRHVCAID 210 (768)
Q Consensus 147 ~~~~~----------~~~~~~~v~~--G~~h~~~l~~~g~v~~wG~~~~g~-~-~~~~~~~~~~~~i~--~G~~h~~al~ 210 (768)
..... ....+..++. ....-+.-..||+|..|=-..... . .........+..++ ....+-..-.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 160 (337)
T 1gxr_A 81 HPGNKSPVSQLDCLNRDNYIRSCKLLPDGCTLIVGGEASTLSIWDLAAPTPRIKAELTSSAPACYALAISPDSKVCFSCC 160 (337)
T ss_dssp STTCCSCSEEEECSCTTSBEEEEEECTTSSEEEEEESSSEEEEEECCCC--EEEEEEECSSSCEEEEEECTTSSEEEEEE
T ss_pred CCCceeeeecccccCCCCcEEEEEEcCCCCEEEEEcCCCcEEEEECCCCCcceeeecccCCCceEEEEECCCCCEEEEEe
Confidence 32211 1223444433 233444446679999996443221 1 11111123455544 3444555557
Q ss_pred cCCcEEEeecCCCCC------CCCCeEEEec--cCCeeEEEeeCCeEEEEecCCCCCCC-CCCCCCeEEEEe--cCCeEE
Q 046311 211 DDQELRCWGDSVGEV------PQGKFKALAL--GENRSCALRNNQKVVCWGQNGFTLPD-SLQGKPFVSIEA--KRSVFC 279 (768)
Q Consensus 211 ~~g~v~~wG~n~~gq------~~~~~~~ia~--G~~h~~al~~dg~v~~WG~n~~gq~~-~~~~~~~~~i~~--g~~h~~ 279 (768)
.||+|+.|=-..... ....+..++. ...+-+.-..||.|+.|--.....+. ......+..++. .+.+.+
T Consensus 161 ~dg~v~~~d~~~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~~~~~v~~~~~s~~~~~l~ 240 (337)
T 1gxr_A 161 SDGNIAVWDLHNQTLVRQFQGHTDGASCIDISNDGTKLWTGGLDNTVRSWDLREGRQLQQHDFTSQIFSLGYCPTGEWLA 240 (337)
T ss_dssp TTSCEEEEETTTTEEEEEECCCSSCEEEEEECTTSSEEEEEETTSEEEEEETTTTEEEEEEECSSCEEEEEECTTSSEEE
T ss_pred CCCcEEEEeCCCCceeeeeecccCceEEEEECCCCCEEEEEecCCcEEEEECCCCceEeeecCCCceEEEEECCCCCEEE
Confidence 889999996543221 1224555544 33344444579999999654322111 111123333332 222333
Q ss_pred EEEecCCeEEEEeCC
Q 046311 280 GVLTSNYSLYCWGNE 294 (768)
Q Consensus 280 ~l~~~~g~~~~wG~n 294 (768)
.- ..||.++.|=..
T Consensus 241 ~~-~~~~~i~~~~~~ 254 (337)
T 1gxr_A 241 VG-MESSNVEVLHVN 254 (337)
T ss_dssp EE-ETTSCEEEEETT
T ss_pred EE-cCCCcEEEEECC
Confidence 22 567777777443
|
| >2zwa_A Leucine carboxyl methyltransferase 2; HET: SAH CIT; 1.70A {Saccharomyces cerevisiae} PDB: 2zw9_A* 2zzk_A* | Back alignment and structure |
|---|
Probab=81.03 E-value=13 Score=43.00 Aligned_cols=169 Identities=8% Similarity=-0.118 Sum_probs=89.4
Q ss_pred CCeeeeeeeeccCC-CCcEEeccCCCC-CcccccccccCC--CCeeEEe----cCCCeEEEEEeCCCcEEEccCCCCCC-
Q 046311 80 DGFLCTLITFSASS-SSVMHCWRFSAD-GIINDYKRIYRG--PALQQLE----AGNSHICGLVNGTNDLHWWQWPDFNS- 150 (768)
Q Consensus 80 ~~~~c~l~~~~~~~-~g~~~~WG~n~~-gql~~~~~~~~~--~~~~~i~----~G~~h~~al~~~~g~~~~Wg~~~~~~- 150 (768)
.+|+++. .. ++.+|..|.... ++...-..++.. ..|..++ .=..|++++ ..+|.+|..|......
T Consensus 441 ~~hs~~~-----~~~~~~lyv~GG~~~~~~~~~dv~~yd~~t~~W~~~~~~p~~R~~h~~~~-~~~~~iyv~GG~~~~~~ 514 (695)
T 2zwa_A 441 MCHTFTT-----ISRNNQLLLIGGRKAPHQGLSDNWIFDMKTREWSMIKSLSHTRFRHSACS-LPDGNVLILGGVTEGPA 514 (695)
T ss_dssp BSCEEEE-----ETTTTEEEEECCBSSTTCBCCCCEEEETTTTEEEECCCCSBCCBSCEEEE-CTTSCEEEECCBCSSCS
T ss_pred cceEEEE-----EccCCEEEEEcCCCCCCCccccEEEEeCCCCcEEECCCCCCCcccceEEE-EcCCEEEEECCCCCCCC
Confidence 4688777 34 889999986433 211111112211 1344442 224677776 5699999998643222
Q ss_pred -----CCCCceEEEEe-------cCCeEEEE-eeC-CeEEEecCCC-CCCccc-----ccCCCcC------eEEEec---
Q 046311 151 -----TSIHNFSNIAV-------GEDFVCGL-LEN-GTITCFGSRN-SPTSVT-----QKVPSGI------FRVVAA--- 201 (768)
Q Consensus 151 -----~~~~~~~~v~~-------G~~h~~~l-~~~-g~v~~wG~~~-~g~~~~-----~~~~~~~------~~~i~~--- 201 (768)
.....+..++. =..|++++ ..+ |++|++|... .+.... -...... |..+..
T Consensus 515 v~~yd~~t~~W~~~~~~g~~p~~r~~~~a~v~~~~~~~iyv~GG~~~~~~~~~~~v~~yd~~~~~w~~~~~W~~~~~~p~ 594 (695)
T 2zwa_A 515 MLLYNVTEEIFKDVTPKDEFFQNSLVSAGLEFDPVSKQGIILGGGFMDQTTVSDKAIIFKYDAENATEPITVIKKLQHPL 594 (695)
T ss_dssp EEEEETTTTEEEECCCSSGGGGSCCBSCEEEEETTTTEEEEECCBCTTSSCBCCEEEEEEECTTCSSCCEEEEEEEECGG
T ss_pred EEEEECCCCceEEccCCCCCCCcccceeEEEEeCCCCEEEEECCcCCCCCeeeCcEEEEEccCCccccceEEEEcCCCCC
Confidence 11344666653 23566444 444 8999999542 221100 0111123 666643
Q ss_pred --cCceeEEEecCCcEEEeecCCCCC---CC----------CCeEEEec-----------cCCeeEEEeeCCeEEEEec
Q 046311 202 --GFRHVCAIDDDQELRCWGDSVGEV---PQ----------GKFKALAL-----------GENRSCALRNNQKVVCWGQ 254 (768)
Q Consensus 202 --G~~h~~al~~~g~v~~wG~n~~gq---~~----------~~~~~ia~-----------G~~h~~al~~dg~v~~WG~ 254 (768)
-..|++++..||++|..|...... .. ..|..+.. -..|+++...||+++..|-
T Consensus 595 ~~R~~~~~~~~~~~~iyv~GG~~~~~~~~~~~~v~~yd~~t~~W~~~~~p~~~~~~~~p~~~gh~~~~~~~g~i~v~GG 673 (695)
T 2zwa_A 595 FQRYGSQIKYITPRKLLIVGGTSPSGLFDRTNSIISLDPLSETLTSIPISRRIWEDHSLMLAGFSLVSTSMGTIHIIGG 673 (695)
T ss_dssp GCCBSCEEEEEETTEEEEECCBCSSCCCCTTTSEEEEETTTTEEEECCCCHHHHHHSCCCCSSCEEECC---CEEEECC
T ss_pred CCcccceEEEeCCCEEEEECCccCCCCCCCCCeEEEEECCCCeEEEeeccccccCCCCccceeeeEEEeCCCEEEEEeC
Confidence 246888887779999998542211 11 13443321 1237777777778888874
|
| >4aez_A CDC20, WD repeat-containing protein SLP1; cell cycle, KEN-BOX, D-BOX, APC/C; 2.30A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=80.53 E-value=59 Score=33.92 Aligned_cols=200 Identities=11% Similarity=0.107 Sum_probs=103.1
Q ss_pred CCCCcEEeccCCCCCcccccccccCCCCeeEEec--CCCeEEEEEeCCCcEEEccCCCCCCC-----CCCceEEEEecCC
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRGPALQQLEA--GNSHICGLVNGTNDLHWWQWPDFNST-----SIHNFSNIAVGED 164 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~--G~~h~~al~~~~g~~~~Wg~~~~~~~-----~~~~~~~v~~G~~ 164 (768)
..|++|+.|-... |+............|..|+- .+.+. +.-..||.|..|-....... ....+..++....
T Consensus 110 ~~d~~v~lw~~~~-~~~~~~~~~~~~~~v~~v~~s~~~~~l-~~~~~dg~i~iwd~~~~~~~~~~~~~~~~v~~~~~~~~ 187 (401)
T 4aez_A 110 ALERNVYVWNADS-GSVSALAETDESTYVASVKWSHDGSFL-SVGLGNGLVDIYDVESQTKLRTMAGHQARVGCLSWNRH 187 (401)
T ss_dssp EETTEEEEEETTT-CCEEEEEECCTTCCEEEEEECTTSSEE-EEEETTSCEEEEETTTCCEEEEECCCSSCEEEEEEETT
T ss_pred ECCCeEEEeeCCC-CcEeEeeecCCCCCEEEEEECCCCCEE-EEECCCCeEEEEECcCCeEEEEecCCCCceEEEEECCC
Confidence 5789999997644 33311111112334555553 23333 33378999999965432211 1345777777666
Q ss_pred eEEEEeeCCeEEEecCCCCCCcc-cccCCCcCeEEEec--cCceeEEEecCCcEEEeecCCCCC------CCCCeEEEec
Q 046311 165 FVCGLLENGTITCFGSRNSPTSV-TQKVPSGIFRVVAA--GFRHVCAIDDDQELRCWGDSVGEV------PQGKFKALAL 235 (768)
Q Consensus 165 h~~~l~~~g~v~~wG~~~~g~~~-~~~~~~~~~~~i~~--G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ia~ 235 (768)
..+.-..||+|..|=-...+... ........+..++- -+.+-..-..||+|..|=-..... ....+..|+-
T Consensus 188 ~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~s~~~d~~v~iwd~~~~~~~~~~~~~~~~v~~~~~ 267 (401)
T 4aez_A 188 VLSSGSRSGAIHHHDVRIANHQIGTLQGHSSEVCGLAWRSDGLQLASGGNDNVVQIWDARSSIPKFTKTNHNAAVKAVAW 267 (401)
T ss_dssp EEEEEETTSEEEEEETTSSSCEEEEEECCSSCEEEEEECTTSSEEEEEETTSCEEEEETTCSSEEEEECCCSSCCCEEEE
T ss_pred EEEEEcCCCCEEEEecccCcceeeEEcCCCCCeeEEEEcCCCCEEEEEeCCCeEEEccCCCCCccEEecCCcceEEEEEE
Confidence 66666778999999754322221 11111245555543 333444447789999996543211 1124444443
Q ss_pred c--CCeeEEEe---eCCeEEEEecCCCCCCC-CCCCCCeEEEEe--cCCeEEEEEe--cCCeEEEEeCC
Q 046311 236 G--ENRSCALR---NNQKVVCWGQNGFTLPD-SLQGKPFVSIEA--KRSVFCGVLT--SNYSLYCWGNE 294 (768)
Q Consensus 236 G--~~h~~al~---~dg~v~~WG~n~~gq~~-~~~~~~~~~i~~--g~~h~~~l~~--~~g~~~~wG~n 294 (768)
- ..+-.+.. .||+|..|=-.....+. ......+..++. .+...+.. . .||.++.|=..
T Consensus 268 ~p~~~~ll~~~~gs~d~~i~i~d~~~~~~~~~~~~~~~v~~~~~s~~~~~l~~~-~g~~dg~i~v~~~~ 335 (401)
T 4aez_A 268 CPWQSNLLATGGGTMDKQIHFWNAATGARVNTVDAGSQVTSLIWSPHSKEIMST-HGFPDNNLSIWSYS 335 (401)
T ss_dssp CTTSTTEEEEECCTTTCEEEEEETTTCCEEEEEECSSCEEEEEECSSSSEEEEE-ECTTTCEEEEEEEE
T ss_pred CCCCCCEEEEecCCCCCEEEEEECCCCCEEEEEeCCCcEEEEEECCCCCeEEEE-eecCCCcEEEEecC
Confidence 2 23333333 48999999654322111 111223444433 22223222 2 58888888543
|
| >3k26_A Polycomb protein EED; WD40, structural genomics, NPPSFA, national project on prote structural and functional analysis, structural genomics CON SGC; HET: M3L; 1.58A {Homo sapiens} PDB: 3jzn_A* 3k27_A* 3jpx_A* 3jzg_A* 3jzh_A* 3iiw_A* 3ijc_A* 3iiy_A* 3ij0_A* 3ij1_A* 2qxv_A | Back alignment and structure |
|---|
Probab=80.01 E-value=39 Score=34.18 Aligned_cols=197 Identities=9% Similarity=0.085 Sum_probs=99.8
Q ss_pred CCCCcEEeccCCCCCcccccccc-cCCCCeeEEec---CCCeEEEEEeCCCcEEEccCCCCCC--------CCCCceEEE
Q 046311 92 SSSSVMHCWRFSADGIINDYKRI-YRGPALQQLEA---GNSHICGLVNGTNDLHWWQWPDFNS--------TSIHNFSNI 159 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~-~~~~~~~~i~~---G~~h~~al~~~~g~~~~Wg~~~~~~--------~~~~~~~~v 159 (768)
..||+|..|-.+. +++. ... .....|..|+- .+...+.- ..||+|+.|-...... .....+..+
T Consensus 92 ~~dg~i~v~d~~~-~~~~--~~~~~~~~~i~~~~~~~~~~~~l~s~-~~dg~i~iwd~~~~~~~~~~~~~~~~~~~v~~~ 167 (366)
T 3k26_A 92 GSRGIIRIINPIT-MQCI--KHYVGHGNAINELKFHPRDPNLLLSV-SKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSA 167 (366)
T ss_dssp ETTCEEEEECTTT-CCEE--EEEESCCSCEEEEEECSSCTTEEEEE-ETTSCEEEEETTTTEEEEEECSTTSCSSCEEEE
T ss_pred cCCCEEEEEEchh-ceEe--eeecCCCCcEEEEEECCCCCCEEEEE-eCCCeEEEEEeecCeEEEEecccccccCceeEE
Confidence 5789999996554 3321 111 12335666664 23333333 7899999996542211 112345555
Q ss_pred Ee--cCCeEEEEeeCCeEEEecCCCCCCcc---------c-------------------ccCCCcCeEEEeccCceeEEE
Q 046311 160 AV--GEDFVCGLLENGTITCFGSRNSPTSV---------T-------------------QKVPSGIFRVVAAGFRHVCAI 209 (768)
Q Consensus 160 ~~--G~~h~~~l~~~g~v~~wG~~~~g~~~---------~-------------------~~~~~~~~~~i~~G~~h~~al 209 (768)
+. -..+-+.-..||+|..|=-....... + .......+..|+--..+.+.-
T Consensus 168 ~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~ 247 (366)
T 3k26_A 168 DYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSK 247 (366)
T ss_dssp EECTTSSEEEEEETTSCEEEEESCSHHHHHHHHHHHTCCGGGCSSCCCCEEECCCSEEECSSCSSCCCEEEEETTEEEEE
T ss_pred EECCCCCEEEEecCCCCEEEEECCCCccccccceeEEecCCCCcccccceeeccCccccccCCcceEEEEEEcCCEEEEE
Confidence 53 23344444568999999643210000 0 000112344444324455555
Q ss_pred ecCCcEEEeecCCCCCC------C-C-------------CeEEE--ecc--CCeeEEEeeCCeEEEEecCCCCCC-----
Q 046311 210 DDDQELRCWGDSVGEVP------Q-G-------------KFKAL--ALG--ENRSCALRNNQKVVCWGQNGFTLP----- 260 (768)
Q Consensus 210 ~~~g~v~~wG~n~~gq~------~-~-------------~~~~i--a~G--~~h~~al~~dg~v~~WG~n~~gq~----- 260 (768)
..||+|..|=-....+. . . .+..+ +.. ..+-..-..||.|+.|--+.....
T Consensus 248 ~~d~~i~~wd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~s~~~~~~~l~~~~~dg~i~vwd~~~~~~~~~~~~ 327 (366)
T 3k26_A 248 SCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCT 327 (366)
T ss_dssp CSSSEEEEEEESSTTCCGGGCCTTCCCEEEEEEEECSSCCSSCCCCEECTTSSEEEEECTTSCEEEEECCSSSGGGCEEE
T ss_pred ecCCEEEEEeCCCccccccccccCCcchheeccccccCCcEEEEEEcCCCCCcEEEEEecCCcEEEEECCCCCCccccce
Confidence 77999999975433220 0 0 12122 111 333344457899999976543211
Q ss_pred --CCC-CCCCeEEEEe--cCCeEEEEEecCCeEEEEeC
Q 046311 261 --DSL-QGKPFVSIEA--KRSVFCGVLTSNYSLYCWGN 293 (768)
Q Consensus 261 --~~~-~~~~~~~i~~--g~~h~~~l~~~~g~~~~wG~ 293 (768)
... ....+..++- -+.+...- ..||.|+.|=-
T Consensus 328 ~~~~~~~~~~v~~~~~s~~~~~l~s~-~~dg~i~iwd~ 364 (366)
T 3k26_A 328 TLTHHKCGAAIRQTSFSRDSSILIAV-CDDASIWRWDR 364 (366)
T ss_dssp EECCTTCCSCEEEEEECTTSSEEEEE-ETTSEEEEEEC
T ss_pred EEcccccCCceEEEEeCCCCCeEEEE-eCCCEEEEEEe
Confidence 111 1244555543 33344444 78999999943
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 768 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 5e-06 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 5e-05 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 0.001 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 9e-06 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 3e-05 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 5e-05 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 8e-71
Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 38/295 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ +IGSGSFG VYK VAVK +++ + + AF NE+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPT---------PQQLQAFKNEVG 56
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L + H N++ +G+ + ++ ++ E +L+ HLH ++ I +A
Sbjct: 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFE---MIKLIDIARQ 112
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A+G++YLH SIIHRD+KS+N+ L T K+ DFGL+ + SH + +G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 639 VGYMDPEYYRLQQ---LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
+ +M PE R+Q + +SDVY+FG+VL E+++G +N
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------------- 214
Query: 696 RDEIHRVLDRNVPPPTPFEI--EAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
RD+I ++ R P ++ + L A+C+ + RP +I+ S+E
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-65
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 36/289 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++G+G FG V+ + ++VAVK K+ +AF+ E
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL------------KQGSMSPDAFLAEAN 60
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H+ LVRL +I EY+ENG+L D L P + + +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQ 117
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A G+ ++ E + IHRD++++N+L+ T + K++DFGL+ + D+E A
Sbjct: 118 IAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFP 173
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
+ + PE T KSDV+SFG++L EI++ R + E
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------NPE 218
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ + L+R P Y L C +RP+ + + LE
Sbjct: 219 VIQNLERGYRMVRPDNCPEELY--QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-63
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 36/290 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ + +IGSG FG V+ + +VA+K + + FI E E
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI------------REGAMSEEDFIEEAE 52
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H LV+L G C ++ L++E++E+G L D+L + L + + + LD
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLD 109
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
G+ YL E +IHRD+ + N L+ KVSDFG++ DD+ S
Sbjct: 110 VCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFP 165
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
V + PE + + + KSDV+SFGV++ E+ S + + + E
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------------NSE 210
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
+ + P Y + C +RP+ + ++ L
Sbjct: 211 VVEDISTGFRLYKPRLASTHVY--QIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 2e-63
Identities = 70/303 (23%), Positives = 118/303 (38%), Gaps = 38/303 (12%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
IG G FG V++ G +VAVK +E++ E+ L H
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIF------------SSREERSWFREAEIYQTVMLRH 56
Query: 526 KNLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAAR 581
+N++ + N + L+ +Y E+G+L D+L+ + IK+AL A
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTAS 111
Query: 582 GIEYLHEYAV-----PSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLSLR 634
G+ +LH V P+I HRD+KS N+L+ T ++D GL+ D
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 635 AAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688
GT YM PE + +++D+Y+ G+V EI +
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 689 FVVPYIVRDEIHRVLDRNVPPPTP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745
V + V ++ + P P EA+ + + +C G R + I +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291
Query: 746 LER 748
L +
Sbjct: 292 LSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 2e-62
Identities = 70/321 (21%), Positives = 136/321 (42%), Gaps = 49/321 (15%)
Query: 446 LEEFSLEILLEATNNFSE---------DHKIGSGSFGAVYKATLDDGSQ----VAVKRAE 492
++ F+ E EA F++ + IG+G FG V L + VA+K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-- 61
Query: 493 ISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGT 552
+ + E + F++E + + H N++ L G ++I E++ENG+
Sbjct: 62 --------LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 113
Query: 553 LHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612
L L + + + A G++YL + + +HRD+ + N+L+++
Sbjct: 114 LDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVC 167
Query: 613 KVSDFGLSLIGPEDDESHLSLRA---AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEIL 669
KVSDFGLS +D A + + PE + ++ T SDV+S+G+V+ E++
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227
Query: 670 SGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCV 729
S + ++ ++++ P P + + + L DC
Sbjct: 228 SYGERPYWDMT---------------NQDVINAIEQDYRLPPPMDCPSALHQ--LMLDCW 270
Query: 730 TLEGRNRPSMTEIVNSLERAL 750
+ +RP +IVN+L++ +
Sbjct: 271 QKDRNHRPKFGQIVNTLDKMI 291
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-61
Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 36/289 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ + ++G+G FG V VA+K K ++ FI E +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI------------KEGSMSEDEFIEEAK 51
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ L H+ LV+L G C + +I EY+ NG L ++L + +++ D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ---TQQLLEMCKD 108
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+EYL +HRD+ + N L++ KVSDFGLS DDE S+ +
Sbjct: 109 VCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
V + PE + + KSD+++FGV++ EI S + + E
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------------NSE 209
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ + + P Y + C + RP+ +++++
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYT--IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-61
Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 24/306 (7%)
Query: 451 LEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDK 509
+E+ ++F + ++G+G+ G V+K + G +A K I + +
Sbjct: 1 MEL---KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL----------IHLEIKPAI 47
Query: 510 DNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSW 569
N I EL+ L + +V G E + E+++ G+L L + +
Sbjct: 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRI-PE 103
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDES 629
KV++ +G+ YL E I+HRD+K SN+L+++ K+ DFG+S +
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689
++ GT YM PE + + +SD++S G+ L+E+ G I +
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
V + R P + + D + E + +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 750 LAACLV 755
+ CL+
Sbjct: 278 VNKCLI 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-60
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 42/291 (14%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
IG G FG V G++VAVK + + AF+ E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-------------KNDATAQAFLAEAS 52
Query: 519 SLSRLHHKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+++L H NLV+LLG E++ ++ EY+ G+L D+L + + S L +K +L
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVL-GGDCLLKFSL 110
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
D +EYL + +HRD+ + NVL+ AKVSDFGL+ ++
Sbjct: 111 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKL 162
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
V + PE R ++ + KSDV+SFG++L EI S R +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------------LK 207
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
++ +++ P Y + +C L+ RPS ++ LE
Sbjct: 208 DVVPRVEKGYKMDAPDGCPPAVY--EVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-60
Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 38/300 (12%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKATL---DDGSQVAVKRAEISSTSSYAIGTKRQED 508
++ L+ N D ++G G+FG+V + VA+K + ++
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV----------LKQGTEKA 51
Query: 509 KDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
+ E + + +L + +VRL+G C+ +L+ E G LH L + P
Sbjct: 52 DTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP--- 107
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDD 627
++ + G++YL E + +HRD+ + NVLL AK+SDFGLS +G +D
Sbjct: 108 VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV 687
+ + PE ++ + +SDV+S+GV + E LS + ++ G
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------ 218
Query: 688 DFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
E+ +++ P E Y L +DC + +RP + +
Sbjct: 219 ---------PEVMAFIEQGKRMECPPECPPELY--ALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 6e-60
Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 59/327 (18%)
Query: 450 SLEILLEATNNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGT 503
SLE NN IG G+FG V++A + + VAVK +
Sbjct: 7 SLEY---PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM----------LKE 53
Query: 504 KRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSS 563
+ D F E ++ + N+V+LLG C L++EY+ G L++ L +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 564 SPLK--------------------SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSN 603
+ S ++ +A A G+ YL E +HRD+ + N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 604 VLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGV 663
L+ K++DFGLS D A + +M PE + T +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 664 VLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY 723
VL EI S + + I+ V D N+ +
Sbjct: 231 VLWEIFSYGLQPYYGMA--------------HEEVIYYVRDGNILACPENCPLELY---N 273
Query: 724 LAADCVTLEGRNRPSMTEIVNSLERAL 750
L C + +RPS I L+R
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRMC 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (513), Expect = 1e-59
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 36/304 (11%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + HK+G G +G VY+ VAVK K + F+ E
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT------------LKEDTMEVEEFLKEA 64
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+ + H NLV+LLG C +I E++ G L D+L S + +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMAT 122
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ +EYL + + IHRD+ + N L+ KV+DFGLS + D A
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKF 178
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
+ + PE + + KSDV++FGV+L EI + + + +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LS 223
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757
+++ +L+++ P Y L C +RPS EI + E +S
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
Query: 758 SISR 761
+ +
Sbjct: 282 EVEK 285
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-59
Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 50/314 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
N S +G+G+FG V +AT D VAVK + + A
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM----------LKPSAHLTEREA 72
Query: 513 FINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK---- 567
++EL+ LS L +H N+V LLG C ++I EY G L + L + S
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 568 ----------SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
+ + A+G+ +L + IHRD+ + N+LL K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDF 189
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
GL+ D + A V +M PE T +SDV+S+G+ L E+ S + +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737
V + ++++ +P A Y + C + RP
Sbjct: 250 GMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMY--DIMKTCWDADPLKRP 293
Query: 738 SMTEIVNSLERALA 751
+ +IV +E+ ++
Sbjct: 294 TFKQIVQLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 77/315 (24%), Positives = 123/315 (39%), Gaps = 55/315 (17%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQ------VAVKRAEISSTSSYAIGTKRQEDKDNA 512
N +GSG+FG V AT S+ VAVK + K + A
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM----------LKEKADSSEREA 86
Query: 513 FINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK---- 567
++EL+ +++L H+N+V LLG C LI+EY G L ++L + +
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146
Query: 568 ---------------SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612
++ + A A+G+E+L S +HRD+ + NVL+
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVV 203
Query: 613 KVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY 672
K+ DFGL+ D + A V +M PE T KSDV+S+G++L EI S
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 673 RAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLE 732
+ V ++++ PF Y+ + C +
Sbjct: 264 VNPYPGIP--------------VDANFYKLIQNGFKMDQPFYATEEIYI--IMQSCWAFD 307
Query: 733 GRNRPSMTEIVNSLE 747
R RPS + + L
Sbjct: 308 SRKRPSFPNLTSFLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 36/289 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ + K+G G FG V+ T + ++VA+K K AF+ E +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL------------KPGTMSPEAFLQEAQ 64
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+ +L H+ LV+L ++ EY+ G+L D L + P + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 121
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
A G+ Y+ + +HRD++++N+L+ KV+DFGL+ + ED+E A
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFP 177
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
+ + PE + T KSDV+SFG++L E+ + R + E
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NRE 222
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ ++R P P E + L C E RP+ + LE
Sbjct: 223 VLDQVERGYRMPCPPECPESLH--DLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-58
Identities = 72/300 (24%), Positives = 128/300 (42%), Gaps = 39/300 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQ-----VAVKRAEISSTSSYAIGTKRQEDKDNAF 513
+ + IG+G FG VYK L S VA+K + E + F
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT----------LKAGYTEKQRVDF 56
Query: 514 INELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI 573
+ E + + H N++RL G ++I EY+ENG L L S +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLV 113
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLS 632
+ A G++YL + +HRD+ + N+L+++ KVSDFGLS ++ + + ++ +
Sbjct: 114 GMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692
+ + PE ++ T SDV+SFG+V+ E+++ + +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------ 218
Query: 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752
E+ + ++ PTP + + Y L C E RP +IV+ L++ + A
Sbjct: 219 ---NHEVMKAINDGFRLPTPMDCPSAIY--QLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-58
Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 38/289 (13%)
Query: 463 EDHKIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
ED ++GSG+FG V K VAVK + + + + E
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANV 61
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
+ +L + +VR++G CE +L+ E E G L+ +L + I++
Sbjct: 62 MQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQV 116
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSLRAAGT 638
+ G++YL E + +HRD+ + NVLL AK+SDFGLS + +++
Sbjct: 117 SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
V + PE + + KSDV+SFGV++ E S + +R G E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------------SE 218
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+ +L++ P Y L C T + NRP + L
Sbjct: 219 VTAMLEKGERMGCPAGCPREMY--DLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 34/290 (11%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
++ + IG+GS+G K DG + K + S + E + ++E+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---------EAEKQMLVSEVN 55
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVL--IYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
L L H N+VR DR L + EY E G L + ++V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 577 LDAARGIEYLHE--YAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
++ H +++HRD+K +NV LD K+ DFGL+ I + ++ +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
GT YM PE EKSD++S G +L E+ +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------- 219
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
E+ + P+ + + L+ +RPS+ EI+
Sbjct: 220 --KELAGKIREGKFRRIPYRYSDELN--EIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 86/309 (27%), Positives = 123/309 (39%), Gaps = 51/309 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQ---VAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
N+ IG G+FG V KA + A+KR + +D F
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR----------MKEYASKDDHRDFAG 59
Query: 516 ELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHN-------------PQ 561
ELE L +L HH N++ LLG CE R L EY +G L D L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 562 SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621
++S L S + A D ARG++YL + IHRD+ + N+L+ + AK++DFGLS
Sbjct: 120 TASTL-SSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 622 IGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681
+ V +M E T SDV+S+GV+L EI+S +
Sbjct: 176 GQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT- 231
Query: 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741
E++ L + P + Y L C + RPS +
Sbjct: 232 --------------CAELYEKLPQGYRLEKPLNCDDEVY--DLMRQCWREKPYERPSFAQ 275
Query: 742 IVNSLERAL 750
I+ SL R L
Sbjct: 276 ILVSLNRML 284
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 2e-57
Identities = 68/308 (22%), Positives = 114/308 (37%), Gaps = 44/308 (14%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELES 519
FS+ +IG GSFGAVY A + + VA+K+ S K+ +K I E+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRF 68
Query: 520 LSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDA 579
L +L H N ++ G + L+ EY + + PL V A
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PL-QEVEIAAVTHGA 124
Query: 580 ARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTV 639
+G+ YLH ++IHRD+K+ N+LL K+ DFG + I + GT
Sbjct: 125 LQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTP 175
Query: 640 GYMDPEYYRLQ---QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
+M PE Q K DV+S G+ +E+ + +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------M 220
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAACL 754
++ + P C+ ++RP+ ++ + R +
Sbjct: 221 SALYHIAQNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278
Query: 755 VSPSISRS 762
+ I R+
Sbjct: 279 IMDLIQRT 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 41/287 (14%)
Query: 464 DHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
D +IG GSF VYK + +VA + + + + F E E L
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---------KSERQRFKEEAEMLKG 64
Query: 523 LHHKNLVRLLGFCED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L H N+VR E + VL+ E + +GTL +L +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK----IKVLRSWCRQ 120
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+G+++LH P IIHRD+K N+ + T + K+ D GL+ + + + G
Sbjct: 121 ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIG 175
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697
T +M PE Y ++ E DVY+FG+ +LE+ + N
Sbjct: 176 TPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN---------------AA 219
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+I+R + V P F+ A+ V + C+ R S+ +++N
Sbjct: 220 QIYRRVTSGVKPA-SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-57
Identities = 77/313 (24%), Positives = 126/313 (40%), Gaps = 42/313 (13%)
Query: 460 NFSEDHKIGSGSFGAVYKATLDDGSQ----VAVKRAEISSTSSYAIGTKRQEDKDNAFIN 515
+F+E IG G FG VY TL D AVK + + + F+
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKS----------LNRITDIGEVSQFLT 77
Query: 516 ELESLSRLHHKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E + H N++ LLG C +++ Y+++G L + + N + I
Sbjct: 78 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIG 134
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDDESHLS 632
L A+G + A +HRD+ + N +LD +T KV+DFGL+ + E D H
Sbjct: 135 FGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692
A V +M E + Q+ T KSDV+SFGV+L E+++ + N
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------------ 239
Query: 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752
+I L + P Y + C + RPS +E+V+ + +
Sbjct: 240 ---TFDITVYLLQGRRLLQPEYCPDPLYE--VMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 753 CLVSPSISRSATS 765
+ + +AT
Sbjct: 295 FIGEHYVHVNATY 307
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 66/288 (22%), Positives = 109/288 (37%), Gaps = 35/288 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
++ +G G++G V A VAVK + KR D E+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI----------VDMKRAVDCPENIKKEI 54
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L+H+N+V+ G + N + L EY G L D + P +
Sbjct: 55 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFH 110
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
G+ YLH I HRDIK N+LLD K+SDFGL+ + ++ L + G
Sbjct: 111 QLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 638 TVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
T+ Y+ PE + ++ E DV+S G+VL +L+G + +
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--------------SC 213
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
E ++ +I++ L + R ++ +I
Sbjct: 214 QEYSDWKEKKTYLNPWKKIDSAPL--ALLHKILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 8e-56
Identities = 70/298 (23%), Positives = 110/298 (36%), Gaps = 46/298 (15%)
Query: 448 EFSLEILLEATNNFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQ 506
+++LE +F +G G FG VY A +A+K + +
Sbjct: 2 QWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE--------K 46
Query: 507 EDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPL 566
++ E+E S L H N++RL G+ D LI EY GT++ L S
Sbjct: 47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKF 103
Query: 567 KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
+ A + Y H +IHRDIK N+LL + K++DFG S+ P
Sbjct: 104 -DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686
+ L GT+ Y+ PE + EK D++S GV+ E L G
Sbjct: 160 RRTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------- 208
Query: 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
++ R+ P A L + + RP + E++
Sbjct: 209 --------YQETYKRISRVEFTFPDFVTEGARD----LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 61/292 (20%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 461 FSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA---FINE 516
F + +GSG+FG VYK + +G +V + AI R+ A ++E
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---------VAIKELREATSPKANKEILDE 61
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
++ + + ++ RLLG C + LI + + G L D++ + + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG---SQYLLNWC 117
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ A+G+ YL + ++HRD+ + NVL+ K++DFGL+ + +++ + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
+ +M E + T +SDV+S+GV + E+++ +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------------A 219
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748
EI +L++ P P Y+ + C ++ +RP E++ +
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYM--IMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 36/296 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
+ K+G GSFG V + D VAVK + S Q + + FI
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--------QPEAMDDFI 59
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E+ ++ L H+NL+RL G + ++ E G+L D L Q +
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSR 115
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDDESHLSL 633
A+ A G+ YL IHRD+ + N+LL K+ DFGL + DD +
Sbjct: 116 YAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693
+ PE + + + SD + FGV L E+ + + NG
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------ 220
Query: 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
+H++ P P + Y + C + +RP+ + + L A
Sbjct: 221 --SQILHKIDKEGERLPRPEDCPQDIY--NVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 58/285 (20%), Positives = 108/285 (37%), Gaps = 41/285 (14%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++G G+FG VYKA + A K + + E++ ++ E++ L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVID-----------TKSEEELEDYMVEIDILASCD 67
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N+V+LL N ++ E+ G + + + PL + V +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPL-TESQIQVVCKQTLDALN 124
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH+ IIHRD+K+ N+L K++DFG+S + S GT +M P
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179
Query: 645 EYYRLQQL-----TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699
E + K+DV+S G+ L+E+ H + +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----------------MRV 223
Query: 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+ ++ PP + C+ R + ++++
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 75/314 (23%), Positives = 122/314 (38%), Gaps = 51/314 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL--------DDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
+ +G G+FG V A + ++VAVK + + E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----------LKSDATEKDL 62
Query: 511 NAFINELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK-- 567
+ I+E+E + + HKN++ LLG C +I EY G L ++L +
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122
Query: 568 ----------SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617
S + A ARG+EYL IHRD+ + NVL+ K++DF
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677
GL+ D + V +M PE + T +SDV+SFGV+L EI + + +
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239
Query: 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737
+E+ ++L P Y+ + DC RP
Sbjct: 240 GVP---------------VEELFKLLKEGHRMDKPSNCTNELYM--MMRDCWHAVPSQRP 282
Query: 738 SMTEIVNSLERALA 751
+ ++V L+R +A
Sbjct: 283 TFKQLVEDLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-53
Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 39/296 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
IG G FG V++ + VA+K + + + F+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----------SDSVREKFL 56
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
E ++ + H ++V+L+G + N +I E G L L + S + I
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLD---LASLIL 112
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
A + + YL +HRDI + NVL+ + K+ DFGLS ED + + +
Sbjct: 113 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASK 168
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
+ +M PE ++ T SDV+ FGV + EIL +
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------------- 214
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750
+++ ++ P P Y L C + RP TE+ L L
Sbjct: 215 -NNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 67/309 (21%), Positives = 121/309 (39%), Gaps = 42/309 (13%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
++ KIG G+ G VY A + G +VA+++ +Q+ K INE
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-----------LQQQPKKELIINE 67
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+ + + N+V L +E ++ EYL G+L D + V
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVC 122
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ + +E+LH +IHRDIKS N+LL + K++DFG E
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMV 177
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
GT +M PE + K D++S G++ +E++ G +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---------------L 222
Query: 697 DEIHRVLDRNVPPPT-PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERALAAC 753
++ + P P ++ A+ C+ ++ R S E++ L+ A
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 754 LVSPSISRS 762
++P I+ +
Sbjct: 281 SLTPLIAAA 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-52
Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 42/304 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL------DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
+ ++G GSFG VY+ + ++VA+K + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT----------VNEAASMRERIE 69
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQ------SSSPL 566
F+NE + + ++VRLLG ++I E + G L +L + +
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 567 KSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPED 626
S I++A + A G+ YL+ +HRD+ + N ++ +T K+ DFG++ E
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 627 DESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686
D + V +M PE + T SDV+SFGVVL EI + ++ +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 240
Query: 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
+ V++ + + + L C + RPS EI++S+
Sbjct: 241 --------NEQVLRFVMEGGLLDKPDNCPDMLF---ELMRMCWQYNPKMRPSFLEIISSI 289
Query: 747 ERAL 750
+ +
Sbjct: 290 KEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-51
Identities = 77/314 (24%), Positives = 122/314 (38%), Gaps = 49/314 (15%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT------LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
+ +G G+FG V +A VAVK + +T + A
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----------HSEHRA 62
Query: 513 FINELESLSR-LHHKNLVRLLGFC-EDRNERVLIYEYLENGTLHDHLHNPQSSSPLK--- 567
++EL+ L HH N+V LLG C + ++I E+ + G L +L + ++
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 568 ---------SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618
+ I + A+G+E+L IHRD+ + N+LL K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRT 678
L+ +D + A + +M PE + T +SDV+SFGV+L EI S + +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 679 HNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS 738
+ +E R L P Y DC E RP+
Sbjct: 240 VK--------------IDEEFCRRLKEGTRMRAPDYTTPEMY--QTMLDCWHGEPSQRPT 283
Query: 739 MTEIVNSLERALAA 752
+E+V L L A
Sbjct: 284 FSELVEHLGNLLQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 35/289 (12%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+F +G GSF V A L + A+K E E+K E +
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--------ENKVPYVTRERD 60
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
+SRL H V+L +D + Y +NG L ++ S +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAE 116
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+EYLH IIHRD+K N+LL+ +++DFG + + + + + GT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 639 VGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698
Y+ PE + + SD+++ G ++ ++++G R N
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN--------------EYLI 218
Query: 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747
+++ P F +A L + L+ R E+
Sbjct: 219 FQKIIKLEYDFPEKFFPKARD----LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (431), Expect = 2e-48
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 37/300 (12%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
++ + +G G V+ A L VAVK R F E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--------ARDPSFYLRFRRE 57
Query: 517 LESLSRLHHKNLVRLLGFCEDRNER----VLIYEYLENGTLHDHLHNPQSSSPLKSWPAR 572
++ + L+H +V + E ++ EY++ TL D +H +
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRA 113
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
I+V DA + + + H+ IIHRD+K +N+++ AT KV DFG++ + S
Sbjct: 114 IEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 633 LRA-AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
A GT Y+ PE R + +SDVYS G VL E+L+G
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----------- 219
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-SMTEIVNSLERAL 750
++ + + PP+ A + + + NR + E+ L R
Sbjct: 220 ----VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (435), Expect = 4e-48
Identities = 53/289 (18%), Positives = 107/289 (37%), Gaps = 38/289 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+++ ++G+G+FG V++ T G+ A K E E+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-----------MTPHESDKETVRKEI 74
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+++S L H LV L ED NE V+IYE++ G L + + + + ++
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMR 131
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLL--DATWTAKVSDFGLSLIGPEDDESHLSLRA 635
+G+ ++HE + +H D+K N++ + K+ DFGL+ D
Sbjct: 132 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVT 185
Query: 636 AGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695
GT + PE + + +D++S GV+ +LSG ++
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------------- 230
Query: 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+ + V + + + R ++ + +
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 5e-48
Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 38/282 (13%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
++GSG+FG V++ G K NE+ +++LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFIN-----------TPYPLDKYTVKNEISIMNQLH 84
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H L+ L ED+ E VLI E+L G L D + I A G++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYMRQACEGLK 141
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDAT--WTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
++HE SI+H DIK N++ + + K+ DFGL+ D+ T +
Sbjct: 142 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFA 195
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
PE + + +D+++ GV+ +LSG + + + V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------------LETLQNV 240
Query: 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+ + + E R R ++ + +
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 4e-47
Identities = 54/288 (18%), Positives = 101/288 (35%), Gaps = 33/288 (11%)
Query: 458 TNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINE 516
+ + +G+G+F V A VA+K I K E K+ + NE
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC----------IAKKALEGKEGSMENE 57
Query: 517 LESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+ L ++ H N+V L E LI + + G L D + + ++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLI 113
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
++YLH+ + + LD +SDFGLS + +D + A
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC 170
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696
GT GY+ PE + ++ D +S GV+ +L GY + ++
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---------------A 215
Query: 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
++L +P+ + + + R + + +
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 7e-47
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 35/293 (11%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
N+ +G G V + + AVK I T + + ++ A + E++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKI--IDVTGGGSFSAEEVQELREATLKEVD 61
Query: 519 SLSRLH-HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L ++ H N+++L E L+++ ++ G L D+L + S K+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMR 117
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
I LH+ +I+HRD+K N+LLD K++DFG S + D G
Sbjct: 118 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCG 171
Query: 638 TVGYMDPEYYRLQQL------TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691
T Y+ PE ++ D++S GV++ +L+G
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------- 220
Query: 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
+ ++ N +P + V L + + ++ + R + E +
Sbjct: 221 ----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 47/282 (16%), Positives = 98/282 (34%), Gaps = 39/282 (13%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+G G FG V++ K K + E+ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKF------------VKVKGTDQVLVKKEISILNIAR 59
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H+N++ L E E V+I+E++ + + ++ S+ L + + ++
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFEL-NEREIVSYVHQVCEALQ 116
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDA--TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYM 642
+LH +I H DI+ N++ + T K+ +FG + D L Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYY 170
Query: 643 DPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIHRV 702
PE ++ ++ +D++S G ++ +LSG N + I +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------------QQIIENI 215
Query: 703 LDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
++ E + E ++R + +E +
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 4e-45
Identities = 62/261 (23%), Positives = 100/261 (38%), Gaps = 30/261 (11%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N+FS IG G FG VY D G A+K + I K+ E L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-----IKMKQGETLALNERIML 58
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+S +V + ++ I + + G LH HL + S A
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAA 114
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ G+E++H +++RD+K +N+LLD ++SD GL+ + G
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----G 167
Query: 638 TVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSGYR-----------AIHRTHNGTPRN 685
T GYM PE + +D +S G +L ++L G+ I R
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 686 VVDFVVPYIVRDEIHRVLDRN 706
+ D P +R + +L R+
Sbjct: 228 LPDSFSPE-LRSLLEGLLQRD 247
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 2e-42
Identities = 63/261 (24%), Positives = 109/261 (41%), Gaps = 31/261 (11%)
Query: 449 FSLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQE 507
+SL+ +F +G+GSFG V+ +G A+K +
Sbjct: 1 YSLQ-------DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--------L 45
Query: 508 DKDNAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLK 567
+ +E LS + H ++R+ G +D + +I +Y+E G L L S
Sbjct: 46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRF 101
Query: 568 SWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDD 627
P A + +EYLH II+RD+K N+LLD K++DFG + P+
Sbjct: 102 PNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI-HRTHNGTPRNV 686
+ GT Y+ PE + + D +SFG+++ E+L+GY T +
Sbjct: 159 YTL-----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
Query: 687 V--DFVVPYIVRDEIHRVLDR 705
+ + P +++ +L R
Sbjct: 214 LNAELRFPPFFNEDVKDLLSR 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 42/311 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + ++GSG F V K G Q A K + T S G R++ E+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-----IEREV 64
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L + H N++ L E++ + +LI E + G L D L +S + +
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLK 120
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLD----ATWTAKVSDFGLSLIGPEDDESHLSL 633
G+ YLH I H D+K N++L K+ DFGL+ +E
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 174
Query: 634 RAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693
GT ++ PE + L ++D++S GV+ +LSG
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------- 221
Query: 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN-------SL 746
++ + V N + A + + + R ++ + +
Sbjct: 222 --QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 747 ERALAACLVSP 757
++AL++ P
Sbjct: 280 QQALSSAWSHP 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 19/217 (8%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+F +G GSFG V+ A A+K + +D + E
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--------DDDVECTMVEK 53
Query: 518 ESLSR-LHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
LS H L + + + + EYL G L H+ + A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYA 109
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAA 636
+ G+++LH I++RD+K N+LLD K++DFG+ D +
Sbjct: 110 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--C 164
Query: 637 GTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
GT Y+ PE Q+ D +SFGV+L E+L G
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-42
Identities = 58/300 (19%), Positives = 103/300 (34%), Gaps = 24/300 (8%)
Query: 457 ATNNFSEDHKIGSGSFGAVYKAT--LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
A + +IG G++G V+KA + G VA+KR + + G + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREV 58
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLH--DHLHNPQSSSPLKSWPAR 572
L L H N+VRL C L + + + P
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118
Query: 573 IKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLS 632
+ RG+++LH + ++HRD+K N+L+ ++ K++DFGL+ I
Sbjct: 119 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-- 173
Query: 633 LRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI-HRTHNGTPRNVVDFV- 690
T+ Y PE D++S G + E+ + ++D +
Sbjct: 174 -SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 691 ------VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
P V ++ P F + L C+T R S ++
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 6e-42
Identities = 59/301 (19%), Positives = 102/301 (33%), Gaps = 39/301 (12%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N + KIGSGSFG +Y T + G +VA+K + + K E
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------------ECVKTKHPQLHIES 53
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
+ + + + +C + ++ L +L D + S S + +A
Sbjct: 54 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLAD 110
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVL---LDATWTAKVSDFGLSLIGPEDDES----- 629
IEY+H + IHRD+K N L + DFGL+ +
Sbjct: 111 QMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 630 HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF 689
+ GT Y + + + + D+ S G VL+ G T R +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 690 VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749
+ + I VL + P E Y+ + C +L ++P + +
Sbjct: 228 ISEKKMSTPI-EVLCKGYPS------EFATYLNF----CRSLRFDDKPDYSYLRQLFRNL 276
Query: 750 L 750
Sbjct: 277 F 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (375), Expect = 1e-40
Identities = 52/304 (17%), Positives = 95/304 (31%), Gaps = 43/304 (14%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
++ +IG GSFG +++ T L + QVA+K + + +E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------------EPRRSDAPQLRDEY 51
Query: 518 ESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVA 576
+ L + + F ++ VL+ + L S A
Sbjct: 52 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAA 107
Query: 577 LDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-----TWTAKVSDFGLSLIGPEDDES-- 629
++ +HE S+++RDIK N L+ V DFG+ +
Sbjct: 108 KQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 630 ---HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686
+GT YM + ++ + + D+ + G V + L G T +
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSL 746
+ + + R L P E Y+ Y L P +
Sbjct: 225 YERIGEKKQSTPL-RELCAGFPE------EFYKYMHY----ARNLAFDATPDYDYLQGLF 273
Query: 747 ERAL 750
+ L
Sbjct: 274 SKVL 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 37/310 (11%)
Query: 454 LLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNA 512
+ + ++ IG G++G V A + +VA+K+ I +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKK----------ISPFEHQTYCQR 52
Query: 513 FINELESLSRLHHKNLVRLLGFCEDRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKS 568
+ E++ L R H+N++ + + V + +L L+ L S
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LS 107
Query: 569 WPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS-LIGPEDD 627
RG++Y+H +++HRD+K SN+LL+ T K+ DFGL+ + P+ D
Sbjct: 108 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSG------------YRA 674
+ T Y PE + T+ D++S G +L E+LS
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224
Query: 675 IHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGR 734
I + ++ ++ R+ + + +N P A + L +T
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
Query: 735 NRPSMTEIVN 744
R + + +
Sbjct: 285 KRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-40
Identities = 56/290 (19%), Positives = 101/290 (34%), Gaps = 44/290 (15%)
Query: 464 DHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR 522
+G G G V + + A+K E+E R
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML----------------QDCPKARREVELHWR 60
Query: 523 L-HHKNLVRLLGFCED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
++VR++ E+ R +++ E L+ G L + + + + ++
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAF-TEREASEIMK 118
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW---TAKVSDFGLSLIGPEDDESHLSLR 634
I+YLH +I HRD+K N+L + K++DFG + +
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---T 172
Query: 635 AAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694
T Y+ PE ++ + D++S GV++ +L GY + H I
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------I 221
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
R+ P P E V L + + E R ++TE +N
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 57/291 (19%), Positives = 113/291 (38%), Gaps = 28/291 (9%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+G G F VYKA + VA+K+ ++ S + ++ + + E++ L L
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------EAKDGINRTALREIKLLQELS 58
Query: 525 HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIE 584
H N++ LL ++ L+++++E N S + + L +G+E
Sbjct: 59 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLE 114
Query: 585 YLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDP 644
YLH++ I+HRD+K +N+LLD K++DFGL+ + ++ T Y P
Sbjct: 115 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 645 EYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIH-RTHNGTPRNVVDFVVPYIVRD----- 697
E ++ D+++ G +L E+L + + + + +
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAAD----CVTLEGRNRPSMTEIVN 744
+ + P P + G D R + T+ +
Sbjct: 230 SLPDYVTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (366), Expect = 2e-39
Identities = 58/298 (19%), Positives = 113/298 (37%), Gaps = 31/298 (10%)
Query: 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
+ KIG G++G VYKA + G A+K+ + K E + I E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE---------KEDEGIPSTTIREIS 52
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L L H N+V+L + VL++E+L+ L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQ 108
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
GI Y H+ ++HRD+K N+L++ K++DFGL+ + T
Sbjct: 109 LLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVT 163
Query: 639 VGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN-----------GTPRNV 686
+ Y P+ ++ + D++S G + E+++G GTP +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
V + + + + + +P + + + + L + + L+ R + + +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID-LLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 29/297 (9%)
Query: 460 NFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELE 518
NF + KIG G++G VYKA G VA+K+ + E + I E+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD---------TETEGVPSTAIREIS 53
Query: 519 SLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALD 578
L L+H N+V+LL N+ L++E+L + + P P
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP---LPLIKSYLFQ 110
Query: 579 AARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGT 638
+G+ + H ++HRD+K N+L++ K++DFGL+ ++ T
Sbjct: 111 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVT 165
Query: 639 VGYMDPE-YYRLQQLTEKSDVYSFGVVLLEILSGYRAIH-RTHNGTPRNVVDFVV--PYI 694
+ Y PE + + D++S G + E+++ + + + +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAAD-------CVTLEGRNRPSMTEIVN 744
V + + D P + V L D + + R S +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 61/284 (21%), Positives = 100/284 (35%), Gaps = 45/284 (15%)
Query: 466 KIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH 524
+GSG FG+VY + D VA+K E S + E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-----WGELPNGTRVPMEVVLLKKVS 65
Query: 525 --HKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARG 582
++RLL + E + VLI E E + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ---EELARSFFWQVLEA 122
Query: 583 IEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGY 641
+ + H ++HRDIK N+L+D K+ DFG + + + GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVY 175
Query: 642 MDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDEIH 700
PE+ R + + V+S G++L +++ G P+ +EI
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEEII 217
Query: 701 RVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744
R E + L C+ L +RP+ EI N
Sbjct: 218 R-GQVFFRQRVSSECQH------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 78/315 (24%), Positives = 114/315 (36%), Gaps = 63/315 (20%)
Query: 460 NFSEDHKIGSGSFGAVYKATL-DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFIN-EL 517
++++ IG+GSFG VY+A L D G VA+K+ +D F N EL
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----------------LQDKRFKNREL 64
Query: 518 ESLSRLHHKNLVRLLGFCEDRNER------VLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
+ + +L H N+VRL F E+ L+ +Y+ H ++ L
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIY 123
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGPEDDESH 630
R + Y+H I HRDIK N+LLD T K+ DFG + + +
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 631 LSLRAAGTVGYMDP-EYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN--------- 680
+ Y P + T DV+S G VL E+L G
Sbjct: 181 ---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 681 --GTP---------RNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCV 729
GTP N +F P I +V PP EA+A L + +
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP------EAIA----LCSRLL 287
Query: 730 TLEGRNRPSMTEIVN 744
R + E
Sbjct: 288 EYTPTARLTPLEACA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 18/216 (8%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
N+F +G G+FG V G A+K + +D+ + E
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--------KDEVAHTVTES 56
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L H L L + + + EY G L HL + + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGA 112
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ +EYLH +++RDIK N++LD K++DFGL G D + + G
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CG 167
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
T Y+ PE D + GVV+ E++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 57/311 (18%), Positives = 116/311 (37%), Gaps = 41/311 (13%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + + KIG G+FG V+KA G +VA+K+ + +E + E+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME---------NEKEGFPITALREI 60
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERV--------LIYEYLENGTLHDHLHNPQSSSPLKSW 569
+ L L H+N+V L+ C + L++++ E+ + +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTL 116
Query: 570 PARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLS--LIGPEDD 627
+V G+ Y+H I+HRD+K++NVL+ K++DFGL+ ++
Sbjct: 117 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173
Query: 628 ESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSG------------YRA 674
+ + T+ Y PE ++ D++ G ++ E+ +
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233
Query: 675 IHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGY-LAADCVTLEG 733
I + V V Y + +++ V + + L + L+
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293
Query: 734 RNRPSMTEIVN 744
R + +N
Sbjct: 294 AQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-36
Identities = 52/298 (17%), Positives = 102/298 (34%), Gaps = 29/298 (9%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ + KIG G++G V+KA + VA+KR + E ++ + E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---------DDDEGVPSSALREI 52
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L L HKN+VRL + L++E+ + V
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-------NGDLDPEIVKS 105
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
+ ++ L +++HRD+K N+L++ K+++FGL+ S
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVT 164
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAI--HRTHNGTPRNVVDFVV--PY 693
+ + + D++S G + E+ + R + + + + +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAAD-------CVTLEGRNRPSMTEIVN 744
+ ++ D P P V V L A + R S E +
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 2e-34
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 21/216 (9%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ F +G+GSFG V + G+ A+K + + +NE
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--------LKQIEHTLNEK 92
Query: 518 ESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVAL 577
L ++ LV+L +D + ++ EY+ G + HL S P A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAA 148
Query: 578 DAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAG 637
EYLH +I+RD+K N+L+D +V+DFG + + G
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CG 200
Query: 638 TVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYR 673
T + PE + + D ++ GV++ E+ +GY
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 54/303 (17%), Positives = 103/303 (33%), Gaps = 31/303 (10%)
Query: 456 EATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
E + + +GSG++GAV A G++VA+K+ S E
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS---------ELFAKRAY 65
Query: 515 NELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIK 574
EL L + H+N++ LL ++
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 575 VALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLR 634
+ +G+ Y+H IIHRD+K N+ ++ K+ DFGL+ + ++
Sbjct: 126 LVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV--- 179
Query: 635 AAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSG------------YRAIHRTHNG 681
T Y PE + T+ D++S G ++ E+++G + I +
Sbjct: 180 --VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTE 741
P V + ++ + + + A L + L+ R + E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 742 IVN 744
+
Sbjct: 298 ALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 3e-32
Identities = 44/237 (18%), Positives = 87/237 (36%), Gaps = 33/237 (13%)
Query: 450 SLEILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQED 508
S + +++ K+G G + V++A + + +V VK +
Sbjct: 26 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------------KPV 71
Query: 509 KDNAFINELESLSRL-HHKNLVRLLGFCEDRNER--VLIYEYLENGTLHDHLHNPQSSSP 565
K E++ L L N++ L +D R L++E++ N
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------T 125
Query: 566 LKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAKVSDFGLSLIGP 624
L + R + + ++Y H I+HRD+K NV++D ++ D+GL+
Sbjct: 126 LTDYDIR-FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 625 EDDESHLSLRAAGTVGYMDPEYYR-LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHN 680
E + + + PE Q D++S G +L ++ H+
Sbjct: 182 PGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 22/222 (9%)
Query: 459 NNFSEDHKIGSGSFGAVYKATL----DDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFI 514
NF +G+G++G V+ D G A+K + ++ A T+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-------TR 76
Query: 515 NELESLSRL-HHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARI 573
E + L + LV L + + LI +Y+ G L HL + + +
Sbjct: 77 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ---- 132
Query: 574 KVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSL 633
+ + L II+RDIK N+LLD+ ++DFGLS DE+ +
Sbjct: 133 ---IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAY 188
Query: 634 RAAGTVGYMDPEYYRLQQ--LTEKSDVYSFGVVLLEILSGYR 673
GT+ YM P+ R + D +S GV++ E+L+G
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 31/307 (10%)
Query: 452 EILLEATNNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKD 510
+ + E + +GSG++G+V A G +VAVK+ +S I KR
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKR----- 63
Query: 511 NAFINELESLSRLHHKNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWP 570
EL L + H+N++ LL + L N +
Sbjct: 64 --TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 571 ARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESH 630
+ RG++Y+H IIHRD+K SN+ ++ K+ DFGL+ ++ +
Sbjct: 122 HVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 631 LSLRAAGTVGYMDPEYY-RLQQLTEKSDVYSFGVVLLEILSG------------YRAIHR 677
T Y PE + D++S G ++ E+L+G + I R
Sbjct: 179 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP 737
++ + R+ I + I A L + L+ R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 738 SMTEIVN 744
+ + +
Sbjct: 294 TAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 7e-29
Identities = 56/316 (17%), Positives = 102/316 (32%), Gaps = 52/316 (16%)
Query: 459 NNFSEDHKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINEL 517
+ IGSG+ G V A VA+K+ + + EL
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN---------QTHAKRAYREL 67
Query: 518 ESLSRLHHKNLVRLLGFC------EDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPA 571
+ ++HKN++ LL E+ + L+ E ++
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHL 631
+ GI++LH IIHRD+K SN+++ + T K+ DFGL+
Sbjct: 121 MSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT- 176
Query: 632 SLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG------------YRAIHRTH 679
T Y PE E D++S G ++ E++ + +
Sbjct: 177 --PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 680 NGTPRNVVDFVVPYIVRDEIHRVLDRNVPPP-------TPFEIEAVAYVGYLAAD----C 728
+ + P + +R + P P + E A D
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 729 VTLEGRNRPSMTEIVN 744
+ ++ R S+ + +
Sbjct: 295 LVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 1e-26
Identities = 36/221 (16%), Positives = 78/221 (35%), Gaps = 28/221 (12%)
Query: 465 HKIGSGSFGAVYKAT-LDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL 523
K+G G F V+ A + + + VA+K + + A +E++ L R+
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKI------------VRGDKVYTEAAEDEIKLLQRV 66
Query: 524 HHKNLVRLLGFCEDRNERVLIYEY------------LENGTLHDHLHNPQSSSPLKSWPA 571
+ + + + ++L + E + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 572 RIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT-WTAKVSDFGLSLIGPEDDESH 630
+++ G++Y+H IIH DIK NVL++ + ++ +G
Sbjct: 127 VKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 631 LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671
+ T Y PE +D++S ++ E+++G
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (254), Expect = 2e-25
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 19/203 (9%)
Query: 466 KIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH 525
+G G AV+ + + VK ++ TS + KR + D F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKR-DYGDLHFSVLAIRSARNEF 65
Query: 526 KNLVRLLGFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEY 585
+ L +L G +Y + N L + + + P + +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 586 LHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL-IGPEDDESHLSLRAAGTVGYMDP 644
+ I+H D+ NVL+ + DF S+ +G E L R +
Sbjct: 119 FYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILE-RDVRNI----I 169
Query: 645 EYYRLQQLTEKSDVYSFGVVLLE 667
Y+ + + D+ S +L+
Sbjct: 170 TYFS-RTYRTEKDINSAIDRILQ 191
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 28/262 (10%), Positives = 55/262 (20%), Gaps = 24/262 (9%)
Query: 160 AVGEDFVCGLLENGTITCFGS--------------RNSPTSVTQKVPSGIFRVVAAGFRH 205
V E G + G R P V+ +P + AG H
Sbjct: 2 KVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVS--IPEDV-VQAEAGGMH 58
Query: 206 VCAIDDDQELRCWGD-SVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ 264
+ ++ +G G + + + L+ V G +
Sbjct: 59 TVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDG 118
Query: 265 GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHMVFERVLPGPCTNTC---PCPMLP 321
+ G+L + T +
Sbjct: 119 RVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLYTLGC 178
Query: 322 GSGNVCGEGQIICQPCFEKTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVV 381
G G + + + P+ GSRG + G + +
Sbjct: 179 GEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAF---CGAYFTFAI 235
Query: 382 VLVSAFFGYKHCKCKGCRVHDS 403
+G+ +
Sbjct: 236 SHEGHVYGFGLSNYHQLGTPGT 257
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 19/183 (10%), Positives = 47/183 (25%), Gaps = 24/183 (13%)
Query: 87 ITFSASSSSVMHCWRFSADGIINDYKRI-YRGPALQQLEAGNSHICGLVNGTNDLHWWQW 145
+ F + + S +G + + Y E+ + W +
Sbjct: 220 VRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGF 279
Query: 146 PDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRH 205
++ S G ++ PT +++ + VA G
Sbjct: 280 SGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISR--LPAV-SSVACGASV 336
Query: 206 VCAIDDDQELRCWGD--------------------SVGEVPQGKFKALALGENRSCALRN 245
A+ D + WG ++ +++ G + L
Sbjct: 337 GYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVK 396
Query: 246 NQK 248
+++
Sbjct: 397 DKE 399
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 0.001
Identities = 24/222 (10%), Positives = 53/222 (23%), Gaps = 36/222 (16%)
Query: 84 CTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWW 143
+ ++ + ++ R P L G +
Sbjct: 154 VVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGL----ERLLVPKCV 209
Query: 144 QWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGF 203
S F + G F + G + FG N +
Sbjct: 210 MLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSN--------------------Y 249
Query: 204 RHVCAIDDDQELRCWGDSVGEVPQGKFKALALGENRSCALRNNQKVVCWGQ-------NG 256
+ + + + + + G++ + + + K G+ G
Sbjct: 250 HQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLG 309
Query: 257 FTLPDSLQGKPFVSIEAKRSVFCG-----VLTSNYSLYCWGN 293
+ + A SV CG +T + ++ WG
Sbjct: 310 EGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRVFAWGM 351
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 45.9 bits (107), Expect = 9e-06
Identities = 37/239 (15%), Positives = 65/239 (27%), Gaps = 22/239 (9%)
Query: 65 IPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLE 124
+P + +I G L V+ W + +G + G +
Sbjct: 20 VPAEAQSGVDAIAGGYFHGLAL-----KGGKVL-GWGANLNGQLTMPAATQSGV--DAIA 71
Query: 125 AGNSHICGLVNGTNDLH---WWQWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGSR 181
AGN H L +G + + IA G L + I
Sbjct: 72 AGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKDGKVIAWGDDS 131
Query: 182 NSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCW-----GDSVGEVPQGKFKALALG 236
+ T+V + SG+ G + + + W G + G
Sbjct: 132 DGQTTVPAEAQSGVT--ALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAG 189
Query: 237 ENRSCALRNNQKVVCWGQN--GFTLPDSLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGN 293
+ KV+ WG N T + +I + + N + WG+
Sbjct: 190 GIFHSLALKDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLAL--KNGKVIAWGS 246
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 44.4 bits (103), Expect = 3e-05
Identities = 25/164 (15%), Positives = 50/164 (30%), Gaps = 5/164 (3%)
Query: 84 CTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWW 143
A + W +DG G + +
Sbjct: 111 AGAWASYALKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNY 170
Query: 144 QWPDFNSTSIHNFSNIAVGEDFVCGLLENGTITCFGS-RNSPTSVTQKVPSGIFRVVAAG 202
+ + G F L++G + +G R T+V + SG+ +A+G
Sbjct: 171 FGQTTVPAEAQSGVDDVAGGIFHSLALKDGKVIAWGDNRYKQTTVPTEALSGV-SAIASG 229
Query: 203 FRHVCAIDDDQELRCWGD--SVGEVPQGKFKALALGENRSCALR 244
+ A+ + ++ WG + Q ++ G N + AL+
Sbjct: 230 EWYSLALKNG-KVIAWGSSRTAPSSVQSGVSSIEAGPNAAYALK 272
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 43.6 bits (101), Expect = 5e-05
Identities = 31/234 (13%), Positives = 64/234 (27%), Gaps = 17/234 (7%)
Query: 173 GTITCFGSRNS--PTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDS------VGE 224
++ +G N +V + SG+ +A G+ H A+ + + WG + +
Sbjct: 4 TSVVAWGGNNDWGEATVPAEAQSGV-DAIAGGYFHGLALKGGK-VLGWGANLNGQLTMPA 61
Query: 225 VPQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQGKPFVSIEAKRSVFCGVLTS 284
Q A+A G S AL++ + + G + + V A + L
Sbjct: 62 ATQSGVDAIAAGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKD 121
Query: 285 NYSLYCWGNES-----FSSNHMVFERVLPGPCTNTCPCPMLPGSGNVCGEGQIICQPCFE 339
+ + + + G T + GQ +
Sbjct: 122 GKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQ 181
Query: 340 KTSVTPSPTPQPQQPPESGSRGGWSGRMVALLVVGCLGSLVVVLVSAFFGYKHC 393
+ + G W V V +++ G +
Sbjct: 182 SGVDDVAGGIFHSLALKDGKVIAWGDNRYKQTTVPTEALSGVSAIAS--GEWYS 233
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 36/194 (18%), Positives = 58/194 (29%), Gaps = 13/194 (6%)
Query: 97 MHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPD---FNSTSI 153
+ A + + + W D
Sbjct: 82 DGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKDGKVIAWGDDSDGQTTVPAEA 141
Query: 154 HNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQ 213
+ G + ++NG + +G + VA G H A+ D
Sbjct: 142 QSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALKDG- 200
Query: 214 ELRCWGD------SVGEVPQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQGKP 267
++ WGD +V A+A GE S AL+N KV+ WG + P S+Q
Sbjct: 201 KVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALKNG-KVIAWGSSRTA-PSSVQSG- 257
Query: 268 FVSIEAKRSVFCGV 281
SIEA + +
Sbjct: 258 VSSIEAGPNAAYAL 271
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 768 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.09 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 95.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.69 | |
| d1p22a2 | 293 | F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Hom | 94.33 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 91.61 | |
| d2ovrb2 | 342 | F-box/WD repeat-containing protein 7, FBXW7 {Human | 90.66 | |
| d2ovrb2 | 342 | F-box/WD repeat-containing protein 7, FBXW7 {Human | 90.43 | |
| d1p22a2 | 293 | F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Hom | 87.77 | |
| d1nexb2 | 355 | Cdc4 propeller domain {Baker's yeast (Saccharomyce | 82.71 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=424.39 Aligned_cols=263 Identities=30% Similarity=0.508 Sum_probs=204.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
.++|++.++||+|+||+||+|+++ ..||||+++... ..+...+.|.+|++++++++||||+++++++.+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~---------~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS---------CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 357899999999999999999865 469999986432 223456789999999999999999999998754
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+..++||||+++|+|.++|+... ..+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred -cEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 56899999999999999997533 23689999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
|+++...............||+.|||||++.. ..++.++|||||||+||||+||+.||......
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------------- 215 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------- 215 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------------
Confidence 99976554333333345679999999999864 35789999999999999999999999643221
Q ss_pred hhhhHHhhhccCCCCC--CcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 695 VRDEIHRVLDRNVPPP--TPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
..+...+......+ .....+.+..+.+|+.+||+.||++||||+||++.|+.+.++.
T Consensus 216 --~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 216 --DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp --HHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --HHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11111111111111 1112233466789999999999999999999999999888643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=416.99 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||+++++++.++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC------------cCcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 468888999999999999999988889999987532 12346799999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... ..+++..+++++.|+++||+|||+++ |+||||||+||||++++.+||+|||
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC
T ss_pred CceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccc
Confidence 99999999999999999987532 34688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+++........ ......||+.|||||++....++.++|||||||+||||+|+..|+..... . .+
T Consensus 147 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~-------------~~ 210 (263)
T d1sm2a_ 147 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--N-------------SE 210 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--H-------------HH
T ss_pred hheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--H-------------HH
Confidence 99765433322 12234689999999999999999999999999999999996554432211 0 11
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
+.+.+........+ ...+..+.+|+.+||+.||++||||+||++.|++++++
T Consensus 211 ~~~~i~~~~~~~~p--~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 211 VVEDISTGFRLYKP--RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCc--cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11111111111111 12234577999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=414.40 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+.+ +++.||||++.... ..+..+.|.+|++++++++||||+++++++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------AVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 57889999999999999999975 78999999986532 11234568999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..+|||||+++|+|.++|... ..+++.....++.||++||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccc
Confidence 99999999999999999999753 24688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+|+...............||+.|||||++....+ +.++|||||||+||||+||+.||........
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------------- 214 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------------- 214 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------------
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------------
Confidence 99986544433333345679999999999987776 5789999999999999999999975432110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
............ ......+..+.+|+.+||+.||++|||++|+++
T Consensus 215 -~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 215 -EYSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -HHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHhcCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111111 111223455678999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=413.47 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=207.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||++++++.+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC------------cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 468888999999999999999988889999998532 1234579999999999999999999998754
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... ...+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 56799999999999999886532 123689999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+++....... .......||+.|||||++....++.++|||||||+||||+||..|+..... ..+
T Consensus 155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---------------~~~ 218 (272)
T d1qpca_ 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------NPE 218 (272)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHH
T ss_pred ceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---------------HHH
Confidence 9986543322 222345689999999999988999999999999999999997666543211 011
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+...+.....+..+ ...+..+.+|+.+||+.||++||||+||++.|++.+.+.
T Consensus 219 ~~~~i~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 219 VIQNLERGYRMVRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCc--ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 11111111111111 123456779999999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-49 Score=417.06 Aligned_cols=260 Identities=26% Similarity=0.481 Sum_probs=198.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC---eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS---QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~---~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.++||+|+||+||+|+++ +++ .||||++... ..+...++|.+|+++|++++|||||+++++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----------YTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----------cCHHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 45777899999999999999875 332 5788876432 223455789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+.+..++||||+++|+|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+||||+.++++||
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl 169 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 169 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEE
Confidence 999999999999999999999987532 34689999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcc---cccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccc
Q 046311 615 SDFGLSLIGPEDDESH---LSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 690 (768)
+|||+++......... ......+|+.|||||++....++.++|||||||+||||+| |+.||.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---------- 239 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---------- 239 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----------
Confidence 9999998654332211 1122457999999999999999999999999999999998 8999864321
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.++...+......+. ..+.+..+.+|+.+||+.||++||||+||++.|+++++.
T Consensus 240 ------~~~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 ------QDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHHHcCCCCCC--CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111111222221111 123345678999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=410.31 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=204.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|+..++||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----------QPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-----------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-----------ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence 47999999999999999999864 79999999986431 1234678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..||||||+++|+|.+++... .+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccc
Confidence 99999999999999999988642 3688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++........ .....||+.|||||++.+..++.++|||||||++|||+||+.||...... +
T Consensus 161 G~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------------~ 223 (293)
T d1yhwa1 161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---------------R 223 (293)
T ss_dssp TTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------H
T ss_pred hhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---------------H
Confidence 999865433222 23457999999999999999999999999999999999999999643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+..+.....+. .......+..+.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 224 ALYLIATNGTPE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHCSCC-CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCC-CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111121111111 1112234566789999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-49 Score=416.18 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=211.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+++ +++.||||+++.. ....++|.+|+++|++++|||||++++++.+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc------------cchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 46788899999999999999976 5889999987532 1234679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.+++.... ...+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCeeEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence 999999999999999999996532 234688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++....... .......||+.|||||++....++.++||||||+++|||++|..|+..... ..
T Consensus 160 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---------------~~ 223 (287)
T d1opja_ 160 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LS 223 (287)
T ss_dssp CCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---------------HH
T ss_pred cceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---------------HH
Confidence 99986544332 222234589999999999999999999999999999999998777643221 12
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.+.+.+.....++.+ ...+..+.+|+.+||+.||++|||++||++.|+.+++..
T Consensus 224 ~~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 224 QVYELLEKDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHHHHHhcCCCCCCC--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 222333333222211 123456789999999999999999999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=404.31 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=208.3
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||+++++++.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~------------~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS------------MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS------------SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc------------CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 5789999999999999999999888899999986431 2345799999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... ...++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcch
Confidence 99999999999999999976532 34578899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
+++........ ......+|+.|+|||++....++.++||||||+++|||+| |+.||..... .
T Consensus 146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----------------~ 208 (258)
T d1k2pa_ 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------S 208 (258)
T ss_dssp SCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------H
T ss_pred hheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----------------H
Confidence 99765443322 2234568999999999999999999999999999999998 7888864321 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLER 748 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 748 (768)
++...+........+ ...+..+.+|+.+||+.||++|||++||++.|.+
T Consensus 209 ~~~~~i~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 209 ETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHTTCCCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCc--ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111111111111111 1233567899999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=412.95 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=194.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.+ +|+.||||++.... ..+...+.|.+|++++++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---------SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---------CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 46889999999999999999875 78999999986542 223445679999999999999999999999865
Q ss_pred --CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEecCCCCCCeEECCCCcEE
Q 046311 538 --RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAV--PSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 538 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~--~~ivHrDiKp~NILl~~~~~~k 613 (768)
.+..|+||||+++|+|.+++.........+++..++.++.|++.||+|||+++. .+|+||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 456899999999999999996543333457899999999999999999998651 2499999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||+++....... ......||+.|||||++....++.++|||||||++|||+||+.||..... .
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~--------- 220 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K--------- 220 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H---------
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---H---------
Confidence 999999986543322 12245799999999999999999999999999999999999999964321 0
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+-...+.....+.. ....+..+.+|+.+||+.||++|||++|+++
T Consensus 221 ---~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 ---ELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11112222222211 1123456779999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=408.93 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=204.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.+ +++.||||++.... .........+.+|++++++++||||+++++++.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH--------ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 46888999999999999999975 68999999986431 1122345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..++||||+++|+|.+++... ..+++.....++.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccc
Confidence 99999999999999999999643 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++....... ....||+.|||||++.+..++.++|||||||+||||++|+.||..... .+
T Consensus 151 G~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------------~~ 211 (263)
T d2j4za1 151 GWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------------QE 211 (263)
T ss_dssp CSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred ceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---------------HH
Confidence 99976543222 245799999999999999999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
....+.......+. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 212 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 212 TYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12222222222221 23455778999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=408.25 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=202.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcCC-----CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDG-----SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
+.|++.++||+|+||+||+|.++.. ..||||+++.. ..+....+|++|++++++++|||||++++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----------YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc----------cChHHHHHHHHHHHHHHhcCCCCEeeeeE
Confidence 3577889999999999999987632 36999988532 12344567999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.+.+..++||||+.+++|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+||||+.++.+|
T Consensus 77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~K 150 (283)
T d1mqba_ 77 VISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCK 150 (283)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEE
Confidence 9999999999999999999999886532 34689999999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCC-cccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++....... ........||+.|||||++....++.++|||||||+||||+++..|+.....
T Consensus 151 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~------------ 218 (283)
T d1mqba_ 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------ 218 (283)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------------
T ss_pred EcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC------------
Confidence 999999986543322 1222334689999999999999999999999999999999997666543211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
..++.+.+.....++.+ .+.+..+.+|+.+||+.||++||||.||++.|+++++.
T Consensus 219 ---~~~~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 219 ---NHEVMKAINDGFRLPTP--MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---HHHHHHHHHTTCCCCCC--TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHHhccCCCCCc--hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122222222222221 22345678999999999999999999999999998874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=405.78 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=206.1
Q ss_pred CCCCcCc-eeccCCceEEEEEEEc---CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDH-KIGSGSFGAVYKATLD---DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. ..+...++|.+|+++|++++|||||+++++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----------cCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 3556666 4999999999999764 3457999998642 123456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+ +..+|||||+++|+|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl 150 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKI 150 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEE
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceee
Confidence 875 46899999999999999986532 34689999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||+++........ .......||+.|||||++....++.++|||||||++|||+| |+.||......
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----------- 219 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------- 219 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----------
Confidence 999999865443322 22223468999999999998999999999999999999998 89998643211
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
++...+.....++. ....+..+.+|+.+||+.||++||||.+|++.|+......
T Consensus 220 -----~~~~~i~~~~~~~~--p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 220 -----EVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -----HHHHHHHTTCCCCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCCC--CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11111111111111 1123456779999999999999999999999999877544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=401.77 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=196.3
Q ss_pred CcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc---
Q 046311 462 SEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED--- 537 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 537 (768)
+..++||+|+||+||+|++. +++.||+|++.... ..+...+.|.+|+++|++++||||+++++++.+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 55678999999999999876 68899999986531 223445689999999999999999999999865
Q ss_pred -CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC-CCCcEEEe
Q 046311 538 -RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD-ATWTAKVS 615 (768)
Q Consensus 538 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~-~~~~~kl~ 615 (768)
....++||||+++|+|.+++.+. ..+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEe
Confidence 34679999999999999999653 24688899999999999999999986 4599999999999996 57899999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++...... .....||+.|||||++.. .++.++|||||||+||||++|+.||.....
T Consensus 158 DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--------------- 217 (270)
T d1t4ha_ 158 DLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--------------- 217 (270)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------------
T ss_pred ecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---------------
Confidence 999997543322 224579999999999874 699999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...+.+.+.....+ ........+.+.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 218 AAQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCC-cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111222222111 1122223455779999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=417.19 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=206.0
Q ss_pred CCCCcCceeccCCceEEEEEEEcC-C-----CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD-G-----SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.++||+|+||+||+|++.. + ..||||.+... ........|.+|+.++.++ +|||||++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----------ADSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----------cCHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 578889999999999999998652 2 26899987532 1223456789999999998 89999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQSS-------------------SPLKSWPARIKVALDAARGIEYLHEYAVP 592 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~ia~~ia~gL~yLH~~~~~ 592 (768)
++++.+.+..+|||||+++|+|.++|+..... ...+++..++.++.||++||+|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999764321 234688999999999999999999998
Q ss_pred CeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-C
Q 046311 593 SIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-G 671 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G 671 (768)
|+||||||+|||++.++.+||+|||+|+...............||+.|||||++....++.++|||||||+||||+| |
T Consensus 185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 99999999999999999999999999976544443333334568999999999999999999999999999999998 8
Q ss_pred CcccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHH
Q 046311 672 YRAIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLE 747 (768)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 747 (768)
+.||...... ..+.+++.....++.+ ...+..+.+||.+||+.||++|||++||++.|.
T Consensus 264 ~~Pf~~~~~~---------------~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPVD---------------ANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCCS---------------HHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCHH---------------HHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9998643221 1122333332222211 123456789999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=401.85 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=199.5
Q ss_pred ceeccCCceEEEEEEEcC---CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCee
Q 046311 465 HKIGSGSFGAVYKATLDD---GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNER 541 (768)
Q Consensus 465 ~~LG~G~fG~Vy~~~~~~---g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 541 (768)
++||+|+||+||+|.+++ ++.||||+++... ..+...++|.+|+++|++++|||||++++++.++ ..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 579999999999998653 4679999986431 1234457899999999999999999999998654 57
Q ss_pred EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 542 VLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 542 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
+|||||+++|+|.++++.. ..+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~lvmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~ 155 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 155 (277)
T ss_dssp EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhh
Confidence 8999999999999999753 33689999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhhhhH
Q 046311 622 IGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVRDEI 699 (768)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (768)
........ .......||+.|||||++....++.++|||||||++|||+| |+.||..... .++
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----------------~~~ 219 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEV 219 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHH
T ss_pred hccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----------------HHH
Confidence 65433222 22234568999999999999999999999999999999998 8999864321 112
Q ss_pred HhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 700 HRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
.+.+....+++.+ ...+..+.+|+.+||+.||++|||++||++.|+.....
T Consensus 220 ~~~i~~~~~~~~p--~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 220 TAMLEKGERMGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCC--cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 2222222221111 12345678999999999999999999999999887643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=407.69 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=201.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
+.|++.++||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----------EEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----------SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 35888999999999999999875 68999999986431 2334568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..+|||||+++|+|.+++.+.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++++||+||
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEec
Confidence 999999999999999999986422 23688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccc-----cCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYR-----LQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|++....... .......||+.|||||++. ...++.++|||||||+||||+||+.||......
T Consensus 155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----------- 221 (288)
T d2jfla1 155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----------- 221 (288)
T ss_dssp TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----------
T ss_pred hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----------
Confidence 9996532211 1122457999999999984 456899999999999999999999999643221
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+.+.++.....+. .......+..+.+|+.+||+.||++|||++|+++
T Consensus 222 ----~~~~~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 222 ----RVLLKIAKSEPPT-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHcCCCCC-CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112222222111 1122234566789999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=409.82 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=202.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+|+.. +++.||||++.... ...+...+.+.+|++++++++||||+++++++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH--------ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 46889999999999999999875 78999999986431 1123345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
++..|+||||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccc
Confidence 99999999999999999998653 23688889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...............||+.|||||++.+..++.++|||||||+||||+||+.||..... .+
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------~~ 217 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------YL 217 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---------------HH
Confidence 999866544333333345799999999999999999999999999999999999999964321 01
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
-...++...+..+. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 218 IFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11222222222222 22355779999999999999999999755
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=406.82 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=192.1
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.+.|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+|+++|++++||||+++++++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----------EGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356899999999999999999875 689999999875321 123356889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC---CCCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD---ATWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~---~~~~~k 613 (768)
+++..||||||+++|+|.++|... ..+++.....++.||+.||+|||+++ |+||||||+|||+. +++.+|
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vk 150 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIM 150 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEE
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEE
Confidence 999999999999999999999753 24688999999999999999999998 99999999999994 578999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||+++....... .....||+.|||||++.+..++.++|||||||+||||++|+.||.....
T Consensus 151 l~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------- 214 (307)
T d1a06a_ 151 ISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------------- 214 (307)
T ss_dssp ECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------
T ss_pred EeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------------
Confidence 999999976443322 2245799999999999999999999999999999999999999964321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+-...++......+.+...+.+..+.+|+.+||+.||++|||++|+++
T Consensus 215 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 215 --AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112223333333222223344566789999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=400.48 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=207.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+.+ +|+.||||+++..... ........+.|.+|+++|++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~-----~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK-----SSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSST-----TCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----hhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 57999999999999999999975 7899999999764321 11222346789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC----cEE
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW----TAK 613 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~----~~k 613 (768)
.+..+|||||+++|+|.++|... ..+++...+.++.|++.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEE
T ss_pred CCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceE
Confidence 99999999999999999999653 23688999999999999999999998 99999999999998776 599
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccch
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
|+|||++......... ....+|+.|+|||++....++.++|||||||+||||++|+.||.....
T Consensus 158 l~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------- 221 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------- 221 (293)
T ss_dssp ECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------
T ss_pred ecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------------
Confidence 9999999765433322 234689999999999999999999999999999999999999964321
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..+.......+.......+..+.+|+.+||+.||++|||++|+++
T Consensus 222 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 --QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112222222222221222233456779999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-47 Score=408.20 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=205.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 94 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------HESDKETVRKEIQTMSVLRHPTLVNLHDAFED 94 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 47899999999999999999875 7899999998532 12345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC--CCCcEEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--ATWTAKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--~~~~~kl~ 615 (768)
++..+|||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+
T Consensus 95 ~~~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~ 168 (350)
T d1koaa2 95 DNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 168 (350)
T ss_dssp TTEEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEe
Confidence 999999999999999999996532 23688999999999999999999999 99999999999995 46789999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||+++....... .....||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 169 DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------------- 230 (350)
T d1koaa2 169 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------------- 230 (350)
T ss_dssp CCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred ecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---------------
Confidence 9999986544332 2235799999999999999999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..+.......+.......+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 231 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223333222222222334566789999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.37 Aligned_cols=269 Identities=22% Similarity=0.343 Sum_probs=205.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||+||+|+.. +++.||+|+++... .+.....+.+|+.+|++++|||||++++++.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 457999999999999999999975 78999999986431 2234567899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecCCCCCCeEECCCCcEEEe
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEY-AVPSIIHRDIKSSNVLLDATWTAKVS 615 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDiKp~NILl~~~~~~kl~ 615 (768)
+.+..++||||+++|+|.+++.+. ..+++..+..++.|+++||.|||++ + |+||||||+||||+.++++||+
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEe
Confidence 999999999999999999999753 2368889999999999999999974 6 9999999999999999999999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc-------
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD------- 688 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~------- 688 (768)
|||+|+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.............
T Consensus 148 DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 148 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp CCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred eCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 99999753221 1224579999999999999999999999999999999999999996533211000000
Q ss_pred --c------------------ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH--HH
Q 046311 689 --F------------------VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN--SL 746 (768)
Q Consensus 689 --~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~--~L 746 (768)
. ..+....+..........+. .+ ....+..+.+|+.+||+.||++|||++|+++ .|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK-LP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCC-CC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCcc-Cc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 0 00000001111111111111 11 1112355778999999999999999999998 35
Q ss_pred HHH
Q 046311 747 ERA 749 (768)
Q Consensus 747 ~~~ 749 (768)
++.
T Consensus 302 ~~~ 304 (322)
T d1s9ja_ 302 KRS 304 (322)
T ss_dssp HHH
T ss_pred CcC
Confidence 543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=403.00 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=202.7
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.+.||+|+||+||+|+++++++||||+++.. ....+.|.+|+.++++++|||||++++++.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~------------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc------------cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 478999999999999999999988889999998532 1234679999999999999999999999854
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|.+++.... ...++|..+++++.||++||+|||+++ |+||||||+||||+.++++||+|||
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeEEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccc
Confidence 56899999999999999986532 234699999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRDE 698 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (768)
+++....... .......||+.|+|||++....++.++||||||++||||+||..|+..... ..+
T Consensus 159 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------------~~~ 222 (285)
T d1fmka3 159 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NRE 222 (285)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHH
T ss_pred hhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------------HHH
Confidence 9976543322 222235689999999999999999999999999999999997766543221 111
Q ss_pred HHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 699 IHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
+...+......+. ..+.+..+.+|+.+||+.||++||+|++|+++|++.+...
T Consensus 223 ~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 223 VLDQVERGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHTTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHhcCCCCC--CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1122222222111 1233456789999999999999999999999999877543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=406.48 Aligned_cols=262 Identities=29% Similarity=0.387 Sum_probs=208.7
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRL 531 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 531 (768)
.++|++.++||+|+||+||+|+++ +++.||||+++.. ......++|.+|++++++++||||+++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh----------cChHHHHHHHHHHHHHHhcCCCCcccc
Confidence 467999999999999999999864 3578999987532 223456789999999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS--------------------SSPLKSWPARIKVALDAARGIEYLHEYAV 591 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~ 591 (768)
++++.+.+..+++|||+++|+|.++|+.... ....+++..++.++.|++.||+|||+++
T Consensus 82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~- 160 (301)
T d1lufa_ 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 160 (301)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-
Confidence 9999999999999999999999999864221 1234688899999999999999999998
Q ss_pred CCeEecCCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcC
Q 046311 592 PSIIHRDIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSG 671 (768)
Q Consensus 592 ~~ivHrDiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG 671 (768)
|+||||||+||||+.++.+||+|||+++...............+|+.|+|||.+....++.++|||||||+||||++|
T Consensus 161 --ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 161 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 999999999999999999999999999754443333333445789999999999999999999999999999999999
Q ss_pred Cc-ccccCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHH
Q 046311 672 YR-AIHRTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERAL 750 (768)
Q Consensus 672 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l 750 (768)
.. ||..... .+-...+.+...++. ....+..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 239 ~~~p~~~~~~---------------~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAH---------------EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCH---------------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCCH---------------HHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 64 5543211 111222223222211 1123456779999999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-46 Score=406.03 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=205.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+++|++|+||||+++++++.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------YPLDKYTVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----------chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46889999999999999999875 7999999998643 12334678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC--CCCcEEEe
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD--ATWTAKVS 615 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~--~~~~~kl~ 615 (768)
++..||||||+++|+|.+++.... ..+++...+.++.||+.||+|||+++ |+||||||+||||+ .++.+||+
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEEC
T ss_pred CCEEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEe
Confidence 999999999999999999886532 33688999999999999999999998 99999999999997 67899999
Q ss_pred eccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 616 DFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
|||++........ .....||+.|||||++.+..++.++|||||||+||||+||+.||.....
T Consensus 172 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------------- 233 (352)
T d1koba_ 172 DFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------------- 233 (352)
T ss_dssp CCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------------
T ss_pred ecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------------
Confidence 9999987654332 2234689999999999999999999999999999999999999964321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..+.......+.......+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223332222222222234566789999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-47 Score=401.98 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=200.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
.|+..++||+|+||+||+|+.. +++.||||++.... .......+.|.+|+++|++++|||||++++++.+.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--------SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 4888999999999999999865 78899999987532 12234556799999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..++||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCT
T ss_pred CEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecc
Confidence 9999999999999998776432 23688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc---CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL---QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV 695 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 695 (768)
++...... ....||+.|||||++.. ..|+.++|||||||++|||++|+.||.....
T Consensus 161 ~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------------- 219 (309)
T d1u5ra_ 161 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------- 219 (309)
T ss_dssp TCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------------
T ss_pred cccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 99754322 23469999999999863 4689999999999999999999999864321
Q ss_pred hhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 696 RDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+.+..+.....+... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 220 ~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHSCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122233332222211 1123456779999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-46 Score=394.73 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=203.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ...+.....|.+|++++++++||||+++++++.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--------TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 357999999999999999999864 78999999986432 122345668999999999999999999999987
Q ss_pred cCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 537 DRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 537 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
..+ ..||||||+++++|.+++... ..+++...+.++.||++||+|||+++ |+||||||+|||++.++..
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCE
T ss_pred eccCCCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccc
Confidence 654 378999999999999988653 23688999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCC-CcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 613 KVSDFGLSLIGPEDD-ESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 613 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
+|+|||++....... .........||+.|||||++.+..++.++|||||||+||||+||+.||.....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------- 219 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----------- 219 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------
Confidence 999999986543222 22222345799999999999998999999999999999999999999964321
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-CHHHHHHHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-SMTEIVNSLERAL 750 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~~l 750 (768)
.+...+.+.....++.....+.+..+.+|+.+||+.||++|| |++|+++.|.++.
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 220 ----VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111222222222222222223446678999999999999999 8999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=400.05 Aligned_cols=265 Identities=28% Similarity=0.362 Sum_probs=199.5
Q ss_pred cCCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCcee
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVR 530 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~ 530 (768)
.++|++.++||+|+||.||+|++. +++.||||+++.. ......+.+.+|...+.++ +|+||+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----------~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc----------cCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 357899999999999999999864 2468999987642 1233456788888888777 7899999
Q ss_pred EEEEEEcC-CeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 531 LLGFCEDR-NERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 531 l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
+++++.+. ...++||||+++|+|.++|+.... ....+++..++.++.||++||+|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 99988664 468999999999999999964321 1234688999999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCC-cccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY-RAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~-~p~~ 676 (768)
||||+||||+.++.+||+|||+|+...............||+.|||||++....++.++|||||||++|||+||. .||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998655444433344567999999999999999999999999999999999975 4564
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
..... +.+...+.....+.. ....+..+.+|+.+||+.||++|||++||++.|++++++
T Consensus 239 ~~~~~---------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 239 GVKID---------------EEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCS---------------HHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHH---------------HHHHHHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 32211 111122222111111 112345577999999999999999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=395.27 Aligned_cols=278 Identities=25% Similarity=0.334 Sum_probs=205.2
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|.+.++||+|+||+||+|+++ |+.||||+++.. ......++.|+..+.+++||||+++++++.++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~------------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc------------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 35677899999999999999975 799999987532 11222334566666788999999999999765
Q ss_pred C----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecCCCCCCeEECCC
Q 046311 539 N----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA-----VPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 539 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDiKp~NILl~~~ 609 (768)
+ ..++||||+++|+|.++|++. .++|..+++++.|++.||+|||+.. .++|+||||||+||||+.+
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~ 144 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred CCcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence 4 578999999999999999752 3689999999999999999999741 2349999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc--ccccccccccCccCccccccC------CCCChhhHHHHHHHHHHHHcCCcccccCCCC
Q 046311 610 WTAKVSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQ------QLTEKSDVYSFGVVLLEILSGYRAIHRTHNG 681 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~elltG~~p~~~~~~~ 681 (768)
+.+||+|||+++........ .......||+.|||||++... .++.++|||||||+||||+||..|+......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 99999999999754332211 122345799999999998754 2577999999999999999998887643322
Q ss_pred Ccccccccc-cchhhhhhHHhhhccCCCCCC---cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 682 TPRNVVDFV-VPYIVRDEIHRVLDRNVPPPT---PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 682 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
... ..+.. .............+....+.. ....+....+.+|+.+||+.||++|||+.||++.|+++.+.+..
T Consensus 225 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 225 QLP-YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCT-TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred ccc-hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 211 11111 011111112223333333221 12345667788999999999999999999999999999876643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=392.01 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=195.9
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc-
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED- 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 537 (768)
++|++.++||+|+||.||+|+++ |..||||+++.. ...+.|.+|++++++++||||+++++++.+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-------------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 35778899999999999999986 789999987532 234679999999999999999999999855
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..++||||+++|+|.++|+... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccc
Confidence 456899999999999999996432 123589999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+++...... ....+|+.|+|||++....++.++||||||+++|||+| |+.|+...... .
T Consensus 148 g~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~----------- 208 (262)
T d1byga_ 148 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----------- 208 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---G-----------
T ss_pred ccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---H-----------
Confidence 9997543222 13357899999999998999999999999999999999 67766533211 1
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhh
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAA 752 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~ 752 (768)
+...+.....++. ....+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 209 --~~~~i~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 --VVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --HHHHHTTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCC--CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1111111111111 112345677999999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=399.06 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=213.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRL 531 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 531 (768)
++|++.++||+|+||.||+|++. +++.||||+++.. .......+|.+|+.+++++ +|||||++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------AHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----------cCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 46788899999999999999852 4568999998643 2234556899999999999 79999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhccCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 532 LGFCEDRNERVLIYEYLENGTLHDHLHNPQS--------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 532 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++.+.+..++||||+++|+|.++|+.... ....+++..+++++.||++||+|||+++ |+||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 9999999999999999999999999975431 2234688999999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
||||+|||++.++.+||+|||+++...............||+.|+|||++....++.++||||||+++|||+|+..|+..
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876554444444456789999999999999999999999999999999995555432
Q ss_pred CCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 678 THNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... .+.+.++++...++..+ ...+..+.+|+.+||+.||++||||+||+++|+++++.+
T Consensus 250 ~~~~--------------~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 250 GMPV--------------DSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp TCCS--------------SHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCH--------------HHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 2211 11223333333332221 123456789999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=400.14 Aligned_cols=258 Identities=23% Similarity=0.420 Sum_probs=200.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC----eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS----QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 533 (768)
.+|++.++||+|+||+||+|.+. +|+ +||||+++.. ......++|.+|++++++++|||||++++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g 78 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 78 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 36889999999999999999865 444 5788876532 12334678999999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.++ ..+++|||+.+++|.+++... ...+++..+++++.||++||+|||+++ |+||||||+||||+.++.+|
T Consensus 79 ~~~~~-~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 79 ICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp EEESS-SEEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEE
T ss_pred EEecC-CeeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeE
Confidence 99875 567889999999999988653 234688999999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...............||+.|||||++....++.++||||||++||||+| |+.||.....
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------------ 219 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------ 219 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------------
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------------
Confidence 999999987655444333334568999999999999999999999999999999999 7888754321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.++...+.....++.+ ...+..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 220 ----~~~~~~i~~~~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 220 ----SEISSILEKGERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----GGHHHHHHHTCCCCCC--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCCC--cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1111222222211111 1234567799999999999999999999999998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=396.51 Aligned_cols=261 Identities=33% Similarity=0.461 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCC--eEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGS--QVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 534 (768)
++|++.++||+|+||+||+|+++ ++. .||||+++.. ...+..++|.+|+++|.++ +||||++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----------cChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 57888899999999999999875 444 4777876532 1123445799999999999 79999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQ------------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSS 602 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~ 602 (768)
+.+++..++||||+++|+|.++|+... .....+++..+++++.||++||.|||+++ |+||||||+
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~ 156 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 156 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccc
Confidence 999999999999999999999997642 22345789999999999999999999998 999999999
Q ss_pred CeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcc-cccCCCC
Q 046311 603 NVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRA-IHRTHNG 681 (768)
Q Consensus 603 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p-~~~~~~~ 681 (768)
|||++.++.+||+|||+++........ ....||..|+|||.+....++.++||||||+++|||++|..| |.....
T Consensus 157 NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~- 232 (309)
T d1fvra_ 157 NILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 232 (309)
T ss_dssp GEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred eEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999754322221 234689999999999999999999999999999999998654 432211
Q ss_pred CcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 682 TPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.++...+.....+.. ....+..+.+|+.+||+.||++||||+||++.|+++++..
T Consensus 233 ---------------~~~~~~i~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 233 ---------------AELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---------------HHHHHHGGGTCCCCC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------------HHHHHHHHhcCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111111111111111 1123456789999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=389.72 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=196.1
Q ss_pred CCCCcCceeccCCceEEEEEEEcC----CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD----GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|++.. +..||||.++.. ..+...+.|.+|++++++++||||++++++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 578889999999999999998652 345788876422 223456789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+. ++..++||||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEE
Confidence 85 467899999999999999876432 34688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccch
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVPY 693 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 693 (768)
+|||+++....... .......||+.|+|||++....++.++|||||||+||||+| |+.||...... .+
T Consensus 150 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~------- 218 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV------- 218 (273)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH-------
T ss_pred ccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HH-------
Confidence 99999976443222 12234568999999999999999999999999999999998 88888643221 11
Q ss_pred hhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 694 IVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
...+.+....+ .....+..+.+|+.+||+.||++|||++||++.|+++++..
T Consensus 219 -----~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 219 -----IGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11122211111 11123456789999999999999999999999999988653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.4e-46 Score=387.24 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=208.3
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
++|++.+.||+|+||+||+++.. +++.||||+++........ ....+...+.+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS--AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCC--HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchh--HHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 57899999999999999999874 7899999999765332111 1111233457899999999997 999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+++..||||||+++|+|.++|+.. ..+++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 999999999999999999999643 23689999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCcccccc------CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL------QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
||+++........ ....||+.|+|||++.. ..++.++||||+||+||||+||+.||.....
T Consensus 154 FG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---------- 220 (277)
T d1phka_ 154 FGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---------- 220 (277)
T ss_dssp CTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred chheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----------
Confidence 9999865443222 23579999999999853 3578899999999999999999999974321
Q ss_pred cchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+....++......+.+.....++.+.+|+.+||+.||++|||++|+++
T Consensus 221 -----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 -----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112233333333333333345567889999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=393.63 Aligned_cols=264 Identities=28% Similarity=0.414 Sum_probs=207.4
Q ss_pred CCCCcCceeccCCceEEEEEEEcC--------CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CCCCce
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDD--------GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HHKNLV 529 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv 529 (768)
++|++.+.||+|+||.||+|+... +..||||+++.. ..+....++.+|...+.++ +|||||
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----------cChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 478888999999999999997532 247999987532 2234557889999999888 899999
Q ss_pred eEEEEEEcCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 046311 530 RLLGFCEDRNERVLIYEYLENGTLHDHLHNPQS------------SSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHR 597 (768)
Q Consensus 530 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHr 597 (768)
++++++.+++..++||||+++|+|.++|+.... ....+++..+++++.||++||+|||+++ |+||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHr 159 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHR 159 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEee
Confidence 999999999999999999999999999975432 1234689999999999999999999998 9999
Q ss_pred CCCCCCeEECCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccc
Q 046311 598 DIKSSNVLLDATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIH 676 (768)
Q Consensus 598 DiKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~ 676 (768)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999986554444344445678999999999999999999999999999999998 677775
Q ss_pred cCCCCCcccccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhc
Q 046311 677 RTHNGTPRNVVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAAC 753 (768)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~ 753 (768)
.... ..+.+.+.....+..+ ...+..+.+|+.+||+.||++|||+.||++.|+++++..
T Consensus 240 ~~~~----------------~~~~~~i~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 240 GVPV----------------EELFKLLKEGHRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp TCCH----------------HHHHHHHHTTCCCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCH----------------HHHHHHHHcCCCCCCC--ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 3221 1122222222222111 123456789999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=396.97 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=209.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||.||+++.+ +++.||||+++.... ......+.+.+|+.+|++++||||+++++++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--------cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 46889999999999999999975 799999999874311 122345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|+||||+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeec
Confidence 999999999999999999997532 3577788899999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +
T Consensus 150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---------------~ 212 (337)
T d1o6la_ 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------R 212 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------------H
T ss_pred ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---------------H
Confidence 99986543222 122457999999999999999999999999999999999999999643210 1
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHHH-------HHHHHhhcccC
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVNS-------LERALAACLVS 756 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~-------L~~~l~~~~~~ 756 (768)
-...+....+..+.. .+..+.+|+.+||+.||++||+ ++|+++. ++++.+....+
T Consensus 213 ~~~~i~~~~~~~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~ 279 (337)
T d1o6la_ 213 LFELILMEEIRFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279 (337)
T ss_dssp HHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHhcCCCCCCcc----CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCC
Confidence 112222222222222 3345678999999999999995 8888872 45555544433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=391.73 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=196.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc--CC--CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD--DG--SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~--~g--~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
++|++.+.||+|+||.||+|+++ ++ ..||||+++... ...+...++|.+|+++|++++||||++++++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--------~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--------LSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh--------cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 46888999999999999999864 22 368999876432 1223455789999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
+.+ +..++||||+++|+|.+++.... ..+++..+++++.||++||.|||+++ |+||||||+||||+.++++||
T Consensus 80 ~~~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 80 VLT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred Eee-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceee
Confidence 976 46789999999999999886532 23688999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCc-ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHc-CCcccccCCCCCcccccccccc
Q 046311 615 SDFGLSLIGPEDDES-HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILS-GYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 615 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 692 (768)
+|||+++........ .......++..|+|||++....++.++||||||+++|||+| |+.||.....
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------------ 220 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------ 220 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------------
Confidence 999999865443322 22233467889999999999999999999999999999998 8999864321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERA 749 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~ 749 (768)
.+....+......++. ....+..+.+|+.+||+.||++||||+||++.|+++
T Consensus 221 ---~~~~~~i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 ---SQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---HHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHhCCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112222222222211 122345678999999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-45 Score=389.74 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=203.2
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.+.||+|+||+||+++.+ +|+.||||+++.... ......+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 75 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--------cCHHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence 46888999999999999999975 689999999864311 122345679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|+||||+++|+|.+++.... ..++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecC
Confidence 999999999999999999987532 3467778889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...... ....||+.|||||++.+..++.++|||||||+||||+||+.||..... .+
T Consensus 149 G~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---------------~~ 208 (316)
T d1fota_ 149 GFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------------MK 208 (316)
T ss_dssp SSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------------HH
T ss_pred ccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---------------HH
Confidence 9998654322 235799999999999999999999999999999999999999964321 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
...+++......+. ..+..+.+++.+||+.||.+|| |++|+++
T Consensus 209 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 209 TYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12233333322222 2234567899999999999996 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=387.75 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=202.6
Q ss_pred CceeccCCceEEEEEEEcCC----CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc-C
Q 046311 464 DHKIGSGSFGAVYKATLDDG----SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED-R 538 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g----~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 538 (768)
.++||+|+||+||+|++.+. ..||||+++.. ......++|.+|+++|++++||||+++++++.+ +
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC----------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 47899999999999987532 25899988532 234456789999999999999999999999865 5
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
...++||||+++|+|.++++... ...++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSG
T ss_pred CceEEEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEeccc
Confidence 68899999999999999997633 33578889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCc--ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 619 LSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 619 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
+++........ .......||+.|+|||.+....++.++||||||++||||+||..|+....... .+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~---------- 243 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI---------- 243 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----------
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH----------
Confidence 99865433221 12223468999999999999999999999999999999999888876432211 11
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhccc
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLV 755 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~ 755 (768)
...+.....+. .+ ......+.+|+.+||+.||++||+|.||++.|++++..-..
T Consensus 244 --~~~i~~g~~~~-~p--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 244 --TVYLLQGRRLL-QP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp --HHHHHTTCCCC-CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --HHHHHcCCCCC-Cc--ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 11111111111 11 12234577999999999999999999999999999876443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=392.95 Aligned_cols=251 Identities=17% Similarity=0.252 Sum_probs=205.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.+.||+|+||+||+|... +++.||||.++.. ......+.+|+++|++++||||+++++++.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 71 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------GTDQVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------THHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------------cccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 468999999999999999999875 6889999998643 123456889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC--CCcEEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--TWTAKV 614 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--~~~~kl 614 (768)
+.+..||||||+++|+|.+++.... ..+++.....++.||++||+|||+++ |+||||||+|||++. ...+||
T Consensus 72 ~~~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 72 SMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEE
Confidence 9999999999999999999997532 23688899999999999999999998 999999999999985 458999
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI 694 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 694 (768)
+|||+++....... .....+|+.|+|||.+....++.++|||||||++|||++|+.||.....
T Consensus 146 ~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------------- 208 (321)
T d1tkia_ 146 IEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------------- 208 (321)
T ss_dssp CCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------------
T ss_pred cccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------------
Confidence 99999986543332 2234689999999999999999999999999999999999999964321
Q ss_pred hhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
.+-...++......+.......+..+.+|+.+||+.||++|||++|+++
T Consensus 209 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 209 -QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112233333332222111233556789999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-45 Score=396.66 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=198.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+|+.. +|+.||||++..... .....+.......+|+++++.++||||+++++++.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~-----~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-----KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc-----chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 57899999999999999999975 689999999864311 001111122233445788888899999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
.+..|+||||+++|+|.++|... ..+++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred CCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeee
Confidence 99999999999999999999653 23577888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
|+|+....... ....||+.|||||++.. ..++.++|||||||+||||+||+.||.........
T Consensus 152 Gla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------------ 215 (364)
T d1omwa3 152 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------------ 215 (364)
T ss_dssp TTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH------------
T ss_pred ceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH------------
Confidence 99986543322 23479999999999864 56899999999999999999999999754332110
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCC-----HHHHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPS-----MTEIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~ 744 (768)
.-...........+ ...+..+.+|+.+||+.||++||| ++|+++
T Consensus 216 ~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 EIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHSSSCCCCCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHhcccCCCCCC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111111111111 123455779999999999999999 688875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=392.92 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=209.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc------CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD------DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLL 532 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 532 (768)
++|++.++||+|+||+||+|.+. ++..||||+++.. ........|.+|++++++++||||++++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----------~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----------cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 57888899999999999999763 3578999987532 1234456799999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEE
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQ------SSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLL 606 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl 606 (768)
+++..++..++||||+++|+|.++++... ......++..+++++.|+++||.|||+++ |+||||||+||||
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 99999999999999999999999986421 12234588999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCC-cccccCCCCCccc
Q 046311 607 DATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGY-RAIHRTHNGTPRN 685 (768)
Q Consensus 607 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~ 685 (768)
+.++++||+|||+++...............+|+.|+|||.+....++.++||||||++||||+||. .|+.....
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----- 241 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 241 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998654444333344456899999999999999999999999999999999985 45532211
Q ss_pred ccccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHh
Q 046311 686 VVDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALA 751 (768)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~ 751 (768)
.+.+..+.+...++. ....+..+.+|+.+||+.+|++||||+||++.|++.++
T Consensus 242 ----------~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 242 ----------EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------HHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111222333222211 11234567899999999999999999999999988765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-44 Score=390.08 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||.||+++.+ +|+.||||++..... ......+.+.+|+++|++++||||+++++++.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--------cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 47899999999999999999875 799999999864311 112345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++||||+.+|+|.+++.... .+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeec
Confidence 999999999999999999996532 3688899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhhh
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVRD 697 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (768)
|+++...... ....||+.|||||++.+..++.++|||||||+||||+||+.||..... ..
T Consensus 186 G~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------------~~ 245 (350)
T d1rdqe_ 186 GFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQ 245 (350)
T ss_dssp TTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------HH
T ss_pred eeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---------------HH
Confidence 9998654322 234799999999999999999999999999999999999999964311 11
Q ss_pred hHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 698 EIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
....+.......+. ..+..+.+|+.+||+.||.+|+ |++|+++
T Consensus 246 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 246 IYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhcCCCCCCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12223333333222 2334577999999999999994 8999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=388.61 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=196.9
Q ss_pred CCCCcCc-eeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhc-CCCCCceeEEEEE
Q 046311 459 NNFSEDH-KIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSR-LHHKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~~-~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~ 535 (768)
++|.+.+ .||+|+||+||+|+.. +++.||||+++.. ..+.+|++++.+ ++||||+++++++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------------~~~~~E~~~~~~~~~hpnIv~l~~~~ 74 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------------PKARREVELHWRASQCPHIVRIVDVY 74 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------------HHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 4787765 5999999999999874 7899999987532 346789988655 4899999999998
Q ss_pred Ec----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---
Q 046311 536 ED----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA--- 608 (768)
Q Consensus 536 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~--- 608 (768)
.+ +...|+||||+++|+|.++|..... ..+++.....++.||+.||+|||+++ |+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~ 149 (335)
T d2ozaa1 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 149 (335)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSST
T ss_pred eecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccc
Confidence 65 4568999999999999999975322 34688899999999999999999998 999999999999975
Q ss_pred CCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 609 TWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 609 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
++.+||+|||+++........ ....||+.|||||++.+..++.++|||||||+||||+||+.||...........
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-- 224 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-- 224 (335)
T ss_dssp TCCEEECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--
Confidence 567999999999865443322 245799999999999999999999999999999999999999975433211000
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
. ...+.......+.+...+.+..+.+|+.+||+.||++|||+.|+++
T Consensus 225 -~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 225 -M--------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -H--------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0011111112222233345677889999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=383.05 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=199.7
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHh-cCCCCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLS-RLHHKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~ 536 (768)
++|++.++||+|+||+||+|+.. +++.||||+++.... ..+...+.+.+|..++. .++||||+++++++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--------~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~ 73 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--------cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence 47889999999999999999875 789999999864311 11233455667777665 689999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSD 616 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~D 616 (768)
+.+..||||||+++|+|.++++... .+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred cCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccc
Confidence 9999999999999999999997532 3577888999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhhh
Q 046311 617 FGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIVR 696 (768)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (768)
||+++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 147 FG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~------------ 209 (320)
T d1xjda_ 147 FGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---E------------ 209 (320)
T ss_dssp CTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H------------
T ss_pred cchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---H------------
Confidence 9999754433222 2245799999999999999999999999999999999999999964321 0
Q ss_pred hhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHH-HHHH
Q 046311 697 DEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMT-EIVN 744 (768)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 744 (768)
.-...+.......+. ..+..+.+|+.+||+.||++||++. |+++
T Consensus 210 ~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 ELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHcCCCCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111122222222211 2245577999999999999999996 7754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=381.31 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=190.4
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcCCeeE
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 542 (768)
.++||+|+||+||+|+.+ +++.||||+++..... ...+...+.+.+|++++++++|||||++++++.+++..+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh------hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 578999999999999875 6899999998654211 111223457899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFGLSLI 622 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~~ 622 (768)
|||||+.++++..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 77 ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp EEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 999999998777766432 33567788899999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchhh---hhh
Q 046311 623 GPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYIV---RDE 698 (768)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 698 (768)
....... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+. ......... .+.
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQ 224 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhh
Confidence 5433322 223478999999999864 4679999999999999999999999864321100 000000000 000
Q ss_pred H---Hh---hhccCCCCCCcc---hHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 699 I---HR---VLDRNVPPPTPF---EIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 699 ~---~~---~~~~~~~~~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
. .. .......+..+. .......+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00 000000000000 0112356779999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=379.17 Aligned_cols=270 Identities=21% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+.. +++.||||+++... ..+.....+.+|+++|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------cChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 47899999999999999999874 78999999986431 112334678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
+...++||||+.+ ++.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DF 146 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADF 146 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECST
T ss_pred ccceeEEEeecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccC
Confidence 9999999999976 4444443221 234688999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCC-CCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-cccc-cc-ch
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDF-VV-PY 693 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~-~~-~~ 693 (768)
|+++........ .....||+.|+|||++.... ++.++|||||||++|||++|+.||.......... .... .. ..
T Consensus 147 G~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 147 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp THHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 999765433222 22347999999999877655 5889999999999999999999996432110000 0000 00 00
Q ss_pred hhhhhHHhhhc--cCCCCC--Cc---chHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 694 IVRDEIHRVLD--RNVPPP--TP---FEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 694 ~~~~~~~~~~~--~~~~~~--~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..........+ ...+.. .. ........+.+|+.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000 000000 00 001223567789999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-44 Score=374.53 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=197.3
Q ss_pred CCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
++|++.++||+|+||+||+|+.++++.||||+++... ..+...+.|.+|+.+|++++||||+++++++.+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 72 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh---------cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC
Confidence 5789999999999999999999999999999986532 1233457899999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 046311 539 NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDFG 618 (768)
Q Consensus 539 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DFG 618 (768)
+..+++|||+.++.+..+.... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccc
Confidence 9999999999887777766432 34688999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-ccccc-cc-hh
Q 046311 619 LSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-VVDFV-VP-YI 694 (768)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~-~~-~~ 694 (768)
++......... .....+++.|+|||.+.. ..++.++|||||||++|||++|+.||......+... ..... .+ ..
T Consensus 146 ~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 146 LARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 99764332221 123368999999999875 456899999999999999999999996432110000 00000 00 00
Q ss_pred hhhhHHhh--hccCCC-----CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 VRDEIHRV--LDRNVP-----PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ~~~~~~~~--~~~~~~-----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+. .+.... +...........+.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 000000 000011122356779999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=370.09 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=194.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGFC 535 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~ 535 (768)
++|++.++||+|+||+||+|+.. +++.||||+++........ ......++.+|+.++++++ ||||+++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-----ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEE-----ECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchh-----hhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 57999999999999999999875 7899999998754322111 1112234668999999986 89999999999
Q ss_pred EcCCeeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-CCcEE
Q 046311 536 EDRNERVLIYEYLEN-GTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-TWTAK 613 (768)
Q Consensus 536 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-~~~~k 613 (768)
.+.+..++||||+.+ ++|.+++... ..+++.....++.||++||+|||+++ |+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEE
Confidence 999999999999976 6788887542 23688899999999999999999998 999999999999985 47999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccCCC-CChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQL-TEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVP 692 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 692 (768)
|+|||+++...... .....||+.|||||++....+ +.++|||||||+||||+||+.||....
T Consensus 152 l~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------- 214 (273)
T d1xwsa_ 152 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------- 214 (273)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred ECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------
Confidence 99999997643322 224579999999999987665 577999999999999999999986321
Q ss_pred hhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 693 YIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
+++......+. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 215 --------~i~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 --------EIIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------HHHHCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHhhcccCCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111111111 12345678999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=375.36 Aligned_cols=269 Identities=23% Similarity=0.333 Sum_probs=191.6
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-C-CCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC---CCCCceeEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-D-GSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL---HHKNLVRLL 532 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~ 532 (768)
.++|++.++||+|+||+||+|+.. + ++.||||+++..... +.....+.+|+.+++.| +||||++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~~E~~~l~~l~~~~HpnIv~~~ 76 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---------EGMPLSTIREVAVLRHLETFEHPNVVRLF 76 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---------TSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc---------chHHHHHHHHHHHHHHHhhcCCCCcceee
Confidence 368999999999999999999874 4 567999998754221 11122355666665554 899999999
Q ss_pred EEEEc-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEEC
Q 046311 533 GFCED-----RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLD 607 (768)
Q Consensus 533 ~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~ 607 (768)
+++.. ....+++|||++++++....... ...+++.....++.|++.||+|||+++ |+||||||+|||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~ 150 (305)
T d1blxa_ 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT 150 (305)
T ss_dssp EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eeecccccccCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEc
Confidence 99853 34678999999987776554432 234578888899999999999999998 99999999999999
Q ss_pred CCCcEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccc-c
Q 046311 608 ATWTAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRN-V 686 (768)
Q Consensus 608 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~ 686 (768)
.++.+||+|||++....... ......||+.|||||++....++.++|||||||++|||+||+.||.......... +
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 151 SSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp TTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999987543222 2234579999999999999999999999999999999999999996432110000 0
Q ss_pred ccc-------ccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 687 VDF-------VVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 687 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
... ..+................+...........+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000000000000000000111123355678999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-42 Score=363.74 Aligned_cols=268 Identities=21% Similarity=0.204 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL-VRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~ 536 (768)
++|++.++||+|+||+||+|++. +++.||||++.... ...++.+|++++++++|+|+ +.+..++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~ 73 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------KHPQLHIESKIYKMMQGGVGIPTIRWCGA 73 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-------------TSCCHHHHHHHHHHSTTSTTCCCEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-------------cCHHHHHHHHHHHHccCCCcccEEEEEEe
Confidence 57999999999999999999874 68999999876431 11247789999999987665 55556667
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC---CCcEE
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA---TWTAK 613 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~---~~~~k 613 (768)
+.+..++||||+. ++|.+.+.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++. +..+|
T Consensus 74 ~~~~~~ivme~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 74 EGDYNVMVMELLG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred cCCEEEEEEEEcC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceee
Confidence 8888999999994 57766664322 34688999999999999999999998 999999999999864 55799
Q ss_pred EeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccc
Q 046311 614 VSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVD 688 (768)
Q Consensus 614 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 688 (768)
|+|||+|+........ .......||+.|||||++.+..++.++||||||+++|||+||+.||.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 9999999865432211 12234579999999999999999999999999999999999999997544322111100
Q ss_pred cccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCC
Q 046311 689 FVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSP 757 (768)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~ 757 (768)
............. + ....+..+.+++..||+.+|++||+++++.+.|++++.....+.
T Consensus 227 ~~~~~~~~~~~~~-~----------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 227 RISEKKMSTPIEV-L----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HHHHHHHHSCHHH-H----------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred HhhcccCCCChhH-h----------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 0000000000000 0 01223557789999999999999999999999999887654444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-42 Score=361.05 Aligned_cols=269 Identities=18% Similarity=0.190 Sum_probs=206.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~ 536 (768)
++|++.++||+|+||+||+|++. +++.||||++.... ....+.+|++.++.|+| +|++.+++++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 71 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------------TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-------------CcHHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence 57999999999999999999965 68999999875421 11246778889998865 89999999999
Q ss_pred cCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECC-----CCc
Q 046311 537 DRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDA-----TWT 611 (768)
Q Consensus 537 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~-----~~~ 611 (768)
+....++||||+ +++|.++++... ..+++...+.++.|++.||+|||+++ |+||||||+|||++. ++.
T Consensus 72 ~~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 72 EGLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTC
T ss_pred cCCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCc
Confidence 999999999998 679999986533 34688899999999999999999999 999999999999964 578
Q ss_pred EEEeeccccccCCCCCCc-----ccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 612 AKVSDFGLSLIGPEDDES-----HLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+||+|||+++........ .......||+.|||||++.+..++.++||||||+++|||+||+.||...........
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 224 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence 999999999764332211 112245799999999999999999999999999999999999999975433221111
Q ss_pred cccccchhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHHHHHHHhhcccCCC
Q 046311 687 VDFVVPYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNSLERALAACLVSPS 758 (768)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~~l~~~~~~~~ 758 (768)
..............++ ....++.+.+++..|+..+|++||+++.+.+.|++++.......+
T Consensus 225 ~~~i~~~~~~~~~~~l-----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 225 YERIGEKKQSTPLREL-----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHHHHHHHHSCHHHH-----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred HHHHHhccCCCChHHh-----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence 0000000000000000 011234577899999999999999999999999999876655443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=364.32 Aligned_cols=271 Identities=21% Similarity=0.305 Sum_probs=191.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+.. +|+.||||++.... ..+....++.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-------------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------cchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 57999999999999999999975 79999999986532 123345678899999999999999999998855
Q ss_pred --------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCC
Q 046311 538 --------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDAT 609 (768)
Q Consensus 538 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~ 609 (768)
+...++||||++++.+..+... ....+......++.|+++||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD 153 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred ccccccccCceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCC
Confidence 3467899999988776655543 223577888899999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCc--ccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc
Q 046311 610 WTAKVSDFGLSLIGPEDDES--HLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV 686 (768)
Q Consensus 610 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 686 (768)
+.+||+|||++......... .......||+.|+|||++... .++.++|||||||++|||++|+.||...........
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence 99999999999754432221 122234699999999998754 689999999999999999999999964321100000
Q ss_pred c-ccc-------cchhhhhhHHhhhccCCCCCCcch-----HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 V-DFV-------VPYIVRDEIHRVLDRNVPPPTPFE-----IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
. ... ............+........... ......+.+|+.+||+.||++|||++|+++.
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 000 000000000000100001111111 1113456689999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=356.23 Aligned_cols=266 Identities=19% Similarity=0.251 Sum_probs=200.8
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|+.. +++.||||+++... ..+....++.+|+.++++++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---------CChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 47899999999999999999975 78999999986532 223456789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 046311 538 RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKVSDF 617 (768)
Q Consensus 538 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl~DF 617 (768)
....++|||++.+++|..++... ...++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DF 145 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANF 145 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeec
Confidence 99999999999999999888653 23578888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccccCccCccccccCC-CCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccccchh--
Q 046311 618 GLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQ-LTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVVPYI-- 694 (768)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 694 (768)
|.++......... ....+++.|+|||++.... ++.++|||||||++|||++|+.||....... ..........
T Consensus 146 G~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~ 221 (292)
T d1unla_ 146 GLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGT 221 (292)
T ss_dssp TTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCC
T ss_pred chhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCC
Confidence 9998654433222 2335788999999987654 6899999999999999999999975322110 0000000000
Q ss_pred ----hhhhHHhhhcc-------CCCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 695 ----VRDEIHRVLDR-------NVPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 695 ----~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
......+..+. ...............+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 000001111223455678999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=367.42 Aligned_cols=270 Identities=22% Similarity=0.288 Sum_probs=194.0
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
..+|++.++||+|+||+||+|+.+ +++.||||+++.. ......+.+++|+++|++++||||+++++++.
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~ 76 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----------EHQTYCQRTLREIKILLRFRHENIIGINDIIR 76 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----------cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence 457999999999999999999864 7999999998642 12344568899999999999999999999986
Q ss_pred cCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcE
Q 046311 537 DRN----ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTA 612 (768)
Q Consensus 537 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~ 612 (768)
... ..++++||+.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+
T Consensus 77 ~~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~ 148 (345)
T d1pmea_ 77 APTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDL 148 (345)
T ss_dssp CSSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred eccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCE
Confidence 643 235556667799999999642 3688999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCC-cccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccc-
Q 046311 613 KVSDFGLSLIGPEDDE-SHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDF- 689 (768)
Q Consensus 613 kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~- 689 (768)
||+|||++........ ........||+.|+|||++.. ..++.++||||+|+++|||++|+.||......+.......
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 9999999975433222 112234578999999999854 5678999999999999999999999964321100000000
Q ss_pred -ccch------hhhhhHHhhhccCCC-CCCcch---HHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 690 -VVPY------IVRDEIHRVLDRNVP-PPTPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 690 -~~~~------~~~~~~~~~~~~~~~-~~~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
..+. ............... ...+.. ......+.+|+.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000000011110000 001110 1123457799999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=366.69 Aligned_cols=269 Identities=20% Similarity=0.278 Sum_probs=193.2
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||+||+|... +++.||||+++.. ...+...+.+.+|+++|++++|||||++++++.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---------~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---------TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---------hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 468999999999999999999875 6999999998642 122345578899999999999999999999997
Q ss_pred cCC------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC
Q 046311 537 DRN------ERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW 610 (768)
Q Consensus 537 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~ 610 (768)
..+ +.++||||+ +.+|..+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~ 158 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDC 158 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccc
Confidence 654 579999999 5578777753 23688999999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc-c
Q 046311 611 TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV-D 688 (768)
Q Consensus 611 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~ 688 (768)
.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .
T Consensus 159 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 159 ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 99999999998654322 23468999999999875 45789999999999999999999999643211000000 0
Q ss_pred -------cccchhh---hhhHHhhhccCCC-CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHH
Q 046311 689 -------FVVPYIV---RDEIHRVLDRNVP-PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERA 749 (768)
Q Consensus 689 -------~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~ 749 (768)
....... .......+..... ............+.+|+.+||+.||++|||++|+++. |+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 0001111111000 0000111223456789999999999999999999974 5443
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=1.1e-39 Score=340.44 Aligned_cols=232 Identities=16% Similarity=0.226 Sum_probs=192.7
Q ss_pred CcceeecC------CccccCCCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccccccCCCCeeEEecCC
Q 046311 54 DFSLNCSI------PQLIPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGN 127 (768)
Q Consensus 54 ~~~~~~~~------~~~~~~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~ 127 (768)
..++.||+ ..++++...-.+.+|++|..|+|+| + ||+|||||.|.+|||+.|.... ..+++|++|.
T Consensus 3 ~~sv~~WG~~~~~~~~~~~~~~~~~i~~va~G~~h~~al-----~-dG~v~~wG~N~~GQlG~~~~~~--~~v~~v~~G~ 74 (273)
T d1jtdb_ 3 ATSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLAL-----K-GGKVLGWGANLNGQLTMPAATQ--SGVDAIAAGN 74 (273)
T ss_dssp CSEEEEESSCCSSSTTCCCGGGSSSEEEEEECSSEEEEE-----E-TTEEEEEECCTTSTTSCCGGGG--SCCCEEEECS
T ss_pred CCEEEEECCCCCCCceeccccCCCCcEEEEccCCEEEEE-----E-CCEEEEEeCCCCCceeeeeccc--ccceEEecCC
Confidence 35677775 2223333334789999999999999 6 8999999999999998876654 3688999999
Q ss_pred CeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEecc
Q 046311 128 SHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAG 202 (768)
Q Consensus 128 ~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G 202 (768)
.|+|+| + ||+|||||.|.+||++ ...+..|++|..|+|++. ||++++||.+..++..........+..++++
T Consensus 75 ~~~~al-~-dg~v~~wG~~~~gq~~~~~~~~~~~~~i~~~~~~~~~~~-dg~v~~~g~~~~~~~~~~~~~~~~v~~~~~~ 151 (273)
T d1jtdb_ 75 YHSLAL-K-DGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALK-DGKVIAWGDDSDGQTTVPAEAQSGVTALDGG 151 (273)
T ss_dssp SEEEEE-E-TTEEEEEECCTTSTTCCCGGGGSSCCEEEEETTEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEEEEEEC
T ss_pred Cceeee-e-eeeeeccCCCcceeeccccccccceeEEeeecccccccc-cccceecccCCCCceeeeccCCceEEEEecc
Confidence 999998 6 8999999999999987 345889999999999885 8999999999887765444444567777665
Q ss_pred CceeEEEecCCcEEEeecCCCCCCC------CCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC--CCCeEEEEec
Q 046311 203 FRHVCAIDDDQELRCWGDSVGEVPQ------GKFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ--GKPFVSIEAK 274 (768)
Q Consensus 203 ~~h~~al~~~g~v~~wG~n~~gq~~------~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~--~~~~~~i~~g 274 (768)
. |+|++.++|.++|||.|..+|.. .+|++|++|.+|+|+|+ ||+|||||.|.+||++.+. ...+++|++|
T Consensus 152 ~-~~~~~~~~g~~~~~G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l~-dG~v~~WG~n~~Gql~~~~~~~~~v~~I~~G 229 (273)
T d1jtdb_ 152 V-YTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALK-DGKVIAWGDNRYKQTTVPTEALSGVSAIASG 229 (273)
T ss_dssp S-SEEEEEETTEEEEEECCTTSTTSCCGGGSSSEEEEEECSSEEEEEE-TTEEEEEECCTTSTTCCCGGGGSSCCEEEEC
T ss_pred c-eeeeeecccceeEeecccCCcccccccccCCccceeccceeeEEEe-cCcEEEcCCCCCCccCCCccCCCCcEEEEeC
Confidence 5 55666678999999999999832 38999999999999997 8999999999999999764 3579999999
Q ss_pred CCeEEEEEecCCeEEEEeCCCCCCCc
Q 046311 275 RSVFCGVLTSNYSLYCWGNESFSSNH 300 (768)
Q Consensus 275 ~~h~~~l~~~~g~~~~wG~n~~~~~~ 300 (768)
..|+|+| + ||+|||||+|...+..
T Consensus 230 ~~~~~~l-~-~g~v~~WG~~~~~~~~ 253 (273)
T d1jtdb_ 230 EWYSLAL-K-NGKVIAWGSSRTAPSS 253 (273)
T ss_dssp SSCEEEE-E-TTEEEEESTTCCCCGG
T ss_pred cceEEEE-E-CCEEEEECCCCCCCCC
Confidence 9999998 5 8999999999766544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=367.38 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=190.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEcC
Q 046311 460 NFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCEDR 538 (768)
Q Consensus 460 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 538 (768)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------------~~~~Ei~il~~l~h~niv~~~~~~~~~ 85 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------------FKNRELQIMRKLDHCNIVRLRYFFYSS 85 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------------SCCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------------HHHHHHHHHHhcCCCCCCcEEEEEEec
Confidence 4777899999999999999975 689999999864311 123699999999999999999998543
Q ss_pred ------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-c
Q 046311 539 ------NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-T 611 (768)
Q Consensus 539 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~ 611 (768)
.+.+|||||++++.+..+.+. ......+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .
T Consensus 86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~ 161 (350)
T d1q5ka_ 86 GEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAV 161 (350)
T ss_dssp --CCSCCEEEEEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCC
T ss_pred CccCCceEEEEEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCc
Confidence 357899999987644443321 112334688899999999999999999998 99999999999999775 8
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCcccccc-CCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccccccc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRL-QQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFV 690 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 690 (768)
+||+|||++......... ....||+.|+|||.+.. ..++.++|||||||++|||++|+.||........ +....
T Consensus 162 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~ 236 (350)
T d1q5ka_ 162 LKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII 236 (350)
T ss_dssp EEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHH
T ss_pred eeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHH
Confidence 999999999765433322 23468999999998764 5789999999999999999999999964322110 00000
Q ss_pred --cchhhhhhHHhh----hccCCCCCC------cchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH--HHHH
Q 046311 691 --VPYIVRDEIHRV----LDRNVPPPT------PFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS--LERA 749 (768)
Q Consensus 691 --~~~~~~~~~~~~----~~~~~~~~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~~ 749 (768)
......+.+... .+...+... .........+.+|+.+||+.||++|||++|+++. |+++
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000000001110 111111000 0011234557799999999999999999999863 4444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=362.17 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=197.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc----CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCC-CCceeEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD----DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHH-KNLVRLLG 533 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~ 533 (768)
++|++.+.||+|+||+||+|+.. +|+.||||.++..... ......+.+.+|++++++++| |||+++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-------EEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-------cchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 46899999999999999999752 4789999998643211 112234567889999999966 89999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEE
Q 046311 534 FCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAK 613 (768)
Q Consensus 534 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~k 613 (768)
++.+....+++|||+.+|+|.+++.... .........++.||+.||+|||+++ |+||||||+||||+.++.+|
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eeccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEE
Confidence 9999999999999999999999997532 2356778889999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccC--CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ--QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVVDFVV 691 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 691 (768)
|+|||+++....... .......|++.|++||.+... .++.++|||||||+||||+||+.||......... .
T Consensus 170 L~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~--- 242 (322)
T d1vzoa_ 170 LTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---A--- 242 (322)
T ss_dssp ESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---H---
T ss_pred Eeeccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H---
Confidence 999999976543222 222345799999999998754 4788999999999999999999999754332210 0
Q ss_pred chhhhhhHHhhhccCCCCCCcchHHHHHHHHHHHHHcccccCCCCC-----CHHHHHH
Q 046311 692 PYIVRDEIHRVLDRNVPPPTPFEIEAVAYVGYLAADCVTLEGRNRP-----SMTEIVN 744 (768)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~ 744 (768)
.+ .........+.+ .+.+..+.+|+.+||+.||++|| |++|+++
T Consensus 243 -~i----~~~~~~~~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 243 -EI----SRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HH----HHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -HH----HHhcccCCCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00 111111111111 12346677899999999999999 4788886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=357.10 Aligned_cols=259 Identities=17% Similarity=0.247 Sum_probs=192.5
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGFCE 536 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 536 (768)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------------KKKKIKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--------------HHHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence 57999999999999999999874 7899999997532 2356889999999995 999999999997
Q ss_pred cC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCC-cEE
Q 046311 537 DR--NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATW-TAK 613 (768)
Q Consensus 537 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~-~~k 613 (768)
.. ...++||||+++++|.++.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 101 ~~~~~~~~~v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vk 170 (328)
T d3bqca1 101 DPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR 170 (328)
T ss_dssp CTTTCSEEEEEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCCceeEEEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeee
Confidence 43 56899999999999988753 2578889999999999999999999 99999999999998654 699
Q ss_pred EeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCcc--cccccc
Q 046311 614 VSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPR--NVVDFV 690 (768)
Q Consensus 614 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~~~~~~ 690 (768)
|+|||+++........ ....+|+.|+|||.+... .++.++||||||+++|||++|+.||......... .+....
T Consensus 171 l~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 171 LIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp ECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 9999999865443322 234689999999998754 5799999999999999999999998654321100 000000
Q ss_pred cchhhh-----------hhHHhhhccCCC------CCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 691 VPYIVR-----------DEIHRVLDRNVP------PPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 691 ~~~~~~-----------~~~~~~~~~~~~------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
...... ............ ............+.+|+.+||+.||++|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000000 000111123455779999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=358.52 Aligned_cols=263 Identities=20% Similarity=0.253 Sum_probs=190.4
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEc
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCED 537 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 537 (768)
++|++.++||+|+||+||+|.+. +|+.||||+++... ..+....++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh---------cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 57999999999999999999876 69999999986531 223445678999999999999999999999964
Q ss_pred ------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 538 ------RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 538 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
....|+||||+.++ |.+.+.. .+++.....++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred ccccccCceeEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccc
Confidence 36789999999765 4454432 2578889999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCcccccCCCCCcccc-----
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNV----- 686 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~----- 686 (768)
+|++|||+++....... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 158 ~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~ 234 (355)
T d2b1pa1 158 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_dssp EEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999875443322 2234689999999999999999999999999999999999999964321100000
Q ss_pred ----cccccchhhhhhHHhhhccC----------------CCCCCcchHHHHHHHHHHHHHcccccCCCCCCHHHHHHH
Q 046311 687 ----VDFVVPYIVRDEIHRVLDRN----------------VPPPTPFEIEAVAYVGYLAADCVTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 687 ----~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 745 (768)
.++. .. ............ ..............+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 235 GTPCPEFM-KK-LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCCHHHH-TT-SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCHHHH-HH-hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 000111111111 111112233456778899999999999999999999864
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=353.28 Aligned_cols=247 Identities=15% Similarity=0.137 Sum_probs=205.6
Q ss_pred ceeEEeccCCCCCCcceeecC------------------CccccCCCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccC
Q 046311 41 SLVCALIPSSRPGDFSLNCSI------------------PQLIPVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRF 102 (768)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~ 102 (768)
.|+|++.. ++.++||+ |.+| +..-.+..|++|..|+|+| +.+|.|||||.
T Consensus 6 ~h~~~~~~-----~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v--~~~~~i~~ia~G~~h~~al-----~~~G~vy~wG~ 73 (401)
T d1a12a_ 6 SHRSHSTE-----PGLVLTLGQGDVGQLGLGENVMERKKPALV--SIPEDVVQAEAGGMHTVCL-----SKSGQVYSFGC 73 (401)
T ss_dssp CCTTCCCC-----CBEEEEEEECTTSTTCSCTTCCEEEEEEEE--CCSSCEEEEEECSSEEEEE-----ETTSCEEEEEC
T ss_pred eEEEEECC-----CCEEEEEeCCCCCCCCCCCCCceeccCEEe--CCCCCeEEEEeCCCEEEEE-----eCCCEEEEEeC
Confidence 58888885 56777773 2222 2223689999999999999 89999999999
Q ss_pred CCCCccccc----------ccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC------------------CC
Q 046311 103 SADGIINDY----------KRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS------------------IH 154 (768)
Q Consensus 103 n~~gql~~~----------~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~------------------~~ 154 (768)
|.+|||+.. ..+....++++|++|..|+|++ +++|+|||||.+..++.+ ..
T Consensus 74 n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~-~~~g~v~~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (401)
T d1a12a_ 74 NDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL-TDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDV 152 (401)
T ss_dssp CTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEE-ETTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSS
T ss_pred CCCCCCCcccccccccccccccccccceeeecccccceeec-cccccceeccccccccccccccCCccccceeeeeccCC
Confidence 999999532 2333445899999999999999 999999999988555432 34
Q ss_pred ceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccC----------------------------CCcCeEEEeccCcee
Q 046311 155 NFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKV----------------------------PSGIFRVVAAGFRHV 206 (768)
Q Consensus 155 ~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~----------------------------~~~~~~~i~~G~~h~ 206 (768)
.+++|++|..|+++++.+|++|+||.|.++|++.... ...++.+|+||.+|+
T Consensus 153 ~i~~i~~g~~~~~~~~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~ 232 (401)
T d1a12a_ 153 PVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFT 232 (401)
T ss_dssp CEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEE
T ss_pred ceeEEEecccceeeeecCCcccccccCCccccCCCCccccccCCccccccccccceeeccccCCCCCceEEEEEecCCeE
Confidence 5899999999999999999999999999887642110 114789999999999
Q ss_pred EEEecCCcEEEeecCCCCCCCC--------------------CeEEEeccCCeeEEEeeCCeEEEEecCCCCCCCCCC--
Q 046311 207 CAIDDDQELRCWGDSVGEVPQG--------------------KFKALALGENRSCALRNNQKVVCWGQNGFTLPDSLQ-- 264 (768)
Q Consensus 207 ~al~~~g~v~~wG~n~~gq~~~--------------------~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~~~~-- 264 (768)
|+|+.||+||+||.|.+++... .+++|++|..|+++|++||.|||||.|.+||||...
T Consensus 233 ~~l~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~g~~~~~~l~~~g~v~~wG~n~~gqlG~g~~~ 312 (401)
T d1a12a_ 233 FAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGA 312 (401)
T ss_dssp EEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEETTSCEEEEECCGGGTTCSCTTC
T ss_pred EEEecCCeEeeecccceecccccccccceeccccccccccceeEEEEeeeccceeeeccCCCEEEecccccCccCCCccc
Confidence 9999999999999999888331 589999999999999999999999999999998432
Q ss_pred -----------CCCeEEEEecCCeEEEEEecCCeEEEEeCCCCCCCcc
Q 046311 265 -----------GKPFVSIEAKRSVFCGVLTSNYSLYCWGNESFSSNHM 301 (768)
Q Consensus 265 -----------~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n~~~~~~~ 301 (768)
...+++|+||.+|+|+| ++||.|||||.|.+++...
T Consensus 313 ~~~~~P~~i~~~~~i~~Is~G~~hs~al-t~dG~v~~WG~n~~GQLG~ 359 (401)
T d1a12a_ 313 EEKSIPTLISRLPAVSSVACGASVGYAV-TKDGRVFAWGMGTNYQLGT 359 (401)
T ss_dssp CCEEEEEECCSSSSEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCS
T ss_pred ccccCCEEcCCCCCeEEEEeeCCEEEEE-eCCCeEEEEecCCCCCCCC
Confidence 23699999999999999 9999999999998876553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=358.13 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=192.4
Q ss_pred cCCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 046311 458 TNNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNLVRLLGFCE 536 (768)
Q Consensus 458 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 536 (768)
.++|++.++||+|+||+||+|+.. +++.||||+++.. .......+.+.+|+++|++++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---------hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 468999999999999999999864 7999999998643 122344567899999999999999999999986
Q ss_pred cC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCc
Q 046311 537 DR-----NERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWT 611 (768)
Q Consensus 537 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~ 611 (768)
.. ...+++|||+.+|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~ 159 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 159 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccc
Confidence 43 3446777888899999999642 3688899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCcccccccccccCccCccccccC-CCCChhhHHHHHHHHHHHHcCCcccccCCCCCccccc-cc
Q 046311 612 AKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQ-QLTEKSDVYSFGVVLLEILSGYRAIHRTHNGTPRNVV-DF 689 (768)
Q Consensus 612 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~~ 689 (768)
+|++|||++...... .....||+.|+|||++... .++.++||||||+++|||++|+.||............ ..
T Consensus 160 ~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 160 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp EEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998653321 1234689999999987654 5689999999999999999999999643211000000 00
Q ss_pred -------ccchhhhhhHHhhhccCCCCC-Ccch---HHHHHHHHHHHHHcccccCCCCCCHHHHHH
Q 046311 690 -------VVPYIVRDEIHRVLDRNVPPP-TPFE---IEAVAYVGYLAADCVTLEGRNRPSMTEIVN 744 (768)
Q Consensus 690 -------~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 744 (768)
..................... .... ......+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000111111111100 0000 112355679999999999999999999987
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=332.43 Aligned_cols=244 Identities=14% Similarity=0.160 Sum_probs=201.1
Q ss_pred cceeeeecCCceeEEeccCCCCCCcceeecC----Cc-----------ccc--CCCCCCeeEEeeCCCeeeeeeeeccCC
Q 046311 31 TFSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQ-----------LIP--VNPNASFASIVSGDGFLCTLITFSASS 93 (768)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----------~~~--~~~~~~~~~v~~G~~~~c~l~~~~~~~ 93 (768)
..++.|++|..|+|||.. ++.+|||+ +| +++ +.....+.+|++|..|+|++ +.
T Consensus 47 ~~i~~ia~G~~h~~al~~-----~G~vy~wG~n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~-----~~ 116 (401)
T d1a12a_ 47 EDVVQAEAGGMHTVCLSK-----SGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL-----TD 116 (401)
T ss_dssp SCEEEEEECSSEEEEEET-----TSCEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEE-----ET
T ss_pred CCeEEEEeCCCEEEEEeC-----CCEEEEEeCCCCCCCCcccccccccccccccccccceeeecccccceeec-----cc
Confidence 358889999999999996 56788885 11 112 22333678999999999999 89
Q ss_pred CCcEEeccCCCCCccc--ccc---------cccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC----------
Q 046311 94 SSVMHCWRFSADGIIN--DYK---------RIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS---------- 152 (768)
Q Consensus 94 ~g~~~~WG~n~~gql~--~~~---------~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~---------- 152 (768)
+|.|||||.+.++++. ... .......+++|++|..|++++ +.+|.+|+||.|.++|+|
T Consensus 117 ~g~v~~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~-~~~g~~~~~G~n~~gqlg~~~~~~~~~~ 195 (401)
T d1a12a_ 117 DGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVML-TADGDLYTLGCGEQGQLGRVPELFANRG 195 (401)
T ss_dssp TSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSCGGGTSSSC
T ss_pred cccceeccccccccccccccCCccccceeeeeccCCceeEEEecccceeee-ecCCcccccccCCccccCCCCccccccC
Confidence 9999999998766642 111 112234799999999999999 999999999999999887
Q ss_pred -----------------------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccC--------------CCcC
Q 046311 153 -----------------------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKV--------------PSGI 195 (768)
Q Consensus 153 -----------------------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~--------------~~~~ 195 (768)
..++.+|++|..|+|+|+.+|+||+||.|.+++.+.... ....
T Consensus 196 ~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~ 275 (401)
T d1a12a_ 196 GRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKS 275 (401)
T ss_dssp GGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCC
T ss_pred CccccccccccceeeccccCCCCCceEEEEEecCCeEEEEecCCeEeeecccceecccccccccceecccccccccccee
Confidence 134889999999999999999999999998888642211 1156
Q ss_pred eEEEeccCceeEEEecCCcEEEeecCCCCCCC-----------------CCeEEEeccCCeeEEEeeCCeEEEEecCCCC
Q 046311 196 FRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ-----------------GKFKALALGENRSCALRNNQKVVCWGQNGFT 258 (768)
Q Consensus 196 ~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~-----------------~~~~~ia~G~~h~~al~~dg~v~~WG~n~~g 258 (768)
+++|++|..|+++++++|.|||||.|.+||.+ .+|++|++|.+|+|||++||+|||||.|.+|
T Consensus 276 ~~~i~~g~~~~~~l~~~g~v~~wG~n~~gqlG~g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt~dG~v~~WG~n~~G 355 (401)
T d1a12a_ 276 WVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNY 355 (401)
T ss_dssp EEEEEECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEETTSCEEEEECCTTS
T ss_pred EEEEeeeccceeeeccCCCEEEecccccCccCCCcccccccCCEEcCCCCCeEEEEeeCCEEEEEeCCCeEEEEecCCCC
Confidence 89999999999999999999999999998832 1799999999999999999999999999999
Q ss_pred CCCCCC----------------CCCeEEEEecCCeEEEEEecCC
Q 046311 259 LPDSLQ----------------GKPFVSIEAKRSVFCGVLTSNY 286 (768)
Q Consensus 259 q~~~~~----------------~~~~~~i~~g~~h~~~l~~~~g 286 (768)
|||... +..+.+|+||.+|+|+| ++||
T Consensus 356 QLG~G~~~~~~~P~~v~~~~~~~~~v~~v~~G~~hs~~l-~~d~ 398 (401)
T d1a12a_ 356 QLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLL-VKDK 398 (401)
T ss_dssp TTCSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEE-EEEC
T ss_pred CCCCCCCCCEecCEEeeccCCCCCEEEEEEEccceEEEE-EECC
Confidence 998432 12589999999999999 6776
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=3.3e-36 Score=313.85 Aligned_cols=232 Identities=20% Similarity=0.212 Sum_probs=193.5
Q ss_pred cccceeeeecCCceeEEeccCCCCCCcceeecC----Cccc-cCCCCCCeeEEeeCCCeeeeeeeeccCCCCcEEeccCC
Q 046311 29 LSTFSVSETGNQSLVCALIPSSRPGDFSLNCSI----PQLI-PVNPNASFASIVSGDGFLCTLITFSASSSSVMHCWRFS 103 (768)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n 103 (768)
....+++|++|..|+|||. ++.++||+ +|.- +......+.+|++|..|+|+| + ||++||||.|
T Consensus 24 ~~~~i~~va~G~~h~~al~------dG~v~~wG~N~~GQlG~~~~~~~~v~~v~~G~~~~~al-----~-dg~v~~wG~~ 91 (273)
T d1jtdb_ 24 AQSGVDAIAGGYFHGLALK------GGKVLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLAL-----K-DGEVIAWGGN 91 (273)
T ss_dssp GSSSEEEEEECSSEEEEEE------TTEEEEEECCTTSTTSCCGGGGSCCCEEEECSSEEEEE-----E-TTEEEEEECC
T ss_pred CCCCcEEEEccCCEEEEEE------CCEEEEEeCCCCCceeeeecccccceEEecCCCceeee-----e-eeeeeccCCC
Confidence 3556899999999999997 46899996 2211 122233679999999999999 5 8999999999
Q ss_pred CCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEecCCeEEEEeeCCeEEEe
Q 046311 104 ADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAVGEDFVCGLLENGTITCF 178 (768)
Q Consensus 104 ~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~G~~h~~~l~~~g~v~~w 178 (768)
.+||+..|.+.. ..+..|++|..|+|++ . ||++++||.+..++.. ...+..++ |..|+|+++++|.++||
T Consensus 92 ~~gq~~~~~~~~--~~~~~i~~~~~~~~~~-~-dg~v~~~g~~~~~~~~~~~~~~~~v~~~~-~~~~~~~~~~~g~~~~~ 166 (273)
T d1jtdb_ 92 EDGQTTVPAEAR--SGVDAIAAGAWASYAL-K-DGKVIAWGDDSDGQTTVPAEAQSGVTALD-GGVYTALAVKNGGVIAW 166 (273)
T ss_dssp TTSTTCCCGGGG--SSCCEEEEETTEEEEE-E-TTEEEEEECCTTSTTSCCGGGGSSEEEEE-ECSSEEEEEETTEEEEE
T ss_pred cceeeccccccc--cceeEEeeeccccccc-c-cccceecccCCCCceeeeccCCceEEEEe-ccceeeeeecccceeEe
Confidence 999998776663 3577899999999998 4 8999999999887665 23455555 55666777789999999
Q ss_pred cCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCCCC------CCeEEEeccCCeeEEEeeCCeEEEE
Q 046311 179 GSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEVPQ------GKFKALALGENRSCALRNNQKVVCW 252 (768)
Q Consensus 179 G~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq~~------~~~~~ia~G~~h~~al~~dg~v~~W 252 (768)
|.+.++|.........+|++|++|..|+|+|+ ||+|||||.|.+||.. .+|++|++|..|+|+|+ ||+||||
T Consensus 167 G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l~-dG~v~~WG~n~~Gql~~~~~~~~~v~~I~~G~~~~~~l~-~g~v~~W 244 (273)
T d1jtdb_ 167 GDNYFGQTTVPAEAQSGVDDVAGGIFHSLALK-DGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALK-NGKVIAW 244 (273)
T ss_dssp ECCTTSTTSCCGGGSSSEEEEEECSSEEEEEE-TTEEEEEECCTTSTTCCCGGGGSSCCEEEECSSCEEEEE-TTEEEEE
T ss_pred ecccCCcccccccccCCccceeccceeeEEEe-cCcEEEcCCCCCCccCCCccCCCCcEEEEeCcceEEEEE-CCEEEEE
Confidence 99999998654545579999999999999987 8999999999999943 27999999999999996 9999999
Q ss_pred ecCCCCCCCCCCCCCeEEEEecCCeEEEE
Q 046311 253 GQNGFTLPDSLQGKPFVSIEAKRSVFCGV 281 (768)
Q Consensus 253 G~n~~gq~~~~~~~~~~~i~~g~~h~~~l 281 (768)
|+|.++|++++ ..+.+|.+|..|++||
T Consensus 245 G~~~~~~~~~~--~~~~~i~~~~~~~~al 271 (273)
T d1jtdb_ 245 GSSRTAPSSVQ--SGVSSIEAGPNAAYAL 271 (273)
T ss_dssp STTCCCCGGGS--SCEEEEEECSSCEEEE
T ss_pred CCCCCCCCCCC--CCceeEEeCcceEEEe
Confidence 99999998665 5699999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-36 Score=325.08 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=185.9
Q ss_pred CCCCcCceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-----------CC
Q 046311 459 NNFSEDHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-----------HK 526 (768)
Q Consensus 459 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------Hp 526 (768)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++++.++ |+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------------ccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 35999999999999999999975 7999999998632 223456778888888775 57
Q ss_pred CceeEEEEEEc--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecCCCCCC
Q 046311 527 NLVRLLGFCED--RNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE-YAVPSIIHRDIKSSN 603 (768)
Q Consensus 527 nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDiKp~N 603 (768)
||+++++++.. ....+++|+++..+.......... .....++..+..++.||++||+|||+ .+ |+||||||+|
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~N 156 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 156 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhH
Confidence 89999988754 456677777766554333322211 22345778889999999999999998 66 9999999999
Q ss_pred eEECCCC------cEEEeeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHHHHHHHcCCccccc
Q 046311 604 VLLDATW------TAKVSDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVVLLEILSGYRAIHR 677 (768)
Q Consensus 604 ILl~~~~------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~elltG~~p~~~ 677 (768)
|||+.++ .++++|||.+....... ....||+.|+|||++....++.++||||||++++||++|+.||..
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 9997654 49999999997543222 234689999999999999999999999999999999999999975
Q ss_pred CCCCCcccccccccchh------hhhh------HHhhhcc-----CCCC------------CCcchHHHHHHHHHHHHHc
Q 046311 678 THNGTPRNVVDFVVPYI------VRDE------IHRVLDR-----NVPP------------PTPFEIEAVAYVGYLAADC 728 (768)
Q Consensus 678 ~~~~~~~~~~~~~~~~~------~~~~------~~~~~~~-----~~~~------------~~~~~~~~~~~l~~Li~~C 728 (768)
..........+.....+ .... .....+. .... ...........+.+|+.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 43321111000000000 0000 0000000 0000 0112345567888999999
Q ss_pred ccccCCCCCCHHHHHHH
Q 046311 729 VTLEGRNRPSMTEIVNS 745 (768)
Q Consensus 729 l~~dP~~RPs~~evl~~ 745 (768)
|+.||++|||++|+++.
T Consensus 312 L~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GCSSTTTCBCHHHHHTC
T ss_pred CCCChhHCcCHHHHhcC
Confidence 99999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.2e-22 Score=198.77 Aligned_cols=179 Identities=17% Similarity=0.132 Sum_probs=121.0
Q ss_pred CcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCccccccc-------ccchhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 046311 462 SEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGT-------KRQEDKDNAFINELESLSRLHHKNLVRLLGF 534 (768)
Q Consensus 462 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 534 (768)
.+.++||+|+||+||+|+..+|+.||||+++........... .........+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999888999999987643211000000 0111223456678999999999999998865
Q ss_pred EEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCCeEECCCCcEEE
Q 046311 535 CEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYAVPSIIHRDIKSSNVLLDATWTAKV 614 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDiKp~NILl~~~~~~kl 614 (768)
. ..+++|||+++..+.++. .....+++.|++++|+|||+++ |+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~l~-----------~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRVR-----------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGGCC-----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccchh-----------hHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 3 237999999886654432 1223578999999999999998 9999999999999865 5899
Q ss_pred eeccccccCCCCCCcccccccccccCccCccccccCCCCChhhHHHHHHH
Q 046311 615 SDFGLSLIGPEDDESHLSLRAAGTVGYMDPEYYRLQQLTEKSDVYSFGVV 664 (768)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl 664 (768)
+|||+|.............+ ....+ .|. ..+.|+.++|+||+.--
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~~~-~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVRNI-ITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHHHH-HHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHHHH-HHH-HcCCCCCcccHHHHHHH
Confidence 99999975432211100000 00000 011 13567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.5e-06 Score=86.77 Aligned_cols=147 Identities=16% Similarity=0.123 Sum_probs=97.4
Q ss_pred HHHHcCCCCcCceeccCCceEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEE
Q 046311 454 LLEATNNFSEDHKIGSGSFGAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLL 532 (768)
Q Consensus 454 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~ 532 (768)
+......|+..+..+.++...||+...+ ++.+.+|+...... .....+.+|...+..+. +--+.+++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-----------~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-----------GTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-----------TSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-----------cchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3344456666555554556789998754 56778887653211 11224667888777663 33356788
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------
Q 046311 533 GFCEDRNERVLIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHEYA---------------------- 590 (768)
Q Consensus 533 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~~~---------------------- 590 (768)
.+..+.+..++||+++++.++.+..... .. ...++.++++.|..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 8888888999999999998886654221 01 1234556666666666421
Q ss_pred ----------------------------------CCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 591 ----------------------------------VPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 591 ----------------------------------~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
.+.++|+|+.|.|||++++...-|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=6.7e-06 Score=81.43 Aligned_cols=130 Identities=16% Similarity=0.111 Sum_probs=85.2
Q ss_pred eeccCCc-eEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC--CCCceeEEEEEEcCCeeE
Q 046311 466 KIGSGSF-GAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH--HKNLVRLLGFCEDRNERV 542 (768)
Q Consensus 466 ~LG~G~f-G~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~ 542 (768)
.+..|.. ..||+...+++..+++|..... ....+.+|.+.++.+. .-.+.+++.+..+.+..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--------------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc--------------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 3445553 6799999888888999975432 1123566777776663 233667888888888899
Q ss_pred EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------
Q 046311 543 LIYEYLENGTLHDHLHNPQSSSPLKSWPARIKVALDAARGIEYLHE---------------------------------- 588 (768)
Q Consensus 543 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~ia~~ia~gL~yLH~---------------------------------- 588 (768)
+||||++|.++.+... . ...++.++.+.|+-||+
T Consensus 83 ~v~~~i~G~~~~~~~~---------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSSHL---------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 150 (255)
T ss_dssp EEEECCSSEETTTSCC---------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred EEEEeeeccccccccc---------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhcccccc
Confidence 9999999876644211 0 01122333334444442
Q ss_pred -----------------C----CCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 589 -----------------Y----AVPSIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 589 -----------------~----~~~~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 151 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11238999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00029 Score=74.29 Aligned_cols=84 Identities=18% Similarity=0.147 Sum_probs=48.6
Q ss_pred CceeccCCceEEEEEEEc-CCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcC-CC--CCceeEEEEEEcCC
Q 046311 464 DHKIGSGSFGAVYKATLD-DGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRL-HH--KNLVRLLGFCEDRN 539 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H--pnIv~l~~~~~~~~ 539 (768)
.+.||.|....||+.+.. +++.++||.-..... ......+....+...|.+.|+.+ .+ ..+.+++.+ +.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r----~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK----VVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGG----C--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhc----ccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 356899999999999865 467899997543210 00000011122344577777655 22 345556544 455
Q ss_pred eeEEEEEeccCCCh
Q 046311 540 ERVLIYEYLENGTL 553 (768)
Q Consensus 540 ~~~lV~E~~~~gsL 553 (768)
..++|||++++..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 67899999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.0015 Score=66.60 Aligned_cols=69 Identities=10% Similarity=0.114 Sum_probs=43.9
Q ss_pred eEEEEEEEcCCCeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCCCCCc--eeEE-----EEEEcCCeeEEEE
Q 046311 473 GAVYKATLDDGSQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLHHKNL--VRLL-----GFCEDRNERVLIY 545 (768)
Q Consensus 473 G~Vy~~~~~~g~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~-----~~~~~~~~~~lV~ 545 (768)
-.||+.+.++|+.+++|..+.. ....+++..|.+.+..|....+ +..+ ..+...+..+.++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~------------~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE------------RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT------------TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC------------CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 5899999999999999986532 1123456677777776632221 1111 1234456778899
Q ss_pred EeccCCCh
Q 046311 546 EYLENGTL 553 (768)
Q Consensus 546 E~~~~gsL 553 (768)
++++|..+
T Consensus 104 ~~~~G~~~ 111 (325)
T d1zyla1 104 PSVGGRQF 111 (325)
T ss_dssp ECCCCEEC
T ss_pred eecCCcCC
Confidence 99987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.09 E-value=0.0092 Score=62.27 Aligned_cols=74 Identities=15% Similarity=0.212 Sum_probs=46.9
Q ss_pred CceeccCCceEEEEEEEcCC--------CeEEEEEEeeccCcccccccccchhhHHHHHHHHHHHhcCC-CCCceeEEEE
Q 046311 464 DHKIGSGSFGAVYKATLDDG--------SQVAVKRAEISSTSSYAIGTKRQEDKDNAFINELESLSRLH-HKNLVRLLGF 534 (768)
Q Consensus 464 ~~~LG~G~fG~Vy~~~~~~g--------~~vaVK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 534 (768)
.+.|+.|-.=.+|+....++ +.|.+++.. .. ....+..+|..+++.+. +.-..+++++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~------------~~~idr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP------------ETESHLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC------------CCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc------------chhhHHHHHHHHHHHHHhCCCCCeEEEE
Confidence 36788888899999987543 345555432 10 11233457888888774 4334567777
Q ss_pred EEcCCeeEEEEEeccCCChh
Q 046311 535 CEDRNERVLIYEYLENGTLH 554 (768)
Q Consensus 535 ~~~~~~~~lV~E~~~~gsL~ 554 (768)
+.+ .+||||+++..|.
T Consensus 114 ~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 114 FSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp ETT----EEEECCCCEEECC
T ss_pred cCC----ceEEEEeccccCC
Confidence 643 6899999876553
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=95.85 E-value=0.011 Score=60.59 Aligned_cols=197 Identities=8% Similarity=-0.064 Sum_probs=104.3
Q ss_pred CCCCcEEeccCCCCCcccccccccCC--CCeeEE----ecCCCeEEEEEeCCCcEEEccCCCCCCCC----------CCc
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYRG--PALQQL----EAGNSHICGLVNGTNDLHWWQWPDFNSTS----------IHN 155 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~~--~~~~~i----~~G~~h~~al~~~~g~~~~Wg~~~~~~~~----------~~~ 155 (768)
..||.++.-|....... .++.. ..++.+ .....|++++ ..||+++..|....+... ...
T Consensus 84 ~~~g~i~v~Gg~~~~~~----~~yd~~~~~w~~~~~~~~~r~~~~~~~-~~dG~v~v~GG~~~~~~~~~~v~~yd~~~~~ 158 (387)
T d1k3ia3 84 DGNGQIVVTGGNDAKKT----SLYDSSSDSWIPGPDMQVARGYQSSAT-MSDGRVFTIGGSWSGGVFEKNGEVYSPSSKT 158 (387)
T ss_dssp CTTSCEEEECSSSTTCE----EEEEGGGTEEEECCCCSSCCSSCEEEE-CTTSCEEEECCCCCSSSCCCCEEEEETTTTE
T ss_pred ecCCcEEEeecCCCcce----eEecCccCcccccccccccccccceee-ecCCceeeeccccccccccceeeeecCCCCc
Confidence 68999998886543222 11110 112222 1335799998 899999999875332211 122
Q ss_pred eEEEE-----------------ecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCe------------EEEeccCcee
Q 046311 156 FSNIA-----------------VGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIF------------RVVAAGFRHV 206 (768)
Q Consensus 156 ~~~v~-----------------~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~------------~~i~~G~~h~ 206 (768)
+..+. .+.+..+....+|+++.+|......... ......+ ...+....|+
T Consensus 159 W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (387)
T d1k3ia3 159 WTSLPNAKVNPMLTADKQGLYRSDNHAWLFGWKKGSVFQAGPSTAMNWYY-TSGSGDVKSAGKRQSNRGVAPDAMCGNAV 237 (387)
T ss_dssp EEEETTSCSGGGCCCCTTGGGTTTCSCCEEECGGGCEEECCSSSEEEEEE-CSTTCEEEEEEECEETTEECCCCBTCEEE
T ss_pred eeecCCCcccccccccccceeeccceeEEEEeCCCCEEEecCcCCcEEec-CcccCcEeeccccccCcccCcccccccEE
Confidence 22221 1223334455678888888542211110 0001111 1112222333
Q ss_pred EEEecCCcEEEeecCCCCCCCC------------------CeEEE----eccCCeeEEEeeCCeEEEEecCCCCCCCC--
Q 046311 207 CAIDDDQELRCWGDSVGEVPQG------------------KFKAL----ALGENRSCALRNNQKVVCWGQNGFTLPDS-- 262 (768)
Q Consensus 207 ~al~~~g~v~~wG~n~~gq~~~------------------~~~~i----a~G~~h~~al~~dg~v~~WG~n~~gq~~~-- 262 (768)
+....+|+|+.+|....++... .+..+ ..-..|+.++..||+|+..|-+..+....
T Consensus 238 ~~~~~~g~v~v~GG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~r~~~~~~~~~dg~i~v~GG~~~~~~~~~~ 317 (387)
T d1k3ia3 238 MYDAVKGKILTFGGSPDYQDSDATTNAHIITLGEPGTSPNTVFASNGLYFARTFHTSVVLPDGSTFITGGQRRGIPFEDS 317 (387)
T ss_dssp EEETTTTEEEEECCBSSSSSSBCCCCEEEEECCSTTSCCEEEECTTCCSSCCBSCEEEECTTSCEEEECCBSBCCTTCCC
T ss_pred EeeccCCceEEEEeccCCCCCcccceeecccccccccCCCceeeccccccccccceeeeccCCeEEEECCcccCccCCCC
Confidence 3335689999998554333110 11111 12246777777899999998765443221
Q ss_pred ----------CCCCCeEEEE----ecCCeEEEEEecCCeEEEEeCC
Q 046311 263 ----------LQGKPFVSIE----AKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 263 ----------~~~~~~~~i~----~g~~h~~~l~~~~g~~~~wG~n 294 (768)
+....++.++ .-..|+.+++..||+|+..|.+
T Consensus 318 ~~~~~ve~Ydp~~~~W~~~~~~~~~R~~Hs~a~l~~dG~v~v~GG~ 363 (387)
T d1k3ia3 318 TPVFTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLPDGRVFNGGGG 363 (387)
T ss_dssp SBCCCCEEEEGGGTEEEECCCCSSCCCTTEEEEECTTSCEEEEECC
T ss_pred cEeceEEEEECCCCeEEECCCCCCcccceEEEEECCCCEEEEEeCC
Confidence 1122455553 3346888776899999999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.69 E-value=0.027 Score=56.32 Aligned_cols=29 Identities=24% Similarity=0.337 Sum_probs=26.0
Q ss_pred CeEecCCCCCCeEECCCCcEEEeeccccc
Q 046311 593 SIIHRDIKSSNVLLDATWTAKVSDFGLSL 621 (768)
Q Consensus 593 ~ivHrDiKp~NILl~~~~~~kl~DFGla~ 621 (768)
++||+|+.++|||++.+...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899999874
|
| >d1p22a2 b.69.4.1 (A:253-545) F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD-repeat protein 1 (beta-TRCP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.33 E-value=2 Score=39.65 Aligned_cols=211 Identities=12% Similarity=0.189 Sum_probs=114.1
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST 151 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~ 151 (768)
.+.+|+--+.+...- ..|+++..|-.....+..... ...........-....... ..++.+..|........
T Consensus 57 ~V~~v~~~~~~l~s~-----s~D~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 128 (293)
T d1p22a2 57 SVLCLQYDERVIITG-----SSDSTVRVWDVNTGEMLNTLI--HHCEAVLHLRFNNGMMVTC-SKDRSIAVWDMASPTDI 128 (293)
T ss_dssp CEEEEECCSSEEEEE-----ETTSCEEEEESSSCCEEEEEC--CCCSCEEEEECCTTEEEEE-ETTSCEEEEECSSSSCC
T ss_pred CEeeeecccceeecc-----ccccccccccccccccccccc--ccccccccccccccceeec-ccccceeEeeccccccc
Confidence 556666533332222 578899999665544431111 1111222232223333333 67888888865433311
Q ss_pred C--------CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCC
Q 046311 152 S--------IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVG 223 (768)
Q Consensus 152 ~--------~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~ 223 (768)
. ...+..+............||++..|-.........-......+..++....+..+-..||+|..|-....
T Consensus 129 ~~~~~~~~~~~~v~~~~~~~~~~~~~s~d~~i~~~d~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~dg~i~i~d~~~~ 208 (293)
T d1p22a2 129 TLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTSTCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIECG 208 (293)
T ss_dssp EEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTTC
T ss_pred cccccccccccccccceecccccccccCCCceeeecCCCCcEEEEEcccccccccccCCCCeEEEecCCCEEEEEecccc
Confidence 1 23355566666777777789999999755332222212223456667766777777789999999964432
Q ss_pred CC------CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCC----C-------CCCCCCeEEEEecCCeEEEEEecCC
Q 046311 224 EV------PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLP----D-------SLQGKPFVSIEAKRSVFCGVLTSNY 286 (768)
Q Consensus 224 gq------~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~----~-------~~~~~~~~~i~~g~~h~~~l~~~~g 286 (768)
.. ....+..++.....-.+-..||+|..|--...... + ......|..++.-+.+...- ..||
T Consensus 209 ~~~~~~~~~~~~v~~~~~~~~~l~sg~~dg~i~iwd~~~~~~~~~~~~~~~~~~~~~H~~~V~~v~~d~~~l~s~-s~Dg 287 (293)
T d1p22a2 209 ACLRVLEGHEELVRCIRFDNKRIVSGAYDGKIKVWDLVAALDPRAPAGTLCLRTLVEHSGRVFRLQFDEFQIVSS-SHDD 287 (293)
T ss_dssp CEEEEECCCSSCEEEEECCSSEEEEEETTSCEEEEEHHHHTSTTSCTTTTEEEEECCCSSCCCCEEECSSCEEEC-CSSS
T ss_pred eeeeeecccceeeeeccccceEEEEEcCCCEEEEEECCCCccccccCCceeeEEecCCCCCEEEEEEcCCEEEEE-ecCC
Confidence 22 11245566665555555568999999952211111 0 00112344444444443333 5789
Q ss_pred eEEEE
Q 046311 287 SLYCW 291 (768)
Q Consensus 287 ~~~~w 291 (768)
+|+.|
T Consensus 288 ~i~iW 292 (293)
T d1p22a2 288 TILIW 292 (293)
T ss_dssp EEEEE
T ss_pred EEEEe
Confidence 99988
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=91.61 E-value=0.47 Score=47.68 Aligned_cols=57 Identities=18% Similarity=0.071 Sum_probs=38.4
Q ss_pred CceeEEEecCCcEEEeecCCCCCC----------------CCCeEEEe----ccCCeeEE-EeeCCeEEEEecCCCCC
Q 046311 203 FRHVCAIDDDQELRCWGDSVGEVP----------------QGKFKALA----LGENRSCA-LRNNQKVVCWGQNGFTL 259 (768)
Q Consensus 203 ~~h~~al~~~g~v~~wG~n~~gq~----------------~~~~~~ia----~G~~h~~a-l~~dg~v~~WG~n~~gq 259 (768)
..|+.++..||+|+..|.+..+.. ...|+.++ .-..|+.+ |..||+|+..|-+..+.
T Consensus 290 ~~~~~~~~~dg~i~v~GG~~~~~~~~~~~~~~~ve~Ydp~~~~W~~~~~~~~~R~~Hs~a~l~~dG~v~v~GG~~~~~ 367 (387)
T d1k3ia3 290 TFHTSVVLPDGSTFITGGQRRGIPFEDSTPVFTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLPDGRVFNGGGGLCGD 367 (387)
T ss_dssp BSCEEEECTTSCEEEECCBSBCCTTCCCSBCCCCEEEEGGGTEEEECCCCSSCCCTTEEEEECTTSCEEEEECCCCTT
T ss_pred ccceeeeccCCeEEEECCcccCccCCCCcEeceEEEEECCCCeEEECCCCCCcccceEEEEECCCCEEEEEeCCCcCC
Confidence 457777778999999987543321 11465553 23467766 56899999999875544
|
| >d2ovrb2 b.69.4.1 (B:2365-2706) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD repeat-containing protein 7, FBXW7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.66 E-value=6.8 Score=36.63 Aligned_cols=197 Identities=11% Similarity=0.108 Sum_probs=111.5
Q ss_pred CCCCcEEeccCCCCCcccccccccC--CCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC-----CCCceEEEEecCC
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYR--GPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST-----SIHNFSNIAVGED 164 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~--~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~-----~~~~~~~v~~G~~ 164 (768)
..||+|..|-.. .|++ ..... ...|.+++--....+.- ..|+++..|........ ....+........
T Consensus 34 s~Dg~i~vWd~~-~~~~---~~~~~~h~~~V~~v~~~~~~l~s~-s~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (342)
T d2ovrb2 34 SDDNTLKVWSAV-TGKC---LRTLVGHTGGVWSSQMRDNIIISG-STDRTLKVWNAETGECIHTLYGHTSTVRCMHLHEK 108 (342)
T ss_dssp ETTSCEEEEETT-TCCE---EEECCCCSSCEEEEEEETTEEEEE-ETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETT
T ss_pred eCCCeEEEEECC-CCCE---EEEEeCCCCCEEEEEeCCCccccc-eecccccccccccccceecccccceeEeeeecccc
Confidence 468999999543 3443 12222 23566666555554444 78999999976533311 1333555566666
Q ss_pred eEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC------CCCCeEEEeccCC
Q 046311 165 FVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV------PQGKFKALALGEN 238 (768)
Q Consensus 165 h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ia~G~~ 238 (768)
.......|+++..|-.............................-..||++..|-...... ....+..++....
T Consensus 109 ~~~~~~~d~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (342)
T d2ovrb2 109 RVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGI 188 (342)
T ss_dssp EEEEEETTSEEEEEESSSCCEEEEEECCSSCEEEEEECSSCEEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSS
T ss_pred cccccccceeEEEeecccccceeeeecccccceeeccccceeeeecCCCeEEEeecccceeeEEEcCcccccccccCCCC
Confidence 6667777899998865432221111111122333333344444457789999997543221 1124455555555
Q ss_pred eeEEEeeCCeEEEEecCCCCCCC--CCCCCCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 239 RSCALRNNQKVVCWGQNGFTLPD--SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 239 h~~al~~dg~v~~WG~n~~gq~~--~~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
+-..-..||+|+.|-......+. ......+..++.-......- ..||.++.|=..
T Consensus 189 ~l~s~~~dg~i~~~d~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~-s~d~~i~iwd~~ 245 (342)
T d2ovrb2 189 HVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNILVSG-NADSTVKIWDIK 245 (342)
T ss_dssp EEEEEETTSCEEEEETTTCCEEEEECCCCSCEEEEEEETTEEEEE-ETTSCEEEEETT
T ss_pred EEEEEeCCCeEEEeecccceeeeEecccccceeEEecCCCEEEEE-cCCCEEEEEecc
Confidence 55555689999999755433222 11223466676666655554 789999999554
|
| >d2ovrb2 b.69.4.1 (B:2365-2706) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD repeat-containing protein 7, FBXW7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.43 E-value=7.1 Score=36.49 Aligned_cols=214 Identities=10% Similarity=0.106 Sum_probs=113.6
Q ss_pred CeeEEeeCCCeeeeeeeeccCCCCcEEeccCCCCCcccccccccCCCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCC
Q 046311 72 SFASIVSGDGFLCTLITFSASSSSVMHCWRFSADGIINDYKRIYRGPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNST 151 (768)
Q Consensus 72 ~~~~v~~G~~~~c~l~~~~~~~~g~~~~WG~n~~gql~~~~~~~~~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~ 151 (768)
.+.++.--....+.- ..|+++..|-........... .....+............. ..|+++..|-.......
T Consensus 59 ~V~~v~~~~~~l~s~-----s~D~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~d~~i~~~~~~~~~~~ 130 (342)
T d2ovrb2 59 GVWSSQMRDNIIISG-----STDRTLKVWNAETGECIHTLY--GHTSTVRCMHLHEKRVVSG-SRDATLRVWDIETGQCL 130 (342)
T ss_dssp CEEEEEEETTEEEEE-----ETTSCEEEEETTTTEEEEEEC--CCSSCEEEEEEETTEEEEE-ETTSEEEEEESSSCCEE
T ss_pred CEEEEEeCCCccccc-----eecccccccccccccceeccc--ccceeEeeeeccccccccc-ccceeEEEeecccccce
Confidence 444554433333333 578899999766544431111 1112333444444444444 67888988865322110
Q ss_pred C-----CCceEEEEecCCeEEEEeeCCeEEEecCCCCCCcccccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC-
Q 046311 152 S-----IHNFSNIAVGEDFVCGLLENGTITCFGSRNSPTSVTQKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV- 225 (768)
Q Consensus 152 ~-----~~~~~~v~~G~~h~~~l~~~g~v~~wG~~~~g~~~~~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq- 225 (768)
. ................-..||++..|-................+..++....+.+.-..||+|..|-......
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~l~s~~~dg~i~~~d~~~~~~~ 210 (342)
T d2ovrb2 131 HVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCI 210 (342)
T ss_dssp EEEECCSSCEEEEEECSSCEEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSEEEEEETTSCEEEEETTTCCEE
T ss_pred eeeecccccceeeccccceeeeecCCCeEEEeecccceeeEEEcCcccccccccCCCCEEEEEeCCCeEEEeecccceee
Confidence 0 1112223333334444456788888864322111111111234455555555655567899999997543222
Q ss_pred -----CCCCeEEEeccCCeeEEEeeCCeEEEEecCCCCCCC-----CCCCCCeEEEEecCCeEEEEEecCCeEEEEeCC
Q 046311 226 -----PQGKFKALALGENRSCALRNNQKVVCWGQNGFTLPD-----SLQGKPFVSIEAKRSVFCGVLTSNYSLYCWGNE 294 (768)
Q Consensus 226 -----~~~~~~~ia~G~~h~~al~~dg~v~~WG~n~~gq~~-----~~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG~n 294 (768)
....+..++.-.+.-..-..||+++.|=........ ......+..++....+.+.- ..||+|..|=-+
T Consensus 211 ~~~~~~~~~v~~~~~~~~~l~s~s~d~~i~iwd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-s~Dg~i~iwd~~ 288 (342)
T d2ovrb2 211 HTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITS-SDDGTVKLWDLK 288 (342)
T ss_dssp EEECCCCSCEEEEEEETTEEEEEETTSCEEEEETTTCCEEEEECSTTSCSSCEEEEEECSSEEEEE-ETTSEEEEEETT
T ss_pred eEecccccceeEEecCCCEEEEEcCCCEEEEEecccccccccccccceeeeceeecccCCCeeEEE-cCCCEEEEEECC
Confidence 122566676666665555689999999655433211 11223566666666555544 689999999544
|
| >d1p22a2 b.69.4.1 (A:253-545) F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD-repeat protein 1 (beta-TRCP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.77 E-value=9.6 Score=34.48 Aligned_cols=195 Identities=9% Similarity=0.111 Sum_probs=111.6
Q ss_pred CCCCcEEeccCCCCCcccccccccC--CCCeeEEecCCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEecCC
Q 046311 92 SSSSVMHCWRFSADGIINDYKRIYR--GPALQQLEAGNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAVGED 164 (768)
Q Consensus 92 ~~~g~~~~WG~n~~gql~~~~~~~~--~~~~~~i~~G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~G~~ 164 (768)
..||+|..|-.+. |++ ..... ...|.+|+--+.....- ..||++..|-........ .........-..
T Consensus 32 s~Dg~i~vWd~~~-~~~---~~~l~~H~~~V~~v~~~~~~l~s~-s~D~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (293)
T d1p22a2 32 LRDNTIKIWDKNT-LEC---KRILTGHTGSVLCLQYDERVIITG-SSDSTVRVWDVNTGEMLNTLIHHCEAVLHLRFNNG 106 (293)
T ss_dssp ESSSCEEEEESSS-CCE---EEEECCCSSCEEEEECCSSEEEEE-ETTSCEEEEESSSCCEEEEECCCCSCEEEEECCTT
T ss_pred eCCCeEEEEECCC-CcE---EEEEecCCCCEeeeecccceeecc-ccccccccccccccccccccccccccccccccccc
Confidence 4789999995543 333 22222 33577887654443333 789999999653222111 122333333344
Q ss_pred eEEEEeeCCeEEEecCCCCCCccc---ccCCCcCeEEEeccCceeEEEecCCcEEEeecCCCCC------CCCCeEEEec
Q 046311 165 FVCGLLENGTITCFGSRNSPTSVT---QKVPSGIFRVVAAGFRHVCAIDDDQELRCWGDSVGEV------PQGKFKALAL 235 (768)
Q Consensus 165 h~~~l~~~g~v~~wG~~~~g~~~~---~~~~~~~~~~i~~G~~h~~al~~~g~v~~wG~n~~gq------~~~~~~~ia~ 235 (768)
.......++.+..|-......... .......+..+.......+....||+|..|-...... ....+..++.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~s~d~~i~~~d~~~~~~~~~~~~~~~~v~~~~~ 186 (293)
T d1p22a2 107 MMVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTSTCEFVRTLNGHKRGIACLQY 186 (293)
T ss_dssp EEEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEE
T ss_pred ceeecccccceeEeeccccccccccccccccccccccceecccccccccCCCceeeecCCCCcEEEEEcccccccccccC
Confidence 445556678888886543322111 1111245556666666777778899999997653322 1225666776
Q ss_pred cCCeeEEEeeCCeEEEEecCCCCCCCC--CCCCCeEEEEecCCeEEEEEecCCeEEEEe
Q 046311 236 GENRSCALRNNQKVVCWGQNGFTLPDS--LQGKPFVSIEAKRSVFCGVLTSNYSLYCWG 292 (768)
Q Consensus 236 G~~h~~al~~dg~v~~WG~n~~gq~~~--~~~~~~~~i~~g~~h~~~l~~~~g~~~~wG 292 (768)
...+..+-..||++..|-......+.. .....+..++........- ..||+++.|-
T Consensus 187 ~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~v~~~~~~~~~l~sg-~~dg~i~iwd 244 (293)
T d1p22a2 187 RDRLVVSGSSDNTIRLWDIECGACLRVLEGHEELVRCIRFDNKRIVSG-AYDGKIKVWD 244 (293)
T ss_dssp ETTEEEEEETTSCEEEEETTTCCEEEEECCCSSCEEEEECCSSEEEEE-ETTSCEEEEE
T ss_pred CCCeEEEecCCCEEEEEecccceeeeeecccceeeeeccccceEEEEE-cCCCEEEEEE
Confidence 677777777999999997554332221 1122345555555444443 6899999994
|
| >d1nexb2 b.69.4.1 (B:370-744) Cdc4 propeller domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Cdc4 propeller domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=82.71 E-value=18 Score=33.64 Aligned_cols=54 Identities=7% Similarity=0.177 Sum_probs=29.5
Q ss_pred CCCeEEEEEeCCCcEEEccCCCCCCCC-----CCceEEEEecCCeEEEEeeCCeEEEecC
Q 046311 126 GNSHICGLVNGTNDLHWWQWPDFNSTS-----IHNFSNIAVGEDFVCGLLENGTITCFGS 180 (768)
Q Consensus 126 G~~h~~al~~~~g~~~~Wg~~~~~~~~-----~~~~~~v~~G~~h~~~l~~~g~v~~wG~ 180 (768)
...+.+.- ..||+++.|-........ ...+..++.-..+-..-..||+|+.|=.
T Consensus 212 ~~~~~~~~-~~d~~i~i~d~~~~~~~~~~~~h~~~v~~~~~~~~~l~~~~~dg~i~iwd~ 270 (355)
T d1nexb2 212 ERKRCISA-SMDTTIRIWDLENGELMYTLQGHTALVGLLRLSDKFLVSAAADGSIRGWDA 270 (355)
T ss_dssp TTTEEEEE-ETTSCEEEEETTTCCEEEEECCCSSCCCEEEECSSEEEEECTTSEEEEEET
T ss_pred cceeeecc-cccceEEeeeccccccccccccccccccccccccceeeeeecccccccccc
Confidence 33444444 678888888653222111 2234555555555555556778888743
|